pert_iname,InChIKey,clinical_phase,moa,target,disease_area,indication
(R)-(-)-apomorphine,VMWNQDUVQKEIOC-CYBMUJFWSA-N,Launched,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A,neurology/psychiatry,Parkinson's Disease
(R)-(-)-rolipram,HJORMJIFDVBMOB-LBPRGKRZSA-N,Phase 1,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,,
(R)-baclofen,KPYSYYIEGFHWSV-QMMMGPOBSA-N,Phase 3,benzodiazepine receptor agonist,GABBR1|GABBR2,,
(S)-(+)-rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,Phase 1,phosphodiesterase inhibitor,PDE4B|PDE4D,,
"[sar9,met(o2)11]-substance-p",OUPXSLGGCPUZJJ-SARDKLJWSA-N,Preclinical,tachykinin antagonist,TACR1,,
"1-((Z)-3-chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium",LDLCEGCJYSDJLX-UPHRSURJSA-N,Preclinical,,,,
"1-(1,2-diphenylethyl)piperidine-(+/-)",JQWJJJYHVHNXJH-LJQANCHMSA-N,Preclinical,glutamate receptor antagonist,,,
1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol,NJEIOWSBPCZKTL-LLVKDONJSA-N,Preclinical,,,,
1-acetyl-4-methylpiperazine,YSDBJKNOEWSFGA-UHFFFAOYSA-N,Preclinical,acetylcholine receptor agonist,,,
1-azakenpaullone,NTSBZVCEIVPKBJ-UHFFFAOYSA-N,Preclinical,glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,,
1-deoxymannojirimycin,LXBIFEVIBLOUGU-KVTDHHQDSA-N,Preclinical,alpha mannosidase inhibitor,MAN2A1,,
1-EBIO,CXUCKELNYMZTRT-UHFFFAOYSA-N,Preclinical,potassium channel activator,KCNN1|KCNN2|KCNN3|KCNN4,,
1-ethyl-2-pyrrolidone,ZFPGARUNNKGOBB-UHFFFAOYSA-N,Preclinical,transdermal absorption-enhancing compound,,,
1-hexadecanal,NIOYUNMRJMEDGI-UHFFFAOYSA-N,Preclinical,sphingosine 1-phosphate receptor substrate,DBI|RHO,,
1-hexadecanol,BXWNKGSJHAJOGX-UHFFFAOYSA-N,Launched,,,dermatology,cosmetic
1-naphthyl-PP1,XSHQBIXMLULFEV-UHFFFAOYSA-N,Preclinical,SRC inhibitor,SRC,,
1-octacosanol,CNNRPFQICPFDPO-UHFFFAOYSA-N,Phase 2,,,,
1-octanol,KBPLFHHGFOOTCA-UHFFFAOYSA-N,Phase 2,,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1,,
1-phenylbiguanide,CUQCMXFWIMOWRP-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR3A|HTR3B,,
"1,12-Besm",PGMIWVSHZMWSSI-UHFFFAOYSA-N,Phase 2,polyamine biosynthesis inhibitor,,,
"1,2,3,4,5,6-hexabromocyclohexane",QFQZKISCBJKVHI-UHFFFAOYSA-N,Preclinical,JAK inhibitor,JAK2,,
"1,3-dipropyl-8-phenylxanthine",CLIGSMOZKDCDRZ-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,,,
"1,4-butanediol",WERYXYBDKMZEQL-UHFFFAOYSA-N,Phase 1,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MAN1B1|PLA2G2A|PLA2G2E,,
"1,5-dicaffeoylquinic-acid",YDDUMTOHNYZQPO-PSEXTPKNSA-N,Phase 1,,,,
10-deacetylbaccatin,YWLXLRUDGLRYDR-ZHPRIASZSA-N,Preclinical,antitumor agent,,,
10-DEBC,GYBXAGDWMCJZJK-UHFFFAOYSA-N,Preclinical,AKT inhibitor,PIM1,,
10-hydroxycamptothecin,HAWSQZCWOQZXHI-FQEVSTJZSA-N,Preclinical,topoisomerase inhibitor,TOP1,,
10058-F4,SVXDHPADAXBMFB-JXMROGBWSA-N,Preclinical,c-Myc inhibitor,,,
12-O-tetradecanoylphorbol-13-acetate,PHEDXBVPIONUQT-RGYGYFBISA-N,Phase 2,PKC activator,KCNT2|TRPV4,,
1400W,RODUKNYOEVZQPR-UHFFFAOYSA-N,Preclinical,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,,
"16,16-dimethylprostaglandin-e2",QAOBBBBDJSWHMU-WMBBNPMCSA-N,Phase 2,prostanoid receptor agonist,HPGD,,
17-hydroxyprogesterone-caproate,DOMWKUIIPQCAJU-LJHIYBGHSA-N,Launched,progesterone receptor agonist,AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR,obstetrics/gynecology,spontaneous preterm birth
17-PA,SINAMTXBCYKFDL-WBJZGETLSA-N,Preclinical,glucocorticoid receptor agonist,,,
1E-1-(2-hydroxy-5-methylphenyl)-1-dodecanone-oxime,NFONIVRMILHYLH-GOSISDBHSA-N,Preclinical,,,,
"1S,2R-phenylpropanolamine",DLNKOYKMWOXYQA-VXNVDRBHSA-N,Withdrawn,adrenergic receptor agonist,,,
2-(1-adamantylamino)benzoic-acid,XKZLSYWCDJZTMW-UHFFFAOYSA-N,Preclinical,,,,
2-(3-mercaptopropyl)pentanedioic-acid,FNLNSQHJKVQCBP-ZCFIWIBFSA-N,Phase 1,glutamate carboxypeptidase inhibitor,FOLH1,,
"2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",UTWSZXBGTLNPOV-UHFFFAOYSA-N,Preclinical,,,,
2-[1-(4-piperonyl)piperazinyl]benzothiazole,BYHKGNWKJMGHGE-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR4,,
2-aminobenzenesulfonamide,YAZSBRQTAHVVGE-UHFFFAOYSA-N,Preclinical,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA6|CA9,,
2-APB,BLZVCIGGICSWIG-UHFFFAOYSA-N,Preclinical,"1,4,5-trisphosphate inhibitor",TRPC1|TRPC3|TRPC4|TRPC5|TRPC6|TRPC7|TRPM2|TRPM3|TRPM6|TRPV1|TRPV6,,
2-BFI,YTJOHEUHUVBKSB-UHFFFAOYSA-N,Preclinical,imidazoline receptor ligand,ADRA2A|ADRA2B|ADRA2C|MAOA|MAOB,,
2-chloro-N6-cyclopentyladenosine,XSMYYYQVWPZWIZ-IDTAVKCVSA-N,Preclinical,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
2-chloroadenosine,BIXYYZIIJIXVFW-UUOKFMHZSA-N,Preclinical,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B,,
2-chloropyrazine,GELVZYOEQVJIRR-UHFFFAOYSA-N,Preclinical,,,,
2-CMDO,OTKUTGIVEREJLL-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,DRD2|DRD4,,
2-deoxy-2-([methyl(nitroso)carbamoyl]amino)hexose,VUVHIMLGTHRGQZ-YTLHQDLWSA-N,Preclinical,,,oncology|endocrinology,pancreatic cancer|hypoglycemia
2-deoxyglucose,PMMURAAUARKVCB-ZXXMMSQZSA-N,Phase 2,glycolysis inhibitor,SLC2A1|SLC2A2|SLC2A3|SLC2A4,,
2-ethoxybenzoic-acid,XDZMPRGFOOFSBL-UHFFFAOYSA-N,Phase 1,analgesic agent,,,
"2-ethyl-1,3-hexanediol",RWLALWYNXFYRGW-JGVFFNPUSA-N,Preclinical,,,,
2-fluoro-2-deoxy-D-galactose,ZCXUVYAZINUVJD-AIECOIEWSA-N,Phase 1,,LCT,,
2-fluorofucose,IRKXGKIPOMIQOD-QYESYBIKSA-N,Phase 1,,,,
"2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione",BWKBPVRNWJFLSC-FROSJQSHSA-N,Preclinical,,,,
2-hydroxyethyl-salicylate,LVYLCBNXHHHPSB-UHFFFAOYSA-N,Launched,,,neurology/psychiatry,pain relief
2-hydroxyflutamide,YPQLFJODEKMJEF-UHFFFAOYSA-N,Phase 2,androgen receptor antagonist,AR,,
2-hydroxysaclofen,WBSMZVIMANOCNX-SECBINFHSA-N,Preclinical,GABA receptor antagonist,GABBR1|GABBR2,,
2-iminobiotin,WWVANQJRLPIHNS-ZKWXMUAHSA-N,Phase 2,nitric oxide synthase inhibitor,NOS1|NOS2,,
2-iodohippuric-acid,CORFWQGVBFFZHF-UHFFFAOYSA-N,Preclinical,,,,
2-iodomelatonin,FJDDSMSDZHURBJ-UHFFFAOYSA-N,Preclinical,melatonin receptor agonist,MTNR1A|MTNR1B|NQO2,,
2-methoxyestradiol,CQOQDQWUFQDJMK-SSTWWWIQSA-N,Phase 2,hypoxia inducible factor inhibitor,COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB,,
2-methyl-5-hydroxytryptamine,WYWNEDARFVJQSG-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR1B|HTR1D|HTR1E|HTR1F|HTR3A|HTR3B|HTR6,,
2-methyl-5-nitrophenol,UMFDLIXUUJMPSI-UHFFFAOYSA-N,Preclinical,,,,
2-methylimidazole,LXBGSDVWAMZHDD-UHFFFAOYSA-N,Preclinical,cholesterol inhibitor,,,
2-octyldodecan-1-ol,LEACJMVNYZDSKR-FQEVSTJZSA-N,Preclinical,,,,
2-oleoylglycerol,UPWGQKDVAURUGE-KTKRTIGZSA-N,Phase 1,glucose dependent insulinotropic receptor ligand,GPR119,,
2-oxoglutaric-acid,KPGXRSRHYNQIFN-UHFFFAOYSA-N,Preclinical,,OXGR1,,
2-oxopropanoate,FEWFXBUNENSNBQ-UHFFFAOYSA-N,Preclinical,pyruvate dehydrogenase kinase inhibitor,ABAT,,
2-phenylmelatonin,OFCLARYYBGKCHN-UHFFFAOYSA-N,Preclinical,melatonin receptor agonist,MTNR1A|MTNR1B,,
2-PMDQ,ONSOQRPYFKDOEB-INIZCTEOSA-N,Preclinical,adrenergic receptor antagonist,ADRA1A,,
2-pyridylethylamine,XPQIPUZPSLAZDV-UHFFFAOYSA-N,Preclinical,histamine receptor agonist,HRH1,,
2-TEDC,KCGLTUBCAGZLHP-XYOKQWHBSA-N,Preclinical,lipoxygenase inhibitor,ALOX12,,
2-thiouracil,ZEMGGZBWXRYJHK-UHFFFAOYSA-N,Preclinical,,,,
"2,3-cis/exo-camphanediol",AYEOSGBMQHXVER-DQUBFYRCSA-N,Phase 1,,,,
"2,3-cis/exo-pinanediol",MOILFCKRQFQVFS-VUMZSGCYSA-N,Phase 1,,,,
"2,3-DCPE",QVEIRCZEBQRCTR-UHFFFAOYSA-N,Preclinical,BCL-XL downregulator,BCL2L1,,
"2,4-dinitrochlorobenzene",VYZAHLCBVHPDDF-UHFFFAOYSA-N,Phase 2,thioredoxin inhibitor,TXN,,
"2,4-dinitrophenol",UFBJCMHMOXMLKC-UHFFFAOYSA-N,Preclinical,ATP synthase inhibitor,APP,,
"2,5-furandimethanol",DSLRVRBSNLHVBH-UHFFFAOYSA-N,Phase 2,hemoglobin modulator,HBB,,
"2,6-dimethylpiperidine",SDGKUVSVPIIUCF-KNVOCYPGSA-N,Preclinical,,,,
2'-C-methylguanosine,NVKAMPJSWMHVDK-GITKWUPZSA-N,Preclinical,HCV inhibitor,,,
2'-MeCCPA,MMPAUXMIDJWGFO-ROMFRFKVSA-N,Preclinical,adenosine receptor agonist,ADORA1,,
20-HETE,NNDIXBJHNLFJJP-DTLRTWKJSA-N,Preclinical,ion channel antagonist,,,
20-hydroxyecdysone,NKDFYOWSKOHCCO-HMIIXLFTSA-N,Phase 2,ecdysone receptor modulator,,,
3-(4-methylbenzylidene)camphor,HEOCBCNFKCOKBX-LBONJMQPSA-N,Launched,endocrine disruptor,,dermatology,sunscreen lotion
3-alpha-bis-(4-fluorophenyl)-methoxytropane,MHNSOBBJZCWUGS-PMOLBWCYSA-N,Preclinical,dopamine uptake inhibitor,CHRM1|SLC6A2|SLC6A3|SLC6A4,,
3-alpha-hydroxy-5-beta-androstan-17-one,QGXBDMJGAMFCBF-BNSUEQOYSA-N,Preclinical,,HSD17B11|IGHG2|SULT2A1,,
3-amino-benzamide,GSCPDZHWVNUUFI-UHFFFAOYSA-N,Phase 2,PARP inhibitor,PARP1,,
3-anilinopropan-1-ol,GZYBSURBYCLNSM-UHFFFAOYSA-N,Preclinical,,,,
3-AQC,IDOXKFDPDOIUMG-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR3A,,
3-bromo-7-nitroindazole,NFSTZPMYAZRZPC-UHFFFAOYSA-N,Preclinical,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,,
3-bromocamphor,NJQADTYRAYFBJN-BYULHYEWSA-N,Launched,,,,
3-bromopyruvate,CHNJCELMWMIDSC-UHFFFAOYSA-N,Preclinical,hexokinase inhibitor,HK2,,
3-carboxy-4-hydroxyphenylglycine-(R),CHZBCZTXSTWCIG-SSDOTTSWSA-N,Preclinical,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C,,
3-carboxy-4-hydroxyphenylglycine-(S),CHZBCZTXSTWCIG-ZETCQYMHSA-N,Preclinical,glutamate receptor antagonist,GRM1|GRM5,,
3-CPMT,OCAXFDULERPAJM-IVAOSVALSA-N,Preclinical,dopamine reuptake inhibitor,,,
3-deazaadenosine,DBZQFUNLCALWDY-GPUHXXMPSA-N,Phase 2,adenosylhomocysteinase inhibitor,AHCY,,
3-deazaneplanocin-A,OMKHWTRUYNAGFG-IEBDPFPHSA-N,Preclinical,histone lysine methyltransferase inhibitor,EZH2,,
3-deazauridine,CBOKZNLSFMZJJA-PRQTWWFRSA-N,Preclinical,cytidine deaminase inhibitor,,,
3-hydroxy-3-phenylpentanamide,MOHYRCCDARWQRM-LLVKDONJSA-N,Phase 1,GABA receptor modulator,,,
3-indolebutyric-acid,JTEDVYBZBROSJT-UHFFFAOYSA-N,Preclinical,,B2M|HLA-A|TRAC|TRBC1,,
3-MATIDA,KOMWRBFEDDEWEP-RXMQYKEDSA-N,Preclinical,glutamate receptor antagonist,GRM1,,
3-methyl-GABA,CZGLBWZXGIAIBU-SCSAIBSYSA-N,Preclinical,GABA aminotransferase activator,ABAT,,
3-methyladenine,ZPBYVFQJHWLTFB-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,PI3,,
3-MPPI,AQASGOHUMGAWJJ-UHFFFAOYSA-N,Preclinical,adrenergic receptor ligand,ADRA1A,,
"3,3'-dichlorobenzaldazine",XMOVWXSCYLINBJ-BEQMOXJMSA-N,Preclinical,glutamate receptor modulator,GRM5,,
"3,3'-diindolylmethane",VFTRKSBEFQDZKX-UHFFFAOYSA-N,Phase 3,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",AR|HIF1A|IFNG|PI3,,
"3,4-DCPG-(+/-)",IJVMOGKBEVRBPP-SSDOTTSWSA-N,Preclinical,glutamate receptor agonist,GRM8,,
"3,4-DCPG-(R)",IJVMOGKBEVRBPP-SSDOTTSWSA-N,Preclinical,glutamate receptor antagonist,,,
"3,4-DCPG-(S)",IJVMOGKBEVRBPP-ZETCQYMHSA-N,Preclinical,glutamate receptor agonist,GRM8,,
"3,4-methylenedioxy-beta-nitrostyrene",KFLWBZPSJQPRDD-ONEGZZNKSA-N,Preclinical,SRC inhibitor|SYK inhibitor,SRC|SYK,,
"3,5-DHPG-(S)",HOOWCUZPEFNHDT-ZETCQYMHSA-N,Preclinical,glutamate receptor agonist,GRM1,,
3'-fluorobenzylspiperone,DXZKTRNEOISOCA-UHFFFAOYSA-N,Preclinical,dopamine receptor ligand,DRD2,,
3PO,UOWGYMNWMDNSTL-ONEGZZNKSA-N,Preclinical,phosphofructokinase inhibitor,PFKFB3,,
4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine,FTJXZACAQRDRNT-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR2A,,
4-(aminomethyl)benzoic-acid,QCTBMLYLENLHLA-UHFFFAOYSA-N,Preclinical,hemostatic agent,,,
"4-acetyl-1,1-dimethylpiperazinium",MSBLMBWXUVQCDY-UHFFFAOYSA-N,Preclinical,acetylcholine receptor agonist,,,
4-aminohippuric-acid,HSMNQINEKMPTIC-UHFFFAOYSA-N,Launched,,SLC22A6,nephrology,renal diagnostic agent
4-carboxy-3-hydroxyphenylglycine-(RS),GXZSAQLJWLCLOX-SSDOTTSWSA-N,Preclinical,glutamate receptor agonist|glutamate receptor antagonist,GRM1,,
4-carboxy-3-hydroxyphenylglycine-(S),GXZSAQLJWLCLOX-ZETCQYMHSA-N,Preclinical,glutamate receptor agonist|glutamate receptor antagonist,GRM1|GRM2,,
4-chlorophenylguanidine,ZSJNJAJDBNFVCA-UHFFFAOYSA-N,Preclinical,urokinase inhibitor,PLAUR,,
4-CMTB,AZYDQCGCBQYFSE-GFCCVEGCSA-N,Preclinical,free fatty acid receptor agonist,FFAR2,,
4-DAMP,HYJRTXSYDAFGJK-UHFFFAOYSA-N,Preclinical,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,,
4-galactosyllactose,FYGDTMLNYKFZSV-QGAOIPDPSA-N,Preclinical,,,,
4-HQN,QMNUDYFKZYBWQX-UHFFFAOYSA-N,Preclinical,PARP inhibitor,PARP1,,
4-hydroxy-phenazone,SKVPTPMWXJSBTF-UHFFFAOYSA-N,Preclinical,,,,
4-IBP,HELCSESNNDZLFM-UHFFFAOYSA-N,Preclinical,sigma receptor agonist,SIGMAR1,,
4-iodo-6-phenylpyrimidine,ZTCJXHNJVLUUMR-UHFFFAOYSA-N,Preclinical,macrophage migration inhibiting factor inhibitor,MIF,,
4-iodo-L-phenylalanine,PZNQZSRPDOEBMS-MRVPVSSYSA-N,Preclinical,,DPP4,,
4-methylgenistein,WUADCCWRTIWANL-UHFFFAOYSA-N,Preclinical,protein tyrosine kinase inhibitor,CYP19A1|ESRRA|ESRRB|ESRRG|FASN,,
4-methylhistamine,UGYXPZQILZRKJJ-UHFFFAOYSA-N,Preclinical,histamine receptor agonist,HRH4,,
4-mu-8C,RTHHSXOVIJWFQP-UHFFFAOYSA-N,Preclinical,IRE1 inhibitor,ERN1,,
4-P-PDOT,RCYLUNPFECYGDW-AEFFLSMTSA-N,Preclinical,melatonin receptor antagonist,MTNR1A|MTNR1B,,
4-phenolsulfonic-acid,FEPBITJSIHRMRT-UHFFFAOYSA-N,Preclinical,,,,
"4-phenyl-1,2,3,4-tetrahydroisoquinoline",OSZMNJRKIPAVOS-HNNXBMFYSA-N,Preclinical,dopamine release inhibitor,,,
4-PPBP,HQGDPZPNAXRCSA-UHFFFAOYSA-N,Preclinical,sigma receptor ligand,SIGMAR1,,
4-propylbenzoic-acid,ATZHGRNFEFVDDJ-UHFFFAOYSA-N,Preclinical,,,,
4-pyrimidinecarbonitrile,ZIEWSZYVEDTXGH-UHFFFAOYSA-N,Preclinical,,,,
4-tert-butylphenol,QHPQWRBYOIRBIT-UHFFFAOYSA-N,Preclinical,,,,
"4,4-pentamethylenepiperidine",LIZKZVQBLDHKCY-UHFFFAOYSA-N,Preclinical,M2 channel blocker,,,
"4,4'-DDT",YVGGHNCTFXOJCH-UHFFFAOYSA-N,Preclinical,,,,
"4,5,6,7-tetrabromobenzotriazole",OMZYUVOATZSGJY-UHFFFAOYSA-N,Preclinical,casein kinase inhibitor,AKT1|CHEK1|CSNK2A1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1,,
4BP-TQS,YNCXHXYZTLIZTO-RLFYNMQTSA-N,Preclinical,nicotinic receptor agonist,CHRNA7,,
4E1RCat,BBQRBOIMSKMFFO-LTGZKZEYSA-N,Preclinical,protein synthesis inhibitor,EIF4E|EIF4G1,,
4EGI-1,KFRKRECSIYXARE-UHFFFAOYSA-N,Preclinical,protein synthesis inhibitor,EIF4E,,
4SC-202,PRXXYMVLYKJITB-IZZDOVSWSA-N,Phase 1,HDAC inhibitor,HDAC1,,
"5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",PXINDYJACXPZIN-UHFFFAOYSA-N,Preclinical,,,,
"5-amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",TZYVRXZQAWPIAB-FCLHUMLKSA-N,Preclinical,,TLR7,,
5-aminolevulinic-acid,ZGXJTSGNIOSYLO-UHFFFAOYSA-N,Launched,oxidizing agent,ALAD,oncology|dermatology,glioma|actinic keratosis (AK)
5-BDBD,NKYMVQPXXTZHSF-UHFFFAOYSA-N,Preclinical,purinergic receptor antagonist,P2RX4,,
5-carboxamidotryptamine,WKZLNEWVIAGNAW-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,,
5-fluoro-3-pyridyl-methanol,GGGJYJXAFSEWNM-UHFFFAOYSA-N,Preclinical,,,,
5-fluoropyrimidine,KSPDSMOWMQFPBL-UHFFFAOYSA-N,Phase 3,kinase inhibitor,,,
5-fluorouracil,GHASVSINZRGABV-UHFFFAOYSA-N,Launched,thymidylate synthase inhibitor,DPYD|TYMS,oncology,colorectal cancer|breast cancer|pancreatic cancer|gastric adenocarcinoma
5-FP,HPABFFGQPLJKBP-UHFFFAOYSA-N,Phase 1,thymidylate synthase inhibitor,TYMS,,
5-HMF,NOEGNKMFWQHSLB-UHFFFAOYSA-N,Phase 2,,,,
5-hydroxydecanoic-acid,LMHJFKYQYDSOQO-SECBINFHSA-N,Preclinical,,,,
5-hydroxyectoine,KIIBBJKLKFTNQO-WHFBIAKZSA-N,Preclinical,,,,
5-hydroxymethyl-tolterodine,DUXZAXCGJSBGDW-HXUWFJFHSA-N,Phase 1,acetylcholine receptor antagonist,CHRM3,,
5-hydroxytryptophan,LDCYZAJDBXYCGN-VIFPVBQESA-N,Launched,neurotransmitter,SLC36A1|SLC36A2,neurology/psychiatry,insomnia
5-iodo-A-85380,RKVRGRXOYDTUEY-QMMMGPOBSA-N,Phase 2,acetylcholine receptor agonist,,,
5-methylfurmethiodide,KOWVJDFMEZKDDT-UHFFFAOYSA-N,Preclinical,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,,
5-methylhydantoin-(D),VMAQYKGITHDWKL-UWTATZPHSA-N,Preclinical,,,,
5-methylhydantoin-(L),VMAQYKGITHDWKL-REOHCLBHSA-N,Preclinical,,,,
5-octanoylsalicylic-acid,IXIGWKNBFPKCCD-UHFFFAOYSA-N,Preclinical,protein kinase activator,,,
"5,7-dichlorokynurenic-acid",BGKFPRIGXAVYNX-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GLRA2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
5'-chloro-5'-deoxy-ENBA-(+/-),PVJGDYDNVNCGBT-CYDCOVMPSA-N,Preclinical,adenosine receptor agonist,ADORA1,,
6-aminochrysene,KIVUHCNVDWYUNP-UHFFFAOYSA-N,Phase 2,transferase inhibitor,,,
6-aminopenicillanic-acid,NGHVIOIJCVXTGV-ALEPSDHESA-N,Preclinical,,,,
6-benzylaminopurine,NWBJYWHLCVSVIJ-UHFFFAOYSA-N,Preclinical,purinergic receptor activator,,,
6-chloromelatonin,LUINDDOUWHRIPW-UHFFFAOYSA-N,Preclinical,melatonin receptor agonist,MTNR1A|MTNR1B,,
6-diazo-5-oxo-L-norleucine,UUTYCZUIECRVAL-YFKPBYRVSA-O,Preclinical,glutamate receptor antagonist|glutaminase inhibitor,,,
6-iodo-nordihydrocapsaicin,AAORACFZMYMFCG-UHFFFAOYSA-N,Preclinical,TRPV antagonist,TRPV1,,
"6,7-dehydro-17-acetoxy-progesterone",URXWVWVPMJSAJD-KOORYGTMSA-N,Preclinical,steroidal progestin,,,
7-aminocephalosporanic-acid,HSHGZXNAXBPPDL-HZGVNTEJSA-N,Preclinical,beta lactamase inhibitor,,,
7-chlorokynurenic-acid,UAWVRVFHMOSAPU-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C,,
7-hydroxy-DPAT,BLYMJBIZMIGWFK-HNNXBMFYSA-N,Preclinical,dopamine receptor agonist,DRD2|DRD3,,
7-hydroxy-PIPAT,RTMIJLQPWFKAFE-GZTQLTBSSA-N,Preclinical,dopamine receptor ligand,DRD3,,
7-hydroxystaurosporine,PBCZSGKMGDDXIJ-KRUBCLEUSA-N,Phase 2,CDK inhibitor|CHK inhibitor|PKC inhibitor,CDK1|CHEK1|CHEK2|GSK3B|LCK|MAPK14|MARK1|MARK3|PDPK1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,,
7-keto-DHEA,VVSMJVQHDZUPIL-XFKPDKBWSA-N,Launched,steroid,,,
7-methoxytacrine,APQPVVOYBLOJDY-UHFFFAOYSA-N,Phase 2,acetylcholinesterase inhibitor,ACHE,,
7-methylxanthine,PFWLFWPASULGAN-UHFFFAOYSA-N,Phase 2,adenosine receptor antagonist,,,
7-nitroindazole,PQCAUHUKTBHUSA-UHFFFAOYSA-N,Preclinical,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,,
"7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one",HBEJFHWHFIAMAI-UHFFFAOYSA-N,Preclinical,,,,
8-bromo-cAMP,DVKQVRZMKBDMDH-UUOKFMHZSA-N,Preclinical,PKA activator,,,
8-bromo-cGMP,YUFCOOWNNHGGOD-UMMCILCDSA-N,Preclinical,PKA activator,PRKG1,,
8-hydroxy-DPAT,ASXGJMSKWNBENU-AWEZNQCLSA-N,Preclinical,serotonin receptor agonist,HTR5A|HTR7,,
8-hydroxy-PIPAT,QBXHUZJZYDSLRH-MDDUGHTDSA-N,Preclinical,dopamine receptor ligand,DRD2|DRD3,,
8-M-PDOT,RVIGBTUDFAGRTQ-NSHDSACASA-N,Preclinical,melatonin receptor agonist,MTNR1A|MTNR1B,,
80841-78-7,QCLFSYYUWPUWQR-UHFFFAOYSA-N,Preclinical,,,,
9-aminoacridine,XJGFWWJLMVZSIG-UHFFFAOYSA-N,Preclinical,,,,
9-aminocamptothecin,FUXVKZWTXQUGMW-FQEVSTJZSA-N,Phase 2,topoisomerase inhibitor,TOP1,,
9-anthracenecarboxylic-acid,XGWFJBFNAQHLEF-UHFFFAOYSA-N,Preclinical,,ANO1|CLCN1,,
A-1070722,VQPBIJGXSXEOCU-UHFFFAOYSA-N,Preclinical,glycogen synthase kinase inhibitor,GSK3A|GSK3B,,
A-1120,MEAQCLPMSVEOQF-UHFFFAOYSA-N,Preclinical,retinoid receptor ligand,RBP4,,
A-1120,"InChI=1S/C20H19F3N2O3/c21-20(22,23)16-7-3-1-5-14(16)13-9-11-25(12-10-13)19(28)24-17-8-4-2-6-15(17)18(26)27/h1-8,13H,9-12H2,(H,24,28)(H,26,27)",Preclinical,retinoid receptor ligand,RBP4,,
A-317491,VQGBOYBIENNKMI-LJAQVGFWSA-N,Preclinical,purinergic receptor antagonist,P2RX3,,
A-33903,MMXSDWJOQSEPSM-MRXNPFEDSA-N,Phase 2,,,,
A-366,BKCDJTRMYWSXMC-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,,
A-381393,SAQMCVDGOIRQTC-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,,,
A-412997,JFCDMGGMCUKHST-UHFFFAOYSA-N,Preclinical,dopamine receptor agonist,DRD4,,
A-438079,MMPAULQSJLVKHP-UHFFFAOYSA-N,Preclinical,purinergic receptor antagonist,P2RX7,,
A-485,VRVJKILQRBSEAG-LFPIHBKWSA-N,Preclinical,histone acetyltransferase inhibitor,,,
A-582941,GTMRUYCIJSNXGB-GASCZTMLSA-N,Preclinical,nicotinic receptor agonist,CHRNA7,,
A-61603,OQFCXJDXHCDLHX-NSHDSACASA-N,Preclinical,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,,
A-674563,BPNUQXPIQBZCMR-IBGZPJMESA-N,Preclinical,AKT inhibitor,AKT1|PKIA|PRKACA,,
A-7,JLUUJHIQVIXTGT-UHFFFAOYSA-N,Preclinical,calmodulin antagonist,,,
A-769662,CTESJDQKVOEUOY-UHFFFAOYSA-N,Preclinical,AMPK activator,,,
A-784168,SDUAWRFBHRAFBM-UHFFFAOYSA-N,Preclinical,transient receptor potential channel antagonist,TRPV1,,
A-803467,VHKBTPQDHDSBSP-UHFFFAOYSA-N,Preclinical,sodium channel blocker,SCN10A,,
A-804598,PQYCRDPLPKGSME-AWEZNQCLSA-N,Preclinical,purinergic receptor antagonist,P2RX7,,
A-839977,GMVNBKZQJFRFAR-UHFFFAOYSA-N,Preclinical,purinergic receptor antagonist,P2RX7,,
A-867744,ABACVOXFUHDKNZ-UHFFFAOYSA-N,Preclinical,acetylcholine receptor allosteric modulator,CHRNA3|CHRNA4|CHRNA7,,
A-887826,JPJGFWKHSMUKFO-UHFFFAOYSA-N,Preclinical,sodium channel blocker,SCN10A,,
A-922500,BOZRFEQDOFSZBV-DHIUTWEWSA-N,Preclinical,diacylglycerol O acyltransferase inhibitor,DGAT1,,
A-939572,DPYTYQFYDLYWHZ-UHFFFAOYSA-N,Preclinical,stearoyl-CoA desaturase inhibitor,SCD,,
A-967079,HKROEBDHHKMNBZ-CHBKHGQFSA-N,Preclinical,transient receptor potential channel antagonist,TRPA1,,
A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,Preclinical,histamine receptor antagonist,ADORA1|AVPR1A|CCR1|CHRM1|CHRM2|CHRM3|CHRM4|DRD3|HTR1A|HTR1B|HTR2A|HTR2B|HTR3A|TACR2,,
A0001,LTVDFSLWFKLJDQ-IEOSBIPESA-N,Phase 2,,,,
A12B4C3,KVHGJAKTBPFFNV-KUXCXQDQSA-N,Preclinical,polynucleotide kinase/phosphatase inhibitor,PNKP,,
A205804,QQGWEXFLMJGCAL-UHFFFAOYSA-N,Preclinical,ICAM1 expression inhibitor,ICAM1|SELE,,
A61603,OQFCXJDXHCDLHX-LLVKDONJSA-N,Preclinical,adrenergic receptor agonist,ADRA1A,,
A66,HBPXWEPKNBHKAX-NSHDSACASA-N,Preclinical,PI3K inhibitor,PIK3CA,,
A740003,PUHSRMSFDASMAE-DEOSSOPVSA-N,Preclinical,purinergic receptor antagonist,P2RX7,,
A77636,QLJOSZATCBCBDR-KLONBWLYSA-N,Preclinical,dopamine receptor agonist,CALY,,
A922500,BOZRFEQDOFSZBV-PKTZIBPZSA-N,Preclinical,diacylglycerol O acyltransferase inhibitor,DGAT1,,
AA-29504,SCOOTUMXCXKEAD-UHFFFAOYSA-N,Preclinical,GABA receptor positive allosteric modulator,GABRA1|GABRA4|GABRB3,,
AAI101,HFZITXBUTWITPT-YWVKMMECSA-O,Phase 3,lactamase inhibitor,,,
AB-423,BBLXLHYPDOMJMO-SNVBAGLBSA-N,Preclinical,HBV capsid assembly inhibitor,,,
abacavir,MCGSCOLBFJQGHM-SCZZXKLOSA-N,Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
abafungin,TYBHXIFFPVFXQW-UHFFFAOYSA-N,Phase 3,sterol methyltransferase inhibitor,,,
abamectin,ZFUKERYTFURFGA-PVVXTEPVSA-N,Launched,benzodiazepine receptor agonist,GABBR1|GABBR2,infectious disease,gastrointestinal parasites
abametapir,PTRATZCAGVBFIQ-UHFFFAOYSA-N,Phase 3,metalloproteinase inhibitor,MMP9,,
abarelix,AIWRTTMUVOZGPW-HSPKUQOVSA-N,Phase 3,gonadotropin releasing factor hormone receptor antagonist,GNRHR,,
ABBV-744,LQPFCYWRBQRRGE-UHFFFAOYSA-N,Phase 1,bromodomain inhibitor,,,
ABC-294640,CAOTVXGYTWCKQE-BRNYJPRKSA-N,Phase 2,sphingosine kinase inhibitor,SPHK2,,
abemaciclib,UZWDCWONPYILKI-UHFFFAOYSA-N,Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer
abiraterone,GZOSMCIZMLWJML-VJLLXTKPSA-N,Launched,androgen biosynthesis inhibitor,CYP11B1|CYP17A1,oncology,prostate cancer
abiraterone-acetate,UVIQSJCZCSLXRZ-UBUQANBQSA-N,Launched,androgen biosynthesis inhibitor,CYP17A1,oncology,prostate cancer
ABT-072,XMZSTQYSBYEENY-RMKNXTFCSA-N,Phase 2,RNA polymerase inhibitor,,,
ABT-202,LVGMMVAWLISWJD-QMMMGPOBSA-N,Phase 1,acetylcholine receptor agonist,,,
ABT-239,KFHYZKCRXNRKRC-MRXNPFEDSA-N,Phase 1,histamine receptor antagonist,HRH1|HRH2|HRH3,,
ABT-491,GDLNHSUSOZEAOR-UHFFFAOYSA-N,Phase 1,platelet activating factor receptor antagonist,PTAFR,,
ABT-639,AGPIHNZOZNKRGT-CYBMUJFWSA-N,Phase 2,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I,,
ABT-702,RQCXKDWOCUJWQZ-UHFFFAOYSA-N,Preclinical,adenosine kinase inhibitor,ADK,,
ABT-724,FRPJGTNLZNXQEX-UHFFFAOYSA-N,Phase 2,dopamine receptor agonist,DRD4,,
ABT-737,HPLNQCPCUACXLM-PGUFJCEWSA-N,Phase 1/Phase 2,BCL inhibitor,BCL2|BCL2L1|BCL2L2,,
ABT-737,"InChI=1S/C42H45ClN6O5S2/c1-46(2)23-22-35(30-55-37-9-4-3-5-10-37)44-40-21-20-38(28-41(40)49(51)52)56(53,54)45-42(50)32-14-18-36(19-15-32)48-26-24-47(25-27-48)29-33-8-6-7-11-39(33)31-12-16-34(43)17-13-31/h3-21,28,35,44H,22-27,29-30H2,1-2H3,(H,45,50)/t35-/m1/s1",Phase 1/Phase 2,BCL inhibitor,BCL2|BCL2L1|BCL2L2,,
ABT-751,URCVCIZFVQDVPM-UHFFFAOYSA-N,Phase 2,tubulin polymerization inhibitor,TUBB,,
ABX-1431,SQZJGTOZFRNWCX-UHFFFAOYSA-N,Phase 2,monoacylglycerol lipase inhibitor,,,
ABX464,OZOGDCZJYVSUBR-UHFFFAOYSA-N,Phase 2,antiviral,,,
AC-186,HSMUKSLNDJOZQG-UHFFFAOYSA-N,Preclinical,estrogen receptor agonist,ESR2,,
AC-261066,HSAOETBFVAWNRP-UHFFFAOYSA-N,Preclinical,retinoid receptor agonist,RARB,,
AC-264613,RQKXQCSEZPQBNZ-QSBCOWLBSA-N,Preclinical,PAR agonist,F2RL1,,
AC-55541,UCUHFWIFSHROPY-SQEMJAKJSA-N,Preclinical,PARP inhibitor,PARP2,,
AC-55649,HXBKPYIEQLLNBK-UHFFFAOYSA-N,Preclinical,retinoid receptor agonist,RARA|RARB,,
AC-710,JVCWPUFNLFSKFS-UHFFFAOYSA-N,Preclinical,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB,,
AC-7954-(+/-),HIVBATDUVFEJFZ-IBGZPJMESA-N,Preclinical,urotensin receptor agonist,UTS2R,,
AC1NDSS5,VZXULFIUJKSVJY-UHFFFAOYSA-N,Phase 1,,,,
AC260584,BWAKMLKESHKOHK-UHFFFAOYSA-N,Preclinical,cholinergic receptor agonist,,,
acadesine,RTRQQBHATOEIAF-UUOKFMHZSA-N,Phase 3,AMPK activator,,,
acalabrutinib,WDENQIQQYWYTPO-IBGZPJMESA-N,Launched,Bruton's tyrosine kinase (BTK) inhibitor,BTK,hematologic malignancy,mantle cell lymphoma (MCL)
acalisib,DOCINCLJNAXZQF-LBPRGKRZSA-N,Phase 1,PI3K inhibitor,PIK3CB|PIK3CD,,
acamprosate,AFCGFAGUEYAMAO-UHFFFAOYSA-N,Launched,glutamate receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM5,neurology/psychiatry,abstinence from alcohol
acarbose,XUFXOAAUWZOOIT-SXARVLRPSA-N,Launched,glucosidase inhibitor,AMY2A|MGAM,endocrinology,diabetes mellitus
ACDPP,RNGRUHWJJPTYNR-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRM5,,
acebilustat,GERJIEKMNDGSCS-DQEYMECFSA-N,Phase 2,leukotriene inhibitor,,,
acebutolol,GOEMGAFJFRBGGG-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRB1,cardiology,hypertension|ventricular arrhythmias
acecainide,KEECCEWTUVWFCV-UHFFFAOYSA-N,Phase 3,polarization inhibitor,SCN5A,,
aceclidine,WRJPSSPFHGNBMG-VIFPVBQESA-N,Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,ophthalmology,glaucoma
aceclofenac,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,Launched,prostanoid receptor antagonist,PTGS2,rheumatology,rheumatoid arthritis|ankylosing spondylitis|osteoarthritis|periarthritis|lumbago|ischiadynia
acedapsone,AMTPYFGPPVFBBI-UHFFFAOYSA-N,Launched,,,infectious disease,leprosy
acedoben,QCXJEYYXVJIFCE-UHFFFAOYSA-N,Phase 2,,,,
acefylline,HCYFGRCYSCXKNQ-UHFFFAOYSA-N,Launched,adenosine receptor agonist,ADORA1,pulmonary,asthma
aceglutamide,KSMRODHGGIIXDV-YFKPBYRVSA-N,Launched,,,gastroenterology,peptic ulcer disease (PUD)
acelarin,NHTKGYOMICWFQZ-LHFSRKHSSA-N,Phase 2/Phase 3,anticancer agent,,,
acemetacin,FSQKKOOTNAMONP-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis
aceneuramic-acid,SQVRNKJHWKZAKO-PFQGKNLYSA-N,Phase 3,,CES1|SELE|SELP,,
acenocoumarol,VABCILAOYCMVPS-HNNXBMFYSA-N,Launched,vitamin K antagonist,VKORC1,hematology,deep vein thrombosis (DVT)
acepromazine,NOSIYYJFMPDDSA-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A,neurology/psychiatry,sedative
acesulfame-potassium,YGCFIWIQZPHFLU-UHFFFAOYSA-N,Phase 3,,,,
acetanilide,FZERHIULMFGESH-UHFFFAOYSA-N,Preclinical,hydrogen peroxide decomposition inhibitor,,,
acetarsol,ODFJOVXVLFUVNQ-UHFFFAOYSA-N,Launched,,,gastroenterology,diarrhea
acetazolamide,BZKPWHYZMXOIDC-UHFFFAOYSA-N,Launched,carbonic anhydrase inhibitor,AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7,ophthalmology,glaucoma
acetohexamide,VGZSUPCWNCWDAN-UHFFFAOYSA-N,Launched,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,endocrinology,diabetes mellitus
acetohydroxamic-acid,RRUDCFGSUDOHDG-UHFFFAOYSA-N,Launched,urease inhibitor,MMP12,infectious disease,urinary tract infections
acetophenazine,WNTYBHLDCKXEOT-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD1|DRD2,neurology/psychiatry,psychosis
acetriazoic-acid,GNOGSFBXBWBTIG-UHFFFAOYSA-N,Preclinical,,,,
acetyl-11-keto-beta-boswellic-acid,HMMGKOVEOFBCAU-OQJDUFEHSA-N,Phase 2,lipoxygenase inhibitor,HSD11B1|HSD11B2,,
acetyl-farnesyl-cysteine,XTURYZYJYQRJDO-BNAHBJSTSA-N,Launched,methyltransferase inhibitor,PPARG,dermatology,acne vulgaris (AV)
acetyl-l-leucine,WXNXCEHXYPACJF-ZETCQYMHSA-N,Launched,,,neurology/psychiatry,vertigo
acetylcholine,OIPILFWXSMYKGL-UHFFFAOYSA-N,Launched,acetylcholine receptor agonist,ACHE|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,neurology/psychiatry|gastroenterology|pulmonary,drowsiness|fatigue|headache|indigestion|chest congestion
acetylcysteine,PWKSKIMOESPYIA-BYPYZUCNSA-N,Launched,mucolytic agent,ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11,gastroenterology,acetaminophen overdose|hepatic injury
acetylsalicylsalicylic-acid,DDSFKIFGAPZBSR-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,,,
acetylspiramycin,ZPCCSZFPOXBNDL-VGQMBGNASA-N,Preclinical,other antibiotic,,,
acexamic-acid,WDSCBUNMANHPFH-UHFFFAOYSA-N,Launched,5 alpha reductase inhibitor,GAST,dermatology,wound healing
acifran,DFDGRKNOFOJBAJ-LBPRGKRZSA-N,Phase 3,cholesterol inhibitor,HCAR2|HCAR3,,
acipimox,DJQOOSBJCLSSEY-UHFFFAOYSA-N,Launched,cholesterol inhibitor,HCAR2,endocrinology,hyperlipidemia
acitazanolast,VWQZJJZGISNFOE-UHFFFAOYSA-N,Launched,mediator release inhibitor,,allergy,allergic rhinitis
acitretin,IHUNBGSDBOWDMA-AQFIFDHZSA-N,Launched,retinoid receptor agonist,RARA|RARB|RARG|RBP1|RXRA|RXRB|RXRG|STAT3,dermatology,psoriasis
acivicin,QAWIHIJWNYOLBE-ZAFYKAAXSA-N,Phase 2,gamma glutamyltransferase inhibitor,CTPS1,,
aclarubicin,USZYSDMBJDPRIF-SVEJIMAYSA-N,Launched,topoisomerase inhibitor,TOP1|TOP2A,hematologic malignancy,acute myeloid leukemia (AML)
aclidinium,ASMXXROZKSBQIH-VITNCHFBSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,pulmonary,bronchitis|emphysema|chronic obstructive pulmonary disease (COPD)
acolbifene,DUYNJNWVGIWJRI-LJAQVGFWSA-N,Phase 3,estrogen receptor antagonist,,,
acoziborole,PTYGDEXEGLDNAZ-UHFFFAOYSA-N,Preclinical,antitrypanosomal,,,
ACPC,PAJPWUMXBYXFCZ-UHFFFAOYSA-N,Phase 1,glutamate receptor antagonist,,,
acriflavine,BCBIBQWDFMQRSJ-UHFFFAOYSA-O,Launched,hypoxia inducible factor inhibitor,HIF1A,infectious disease,fungal infection
acriflavinium,XSIOKTWDEOJMGG-UHFFFAOYSA-O,Launched,hypoxia inducible factor inhibitor,HIF1A,infectious disease,fungal infection
acrisorcin,YZODJQFXMFEJRM-UHFFFAOYSA-N,Launched,other antifungal,,infectious disease,fungal infection
acrivastine,PWACSDKDOHSSQD-IUTFFREVSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis
acrylate,MNNFZYTXMPWOTA-UHFFFAOYSA-N,Phase 3,mucus protecting agent,,,
ACT-132577,DKULOVKANLVDEA-UHFFFAOYSA-N,Launched,endothelin receptor antagonist,EDNRA|EDNRB,pulmonary,pulmonary arterial hypertension (PAH)
ACT-462206,NHPQGZOBHSVTAQ-IBGZPJMESA-N,Phase 1,orexin receptor antagonist,HCRTR1|HCRTR2,,
actarit,MROJXXOCABQVEF-UHFFFAOYSA-N,Launched,interleukin receptor agonist,,rheumatology,rheumatoid arthritis
ACTB-1003,GZPJCJKUZPUFAL-UHFFFAOYSA-N,Phase 1,FGFR inhibitor|VEGFR inhibitor,KDR|TEK,,
actinomycin-d,RJURFGZVJUQBHK-DCUCITLNSA-N,Launched,RNA polymerase inhibitor,,oncology,Wilm's tumor|Ewing's sarcoma|rhabdomyosarcoma|testicular carcinoma
actinoquinol,YAMVZYRZAMBCED-UHFFFAOYSA-N,Preclinical,,,,
acumapimod,VGUSQKZDZHAAEE-UHFFFAOYSA-N,Phase 1,p38 MAPK inhibitor,,,
ACY-1215,QGZYDVAGYRLSKP-UHFFFAOYSA-N,Phase 1/Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6|HDAC8,,
acyclovir,MKUXAQIIEYXACX-UHFFFAOYSA-N,Launched,DNA polymerase inhibitor,PNP,infectious disease,genitial herpes|shingles|chicken pox
AD-5467,CLDJCRWXLDLJLO-CQSZACIVSA-N,Phase 2,aldose reductase inhibitor,AKR1B1,,
adapalene,LZCDAPDGXCYOEH-UHFFFAOYSA-N,Launched,retinoid receptor agonist,RARA|RARB|RARG|RXRA|RXRB|RXRG,dermatology,acne vulgaris (AV)
adaprev,NBSCHQHZLSJFNQ-DVKNGEFBSA-N,Phase 3,TGF beta receptor inhibitor,AKR1B1|GPI|HK1|M6PR|PYGM,,
adaptavir,AKWRNBWMGFUAMF-ZESMOPTKSA-N,Phase 2,CC chemokine receptor antagonist,CCR5,,
adarotene,QAWBIEIZDDIEMW-FPYGCLRLSA-N,Phase 1,retinoid receptor agonist,RARB|RARG,,
adatanserin,HPFLVTSWRFCPCV-UHFFFAOYSA-N,Phase 2,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR2A,,
adavivint,AQDWDWAYVBQMAM-UHFFFAOYSA-N,Phase 1,WNT pathway inhibitor,,,
ADD-233089,OKVOKULYZXODKU-UHFFFAOYSA-N,Phase 1,benzodiazepine receptor agonist,,,
adefovir,SUPKOOSCJHTBAH-UHFFFAOYSA-N,Launched,DNA polymerase inhibitor,,infectious disease,hepatitis B
adefovir-dipivoxil,WOZSCQDILHKSGG-UHFFFAOYSA-N,Launched,DNA polymerase inhibitor,,infectious disease,hepatitis B
adelmidrol,PAHZPHDAJQIETD-UHFFFAOYSA-N,Launched,anti-inflammatory agent,,dermatology,dermatitis
ademetionine,MEFKEPWMEQBLKI-AIRLBKTGSA-O,Launched,methyltransferase stimulant|phosphodiesterase inhibitor,,neurology/psychiatry,depression|attention-deficit/hyperactivity disorder (ADHD)
adenine,GFFGJBXGBJISGV-UHFFFAOYSA-N,Preclinical,protein synthesis stimulant,ACACB|ACP1|APRT|MTAP|PECR|SRPK2,,
adenosine,OIRDTQYFTABQOQ-KQYNXXCUSA-N,Launched,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4,cardiology,Wolff-Parkinson-White Syndrome (WPW)
adenosine-phosphate,UDMBCSSLTHHNCD-KQYNXXCUSA-N,Launched,adenosine receptor agonist,ACSL1|ACSS1|ACSS2|ADCY1|ADK|CREB1|FBP1|HINT1|PDE4B|PDE4D|PIM1|PRKAA1|PRKAB1|PRKAB2|PYGL|TRPM4,,
adenosine-triphosphate,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,Phase 2,adenosine receptor agonist,ABCA1|ABCB1|ABCB11|ABCC2|ABCC8|ABCC9|ABCG1|ABL1|ABL2|ACSL1|ACSS1|ACSS2|ACVR1|ACVR1B|ACVRL1|ADCY1|ADRBK1|ADRBK2|AFG3L2|AKT1|ALK|AMHR2|APAF1|ARAF|ASNA1|ASNS|ASS1|CDK15|GPR17|ITPR1|NAE1|NT5C2|P2RY1|P2RY11|P2RY13|P2RY2|P2RY4|PRKAA1|RYR1|RYR2|RYR3|SLC25A4|TNK2|TRPM4|TRPM7,,
adiphenine,JGOAIQNSOGZNBX-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRNA1,neurology/psychiatry,spasms
adipic-acid,WNLRTRBMVRJNCN-UHFFFAOYSA-N,Preclinical,solute carrier family member inhibitor,SLC22A6,,
adiporon,SHHUPGSHGSNPDB-UHFFFAOYSA-N,Preclinical,adiponectin receptor agonist,ADIPOR1|ADIPOR2,,
ADL5859,OPIKUXLJQFYMSC-UHFFFAOYSA-N,Phase 2,opioid receptor agonist,OPRD1,,
adomeglivant,FASLTMSUPQDLIB-MHZLTWQESA-N,Preclinical,glucagon receptor antagonist,,,
adoprazine,IUVSEUFHPNITEQ-UHFFFAOYSA-N,Phase 2,dopamine receptor antagonist|serotonin receptor agonist,DRD2|HTR1A,,
adrafinil,CGNMLOKEMNBUAI-HXUWFJFHSA-N,Launched,adrenergic receptor agonist,,neurology/psychiatry,fatigue
adrenalone,PZMVOUYYNKPMSI-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA1A,hematology,hemorrhage
adrenosterone,RZRPTBIGEANTGU-IRIMSJTPSA-N,Preclinical,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1|HSD11B2,,
ADX-10059,MEDCLNYIYBERKO-UHFFFAOYSA-N,Phase 2,glutamate receptor negative allosteric modulator,GRM5,,
ADX-47273,VXQCCZHCFBHTTD-HNNXBMFYSA-N,Preclinical,glutamate receptor modulator,GRM5,,
AEE788,OONFNUWBHFSNBT-HXUWFJFHSA-N,Phase 1/Phase 2,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR,,
AEG3482,MQUYTXDAVCOCMX-UHFFFAOYSA-N,Preclinical,HSP inducer,,,
AF38469,JWCUSQCZMQIBMR-UHFFFAOYSA-N,Preclinical,sortilin inhibitor,SORT1,,
afalanine,CBQJSKKFNMDLON-JTQLQIEISA-N,Phase 3,dopamine receptor agonist,DRD2,,
afamelanotide,UAHFGYDRQSXQEB-LEBBXHLNSA-N,Launched,melanocyte-stimulating hormone mimetic,,,
afatinib,ULXXDDBFHOBEHA-CWDCEQMOSA-N,Launched,EGFR inhibitor,EGFR|ERBB2|ERBB4,oncology,non-small cell lung cancer (NSCLC)
afimoxifene,TXUZVZSFRXZGTL-QPLCGJKRSA-N,Phase 2,estrogen receptor antagonist,ESR1|ESR2|ESRRG|PLD1|PRKCD|PRKCE|PRKCQ|PRKCZ,,
afloqualone,VDOSWXIDETXFET-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,,neurology/psychiatry,sedative
AFN-1252,QXTWSUQCXCWEHF-JXMROGBWSA-N,Phase 2,FABI inhibitor,,,
afobazole,WWNUCVSRRUDYPP-UHFFFAOYSA-N,Launched,anxiolytic,,neurology/psychiatry,anxiety
AG-1024,ABBADGFSRBWENF-UHFFFAOYSA-N,Preclinical,insulin growth factor receptor inhibitor,IGF1R,,
AG-14361,SEKJSSBJKFLZIT-UHFFFAOYSA-N,Preclinical,PARP inhibitor,PARP1,,
AG-490,TUCIOBMMDDOEMM-RIYZIHGNSA-N,Preclinical,EGFR inhibitor|JAK inhibitor,EGFR|JAK2|JAK3,,
AG-555,GSQOBTOAOGXIFL-LFIBNONCSA-N,Preclinical,tyrosine kinase inhibitor,CDK2,,
AG-556,GWCNJMUSWLTSCW-SFQUDFHCSA-N,Preclinical,tyrosine kinase inhibitor,,,
AGI-5198,FNYGWXSATBUBER-AREMUKBSSA-N,Preclinical,isocitrate dehydrogenase inhibitor,IDH1,,
AGI-6780,CCAWRGNYALGPQH-UHFFFAOYSA-N,Preclinical,isocitrate dehydrogenase inhibitor,IDH2,,
AGM-1470,MSHZHSPISPJWHW-FRDQJGBZSA-N,Phase 2,cell cycle inhibitor,METAP2,,
agmatine,QYPPJABKJHAVHS-UHFFFAOYSA-N,Phase 3,nitric oxide synthase inhibitor,ADRA2C|ASIC3|CACNA1B|CHRNA1|GRIN1|KCNJ1|NISCH,,
AGN-192403,SHXVJSFOJHMEEQ-AXTSPUMRSA-N,Preclinical,imidazoline receptor ligand,NISCH,,
AGN-194310,LHUPKWKWYWOMSK-UHFFFAOYSA-N,Phase 3,retinoid receptor antagonist,RXRA|RXRB|RXRG,,
AGN-195183,PNAWUIKCVQSLFG-UHFFFAOYSA-N,Phase 1/Phase 2,retinoid receptor agonist,RARA,,
agomelatine,YJYPHIXNFHFHND-UHFFFAOYSA-N,Launched,melatonin receptor agonist|serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B,neurology/psychiatry,depression
AGP-103,UKMSUNONTOPOIO-UHFFFAOYSA-N,Launched,membrane permeability inhibitor,,,
AH-7614,OZCQEUZTOAAWDK-UHFFFAOYSA-N,Preclinical,free fatty acid receptor antagonist,FFAR4,,
AH11110,HSVZQQYIMKLNLN-GOSISDBHSA-N,Preclinical,adrenergic receptor ligand,ADRA1B,,
AH6809,AQFFXPQJLZFABJ-UHFFFAOYSA-N,Preclinical,prostanoid receptor antagonist,PTGDR|PTGER1|PTGER2|PTGER3,,
AI-10-49,WJBSSBFGPKTMQQ-UHFFFAOYSA-N,Preclinical,core binding factor inhibitor,CBFB,,
AIM-100,XNFHHOXCDUAYSR-SFHVURJKSA-N,Preclinical,tyrosine kinase inhibitor,TNK2,,
AJ76-(+),YGHLYBIUVOLKCV-SMDDNHRTSA-N,Preclinical,dopamine receptor antagonist,DRD2|DRD3|DRD4,,
ajmaline,CJDRUOGAGYHKKD-BDXZSHBPSA-N,Launched,sodium channel blocker,,cardiology,Wolff-Parkinson-White Syndrome (WPW)
AK-7,IYAYHZZWYNXHEQ-UHFFFAOYSA-N,Preclinical,SIRT inhibitor,SIRT2,,
AKBA,HMMGKOVEOFBCAU-BCDBGHSCSA-N,Phase 3,lipoxygenase inhibitor,ALOX5,,
aklomide,GFGSZUNNBQXGMK-UHFFFAOYSA-N,Launched,,,infectious disease,coccidiosis
AL-8697,ZVBTZTQYHOXIBC-UHFFFAOYSA-N,Preclinical,p38 MAPK inhibitor,MAPK14,,
alacepril,FHHHOYXPRDYHEZ-COXVUDFISA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension
alafosfalin,BHAYDBSYOBONRV-IUYQGCFVSA-N,Phase 1,bacterial cell wall synthesis inhibitor,,,
alagebrium,LYLFQLCLUXOFOL-UHFFFAOYSA-N,Phase 2/Phase 3,glycosylation inhibitor,,,
alanine,QNAYBMKLOCPYGJ-UWTATZPHSA-N,Launched,,,,
alanosine,MLFKVJCWGUZWNV-REOHCLBHSA-N,Phase 2,antimetabolite,,,
alantolactone,PXOYOCNNSUAQNS-AGNJHWRGSA-N,Preclinical,apoptosis stimulant|STAT inhibitor,STAT3,,
alaproclate,FZSPJBYOKQPKCD-SECBINFHSA-N,Phase 2,serotonin receptor antagonist,SLC6A4,,
alarelin,QLGKMLRGKPKGKI-QWQCQAQZSA-N,Launched,gonadotropin releasing factor hormone receptor antagonist,GNRH1,,
albendazole,HXHWSAZORRCQMX-UHFFFAOYSA-N,Launched,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,infectious disease,cystic hydatid disease|parenchymal neurocysticercosis
albendazole-oxide,VXTGHWHFYNYFFV-LJQANCHMSA-N,Launched,anthelmintic agent,,infectious disease,cystic hydatid disease|parenchymal neurocysticercosis
albuterol,NDAUXUAQIAJITI-GFCCVEGCSA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma
alcaftadine,MWTBKTRZPHJQLH-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic conjunctivitis
alclofenac,ARHWPKZXBHOEEE-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1,rheumatology,rheumatoid arthritis
alclometasone-dipropionate,DJHCCTTVDRAMEH-FQEREKBASA-N,Launched,glucocorticoid receptor agonist,CYP3A4|NR3C1|SERPINA6,dermatology,corticosteroid-responsive dermatoses
alcuronium,MUQUYTSLDVKIOF-JGNNFNAWSA-N,Launched,muscle relaxant,CHRM1|CHRM2|CHRM3|CHRM4|CHRNA7,neurology/psychiatry,muscle relaxant
alda-1,NMKJFZCBCIUYHI-UHFFFAOYSA-N,Preclinical,aldehyde dehydrogenase activator,ALDH2,,
aldoxorubicin,OBMJQRLIQQTJLR-USGQOSEYSA-N,Phase 3,topoisomerase inhibitor,TOP2A,,
alectinib,KDGFLJKFZUIJMX-UHFFFAOYSA-N,Launched,ALK tyrosine kinase receptor inhibitor,ALK|MET,oncology,non-small cell lung cancer (NSCLC)
alendronate,OGSPWJRAVKPPFI-UHFFFAOYSA-N,Launched,bone resorption inhibitor,ATP6V1A|FDPS|PTPN4|PTPRE|PTPRS,orthopedics,osteoporosis
alexidine,LFVVNPBBFUSSHL-SZPZYZBQSA-N,Preclinical,phosphatidylglycerophosphatase inhibitor,PTPMT1,,
alfacalcidol,OFHCOWSQAMBJIW-AVJTYSNKSA-N,Launched,vitamin D receptor agonist,CYP27B1|VDR,endocrinology,vitamin D deficiency
alfadolone-acetate,QRJOQYLXZPQQMX-FWROMSNXSA-N,Phase 2,benzodiazepine receptor agonist,,,
alfuzosin,WNMJYKCGWZFFKR-CQSZACIVSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,urology,benign prostatic hyperplasia (BPH)
algestone-acetophenide,AHBKIEXBQNRDNL-FVCOMRFXSA-N,Launched,,,endocrinology,contraceptive
alibendol,UMJHTFHIQDEGKB-UHFFFAOYSA-N,Launched,antispasmodic,,gastroenterology,bile stimulation
alimemazine,ZZHLYYDVIOPZBE-AWEZNQCLSA-N,Launched,histamine receptor agonist|histamine receptor antagonist,HRH1,neurology/psychiatry|allergy|pulmonary,sedative|urticaria|itching|cough suppressant
alinidine,OXTYVEUAQHPPMV-UHFFFAOYSA-N,Phase 3,bradycardic effect ,,,
alisertib,ZLHFILGSQDJULK-UHFFFAOYSA-N,Phase 3,Aurora kinase inhibitor,AURKA,,
alisertib,"InChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33)",Phase 3,Aurora kinase inhibitor,AURKA,,
aliskiren-hemifumarate,UXOWGYHJODZGMF-QORCZRPOSA-N,Launched,renin inhibitor,REN,cardiology,hypertension
alisporivir,OLROWHGDTNFZBH-XEMWPYQTSA-N,Phase 3,cyclophilin inhibitor,,,
alizapride,KSEYRUGYKHXGFW-LLVKDONJSA-N,Launched,dopamine receptor antagonist,,gastroenterology,nausea
alizarin,RGCKGOZRHPZPFP-UHFFFAOYSA-N,Preclinical,,,,
allantoin,POJWUDADGALRAB-SFOWXEAESA-N,Launched,cosmetic,,dermatology,skin protectant
allicin,JDLKFOPOAOFWQN-SECBINFHSA-N,Phase 2,cytokine production inhibitor,TRPA1|TRPV1,,
allopurinol,OFCNXPDARWKPPY-UHFFFAOYSA-N,Launched,xanthine oxidase inhibitor,XDH,rheumatology|urology,gout|kidney stones
allopurinol-riboside,KFQUAMTWOJHPEJ-DAGMQNCNSA-N,Phase 2,anti-leishmanial agent|phosphorylase inhibitor,,,
allopurinol-riboside,KFQUAMTWOJHPEJ-NBBQQVJHSA-N,Phase 2,anti-leishmanial agent|phosphorylase inhibitor,,,
allylestrenol,ATXHVCQZZJYMCF-XUDSTZEESA-N,Launched,steroidal progestin,ESR1|PGR|SLC6A9,obstetrics/gynecology,premature labor
allylisothiocyanate,ZOJBYZNEUISWFT-UHFFFAOYSA-N,Preclinical,TRPV agonist,TRPA1,,
allylthiourea,HTKFORQRBXIQHD-UHFFFAOYSA-N,Preclinical,nitrification inhibitor,,,
almitrine,OBDOVFRMEYHSQB-UHFFFAOYSA-N,Launched,neurotransmitter agonist,ATP1A1,pulmonary,chronic obstructive pulmonary disease (COPD)
almorexant,DKMACHNQISHMDN-RPLLCQBOSA-N,Phase 3,orexin receptor antagonist,HCRTR1|HCRTR2,,
almotriptan,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,Launched,serotonin receptor agonist,HTR1B|HTR1D,neurology/psychiatry,migraine headache
aloe-emodin,YDQWDHRMZQUTBA-UHFFFAOYSA-N,Preclinical,anticancer agent,CASP8,,
alogliptin,ZSBOMTDTBDDKMP-OAHLLOKOSA-N,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus
aloin,AFHJQYHRLPMKHU-OSYMLPPYSA-N,Preclinical,angiogenesis inhibitor,,,
aloperine,SKOLRLSBMUGVOY-GBJTYRQASA-N,Preclinical,,,,
alosetron,JSWZEAMFRNKZNL-UHFFFAOYSA-N,Withdrawn,serotonin receptor antagonist,HTR3A,,
alovudine,UXCAQJAQSWSNPQ-XLPZGREQSA-N,Phase 2,DNA synthesis marker,,,
aloxistatin,SRVFFFJZQVENJC-IHRRRGAJSA-N,Phase 3,protease inhibitor,CTSG,,
alpelisib,STUWGJZDJHPWGZ-LBPRGKRZSA-N,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,oncology,breast cancer
alpha-asarone,RKFAZBXYICVSKP-AATRIKPKSA-N,Preclinical,cytochrome P450 inhibitor|HMGCR inhibitor,HMGCR,,
alpha-D-glucopyranose,WQZGKKKJIJFFOK-DVKNGEFBSA-N,Preclinical,,,,
alpha-glucosyl-hesperidin,IMMBLRJLSYJQIZ-RBWYFKFWSA-N,Preclinical,antioxidant,,,
alpha-linolenic-acid,DTOSIQBPPRVQHS-PDBXOOCHSA-N,Phase 3,omega 3 fatty acid stimulant,ELOVL4|FADS1|FADS2|FFAR1|FFAR4|PTGS2|SLC8A1|TRPV1,,
alpha-methylhistamine-dihydrobromide-(R)-(-),XNQIOISZPFVUFG-RXMQYKEDSA-N,Preclinical,histamine receptor agonist,HRH3,,
alpha-methylhistamine-dihydrobromide-(S)-(+),XNQIOISZPFVUFG-YFKPBYRVSA-N,Preclinical,histamine receptor agonist,HRH3,,
alpha-methylserotonin,LYPCGXKCQDYTFV-SSDOTTSWSA-N,Preclinical,serotonin receptor agonist,HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR4,,
alpha-tochopherol,GVJHHUAWPYXKBD-QLVXXPONSA-N,Launched,antioxidant,,endocrinology,vitamin E deficiency
alpha-tochopheryl-acetate,ZAKOWWREFLAJOT-PKIAKLFDSA-N,Launched,antioxidant,,endocrinology,vitamin E deficiency
alpidem,JRTIDHTUMYMPRU-UHFFFAOYSA-N,Withdrawn,benzodiazepine receptor agonist,GABRA1,,
alprenolol,PAZJSJFMUHDSTF-CQSZACIVSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,cardiology,angina pectoris
alprostadil,GMVPRGQOIOIIMI-DWKJAMRDSA-N,Launched,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR,cardiology,congenital heart defects
alrestatin,GCUCIFQCGJIRNT-UHFFFAOYSA-N,Preclinical,aldose reductase inhibitor,AKR1B1,,
ALS-8112,AWSRKKBIPSQHOJ-IBCQBUCCSA-N,Phase 1,,,,
ALS-8176,MJVKYGMNSQJLIN-KYZVSKTDSA-N,Phase 1,RNA polymerase inhibitor,,,
altanserin,SMYALUSCZJXWHG-UHFFFAOYSA-N,Phase 2,serotonin receptor antagonist,HTR2A,,
althiazide,VGLGVJVUHYTIIU-LLVKDONJSA-N,Launched,diuretic,,cardiology,hypertension
altinicline,NUPUDYKEEJNZRG-LBPRGKRZSA-N,Phase 2,nicotinic receptor agonist,CHRNA4|CHRNB2,,
altiratinib,GNNDEPIMDAZHRQ-UHFFFAOYSA-N,Phase 1,MET inhibitor|VEGFR inhibitor,KDR|MET|TEK,,
altrenogest,VWAUPFMBXBWEQY-ANULTFPQSA-N,Launched,progestogen hormone,PGR,endocrinology,estrus
altretamine,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,Launched,DNA synthesis inhibitor,,oncology,ovarian cancer
alverine,ZPFXAOWNKLFJDN-UHFFFAOYSA-N,Launched,muscle relaxant,HTR1A,gastroenterology,irritable bowel syndrome|diverticular disease
alvespimycin,KUFRQPKVAWMTJO-UBNVGODQSA-N,Phase 2,HSP inhibitor,HSP90AA1,,
alvimopan,UPNUIXSCZBYVBB-JVFUWBCBSA-N,Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,gastroenterology,postoperative ileus
alvocidib,BIIVYFLTOXDAOV-YVEFUNNKSA-N,Phase 2,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM,,
ALX-40-4C,LGLVVVCSQBZONM-HCCLCSBVSA-N,Preclinical,CC chemokine receptor antagonist,,,
ALX-5407,FDORQEIHOKEJNX-HSZRJFAPSA-N,Phase 1,glycine transporter inhibitor,SLC6A9,,
AM-1241,ZUHIXXCLLBMBDW-MRXNPFEDSA-N,Preclinical,cannabinoid receptor agonist,CNR1|CNR2,,
AM-24,VAPDZNUFNKUROY-UHFFFAOYSA-N,Phase 2,lipoxygenase inhibitor,ALOX5,,
AM-251,BUZAJRPLUGXRAB-UHFFFAOYSA-N,Preclinical,cannabinoid receptor antagonist,CNR1|GPR18|GPR55,,
AM-281,AJFFBPZYXRNAIC-UHFFFAOYSA-N,Preclinical,cannabinoid receptor antagonist,CNR1|CNR2|GPR55,,
AM-404,IJBZOOZRAXHERC-DOFZRALJSA-N,Preclinical,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,CNR1|CNR2|FAAH|TRPV1,,
AM-580,SZWKGOZKRMMLAJ-UHFFFAOYSA-N,Preclinical,retinoid receptor agonist,RARA,,
AM-630,JHOTYHDSLIUKCJ-UHFFFAOYSA-N,Preclinical,cannabinoid receptor antagonist,CNR1|CNR2,,
AM-92016,BQBSHJUQVIWEFM-MRXNPFEDSA-N,Preclinical,potassium channel blocker,GRIN1,,
AM095,LNDDRUPAICPXIN-GOSISDBHSA-N,Preclinical,lysophosphatidic acid receptor antagonist,,,
AM211,OPXIRFWNLBDKQB-UHFFFAOYSA-N,Preclinical,prostaglandin inhibitor,,,
AM679,VYXWHVDEWWHDLH-LJAQVGFWSA-N,Preclinical,cannabinoid receptor agonist|lipoxygenase inhibitor,ALOX5AP|CNR1|CNR2,,
amantadine,DKNWSYNQZKUICI-UHFFFAOYSA-N,Launched,glutamate receptor antagonist,DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A,infectious disease|neurology/psychiatry,influenza A virus infection|Parkinson's Disease
ambazone,HQDSAVMTLKVTGJ-UHFFFAOYSA-N,Phase 1,DNA damage inducer,,,
ambenonium,OMHBPUNFVFNHJK-UHFFFAOYSA-P,Launched,cholinesterase inhibitor,ACHE,neurology/psychiatry,myasthenia gravis
ambrisentan,OUJTZYPIHDYQMC-LJQANCHMSA-N,Launched,endothelin receptor antagonist,EDNRA|EDNRB,pulmonary,pulmonary arterial hypertension (PAH)
ambroxol,JBDGDEWWOUBZPM-XYPYZODXSA-N,Launched,sodium channel blocker,CYP3A4,pulmonary,bronchitis
amcasertib,QDWKGEFGLQMDAM-JJIBRWJFSA-N,Phase 2,kinase inhibitor,,,
amcinonide,ILKJAFIWWBXGDU-KNPIAJNZSA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
AMD-3465,CWJJHESJXJQCJA-UHFFFAOYSA-N,Preclinical,CC chemokine receptor antagonist,CXCR4,,
AMD11070,WVLHHLRVNDMIAR-IBGZPJMESA-N,Phase 3,CC chemokine receptor antagonist,CCR5|CXCR4,,
amdinocillin,BWWVAEOLVKTZFQ-ISVUSNJMSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|gram-negative bacterial infections
ameltolide,HZIWGOAXOBPQGY-UHFFFAOYSA-N,Preclinical,anticonvulsant,,,
amenamevir,MNHNIVNAFBSLLX-UHFFFAOYSA-N,Phase 1,helicase primase inhibitor,,,
ametantrone,FFGSXKJJVBXWCY-UHFFFAOYSA-N,Preclinical,anticancer agent,,,
amezinium,VXROHTDSRBRJLN-UHFFFAOYSA-O,Launched,adrenergic receptor agonist,ADRB2,cardiology,hypotension
amfenac,SOYCMDCMZDHQFP-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
amflutizole,KVMCEGAWQYTFKC-UHFFFAOYSA-N,Phase 2,xanthine oxidase inhibitor,XDH,,
AMG-176,JQNINBDKGLWYMU-PTJFNUENSA-N,Phase 1,MCL1 inhibitor,,,
AMG-208,HEAIZQNMNCHNFD-UHFFFAOYSA-N,Phase 1,tyrosine kinase inhibitor,MET,,
AMG-232,DRLCSJFKKILATL-YWCVFVGNSA-N,Phase 2,MDM inhibitor,MDM2,,
AMG-319,KWRYMZHCQIOOEB-LBPRGKRZSA-N,Phase 2,PI3K inhibitor,PIK3CD,,
AMG-337,DWHXUGDWKAIASB-CQSZACIVSA-N,Phase 2,MET inhibitor,MET,,
AMG-487,WQTKNBPCJKRYPA-OAQYLSRUSA-N,Phase 2,CC chemokine receptor antagonist,,,
AMG-487-(+/-),WQTKNBPCJKRYPA-OAQYLSRUSA-N,Phase 2,CC chemokine receptor antagonist,CXCR3,,
AMG-510,NXQKSXLFSAEQCZ-SFHVURJKSA-N,Phase 1/Phase 2,K-Ras inhibitor,,,
AMG-517,YUTIXVXZQIQWGY-UHFFFAOYSA-N,Phase 1,TRPV antagonist,TRPV1,,
AMG-548,RQVKVJIRFKVPBF-VWLOTQADSA-N,Phase 1,MAP kinase inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,,
AMG-837,ZOPNBMMVVZRSGH-NRFANRHFSA-N,Phase 1,free fatty acid receptor agonist,FFAR1,,
AMG-925,BBUVDDPUURMFOX-SAABIXHNSA-N,Phase 1,CDK inhibitor|FLT3 inhibitor,CDK4|CDK6|FLT3,,
AMG-9810,GZTFUVZVLYUPRG-IZZDOVSWSA-N,Preclinical,TRPV antagonist,TRPV1,,
AMG-PERK-44,YPPSMYLMSKHYAY-UHFFFAOYSA-N,Preclinical,PERK inhibitor,EIF2AK4,,
AMG319,KWRYMZHCQIOOEB-GFCCVEGCSA-N,Phase 2,PI3K inhibitor,PIK3CD,,
AMG458,GLBZSOQDAOLMGC-UHFFFAOYSA-N,Preclinical,MET inhibitor,MET,,
AMG900,IVUGFMLRJOCGAS-UHFFFAOYSA-N,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,
AMI-1,PCGISRHGYLRXSR-UHFFFAOYSA-N,Preclinical,protein arginine N-methyltransferase inhibitor,PRMT1,,
amibegron,RDJQCOBTKKAQAH-FPOVZHCZSA-N,Phase 3,adrenergic receptor agonist,ADRB3,,
amidopyrine,RMMXTBMQSGEXHJ-UHFFFAOYSA-N,Launched,analgesic agent,,dermatology,dermatitis herpetiformis (DH)
amifampridine,OYTKINVCDFNREN-UHFFFAOYSA-N,Launched,potassium channel blocker,,neurology/psychiatry,Lambert-Eaton myasthenic syndrome (LEMS)
amiflamine,HFQMYSHATTXRTC-SNVBAGLBSA-N,Phase 1,monoamine oxidase inhibitor,MAOA|SLC6A2,,
amifostine,JKOQGQFVAUAYPM-UHFFFAOYSA-N,Launched,reducing agent,ALPPL2|ENPP1,nephrology,renal toxicity
amikacin,LKCWBDHBTVXHDL-RMDFUYIESA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections
amiloride,XSDQTOBWRPYKKA-UHFFFAOYSA-N,Launched,sodium channel blocker,AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2,cardiology,hypertension|congestive heart failure
amineptine,ONNOFKFOZAJDHT-UHFFFAOYSA-N,Withdrawn,dopamine receptor agonist,SLC6A2|SLC6A4,,
aminocaproic-acid,SLXKOJJOQWFEFD-UHFFFAOYSA-N,Launched,plasminogen activator inhibitor,LPA|PLAT|PLG,hematology,fibrinolytic bleeding
aminoglutethimide,ROBVIMPUHSLWNV-ZDUSSCGKSA-N,Launched,glucocorticoid receptor antagonist,CYP11A1|CYP19A1,endocrinology|oncology,Cushing's syndrome|breast cancer
aminoguanidine,HAMNKKUPIHEESI-UHFFFAOYSA-N,Phase 3,nitric oxide synthase inhibitor,AKR1B1|NOS2|TIMP3,,
aminohydroxybutyric-acid,YQGDEPYYFWUPGO-VKHMYHEASA-N,Launched,,,neurology/psychiatry,epilepsy
aminolevulinic-acid-benzyl-ester,AFFZCQDLQIEQGB-UHFFFAOYSA-N,Phase 1,,,,
aminomethyltransferase,BATVOUKHGLKDGQ-BYPYZUCNSA-N,Preclinical,nitric oxide synthase inhibitor,NOS2,,
aminopentamide,NARHAGIVSFTMIG-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM1,gastroenterology,acute abdominal visceral spasm|hypertrophic gastritis (GHG)|nausea
aminophylline,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,Launched,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,pulmonary,asthma|bronchitis|emphysema
aminopterin,TVZGACDUOSZQKY-LBPRGKRZSA-N,Phase 3,dihydrofolate reductase inhibitor,DHFR|SLC46A1,,
aminopurvalanol-a,RAMROQQYRRQPDL-HNNXBMFYSA-N,Preclinical,CDK inhibitor|tyrosine kinase inhibitor,CDK1|CDK2|CDK5,,
aminosalicylate,WUBBRNOQWQTFEX-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2,gastroenterology,inflammatory bowel disease|ulcerative colitis
aminothiadiazole,QUKGLNCXGVWCJX-UHFFFAOYSA-N,Phase 2,inosine monophosphate dehydrogenase inhibitor,ADORA3|IMPDH1,,
aminothiazole,RAIPHJJURHTUIC-UHFFFAOYSA-N,Preclinical,cyclin D inhibitor,NOS2,,
amiodarone,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,Launched,potassium channel blocker,ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2,cardiology,ventricular arrhythmias
amiprilose,YXBQLONCIPUQKO-UJPOAAIJSA-N,Phase 3,CD antagonist,,,
amiselimod,JVCPIJKPAKAIIP-UHFFFAOYSA-N,Phase 2,sphingosine 1-phosphate receptor modulator,,,
amisulpride,NTJOBXMMWNYJFB-GFCCVEGCSA-N,Launched,dopamine receptor antagonist,DRD2,neurology/psychiatry,psychosis|bipolar disorder|schizophrenia
amitifadine,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,Phase 3,serotonin transporter (SERT) inhibitor,SLC6A2|SLC6A3|SLC6A4,,
amitraz,QXAITBQSYVNQDR-ZIOPAAQOSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA2A,infectious disease,generalized demodicosis
amitriptyline,KRMDCWKBEZIMAB-UHFFFAOYSA-N,Launched,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin–norepinephrine reuptake inhibitor (SNRI),ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4,neurology/psychiatry,depression
amlexanox,SGRYPYWGNKJSDL-UHFFFAOYSA-N,Launched,histamine receptor modulator,FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13,dental|pulmonary|ophthalmology|allergy,aphthous ulcers|asthma|conjunctivitis|allergic rhinitis
amlodipine,HTIQEAQVCYTUBX-QGZVFWFLSA-N,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1,cardiology,hypertension|chronic stable angina|vasospastic angina|coronary artery disease (CAD)
ammonium-glycyrrhizinate,LPLVUJXQOOQHMX-QWBHMCJMSA-N,Launched,thrombin inhibitor,HSD11B1|HSD11B2|SLCO1B1|SLCO1B3,dermatology,cosmetic
ammonium-lactate,RZOBLYBZQXQGFY-HSHFZTNMSA-N,Launched,,HCAR1,dermatology,xerosis cutis|ichthyosis vulgaris
ammonium-perfluorocaprylate,SNGREZUHAYWORS-UHFFFAOYSA-N,Phase 1,Pim kinase inhibitor,PIM1,,
AMN-082,DTZDSNQYNPNCPK-UHFFFAOYSA-N,Preclinical,glutamate receptor modulator,GRM7,,
amodiaquine,OVCDSSHSILBFBN-UHFFFAOYSA-N,Launched,histamine receptor agonist,HNMT,infectious disease,malaria
amonafide,UPALIKSFLSVKIS-UHFFFAOYSA-N,Phase 3,topoisomerase inhibitor,TOP2A|TOP2B,,
amorolfine,MQHLMHIZUIDKOO-KURKYZTESA-N,Launched,membrane integrity inhibitor,,infectious disease,onychomycosis
amoxapine,QWGDMFLQWFTERH-UHFFFAOYSA-N,Launched,norepinephrine reputake inhibitor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression
amoxicillin,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,Launched,penicillin binding protein inhibitor,CYP2C19|SLC15A1|SLC15A2|SLC22A6,infectious disease|gastroenterology,skin infections|duodenal ulcer disease|gonorrhea|ear infections|throat infections|genitourinary tract infections|respiratory tract infections
AMPA-(RS),UUDAMDVQRQNNHZ-RXMQYKEDSA-N,Preclinical,glutamate receptor agonist,GRIN1,,
AMPA-(S),UUDAMDVQRQNNHZ-YFKPBYRVSA-N,Preclinical,glutamate receptor agonist,GRIA2|GRIN1,,
ampalex,ANDGGVOPIJEHOF-UHFFFAOYSA-N,Phase 2,glutamate receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,,
amperozide,NNAIYOXJNVGUOM-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,FAAH|HTR2A,neurology/psychiatry,psychosis
amphotericin-b,APKFDSVGJQXUKY-ZNVUZQDLSA-N,Launched,membrane permeability enhancer,,infectious disease,fungal infection
ampicillin,AVKUERGKIZMTKX-NJBDSQKTSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|meningitis|bacterial septicemia|endocarditis|urinary tract infections|gastrointestinal infections
ampiroxicam,LSNWBKACGXCGAJ-ZDUSSCGKSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
amprenavir,YMARZQAQMVYCKC-OEMFJLHTSA-N,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
amprolium,IPZFPROOBOUEIG-UHFFFAOYSA-N,Launched,thiamine uptake blocker,,infectious disease,coccidiosis
ampyrone,RLFWWDJHLFCNIJ-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,,,
amrinone,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE3A|PDE3B|PDE4B|TNF,cardiology,congestive heart failure
amrubicin,VJZITPJGSQKZMX-XDPRQOKASA-N,Launched,topoisomerase inhibitor,TOP2A|TOP2B,oncology,small cell lung cancer
amsacrine,XCPGHVQEEXUHNC-UHFFFAOYSA-N,Launched,topoisomerase inhibitor,KCNH2|TOP2A,hematologic malignancy,acute lymphoblastic leukemia (ALL)
amthamine,LHVRFUVVRXGZPV-UHFFFAOYSA-N,Preclinical,histamine receptor agonist,HRH2,,
amtolmetin-guacil,CWJNMKKMGIAGDK-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,rheumatoid arthritis|osteoarthritis
amuvatinib,FOFDIMHVKGYHRU-UHFFFAOYSA-N,Phase 2,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,,
amuvatinib,"InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)",Phase 2,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,KIT|MET,,
amygdalin,XUCIJNAGGSZNQT-JHSLDZJXSA-N,Phase 2,caspase activator,CASP3,,
amyl-nitrite,GVGUCRAJNQYOSE-UHFFFAOYSA-N,Preclinical,atrial natriuretic peptide receptor agonist,,,
amyleine,FDMBBCOBEAVDAO-AWEZNQCLSA-N,Preclinical,local anesthetic,,,
amylene-hydrate,MSXVEPNJUHWQHW-UHFFFAOYSA-N,Preclinical,local anesthetic,,,
AMZ30,GUCUORSUHTZMBW-YBFXNURJSA-N,Preclinical,protein phosphatase inhibitor,,,
AN2718,HMAFTPZYFJFEHK-UHFFFAOYSA-N,Phase 1,leucyl-tRNA synthetase inhibitor,,,
ANA-12,TUSCYCAIGRVBMD-KRWDZBQOSA-N,Preclinical,tropomyosin receptor kinase inhibitor,NTRK2,,
anabasine,MTXSIJUGVMTTMU-SNVBAGLBSA-N,Preclinical,acetylcholine receptor agonist,,,
anacetrapib,MZZLGJHLQGUVPN-HAWMADMCSA-N,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,,
anagliptin,LDXYBEHACFJIEL-HNNXBMFYSA-N,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus
anagrelide,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE3A,hematology|hematologic malignancy,thrombocythemia|myeloproliferative neoplasms
anamorelin,VQPFSIRUEPQQPP-MXBOTTGLSA-N,Phase 3,growth hormone secretagogue receptor agonist,GHSR,,
anandamide,LGEQQWMQCRIYKG-DOFZRALJSA-N,Phase 2,cannabinoid receptor agonist,CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1,,
anastrozole,YBBLVLTVTVSKRW-UHFFFAOYSA-N,Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer
andarine,YVXVTLGIDOACBJ-SFHVURJKSA-N,Phase 1,androgen receptor modulator,AR,,
andrographolide,BOJKULTULYSRAS-OTESTREVSA-N,Phase 2,tumor necrosis factor production inhibitor,IL1B|IL6|NFKB1|NFKB2|TNF,,
androstenone,HFVMLYAGWXSTQI-UGRKVPRCSA-N,Preclinical,steroid,,,
androsterone,QGXBDMJGAMFCBF-HLUDHZFRSA-N,Preclinical,androgen receptor agonist,,,
anecortave-acetate,YUWPMEXLKGOSBF-GACAOOTBSA-N,Launched,angiogenesis inhibitor,,ophthalmology,macular degeneration
anethole,RUVINXPYWBROJD-ONEGZZNKSA-N,Launched,glutathione transferase stimulant,,,
anethole-trithione,KYLIZBIRMBGUOP-UHFFFAOYSA-N,Launched,glutathione transferase stimulant,,dental,xerostomia
anguidine,AUGQEEXBDZWUJY-ZLJUKNTDSA-N,Phase 2,protein synthesis inhibitor,SLC5A1,,
anidulafungin,JHVAMHSQVVQIOT-MFAJLEFUSA-N,Launched,"fungal 1,3-beta-D-glucan synthase inhibitor",,infectious disease,candidemia|fungal infection|esophageal candidiasis
aniracetam,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,Launched,glutamate receptor agonist,DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A,,
anisindione,XRCFXMGQEVUZFC-UHFFFAOYSA-N,Launched,vitamin K antagonist,GGCX,hematology,deep vein thrombosis (DVT)
anisodamine,WTQYWNWRJNXDEG-JKJDWNRSSA-N,Phase 3,lipid peroxidase inhibitor,ADRA1A,,
anisomycin,YKJYKKNCCRKFSL-RDBSUJKOSA-N,Preclinical,DNA synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,,
anisotropine,XGGHHHBGPSNXFE-ZSHCYNCHSA-N,Launched,acetylcholine receptor antagonist,,gastroenterology,peptic ulcer disease (PUD)
anlotinib,KSMZEXLVHXZPEF-UHFFFAOYSA-N,Launched,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR|PDGFRB,,
anpirtoline,GGALEXMXDMUMDM-UHFFFAOYSA-N,Phase 1,serotonin receptor agonist,HTR1B,,
ANR-94,QUGDTMONBLMLLD-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA2A,,
ansamitocin-p-3,OPQNCARIZFLNLF-HSBZPDDFSA-N,Preclinical,apoptosis stimulant,,,
antagonist-g,CUCSSYAUKKIDJV-FAXBSAIASA-N,Phase 1,neuropeptide receptor antagonist,MAPK8,,
antalarmin,IXPROWGEHNVJOY-UHFFFAOYSA-N,Preclinical,corticotropin releasing factor receptor antagonist,CRHR1,,
antazoline,REYFJDPCWQRWAA-UHFFFAOYSA-N,Launched,antihistamine,HRH1,ophthalmology|otolaryngology,conjunctivitis|nasal congestion
anthralin,NUZWLKWWNNJHPT-UHFFFAOYSA-N,Launched,DNA synthesis inhibitor,,dermatology,psoriasis
anthraquinone,RZVHIXYEVGDQDX-UHFFFAOYSA-N,Preclinical,CDC inhibitor,CDC25B,,
antimony-potassium,ZCIXFSVENQDMCK-SOMOIXMJSA-J,Phase 2,,,,
antimonyl,ZCIXFSVENQDMCK-UHFFFAOYSA-J,Phase 1,,,,
antimycin-A,UIFFUZWRFRDZJC-SBOOETFBSA-N,Preclinical,ATP synthase inhibitor,CYCS,,
antioxine,RECUKUPTGUEGMW-UHFFFAOYSA-N,Launched,,,,
AP-18,MHTJEUOFLVQMCL-NJHPPEEMSA-N,Preclinical,transient receptor potential channel antagonist,TRPA1,,
AP1903,GQLCLPLEEOUJQC-ZTQDTCGGSA-N,Phase 1/Phase 2,,MTOR,,
AP26113,OVDSPTSBIQCAIN-UHFFFAOYSA-N,Phase 2,ALK tyrosine kinase receptor inhibitor,ALK|EGFR,,
apabetalone,NETXMUIMUZJUTB-UHFFFAOYSA-N,Phase 3,apolipoprotein expression enhancer,BRD3,,
apafant,JGPJQFOROWSRRS-UHFFFAOYSA-N,Phase 3,platelet activating factor receptor antagonist,PTAFR,,
apalutamide,HJBWBFZLDZWPHF-UHFFFAOYSA-N,Launched,androgen receptor antagonist,,oncology,prostate cancer
apararenone,AZNHWXAFPBYFGH-UHFFFAOYSA-N,Preclinical,mineralocorticoid receptor antagonist,,,
apatinib,WPEWQEMJFLWMLV-UHFFFAOYSA-N,Phase 3,RET tyrosine kinase inhibitor,CSK|KDR|KIT|RET,,
APC-100,SEBPXHSZHLFWRL-UHFFFAOYSA-N,Phase 1/Phase 2,androgen receptor antagonist|anti-inflammatory agent,AR,,
APcK-110,CAMGZGMEPKFVMF-UHFFFAOYSA-N,Preclinical,KIT inhibitor,KIT|STAT3,,
APD597,WPDCHTSXOPUOII-UHFFFAOYSA-N,Phase 1,glucose dependent insulinotropic receptor agonist,GPR119,,
APD668,XTRUQJBVQBUKSQ-UHFFFAOYSA-N,Phase 1,glucose dependent insulinotropic receptor agonist,GPR119,,
aphidicolin,NOFOAYPPHIUXJR-APNQCZIXSA-N,Phase 1,RNA synthesis inhibitor,,,
API-001,DGPGXHRHNRYVDH-UHFFFAOYSA-N,Phase 2,sigma receptor antagonist,SIGMAR1,,
API-1,SPBWHPXCWJLQRU-FITJORAGSA-N,Preclinical,AKT inhibitor,AKT1|AKT2|AKT3,,
apigenin,KZNIFHPLKGYRTM-UHFFFAOYSA-N,Preclinical,casein kinase inhibitor|cell proliferation inhibitor,AKR1B1|AR|CDK6|CFTR|CYP19A1|CYP1B1|HSD17B1,,
apixaban,QNZCBYKSOIHPEH-UHFFFAOYSA-N,Launched,coagulation factor inhibitor,F10,neurology/psychiatry|hematology|cardiology,stroke|systemic embolism|pulmonary embolism (PE)|atrial fibrillation (AF)|deep vein thrombosis (DVT)
apocynin,DFYRUELUNQRZTB-UHFFFAOYSA-N,Phase 1,NADPH oxidase inhibitor,NOX4,,
apoptosis-activator-II,KGRJPLRFGLMQMV-UHFFFAOYSA-N,Preclinical,carboxylesterase inhibitor,BCHE|CES1,,
APR-246,BGBNULCRKBVAKL-SNVBAGLBSA-N,Phase 3,p53 activator,TP53,,
apraclonidine,IEJXVRYNEISIKR-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C,ophthalmology,glaucoma|intraocular pressure
apramycin,XZNUGFQTQHRASN-XQENGBIVSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections
apratastat,MAVDNGWEBZTACC-HNNXBMFYSA-N,Phase 2,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,ADAM17|MMP1|MMP13|MMP9,,
apremilast,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,dermatology|rheumatology,psoriasis|psoriatic arthritis
aprepitant,ATALOFNDEOCMKK-OITMNORJSA-N,Launched,tachykinin antagonist,TACR1,gastroenterology,nausea|vomiting
apricitabine,RYMCFYKJDVMSIR-RNFRBKRXSA-N,Phase 3,nucleoside reverse transcriptase inhibitor,,,
aprindine,NZLBHDRPUJLHCE-UHFFFAOYSA-N,Launched,voltage-gated sodium channel blocker,CALM1|SCN5A,cardiology,cardiac arrythmia
apronal,KSUUMAWCGDNLFK-ZETCQYMHSA-N,Preclinical,cytochrome P450 modulator,,,
aptiganel,BFNCJMURTMZBTE-UHFFFAOYSA-N,Phase 3,glutamate receptor antagonist,GRIN1,,
APTO-253,NIRXBXIPHUTNNI-UHFFFAOYSA-N,Phase 1,krüppel-like factor expression enhancer,KLF4,,
APY-29,WJNBSTLIALIIEW-UHFFFAOYSA-N,Preclinical,serine/threonine kinase inhibitor,ERN1,,
APY0201,RFZQYGBLRIKROZ-PCLIKHOPSA-N,Preclinical,phosphoinositide dependent kinase inhibitor,IL12A|IL12B|PIKFYVE,,
apyramide,KWUFTKVMXUYTBF-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,,,
AQ-13,NCPLTAGJJVCHOW-UHFFFAOYSA-N,Phase 2,antimalarial agent,,,
AQ-RA741,BCUGCHZRMKTPMU-UHFFFAOYSA-N,Preclinical,acetylcholine receptor antagonist,CHRM2,,
AQW-051,NPDLTEZXGWRMLQ-IBGZPJMESA-N,Preclinical,nicotinic receptor agonist,,,
AR-12,YULUCECVQOCQFQ-UHFFFAOYSA-N,Phase 1,phosphoinositide dependent kinase inhibitor,PDPK1,,
AR-42,LAMIXXKAWNLXOC-INIZCTEOSA-N,Phase 1,HDAC inhibitor,HDAC1,,
AR-A014418,YAEMHJKFIIIULI-UHFFFAOYSA-N,Preclinical,glycogen synthase kinase inhibitor,GSK3B,,
AR-C155858,ISIVOJWVBJIOFM-ZDUSSCGKSA-N,Preclinical,monocarboxylate transporter inhibitor,SLC16A1|SLC16A7,,
arachidonic-acid,YZXBAPSDXZZRGB-DOFZRALJSA-N,Phase 1,cytochrome P450 inhibitor,CLCN2|KCNJ4|KCNK10|KCNK18|KCNK2|PRKCZ|PTGS1|TRPC6|TRPM2,,
aramchol,SHKXZIQNFMOPBS-OOMQYRRCSA-N,Phase 2/Phase 3,stearoyl-CoA desaturase inhibitor,,,
arbidol,KCFYEAOKVJSACF-UHFFFAOYSA-N,Launched,cytochrome P450 inhibitor,CYP3A4,infectious disease,influenza A virus infection
arbutin,BJRNKVDFDLYUGJ-RMPHRYRLSA-N,Phase 2/Phase 3,melanin inhibitor,TYR,,
ARC-239,JFNKXGOEOQCXDM-UHFFFAOYSA-N,Preclinical,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,,
arctigenin,NQWVSMVXKMHKTF-JKSUJKDBSA-N,Preclinical,MEK inhibitor,CHUK|MAP2K1,,
arcyriaflavin-a,KAJXOWFGKYKMMZ-UHFFFAOYSA-N,Preclinical,CDK inhibitor,CCND1|CDK4,,
ardeparin,HXSDFQWQRCUQHF-IDOMHHBZSA-N,Withdrawn,thrombin inhibitor,SERPIND1,,
arecaidine-but-2-ynyl-ester,LBFWTPRSXIRKMZ-UHFFFAOYSA-N,Preclinical,acetylcholine receptor agonist,CHRM2,,
arecaidine-propargyl-ester,SPHRJZBOFYIKMC-UHFFFAOYSA-N,Preclinical,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,,
arecoline,HJJPJSXJAXAIPN-UHFFFAOYSA-N,Phase 1,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,,
argatroban,KXNPVXPOPUZYGB-XYVMCAHJSA-N,Launched,thrombin inhibitor,F2,hematology,heparin-induced thrombocytopenia (HIT)
argireline,RJZNPROJTJSYLC-LLINQDLYSA-N,Phase 3,neurotransmitter release inhibitor,,,
arglabin,UVJYAKBJSGRTHA-CUZKYEQNSA-N,Launched,farnesyltransferase inhibitor,FNTA|NFKB1,,
aripiprazole,CEUORZQYGODEFX-UHFFFAOYSA-N,Launched,serotonin receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7,neurology/psychiatry,depression|schizophrenia|bipolar disorder
aripiprazole-lauroxil,DDINXHAORAAYAD-UHFFFAOYSA-N,Launched,serotonin receptor agonist,,neurology/psychiatry,schizophrenia
arofylline,GVTLDPJNRVMCAL-UHFFFAOYSA-N,Phase 3,phosphodiesterase inhibitor,PDE4A,,
arotinolol,BHIAIPWSVYSKJS-SECBINFHSA-N,Launched,adrenergic receptor antagonist,ADRB3,cardiology|neurology/psychiatry,hypertension|tremors
ARQ-092,HNFMVVHMKGFCMB-UHFFFAOYSA-N,Phase 1,AKT inhibitor,AKT2,,
ARQ-621,UPJSUQWHUVLLNW-XMMPIXPASA-N,Phase 1,kinesin-like spindle protein inhibitor,KIF11,,
ARRY-334543,UWXSAYUXVSFDBQ-CYBMUJFWSA-N,Phase 2/Phase 3,EGFR inhibitor,ERBB2,,
arsanilic-acid,XKNKHVGWJDPIRJ-UHFFFAOYSA-N,Phase 1,,LYZ,,
arsenic-trioxide,IKWTVSLWAPBBKU-UHFFFAOYSA-N,Launched,apoptosis stimulant,AKT1|CCND1|IKBKB|JUN|MAPK1|MAPK3|TXNRD1,gastroenterology,diarrhea
artemether,SXYIRMFQILZOAM-HVNFFKDJSA-N,Launched,antimalarial agent,ATP1A1,infectious disease,malaria
artemisinin,BLUAFEHZUWYNDE-NNWCWBAJSA-N,Launched,DNA synthesis inhibitor,CYP2B6,infectious disease,malaria
artemotil,NLYNIRQVMRLPIQ-XQLAAWPRSA-N,Launched,,,infectious disease,malaria
artesunate,FIHJKUPKCHIPAT-AHIGJZGOSA-N,Launched,DNA synthesis inhibitor,,infectious disease,malaria
articaine,QTGIAADRBBLJGA-VIFPVBQESA-N,Launched,local anesthetic,,neurology/psychiatry,local anesthetic
arundic-acid,YCYMCMYLORLIJX-SNVBAGLBSA-N,Phase 2/Phase 3,astrocyte modulating agent,PTGS2|S100B,,
ARV-825,RWLOGRLTDKDANT-ZPGRZCPFSA-N,Preclinical,bromodomain inhibitor,BRD4,,
AS-1269574,DUKPGOOUJNUIOI-UHFFFAOYSA-N,Preclinical,glucose dependent insulinotropic receptor agonist,GPR119,,
AS-1892802,WDTFYYZHMRBVHK-LJQANCHMSA-N,Preclinical,rho associated kinase inhibitor,ROCK1,,
AS-1949490,RFZPGNRLOKVZJY-AWEZNQCLSA-N,Preclinical,SHIP2 phosphatase inhibitor,INPP5D,,
AS-2034178,VENOXIKBBUVHRY-UHFFFAOYSA-N,Preclinical,free fatty acid receptor agonist,FFAR1,,
AS-2444697,JANBIXNDYNRYQP-UHFFFAOYSA-N,Preclinical,interleukin inhibitor,IRAK4,,
AS-252424,OYYVWNDMOQPMGE-SDQBBNPISA-N,Preclinical,PI3K inhibitor,PIK3CG,,
AS-604850,SRLVNYDXMUGOFI-YWEYNIOJSA-N,Preclinical,PI3K inhibitor,PIK3CA|PIK3CG,,
AS-703026,VIUAUNHCRHHYNE-JTQLQIEISA-N,Phase 2,MEK inhibitor,MAP2K1|MAP2K2,,
AS-77,KINMYBBFQRSVLL-UHFFFAOYSA-N,Phase 1,potassium channel blocker,KCNA3|KCNA5|KCNN4,,
ASA-404,XGOYIMQSIKSOBS-UHFFFAOYSA-N,Phase 3,angiogenesis inhibitor,,,
asapiprant,ZMZNWNTZRWXTJU-UHFFFAOYSA-N,Preclinical,prostaglandin inhibitor,,,
asaraldehyde,IAJBQAYHSQIQRE-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,PTGS2,,
ASC-J9,ZMGUKFHHNQMKJI-URFDALOKSA-N,Phase 2,androgen receptor enhancer,AR,,
asciminib,VOVZXURTCKPRDQ-CQSZACIVSA-N,Phase 2,Bcr-Abl kinase inhibitor,,,
ascomycin,ZDQSOHOQTUFQEM-MONOPTSESA-N,Preclinical,calcineurin inhibitor,FKBP1A,,
ascorbic-acid,KRGQEOSDQHTZMX-TXQLHFEISA-N,Launched,antioxidant,SLC23A1|SLC23A2,endocrinology,scurvy
asenapine,VSWBSWWIRNCQIJ-HUUCEWRRSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A,neurology/psychiatry,schizophrenia|bipolar disorder
asiatic-acid,JXSVIVRDWWRQRT-UYDOISQJSA-N,Preclinical,apoptosis stimulant,PYGM,,
asimadoline,JHLHNYVMZCADTC-LOSJGSFVSA-N,Phase 3,opioid receptor agonist,OPRK1,,
asivatrep,UKGJZDSUJSPAJL-YPUOHESYSA-N,Phase 3,transient receptor potential channel antagonist,,,
ASP-2535,FQGLDGKVKDPVLO-UHFFFAOYSA-N,Phase 1,glycine transporter inhibitor,SLC6A9,,
ASP-6537,OBAICMYWONZOSZ-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,,,
ASP-9521,OXSCPDKUZWPWFR-UHFFFAOYSA-N,Preclinical,aldo-keto reductase inhibitor,,,
ASP3026,MGGBYMDAPCCKCT-UHFFFAOYSA-N,Phase 1,ALK tyrosine kinase receptor inhibitor,ALK,,
aspartame,IAOZJIPTCAWIRG-QWRGUYRKSA-N,Launched,,TAS1R2|TRPV1,,
aspirin,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53,neurology/psychiatry|endocrinology|dental,headache|fever|toothache|muscle pain
AST-1306,MVZGYPSXNDCANY-UHFFFAOYSA-N,Phase 1,EGFR inhibitor,EGFR|ERBB2,,
astaxanthin,MQZIGYBFDRPAKN-UWFIBFSHSA-N,Launched,antioxidant,,,
astemizole,GXDALQBWZGODGZ-UHFFFAOYSA-N,Withdrawn,histamine receptor antagonist,HRH1|KCNH1|KCNH2,,
astilbin,ZROGCCBNZBKLEL-MPRHSVQHSA-N,Preclinical,nuclear factor erythroid derived|like (NRF2) activator,,,
astragaloside-a,QMNWISYXSJWHRY-AUJDEUPOSA-N,Preclinical,anti-inflammatory agent,,,
ASTX660,YCXOHEXZVKOGEV-DNRQZRRGSA-N,Phase 1/Phase 2,apoptosis inhibitor,,,
asunaprevir,XRWSZZJLZRKHHD-WVWIJVSJSA-N,Phase 3,HCV inhibitor,,,
asymmetrical-dimethylarginine,YDGMGEXADBMOMJ-LURJTMIESA-N,Phase 1,nitric oxide synthase inhibitor,NOS2|NOS3,,
AT-1015,BSPMYKLEFGUTSI-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR2A,,
AT-406,LSXUTRRVVSPWDZ-MKKUMYSQSA-N,Phase 1,IAP antagonist ,,,
AT-7519,OVPNQJVDAFNBDN-UHFFFAOYSA-N,Phase 2,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK6|CDK9,,
AT-9283,LOLPPWBBNUVNQZ-UHFFFAOYSA-N,Phase 2,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,,
AT-9283,"InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)",Phase 2,Aurora kinase inhibitor|JAK inhibitor,AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A,,
AT13148,IIRWNGPLJQXWFJ-KRWDZBQOSA-N,Phase 1,protein kinase inhibitor,AKT1|AKT2|AKT3|ROCK1|ROCK2|SGK3,,
AT13387,IFRGXKKQHBVPCQ-UHFFFAOYSA-N,Phase 2,HSP inhibitor,HSP90AA1,,
AT7867,LZMOSYUFVYJEPY-UHFFFAOYSA-N,Preclinical,AKT inhibitor,AKT2|GSK3B|PKIA|PRKACA,,
ataluren,OOUGLTULBSNHNF-UHFFFAOYSA-N,Launched,CFTR channel agonist|dystrophin stimulant,DMD,genetics|pulmonary,duchenne muscular dystrophy (DMD)|cystic fibrosis
atazanavir,AXRYRYVKAWYZBR-GASGPIRDSA-N,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
ATB-346,YCNMAPLPQYQJFC-CYBMUJFWSA-N,Phase 2,cyclooxygenase inhibitor,PTGER2,,
atenolol-(-),METKIMKYRPQLGS-LBPRGKRZSA-N,Launched,adrenergic receptor antagonist,,cardiology,hypertension
atenolol-(+),METKIMKYRPQLGS-GFCCVEGCSA-N,Preclinical,adrenergic receptor antagonist,,,
atenolol-(+/-),METKIMKYRPQLGS-GFCCVEGCSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|LTF|PLA2G2E,cardiology,hypertension|angina pectoris
atglistatin,AWOPBSAJHCUSAS-UHFFFAOYSA-N,Preclinical,adipose triglyceride lipase inhibitor,,,
aticaprant,ZHPMYDSXGRRERG-DEOSSOPVSA-N,Phase 2,opioid receptor antagonist,,,
atipamezole,HSWPZIDYAHLZDD-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,,neurology/psychiatry,reverse sedative
atiprimod,SERHTTSLBVGRBY-UHFFFAOYSA-N,Phase 2,JAK inhibitor|STAT inhibitor,JAK2|STAT3,,
atizoram,LITNEAPWQHVPOK-FFSVYQOJSA-N,Phase 2,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,,
ATN-161,MMHDBUJXLOFTLC-WOYTXXSLSA-N,Phase 2,integrin antagonist,ITGA5|ITGAV|ITGB1|ITGB3,,
atomoxetine,VHGCDTVCOLNTBX-QGZVFWFLSA-N,Launched,norepinephrine transporter inhibitor,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,attention-deficit/hyperactivity disorder (ADHD)
atorvastatin,XUKUURHRXDUEBC-KAYWLYCHSA-N,Launched,HMGCR inhibitor,AHR|DPP4|HMGCR,neurology/psychiatry|cardiology,stroke|heart attack
atosiban,VWXRQYYUEIYXCZ-ZJBFWUDNSA-N,Launched,oxytocin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,neurology/psychiatry|cardiology|endocrinology,stroke|angina pectoris|myocardial infarction|hyperlipidemia
atovaquone,UYFLKEIEOREOFC-ZXYWRSMDSA-N,Launched,mitochondrial electron transport inhibitor,,infectious disease,pneumonia
ATPA,PIXJURSCCVBKRF-ZCFIWIBFSA-N,Preclinical,glutamate receptor agonist,GRIK1,,
atractylenolide-i,ZTVSGQPHMUYCRS-SWLSCSKDSA-N,Preclinical,JAK inhibitor,,,
atracurium,YXSLJKQTIDHPOT-MWAPPURBSA-N,Launched,acetylcholine receptor antagonist,,critical care|neurology/psychiatry,endotracheal intubation|muscle relaxant
atrasentan,MOTJMGVDPWRKOC-QPVYNBJUSA-N,Phase 3,endothelin receptor antagonist,EDNRA,,
atropine,RKUNBYITZUJHSG-JJXSEGSLSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,ophthalmology,cycloplegia|mydriasis|amblyopia
atropine-oxide,HGWPFSBHDACWNL-JFBPSJKJSA-N,Preclinical,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,,
atuveciclib,ACWKGTGIJRCOOM-HHHXNRCGSA-N,Phase 1,CDK9 inhibitor,,,
auranofin,AUJRCFUBUPVWSZ-XTZHGVARSA-M,Launched,NFkB pathway inhibitor,IKBKB|PRDX5|TRPA1,rheumatology,rheumatoid arthritis
aurora-a-inhibitor-i,AKSIZPIFQAYJGF-UHFFFAOYSA-N,Preclinical,Aurora kinase inhibitor,AURKA,,
aurothioglucose,XHVAWZZCDCWGBK-WYRLRVFGSA-M,Launched,PKC inhibitor,PRKCI,rheumatology,rheumatoid arthritis
AUT-1,AMAOXEGBJHLCSF-CQSZACIVSA-N,Preclinical,potassium channel activator,,,
autotaxin-modulator-1,PZASAAIJIFDWSB-PQGZPOPSSA-N,Preclinical,autotaxin inhibitor,ENPP2,,
AV-412,ZAJXXUDARPGGOC-UHFFFAOYSA-N,Phase 1,protein tyrosine kinase inhibitor,EGFR|ERBB2,,
AV-608,NXLUTEDAEFXMQR-BJKOFHAPSA-N,Phase 2,tachykinin antagonist,TACR1,,
avacopan,PUKBOVABABRILL-YZNIXAGQSA-N,Phase 2,complement inhibitor,,,
avadomide,RSNPAKAFCAAMBH-JTQLQIEISA-N,Phase 2,antitumor agent,,,
avagacestat,XEAOPVUAMONVLA-QGZVFWFLSA-N,Phase 2,gamma secretase inhibitor,PSEN1,,
avanafil,WEAJZXNPAWBCOA-INIZCTEOSA-N,Launched,phosphodiesterase inhibitor,PDE5A,urology,erectile dysfunction
avapritinib,DWYRIWUZIJHQKQ-SANMLTNESA-N,Launched,KIT inhibitor,,,
avasimibe,PTQXTEKSNBVPQJ-UHFFFAOYSA-N,Phase 3,ACAT inhibitor,CES1,,
avatrombopag,OFZJKCQENFPZBH-UHFFFAOYSA-N,Launched,thrombopoietin receptor agonist,MPL,hematology,thrombocytopenia
AVE-0991,QTOZBSNPDCWHPV-UHFFFAOYSA-N,Preclinical,angiotensin receptor agonist,MRGPRX1,,
AVE-3085,OKCJNSDIVCXYAL-UHFFFAOYSA-N,Preclinical,nitric oxide synthase stimulant,,,
AVex-73,BOTHKNZTGGXFEQ-GOSISDBHSA-N,Preclinical,sigma receptor agonist,,,
avibactam,NDCUAPJVLWFHHB-UHNVWZDZSA-N,Launched,beta lactamase inhibitor,,infectious disease,intra-abdominal infections|urinary tract infections|pyelonephritis
avitinib,UOFYSRZSLXWIQB-UHFFFAOYSA-N,Phase 2,EGFR inhibitor,,,
AVL-292,KXBDTLQSDKGAEB-UHFFFAOYSA-N,Phase 2,Bruton's tyrosine kinase (BTK) inhibitor,BTK|YES1,,
AVN-492,SNPPEHMSSOEYDH-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,,,
AVN-944,GYCPCOJTCINIFZ-OXJNMPFZSA-N,Phase 2,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,,
avobenzone,LKIIIESDXWZZRE-UHFFFAOYSA-N,Launched,topical sunscreen agent,,dermatology,cosmetic|sunscreen lotion
avoralstat,TUWMKPVJGGWGNL-UHFFFAOYSA-N,Phase 3,kallikrein inhibitor,,,
avridine,WXNRAKRZUCLRBP-UHFFFAOYSA-N,Preclinical,immunostimulant,,,
AX-024,VMMKGVRPILDZML-UHFFFAOYSA-N,Preclinical,cytokine production inhibitor,,,
axitinib,RITAVMQDGBJQJZ-FMIVXFBMSA-N,Launched,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|FLT1|FLT4|KDR|PLK4,oncology,renal cell carcinoma (RCC)
AY-9944,RZRPZWGIOOZIBE-IYARVYRRSA-N,Preclinical,hedgehog pathway modulator,,,
AZ-10417808,VUBILPOZTRGZJK-UHFFFAOYSA-N,Preclinical,caspase inhibitor,CASP3,,
AZ-10606120,FQMZXMVHHKXGTM-UHFFFAOYSA-N,Preclinical,purinergic receptor antagonist,P2RX7,,
AZ-12080282,KMSKKYBHDQYHMC-UHFFFAOYSA-N,Preclinical,hedgehog pathway inhibitor,DHH,,
AZ-628,ZGBGPEDJXCYQPH-UHFFFAOYSA-N,Preclinical,RAF inhibitor,BRAF|RAF1,,
AZ-7371,VDRYGTNDKXIPSK-UHFFFAOYSA-N,Preclinical,antibacterial ,,,
AZ191,ZYVXTMKTGDARKR-UHFFFAOYSA-N,Preclinical,DYRK inhibitor,DYRK1B,,
AZ20,SCGCBAAYLFTIJU-CQSZACIVSA-N,Preclinical,ATR kinase inhibitor,ATR|MTOR,,
AZ3146,YUKWVHPTFRQHMF-UHFFFAOYSA-N,Preclinical,monopolar spindle 1 kinase inhibitor,,,
AZ505,LIBVHXXKHSODII-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,SMYD2,,
AZ5104,IQNVEOMHJHBNHC-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR,,
AZ7550,ZROCWKZRGJYPTG-UHFFFAOYSA-N,Phase 1,insulin growth factor receptor inhibitor,,,
AZ960,SUNXHXDJOIXABJ-NSHDSACASA-N,Preclinical,JAK inhibitor,JAK2,,
azacitidine,NMUSYJAQQFHJEW-KVTDHHQDSA-N,Launched,DNA methyltransferase inhibitor,DNMT1|DNMT3A,hematologic malignancy|hematology,myelodysplastic diseases (MDS)|anemia|chronic myelomonocytic leukemia (CMMoL)
azacyclonol,ZMISODWVFHHWNR-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,HRH1,,
azaguanine-8,LPXQRXLUHJKZIE-UHFFFAOYSA-N,Preclinical,purine antagonist,PNP,,
azalomycin-B,OSERMIPXNLXAPD-MJMYBOKFSA-N,Preclinical,bacterial 50S ribosomal subunit inhibitor,,,
azaperone,XTKDAFGWCDAMPY-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD2|DRD3,neurology/psychiatry,sedative
azapropazone,MPHPHYZQRGLTBO-LLVKDONJSA-N,Withdrawn,cyclooxygenase inhibitor,PTGS2,,
azaserine,YXEASJLRXGZRHS-VKHMYHEASA-O,Preclinical,purine antagonist,,,
azasetron,WUKZPHOXUVCQOR-ZDUSSCGKSA-N,Launched,serotonin receptor antagonist,HTR3A|HTR3B,infectious disease,genitial herpes
azatadine,SEBMTIQKRHYNIT-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis
azathioprine,LMEKQMALGUDUQG-UHFFFAOYSA-N,Launched,dehydrogenase inhibitor,HPRT1|IMPDH1|PPAT,transplant|rheumatology,renal homotransplantation|rheumatoid arthritis
AZD0156,AOTRIQLYUAFVSC-UHFFFAOYSA-N,Phase 1,ATM kinase inhibitor,,,
AZD1080,RDXUCTYBYOIJGA-UHFFFAOYSA-N,Phase 1,glycogen synthase kinase inhibitor,GSK3A|GSK3B,,
AZD1208,MCUJKPPARUPFJM-UWCCDQBKSA-N,Phase 1,Pim kinase inhibitor,PIM1|PIM2|PIM3,,
AZD1283,NEMHKCNXXRQYRF-UHFFFAOYSA-N,Preclinical,purinergic receptor antagonist,P2RY12,,
AZD1390,VQSZIPCGAGVRRP-UHFFFAOYSA-N,Phase 1,ATM kinase inhibitor,,,
AZD1446,GTUIQNHJSXQMKW-HTQZYQBOSA-N,Phase 2,acetylcholine receptor agonist,CHRNA4|CHRNB2,,
AZD1480,PDOQBOJDRPLBQU-QMMMGPOBSA-N,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,,
AZD1981,JWYIGNODXSRKGP-UHFFFAOYSA-N,Phase 2,CRTH receptor antagonist,PTGDR2,,
AZD2014,JUSFANSTBFGBAF-IRXDYDNUSA-N,Phase 2,mTOR inhibitor,MTOR,,
AZD2461,HYNBNUYQTQIHJK-UHFFFAOYSA-N,Phase 1,PARP inhibitor,,,
AZD2858,FHCSBLWRGCOVPT-UHFFFAOYSA-N,Preclinical,glycogen synthase kinase inhibitor,GSK3B,,
AZD3264,NMFIXEFNQPDISY-ZDUSSCGKSA-N,Preclinical,IKK inhibitor,IKBKB,,
AZD3463,GCYIGMXOIWJGBU-UHFFFAOYSA-N,Preclinical,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,ALK|IGF1R,,
AZD3514,JMEYDSHPKCSIJC-UHFFFAOYSA-N,Phase 1,androgen receptor modulator,AR,,
AZD3759,MXDSJQHFFDGFDK-CYBMUJFWSA-N,Phase 2/Phase 3,EGFR inhibitor,EGFR,,
AZD3839,MRXBCEQZNKUUIP-DEOSSOPVSA-N,Phase 1,beta-secretase inhibitor,BACE1,,
AZD3965,PRNXOFBDXNTIFG-FQEVSTJZSA-N,Phase 1,monocarboxylate transporter inhibitor,SLC16A1,,
AZD3988,NGEBYTLALFOQKI-HDJSIYSDSA-N,Preclinical,diacylglycerol kinase inhibitor,DGAT1,,
AZD4282,DHMQDGOQFOQNFH-UHFFFAOYSA-N,Phase 1,glutamate receptor antagonist,AGXT|AGXT2|ALAS1|ALAS2|BAAT|GARS|GATM|GCAT|GCSH|GLDC|GLRA1|GLRA2|GLRA3|GLRB|GLYAT|GLYATL1|GLYATL2|GNMT|GPR18|GPRC6A|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3B|GSS|PIPOX|SHMT1|SHMT2|SLC32A1|SLC36A1|SLC6A5|SLC6A9,,
AZD4547,VRQMAABPASPXMW-HDICACEKSA-N,Phase 2/Phase 3,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,,
AZD4547,"InChI=1S/C26H33N5O3/c1-17-15-31(16-18(2)27-17)22-9-6-20(7-10-22)26(32)28-25-13-21(29-30-25)8-5-19-11-23(33-3)14-24(12-19)34-4/h6-7,9-14,17-18,27H,5,8,15-16H2,1-4H3,(H2,28,29,30,32)/t17-,18+",Phase 2/Phase 3,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR,,
AZD4573,AVIWDYSJSPOOAR-LSDHHAIUSA-N,Phase 1,CDK9 inhibitor,,,
AZD4635,NCWQLHHDGDXIJN-UHFFFAOYSA-N,Phase 1/Phase 2,adenosine receptor antagonist,,,
AZD5069,QZECRCLSIGFCIO-RISCZKNCSA-N,Phase 2,CC chemokine receptor antagonist,CXCR2,,
AZD5153,RSMYFSPOTCDHHJ-GOSISDBHSA-N,Phase 1,bromodomain inhibitor,,,
AZD5363,JDUBGYFRJFOXQC-KRWDZBQOSA-N,Phase 3,AKT inhibitor,AKT1|AKT2|AKT3,,
AZD5438,WJRRGYBTGDJBFX-UHFFFAOYSA-N,Phase 1,CDK inhibitor,KCNH2,,
AZD5438,"InChI=1S/C18H21N5O2S/c1-12(2)23-13(3)20-11-17(23)16-9-10-19-18(22-16)21-14-5-7-15(8-6-14)26(4,24)25/h5-12H,1-4H3,(H,19,21,22)",Phase 1,CDK inhibitor,KCNH2,,
AZD5582,WLMCRYCCYXHPQF-ZVMUOSSASA-N,Preclinical,XIAP inhibitor,BIRC2|BIRC3|XIAP,,
AZD5991,KBQCEQAXHPIRTF-UHFFFAOYSA-N,Phase 1,MCL1 inhibitor,,,
AZD6482,IRTDIKMSKMREGO-OAHLLOKOSA-N,Phase 1,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
AZD6738,OHUHVTCQTUDPIJ-MUWSIPGASA-N,Phase 2,ATR kinase inhibitor,ATR,,
AZD6765,FWUQWDCOOWEXRY-ZDUSSCGKSA-N,Phase 2,glutamate receptor antagonist,GRIN1,,
AZD7545,DTDZLJHKVNTQGZ-GOSISDBHSA-N,Phase 1,pyruvate dehydrogenase kinase inhibitor,PDK1,,
AZD7594,ZZWJKLGCDHYVMB-BWGXUDETSA-N,Phase 2,glucocorticoid receptor modulator,,,
AZD7687,YXFNPRHZMOGREC-SHTZXODSSA-N,Phase 1,diacylglycerol O acyltransferase inhibitor,DGAT1,,
AZD7762,IAYGCINLNONXHY-LBPRGKRZSA-N,Phase 1,CHK inhibitor,CHEK1|CHEK2,,
AZD7986,AEXFXNFMSAAELR-RXVVDRJESA-N,Phase 1,dipeptidyl peptidase inhibitor,,,
AZD8055,KVLFRAWTRWDEDF-IRXDYDNUSA-N,Phase 1,mTOR inhibitor,MTOR,,
AZD8186,LMJFJIDLEAWOQJ-CQSZACIVSA-N,Phase 1,PI3K inhibitor,PIK3CB|PIK3CD,,
AZD8330,RWEVIPRMPFNTLO-UHFFFAOYSA-N,Phase 1,MEK inhibitor,MAP3K1,,
AZD8797,ZMQSLMZOWVGBSM-GXTWGEPZSA-N,Preclinical,CC chemokine receptor antagonist,,,
AZD8835,ZGRDYKFVDCFJCZ-UHFFFAOYSA-N,Phase 1,PI3K inhibitor,PIK3CA|PIK3CD,,
AZD8931,DFJSJLGUIXFDJP-UHFFFAOYSA-N,Phase 2,EGFR inhibitor,EGFR|ERBB2|ERBB3,,
AZD9056,HSQAARMBHJCUOK-UHFFFAOYSA-N,Phase 2,purinergic receptor antagonist,,,
AZD9272,RBSPCALDSNXWEP-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRM5,,
AZD9496,DFBDRVGWBHBJNR-BBNFHIFMSA-N,Phase 1,estrogen receptor agonist,ESR1,,
AZD9668,QNQZWEGMKJBHEM-UHFFFAOYSA-N,Phase 2,elastase inhibitor,ELANE,,
azelaic-acid,BDJRBEYXGGNYIS-UHFFFAOYSA-N,Launched,tyrosinase inhibitor,AKR1D1|SRD5A2|TYR,dermatology,rosacea
azelastine,MBUVEWMHONZEQD-SFHVURJKSA-N,Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis
azeliragon,KJNNWYBAOPXVJY-UHFFFAOYSA-N,Phase 3,RAGE receptor antagonist,AGER,,
azelnidipine,ZKFQEACEUNWPMT-MUUNZHRXSA-N,Launched,calcium channel blocker,CACNA1C,cardiology,hypertension
azilsartan,KGSXMPPBFPAXLY-UHFFFAOYSA-N,Launched,angiotensin receptor antagonist,AGTR1|AGTR2,cardiology,hypertension
azilsartan-medoxomil,QJFSABGVXDWMIW-UHFFFAOYSA-N,Launched,angiotensin receptor antagonist,AGTR1|AGTR2,cardiology,hypertension
azimilide,MREBEPTUUMTTIA-PCLIKHOPSA-N,Phase 3,potassium channel blocker,KCNA5,,
azithromycin,MQTOSJVFKKJCRP-CBLJCGFISA-N,Launched,bacterial 50S ribosomal subunit inhibitor,MLNR,infectious disease,pelvic inflammatory disease|pneumonia
azlocillin,JTWOMNBEOCYFNV-NFFDBFGFSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections
AZM-475271,WPOXAFXHRJYEIC-UHFFFAOYSA-N,Preclinical,SRC inhibitor,SRC,,
azodicarbonamide,XOZUGNYVDXMRKW-AATRIKPKSA-N,Phase 2,DNA synthesis inhibitor,,,
azomycin-(2-nitroimidazole),YZEUHQHUFTYLPH-UHFFFAOYSA-N,Preclinical,protein synthesis inhibitor,,,
azosemide,HMEDEBAJARCKCT-UHFFFAOYSA-N,Launched,electrolyte reabsorption inhibitor,SLC12A1|SLC12A2,cardiology,edema
aztreonam,WZPBZJONDBGPKJ-VEHQQRBSSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|respiratory tract infections|bacterial septicemia|skin infections|intra-abdominal infections|gynecologic infections
bacampicillin,PFOLLRNADZZWEX-XIJZRVNUSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections
bacitracin,CLKOFPXJLQSYAH-BBLSSJOMSA-N,Launched,bacterial cell wall synthesis inhibitor,IDE,infectious disease,first-aid antibiotic
bacitracin-zinc,UCRLQOPRDMGYOA-PIGMFEANSA-L,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,first-aid antibiotic
baclofen,KPYSYYIEGFHWSV-MRVPVSSYSA-N,Launched,benzodiazepine receptor agonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,neurology/psychiatry,multiple sclerosis|spasms
BADGE,LCFVJGUPQDGYKZ-PMACEKPBSA-N,Preclinical,PPAR receptor antagonist,PPARG,,
bafetinib,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N,Phase 2,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,ABL1|BCR|LYN,,
bafilomycin-a1,XDHNQDDQEHDUTM-UTRUWJARSA-N,Preclinical,ATPase inhibitor,,,
BAG-956,GVPAGJWVBUZHNQ-UHFFFAOYSA-N,Preclinical,phosphoinositide dependent kinase inhibitor,PIK3CG,,
baicalein,WTNAEULBGCSUSK-UHFFFAOYSA-N,Preclinical,lipoxygenase inhibitor,ALOX5|GLO1|PREP|SELL|SELP|TNF|XDH,,
baicalin,DAIGSUHCWOZEQG-ZFORQUDYSA-N,Launched,beta glucuronidase inhibitor,PREP,neurology/psychiatry,anxiety
bakuchiol,LFYJSSARVMHQJB-QIXNEVBVSA-N,Phase 2,DNA polymerase inhibitor,HIF1A,,
balaglitazone,IETKPTYAGKZLKY-MRXNPFEDSA-N,Phase 3,insulin sensitizer|PPAR receptor partial agonist,PPARG,,
balapiravir,VKXWOLCNTHXCLF-DXEZIKHYSA-N,Phase 2,RNA polymerase inhibitor,,,
balicatib,LLCRBOWRJOUJAE-UHFFFAOYSA-N,Phase 2,cathepsin inhibitor,CTSK,,
balofloxacin,MGQLHRYJBWGORO-NSHDSACASA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections
baloxavir,FIDLLEYNNRGVFR-CTNGQTDRSA-N,Phase 3,endonuclease inhibitor,,,
baloxavir-marboxil,RZVPBGBYGMDSBG-GGAORHGYSA-N,Launched,endonuclease inhibitor,,infectious disease,influenza A virus infection
balsalazide,IPOKCKJONYRRHP-FMQUCBEESA-N,Launched,cyclooxygenase inhibitor,ALOX5|PPARG|PTGS1|PTGS2,gastroenterology,ulcerative colitis
BAM7,KOCVKGYKBLJEPK-LYBHJNIJSA-N,Preclinical,BAX activator,BAX,,
bamaquimast,HNQSZPBGDAJIJO-UHFFFAOYSA-N,Preclinical,proton pump inhibitor,,,
bambuterol,ANZXOIAKUNOVQU-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRB2|BCHE,pulmonary,asthma
BAN-ORL-24,MAKMQGKJURAJEN-RUZDIDTESA-N,Preclinical,nociceptin/orphanin FQ receptor antagonist,OPRL1,,
banoxantrone,YZBAXVICWUUHGG-UHFFFAOYSA-N,Phase 1/Phase 2,topoisomerase inhibitor,TOP2A,,
barasertib,GBJVVSCPOBPEIT-UHFFFAOYSA-N,Phase 2/Phase 3,Aurora kinase inhibitor,AURKA|AURKB,,
barasertib-HQPA,QYZOGCMHVIGURT-UHFFFAOYSA-N,Phase 2/Phase 3,Aurora kinase inhibitor,AURKB,,
barasertib-HQPA,"InChI=1S/C26H30FN7O3/c1-2-34(10-11-35)9-4-12-37-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(36)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17,35H,2,4,9-12,15H2,1H3,(H,30,36)(H2,28,29,31,32,33)",Phase 2/Phase 3,Aurora kinase inhibitor,AURKB,,
bardoxolone,TXGZJQLMVSIZEI-UQMAOPSPSA-N,Phase 1,nuclear factor erythroid derived|like (NRF2) activator,NOS2|PPARG,,
bardoxolone,"InChI=1S/C31H41NO4/c1-26(2)10-12-31(25(35)36)13-11-30(7)23(19(31)16-26)20(33)14-22-28(5)15-18(17-32)24(34)27(3,4)21(28)8-9-29(22,30)6/h14-15,19,21,23H,8-13,16H2,1-7H3,(H,35,36)/t19-,21-,23-,28-,29+,30+,31-/m0/s1",Phase 1,nuclear factor erythroid derived|like (NRF2) activator,NOS2|PPARG,,
bardoxolone-methyl,WPTTVJLTNAWYAO-KPOXMGGZSA-N,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,,
bardoxolone-methyl,"InChI=1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1",Phase 3,nuclear factor erythroid derived|like (NRF2) activator,PPARG|STAT3,,
baricitinib,XUZMWHLSFXCVMG-UHFFFAOYSA-N,Launched,JAK inhibitor,JAK1|JAK2,rheumatology,rheumatoid arthritis
barium-6-O-phosphonato-D-glucose,VFRROHXSMXFLSN-SLPGGIOYSA-N,Preclinical,,,,
barnidipine,VXMOONUMYLCFJD-DHLKQENFSA-N,Launched,calcium channel blocker,,cardiology,hypertension
basic-fuchsin,YDCMWLQSPFTWCS-UHFFFAOYSA-N,Preclinical,,,,
basimglurant,UPZWINBEAHDTLA-UHFFFAOYSA-N,Phase 2,glutamate receptor antagonist,GRM5,,
basmisanil,VCGRFBXVSFAGGA-UHFFFAOYSA-N,Phase 2,GABA receptor inverse agonist,,,
batefenterol,URWYQGVSPQJGGB-DHUJRADRSA-N,Phase 2,acetylcholine receptor antagonist|adrenergic receptor agonist,,,
batimastat,XFILPEOLDIKJHX-QYZOEREBSA-N,Phase 3,matrix metalloprotease inhibitor,ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8,,
bavisant,BGBVSGSIXIIREO-UHFFFAOYSA-N,Phase 2,histamine receptor antagonist,HRH3,,
BAX-channel-blocker,KUUJEXLRLIPQQJ-HNNXBMFYSA-N,Preclinical,cytochrome C release inhibitor,BAX,,
BAY-11-7082,DOEWDSDBFRHVAP-KRXBUXKQSA-N,Preclinical,NFkB pathway inhibitor,RELA,,
BAY-11-7085,VHKZGNPOHPFPER-ONNFQVAWSA-N,Preclinical,NFkB pathway inhibitor,NFKBIA,,
BAY-1251152,YZCUMZWULWOUMD-MUUNZHRXSA-N,Phase 1,CDK9 inhibitor,,,
BAY-1436032,RNMAUIMMNAHKQR-QFBILLFUSA-N,Phase 1,isocitrate dehydrogenase inhibitor,,,
BAY-1895344,YBXRSCXGRPSTMW-CYBMUJFWSA-N,Phase 1,ATR kinase inhibitor,,,
BAY-2402234,KNVJMHHAXCPZHF-JTQLQIEISA-N,Phase 1,dihydroorotate dehydrogenase inhibitor,,,
BAY-41-2272,ATOAHNRJAXSBOR-UHFFFAOYSA-N,Preclinical,guanylyl cyclase activator,GUCY1A3|GUCY1B3,,
BAY-60-6583,ZTYHZMAZUWOXNC-UHFFFAOYSA-N,Preclinical,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
BAY-60-7550,MYTWFJKBZGMYCS-NQIIRXRSSA-N,Preclinical,phosphodiesterase inhibitor,PDE2A,,
BAY-61-3606,JWQOJVOKBAAAAR-UHFFFAOYSA-N,Preclinical,SYK inhibitor,SYK,,
BAY-8002,CLAUJSRBKSRTGQ-UHFFFAOYSA-N,Preclinical,monocarboxylate transporter inhibitor,,,
BAY-85-8050,JPSHPWJJSVEEAX-GBXIJSLDSA-N,Phase 1,,,,
BAY-87-2243,CDJNNOJINJAXPV-UHFFFAOYSA-N,Phase 1,hypoxia inducible factor inhibitor,HIF1A,,
BAY-K-8644-(+/-),ZFLWDHHVRRZMEI-CYBMUJFWSA-N,Preclinical,L-type calcium channel blocker,,,
BAY-K-8644-(s)-(-),ZFLWDHHVRRZMEI-ZDUSSCGKSA-N,Preclinical,L-type calcium channel activator,CACNA1C,,
BAY-W-9798,AVFYPHPSIBAAME-UHFFFAOYSA-N,Phase 2,antioxidant,,,
BAY1125976,JBGYKRAZYDNCNV-UHFFFAOYSA-N,Phase 1,AKT inhibitor,,,
BAY1217389,WNEILUNVMHVMPH-UHFFFAOYSA-N,Phase 1,kinase inhibitor,,,
BAZ2-ICR,RRZVGDGTWNQAPW-UHFFFAOYSA-N,Preclinical,bromodomain inhibitor,ZNF215,,
bazedoxifene,UCJGJABZCDBEDK-UHFFFAOYSA-N,Launched,selective estrogen receptor modulator (SERM),ESR1|ESR2,orthopedics|endocrinology,osteoporosis|menopause
BC-11,KDQVMGQHPAKJAN-UHFFFAOYSA-N,Preclinical,urokinase inhibitor,PLAU,,
BCI-540,PSPGQHXMUKWNDI-UHFFFAOYSA-N,Phase 2,glutamate receptor agonist,,,
BCTC,ROGUAPYLUCHQGK-UHFFFAOYSA-N,Preclinical,TRPV antagonist,TRPV1,,
BCX-1470,OTGQTQBPQCRNRG-UHFFFAOYSA-N,Phase 1,complement inhibitor|serine protease inhibitor,CFD,,
BD-1008,ASGIQUHBAVIOTI-UHFFFAOYSA-N,Preclinical,sigma receptor antagonist,,,
BD-1047,MGVRNMUKTZOQOW-UHFFFAOYSA-N,Preclinical,adrenergic receptor antagonist,SIGMAR1,,
BD-1063,SUIZRDJCBVPASY-UHFFFAOYSA-N,Preclinical,sigma receptor antagonist,SIGMAR1,,
BE-2254,PZZOEXPDTYIBPI-MRXNPFEDSA-N,Phase 2,adrenergic receptor antagonist,ADRA1A,,
BEBT-908,TWJZFXHSPBBPNI-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,,,
beclabuvir,ZTTKEBYSXUCBSE-QDFUAKMASA-N,Phase 2,antiviral,,,
beclamide,JPYQFYIEOUVJDU-UHFFFAOYSA-N,Launched,anticonvulsant,,neurology/psychiatry,sedative|seizures
beclomethasone,NBMKJKDGKREAPL-DGLOSGAVSA-N,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,allergy,allergic rhinitis
beclomethasone-dipropionate,KUVIULQEHSCUHY-XYWKZLDCSA-N,Launched,glucocorticoid receptor agonist,GPR97|NR3C1,allergy,allergic rhinitis
bedaquiline,QUIJNHUBAXPXFS-XLJNKUFUSA-N,Launched,ATPase inhibitor,,infectious disease,tuberculosis
befuraline,SRIJFPBZWUFLFD-UHFFFAOYSA-N,Phase 2,,,,
begacestat,PSXOKXJMVRSARX-SCSAIBSYSA-N,Phase 1,gamma secretase inhibitor,PSEN1,,
bekanamycin,SKKLOUVUUNMCJE-FQSMHNGLSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections
belinostat,NCNRHFGMJRPRSK-MDZDMXLPSA-N,Launched,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,peripheral T-cell lymphoma (PTCL)
belinostat,"InChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+",Launched,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,peripheral T-cell lymphoma (PTCL)
belizatinib,WSTUJEXAPHIEIM-FEGDYQJNSA-N,Preclinical,receptor tyrosine protein kinase inhibitor,,,
belotecan,LNHWXBUNXOXMRL-VWLOTQADSA-N,Phase 3,topoisomerase inhibitor,,,
bemegride,ORRZGUBHBVWWOP-UHFFFAOYSA-N,Launched,chemoreceptor agonist,GABRA1,critical care,poison antidote
bemesetron,MNJNPLVXBISNSX-WDNDVIMCSA-N,Phase 3,serotonin receptor antagonist,HTR3A|HTR3B,,
bemotrizinol,XVAMCHGMPYWHNL-MKPDMIMOSA-N,Launched,,,dermatology,sunscreen lotion
bempedoic-acid,HYHMLYSLQUKXKP-UHFFFAOYSA-N,Launched,AMPK inhibitor,ACLY,,
benactyzine,IVQOFBKHQCTVQV-UHFFFAOYSA-N,Preclinical,butyrylcholinesterase inhibitor,,,
benaxibine,VXMVXDITZWJXJN-RMPHRYRLSA-N,Phase 1,,,,
benazepril,XPCFTKFZXHTYIP-PMACEKPBSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension
bendamustine,YTKUWDBFDASYHO-UHFFFAOYSA-N,Launched,DNA inhibitor,,hematologic malignancy,chronic lymphocytic leukemia (CLL)|non-Hodgkin lymphoma (NHL)
bendazac,BYFMCKSPFYVMOU-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry|rheumatology,muscle pain|joint pain
bendazol,YTLQFZVCLXFFRK-UHFFFAOYSA-N,Launched,nitric oxide synthase stimulant,,,
bendroflumethiazide,HDWIHXWEUNVBIY-CQSZACIVSA-N,Launched,sodium/potassium/chloride transporter inhibitor,SLC12A1|SLC12A3,cardiology,hypertension
benethamine,UPABQMWFWCMOFV-UHFFFAOYSA-N,Preclinical,,,,
benfluorex,CJAVTWRYCDNHSM-AWEZNQCLSA-N,Withdrawn,gluconeogenesis inhibitor,HMGCR,,
benfluralin,SMDHCQAYESWHAE-UHFFFAOYSA-N,Phase 3,,CYP1A1|CYP1A2|CYP2B6|CYP3A4|ESR1|MMP1|SULT2A1|UGT1A1,,
benfotiamine,BTNNPSLJPBRMLZ-LGMDPLHJSA-N,Launched,antioxidant,AGER,rheumatology,lumbago
benidipine,QZVNQOLPLYWLHQ-ZEQKJWHPSA-N,Launched,calcium channel blocker,CACNA1C|CACNA1G,cardiology,hypertension
benperidol,FEBOTPHFXYHVPL-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD2,neurology/psychiatry,schizophrenia
benproperine,JTUQXGZRVLWBCR-SFHVURJKSA-N,Launched,antitussive,SCN5A,pulmonary,cough suppressant
benserazide,BNQDCRGUHNALGH-UHFFFAOYSA-N,Launched,DOPA decarboxylase inhibitor,DDC,neurology/psychiatry,Parkinson's Disease
bentiromide,SPPTWHFVYKCNNK-FQEVSTJZSA-N,Launched,,HPN,gastroenterology,pancreas diagnostic agent
benurestat,JFZGBMJPJZDNNT-UHFFFAOYSA-N,Phase 1,urease inhibitor,,,
benzalkonium,VVZBFOKBSDGVGZ-UHFFFAOYSA-N,Launched,cationic surfactant,,dermatology,abrasions|superficial cuts
benzamil,KXDROGADUISDGY-UHFFFAOYSA-N,Phase 2,sodium channel blocker,ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1,,
benzbromarone,WHQCHUCQKNIQEC-UHFFFAOYSA-N,Launched,chloride channel blocker,ABCC1,rheumatology,gout
"benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]",PHFWPIKQCFQPJY-CYBMUJFWSA-N,Preclinical,,,,
benzethonium,SIYLLGKDQZGJHK-UHFFFAOYSA-N,Launched,sodium channel blocker,SCN10A,infectious disease,first-aid antiseptic
benznidazole,CULUWZNBISUWAS-UHFFFAOYSA-N,Launched,DNA synthesis inhibitor,,infectious disease,Chagas disease
benzo[d]thiazole-2(3H)-thione,YXIWHUQXZSMYRE-UHFFFAOYSA-N,Phase 1,,,,
benzocaine,BLFLLBZGZJTVJG-UHFFFAOYSA-N,Launched,sodium channel blocker,SCN10A,infectious disease,first-aid antiseptic
benzoclidine,AHKAOMZZTQULDS-ZDUSSCGKSA-N,Preclinical,,,,
benzofenac,DFHBBMJTBBLQSA-UHFFFAOYSA-N,Phase 1,,,,
benzoic-acid,WPYMKLBDIGXBTP-UHFFFAOYSA-N,Launched,food preservative,DAO|HRSP12|PRDX5|RAB9A,infectious disease,tinea pedis
benzoin,ISAOCJYIOMOJEB-CYBMUJFWSA-N,Preclinical,,CES1,,
benzonatate,MAFMQEKGGFWBAB-UHFFFAOYSA-N,Launched,local anesthetic,SCN5A,pulmonary,cough suppressant
benzoquinonium-dibromide,YERABYSOHUZTPQ-UHFFFAOYSA-P,Preclinical,cholinergic receptor antagonist,CHRNA1,,
benzotript,QJERBBQXOMUURJ-INIZCTEOSA-N,Phase 1,CCK receptor antagonist,CCKAR|CCKBR,,
benzoxiquine,BHKPHCKISVSDGV-UHFFFAOYSA-N,Preclinical,antiinfective drug,,,
benzoyl-peroxide,OMPJBNCRMGITSC-UHFFFAOYSA-N,Launched,oxidizing agent,,dermatology,acne vulgaris (AV)
benzoylpas,GNZCRYWFWKFIDM-UHFFFAOYSA-N,Preclinical,,,,
benzthiazide,MQMCZGVMQZPYQA-UHFFFAOYSA-N,Launched,carbonic anhydrase inhibitor,CA2,cardiology,hypertension|edema
benztropine-mesylate,GIJXKZJWITVLHI-PMOLBWCYSA-N,Launched,acetylcholine receptor antagonist,CHRM1|HRH1|SLC6A3,neurology/psychiatry,extrapyramidal symptoms (EPS)|Parkinson's Disease
benzydamine,CNBGNNVCVSKAQZ-UHFFFAOYSA-N,Launched,prostanoid receptor antagonist,,dental|otolaryngology,mouth inflammation|throat inflammation
benzyl-alcohol,WVDDGKGOMKODPV-UHFFFAOYSA-N,Launched,local anesthetic,,infectious disease,virus herpes simplex (HSV)
benzyl-benzoate,SESFRYSPDFLNCH-UHFFFAOYSA-N,Launched,lipase inhibitor,LIPE,allergy,sweet itch
benzyl-isothiocyanate,MDKCFLQDBWCQCV-UHFFFAOYSA-N,Preclinical,methylazoxymethanol acetate inhibitor,,,
benzyldimethylhexadecylammonium,QDYLMAYUEZBUFO-UHFFFAOYSA-N,Preclinical,cationic surfactant,,,
benzyldimethyloctylammonium,SHFLYPPECXRCFO-UHFFFAOYSA-N,Preclinical,,,,
benzylpenicillin,JGSARLDLIJGVTE-MBNYWOFBSA-N,Launched,penicillin binding protein inhibitor,,infectious disease,celluitis|meningitis|endocarditis|syphilis|pneumonia|bacterial septicemia
bephenium-hydroxynaphthoate,AVWWVJUMXRXPNF-UHFFFAOYSA-N,Launched,anthelmintic agent,,infectious disease,ascariasis
bepotastine,YWGDOWXRIALTES-NRFANRHFSA-N,Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis
bepridil,UIEATEWHFDRYRU-UHFFFAOYSA-N,Launched,calcium channel blocker,KCNQ4,cardiology,angina pectoris
berberine,YBHILYKTIRIUTE-UHFFFAOYSA-N,Launched,LDL receptor activator,LDLR,,
bergapten,BGEBZHIAGXMEMV-UHFFFAOYSA-N,Phase 3,,,,
bergenin,YWJXCIXBAKGUKZ-HJJNZUOJSA-N,Preclinical,interleukin inhibitor,IL1B|TNF,,
besifloxacin,QFFGVLORLPOAEC-SNVBAGLBSA-N,Launched,bacterial DNA gyrase inhibitor,,ophthalmology,conjunctivitis
BET-BAY-002,AGYIAWHWIUZNSD-INIZCTEOSA-N,Preclinical,bromodomain inhibitor,,,
beta-amyloid-synthesis-inhibitor,GYNDFOLSPPBBIK-UHFFFAOYSA-N,Preclinical,beta amyloid synthesis inhibitor,APP,,
beta-carotene,OENHQHLEOONYIE-JLTXGRSLSA-N,Launched,,,,
beta-CCB,WGNGIELOOKACSB-UHFFFAOYSA-N,Launched,benzodiazepine receptor ligand,GABRA1|GABRG2,,
beta-elemene,OPFTUNCRGUEPRZ-QLFBSQMISA-N,Launched,apoptosis stimulant,MMP2|MMP9,,
beta-funaltrexamine,PQKHESYTSKMWFP-WZJCLRDWSA-N,Preclinical,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,,
beta-glycerophosphoric-acid,DHCLVCXQIBBOPH-UHFFFAOYSA-N,Preclinical,,,,
beta-hydroxy-beta-methylbutyrate,KORPMXSVHOHPMS-UHFFFAOYSA-N,Launched,protein synthesis stimulant,MTOR,,
beta-hydroxybutyrate,WHBMMWSBFZVSSR-UHFFFAOYSA-N,Phase 1,,HCAR2,,
beta-lapachone,QZPQTZZNNJUOLS-UHFFFAOYSA-N,Phase 2,topoisomerase inhibitor,TOP1,,
beta-naphthol,JWAZRIHNYRIHIV-UHFFFAOYSA-N,Preclinical,,,,
betahistine,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,Launched,histamine receptor agonist|histamine receptor antagonist,HRH1|HRH3,neurology/psychiatry,Meniere's disease
betaine,KWIUHFFTVRNATP-UHFFFAOYSA-O,Launched,nitric oxide donor,,metabolism,homocystinuria
betamethasone,UREBDLICKHMUKA-DVTGEIKXSA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
betamethasone-acetate,AKUJBENLRBOFTD-QZIXMDIESA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
betamethasone-butyrate-propionate,VXOWJCTXWVWLLC-REGDIAEZSA-N,Launched,,,rheumatology,rheumatoid arthritis
betamethasone-dipropionate,CIWBQSYVNNPZIQ-XYWKZLDCSA-N,Launched,anti-inflammatory agent,NR3C1,dermatology,corticosteroid-responsive dermatoses
betamethasone-phosphate,VQODGRNSFPNSQE-DVTGEIKXSA-N,Launched,,,rheumatology,rheumatoid arthritis
betamethasone-valerate,SNHRLVCMMWUAJD-SUYDQAKGSA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
betamipron,CWXYHOHYCJXYFQ-UHFFFAOYSA-N,Launched,panipenem uptake inhibitor,,nephrology,renal toxicity
betaxolol,NWIUTZDMDHAVTP-QGZVFWFLSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,ophthalmology,intraocular pressure|glaucoma|ocular hypertension
betazole,JXDFEQONERDKSS-UHFFFAOYSA-N,Launched,histamine receptor agonist,HRH2,gastroenterology,gastric hypersecretion diagnostic
bethanechol,NZUPCNDJBJXXRF-LURJTMIESA-O,Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,urology,urinary retention
BETP,NTDFYGSSDDMNHI-NDEPHWFRSA-N,Preclinical,GLP receptor positive allosteric modulator,GLP1R,,
betrixaban,XHOLNRLADUSQLD-UHFFFAOYSA-N,Launched,coagulation factor inhibitor,KCNH2,hematology,deep vein thrombosis (DVT)
betulinic-acid,QGJZLNKBHJESQX-FZFNOLFKSA-N,Phase 1/Phase 2,apoptosis stimulant|NFkB pathway inhibitor,GPBAR1,,
bevantolol,HXLAFSUPPDYFEO-QGZVFWFLSA-N,Launched,adrenergic receptor antagonist,,cardiology,angina pectoris|hypertension
bevenopran,ZGCYVRNZWGUXNQ-UHFFFAOYSA-N,Phase 1,opioid receptor antagonist,,,
bevirimat-dimeglumine,YJEJKUQEXFSVCJ-WRFMNRASSA-N,Phase 2,HIV capsid assembly inhibitor,,,
bexagliflozin,BTCRKOKVYTVOLU-SJSRKZJXSA-N,Phase 3,solute carrier family member inhibitor,,,
bexarotene,NAVMQTYZDKMPEU-UHFFFAOYSA-N,Launched,retinoid receptor agonist,RXRA|RXRB|RXRG,hematologic malignancy,cutaneous T-cell lymphoma (CTCL)
bezafibrate,IIBYAHWJQTYFKB-UHFFFAOYSA-N,Launched,PPAR receptor agonist,PPARA|PPARD|PPARG,cardiology,cholesterol
BFH772,JNLSTLQFDDAULK-UHFFFAOYSA-N,Phase 2,VEGFR inhibitor,,,
BGP-15,MVLOQULXIYSERZ-ZDUSSCGKSA-N,Phase 2,PARP inhibitor,,,
BGT226,BMMXYEBLEBULND-UHFFFAOYSA-N,Phase 1/Phase 2,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CG,,
BHQ,JZODKRWQWUWGCD-UHFFFAOYSA-N,Preclinical,ATPase inhibitor,ATP2A1,,
BI-224436,MIXIIJCBELCMCZ-VWLOTQADSA-N,Phase 1,HIV integrase inhibitor,,,
BI-2536,XQVVPGYIWAGRNI-JOCHJYFZSA-N,Phase 2,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,,
BI-2536,"InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1",Phase 2,PLK inhibitor,BRD4|PLK1|PLK2|PLK3,,
BI-409306,BZTIJCSHNVZMES-UHFFFAOYSA-N,Phase 1,phosphodiesterase inhibitor,,,
BI-78D3,QFRLDZGQEZCCJZ-UHFFFAOYSA-N,Preclinical,JNK inhibitor,MAPK8,,
BI-847325,FLBNLJLONKAPLR-BYYHNAKLSA-N,Phase 1,Aurora kinase inhibitor|MEK inhibitor,AURKA|AURKB|AURKC|MAP2K1|MAP2K2,,
BI-D1870,DTEKTGDVSARYDS-NSHDSACASA-N,Preclinical,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3|RPS6KA6,,
BIA-10-2474,DOWVMJFBDGWVML-UHFFFAOYSA-N,Preclinical,Fatty acid hydrolase inhibitor,,,
biapenem,MRMBZHPJVKCOMA-YJFSRANCSA-O,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,bacterial septicemia|pneumonia|urinary tract infections
BIBN4096,ITIXDWVDFFXNEG-JHOUSYSJSA-N,Phase 2,calcitonin antagonist,CALCA|CALCRL|RAMP1,,
BIBR-1532,PGFQXGLPJUCTOI-WYMLVPIESA-N,Preclinical,telomerase inhibitor,TERT,,
BIBU-1361,JUGSLZCFNSTKBN-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR,,
BIBX-1382,FTFRZXFNZVCRSK-UHFFFAOYSA-N,Phase 1,EGFR inhibitor,EGFR|ERBB2,,
bicalutamide,LKJPYSCBVHEWIU-UHFFFAOYSA-N,Launched,androgen receptor antagonist,AR,oncology,prostate cancer
bicifadine,OFYVIGTWSQPCLF-NWDGAFQWSA-N,Phase 3,dopamine reuptake inhibitor|serotonin receptor antagonist,,,
bictegravir,SOLUWJRYJLAZCX-LYOVBCGYSA-N,Launched,HIV integrase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
bicuculline-(+),IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Preclinical,GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|KCNN1,,
bicuculline-methochloride-(-),WDIQXKYUSINZME-RBUKOAKNSA-N,Preclinical,GABA receptor antagonist,,,
bicyclol,KXMTXZACPVCDMH-UHFFFAOYSA-N,Launched,NFkB pathway inhibitor,HSPA1A|HSPB1,infectious disease,hepatitis B|hepatitis C
bifemelane,QSQQPMHPCBLLGX-UHFFFAOYSA-N,Launched,acetylcholine release enhancer,MAOA|MAOB,ophthalmology|neurology/psychiatry,glaucoma|senile dementia
bifendate,JMZOMFYRADAWOG-UHFFFAOYSA-N,Launched,,,infectious disease,hepatitis B|hepatitis C
bifonazole,OCAPBUJLXMYKEJ-QFIPXVFZSA-N,Launched,sterol demethylase inhibitor,,infectious disease,tinea pedis|tinea cruris
BIIB021,QULDDKSCVCJTPV-UHFFFAOYSA-N,Phase 2,HSP inhibitor,HSP90AA1,,
bilastine,ACCMWZWAEFYUGZ-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis
bilobalide,MOLPUWBMSBJXER-YDGSQGCISA-N,Preclinical,GABA receptor modulator,GLRA1|GLRA2|GLRB|HTR3A|HTR3B,,
bimatoprost,AQOKCDNYWBIDND-FTOWTWDKSA-N,Launched,prostanoid receptor agonist,AKR1C3|PTGER1|PTGER3|PTGFR,ophthalmology,intraocular pressure|glaucoma|ocular hypertension
BIMU-8,AFOFVIBWSLOHFR-QDMKHBRRSA-N,Preclinical,serotonin receptor agonist,HTR4,,
BINA,KMKBEESNZAPKMP-AREMUKBSSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM2,,
bindarit,MTHORRSSURHQPZ-UHFFFAOYSA-N,Phase 2,NFkB pathway inhibitor,CCL2|CCL7|CCL8,,
binimetinib,ACWZRVQXLIRSDF-UHFFFAOYSA-N,Launched,MEK inhibitor,MAP2K1|MAP2K2,oncology,melanoma
BIO-1211,NVVGCQABIHSJSQ-KFZSMJGVSA-N,Phase 2,integrin antagonist,ITGA4|ITGB1,,
BIO-5192,MNQBPRHHZPXCKZ-ZDCRTTOTSA-N,Preclinical,integrin inhibitor,ITGA4|ITGB1,,
biotin,YBJHBAHKTGYVGT-ZKWXMUAHSA-N,Launched,vitamin B,ACACA|ACACB|HLCS|MCCC1|MCCC2|PC|PCCA|PCCB|SLC5A6,,
bipenamol,HLAFSNJRKZLMPT-UHFFFAOYSA-N,Phase 2,dipeptidyl peptidase inhibitor,CTSC,,
biperiden,YSXKPIUOCJLQIE-UYWIDEMCSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,neurology/psychiatry,Parkinson's Disease
birinapant,PKWRMUKBEYJEIX-DXXQBUJASA-N,Phase 2,XIAP inhibitor,BIRC2|XIAP,,
birinapant,"InChI=1S/C42H56F2N8O6/c1-7-33(49-39(55)21(3)45-5)41(57)51-19-27(53)15-25(51)17-31-29-11-9-23(43)13-35(29)47-37(31)38-32(30-12-10-24(44)14-36(30)48-38)18-26-16-28(54)20-52(26)42(58)34(8-2)50-40(56)22(4)46-6/h9-14,21-22,25-28,33-34,45-48,53-54H,7-8,15-20H2,1-6H3,(H,49,55)(H,50,56)/t21-,22-,25-,26-,27-,28-,33-,34-/m0/s1",Phase 2,XIAP inhibitor,BIRC2|XIAP,,
BIRT-377,FJNJHZQMQRVZEE-GOSISDBHSA-N,Preclinical,lymphocyte function-associated antigen negative modulator,ICAM1,,
bis(maltolato)oxovanadium(IV),XUOLEICXAPEOSI-UHFFFAOYSA-L,Phase 2,tyrosine phosphatase inhibitor,PTPN1,,
bisacodyl,KHOITXIGCFIULA-UHFFFAOYSA-N,Launched,laxative,,gastroenterology,constipation
bisantrene,NJSMWLQOCQIOPE-OCHFTUDZSA-N,Phase 2,topoisomerase inhibitor,,,
bisindolylmaleimide-IX,DSXXEELGXBCYNQ-UHFFFAOYSA-N,Preclinical,PKC inhibitor,AKT1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SIRT1,,
bismuth-oxalate,PEBMBOMJLWXKFI-UHFFFAOYSA-N,Preclinical,,,,
bismuth-subcitrate-potassium,KNOSZBQOKCZXTI-UHFFFAOYSA-K,Launched,,,gastroenterology,duodenal ulcer disease
bismuth-subgallate,JAONZGLTYYUPCT-UHFFFAOYSA-K,Launched,nitric oxide synthase inhibitor,NOS1,gastroenterology,internal deoderant
bismuth-subsalicylate,ZREIPSZUJIFJNP-UHFFFAOYSA-K,Launched,antacid,,gastroenterology,diarrhea
bismuth(III)-trifluoromethanesulfonate,BQFARKYNYLKHRD-UHFFFAOYSA-N,Preclinical,direct substitution catalyst,,,
bisoctrizole,FQUNFJULCYSSOP-UHFFFAOYSA-N,Phase 2,,,,
bisoprolol,VHYCDWMUTMEGQY-QGZVFWFLSA-N,Launched,adrenergic receptor antagonist,ADRB1,cardiology,hypertension
bisphenol-A,IISBACLAFKSPIT-UHFFFAOYSA-N,Phase 1,synthetic estrogen,AR|ESR1|ESR2|ESRRG|PPARG,,
bithionol,JFIOVJDNOJYLKP-UHFFFAOYSA-N,Withdrawn,autotaxin inhibitor,ESR1|ESR2|MCL1,,
bithionol,"InChI=1S/C12H6Cl4O2S/c13-5-1-7(15)11(17)9(3-5)19-10-4-6(14)2-8(16)12(10)18/h1-4,17-18H",Withdrawn,autotaxin inhibitor,ESR1|ESR2|MCL1,,
bitopertin,YUUGYIUSCYNSQR-LBPRGKRZSA-N,Phase 3,glycine transporter inhibitor,SLC6A5|SLC6A9,,
bitoscanate,OMWQUXGVXQELIX-UHFFFAOYSA-N,Preclinical,anthelmintic agent,,,
bivalirudin,OIRCOABEOLEUMC-GEJPAHFPSA-N,Launched,thrombin inhibitor,F2,cardiology,angina pectoris
BIX-01294,OSXFATOLZGZLSK-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,,
BIX-02188,FSZPIAXLCCQFCM-FCQUAONHSA-N,Preclinical,MEK inhibitor,MAP2K5,,
BIX-02189,HOMJAAIVTDVQJA-IZHYLOQSSA-N,Preclinical,MEK inhibitor,MAP2K5|MAPK7,,
BL-5583,DYSJMQABFPKAQM-UHFFFAOYSA-N,Preclinical,hypercalcaemic agent,,,
blebbistatin-(-),LZAXPYOBKSJSEX-GOSISDBHSA-N,Preclinical,ATPase inhibitor,,,
blebbistatin-(+/-),LZAXPYOBKSJSEX-GOSISDBHSA-N,Preclinical,ATPase inhibitor,MYH14|MYH2,,
bleomycetin,QYOAUOAXCQAEMW-DDZPZTJXSA-N,Launched,EGFR expression inhibitor,,,
bleomycin,OYVAGSVQBOHSSS-WMBAVFRVSA-O,Launched,DNA synthesis inhibitor,,hematologic malignancy|pulmonary|oncology,non-Hodgkin lymphoma (NHL)|Hodgkin's lymphoma|pleural effusion|testicular carcinoma|squamous cell carcinoma
blonanserin,XVGOZDAJGBALKS-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,neurology/psychiatry,schizophrenia
BLU9931,TXEBNKKOLVBTFK-UHFFFAOYSA-N,Preclinical,FGFR inhibitor,FGFR4,,
BLZ945,ADZBMFGQQWPHMJ-RHSMWYFYSA-N,Phase 1/Phase 2,CSF1R inhibitor,,,
BML-190,BJSDNVVWJYDOLK-UHFFFAOYSA-N,Preclinical,cannabinoid receptor inverse agonist,CNR2,,
BML-284,FABQUVYDAXWUQP-UHFFFAOYSA-N,Preclinical,WNT agonist,,,
BMS-182874,MJRGSRRZKSJHOE-UHFFFAOYSA-N,Phase 2,endothelin receptor antagonist,EDNRA,,
BMS-191011,QKOWACXSXTXRKA-UHFFFAOYSA-N,Preclinical,potassium channel activator,KCNMA1,,
BMS-191095,SMIKIPXIDLITMP-LEWJYISDSA-N,Phase 1,KATP activator|potassium channel agonist,,,
BMS-207940,ORJRYNKVKJAJPY-UHFFFAOYSA-N,Preclinical,endothelin receptor antagonist,,,
BMS-214662,OLCWFLWEHWLBTO-HSZRJFAPSA-N,Phase 1,farnesyltransferase inhibitor,,,
BMS-265246,SCFMWQIQBVZOQR-UHFFFAOYSA-N,Preclinical,CDK inhibitor,CDK1|CDK2,,
BMS-299897,IZAOBRWCUGOKNH-OAHLLOKOSA-N,Phase 1,gamma secretase inhibitor,,,
BMS-309403,SJRVJRYZAQYCEE-UHFFFAOYSA-N,Preclinical,fatty acid binding protein inhibitor,FABP4,,
BMS-345541,PSPFQEBFYXJZEV-UHFFFAOYSA-N,Preclinical,IKK inhibitor,CHUK|IKBKB,,
BMS-387032,OUSFTKFNBAZUKL-UHFFFAOYSA-N,Phase 1,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,CDK2|CDK7|CDK9,,
BMS-470539,GULVVTHHUIIMRL-WUFINQPMSA-N,Preclinical,melanocortin receptor agonist,MC1R,,
BMS-536924,ZWVZORIKUNOTCS-OAQYLSRUSA-N,Preclinical,IGF-1 inhibitor,AKT1|CCNE1|CDK2|CYP3A4|ERBB2|IGF1R|KDR|LCK|MAPK1|MET|PDGFRA|PDGFRB,,
BMS-566419,XEVJUIZOZCFECP-UHFFFAOYSA-N,Preclinical,inosine monophosphate dehydrogenase inhibitor,IMPDH1|IMPDH2,,
BMS-582949,GDTQLZHHDRRBEB-UHFFFAOYSA-N,Phase 2,p38 MAPK inhibitor,,,
BMS-587101,NXNKJLOEGWSJGI-BKMJKUGQSA-N,Phase 2,integrin antagonist,ITGAL|ITGB2,,
BMS-599626,LUJZZYWHBDHDQX-QFIPXVFZSA-N,Phase 1,EGFR inhibitor|protein tyrosine kinase inhibitor,EGFR|ERBB2|ERBB4,,
BMS-626529,QRPZBKAMSFHVRW-UHFFFAOYSA-N,Phase 3,HIV attachment inhibitor,,,
BMS-626531,ZZZJRULMCGMYRH-UHFFFAOYSA-N,Phase 1,p38 MAPK inhibitor,,,
BMS-649,ZZUKALQMHNSWTK-UHFFFAOYSA-N,Preclinical,retinoid receptor agonist,RXRA,,
BMS-688521,LILGMDXLRPEBNH-HFZDXXHNSA-N,Preclinical,ICAM1 antagonist|leukocyte function-associated antigen receptor antagonist,ICAM1,,
BMS-690514,CSGQVNMSRKWUSH-IAGOWNOFSA-N,Phase 2,EGFR inhibitor|VEGFR inhibitor,EGFR|ERBB2|FLT3|KDR,,
BMS-707035,VNIWZCGZPBJWBI-UHFFFAOYSA-N,Phase 2,HIV integrase inhibitor,,,
BMS-754807,LQVXSNNAFNGRAH-QHCPKHFHSA-N,Phase 2,IGF-1 inhibitor,AKT1|IGF1R,,
BMS-770767,HNXGIFYHJKEXNA-KDURUIRLSA-N,Phase 2,11-beta-HSD1 inhibitor,,,
BMS-777607,VNBRGSXVFBYQNN-UHFFFAOYSA-N,Phase 1/Phase 2,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,AXL|MERTK|MET|MST1R|TYRO3,,
BMS-779788,JLPURTXCSILYLW-UHFFFAOYSA-N,Phase 1,LXR agonist,,,
BMS-806,OKGPFTLYBPQBIX-CQSZACIVSA-N,Phase 1,HIV attachment inhibitor,,,
BMS-813160,CMVHFGNTABZQJU-HCXYKTFWSA-N,Phase 2,CC chemokine receptor antagonist,,,
BMS-817378,KXDZWUPUSDCGDD-UHFFFAOYSA-N,Phase 1,c-Met inhibitor|VEGFR inhibitor,KDR|MET,,
BMS-833923,KLRRGBHZCJLIEL-UHFFFAOYSA-N,Phase 2,smoothened receptor antagonist,SMO,,
BMS-863233,JJWLXRKVUJDJKG-VIFPVBQESA-N,Phase 1/Phase 2,CDC inhibitor,CDC7|PIM1,,
BMS-906024,AYOUDDAETNMCBW-GSHUGGBRSA-N,Phase 1,gamma secretase inhibitor,,,
BMS-911543,JCINBYQJBYJGDM-UHFFFAOYSA-N,Phase 1/Phase 2,JAK inhibitor,,,
BMS-935177,TVJRDCQUZMGBAB-UHFFFAOYSA-N,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,,,
BMS-983970,RANYIWAZSQWERN-WLENULPWSA-N,Phase 1,notch signaling inhibitor,,,
BMS-986020,GQBRZBHEPUQRPL-LJQANCHMSA-N,Phase 2,lysophosphatidic acid receptor antagonist,LPAR1,,
BMS-986142,ZRYMMWAJAFUANM-INIZCTEOSA-N,Phase 2,Bruton's tyrosine kinase (BTK) inhibitor,,,
BMS-986158,KGERZPVQIRYWRK-GDLZYMKVSA-N,Phase 1/Phase 2,bromodomain inhibitor,,,
BMS-986195,VJPPLCNBDLZIFG-ZDUSSCGKSA-N,Phase 1,Bruton's tyrosine kinase (BTK) inhibitor,,,
BMS-986205,KRTIYQIPSAGSBP-ZACQAIPSSA-N,Phase 3,"indoleamine 2,3-dioxygenase inhibitor",,,
BMS-CCR2-22,IBPXYDUJQWENPM-XZOQPEGZSA-N,Preclinical,CC chemokine receptor antagonist,CCR2,,
BMY-14802,ZXUYYZPJUGQHLQ-KRWDZBQOSA-N,Phase 2,sigma receptor antagonist,HTR1A,,
BMY-45778,DSRSEEYZGWTODH-UHFFFAOYSA-N,Preclinical,IP1 prostacyclin receptor agonist,PTGIR,,
BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,Preclinical,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A,,
BNC105,RADMJHVVIZTENA-UHFFFAOYSA-N,Phase 2,tubulin polymerization inhibitor,,,
BNTX,WXOUFNFMPVMGFZ-BDQAUFNLSA-N,Preclinical,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,,
boceprevir,LHHCSNFAOIFYRV-ZYNAIFEFSA-N,Launched,HCV inhibitor,CMA1|CTSA|CTSF|CTSK|CTSL|CTSS,infectious disease,hepatitis C
bonaphthone,MXWZRRPNVLCHMY-UHFFFAOYSA-N,Phase 3,,,,
bopindolol,UUOJIACWOAYWEZ-GOSISDBHSA-N,Launched,adrenergic receptor antagonist,,cardiology,hypertension|coronary artery disease (CAD)
bornyl-acetate,KGEKLUUHTZCSIP-JFGNBEQYSA-N,Preclinical,,,,
boronophenylalanine,NFIVJOSXJDORSP-QMMMGPOBSA-N,Phase 2,,,,
bortezomib,GXJABQQUPOEUTA-RDJZCZTQSA-N,Launched,NFkB pathway inhibitor|proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA,hematologic malignancy,multiple myeloma|mantle cell lymphoma (MCL)
BOS-172722,SGWLRDAOCLITOM-UHFFFAOYSA-N,Phase 1,monopolar spindle 1 kinase inhibitor,,,
bosentan,GJPICJJJRGTNOD-UHFFFAOYSA-N,Launched,endothelin receptor antagonist,EDNRA|EDNRB,pulmonary,pulmonary arterial hypertension (PAH)
bosutinib,UBPYILGKFZZVDX-UHFFFAOYSA-N,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor,ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK,hematologic malignancy,chronic myeloid leukemia (CML)
BP-554,VUSNBQDZGKZEDL-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR1A,,
BP-897,MNHDKMDLOJSCGN-UHFFFAOYSA-N,Phase 2,dopamine receptor agonist,ADRA1A|ADRA1D|ADRA2A|DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2B,,
BQ-123,VYCMAAOURFJIHD-PJNXIOHISA-N,Phase 2,endothelin receptor antagonist,EDNRA,,
BQ-788,LPAHKJMGDSJDRG-DJYQTOCQSA-N,Phase 1,endothelin receptor antagonist,EDNRB,,
BQU57,QFUFJOJDXRWBNA-YUZLPWPTSA-N,Preclinical,Ras GTPase inhibitor,RALA|RALB,,
BRD4770,UCGWYCMPZXDHNR-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT2,,
BRD7389,XASCINRGTHLHGM-UHFFFAOYSA-N,Preclinical,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3,,
BRD7389,"InChI=1S/C24H18N2O2/c27-23-17-10-5-4-9-16(17)21-20-18(23)11-6-12-19(20)26-24(28)22(21)25-14-13-15-7-2-1-3-8-15/h1-12,25H,13-14H2,(H,26,28)",Preclinical,ribosomal protein inhibitor,RPS6KA1|RPS6KA2|RPS6KA3,,
BRD9876,MKILROQBJOOZKC-UHFFFAOYSA-N,Preclinical,kinesin inhibitor,KIF11,,
brefeldin-A,KQNZDYYTLMIZCT-KQPMLPITSA-N,Preclinical,protein synthesis inhibitor,ARF1|CYTH2,,
bremelanotide,FFHBJDQSGDNCIV-VEUPWBLKSA-N,Launched,melanocortin receptor agonist,MC1R|MC2R|MC3R|MC4R|MC5R,neurology/psychiatry,hypoactive sexual desire disorder
brequinar,PHEZJEYUWHETKO-UHFFFAOYSA-N,Phase 2,dihydroorotate dehydrogenase inhibitor,DHODH,,
bretazenil,LWUDDYHYYNNIQI-ZDUSSCGKSA-N,Phase 2,GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,,
bretylium,AAQOQKQBGPPFNS-UHFFFAOYSA-N,Launched,norepinephrine inhibitor,ATP1A1,cardiology,ventricular arrhythmias|ventricular fibrillation (VF)|ventricular tachycardia (VT)
brexpiprazole,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,Launched,dopamine receptor partial agonist,DRD2,neurology/psychiatry,depression|schizophrenia
briciclib,LXENKEWVEVKKGV-BQYQJAHWSA-N,Phase 1,cyclin D inhibitor,CCND1,,
brigatinib,AILRADAXUVEEIR-UHFFFAOYSA-N,Launched,ALK tyrosine kinase receptor inhibitor|EGFR inhibitor,ALK|EGFR,oncology,non-small cell lung cancer (NSCLC)
brilliant-green,HXCILVUBKWANLN-UHFFFAOYSA-N,Launched,,,infectious disease,antiseptic
brimonidine,XYLJNLCSTIOKRM-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,ophthalmology,intraocular pressure|glaucoma|ocular hypertension
brincidofovir,WXJFKKQWPMNTIM-VWLOTQADSA-N,Phase 3,antiviral,,,
brinzolamide,HCRKCZRJWPKOAR-JTQLQIEISA-N,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA5A|CA7,ophthalmology,intraocular pressure|glaucoma|ocular hypertension
brivanib,WCWUXEGQKLTGDX-LLVKDONJSA-N,Phase 3,FGFR inhibitor|VEGFR inhibitor,CYP3A4|FGFR1|FLT1|KCNH2|KDR,,
brivanib-alaninate,LTEJRLHKIYCEOX-OCCSQVGLSA-N,Phase 3,FGFR inhibitor|VEGFR inhibitor,FGFR3,,
brivudine,ODZBBRURCPAEIQ-PIXDULNESA-N,Launched,DNA directed DNA polymerase inhibitor,,infectious disease,shingles
BRL-15572,QJHCTHPYUOXOGM-DEOSSOPVSA-N,Preclinical,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6,,
BRL-26314,SAOHCSVJQIAGDD-OAHLLOKOSA-N,Phase 1,cholesterol inhibitor,LPL,,
BRL-37344,ZGGNJJJYUVRADP-ACJLOTCBSA-N,Phase 2,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,,
BRL-44408,SGOFAUSEYBZKDQ-SNVBAGLBSA-N,Preclinical,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C,,
BRL-50481,IFIUFCJFLGCQPH-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,PDE7A|PDE7B,,
BRL-52537,GHCCBWMZKJQGLS-OAHLLOKOSA-N,Preclinical,opioid receptor agonist,OPRK1,,
BRL-54443,WKNFADCGOAHBPG-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR1E|HTR1F,,
brolitene,OSCTXCOERRNGLW-VOTSOKGWSA-N,Launched,muscle relaxant,RYR1,rheumatology,lumbago
bromantan,LWJALJDRFBXHKX-UHFFFAOYSA-N,Launched,dopamine reuptake inhibitor|serotonin reuptake inhibitor,,neurology/psychiatry,neurasthenia
bromebric-acid,UPZFHUODAYGHDZ-TWGQIWQCSA-N,Preclinical,DNA synthesis inhibitor|purine antagonist,,,
bromfenac,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,,
bromhexine,OJGDCBLYJGHCIH-UHFFFAOYSA-N,Launched,mucolytic agent,,pulmonary,chest congestion
bromindione,NPUZIGSOEWMFKK-UHFFFAOYSA-N,Phase 2,anticoagulant,,,
bromisoval,CMCCHHWTTBEZNM-SCSAIBSYSA-N,Preclinical,anti-inflammatory agent,,,
bromocriptine,OZVBMTJYIDMWIL-AYFBDAFISA-N,Launched,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,endocrinology|neurology/psychiatry,hyperprolactinemia|Parkinson's Disease|acromegaly
bromopride,GIYAQDDTCWHPPL-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD2,gastroenterology,nausea|vomiting|gastroesophageal reflux disease (GERD)
bromosporine,UYBRROMMFMPJAN-UHFFFAOYSA-N,Preclinical,bromodomain inhibitor,,,
bromperidol,RKLNONIVDFXQRX-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD2,neurology/psychiatry,schizophrenia
brompheniramine,ZDIGNSYAACHWNL-HNNXBMFYSA-N,Launched,histamine receptor antagonist,HRH1,allergy|otolaryngology,allergic rhinitis|common cold
bronopol,LVDKZNITIUWNER-UHFFFAOYSA-N,Launched,,,obstetrics/gynecology,mastitis
bropirimine,CIUUIPMOFZIWIZ-UHFFFAOYSA-N,Phase 3,interferon inducer,,,
broxaldine,IJTPLVAAROHGGB-UHFFFAOYSA-N,Preclinical,,,,
broxaterol,JBRBWHCVRGURBA-ZCFIWIBFSA-N,Phase 3,adrenergic receptor agonist,ADRB2,,
broxuridine,WOVKYSAHUYNSMH-RRKCRQDMSA-N,Phase 2,antimetabolite,,,
broxyquinoline,ZDASUJMDVPTNTF-UHFFFAOYSA-N,Phase 1,antiprotozoal agent,,,
bruceantin,KMCZIPGKKBSLEX-AOHBHZTBSA-N,Phase 2,protein synthesis inhibitor,,,
brucine,RRKTZKIUPZVBMF-IBTVXLQLSA-N,Preclinical,glycine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,,
BS-181,DNYBIOICMDTDAP-UHFFFAOYSA-N,Preclinical,CDK inhibitor,CDK7,,
BT-11,MVHWZNBAQIGPOQ-UHFFFAOYSA-N,Phase 2,cAMP stimulant,,,
BTB06584,WNDWKKPBLAKXMI-UHFFFAOYSA-N,Preclinical,ATPase inhibitor,ATP5F1,,
BTB1,VZDUQPHKUBZMLW-UHFFFAOYSA-N,Preclinical,mitotic kinesin inhibitor,KIF18A,,
BTK-IN-1,SPSNKQVUYDXOGY-OAHLLOKOSA-N,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,,,
BTS,WTHKAJZQYNKTCJ-UHFFFAOYSA-N,Preclinical,,,,
BTS-54505,WQSACWZKKZPCHN-CQSZACIVSA-N,Withdrawn,dopamine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,,
BTS-71321,GRKYRJREJPZXIU-UHFFFAOYSA-N,Phase 2,,,,
BTS-72664,FCEPUTGEUCVRRI-SECBINFHSA-N,Phase 1,GABA receptor antagonist,GABBR1,,
BTT-3033,NSLIQOPYDUKWTA-UHFFFAOYSA-N,Preclinical,integrin inhibitor,ITGA2|ITGB1,,
BTZ043-racemate,GTUIRORNXIOHQR-VIFPVBQESA-N,Phase 1/Phase 2,DPRE1 inhibitor,,,
BU-224,OSUVWJGCKQEMHK-UHFFFAOYSA-N,Preclinical,imidazoline receptor ligand,MAOA|MAOB,,
BU-239,MQSSFHXQKUSFIW-UHFFFAOYSA-N,Preclinical,imidazoline receptor agonist|imidazoline receptor ligand,,,
BU-239,"InChI=1S/C11H10N4/c1-2-4-9-8(3-1)14-7-10(15-9)11-12-5-6-13-11/h1-4,7H,5-6H2,(H,12,13)",Preclinical,imidazoline receptor agonist|imidazoline receptor ligand,,,
BU226,ZXRSVNHYTSSFMN-UHFFFAOYSA-N,Preclinical,imidazoline receptor ligand,,,
bucetin,LIAWQASKBFCRNR-SECBINFHSA-N,Withdrawn,analgesic agent,,,
bucillamine,VUAFHZCUKUDDBC-BYPYZUCNSA-N,Launched,immunosuppressant,,rheumatology,rheumatoid arthritis
bucladesine,CJGYSWNGNKCJSB-YVLZZHOMSA-N,Launched,adenosine receptor agonist|cAMP stimulant,PRKACA,dermatology,skin ulcer
buclizine,MOYGZHXDRJNJEP-MHZLTWQESA-N,Launched,histamine receptor antagonist,HRH1,neurology/psychiatry,migraine headache
budesonide,VOVIALXJUBGFJZ-AMTWPJRWSA-N,Launched,glucocorticoid receptor agonist,NR3C1,gastroenterology,Crohn's disease
budipine,QIHLUZAFSSMXHQ-UHFFFAOYSA-N,Launched,glutamate receptor antagonist,GRIN1,neurology/psychiatry,Parkinson's Disease
bufexamac,MXJWRABVEGLYDG-UHFFFAOYSA-N,Withdrawn,cyclooxygenase inhibitor,HDAC10|HDAC6,,
buflomedil,OWYLAEYXIQKAOL-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist|calcium channel blocker,ADRA1A,cardiology,peripheral artery disease (PAD)
bumetanide,MAEIEVLCKWDQJH-UHFFFAOYSA-N,Launched,solute carrier family member inhibitor,CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5,cardiology,edema|congestive heart failure
bunazosin,RHLJLALHBZGAFM-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRA1A,ophthalmology,glaucoma|intraocular pressure
buparlisib,CWHUFRVAEUJCEF-UHFFFAOYSA-N,Phase 3,PI3K inhibitor,PIK3CA|PIK3CG,,
buparvaquone,OMMKCJLAGTXGLC-MQBCKMQZSA-N,Launched,antiprotozoal agent,,infectious disease,protozoan infection
buphenine,PTGXAUBQBSGPKF-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRB2,rheumatology,Raynaud's disease
bupicomide,VKSPIPWLHGKJQO-UHFFFAOYSA-N,Phase 1,adrenergic receptor antagonist,ADRB1,,
bupivacaine,LEBVLXFERQHONN-INIZCTEOSA-N,Launched,sodium channel blocker,KCNA5|SCN10A,neurology/psychiatry,peripheral nerve block|caudal epidural block|lumbar epidural block
bupranolol,HQIRNZOQPUAHHV-NSHDSACASA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,cardiology|ophthalmology,hypertension|glaucoma
bupropion,SNPPWIUOZRMYNY-SECBINFHSA-N,Launched,dopamine reuptake inhibitor,SLC6A2|SLC6A3,neurology/psychiatry,depression
buramate,YFLRYAVDPKONNX-UHFFFAOYSA-N,Preclinical,antiepileptic,,,
buserelin,CUWODFFVMXJOKD-UVLQAERKSA-N,Launched,gonadotropin releasing factor hormone receptor agonist,,oncology|obstetrics/gynecology,prostate cancer|endometriosis
buspirone,QWCRAEMEVRGPNT-UHFFFAOYSA-N,Launched,serotonin receptor agonist,DRD2|HTR1A,neurology/psychiatry,generalized anxiety disorder (GAD)
busulfan,COVZYZSDYWQREU-UHFFFAOYSA-N,Launched,DNA inhibitor,,hematologic malignancy,chronic myeloid leukemia (CML)
butabindide,HAQIRIMIVLFYIX-ZFWWWQNUSA-N,Preclinical,tripeptidyl peptidase inhibitor,TPP2,,
butacaine,HQFWVSGBVLEQGA-UHFFFAOYSA-N,Launched,local anesthetic,,neurology/psychiatry,local anesthetic
butaclamol,ZZJYIKPMDIWRSN-HWBMXIPRSA-N,Phase 2,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A,,
butalbital,UZVHFVZFNXBMQJ-UHFFFAOYSA-N,Launched,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,neurology/psychiatry,headache|muscle relaxant
butamben,IUWVALYLNVXWKX-UHFFFAOYSA-N,Withdrawn,sodium channel blocker,,,
butaprost,XRISENIKJUKIHD-LHQZMKCDSA-N,Preclinical,prostaglandin receptor agonist,,,
butein,AYMYWHCQALZEGT-ORCRQEGFSA-N,Preclinical,EGFR inhibitor|SRC inhibitor,ACE,,
butenafine,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,Launched,fungal squalene epoxidase inhibitor,SQLE,infectious disease,tinea pedis|tinea cruris|tinea corporis
buthionine-sulfoximine,KJQFBVYMGADDTQ-CVSPRKDYSA-N,Phase 1,glutathione transferase inhibitor,GCLM,,
butibufen,UULSXYSSHHRCQK-CYBMUJFWSA-N,Withdrawn,cyclooxygenase inhibitor,,,
butoconazole,SWLMUYACZKCSHZ-INIZCTEOSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,vulvovaginal candidiasis
butofilolol,NMBNQRJDEPOXCP-ZDUSSCGKSA-N,Phase 2,adrenergic receptor antagonist,,,
butyl-paraben,QFOHBWFCKVYLES-UHFFFAOYSA-N,Preclinical,DNA synthesis inhibitor,,,
butylated-hydroxyanisole,MRBKEAMVRSLQPH-UHFFFAOYSA-N,Preclinical,antioxidant,,,
butylated-hydroxytoluene,NLZUEZXRPGMBCV-UHFFFAOYSA-N,Phase 1,carbonic anhydrase inhibitor,CA2,,
butylidenephthalide,WMBOCUXXNSOQHM-FLIBITNWSA-N,Phase 1/Phase 2,cyclooxygenase inhibitor,,,
butylphthalide,HJXMNVQARNZTEE-LLVKDONJSA-N,Launched,potassium channel antagonist,KCNK2,neurology/psychiatry,stroke
butylscopolamine-bromide,YBCNXCRZPWQOBR-FRNBUXIHSA-N,Launched,cholinergic receptor antagonist,,gastroenterology,abdominal pain
BVD-523,KSERXGMCDHOLSS-LJQANCHMSA-N,Phase 2,MAP kinase inhibitor,,,
BVT-2733,YDPRNGAPPNPYQQ-UHFFFAOYSA-N,Preclinical,11-beta hydroxysteroid dehydrogenase inhibitor,HSD17B1,,
BVT-948,LLPBUXODFQZPFH-UHFFFAOYSA-N,Preclinical,tyrosine phosphatase inhibitor,PTPN1|PTPN11|PTPN2,,
BW-180C,ZHUJMSMQIPIPTF-IBURTVSXSA-N,Phase 2,opioid receptor agonist,OPRD1|OPRM1,,
BW-348U87,YYLKOELWSMRYHV-VXLYETTFSA-N,Preclinical,antiviral,,,
BW-373U86,LBLDMHBSVIVJPM-YZIHRLCOSA-N,Preclinical,opioid receptor agonist,OPRD1,,
BW-616U,MLPSDBJCWIYSEA-UHFFFAOYSA-N,Preclinical,monoamine oxidase inhibitor,MAOA,,
BW-723C86,ALFGDCNSEBJYSP-LLVKDONJSA-N,Preclinical,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,,
BW-A4C,CEUDWZXMLMKPNN-SOFGYWHQSA-N,Phase 1,lipoxygenase inhibitor,ALOX5,,
BW-B70C,UAIYNMRLUHHRMF-FYJFLYSWSA-N,Preclinical,lipoxygenase inhibitor,ALOX5,,
BX-795,VAVXGGRQQJZYBL-UHFFFAOYSA-N,Preclinical,IKK inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,,
BX-912,DMMILYKXNCVKOJ-UHFFFAOYSA-N,Preclinical,pyruvate dehydrogenase kinase inhibitor,CDK2|CHEK1|GSK3B|KDR|PDK1|PDPK1,,
BYK-204165,BTYSIDSTHDDAJW-LCYFTJDESA-N,Preclinical,PARP inhibitor,PARP1,,
C-021,WYVBISCFCHREDA-UHFFFAOYSA-N,Preclinical,CC chemokine receptor antagonist,CCR4,,
C-1,UPTYCYWTFGTCCG-UHFFFAOYSA-N,Preclinical,protein kinase inhibitor,PRKCA,,
C-751,KLWYPRNPRNPORS-UHFFFAOYSA-N,Preclinical,,,,
C106,GEGPCGHEPLKDLY-DRHSTVBOSA-N,Phase 3,,,,
C11-Acetate,GRTBAGCGDOYUBE-UHFFFAOYSA-N,Phase 3,,ABAT|ACE|AKR1C3|CA2|CELA1|ESR2|FFAR2|FFAR3|HPRT1|LTA4H|MMP12|NOS1|NOS3|PLA2G1B|PTPN1|SOD1|TXN,,
C188-9,QDCJDYWGYVPBDO-UHFFFAOYSA-N,Preclinical,STAT inhibitor,,,
C34,KMIQMFHPUJUDMC-HHARLNAUSA-N,Preclinical,toll-like receptor inhibitor,TLR4,,
C646,HEKJYZZSCQBJGB-UHFFFAOYSA-N,Preclinical,histone acetyltransferase inhibitor,EP300,,
CA-4948,RWIMETUXCNDSLE-UHFFFAOYSA-N,Phase 1,kinase inhibitor,,,
cabagin,YDBYJHTYSHBBAU-YFKPBYRVSA-O,Launched,,,gastroenterology,dyspepsia
cabaletta,HDTRYLNUVZCQOY-LIZSDCNHSA-N,Phase 2,pharmacological chaperone,,,
cabazitaxel,BMQGVNUXMIRLCK-OAGWZNDDSA-N,Launched,microtubule inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,prostate cancer
cabergoline,KORNTPPJEAJQIU-KJXAQDMKSA-N,Launched,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7,endocrinology,hyperprolactinemia
cabotegravir,WCWSTNLSLKSJPK-LKFCYVNXSA-N,Phase 3,HIV integrase inhibitor,,,
cabozantinib,ONIQOQHATWINJY-UHFFFAOYSA-N,Launched,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,oncology,medullary thyroid cancer (MTC)
cabozantinib,"InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)",Launched,RET tyrosine kinase inhibitor|VEGFR inhibitor,KDR|MET|RET,oncology,medullary thyroid cancer (MTC)
CaCCinh-A01,ACLUEOBQFRYTQS-JTQLQIEISA-N,Preclinical,calcium-activated chloride channel inhibitor,CLCA1,,
cadazolid,XWFCFMXQTBGXQW-GOSISDBHSA-N,Phase 3,antibacterial ,,,
cadralazine,QLTVVOATEHFXLT-SECBINFHSA-N,Launched,adrenergic receptor antagonist,,cardiology,hypertension
cafestol,DNJVYWXIDISQRD-HWUKTEKMSA-N,Launched,pregnane X receptor agonist,,,
caffeic-acid,QAIPRVGONGVQAS-DUXPYHPUSA-N,Preclinical,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,ALOX5|MIF,,
caffeic-acid-phenethyl-ester,SWUARLUWKZWEBQ-VQHVLOKHSA-N,Preclinical,HIV integrase inhibitor,RELA,,
caffeine,RYYVLZVUVIJVGH-UHFFFAOYSA-N,Launched,adenosine receptor antagonist|phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3,neurology/psychiatry,fatigue|drowsiness
calcifediol,JWUBBDSIWDLEOM-DTOXIADCSA-N,Launched,vitamin D receptor agonist,VDR,endocrinology,hyperparathyroidism
calcipotriol,LWQQLNNNIPYSNX-UROSTWAQSA-N,Launched,vitamin D receptor agonist,VDR,dermatology,psoriasis
calcitonin,JDJALSWDQPEHEJ-XXZWWZJQSA-N,Launched,calcitonin agonist,,orthopedics,osteoporosis
calcitriol,GMRQFYUYWCNGIN-NKMMMXOESA-N,Launched,vitamin D receptor agonist,VDR,endocrinology|orthopedics,hypocalcemia|hypoparathyroidism|osteoporosis
calcium-gluceptate,KWMLJOLKUYYJFJ-VFUOTHLCSA-N,Launched,,,,
calcium-levofolinate,VVIAGPKUTFNRDU-STQMWFEESA-N,Launched,,,,
Calhex-231,YTFUQWWKTIWYEY-CQLNOVPUSA-N,Preclinical,calcium sensing receptor negative allosteric modulator,CASR,,
calpeptin,PGGUOGKHUUUWAF-ROUUACIJSA-N,Preclinical,calpain inhibitor,,,
camicinal,RZKDEGZIFSJVNA-IBGZPJMESA-N,Phase 2,motilin receptor agonist,MLNR,,
CaMKII-IN-1,LGUUETDTMQTHML-UHFFFAOYSA-N,Preclinical,calcium/calmodulin dependent protein kinase inhibitor,AKT1|CAMK2A|CAMK4|MYLK,,
camobucol,FGBGXESDYFKUFX-UHFFFAOYSA-N,Preclinical,anti-inflammatory agent,,,
camostat-mesilate,XASIMHXSUQUHLV-UHFFFAOYSA-N,Launched,protease inhibitor,PRSS1,gastroenterology,pancreatitis
camphor-(+),DSSYKIVIOFKYAU-XCBNKYQSSA-N,Phase 2,,,,
camphor-(1R),DSSYKIVIOFKYAU-GMSGAONNSA-N,Phase 1,TRPV activator,TRPV1,,
camptothecin,VSJKWCGYPAHWDS-FQEVSTJZSA-N,Phase 3,topoisomerase inhibitor,TOP1,,
camylofine-chlorhydrate,RYOOHIUJEJZCFT-GOSISDBHSA-N,Launched,,,gastroenterology,abdominal pain
canagliflozin,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,Launched,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,endocrinology,diabetes mellitus
candesartan,HTQMVQVXFRQIKW-UHFFFAOYSA-N,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension|congestive heart failure
candesartan-cilexetil,GHOSNRCGJFBJIB-OAQYLSRUSA-N,Launched,angiotensin receptor antagonist,,cardiology,hypertension|congestive heart failure|hypertension
candicidin,HYIZCDMXFDRDFE-RGXQRFNASA-N,Launched,fungal ergosterol inhibitor,,infectious disease,vulvovaginal candidiasis
canertinib,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,Phase 3,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,,
canertinib,"InChI=1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29)",Phase 3,EGFR inhibitor,AKT1|EGFR|ERBB2|ERBB4,,
cangrelor,PAEBIVWUMLRPSK-IDTAVKCVSA-N,Launched,purinergic receptor antagonist,,cardiology,myocardial infarction
canrenone,UJVLDDZCTMKXJK-WNHSNXHDSA-N,Withdrawn,mineralocorticoid receptor antagonist,NR3C2,,
cantharidin,DHZBEENLJMYSHQ-XCVPVQRUSA-N,Launched,protein phosphatase inhibitor,,dermatology,blisters
capadenoson,CITWCLNVRIKQAF-UHFFFAOYSA-N,Phase 2,adenosine receptor agonist,ADORA1,,
capecitabine,GAGWJHPBXLXJQN-UORFTKCHSA-N,Launched,DNA synthesis inhibitor|thymidylate synthase inhibitor,TYMS,oncology,breast cancer|colorectal cancer
capobenic-acid,MPTXLVRHYGBOQY-UHFFFAOYSA-N,Preclinical,,,,
capreomycin,FRXNXDHFQYZYNA-GJTMSUEESA-N,Launched,protein synthesis inhibitor,,infectious disease,tuberculosis
capromorelin,KVLLHLWBPNCVNR-SKCUWOTOSA-N,Preclinical,growth hormone secretagogue receptor agonist,,,
caprylic-acid,WWZKQHOCKIZLMA-UHFFFAOYSA-N,Launched,,,,
capsaicin,YKPUWZUDDOIDPM-SOFGYWHQSA-N,Launched,TRPV agonist,CFTR|TRPV1,neurology/psychiatry|rheumatology,muscle pain|rheumatoid arthritis
capsazepine,DRCMAZOSEIMCHM-UHFFFAOYSA-N,Preclinical,TRPV agonist,TRPV1|TRPV4,,
captamine,DENMGZODXQRYAR-UHFFFAOYSA-N,Preclinical,,,,
captan,LDVVMCZRFWMZSG-WDSKDSINSA-N,Phase 1,,,,
captopril,FAKRSMQSSFJEIM-RQJHMYQMSA-N,Launched,angiotensin converting enzyme inhibitor,ACE|LTA4H|MMP2|MMP9,cardiology|endocrinology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetes mellitus|diabetic nephropathy
caracemide,JURAJLFHWXNPHG-UHFFFAOYSA-N,Phase 2,ribonucleotide reductase inhibitor,RRM1,,
caramiphen,OFAIGZWCDGNZGT-UHFFFAOYSA-N,Launched,cholinergic receptor antagonist,CHRM1|CHRM2,neurology/psychiatry,Parkinson's Disease
carazolol,BQXQGZPYHWWCEB-CYBMUJFWSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,cardiology,angina pectoris|cardiac arrythmia|hypertension|myocardial infarction
carbachol,VPJXQGSRWJZDOB-UHFFFAOYSA-O,Launched,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2,ophthalmology,intraocular pressure
carbadox,OVGGLBAWFMIPPY-WUXMJOGZSA-N,Launched,other antibiotic,,infectious disease|gastroenterology,dysentry|enteritis
carbamazepine,FFGPTBGBLSHEPO-UHFFFAOYSA-N,Launched,carboxamide antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures
carbaril,CVXBEEMKQHEXEN-UHFFFAOYSA-N,Launched,acetylcholinesterase inhibitor,,,
carbarsone,WWXBHTZSYYGCSG-UHFFFAOYSA-N,Launched,antiprotozoal agent,,infectious disease,amebiasis
carbazochrome,OZCACMPSTYQSMM-DKBJHAQFSA-N,Launched,,,hematology,hemorrhage
carbendazim,TWFZGCMQGLPBSX-UHFFFAOYSA-N,Launched,microtubule inhibitor|tubulin polymerization inhibitor,TP53|TUBB,infectious disease,fungicide
carbenicillin,FPPNZSSZRUTDAP-BBGACYKPSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections
carbenoxolone,OBZHEBDUNPOCJG-WBXJDKIVSA-N,Launched,11-beta hydroxysteroid dehydrogenase inhibitor,GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3,gastroenterology|dental,peptic ulcer disease (PUD)|mouth inflammation
carbetapentane,CFJMRBQWBDQYMK-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM2,otolaryngology|pulmonary,common cold|nasal congestion|bronchitis
carbetocin,NSTRIRCPWQHTIA-CPWZVOFUSA-N,Launched,oxytocin receptor agonist,OXTR,hematology,hemorrhage
carbidopa,TZFNLOMSOLWIDK-JTQLQIEISA-N,Launched,aromatic L-amino acid decarboxylase inhibitor,DDC,neurology/psychiatry,Parkinson's Disease
carbimazole,CFOYWRHIYXMDOT-UHFFFAOYSA-N,Launched,antithyroid agent,TPO,endocrinology,hyperthyroidism
carbinoxamine,OJFSXZCBGQGRNV-INIZCTEOSA-N,Launched,histamine receptor antagonist,HRH1,allergy|ophthalmology|otolaryngology|dermatology,allergic rhinitis|conjunctivitis|vasomotor rhinitis|dermatographism
carboplatin,YAYRGNWWLMLWJE-UHFFFAOYSA-L,Launched,DNA alkylating agent|DNA inhibitor,,oncology,ovarian cancer
carboxyamidotriazole,WNRZHQBJSXRYJK-UHFFFAOYSA-N,Phase 3,calcium channel blocker,CXCL8,,
carboxylosartan,ZEUXAIYYDDCIRX-UHFFFAOYSA-N,Phase 1,angiotensin antagonist,AGTR1,,
carboxypyridine-disulfide,GSASOFRDSIKDSN-UHFFFAOYSA-N,Phase 2,,,,
cardiogenol-C,LKBSMPFEKIBRGC-UHFFFAOYSA-N,Preclinical,cardiomyogenesis inducer,,,
cardionogen-1,SWTUPSNBTSPBIH-UHFFFAOYSA-N,Preclinical,WNT signaling inhibitor,CTNNB1,,
carebastine,XGHOVGYJHWQGCC-UHFFFAOYSA-N,Phase 1,histamine receptor antagonist,HRH1,,
carfilzomib,BLMPQMFVWMYDKT-NZTKNTHTSA-N,Launched,proteasome inhibitor,PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9,hematologic malignancy,multiple myeloma
carglumic-acid,LCQLHJZYVOQKHU-VKHMYHEASA-N,Launched,carbamoyl phosphate synthase activator,CPS1,metabolism,hyperammonemia
caricotamide,WEJRSYKFMCUCRQ-UHFFFAOYSA-N,Phase 2,NADPH quinone oxidoreductase inhibitor,NQO2,,
cariporide,IWXNYAIICFKCTM-UHFFFAOYSA-N,Phase 3,sodium/hydrogen exchanger inhibitor,SLC9A1,,
cariprazine,KPWSJANDNDDRMB-QAQDUYKDSA-N,Launched,dopamine receptor antagonist,DRD2|DRD3,neurology/psychiatry,schizophrenia
carmofur,AOCCBINRVIKJHY-UHFFFAOYSA-N,Launched,thymidylate synthase inhibitor,TYMS,oncology,breast cancer|colorectal cancer
carmoterol,IHOXNOQMRZISPV-YJYMSZOUSA-N,Phase 2,adrenergic receptor agonist,ADRB2,,
carmoxirole,AFSOIHMEOKEZJF-UHFFFAOYSA-N,Phase 2,dopamine receptor agonist,DRD2,,
carmustine,IIJOAQBKDPUMEO-UHFFFAOYSA-N,Launched,DNA alkylating agent|DNA inhibitor,GSR,hematologic malignancy|oncology,non-Hodgkin lymphoma (NHL)|Hodgkin's lymphoma|multiple myeloma|glioblastoma|brainstem glioma|medulloblastoma|astrocytoma|ependymoma
carnitine-(D/L),PHIQHXFUZVPYII-LURJTMIESA-O,Phase 3,,,,
carnosine,CQOVPNPJLQNMDC-ZETCQYMHSA-N,Phase 2,antiglycating agent,,,
caroverin,MSPRUJDUTKRMLM-UHFFFAOYSA-N,Phase 3,cytochrome P450 inhibitor,,,
caroxazone,KYCBWEZLKCTALM-UHFFFAOYSA-N,Withdrawn,monoamine oxidase inhibitor,MAOA|MAOB,,
carprofen,PUXBGTOOZJQSKH-MRVPVSSYSA-N,Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,osteoarthritis
carsalam,OAYRYNVEFFWSHK-UHFFFAOYSA-N,Preclinical,analgesic agent,,,
carteolol,LWAFSWPYPHEXKX-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,ophthalmology,intraocular pressure|glaucoma|ocular hypertension
carumonam,UIMOJFJSJSIGLV-JNHMLNOCSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|gram-negative bacterial infections
carvedilol,OGHNVEJMJSYVRP-QGZVFWFLSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,cardiology,myocardial infarction|hypertension
carzenide,UCAGLBKTLXCODC-UHFFFAOYSA-N,Preclinical,,CA1|CA12|CA14|CA2|CA6|CA9,,
casanthranol-variant,XMCJWIFCIIXRGI-BAEVKLAGSA-N,Launched,,,gastroenterology,constipation
casin,RXIUMAOXORBRCY-IBGZPJMESA-N,Preclinical,GTPase inhibitor,CDC42,,
caspofungin,JYIKNQVWKBUSNH-WVDDFWQHSA-N,Launched,"bacterial cell wall synthesis inhibitor|fungal 1,3-beta-D-glucan synthase inhibitor",,infectious disease,candidemia|esophageal candidiasis|aspergillosis|peritonitis|fungal infection
castanospermine,JDVVGAQPNNXQDW-TVNFTVLESA-N,Phase 2,glucosidase inhibitor,GAA|GBA,,
catharanthine,CMKFQVZJOWHHDV-NQZBTDCJSA-N,Preclinical,tubulin polymerization inhibitor,,,
cathepsin-inhibitor-1,MZRVIHRERYCHBL-HNNXBMFYSA-N,Preclinical,cathepsin inhibitor,CTSB|CTSL|CTSV,,
CAY10505,UFBTYTGRUBUUIL-KPKJPENVSA-N,Preclinical,PI3K inhibitor,PIK3CG,,
CB-03-01,GPNHMOZDMYNCPO-PDUMRIMRSA-N,Phase 3,androgen receptor antagonist,AR,,
CB-10-277,GUAZPUYTLMUTMA-ZHACJKMWSA-N,Phase 1,DNA synthesis inhibitor,,,
CB-5083,RDALZZCKQFLGJP-UHFFFAOYSA-N,Phase 1,valosin-containing protein inhibitor,VCP,,
CB-839,PRAAPINBUWJLGA-UHFFFAOYSA-N,Phase 2,glutaminase inhibitor,GLS,,
CBiPES,HDVYXILCBYGKGU-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM2,,
cbl0137,JKCSODVERGVDLT-UHFFFAOYSA-N,Phase 1,histone chaperone inhibitor,,,
CBS-1114,ZOBKPJRHDMKXQG-UHFFFAOYSA-N,Phase 1,lipoxygenase inhibitor,ALOX5,,
CC-115,GMYLVKUGJMYTFB-UHFFFAOYSA-N,Phase 2,DNA protein kinase inhibitor|mTOR inhibitor,MTOR,,
CC-223,UFKLYTOEMRFKAD-SHTZXODSSA-N,Phase 2,mTOR inhibitor,MTOR,,
CC-401,XDJCLCLBSGGNKS-UHFFFAOYSA-N,Phase 1,JNK inhibitor,MAPK8,,
CC-90003,ILUKRINUNLAVMH-UHFFFAOYSA-N,Phase 1,MAP kinase inhibitor,,,
CC-930,IBGLGMOPHJQDJB-IHRRRGAJSA-N,Phase 2,JNK inhibitor,,,
CC4,LEXDAVFCJPDCNA-VNTMZGSJSA-N,Preclinical,nicotinic receptor agonist,CHRNB2,,
CCG-1423,DSMXVSGJIDFLKP-SECBINFHSA-N,Preclinical,apoptosis stimulant,RHOC|SRF,,
CCG-50014,QUIIIYITNGOFEI-UHFFFAOYSA-N,Preclinical,G protein signaling inhibitor,RGS4|RGS8,,
CCG-63802,VFSVKVQMZDJFQX-NBVRZTHBSA-N,Preclinical,G protein signaling inhibitor,RGS4,,
CCG-63808,IPZHFKHGSYRBNT-DTQAZKPQSA-N,Preclinical,G protein signaling inhibitor,RGS4,,
CCMI,VMAKIACTLSBBIY-UHFFFAOYSA-N,Preclinical,acetylcholine receptor allosteric modulator,CHRNA7,,
CCMQ,IFXJDEHFADWURH-UHFFFAOYSA-N,Preclinical,homoquinolinic acid binding inhibitor,,,
CCT-031374,JPCYSKNELCOPKJ-UHFFFAOYSA-N,Preclinical,WNT signaling inhibitor,CTNNB1,,
CCT018159,OWPMENVYXDJDOW-UHFFFAOYSA-N,Preclinical,HSP inhibitor,HSP90AA1|HSP90AB1,,
CCT128930,RZIDZIGAXXNODG-UHFFFAOYSA-N,Preclinical,AKT inhibitor,,,
CCT129202,QYKHWEFPFAGNEV-UHFFFAOYSA-N,Preclinical,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,
CCT137690,GFLQCBTXTRCREJ-UHFFFAOYSA-N,Preclinical,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,
CCT196969,KYYKGSDLXXKQCR-UHFFFAOYSA-N,Preclinical,RAF inhibitor,,,
CCT245737,YBYYWUUUGCNAHQ-LLVKDONJSA-N,Preclinical,kinase inhibitor,,,
CD-1530,VCQGNUWOMLYNNG-UHFFFAOYSA-N,Preclinical,retinoid receptor agonist,RARG,,
CD-437,LDGIHZJOIQSHPB-UHFFFAOYSA-N,Preclinical,retinoid receptor agonist,RARG,,
CDBA,WHGYBXFWUBPSRW-GUJBRCDDSA-N,Phase 3,,,,
CDK1-5-inhibitor,DWHVZCLBMTZRQM-UHFFFAOYSA-N,Preclinical,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3B,,
CDK9-IN-6,XWQVQSXLXAXOPJ-ACRUOGEOSA-N,Preclinical,CDK inhibitor,CDK9,,
CDPPB,BKUIZWILNWHFHD-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM5,,
CE3F4,ZZLQPWXVZCPUGC-LURJTMIESA-N,Preclinical,rap guanine nucleotide exchange factor inhibitor,RAPGEF3,,
cebranopadol,CSMVOZKEWSOFER-RQNOJGIXSA-N,Phase 3,opioid receptor agonist,OPRL1|OPRM1,,
cediranib,XXJWYDDUDKYVKI-UHFFFAOYSA-N,Phase 3,KIT inhibitor|VEGFR inhibitor,CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB,,
cedrol,SVURIXNDRWRAFU-OBORUHMCSA-N,Phase 2,,,,
cedrol-(+),SVURIXNDRWRAFU-OGMFBOKVSA-N,Phase 2,sedative,,,
cefaclor,QYIYFLOTGYLRGG-GPCCPHFNSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology,pneumonia|skin infections|urinary tract infections|respiratory tract infections|tonsillitis|pharyngitis
cefadroxil,BOEGTKLJZSQCCD-UEKVPHQBSA-N,Launched,bacterial cell wall synthesis inhibitor,SLC15A1|SLC15A2|SLC22A6|SLC22A8,infectious disease|otolaryngology,urinary tract infections|skin infections|tonsillitis|pharyngitis
cefalonium,FMZXNVLFJHCSAF-DNVCBOLYSA-O,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections
cefamandole,OLVCFLKTBJRLHI-AXAPSJFSSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|urinary tract infections|respiratory tract infections
cefamandole-nafate,RRJHESVQVSRQEX-SUYBPPKGSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|urinary tract infections|respiratory tract infections
cefathiamidine,JYXACOFERDBGGQ-RHSMWYFYSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections
cefazolin,MLYYVTUWGNIJIB-BXKDBHETSA-N,Launched,bacterial cell wall synthesis inhibitor,PON1,infectious disease,urinary tract infections|skin infections|bacterial septicemia|endocarditis|surgical prophylaxis|bone and joint infections
cefcapene-pivoxil,WVPAABNYMHNFJG-QDVBXLKVSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|pneumonia|urinary tract infections
cefdinir,RTXOFQZKPXMALH-GHXIOONMSA-N,Launched,bacterial cell wall synthesis inhibitor,MPO,infectious disease|otolaryngology|pulmonary,pneumonia|tonsillitis|pharyngitis|bronchitis|skin infections|otitis|sinusitis
cefditoren-pivoxil,AFZFFLVORLEPPO-UVYJNCLZSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|pulmonary|otolaryngology,pneumonia|bronchitis|skin infections|tonsillitis|pharyngitis
cefepime,HVFLCNVBZFFHBT-FKULVZFESA-O,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,pneumonia|urinary tract infections|skin infections|intra-abdominal infections
cefetamet,MQLRYUCJDNBWMV-GHXIOONMSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology|pulmonary,ear infections|pneumonia|otitis|sinusitis|bronchitis|urinary tract infections
cefetamet-pivoxil,DASYMCLQENWCJG-XUKDPADISA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections
cefiderocol,DBPPRLRVDVJOCL-FQRUVTKNSA-O,Launched,antibacterial ,,,
cefixime,OKBVVJOGVLARMR-QSWIMTSFSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology|pulmonary,urinary tract infections|otitis|pharyngitis|tonsillitis|gonorrhea|bronchitis
cefmenoxime,HJJDBAOLQAWBMH-YCRCPZNHSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections
cefmetazole,SNBUBQHDYVFSQF-HIFRSBDPSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|skin infections
cefminox,JSDXOWVAHXDYCU-VXSYNFHWSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections
cefodizime,XDZKBRJLTGRPSS-BGZQYGJUSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|skin infections|gonorrhea
cefonicid,DYAIAHUQIPBDIP-AXAPSJFSSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections
cefoperazone,GCFBRXLSHGKWDP-XCGNWRKASA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections
ceforanide,SLAYUXIURFNXPG-CRAIPNDOSA-N,Launched,penicillin binding protein inhibitor,,infectious disease,gram-negative bacterial infections
cefoselis,ZINFAXPQMLDEEJ-GFVOIPPFSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
cefotaxime,GPRBEKHLDVQUJE-QSWIMTSFSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|bone and joint infections|pelvic inflammatory disease|intra-abdominal infections|skin infections|meningitis|urinary tract infections|bacterial septicemia|gynecologic infections
cefotetan,SRZNHPXWXCNNDU-IXOPCIAXSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|respiratory tract infections|skin infections|gynecologic infections|chlamydia|intra-abdominal infections|bone and joint infections|surgical prophylaxis
cefotiam,QYQDKDWGWDOFFU-IUODEOHRSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,bacterial septicemia|bone and joint infections|respiratory tract infections|skin infections|urinary tract infections
cefotiam-cilexetil,VVFDMWZLBPUKTD-XLHILCRZSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
cefoxitin,WZOZEZRFJCJXNZ-ZBFHGGJFSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|urinary tract infections|intra-abdominal infections|gynecologic infections|bacterial septicemia|bone and joint infections|skin infections
cefozopran,QDUIJCOKQCCXQY-WHJQOFBOSA-O,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
cefpiramide,PWAUCHMQEXVFJR-PMAPCBKXSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections
cefpirome,DKOQGJHPHLTOJR-PUIFZAHNSA-O,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections
cefpodoxime,LTINZAODLRIQIX-OLEGMKQCSA-N,Launched,bacterial cell wall synthesis inhibitor,,otolaryngology|infectious disease|pulmonary,pharyngitis|pneumonia|bronchitis|gonorrhea|skin infections|urinary tract infections|sinusitis|tonsillitis
cefprozil,WDLWHQDACQUCJR-ZAMMOSSLSA-N,Launched,bacterial cell wall synthesis inhibitor,,otolaryngology|infectious disease|pulmonary,pharyngitis|tonsillitis|otitis|sinusitis|respiratory tract infections|skin infections|bronchitis
cefradine,RDLPVSKMFDYCOR-UEKVPHQBSA-N,Launched,bacterial cell wall synthesis inhibitor,CYP3A4,infectious disease|otolaryngology,respiratory tract infections|otitis|skin infections|urinary tract infections|tonsillitis|pharyngitis|pneumonia
cefsulodin,SYLKGLMBLAAGSC-QLVMHMETSA-O,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections
ceftaroline-fosamil,ZCCUWMICIWSJIX-XHNDKCDBSA-O,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|pneumonia
ceftazidime,ORFOPKXBNMVMKC-DWVKKRMSSA-O,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|skin infections|bacterial septicemia|bone and joint infections|gynecologic infections|intra-abdominal infections|meningitis
ceftibuten,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,Launched,bacterial cell wall synthesis inhibitor,,pulmonary|otolaryngology,bronchitis|otitis|pharyngitis|tonsillitis
ceftiofur,ZBHXIWJRIFEVQY-IHMPYVIRSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,pneumonia|respiratory tract infections
ceftizoxim,NNULBSISHYWZJU-LLKWHZGFSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,respiratory tract infections|urinary tract infections|gonorrhea|pelvic inflammatory disease|intra-abdominal infections|bacterial septicemia|skin infections|bone and joint infections|meningitis
ceftobiprole,VOAZJEPQLGBXGO-SDAWRPRTSA-N,Phase 3,antiinfective drug,,,
ceftriaxone,VAAUVRVFOQPIGI-SPQHTLEESA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology,gonorrhea|pneumonia|otitis|skin infections|urinary tract infections|pelvic inflammatory disease|bacterial septicemia|bone and joint infections|intra-abdominal infections|meningitis|surgical prophylaxis
cefuroxime,JFPVXVDWJQMJEE-IZRZKJBUSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections
cefuroxime-axetil,KEJCWVGMRLCZQQ-QFDKGRJDSA-N,Launched,bacterial cell wall synthesis inhibitor,,otolaryngology,pharyngitis|tonsillitis|otitis|sinusitis
celecoxib,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,CA12|PDPK1|PTGS2,rheumatology|endocrinology,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis|primary dysmenorrhea (PD)
celgosivir,HTJGLYIJVSDQAE-VWNXEWBOSA-N,Phase 2,glucosidase inhibitor,,,
celiprolol,JOATXPAWOHTVSZ-INIZCTEOSA-N,Launched,adrenergic receptor antagonist,ADRA2A|ADRB1|ADRB2,genetics,Ehlers-Danlos syndrome (EDS)
cenerimod,KJKKMMMRWISKRF-FQEVSTJZSA-N,Phase 2,sphingosine 1-phosphate receptor modulator,,,
cenicriviroc,PNDKCRDVVKJPKG-WHERJAGFSA-N,Phase 3,CC chemokine receptor antagonist,,,
cenobamate,GFHAXPJGXSQLPT-VIFPVBQESA-N,Launched,GABA receptor modulator|voltage-gated sodium channel blocker,,,
centanafadine,HKHCSWPSUSWGLI-CABCVRRESA-N,Phase 3,dopamine reuptake inhibitor,,,
centazolone,CZXUQBVMAUWSBX-UHFFFAOYSA-N,Phase 1,monoamine oxidase inhibitor,,,
centhaquin,UJNWGFBJUHIJKK-UHFFFAOYSA-N,Phase 1,analgesic agent,,,
centpropazine,ZQPXSRTZFYHSFB-FQEVSTJZSA-N,Phase 3,inositol monophosphatase inhibitor,,,
CEP-32496,DKNUPRMJNUQNHR-UHFFFAOYSA-N,Phase 1/Phase 2,RAF inhibitor,BRAF|RAF1,,
CEP-33779,RFZKSQIFOZZIAQ-UHFFFAOYSA-N,Preclinical,JAK inhibitor,JAK2,,
CEP-37440,BCSHRERPHLTPEE-NRFANRHFSA-N,Phase 1,ALK tyrosine kinase receptor inhibitor,ALK,,
CEP-37440,"InChI=1S/C30H38ClN7O3/c1-32-29(40)23-7-3-4-9-25(23)34-28-24(31)19-33-30(36-28)35-26-11-10-20-18-21(6-5-8-22(20)27(26)41-2)38-14-12-37(13-15-38)16-17-39/h3-4,7,9-11,19,21,39H,5-6,8,12-18H2,1-2H3,(H,32,40)(H2,33,34,35,36)/t21-/m0/s1",Phase 1,ALK tyrosine kinase receptor inhibitor,ALK,,
CEP-40783,FKCWHHYUMFGOPY-UHFFFAOYSA-N,Preclinical,AXL kinase inhibitor,,,
cephalexin,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology,respiratory tract infections|otitis|skin infections|bone and joint infections|genitourinary tract infections
cephalomannine,DBXFAPJCZABTDR-WBYYIXQISA-N,Preclinical,DNA polymerase inhibitor,,,
cephalosporin-c-zn,TVMXJQZBKOMFQK-JFEXGKLBSA-L,Preclinical,bacterial cell wall synthesis inhibitor,,,
cephalothin,XIURVHNZVLADCM-IUODEOHRSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|surgical prophylaxis
cephapirin,UQLLWWBDSUHNEB-CZUORRHYSA-N,Launched,bacterial cell wall synthesis inhibitor,,obstetrics/gynecology,mastitis
cepharanthine,YVPXVXANRNDGTA-WDYNHAJCSA-N,Phase 2,NFkB pathway inhibitor,,,
cephradine,RDLPVSKMFDYCOR-HFAKWTLXSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|respiratory tract infections|urinary tract infections
ceramide,BLTCBVOJNNKFKC-QUDYQQOWSA-N,Launched,phosphoenolpyruvate carboxylase activator|serine/threonine protein phosphatase activator,,dermatology,cosmetic
ceritinib,VERWOWGGCGHDQE-UHFFFAOYSA-N,Launched,ALK tyrosine kinase receptor inhibitor,ALK|FLT3|IGF1R|INSR|TSSK1B,oncology,non-small cell lung cancer (NSCLC)
cerulenin,GVEZIHKRYBHEFX-NQQPLRFYSA-N,Launched,fatty acid synthase inhibitor,FASN,infectious disease,fungal infection
ceruletide,YRALAIOMGQZKOW-HYAOXDFASA-N,Preclinical,CCK receptor agonist,CCKAR,,
cetaben,QXWKHSSBFQDQPR-UHFFFAOYSA-N,Phase 2,ACAT inhibitor|cholesterol inhibitor,PPARA,,
cetilistat,MVCQKIKWYUURMU-UHFFFAOYSA-N,Phase 3,triacylglycerol lipase inhibitor,PNLIP,,
cetirizine,ZKLPARSLTMPFCP-NRFANRHFSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis
cetrimonium,RLGQACBPNDBWTB-UHFFFAOYSA-N,Launched,,,dermatology,cosmetic
cetrorelix,SBNPWPIBESPSIF-MHWMIDJBSA-N,Launched,gonadotropin releasing factor hormone receptor antagonist,GNRHR|LHCGR,endocrinology,premature luteinizing hormone surges
cetylpyridinium,NEUSVAOJNUQRTM-UHFFFAOYSA-N,Launched,,,dental,gingivitis|mouth inflammation
cevimeline,WUTYZMFRCNBCHQ-WPRPVWTQSA-N,Launched,acetylcholine receptor agonist,CHRM3,rheumatology,sjogren's syndrome
cevipabulin,ZUZPCOQWSYNWLU-VIFPVBQESA-N,Phase 1,microtubule stimulant|tubulin polymerization inhibitor,TUBB,,
CF102,IPSYPUKKXMNCNQ-PFHKOEEOSA-N,Phase 2,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
CFI-400945,DADASRPKWOGKCU-FVTQAUBDSA-N,Phase 2,serine/threonine kinase inhibitor,,,
CFI-402257,PMQUGSPFUBGJCZ-CHOKWEPUSA-N,Phase 1/Phase 2,dual specificity protein kinase inhibitor,,,
CFM-1571,YZCSJBGQLATPMH-UHFFFAOYSA-N,Preclinical,guanylate cyclase activator,,,
CFM-2,MJKADKZSYQWGLL-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,,,
CFTRinh-172,JIMHYXZZCWVCMI-RIYZIHGNSA-N,Preclinical,chloride channel blocker,CFTR,,
CG-400549,YCLREGRRHGLOAK-UHFFFAOYSA-N,Phase 2,FABI inhibitor,,,
CGH2466,BEPGKLOHQTXUHX-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3,,
CGK-733,HLCDNLNLQNYZTK-OAQYLSRUSA-N,Preclinical,ATM kinase inhibitor|ATR kinase inhibitor,ATM|ATR,,
CGM097,CLRSLRWKONPSRQ-IIPSPAQQSA-N,Phase 1,MDM inhibitor,MDM2,,
CGP-12177,UMQUQWCJKFOUGV-SECBINFHSA-N,Phase 1,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,,
CGP-13501,XGWATTXMMMANFJ-UHFFFAOYSA-N,Preclinical,GABA receptor modulator,GABBR1,,
CGP-20712A,VFPOVCXWKBYDNF-XFULWGLBSA-N,Preclinical,adrenergic receptor antagonist,ADRB1|ADRB3,,
CGP-25454A,JEMKCYHUYUPGFN-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,,,
CGP-37157,KQEPIRKXSUIUTH-HNNXBMFYSA-N,Preclinical,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor,SLC8A1,,
CGP-37849,BDYHNCZIGYIOGJ-XWCPEMDWSA-N,Phase 1,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
CGP-39551,OKDOWCKDTWNRCB-PTYLAXBQSA-N,Preclinical,NMDA receptor antagonist,,,
CGP-52411,AAALVYBICLMAMA-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR,,
CGP-53353,RONQPWQYDRPRGG-UHFFFAOYSA-N,Preclinical,EGFR inhibitor|PKC inhibitor,EGFR|PRKCB,,
CGP-54626,JGGVBBYJRQOPPA-BBRMVZONSA-N,Preclinical,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,,
CGP-55845,ZODSPDOOCZZEIM-BBRMVZONSA-N,Preclinical,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,,
CGP-57380,UQPMANVRZYYQMD-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor,AURKB|LCK|MKNK1|MKNK2|SGK1,,
CGP-60474,IYNDTACKOAXKBJ-UHFFFAOYSA-N,Preclinical,CDK inhibitor,CDK1|CDK2,,
CGP-71683,UULIGRNKXHCLQN-WGSAOQKQSA-N,Preclinical,neuropeptide receptor antagonist,NPY5R,,
CGP-74514,UTBSBSOBZHXMHI-LSDHHAIUSA-N,Preclinical,CDK inhibitor,CDK1,,
CGP-78608,DPFHVUSPVHRVFL-YFKPBYRVSA-N,Preclinical,glutamate receptor antagonist,,,
CGP-7930,XLWJPQQFJNGUPA-UHFFFAOYSA-N,Preclinical,GABA receptor modulator,GABBR1,,
CGS-15943,MSJODEOZODDVGW-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
CGS-20625,UBLXQFIFWUEVGJ-UHFFFAOYSA-N,Phase 1,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,,
CGS-21680,PAOANWZGLPPROA-RQXXJAGISA-N,Preclinical,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
CGS-9896,QCBUAKLOWCOUCR-UHFFFAOYSA-N,Preclinical,GABA receptor antagonist,GABRA1|GABRB2|GABRG2,,
CH-170,JBXSBZBZASARMY-UHFFFAOYSA-N,Phase 1,,,,
CH-5183284,BEMNJULZEQTDJY-UHFFFAOYSA-N,Phase 2,fibroblast growth factor inhibitor,FGFR1|FGFR2|FGFR3,,
CH223191,LKTNEXPODAWWFM-GHVJWSGMSA-N,Preclinical,aryl hydrocarbon receptor antagonist,AHR,,
CH5132799,JEGHXKRHKHPBJD-UHFFFAOYSA-N,Phase 1,PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
CH55,FOUVTBKPJRMLPE-FMIVXFBMSA-N,Preclinical,retinoid receptor binder,RARA|RARB,,
CHC,AFVLVVWMAFSXCK-VMPITWQZSA-N,Preclinical,monocarboxylate transporter inhibitor,SLC16A1,,
CHC,"InChI=1S/C10H7NO3/c11-6-8(10(13)14)5-7-1-3-9(12)4-2-7/h1-5,12H,(H,13,14)/b8-5+",Preclinical,monocarboxylate transporter inhibitor,SLC16A1,,
chenodeoxycholic-acid,RUDATBOHQWOJDD-BSWAIDMHSA-N,Launched,11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist,HSD11B1|NR1H4,cardiology|gastroenterology,cerebral cholesterosis|gallstones
CHF5074,LIYLTQQDABRNRX-UHFFFAOYSA-N,Phase 2,gamma secretase modulator,PSEN1,,
chicago-sky-blue-6b,BGULJNMSWJQIEK-UHFFFAOYSA-N,Preclinical,glutamate inhibitor|macrophage migration inhibiting factor inhibitor,MIF,,
chidamide,WXHHICFWKXDFOW-BJMVGYQFSA-N,Launched,HDAC inhibitor,HDAC10|HDAC3,hematologic malignancy,peripheral T-cell lymphoma (PTCL)
chiniofon,ZBJWWKFMHOAPNS-UHFFFAOYSA-N,Launched,antiprotozoal agent,,infectious disease,amebiasis
CHIR-124,MOVBBVMDHIRCTG-LJQANCHMSA-N,Preclinical,CHK inhibitor,CHEK1,,
CHIR-98014,MDZCSIDIPDZWKL-UHFFFAOYSA-N,Preclinical,glycogen synthase kinase inhibitor,GSK3A|GSK3B,,
CHIR-99021,AQGNHMOJWBZFQQ-UHFFFAOYSA-N,Preclinical,glycogen synthase kinase inhibitor,CDK1|GSK3A|GSK3B|MAPK1,,
chloralose,OJYGBLRPYBAHRT-IPQSZEQASA-N,Preclinical,,,,
chlorambucil,JCKYGMPEJWAADB-UHFFFAOYSA-N,Launched,DNA inhibitor,,hematologic malignancy,chronic lymphocytic leukemia (CLL)|Hodgkin's lymphoma
chloramine-T,NXTVQNIVUKXOIL-UHFFFAOYSA-N,Launched,,,infectious disease,bacterial gill disease
chloramphenicol,WIIZWVCIJKGZOK-RKDXNWHRSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,CD55,infectious disease|endocrinology,meningitis|fever|cholera
chloramphenicol-palmitate,PXKHGMGELZGJQE-ILBGXUMGSA-N,Launched,protein synthesis inhibitor,,infectious disease|endocrinology,meningitis|fever|cholera
chloramphenicol-sodium-succinate,LIRCDOVJWUGTMW-ZWNOBZJWSA-N,Launched,protein synthesis inhibitor,,infectious disease,gram-negative bacterial infections
chlorazanil,YRZQHIVOIFJEEE-UHFFFAOYSA-N,Preclinical,,,,
chlorcyclizine,WFNAKBGANONZEQ-SFHVURJKSA-N,Launched,histamine receptor antagonist,,allergy,allergic rhinitis
chlorfenson,RZXLPPRPEOUENN-UHFFFAOYSA-N,Phase 2,other antifungal,,,
chlorhexidine,GHXZTYHSJHQHIJ-UHFFFAOYSA-N,Launched,membrane integrity inhibitor,,dermatology|infectious disease|dental,cosmetic|skin infections|gingivitis
chlorhexidine,"InChI=1S/C22H30Cl2N10/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34)",Launched,membrane integrity inhibitor,,dermatology|infectious disease|dental,cosmetic|skin infections|gingivitis
chlorindanol,ATAJVFBUUIBIEO-UHFFFAOYSA-N,Preclinical,,,,
chlorindione,NJDUWAXIURWWLN-UHFFFAOYSA-N,Preclinical,,,,
chlorisondamine-diiodide,IXWDUZLHWJKVPX-UHFFFAOYSA-N,Preclinical,acetylcholine receptor antagonist,CHRNA1,,
chlormadinone-acetate,QMBJSIBWORFWQT-DFXBJWIESA-N,Launched,5 alpha reductase inhibitor,PGR,endocrinology,hypermenorrhea|amenorrhea|oligomenorrhea|polymenorrhea
chlormezanone,WEQAYVWKMWHEJO-LLVKDONJSA-N,Withdrawn,GABA receptor modulator,GABRA1,,
chlormidazole,WNAQOLSMVPFGTE-UHFFFAOYSA-N,Launched,fungal lanosterol demethylase inhibitor,,infectious disease,fungal infection
chlorobutanol,OSASVXMJTNOKOY-UHFFFAOYSA-N,Launched,,,neurology/psychiatry,anesthetic|sedative
chlorocresol,CFKMVGJGLGKFKI-UHFFFAOYSA-N,Launched,ryanodine receptor activator,,infectious disease,first-aid antiseptic
chlorogenic-acid,CWVRJTMFETXNAD-JUHZACGLSA-N,Launched,antioxidant,SLC37A4,neurology/psychiatry|pulmonary|allergy,headache|chest congestion|allergic rhinitis
chlorophyllin,HZDQUOWQHHSPIE-HASICPNOSA-N,Preclinical,,,urology,urinary incontinence
chlorophyllin-copper,ZDOYGJNADZJRFB-PVMVIUQGSA-L,Phase 1,cytochrome P450 inhibitor,,,
chloroprocaine,VDANGULDQQJODZ-UHFFFAOYSA-N,Launched,sodium channel blocker,ATP1A1|CHRNA10|GRIN3A|HTR3A|SCN10A|SLC6A3,neurology/psychiatry,local anesthetic
chloropyramine,ICKFFNBDFNZJSX-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,cardiology|ophthalmology|allergy|pulmonary,edema|conjunctivitis|allergic rhinitis|asthma
chloroquine,WHTVZRBIWZFKQO-CQSZACIVSA-N,Launched,antimalarial agent,MRGPRX1,infectious disease,malaria|amebiasis
chlorothiazide,JBMKAUGHUNFTOL-UHFFFAOYSA-N,Launched,diuretic,CA1|CA2|CA4|SLC12A3,cardiology,hypertension
chlorothymol,KFZXVMNBUMVKLN-UHFFFAOYSA-N,Launched,,,,
chlorotrianisene,BFPSDSIWYFKGBC-UHFFFAOYSA-N,Launched,estrogenic hormone,ESR1|ESR2,endocrinology|oncology,menopause|prostate cancer
chloroxine,WDFKMLRRRCGAKS-UHFFFAOYSA-N,Launched,opioid receptor antagonist,OPRK1,gastroenterology|infectious disease|dermatology,diarrhea|inflammatory bowel disease|giardiasis|dandruff
chloroxoquinoline,XMFXTXKSWIDMER-UHFFFAOYSA-N,Launched,,,,
chloroxylenol,OSDLLIBGSJNGJE-UHFFFAOYSA-N,Launched,ATP synthase inhibitor,,infectious disease,skin infections
chlorphenamine,SOYKEARSMXGVTM-HNNXBMFYSA-N,Launched,histamine receptor antagonist,,allergy,allergic rhinitis|urticaria
chlorphenesin,MXOAEAUPQDYUQM-MRVPVSSYSA-N,Launched,muscle relaxant,,neurology/psychiatry,muscle relaxant|sedative
chlorphenoxamine,KKHPNPMTPORSQE-SFHVURJKSA-N,Preclinical,histamine receptor antagonist,,,
chlorphensin-carbamate,SKPLBLUECSEIFO-QMMMGPOBSA-N,Launched,muscle relaxant,,neurology/psychiatry,spasms
chlorproguanil,ISZNZKHCRKXXAU-UHFFFAOYSA-N,Launched,dihydrofolate reductase inhibitor,DHFR,infectious disease,malaria
chlorpromazine,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5,neurology/psychiatry|gastroenterology|hematology|infectious disease,schizophrenia|nausea|vomiting|acute intermittent porphyria (AIP)|tetanus
chlorpropamide,RKWGIWYCVPQPMF-UHFFFAOYSA-N,Launched,ATP channel blocker,ABCC8|KCNJ10,endocrinology,diabetes mellitus
chlorpropham,CWJSHJJYOPWUGX-UHFFFAOYSA-N,Phase 1,antiviral,,,
chlorprothixene,WSPOMRSOLSGNFJ-AUWJEWJLSA-N,Launched,dopamine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C,neurology/psychiatry,schizophrenia|bipolar disorder
chlorpyrifos,SBPBAQFWLVIOKP-UHFFFAOYSA-N,Launched,acetylcholinesterase inhibitor,ACHE,,
chlorquinaldol,GPTXWRGISTZRIO-UHFFFAOYSA-N,Launched,other antibiotic,,infectious disease,fungal infection
chlortetracycline,RNPLSXLZRGPQCU-YPOKJENWSA-N,Launched,protein synthesis inhibitor,,ophthalmology,conjunctivitis
chlorthalidone,JIVPVXMEBJLZRO-AWEZNQCLSA-N,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1,cardiology|gastroenterology|rheumatology|nephrology,hypertension|edema|congestive heart failure|hepatic cirrhosis|nephrotic syndrome|acute glomerulonephritis (AGN)|chronic renal failure
chlorzoxazone,TZFWDZFKRBELIQ-UHFFFAOYSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,KCNMA1|KCNN4,neurology/psychiatry,muscle relaxant
cholecalciferol,QYSXJUFSXHHAJI-YRZJJWOYSA-N,Launched,,VDR,endocrinology,vitamin D deficiency
cholesterol,HVYWMOMLDIMFJA-DPAQBDIFSA-N,Preclinical,,RORA,,
cholic-acid,BHQCQFFYRZLCQQ-OELDTZBJSA-N,Launched,bile acid,ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B,gastroenterology|neurology/psychiatry|genetics,bile acid synthesis disorders|peroxisomal disorders|Zellweger syndrome
choline,OEYIOHPDSNJKLS-UHFFFAOYSA-N,Phase 3,acetylcholine precursor,ACHE|BCHE|CHRNA2|PCYT1A|PCYT1B|PHOSPHO1|PLD1|PLD2,,
choline-alfoscerate,SUHOQUVVVLNYQR-MRVPVSSYSA-O,Launched,acetylcholine precursor,,,
CHPG,UNIDAFCQFPGYJJ-SSDOTTSWSA-N,Preclinical,glutamate receptor agonist,GRM5,,
CHR-6494,CZZCAOGIEGXMBZ-UHFFFAOYSA-N,Preclinical,serine/threonine kinase inhibitor,GSG2,,
chromanol-(+/-),VCIPBXUEKWCJAU-DZYJZKBLSA-N,Preclinical,potassium channel blocker,,,
"chromanol-293B-(-)-[3R,4S]",HVSJHHXUORMCGK-UONOGXRCSA-N,Preclinical,potassium channel blocker,,,
chromium-picolinate,CBDQOLKNTOMMTL-UHFFFAOYSA-K,Launched,insulin sensitizer,,endocrinology,diabetes mellitus
chromocarb,RVMGXWBCQGAWBR-UHFFFAOYSA-N,Launched,antispasmodic,,,
chrysin,RTIXKCRFFJGDFG-UHFFFAOYSA-N,Phase 1,breast cancer resistance protein inhibitor,AKR1B1|CDK6|CYP19A1|CYP1B1,,
chrysophanic-acid,LQGUBLBATBMXHT-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR|MTOR,,
chuanxiongzine,FINHMKGKINIASC-UHFFFAOYSA-N,Phase 2,,,,
CI-844,KDGUIKPOZGYLQJ-UHFFFAOYSA-N,Phase 2,,,,
CI-923,MJRICTKAEYTJAV-LBPRGKRZSA-N,Phase 1,acetylcholine receptor antagonist,,,
CI-953,ZSBWDKCIIZYQIR-UHFFFAOYSA-N,Phase 1,voltage-gated sodium channel blocker,,,
CI-966,CMHQDSBIBSKHFP-UHFFFAOYSA-N,Phase 1,GAT inhibitor,SLC6A1,,
CI-976,WAFNZAURAWBNDZ-UHFFFAOYSA-N,Phase 1,ACAT inhibitor,ACAT1|CES1,,
ciaftalan-zinc,PODBBOVVOGJETB-UHFFFAOYSA-N,Phase 1,reactive oxygen species stimulant,,,
cianidanol,PFTAWBLQPZVEMU-DZGCQCFKSA-N,Withdrawn,fatty acid synthase inhibitor,PTGS1,,
cibenzoline,IPOBOOXFSRWSHL-INIZCTEOSA-N,Launched,sodium channel blocker,,cardiology,cardiac arrythmia
ciclesonide,LUKZNWIVRBCLON-GXOBDPJESA-N,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,allergy,allergic rhinitis
ciclopirox,SCKYRAXSEDYPSA-UHFFFAOYSA-N,Launched,membrane integrity inhibitor,ATP1A1,infectious disease,onychomycosis
cicloprofen,LRXFKKPEBXIPMW-SNVBAGLBSA-N,Preclinical,cyclooxygenase inhibitor,PTGS1|PTGS2,,
CID-16020046,VGUQVYZXABOXCX-QHCPKHFHSA-N,Preclinical,G protein-coupled receptor antagonist,GPR55,,
CID-2011756,XQJWTJLJEYIUDZ-UHFFFAOYSA-N,Preclinical,protein kinase inhibitor,PKD1,,
CID-2745687,CYNLZIBKERMMOA-AWQFTUOYSA-N,Preclinical,G protein-coupled receptor antagonist,GPR35,,
CID-5458317,BJJVCNWHNQAAGB-HMMYKYKNSA-N,Preclinical,MAP kinase phosphatase inhibitor,MAPK3,,
cidofovir,VWFCHDSQECPREK-LURJTMIESA-N,Launched,DNA polymerase inhibitor,,infectious disease,acquired immunodeficiency syndrome (AIDS)|cytomegalovirus retinitis
ciglitazone,YZFWTZACSRHJQD-OAHLLOKOSA-N,Phase 2,PPAR receptor agonist,PPARG,,
cilastatin,DHSUYTOATWAVLW-WFVMDLQDSA-N,Launched,dehydropeptidase inhibitor,DPEP1,,
cilazapril,HHHKFGXWKKUNCY-FHWLQOOXSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure
cilengitide,AMLYAMJWYAIXIA-VWNVYAMZSA-N,Phase 3,integrin antagonist,ITGAV|ITGB3,,
cilnidipine,KJEBULYHNRNJTE-HGJFNOKFSA-N,Launched,calcium channel blocker,CACNA1B,cardiology,hypertension
cilofexor,KZSKGLFYQAYZCO-UHFFFAOYSA-N,Phase 3,FXR agonist,,,
cilomilast,CFBUZOUXXHZCFB-OYOVHJISSA-N,Phase 3,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4D,,
cilostamide,UIAYVIIHMORPSJ-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,PDE3A|PDE3B,,
cilostazol,RRGUKTPIGVIEKM-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE3A|PDE3B,cardiology,claudication
ciluprevir,PJZPDFUUXKKDNB-KNINVFKUSA-N,Preclinical,serine protease inhibitor,,,
CIM-0216,KSEXDSJYVSEVGF-FQEVSTJZSA-N,Preclinical,transient receptor potential channel agonist,TRPM3,,
cimaterol,BUXRLJCGHZZYNE-GFCCVEGCSA-N,Preclinical,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,,
cimetidine,AQIXAKUUQRKLND-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH2|SLC29A4|SLC47A1|SLC47A2,gastroenterology|hematologic malignancy|endocrinology,duodenal ulcer disease|peptic ulcer disease (PUD)|gastroesophageal reflux disease (GERD)|aggressive systemic mastocytosis (ASM)|Zollinger-Ellison syndrome|endocrine adenoma
cimetropium,QVVOZYKELHAIPX-IGDPVYPXSA-N,Launched,acetylcholine receptor antagonist,CHRM1,gastroenterology,irritable bowel syndrome
cinacalcet,VDHAWDNDOKGFTD-MRXNPFEDSA-N,Launched,calcium channel activator,CASR,endocrinology|nephrology|oncology,hyperparathyroidism|chronic kidney disease (CKD)|parathyroid carcinoma|hypercalcemia
cinacalcet,"InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1",Launched,calcium channel activator,CASR,endocrinology|nephrology|oncology,hyperparathyroidism|chronic kidney disease (CKD)|parathyroid carcinoma|hypercalcemia
cinaciguat,WPYWMXNXEZFMAK-UHFFFAOYSA-N,Phase 2,guanylate cyclase activator,GUCY1A3|GUCY1B3,,
cinalukast,BZMKNPGKXJAIDV-VAWYXSNFSA-N,Phase 2,leukotriene receptor antagonist,CYSLTR1,,
cinanserin,RSUVYMGADVXGOU-BUHFOSPRSA-N,Preclinical,serotonin receptor antagonist,HTR2A,,
cinchocaine,PUFQVTATUTYEAL-UHFFFAOYSA-N,Launched,sodium channel blocker,CALM1|SCN10A|SCN5A,neurology/psychiatry,local anesthetic
cinchonidine,KMPWYEUPVWOPIM-KODHJQJWSA-N,Phase 1,P glycoprotein inhibitor,,,
cinchonine,KMPWYEUPVWOPIM-QAMTZSDWSA-N,Preclinical,P glycoprotein inhibitor,CYP2D6,,
cinchophen,YTRMTPPVNRALON-UHFFFAOYSA-N,Launched,analgesic agent,,rheumatology,gout
cinepazet,XDUOTWNXVDBCDY-VOTSOKGWSA-N,Launched,vasodilator,,,
cinepazide,RCUDFXMNPQNBDU-VOTSOKGWSA-N,Withdrawn,calcium channel activator,,,
cinflumide,NCOOUEIQXVWKTO-QPJJXVBHSA-N,Phase 2,muscle relaxant,,,
cinnamaldehyde,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,Preclinical,aldose reductase inhibitor|TRPV agonist,TRPA1,,
cinnarazine,DERZBLKQOCDDDZ-JLHYYAGUSA-N,Launched,calcium channel blocker,,neurology/psychiatry|gastroenterology|ophthalmology,Meniere's disease|nausea|vomiting|Cogan's syndrome
cinobufotalin,KBKUJJFDSHBPPA-ZNCGZLKOSA-N,Phase 1,anticancer agent,,,
cinoctramide,MDGVCMGGLSOVIQ-MDZDMXLPSA-N,Preclinical,,,,
cinoxacin,VDUWPHTZYNWKRN-UHFFFAOYSA-N,Launched,topoisomerase inhibitor,,infectious disease,urinary tract infections
cinoxate,CMDKPGRTAQVGFQ-RMKNXTFCSA-N,Launched,,,dermatology,sunscreen lotion
CINPA-1,AYQBYSPEGRYKFA-UHFFFAOYSA-N,Preclinical,CAR antagonist,NR1H4|NR1I3|PPARG,,
cinromide,LDCXGZCEMNMWIL-VOTSOKGWSA-N,Phase 3,,,,
cintirorgon,GULSIMHVQYBADX-FQEVSTJZSA-N,Phase 1/Phase 2,ROR agonist,,,
cintriamide,LRLKZVMLJBNNPE-SNAWJCMRSA-N,Preclinical,,,,
cipamfylline,KSPYMJJKQMWWNB-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,,,
cipargamin,CKLPLPZSUQEDRT-WPCRTTGESA-N,Phase 2,antimalarial agent,,,
cipemastat,GFUITADOEPNRML-SJORKVTESA-N,Phase 3,metalloproteinase inhibitor,ADAM17|MMP1|MMP13|MMP2|MMP3|MMP8|MMP9,,
ciprofibrate,KPSRODZRAIWAKH-SNVBAGLBSA-N,Launched,PPAR receptor agonist,PPARA,endocrinology,hyperlipidemia
ciprofloxacin,MYSWGUAQZAJSOK-UHFFFAOYSA-N,Launched,bacterial DNA gyrase inhibitor,TOP2A,otolaryngology,otitis
ciproxifan,ACQBHJXEAYTHCY-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,ADRA2A|ADRA2C|HRH3|HRH4|HTR3A,,
CIQ,VYMILMYEENZHAR-HSZRJFAPSA-N,Preclinical,glutamate receptor potentiator,GRIN2C|GRIN2D,,
cirazoline,YAORIDZYZDUZCM-UHFFFAOYSA-N,Preclinical,adrenergic receptor agonist,ADRA1A,,
"cis-9,trans-11-conjugated-linoleic-acid",JBYXPOFIGCOSSB-GOJKSUSPSA-N,Launched,,,,
cis-aconitic-acid,GTZCVFVGUGFEME-IWQZZHSRSA-N,Preclinical,,ACO2,,
cis-ACPD,YFYNOWXBIBKGHB-CLZZGJSISA-N,Preclinical,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM7|GRM8,,
"cis-exo-camphanediol-2,3",AYEOSGBMQHXVER-AZQAYCESSA-N,Phase 1,nitric oxide stimulant,NOS3,,
cis-urocanic-acid,LOIYMIARKYCTBW-OWOJBTEDSA-N,Phase 2,serotonin receptor agonist,HTR2A,,
cis-urocanic-acid,LOIYMIARKYCTBW-UPHRSURJSA-N,Phase 2,serotonin receptor agonist,HTR2A,,
cisapride,DCSUBABJRXZOMT-IRLDBZIGSA-N,Withdrawn,serotonin receptor agonist,HTR2A|HTR3A|HTR4|KCNH2,,
cisatracurium,YXSLJKQTIDHPOT-LJCJQEJUSA-N,Launched,acetylcholine receptor antagonist,CHRNA2,neurology/psychiatry|critical care,muscle relaxant|endotracheal intubation
cisplatin,DQLATGHUWYMOKM-UHFFFAOYSA-L,Launched,DNA alkylating agent|DNA synthesis inhibitor,XIAP,oncology,testicular carcinoma|ovarian cancer|bladder cancer
citalopram,WSEQXVZVJXJVFP-FQEVSTJZSA-N,Launched,selective serotonin reuptake inhibitor (SSRI),ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression
citarinostat,VLIUIBXPEDFJRF-UHFFFAOYSA-N,Phase 1,HDAC inhibitor,,,
CITCO,ZQWBOKJVVYNKTL-AUEPDCJTSA-N,Preclinical,constitutive androstane receptor (CAR) agonist,NR1I3,,
citicoline,RZZPDXZPRHQOCG-OJAKKHQRSA-O,Launched,glutathione transferase stimulant|membrane permeability enhancer,ACHE|SLC1A2,neurology/psychiatry|ophthalmology,stroke|Alzheimer's disease|senile dementia|Parkinson's Disease|attention-deficit/hyperactivity disorder (ADHD)|glaucoma
citiolone,NRFJZTXWLKPZAV-YFKPBYRVSA-N,Preclinical,lipotropic|mucolytic agent,,,
citric-acid,KRKNYBCHXYNGOX-UHFFFAOYSA-N,Preclinical,coagulation factor inhibitor,AKR1B1|ANG|APRT|BHMT|C8G|CA4|CPB1|CS|CTDSP1|GNMT|HGS|HS3ST3A1|IL4I1|ITPA|LSM6|MDH2|MIF|PDE5A|PKD2L1|PLEKHA1|RNASE1|RNASE3|SRC|TNFSF13B|UCK2,,
CJ-033466,ISKHMDNIWXPUGR-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR4,,
CJ-13610,VPTONMHDLLMOOV-UHFFFAOYSA-N,Phase 2,lipoxygenase inhibitor,,,
CK-101,IDRGFNPZDVBSSE-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,,,
CK-636,ACAKNPKRLPMONU-UHFFFAOYSA-N,Preclinical,actin related protein inhibitor,ACTR2|ACTR3|ARPC1B|ARPC2|ARPC3|ARPC4|ARPC5,,
CKD-712,YGCQFKVNIBDJFW-SFHVURJKSA-N,Phase 1,NFkB pathway inhibitor,JAK2|STAT1,,
CKI-7,OGKYMFFYOWUTKV-UHFFFAOYSA-N,Preclinical,casein kinase inhibitor,CSNK1G2,,
CL-218872,GUOQUXNJZHGPQF-UHFFFAOYSA-N,Phase 1,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,,
CL-225385,ZJRCIQAMTAINCB-UHFFFAOYSA-N,Phase 2,,,,
CL316243,JEDJMKTVUPSHFW-ABAIWWIYSA-N,Phase 2,adrenergic receptor agonist,ADRB3|UCP1|UCP2|UCP3,,
cladribine,PTOAARAWEBMLNO-KVQBGUIXSA-N,Launched,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B,hematologic malignancy,hairy cell leukemia
clamikalant,VXTKXGKPBOLHRY-UHFFFAOYSA-N,Preclinical,ATP-sensitive potassium channel antagonist,,,
clanfenur,SRLPZQAEBMZCIJ-UHFFFAOYSA-N,Preclinical,anticancer agent,,,
clarithromycin,AGOYDEPGAOXOCK-AAFHZFQRSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,CYP3A4,otolaryngology|pulmonary|infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis
clavulanate,HZZVJAQRINQKSD-PBFISZAISA-N,Launched,beta lactamase inhibitor,,otolaryngology,otitis
clebopride,BVPWJMCABCPUQY-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,ACHE|DRD2,gastroenterology,nausea
clemastine,YNNUSGIPVFPVBX-NHCUHLMSSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria
clemizole,CJXAEXPPLWQRFR-UHFFFAOYSA-N,Launched,HCV inhibitor,,allergy,allergic rhinitis
clenbuterol,STJMRWALKKWQGH-SNVBAGLBSA-N,Launched,adrenergic receptor agonist,ABCC8|ADRB2|KCNJ11,pulmonary,chronic obstructive pulmonary disease (COPD)|asthma
cleviprex,KPBZROQVTHLCDU-SFHVURJKSA-N,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S,cardiology,hypertension
clevudine,GBBJCSTXCAQSSJ-XQXXSGGOSA-N,Launched,DNA polymerase inhibitor,,infectious disease,hepatitis B
clidinium,HOOSGZJRQIVJSZ-WEQDKIBNSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM3,gastroenterology,peptic ulcer disease (PUD)|irritable bowel syndrome|enterocolitis
climbazole,OWEGWHBOCFMBLP-CQSZACIVSA-N,Launched,enzyme inducer,,dermatology,dandruff|eczema
clinafloxacin,QGPKADBNRMWEQR-QMMMGPOBSA-N,Phase 3,bacterial DNA gyrase inhibitor,,,
clindamycin,KDLRVYVGXIQJDK-AWPVFWJPSA-N,Launched,protein synthesis inhibitor,,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections
clindamycin-palmitate,OYSKUZDIHNKWLV-PRUAPSLNSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,infectious disease,intra-abdominal infections|skin infections|pneumonia|peritonitis|gynecologic infections
clindamycin-phosphate,UFUVLHLTWXBHGZ-MGZQPHGTSA-N,Launched,protein synthesis inhibitor,,obstetrics/gynecology,bacterial vaginosis
clinofibrate,BMOVQUBVGICXQN-AVJYQCBHSA-N,Launched,lipase clearing factor inhibitor,LPL,endocrinology,hypertriglyceridemia
clioquinol,QCDFBFJGMNKBDO-UHFFFAOYSA-N,Withdrawn,chelating agent,OPRK1,,
clobenpropit,UCAIEVHKDLMIFL-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,HRH1|HRH2|HRH3|HRH4,,
clobetasol-propionate,CBGUOGMQLZIXBE-XGQKBEPLSA-N,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,dermatology,corticosteroid-responsive dermatoses
clobetasone-butyrate,FBRAWBYQGRLCEK-AVVSTMBFSA-N,Launched,corticosteroid agonist,NR3C1,dermatology,eczema|psoriasis|dermatitis
clobutinol,KVHHQGIIZCJATJ-ZSOXZCCMSA-N,Withdrawn,antitussive,,,
clocortolone-pivalate,SXYZQZLHAIHKKY-GSTUPEFVSA-N,Launched,steroid,NR3C1|PLA2G1B,dermatology,corticosteroid-responsive dermatoses
clodronic-acid,ACSIXWWBWUQEHA-UHFFFAOYSA-N,Launched,bone resorption inhibitor,SLC25A4|SLC25A5|SLC25A6,orthopedics|endocrinology|hematologic malignancy,osteoporosis|hyperparathyroidism|hypercalcemia|multiple myeloma
clofarabine,WDDPHFBMKLOVOX-AYQXTPAHSA-N,Launched,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,hematologic malignancy,acute lymphoblastic leukemia (ALL)
clofazimine,WDQPAMHFFCXSNU-BGABXYSRSA-N,Launched,GK0582 inhibitor,,infectious disease,leprosy
clofedanol,WRCHFMBCVFFYEQ-QGZVFWFLSA-N,Launched,histamine receptor antagonist,HRH1,pulmonary,cough suppressant
clofibrate,KNHUKKLJHYUCFP-UHFFFAOYSA-N,Launched,PPAR receptor agonist,LPL|PPARA,endocrinology|cardiology,hyperlipidemia|cholesterol
clofibric-acid,TXCGAZHTZHNUAI-UHFFFAOYSA-N,Launched,PPAR receptor agonist,PPARA,endocrinology,hyperlipidemia
clofilium,WPSYTTKBGAZSCX-UHFFFAOYSA-N,Phase 2,potassium channel blocker,KCNA5|KCNH1,,
clofoctol,HQVZOORKDNCGCK-UHFFFAOYSA-N,Launched,protein synthesis inhibitor,,infectious disease,gram-positive bacterial infections
clomesone,SEHSPJCWCBQHPF-UHFFFAOYSA-N,Phase 1,DNA inhibitor,,,
clomethiazole,PCLITLDOTJTVDJ-UHFFFAOYSA-N,Launched,GABA receptor antagonist|GABA receptor modulator,GABRA1,neurology/psychiatry,Parkinson's Disease|sedative|muscle relaxant
clomifene,GKIRPKYJQBWNGO-QPLCGJKRSA-N,Launched,estrogen receptor antagonist,ESR1,obstetrics/gynecology,infertility
clomipramine,GDLIGKIOYRNHDA-UHFFFAOYSA-N,Launched,serotonin transporter (SERT) inhibitor,GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,obsessive compulsive disorder (OCD)
clonidine,GJSURZIOUXUGAL-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,cardiology|neurology/psychiatry,hypertension|attention-deficit/hyperactivity disorder (ADHD)
clonixin,CLOMYZFHNHFSIQ-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology|infectious disease,rheumatoid arthritis|soft tissue infection
clonixin-lysinate,CVNFYQCHAWFYQI-ZSCHJXSPSA-N,Launched,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief
clopamide,LBXHRAWDUMTPSE-AOOOYVTPSA-N,Launched,sodium/chloride cotransporter inhibitor,,cardiology,hypertension
cloperastine,FLNXBVJLPJNOSI-FQEVSTJZSA-N,Launched,antitussive,,pulmonary,cough suppressant
cloperastine-fendizoate,FLNXBVJLPJNOSI-UHFFFAOYSA-N,Preclinical,potassium channel antagonist,,,
clopidogrel,GKTWGGQPFAXNFI-HNNXBMFYSA-N,Launched,purinergic receptor antagonist,P2RY12,cardiology|neurology/psychiatry,myocardial infarction|stroke|peripheral artery disease (PAD)|acute coronary syndrome (ACS)
clopidol,ZDPIZLCVJAAHHR-UHFFFAOYSA-N,Launched,,,infectious disease,coccidiosis
cloprostenol-(+/-),VJGGHXVGBSZVMZ-QIZQQNKQSA-N,Launched,prostaglandin receptor agonist,PTGDR|PTGER1|PTGER3|PTGFR|TBXA2R,obstetrics/gynecology,endometriosis
cloranolol,XYCMOTOFHFTUIU-SNVBAGLBSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,cardiology,hypertension
clorgiline,BTFHLQRNAMSNLC-UHFFFAOYSA-N,Phase 2,monoamine oxidase inhibitor,MAOA,,
clorotepine,XRYLGRGAWQSVQW-KRWDZBQOSA-N,Launched,adrenergic receptor antagonist|dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|HRH1|HTR2C|HTR6,neurology/psychiatry,psychosis
clorprenaline,SSMSBSWKLKKXGG-LLVKDONJSA-N,Launched,adrenergic receptor agonist,ADRB1|ADRB2,pulmonary,asthma
clorsulon,QOVTVIYTBRHADL-UHFFFAOYSA-N,Launched,glycolysis inhibitor,,infectious disease,gastrointestinal roundworms|lungworms|liver flukes|lice|mites
closantel,JMPFSEBWVLAJKM-KRWDZBQOSA-N,Launched,chitinase inhibitor|NFkB pathway inhibitor,,infectious disease,liver flukes
clotiapine,KAAZGXDPUNNEFN-UHFFFAOYSA-N,Launched,,,neurology/psychiatry,psychosis
clotrimazole,VNFPBHJOKIVQEB-UHFFFAOYSA-N,Launched,cytochrome P450 inhibitor|imidazoline receptor ligand,CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8,infectious disease,vulvovaginal candidiasis|oropharyngeal candidiasis
cloxacillin,LQOLIRLGBULYKD-JKIFEVAISA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections
cloxyquin,CTQMJYWDVABFRZ-UHFFFAOYSA-N,Preclinical,potassium channel activator,KCNK18,,
clozapine,QZUDBNBUXVUHMW-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,neurology/psychiatry,schizophrenia
CM-4620,QQMKTHUGOQDEIL-UHFFFAOYSA-N,Phase 2,calcium release activated channel modulator,,,
CMPD-1,ODYAQBDIXCVKAE-UHFFFAOYSA-N,Preclinical,p38 MAPK inhibitor,GNRHR|MAPK14,,
CNQX,RPXVIAFEQBNEAX-UHFFFAOYSA-N,Phase 1,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,,
CNX-2006,BFSRTTWIPACGMI-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR,,
CNX-774,VVLHQJDAUIPZFH-UHFFFAOYSA-N,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,
CO-101244,VKMFDKYCIKEDMR-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIN2B,,
CO-102862,MHUUDVZSPFRUSK-RQZCQDPDSA-N,Phase 1,sodium channel blocker,SCN4A|SCN9A,,
cobicistat,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,Launched,cytochrome P450 inhibitor,CYP3A4|CYP3A43|CYP3A5|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1)
cobimetinib,BSMCAPRUBJMWDF-KRWDZBQOSA-N,Launched,MEK inhibitor,MAP2K1,oncology,melanoma
coenzyme-A,RGJOEKWQDUBAIZ-IBOSZNHHSA-N,Launched,,ACAT2|CRAT|CS|DBI|HMGCR|KAT2A|KAT2B|KAT5,,
coenzyme-I,BOPGDPNILDQYTO-NNYOXOHSSA-N,Phase 2,,AASS|ACADS|ADH1A|ADH1B|ADH1C|ADH4|ADH5|ADH7|AKR1B1|AKR1C1|AKR1C2|AKR1C3|AKR1C4|ALDH1A1|ALDH1A2|ALDH1A3|ALDH1B1|ALDH2|ALDH3A1|ALDH3A2|ALDH3B1|ALDH3B2|ALDH4A1|ALDH5A1|ALDH6A1|ALDH7A1|ALDH9A1|AMT|BDH1|BLVRA|BLVRB|CDO1|CYB5R3|CYP17A1|CYP4A11|DHCR7|DHFR|DLAT|DLD|EHHADH|GAPDH|GAPDHS|GLUD1|GLUD2|GPD1|GSR|H6PD|HADH|HADHA|HIBADH|HMGCR|HMOX1|HMOX2|HPGD|HSD11B1|HSD11B2|HSD17B1|HSD17B10|HSD17B2|HSD17B3|HSD17B4|HSD17B7|HSD17B8|HSD3B1|HSD3B2|IDH3A|IDH3B|IDH3G|IMPDH1|IMPDH2|LDHA|LDHAL6A|LDHAL6B|LDHB|LDHC|MDH1|MDH2|ME1|ME2|ME3|MSMO1|MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|MTHFD1|MTHFD2|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFB1|NDUFB10|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3|NNT|NQO2|NSDHL|OGDH|PDHA1|PDHA2|PDHB|PHGDH|PYCR1|PYCR2|QDPR|RDH5|SORD|TSTA3|TYR|UGDH,,
coenzyme-Q10,ACTIUHUUMQJHFO-UPTCCGCDSA-N,Launched,,,,
COH29,LGGDLPSXAGQFSG-UHFFFAOYSA-N,Phase 1,ribonucleotide reductase inhibitor,,,
colchicine,IAKHMKGGTNLKSZ-INIZCTEOSA-N,Launched,microtubule inhibitor,GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,rheumatology|endocrinology,gout|fever
colforsin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,Phase 2,adenylyl cyclase activator,ADCY2|ADCY5,,
colforsin-daproate,RSOZZQTUMVBTMR-XGUNBQNXSA-N,Launched,adenylyl cyclase activator,,,
colfosceril-palmitate,KILNVBDSWZSGLL-KXQOOQHDSA-O,Launched,pulmonary surfactant,,pulmonary,respiratory distress syndrome (RDS)
colistimethate,PTQGBRPUALXNCZ-INRRNNIXSA-N,Launched,bacterial permeability inducer,,infectious disease,gram-negative bacterial infections
colistin,YKQOSKADJPQZHB-TULBBYNTSA-N,Launched,bacterial permeability inducer,,infectious disease,gram-negative bacterial infections|gram-negative bacterial infections
combretastatin-A-4,HVXBOLULGPECHP-WAYWQWQTSA-N,Phase 2,tubulin polymerization inhibitor,,,
compound-401,BVRDQVRQVGRNHG-UHFFFAOYSA-N,Preclinical,DNA dependent protein kinase inhibitor,MTOR|PRKDC,,
compound-58112,CUYLJVJMQPPTOS-UHFFFAOYSA-N,Preclinical,,,,
compound-w,JOSXKPZXMVHRKU-UHFFFAOYSA-N,Preclinical,beta-secretase inhibitor,BACE1,,
conivaptan,IKENVDNFQMCRTR-UHFFFAOYSA-N,Launched,vasopressin receptor antagonist,AVPR1A|AVPR2,endocrinology,hyponatremia
convallatoxin,HULMNSIAKWANQO-JQKSAQOKSA-N,Preclinical,cardiac glycoside,,,
copanlisib,PZBCKZWLPGJMAO-UHFFFAOYSA-N,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,hematologic malignancy,follicular lymphoma
copper-histidine,HNDVDQJCIGZPNO-RXMQYKEDSA-N,Phase 3,,SLC15A3|SLC15A4|SLC38A5,,
COR-170,MSJISJDTJJYBFT-UHFFFAOYSA-N,Preclinical,cannabinoid receptor inverse agonist,CNR2,,
cordycepin,OFEZSBMBBKLLBJ-BAJZRUMYSA-N,Phase 1/Phase 2,DNA inhibitor,,,
corosolic-acid,HFGSQOYIOKBQOW-ZSDYHTTISA-N,Phase 2,PKC inhibitor|protein tyrosine kinase inhibitor,HSD11B1|PTPN1,,
CORT-108297,SLKURXRZHJOZOD-RUZDIDTESA-N,Preclinical,glucocorticoid receptor antagonist,,,
corticosterone,OMFXVFTZEKFJBZ-HJTSIMOOSA-N,Preclinical,mineralocorticoid receptor agonist,HSD11B1|NCOA1|NR3C2,,
cortisone,MFYSYFVPBJMHGN-ZPOLXVRWSA-N,Launched,glucocorticoid receptor agonist,NR3C1,gastroenterology|rheumatology|dermatology,ulcerative colitis|rheumatoid arthritis|psoriasis|joint inflammation|eczema
cortisone-acetate,ITRJWOMZKQRYTA-RFZYENFJSA-N,Launched,glucocorticoid receptor agonist,NR3C1,pulmonary|rheumatology|allergy|dermatology|ophthalmology|gastroenterology|infectious disease,asthma|rheumatoid arthritis|urticaria|osteoarthritis|psoriasis|allergic rhinitis|conjunctivitis|ulcerative colitis|meningitis
cortodoxone,WHBHBVVOGNECLV-OBQKJFGGSA-N,Phase 3,androgen receptor antagonist,AR,,
costunolide,HRYLQFBHBWLLLL-AHNJNIBGSA-N,Preclinical,telomerase inhibitor,,,
cot-inhibitor-1,ZWFKJFUFYPOTKL-UHFFFAOYSA-N,Preclinical,MAPK-interacting kinase inhibitor,MAP3K8,,
cot-inhibitor-2,PHNZIIMWDVXPGG-UHFFFAOYSA-N,Preclinical,MAPK-interacting kinase inhibitor,MAP3K8,,
COTI-2,UTDAKQMBNSHJJB-CJLVFECKSA-N,Phase 1,anticancer agent,,,
cotinine,UIKROCXWUNQSPJ-VIFPVBQESA-N,Phase 2,nicotine metabolite,,,
coumarin,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,Launched,vitamin K antagonist,CA1|CA12|CA14|CA2|CA4|CA6|CA9|CYP2A6,gastroenterology|pulmonary,ulcerative colitis|asthma|celiac disease
coumophos,BXNANOICGRISHX-UHFFFAOYSA-N,Preclinical,cholinesterase inhibitor,,,
"CP-105,696",KMNLXCBYBKHKSK-BKMJKUGQSA-N,Preclinical,leukotriene receptor antagonist,,,
CP-316819,WEQLRDLTRCEUHG-PKOBYXMFSA-N,Preclinical,glycogen phosphorylase inhibitor,PYGL,,
CP-339818,MMGAVKCAGQCFHS-LSDHQDQOSA-N,Preclinical,potassium channel blocker,KCNA3,,
CP-376395,VIZBSVDBNLAVAW-UHFFFAOYSA-N,Phase 1,corticotropin releasing factor receptor antagonist,CRHR1,,
CP-471474,QCOQJYRPDUMCNP-UHFFFAOYSA-N,Preclinical,matrix metalloprotease inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,,
CP-532623,TUPKOWFPVAXQFP-OFNKIYASSA-N,Phase 1,cholesteryl ester transfer protein inhibitor,CETP,,
CP-547632,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,Phase 2,kinase inhibitor,,,
CP-640186,LDQKDRLEMKIYMC-XMMPIXPASA-N,Preclinical,acetyl-CoA carboxylase inhibitor,ACACA|ACACB,,
CP-673451,DEEOXSOLTLIWMG-UHFFFAOYSA-N,Preclinical,PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA|PDGFRB,,
CP-724714,LLVZBTWPGQVVLW-SNAWJCMRSA-N,Phase 2,EGFR inhibitor|protein tyrosine kinase inhibitor,ERBB2,,
CP-775146,OISHBINQIFNIPV-JOCHJYFZSA-N,Preclinical,PPAR receptor agonist,PPARA,,
CP-91149,HINJNZFCMLSBCI-PKOBYXMFSA-N,Preclinical,glycogen phosphorylase inhibitor,PYGL,,
CP-93129,PJYVGMRFPFNZCT-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR1A,,
CP-94253,KWQWBZIGHIOKIO-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR1B,,
"CP-945,598",UNAZAADNBYXMIV-UHFFFAOYSA-N,Phase 3,cannabinoid receptor antagonist,CNR1,,
CP-99994,DTQNEFOKTXXQKV-HKUYNNGSSA-N,Phase 2,tachykinin antagonist,TACR1,,
CPA-inhibitor,PONANXDRJJIGPG-MRXNPFEDSA-N,Preclinical,carboxypeptidase inhibitor,CPA1|CPA2,,
CPCCOEt,FXCTZFMSAHZQTR-PFJVYOFESA-N,Preclinical,glutamate receptor antagonist,GRM1,,
CPI-0610,GCWIQUVXWZWCLE-INIZCTEOSA-N,Phase 2,bromodomain inhibitor,BRD4,,
CPI-1189,DJKNRCWSXSZACF-UHFFFAOYSA-N,Phase 2,tumor necrosis factor release inhibitor,TNF,,
CPI-1205,HPODOLXTMDHLLC-QGZVFWFLSA-N,Phase 1/Phase 2,EZH2 inhibitor,,,
CPI-169,LHGUZCKPFXXVPV-GOSISDBHSA-N,Preclinical,histone lysine methyltransferase inhibitor,EZH2,,
CPI-203,QECMENZMDBOLDR-AWEZNQCLSA-N,Preclinical,bromodomain inhibitor,BRD4,,
CPI-360,PFPSFENQCNMITC-MRXNPFEDSA-N,Preclinical,histone lysine methyltransferase inhibitor,EZH2,,
CPI-444,KURQKNMKCGYWRJ-HNNXBMFYSA-N,Phase 1/Phase 2,adenosine receptor antagonist,,,
CPI-613,ZYRLHJIMTROTBO-NRFANRHFSA-N,Phase 3,pyruvate dehydrogenase inhibitor,PDHA1,,
CPP,CUVGUPIVTLGRGI-SSDOTTSWSA-N,Phase 2,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
CPSI-1306-(+/-),GUWOSEVHCSNYFK-LLVKDONJSA-N,Preclinical,macrophage migration inhibiting factor inhibitor,MIF,,
CQS,CTSNHMQGVWXIEG-UHFFFAOYSA-N,Preclinical,,,,
CR8-(R),HOCBJBNQIQQQGT-LJQANCHMSA-N,Preclinical,CDK inhibitor,CCNA2,,
creatine,CVSVTCORWBXHQV-UHFFFAOYSA-N,Launched,,CKB|CKM|CKMT1A|CKMT2|GAMT|SLC6A8,,
creatinine,DDRJAANPRJIHGJ-UHFFFAOYSA-N,Preclinical,,,,
creatinol-phosphate,FOIPWTMKYXWFGC-UHFFFAOYSA-N,Launched,,,,
crenigacestat,YCBAQKQAINQRFW-UGSOOPFHSA-N,Preclinical,notch signaling inhibitor,,,
crenolanib,DYNHJHQFHQTFTP-UHFFFAOYSA-N,Phase 3,PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB,,
cresol,IWDCLRJOBJJRNH-UHFFFAOYSA-N,Launched,,,,
cresopirine,XRBMKGUDDJPAMH-UHFFFAOYSA-N,Preclinical,,,,
cridanimod,UOMKBIIXHQIERR-UHFFFAOYSA-N,Launched,progesterone receptor agonist,PGR,infectious disease,influenza A virus infection
crisaborole,USZAGAREISWJDP-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,dermatology,dermatitis
crisdesalazine,UTMVACIBQLDZLP-UHFFFAOYSA-N,Preclinical,free radical scavenger,,,
crizotinib,KTEIFNKAUNYNJU-GFCCVEGCSA-N,Launched,ALK tyrosine kinase receptor inhibitor,ALK|MET,oncology,non-small cell lung cancer (NSCLC)
crizotinib-(S),KTEIFNKAUNYNJU-LBPRGKRZSA-N,Preclinical,MTH1 inhibitor,NUDT1,,
croconazole,WHPAGCJNPTUGGD-UHFFFAOYSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,fungal infection
crolibulin,JXONINOYTKKXQQ-CQSZACIVSA-N,Phase 1/Phase 2,tubulin polymerization inhibitor,,,
cromakalim,BVMDRSUIADWFLV-PNSAJKJISA-N,Phase 2,,KCNJ8,,
cromoglicic-acid,IMZMKUWMOSJXDT-UHFFFAOYSA-N,Launched,immunosuppressant,KCNMA1|S100P,pulmonary|ophthalmology|allergy|gastroenterology,asthma|conjunctivitis|urticaria|ulcerative colitis
crotamiton,DNTGGZPQPQTDQF-XBXARRHUSA-N,Launched,antipruritic,,infectious disease,scabies
CRT0044876,BIUCOFQROHIAEO-UHFFFAOYSA-N,Preclinical,,,,
cryptotanshinone,GVKKJJOMQCNPGB-JTQLQIEISA-N,Preclinical,acetylcholinesterase inhibitor|STAT inhibitor,STAT3,,
crystal-violet,LGLFFNDHMLKUMI-UHFFFAOYSA-N,Launched,other antibiotic,,,
CS-110266,RGSVXQJPSWZXOP-UHFFFAOYSA-N,Preclinical,dopamine receptor agonist,SLC6A3,,
CS-917,XJMYIJPPDSZOPN-UHFFFAOYSA-N,Phase 2,fructose biphosphate inhibitor,FBP1,,
CT-7758,KYHVWHYLKOHLKA-FQEVSTJZSA-N,Phase 2,integrin antagonist,ITGA4,,
CT7001,YCVGLKWJKIKVBI-MJGOQNOKSA-N,Phase 1/Phase 2,CDK inhibitor,,,
CTEP,GOHCTCOGYKAJLZ-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRM5,,
CTS-1027,ROSNVSQTEGHUKU-UHFFFAOYSA-N,Phase 2,metalloproteinase inhibitor,MMP1|MMP13|MMP2|MMP3|MMP9,,
CTS21166,NIOCOJFPGCXNKL-ZKZXETMPSA-N,Phase 1,beta-secretase inhibitor,BACE1,,
CU-CPT-4a,IAASQMCXDRISAV-CYBMUJFWSA-N,Preclinical,toll-like receptor inhibitor,TLR3,,
CU-T12-9,LITXVDAFEYLWQE-UHFFFAOYSA-N,Preclinical,toll-like receptor agonist,TLR1|TLR2,,
CUDC-101,PLIVFNIUGLLCEK-UHFFFAOYSA-N,Phase 1,EGFR inhibitor,EGFR|ERBB2,,
CUDC-427,HSHPBORBOJIXSQ-HARLFGEKSA-N,Phase 1,apoptosis inhibitor,XIAP,,
CUDC-907,JOWXJLIFIIOYMS-UHFFFAOYSA-N,Phase 2,PI3K inhibitor,HDAC2|PIK3R1,,
CUR-61414,WPHXYKUPFJRJDK-AHWVRZQESA-N,Phase 1,smoothened receptor antagonist,DHH|IHH|SMO,,
curcumin,ZIUSSTSXXLLKKK-SMSFQYLMSA-N,Launched,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH,,
curcumol,QRMPRVXWPCLVNI-YYFQZIEXSA-N,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,,
cutamesine,UVSWWUWQVAQPJR-UHFFFAOYSA-N,Phase 2,sigma receptor agonist,SIGMAR1,,
CV-1808,SCNILGOVBBRMBK-SDBHATRESA-N,Preclinical,adenosine receptor agonist,ADORA2A,,
CVT-10216,YYOOFJZTRCPVFD-UHFFFAOYSA-N,Phase 1,aldehyde dehydrogenase inhibitor,ALDH2,,
CW-008,KCIMKTNQCUDTFI-UHFFFAOYSA-N,Preclinical,PKA activator,PRKACA,,
CX-4945,MUOKSQABCJCOPU-UHFFFAOYSA-N,Phase 1/Phase 2,casein kinase inhibitor,CSNK2A1|CSNK2A2|DAPK3|HIPK3,,
CX-516,BXBNADAPIHHXJQ-UHFFFAOYSA-N,Phase 2/Phase 3,glutamate receptor modulator,,,
CX-5461,XGPBJCHFROADCK-UHFFFAOYSA-N,Phase 1,RNA polymerase inhibitor,,,
CXD101,JHDZMASHNBKTPS-UHFFFAOYSA-N,Phase 1/Phase 2,HDAC inhibitor,,,
CY208-243,WRNKIDLXXXIELU-IEBWSBKVSA-N,Phase 2,dopamine receptor agonist,CALY,,
cyacetacide,HPHBOJANXDKUQD-UHFFFAOYSA-N,Preclinical,,,,
cyamemazine,SLFGIOIONGJGRT-AWEZNQCLSA-N,Launched,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C|HTR7,neurology/psychiatry,schizophrenia|anxiety
cyanocobalamin,RMRCNWBMXRMIRW-WZHZPDAFSA-M,Launched,methylmalonyl CoA mutase stimulant|vitamin B,MUT,hematology|infectious disease|gastroenterology,anemia|fish tapeworm infestation|celiac disease
cyanopindolol,QXIUMMLTJVHILT-GFCCVEGCSA-N,Phase 2,adrenergic receptor antagonist,ADRB1|HTR1A|HTR1D,,
CYC065,DLPIYBKBHMZCJI-WBVHZDCISA-N,Phase 1,CDK inhibitor,,,
CYC116,GPSZYOIFQZPWEJ-UHFFFAOYSA-N,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|KDR,,
cyclamic-acid,HCAJEUSONLESMK-UHFFFAOYSA-N,Preclinical,,,,
cyclandelate,WZHCOOQXZCIUNC-QEJZJMRPSA-N,Launched,calcium channel blocker,,cardiology|rheumatology,claudication|arteriosclerosis|Raynaud's disease
cyclic-AMP,IVOMOUWHDPKRLL-DEGSGYPDSA-N,Preclinical,,CNGA3|TRPM7,,
cyclizine,UVKZSORBKUEBAZ-UHFFFAOYSA-N,Launched,histamine receptor modulator,HRH1|SULT1E1,gastroenterology|neurology/psychiatry,nausea|vomiting|vertigo|motion sickness
cyclobenzaprine,JURKNVYFZMSNLP-UHFFFAOYSA-N,Launched,adrenergic receptor agonist|serotonin receptor agonist,HTR2A,neurology/psychiatry,spasms
cyclocreatine,AMHZIUVRYRVYBA-UHFFFAOYSA-N,Phase 1,creatine kinase substrate,,,
cyclocytidine,BBDAGFIXKZCXAH-CCXZUQQUSA-N,Preclinical,DNA synthesis inhibitor|RNA synthesis inhibitor,,,
cycloheximide,YPHMISFOHDHNIV-FSZOTQKASA-N,Preclinical,protein synthesis inhibitor,RPL3,,
cyclopamine,QASFUMOKHFSJGL-LAFRSMQTSA-N,Preclinical,hedgehog pathway inhibitor,,,
cyclopenthiazide,BKYKPTRYDKTTJY-CYBMUJFWSA-N,Launched,thiazide diuretic,,cardiology,hypertension|congestive heart failure
cyclopentolate,SKYSRIRYMSLOIN-OAHLLOKOSA-N,Launched,acetylcholine receptor antagonist,,ophthalmology,mydriasis|cycloplegia
cyclophosphamide,CMSMOCZEIVJLDB-CQSZACIVSA-N,Launched,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP3A4|CYP3A5|CYP3A7,hematologic malignancy|oncology,Hodgkin's lymphoma|small lymphocytic lymphoma (SLL)|breast cancer|neuroblastoma|Burkitt's lymphoma|multiple myeloma|chronic lymphocytic leukemia (CLL)|acute myeloid leukemia (AML)|acute lymphoblastic leukemia (ALL)|chronic myeloid leukemia (CML)|true histiocytic lymphoma (THL)|retinoblastoma|ovarian cancer
cyclopiazonic-acid,SZINUGQCTHLQAZ-DQYPLSBCSA-N,Preclinical,ATPase inhibitor,ATP2A1,,
cycloserine-(D),DYDCUQKUCUHJBH-UWTATZPHSA-N,Launched,bacterial cell wall synthesis inhibitor,GRIN1,infectious disease,tuberculosis|tuberculosis
cyclosporin-A,PMATZTZNYRCHOR-MAYCVHQQSA-N,Launched,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,rheumatology|dermatology,rheumatoid arthritis|psoriasis
cyclosporin-A,PMATZTZNYRCHOR-CGLBZJNRSA-N,Launched,calcineurin inhibitor,ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3,rheumatology|dermatology,rheumatoid arthritis|psoriasis
cyclothiazide,BOCUKUHCLICSIY-JWUFEOHASA-N,Launched,glutamate receptor modulator,CA2|GRIA1|GRIA2|GRIA3|GRIA4|SLC12A3,cardiology,hypertension
cyclovalone,DHKKONBXGAAFTB-OTYYAQKOSA-N,Launched,breast cancer resistance protein inhibitor,ABCG2,gastroenterology,bile stimulation
cyclovirobuxin-D,GMNAPBAUIVITMI-ABNIRSKTSA-N,Preclinical,calcium channel modulator,,,
CycLuc1,HBZBAMXERPYTFS-SECBINFHSA-N,Preclinical,,,,
CYM-50260,FHPOTBQOUBMMCI-UHFFFAOYSA-N,Preclinical,sphingosine 1-phosphate receptor agonist,S1PR4,,
CYM-50358,QWJOPXDAQCDRRM-UHFFFAOYSA-N,Preclinical,sphingosine 1-phosphate receptor antagonist,S1PR4,,
CYM-50769,QHVSQUYCVUHYKT-UHFFFAOYSA-N,Preclinical,neuropeptide receptor antagonist,NPBWR1,,
CYM-5442,NUIKTBLZSPQGCP-LJQANCHMSA-N,Preclinical,sphingosine 1-phosphate receptor agonist,S1PR1,,
CYM-5520,FMYGNANMYYHBSU-UHFFFAOYSA-N,Preclinical,sphingosine 1-phosphate receptor agonist,S1PR2,,
CYM-5541,NDKGACIWVAOUQH-UHFFFAOYSA-N,Preclinical,sphingosine 1-phosphate receptor agonist,S1PR3,,
cypermethrin,KAATUXNTWXVJKI-CMKODMSKSA-N,Launched,,,infectious disease,flea control
cyproheptadine,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Launched,histamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7,allergy|otolaryngology|ophthalmology|dermatology,allergic rhinitis|vasomotor rhinitis|conjunctivitis|urticaria|dermatographism
cyproterone-acetate,UWFYSQMTEOIJJG-FDTZYFLXSA-N,Launched,androgen receptor antagonist,ADORA1|AR,oncology,prostate cancer
cyromazine,LVQDKIWDGQRHTE-UHFFFAOYSA-N,Launched,,,,
cysteamine,UFULAYFCSOUIOV-UHFFFAOYSA-N,Launched,tissue transglutaminase inhibitor,NPY2R|SST,metabolism,cystinosis
CYT-997,MTJHLONVHHPNSI-IBGZPJMESA-N,Phase 2,tubulin polymerization inhibitor,TUBB,,
cyt387,ZVHNDZWQTBEVRY-UHFFFAOYSA-N,Phase 3,JAK inhibitor,JAK1|JAK2|JAK3,,
cytarabine,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,Launched,ribonucleotide reductase inhibitor,POLA1|POLB|POLD1|POLE,hematologic malignancy,acute lymphoblastic leukemia (ALL)|chronic lymphocytic leukemia (CLL)|acute myeloid leukemia (AML)|non-Hodgkin lymphoma (NHL)
cytidine,UHDGCWIWMRVCDJ-XVFCMESISA-N,Launched,,,,
cytidine,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1",Launched,,,,
cytisine,ANJTVLIZGCUXLD-DTWKUNHWSA-N,Launched,acetylcholine receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4,neurology/psychiatry,nicotinism
cytochalasin-B,GBOGMAARMMDZGR-TYHYBEHESA-N,Phase 2,microtubule inhibitor,ACTB,,
cytochlor,NGGRGTWYSXYVDK-FSDSQADBSA-N,Phase 1,,,,
CZC-54252,CLGWUCNXOBLWFM-UHFFFAOYSA-N,Preclinical,leucine rich repeat kinase inhibitor,LRRK2,,
CZC24832,RXRZPHQBTHQXSV-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,PIK3CG,,
D-(+)-maltose,GUBGYTABKSRVRQ-QUYVBRFLSA-N,Preclinical,,MGAM,,
D-157495,MNLHFGXIUJNDAF-UHFFFAOYSA-N,Preclinical,decapping scavenger enzyme inhibitor,,,
D-3263,ZGTYTFYRCIRWBL-HYVNUMGLSA-N,Phase 1,transient receptor potential channel agonist,,,
D-4476,DPDZHVCKYBCJHW-UHFFFAOYSA-N,Preclinical,TGF beta receptor inhibitor,CSNK1A1|CSNK1D|TGFB1,,
D-64131,ICMIJSRDISNKOC-UHFFFAOYSA-N,Preclinical,microtubule inhibitor,TUBB,,
D-7193,YTPQSLLEROSACP-YUMQZZPRSA-N,Phase 2,,,,
D-alpha-tocopheryl-succinate,IELOKBJPULMYRW-NJQVLOCASA-N,Launched,,,,
D-delta-tocopherol,GZIFEOYASATJEH-VHFRWLAGSA-N,Launched,,,,
D-limonene,XMGQYMWWDOXHJM-JTQLQIEISA-N,Phase 1,,,,
D-phenylalanine,COLNVLDHVKWLRT-MRVPVSSYSA-N,Preclinical,enkephalinase inhibitor,CCBL1|CRH|HCAR3,,
D-serine,MTCFGRXMJLQNBG-UWTATZPHSA-N,Launched,glutamate receptor agonist,GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3,,
"D,L-mevalonic-acid-lactone",JYVXNLLUYHCIIH-ZCFIWIBFSA-N,Preclinical,,,,
D609,PWLXJBSAUKKGCM-UHFFFAOYSA-N,Preclinical,phospholipase inhibitor,,,
DAA-1106,DCRZYADKQRHHSF-UHFFFAOYSA-N,Preclinical,benzodiazepine receptor agonist,TSPO,,
dabigatran,YBSJFWOBGCMAKL-UHFFFAOYSA-N,Launched,thrombin inhibitor,F2,neurology/psychiatry|hematology,stroke|systemic embolism|pulmonary embolism (PE)|deep vein thrombosis (DVT)
dabigatran-etexilate,KSGXQBZTULBEEQ-UHFFFAOYSA-N,Launched,thrombin inhibitor,F2,neurology/psychiatry|hematology,stroke|systemic embolism|pulmonary embolism (PE)|deep vein thrombosis (DVT)
dabrafenib,BFSMGDJOXZAERB-UHFFFAOYSA-N,Launched,RAF inhibitor,BRAF|LIMK1|NEK11|RAF1|SIK1,oncology,melanoma
dacarbazine,FDKXTQMXEQVLRF-ZHACJKMWSA-N,Launched,DNA alkylating agent,PGD|POLA2,oncology|hematologic malignancy,melanoma|Hodgkin's lymphoma
dacinostat,BWDQBBCUWLSASG-MDZDMXLPSA-N,Phase 1,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,
daclatasvir,FKRSSPOQAMALKA-CUPIEXAXSA-N,Launched,HCV inhibitor,,infectious disease,hepatitis C
dacomitinib,LVXJQMNHJWSHET-AATRIKPKSA-N,Launched,EGFR inhibitor,EGFR|ERBB2|ERBB4,,
dactinomycin,RJURFGZVJUQBHK-IIXSONLDSA-N,Launched,RNA polymerase inhibitor,POLR2A,oncology,testicular carcinoma|Wilm's tumor|rhabdomyosarcoma|Ewing's sarcoma|gestational trophoblastic disease (GTD)
daidzein,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,Phase 2,estrogen receptor agonist,ESRRA|ESRRB|ESRRG|TRPC5,,
daidzin,KYQZWONCHDNPDP-QNDFHXLGSA-N,Phase 1,antioxidant,ALDH2,,
dalargin,GDPHPXYFLPDZGH-ABDYMBPTSA-N,Phase 2,opioid receptor agonist,OPRM1,,
dalbavancin,KGPGQDLTDHGEGT-SZUNQUCBSA-N,Launched,bacterial cell wall synthesis inhibitor,PNLIP,infectious disease,skin infections
dalcetrapib,YZQLWPMZQVHJED-UHFFFAOYSA-N,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,,
dalfampridine,NUKYPUAOHBNCPY-UHFFFAOYSA-N,Launched,potassium channel blocker,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,neurology/psychiatry,multiple sclerosis
dalfopristin,SUYRLXYYZQTJHF-FENKCRFESA-N,Preclinical,antibacterial ,,,
daltroban,IULOBWFWYDMECP-UHFFFAOYSA-N,Phase 3,thromboxane receptor antagonist,TBXA2R,,
daminozide,NOQGZXFMHARMLW-UHFFFAOYSA-N,Preclinical,KDM2A inhibitor,KDM2A|KDM7A|PHF8,,
danazol,POZRVZJJTULAOH-LHZXLZLDSA-N,Launched,estrogen receptor antagonist|progesterone receptor agonist,AR|CCL2|ESR1|GNRHR|GNRHR2|PGR,obstetrics/gynecology|cardiology,endometriosis|angioedema
danegaptide,BIZKIHUJGMSVFD-MNOVXSKESA-N,Phase 2,gap junction modulator,,,
danirixin,NGYNBSHYFOFVLS-LBPRGKRZSA-N,Phase 2,CC chemokine receptor antagonist,CXCR2,,
danofloxacin,QMLVECGLEOSESV-RYUDHWBXSA-N,Launched,bacterial DNA gyrase inhibitor,,pulmonary,bovine respiratory disease (BRD)
danoprevir,ZVTDLPBHTSMEJZ-JSZLBQEHSA-N,Phase 3,HCV inhibitor,,,
dantrolene,OZOMQRBLCMDCEG-VIZOYTHASA-N,Launched,calcium channel blocker,RYR1|RYR3,neurology/psychiatry|endocrinology,spasms|malignant hyperthermia (MH)
dantron,QBPFLULOKWLNNW-UHFFFAOYSA-N,Withdrawn,laxative,,,
danusertib,XKFTZKGMDDZMJI-HSZRJFAPSA-N,Phase 2,Aurora kinase inhibitor|growth factor receptor inhibitor,AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK,,
dapagliflozin,JVHXJTBJCFBINQ-ADAARDCZSA-N,Launched,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,endocrinology,diabetes mellitus
dapansutrile,LQFRYKBDZNPJSW-UHFFFAOYSA-N,Phase 2,anti-inflammatory agent,,,
daphnetin,ATEFPOUAMCWAQS-UHFFFAOYSA-N,Preclinical,protein kinase inhibitor,,,
dapiprazole,RFWZESUMWJKKRN-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,ophthalmology,mydriasis
dapivirine,ILAYIAGXTHKHNT-UHFFFAOYSA-N,Phase 3,non-nucleoside reverse transcriptase inhibitor,CYP3A4|CYP3A5,,
dapoxetine,USRHYDPUVLEVMC-FQEVSTJZSA-N,Launched,selective serotonin reuptake inhibitor (SSRI),HTR1A|HTR1B|HTR2C|SLC6A4,urology,premature ejaculation (PE)
daprodustat,NVTKJBXOBFRPLQ-UHFFFAOYSA-N,Phase 3,hypoxia inducible factor inhibitor,EGLN1,,
dapsone,MQJKPEGWNLWLTK-UHFFFAOYSA-N,Launched,bacterial antifolate,DHFR,dermatology|infectious disease,dermatitis herpetiformis (DH)|leprosy
DAPT,DWJXYEABWRJFSP-XOBRGWDASA-N,Preclinical,gamma secretase inhibitor,,,
daptomycin,DOAKLVKFURWEDJ-QCMAZARJSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|endocarditis
darapladib,WDPFJWLDPVQCAJ-UHFFFAOYSA-N,Phase 3,phospholipase inhibitor,PLA2G7,,
darglitazone,QQKNSPHAFATFNQ-UHFFFAOYSA-N,Phase 2,PPAR receptor antagonist,PPARG,,
darifenacin,HXGBXQDTNZMWGS-RUZDIDTESA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,urology,urinary incontinence
darolutamide,BLIJXOOIHRSQRB-NWDGAFQWSA-N,Launched,androgen receptor antagonist,AR,oncology,prostate cancer
darunavir,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,Launched,HIV protease inhibitor,CYP3A4,infectious disease,human immunodeficiency virus (HIV-1)
darusentan,FEJVSJIALLTFRP-LJQANCHMSA-N,Phase 3,endothelin receptor antagonist,EDNRA,,
dasabuvir,NBRBXGKOEOGLOI-UHFFFAOYSA-N,Launched,HCV inhibitor,,infectious disease,hepatitis C
dasatinib,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,Launched,Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor,ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1,hematologic malignancy,chronic myeloid leukemia (CML)|acute lymphoblastic leukemia (ALL)
dasotraline,SRPXSILJHWNFMK-MEDUHNTESA-N,Phase 3,dopamine-norepinephrine-serotonin reuptake inhibitor,,,
DAU-5884,NWXCDQHBVVPPTL-WDNDVIMCSA-N,Preclinical,acetylcholine receptor antagonist,CHRM3,,
daucosterol,NPJICTMALKLTFW-OFUAXYCQSA-N,Phase 2,apoptosis stimulant,,,
daunorubicin,STQGQHZAVUOBTE-VGBVRHCVSA-N,Launched,RNA synthesis inhibitor|topoisomerase inhibitor,TOP2A|TOP2B,hematologic malignancy,acute myeloid leukemia (AML)|acute lymphoblastic leukemia (ALL)
dazmegrel,DEQLGSOHGTZKFB-UHFFFAOYSA-N,Phase 2,thromboxane synthase inhibitor,TBXAS1,,
dazoxiben,XQGZSYKGWHUSDH-UHFFFAOYSA-N,Phase 2,thromboxane synthase inhibitor,TBXAS1,,
DBeQ,QAIMUUJJAJBPCL-UHFFFAOYSA-N,Preclinical,ATPase inhibitor,CASP3,,
DBPR-211,KAIYFJUWIBTYPK-UHFFFAOYSA-N,Preclinical,cannabinoid receptor antagonist,,,
DBPR108,VQKSCYBKUIDZEI-STQMWFEESA-N,Phase 1,dipeptidyl peptidase inhibitor,DPP4,,
DC-260126,CNGHPXKWPGIDSK-UHFFFAOYSA-N,Preclinical,free fatty acid receptor antagonist,FFAR1,,
DCC-2618,WWOXKWLDMLMYQY-UHFFFAOYSA-N,Phase 1,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,KIT|PDGFRA,,
DCEBIO,LKHRMULASXZCLG-UHFFFAOYSA-N,Preclinical,potassium channel activator,KCNN2|KCNN3|KCNN4,,
DCP-LA,CONYTTFKIUJZOF-ZSYWTGECSA-N,Preclinical,protein kinase activator,,,
DCPIB,KHKGTPJPBOQECW-QFIPXVFZSA-N,Preclinical,chloride channel blocker|gap junction modulator|glutamate inhibitor,SLC1A2,,
DDR1-IN-1,AOZPVMOOEJAZGK-UHFFFAOYSA-N,Preclinical,discoidin domain receptor inhibitor,DDR1|DDR2,,
deazaguanine,KXBCLNRMQPRVTP-UHFFFAOYSA-N,Preclinical,DNA synthesis inhibitor,,,
Debio-0932,RVJIQAYFTOPTKK-UHFFFAOYSA-N,Phase 1,HSP inhibitor,,,
debrisoquin,JWPGJSVJDAJRLW-UHFFFAOYSA-N,Launched,adrenergic neuron blocker,SLC6A2,cardiology,hypertension
decamethonium,MTCUAOILFDZKCO-UHFFFAOYSA-N,Launched,acetylcholine receptor agonist,ACHE|CHRNA2,neurology/psychiatry,muscle relaxant
decamethoxine,ZADGGFKUEYIBJC-BPBUSIJASA-N,Phase 2,antiseptic,,,
decernotinib,ASUGUQWIHMTFJL-QGZVFWFLSA-N,Phase 2/Phase 3,JAK inhibitor,JAK3,,
decitabine,XAUDJQYHKZQPEU-KVQBGUIXSA-N,Launched,DNA methyltransferase inhibitor,DNMT1|DNMT3A,hematologic malignancy|hematology,myelodysplastic diseases (MDS)|anemia|chronic myeloid leukemia (CML)
declopramide,YEYAKZXEBSVURO-UHFFFAOYSA-N,Preclinical,cell cycle inhibitor,,,
decloxizine,OXBBIHZWNDPBMQ-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,,,
decoquinate,JHAYEQICABJSTP-UHFFFAOYSA-N,Launched,antiprotozoal agent,,infectious disease,coccidiosis
defactinib,FWLMVFUGMHIOAA-UHFFFAOYSA-N,Phase 2,focal adhesion kinase inhibitor,PTK2,,
deferasirox,BOFQWVMAQOTZIW-UHFFFAOYSA-N,Launched,chelating agent,CYP3A4,hematology,transfusional hemosiderosis|thalassemia|iron overload
deferasirox-iron-chelate,XLHBYAVMDSNIEM-UHFFFAOYSA-L,Launched,,,,
deferiprone,TZXKOCQBRNJULO-UHFFFAOYSA-N,Launched,chelating agent,UGT1A6,hematology,transfusional hemosiderosis|thalassemia|iron overload
deferoxamine-mesylate,UBQYURCVBFRUQT-UHFFFAOYSA-N,Launched,chelating agent,,hematology,acute iron intoxication|iron overload
deflazacort,FBHSPRKOSMHSIF-GRMWVWQJSA-N,Launched,glucocorticoid receptor agonist,NR3C1,rheumatology,joint inflammation
deforolimus,BUROJSBIWGDYCN-LKLUGXJSSA-N,Phase 3,mTOR inhibitor,MTOR,,
degarelix,MEUCPCLKGZSHTA-XYAYPHGZSA-N,Launched,gonadotropin releasing factor hormone receptor antagonist,GNRHR,oncology,prostate cancer
dehydroacetic-acid,PKLPQOJFHFGVBS-UHFFFAOYSA-N,Preclinical,,,,
dehydrocholate,OHXPGWPVLFPUSM-IVFZZBRKSA-N,Preclinical,,,,
dehydrocholate-acid,OHXPGWPVLFPUSM-KLRNGDHRSA-N,Preclinical,,,,
dehydrocorydaline,RFKQJTRWODZPHF-UHFFFAOYSA-N,Phase 3,acetylcholinesterase inhibitor,ACHE,,
dehydroepiandrosterone,FMGSKLZLMKYGDP-USOAJAOKSA-N,Launched,protein synthesis stimulant,ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1,endocrinology,menopause
dehydroepiandrosterone-sulfate,CZWCKYRVOZZJNM-USOAJAOKSA-N,Launched,androgen receptor agonist|estrogen receptor agonist,AR|ESR1|ESR2,endocrinology,menopause
delafloxacin,DYDCPNMLZGFQTM-UHFFFAOYSA-N,Phase 3,antiinfective drug,,,
delamanid,XDAOLTSRNUSPPH-XMMPIXPASA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,tuberculosis
delanzomib,SJFBTAPEPRWNKH-CCKFTAQKSA-N,Phase 1/Phase 2,proteasome inhibitor,CMA1|CTSG|CYP3A4|ELANE,,
delapril,WOUOLAUOZXOLJQ-MBSDFSHPSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension
delavirdine,WHBIGIKBNXZKFE-UHFFFAOYSA-N,Launched,non-nucleoside reverse transcriptase inhibitor,CYP3A4,infectious disease,human immunodeficiency virus (HIV-1)
delcasertib,XPXZTVWPRKJTAA-PJKOMPQUSA-N,Phase 1,PKC inhibitor,,,
delgocitinib,LOWWYYZBZNSPDT-ZBEGNZNMSA-N,Phase 2,JAK inhibitor,,,
delivert,CZGUSIXMZVURDU-FCWOTDAASA-N,Launched,angiotensin receptor agonist,AGTR1|AGTR2,critical care,sepsis
delpazolid,QLUWQAFDTNAYPN-LLVKDONJSA-N,Phase 2,antibacterial,,,
delphinidin,JKHRCGUTYDNCLE-UHFFFAOYSA-O,Phase 2,membrane permeability inhibitor,GLO1,,
delta-tocotrienol,ODADKLYLWWCHNB-LDYBVBFYSA-N,Phase 1,HMGCR inhibitor,HMGCR,,
deltarasin,LTZKEDSUXKTTTC-KXQOOQHDSA-N,Preclinical,phosphodiesterase inhibitor,KRAS,,
demecarium,RWZVPVOZTJJMNU-UHFFFAOYSA-N,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,ophthalmology,intraocular pressure|glaucoma
demeclocycline,JHOHXJYRVSLQCB-AWLLFJHESA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,endocrinology|infectious disease|ophthalmology|urology,fever|respiratory tract infections|psittacosis|trachoma|conjunctivitis|urethritis|chancroid|cholera|syphilis|listeria|anthrax|actinomycosis|tularemia|brucellosis
denatonium-benzoate,ZFQMTVNLDNXRNQ-UHFFFAOYSA-O,Preclinical,,,,
denopamine,VHSBBVZJABQOSG-INIZCTEOSA-N,Launched,adrenergic receptor agonist,,cardiology,angina pectoris
denotivir,ZPBLNADJHWHOEP-UHFFFAOYSA-N,Launched,antiviral,,infectious disease,virus herpes simplex (HSV)|skin infections
deoxyarbutin,GFBCWCDNXDKFRH-NSHDSACASA-N,Preclinical,tyrosinase inhibitor,,,
deoxycholic-acid,KXGVEGMKQFWNSR-LLQZFEROSA-N,Launched,biliverdin reductase A activator|G protein-coupled receptor agonist,FPR1|GPBAR1,endocrinology,submental fat
deoxycorticosterone-acetate,VPGRYOFKCNULNK-ACXQXYJUSA-N,Preclinical,progestogen hormone,NR3C2,,
deoxyepinephrine,NGKZFDYBISXGGS-UHFFFAOYSA-N,Preclinical,adrenergic receptor agonist|dopamine receptor agonist,ADRA1A|DRD1|DRD2,,
deptropine,ZWPODSUQWXAZNC-PMOLBWCYSA-N,Preclinical,histamine receptor antagonist,HRH1,,
dequalinium,PCSWXVJAIHCTMO-UHFFFAOYSA-P,Launched,PKC inhibitor,KCNN1|KCNN3,infectious disease,first-aid antiseptic
deracoxib,WAZQAZKAZLXFMK-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,osteoarthritis
derazantinib,KPJDVVCDVBFRMU-AREMUKBSSA-N,Phase 2,tyrosine kinase inhibitor,,,
deserpidine,CVBMAZKKCSYWQR-WCGOZPBSSA-N,Launched,angiotensin converting enzyme inhibitor,ACE|SLC18A2,cardiology,hypertension
desidustat,IKRKQQLJYBAPQT-UHFFFAOYSA-N,Preclinical,hypoxia inducible factor prolyl hydroxylase inhibitor,,,
desipramine,HCYAFALTSJYZDH-UHFFFAOYSA-N,Launched,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A4|SMPD1,neurology/psychiatry,depression
desisobutyryl-ciclesonide,OXPLANUPKBHPMS-FYSAVPLMSA-N,Launched,cytochrome P450 inhibitor,,allergy,allergic rhinitis
deslanoside,OBATZBGFDSVCJD-LALPQLPRSA-N,Launched,Na/K-ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,cardiology,congestive heart failure|cardiac arrythmia
desloratadine,JAUOIFJMECXRGI-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria
deslorelin,GJKXGJCSJWBJEZ-XRSSZCMZSA-N,Phase 2,gonadotropin releasing factor hormone receptor agonist,,,
desmethylclozapine,JNNOSTQEZICQQP-UHFFFAOYSA-N,Phase 2,acetylcholine receptor agonist,HTR2C,,
desmopressin-acetate,NFLWUMRGJYTJIN-AIOUAYLGSA-N,Launched,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,endocrinology|urology,central diabetes insipidus|nocturnal enuresis
desogestrel,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Launched,progesterone receptor agonist,ESR1|PGR,endocrinology,contraceptive
desonide,WBGKWQHBNHJJPZ-LECWWXJVSA-N,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,gastroenterology,Crohn's disease
desoximetasone,VWVSBHGCDBMOOT-IIEHVVJPSA-N,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,dermatology,corticosteroid-responsive dermatoses
desoxycorticosterone-pivalate,VVOIQBFMTVCINR-WWMZEODYSA-N,Launched,corticosteroid agonist,NR3C2,endocrinology,Addison's disease
desoxycortone,ZESRJSPZRDMNHY-YFWFAHHUSA-N,Preclinical,mineralocorticoid receptor agonist,NR3C1|NR3C2,,
desoxypeganine,WUFQLZTXIWKION-UHFFFAOYSA-N,Phase 1,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,ACHE,,
desvenlafaxine,KYYIDSXMWOZKMP-HNNXBMFYSA-N,Launched,serotonin–norepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression
detomidine,RHDJRPPFURBGLQ-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA2A,neurology/psychiatry,sedative
devazepide,NFHRQQKPEBFUJK-HSZRJFAPSA-N,Preclinical,CCK receptor antagonist,,,
dexamethasone,UREBDLICKHMUKA-CXSFZGCWSA-N,Launched,glucocorticoid receptor agonist,ANXA1|NOS2|NR0B1|NR3C1|NR3C2,endocrinology|rheumatology|allergy|gastroenterology|hematology|neurology/psychiatry|dermatology,hypercalcemia|rheumatoid arthritis|psoriatic arthritis|osteoarthritis|allergic rhinitis|ulcerative colitis|anemia|multiple sclerosis|enteritis|lupus|dermatitis herpetiformis (DH)|nephrotic syndrome|psoriasis
dexamethasone-acetate,AKUJBENLRBOFTD-RPRRAYFGSA-N,Launched,glucocorticoid receptor agonist,,endocrinology|rheumatology|allergy|gastroenterology|hematology|neurology/psychiatry|dermatology,hypercalcemia|rheumatoid arthritis|psoriatic arthritis|osteoarthritis|allergic rhinitis|ulcerative colitis|anemia|multiple sclerosis|enteritis|lupus|dermatitis herpetiformis (DH)|nephrotic syndrome|psoriasis
dexchlorpheniramine,SOYKEARSMXGVTM-HNNXBMFYSA-N,Launched,histamine receptor antagonist,,allergy|cardiology,allergic conjunctivitis|allergic rhinitis|urticaria|angioedema
dexfosfoserine,BZQFBWGGLXLEPQ-REOHCLBHSA-N,Preclinical,membrane integrity inhibitor,CFTR|GRM4|GRM6|GRM7|GRM8|KCNC4|PDPK1|PIM1|PRKACA|PRKCQ|PYGL|PYGM|REG1A|RHO|SERPINB3|SMAD2|TAOK2,,
dexlansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,Launched,ATPase inhibitor,ATP4A,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)
dexloxiglumide,QNQZBKQEIFTHFZ-GOSISDBHSA-N,Phase 3,CCK receptor antagonist,CCKAR,,
dexmedetomidine,CUHVIMMYOGQXCV-NSHDSACASA-N,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,neurology/psychiatry,sedative
dexniguldipine,SVJMLYUFVDMUHP-MGBGTMOVSA-N,Phase 2,calmodulin antagonist,ADORA3,,
dexpanthenol,SNPLKNRPJHDVJA-ZETCQYMHSA-N,Launched,,,gastroenterology,paralytic ileus
dexrazoxane,BMKDZUISNHGIBY-ZETCQYMHSA-N,Launched,chelating agent|topoisomerase inhibitor,TOP2A|TOP2B,cardiology,cardiomyopathy
dextran,FZWBNHMXJMCXLU-BLAUPYHCSA-N,Launched,,,hematology|critical care,thrombosis|hypovolemia
dextromethorphan,MKXZASYAUGDDCJ-NJAFHUGGSA-N,Launched,glutamate receptor antagonist|sigma receptor agonist,CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4,pulmonary,cough suppressant
dextrorotation-nimorazole-phosphate-ester,CCDHHPOGWLYHAX-SNVBAGLBSA-N,Preclinical,antiinfective drug,,,
dextrose,GZCGUPFRVQAUEE-SLPGGIOYSA-N,Launched,,,endocrinology,hypoglycemia
DFB,YYMCVDNIIFNDJK-BEQMOXJMSA-N,Preclinical,glutamate receptor agonist,GRM5,,
DG-172,ZJMDTBBCNMGFMS-SAPNQHFASA-N,Preclinical,PPAR receptor inverse agonist,PPARD,,
DG051,PVCTYSQBVIGZRU-KRWDZBQOSA-N,Preclinical,leukotriene synthesis inhibitor,,,
DH-97,HDOIPCLEKCEANF-UHFFFAOYSA-N,Preclinical,melatonin receptor antagonist,MTNR1B,,
DHBP,XJGZGUSMZSXHJI-UHFFFAOYSA-N,Preclinical,ryanodine receptor blocker,,,
diacerein,TYNLGDBUJLVSMA-UHFFFAOYSA-N,Launched,interleukin inhibitor,IL1B,rheumatology,osteoarthritis
diacetamate,UJAOSPFULOFZRR-UHFFFAOYSA-N,Preclinical,,,,
diadenosine-tetraphosphate,YOAHKNVSNCMZGQ-XPWFQUROSA-N,Phase 1,adenosine kinase inhibitor,P2RY13|P2RY2,,
dianhydrogalactitol,AAFJXZWCNVJTMK-GUCUJZIJSA-N,Phase 3,DNA alkylating agent,,,
diarylpropionitrile,GHZHWDWADLAOIQ-ZDUSSCGKSA-N,Preclinical,estrogen receptor agonist,ESR2,,
diatrizoic-acid,YVPYQUNUQOZFHG-UHFFFAOYSA-N,Launched,,,radiology,contrast agent
diaveridine,LDBTVAXGKYIFHO-UHFFFAOYSA-N,Launched,dihydrofolate reductase inhibitor,,infectious disease,coccidiosis
diazoxide,GDLBFKVLRPITMI-UHFFFAOYSA-N,Launched,potassium channel activator,ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3,endocrinology,hypoglycemia
dibekacin,JJCQSGDBDPYCEO-XVZSLQNASA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections
dibenzepine,QPGGEKPRGVJKQB-UHFFFAOYSA-N,Preclinical,norepinephrine reputake inhibitor,,,
dibenzothiophene,IYYZUPMFVPLQIF-UHFFFAOYSA-N,Preclinical,,,,
dibutyl-phthalate,DOIRQSBPFJWKBE-UHFFFAOYSA-N,Preclinical,,TRPA1,,
dichlorisone-acetate,YNNURTVKPVJVEI-GSLJADNHSA-N,Phase 2,,,,
dichloroacetate,FLWQSOHPGISTPX-UHFFFAOYSA-N,Phase 3,pyruvate dehydrogenase kinase inhibitor,,,
dichlorophen,MDNWOSOZYLHTCG-UHFFFAOYSA-N,Launched,anticestodal agent,,infectious disease,hookworm|tapeworm
dichlorvos,OEBRKCOSUFCWJD-UHFFFAOYSA-N,Launched,acetylcholinesterase inhibitor,,,
diclazuril,ZSZFUDFOPOMEET-GFCCVEGCSA-N,Launched,antiprotozoal agent,,infectious disease,equine protozoal myeloencephalitis (EPM)
diclofenac,DCOPUUMXTXDBNB-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A,rheumatology|neurology/psychiatry,rheumatoid arthritis|osteoarthritis|migraine headache
diclofenamide,GJQPMPFPNINLKP-UHFFFAOYSA-N,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA4|CA7,ophthalmology|neurology/psychiatry,glaucoma|epilepsy
diclofensine,ZJDCGVDEEHWEIG-HNNXBMFYSA-N,Phase 3,dopamine reuptake inhibitor,DRD1|MAOA|MAOB,,
dicloralurea,PPJXIHLNYDVTDI-XIXRPRMCSA-N,Preclinical,,,,
dicloxacillin,YFAGHNZHGGCZAX-JKIFEVAISA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections
dicoumarol,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,Launched,NADPH inhibitor,CRYZ|NQO1|VKORC1,hematology,deep vein thrombosis (DVT)
dicyclohexylamine,XBPCUCUWBYBCDP-UHFFFAOYSA-N,Preclinical,,,,
dicycloverine,CURUTKGFNZGFSE-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,gastroenterology,irritable bowel syndrome
didanosine,BXZVVICBKDXVGW-NKWVEPMBSA-N,Launched,nucleoside reverse transcriptase inhibitor,PNP,infectious disease,human immunodeficiency virus (HIV-1)
dideoxyadenosine,WVXRAFOPTSTNLL-NKWVEPMBSA-N,Phase 1,nucleoside reverse transcriptase inhibitor,,,
didox,QJMCKEPOKRERLN-UHFFFAOYSA-N,Launched,ribonucleotide reductase inhibitor,RRM1,oncology,breast cancer
dienestrol,NFDFQCUYFHCNBW-SCGPFSFSSA-N,Launched,estrogen receptor agonist,ESR1,endocrinology,menopause
dienogest,AZFLJNIPTRTECV-FUMNGEBKSA-N,Launched,progesterone receptor agonist,PGR,endocrinology|obstetrics/gynecology,contraceptive|endometriosis
diethylcarbamazine,RCKMWOKWVGPNJF-UHFFFAOYSA-N,Launched,lipoxygenase inhibitor,ALOX5|PTGS1,infectious disease,filariasis
diethylstilbestrol,RGLYKWWBQGJZGM-ISLYRVAYSA-N,Withdrawn,estrogen receptor agonist,ESR1|ESR2|ESRRB|ESRRG,,
diethyltoluamide,MMOXZBCLCQITDF-UHFFFAOYSA-N,Launched,ionotropic receptor IR40a activator,,dermatology,sunscreen lotion
difenpiramide,PWHROYKAGRUWDQ-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor|prostaglandin inhibitor,,neurology/psychiatry,pain relief
diflorasone-diacetate,BOBLHFUVNSFZPJ-OAEHMYPASA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
difloxacin,NOCJXYPHIIZEHN-UHFFFAOYSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,skin infections|urinary tract infections
diflunisal,HUPFGZXOMWLGNK-UHFFFAOYSA-N,Launched,prostanoid receptor antagonist,PTGS1|PTGS2,rheumatology,rheumatoid arthritis|osteoarthritis
difluprednate,WYQPLTPSGFELIB-JTQPXKBDSA-N,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology,endogenous uveitis
diftalone,CXSJGNHRBWJXEA-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,,endocrinology,thyroiditis
digitoxigenin,XZTUSOXSLKTKJQ-CESUGQOBSA-N,Preclinical,ATPase inhibitor,ATP1A1,,
digitoxin,WDJUZGPOPHTGOT-XUDUSOBPSA-N,Launched,ATPase inhibitor,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,cardiology,congestive heart failure|cardiac arrythmia
digoxigenin,SHIBSTMRCDJXLN-KCZCNTNESA-N,Preclinical,steroid,,,
digoxin,LTMHDMANZUZIPE-SYUUTQQWSA-N,Launched,ATPase inhibitor,ATP1A1,cardiology,congestive heart failure|atrial fibrillation (AF)
dihomo-gamma-linolenic-acid,HOBAELRKJCKHQD-QNEBEIHSSA-N,Phase 2,prostanoid receptor agonist,PTGS1|PTGS2,,
dihydrexidine,BGOQGUHWXBGXJW-RHSMWYFYSA-N,Phase 2,dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|DRD5,,
dihydroartemisinin,BJDCWCLMFKKGEE-ISOSDAIHSA-N,Launched,antimalarial agent,,infectious disease,malaria
dihydroergocristine,DEQITUUQPICUMR-HJPBWRTMSA-N,Launched,adrenergic receptor antagonist|prolactin inhibitor,ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7,neurology/psychiatry,senile dementia|cerebrovascular insufficiency
dihydroergotamine,LUZRJRNZXALNLM-JGRZULCMSA-N,Launched,serotonin receptor agonist,ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,neurology/psychiatry,migraine headache
dihydromyricetin,KJXSIXMJHKAJOD-LSDHHAIUSA-N,Preclinical,,,,
dihydrostreptomycin,DLNWBHHJUACHNB-SNGKZNBCSA-N,Withdrawn,bacterial 30S ribosomal subunit inhibitor,,,
dihydrotachysterol,ILYCWAKSDCYMBB-CEQNRCNESA-N,Launched,vitamin analog,VDR,orthopedics|endocrinology,rickets|hypocalcemia|osteomalacia
dihydroxyacetone,RXKJFZQQPQGTFL-UHFFFAOYSA-N,Launched,,,dermatology,skin protectant
dihydroxyphenylglycine,HOOWCUZPEFNHDT-SSDOTTSWSA-N,Preclinical,glutamate receptor agonist,GRM1|GRM5,,
diiodothyropropionic-acid,WONYMNWUJVKVII-UHFFFAOYSA-N,Phase 2,thyroid hormone stimulant,,,
dilazep,QVZCXCJXTMIDME-UHFFFAOYSA-N,Launched,adenosine reuptake inhibitor,SLC29A1,cardiology,coronary heart disease
dilmapimod,ORVNHOYNEHYKJG-UHFFFAOYSA-N,Phase 1,p38 MAPK inhibitor,,,
diloxanide,BDYYDXJSHYEDGB-UHFFFAOYSA-N,Launched,protein synthesis inhibitor,,infectious disease,amebiasis
diltiazem,HSUGRBWQSSZJOP-RTWAWAEBSA-N,Launched,calcium channel blocker,CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5,cardiology,hypertension|angina pectoris
DIM-C-pPhCO2Me,BBAOKSZCULLDIW-UHFFFAOYSA-N,Preclinical,nuclear receptor antagonist,,,
dimaprit,OLHQOJYVQUNWPL-UHFFFAOYSA-N,Preclinical,histamine receptor agonist,HRH2|HRH3|HRH4,,
dimemorfan,KBEZZLAAKIIPFK-NJAFHUGGSA-N,Launched,sigma receptor agonist,SIGMAR1,pulmonary,cough suppressant
dimenhydrinate,NFLLKCVHYJRNRH-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,neurology/psychiatry|gastroenterology,motion sickness|nausea|vomiting
dimercaprol,WQABCVAJNWAXTE-GSVOUGTGSA-N,Launched,chelating agent,,neurology/psychiatry,metal toxicity
dimercaptosuccinic-acid,ACTRVOBWPAIOHC-XIXRPRMCSA-N,Launched,chelating agent,DNMT1,neurology/psychiatry,metal toxicity
dimesna,BYUKOOOZTSTOOH-UHFFFAOYSA-N,Phase 3,tubulin polymerization inhibitor,,,
dimethadione,JYJFNDQBESEHJQ-UHFFFAOYSA-N,Preclinical,oxazolidine antiepileptic,,,
dimethicone,UQEAIHBTYFGYIE-UHFFFAOYSA-N,Launched,,,dermatology,cosmetic
dimethindene-(S)-(+),MVMQESMQSYOVGV-OAHLLOKOSA-N,Preclinical,acetylcholine receptor antagonist,HRH1,,
dimethisoquin,XNMYNYSCEJBRPZ-UHFFFAOYSA-N,Launched,local anesthetic,,neurology/psychiatry,local anesthetic
dimethyl-fumarate,LDCRTTXIJACKKU-ONEGZZNKSA-N,Launched,nuclear factor erythroid derived|like (NRF2) activator,KEAP1,neurology/psychiatry,multiple sclerosis
dimethyl-isosorbide,MEJYDZQQVZJMPP-YWIQKCBGSA-N,Preclinical,cosmetic moisturizer,,,
dimetindene,MVMQESMQSYOVGV-OAHLLOKOSA-N,Launched,cholinergic receptor antagonist|histamine receptor antagonist,HRH1,allergy,allergic rhinitis
dimetridazole,IBXPYPUJPLLOIN-UHFFFAOYSA-N,Launched,bacterial DNA inhibitor,,infectious disease,protozoan infection
diminazene-aceturate,XNYZHCFCZNMTFY-UHFFFAOYSA-N,Phase 3,angiotensin converting enzyme activator,AOC1|PRDX5|PRSS1,,
dimpylate,FHIVAFMUCKRCQO-UHFFFAOYSA-N,Launched,acetylcholinesterase inhibitor,ACHE,infectious disease,flea control
dinaciclib,PIMQWRZWLQKKBJ-SFHVURJKSA-N,Phase 3,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,,
dinaciclib,"InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1",Phase 3,CDK inhibitor,CDK1|CDK2|CDK5|CDK9,,
dinitolmide,ZEFNOZRLAWVAQF-UHFFFAOYSA-N,Launched,,,infectious disease,coccidiosis
dinoprost,PXGPLTODNUVGFL-YNNPMVKQSA-N,Launched,prostacyclin analog,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,obstetrics/gynecology,labor induction
dinoprostone,XEYBRNLFEZDVAW-ARSRFYASSA-N,Withdrawn,prostanoid receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R,,
dioscin,VNONINPVFQTJOC-ZGXDEBHDSA-N,Preclinical,apoptosis stimulant,CXCR3,,
diosgenin,WQLVFSAGQJTQCK-VKROHFNGSA-N,Preclinical,steroid,,,
diosmetin,MBNGWHIJMBWFHU-UHFFFAOYSA-N,Launched,aryl hydrocarbon receptor agonist,CYP1B1,dermatology,cosmetic
diosmin,GZSOSUNBTXMUFQ-YFAPSIMESA-N,Launched,aryl hydrocarbon receptor agonist|capillary stabilizing agent,AHR,cardiology|hematology|dermatology,chronic venous insufficiency (CVI)|edema|deep vein thrombosis (DVT)|statis dermatitis|heavy leg syndrome
dioxybenzone,MEZZCSHVIGVWFI-UHFFFAOYSA-N,Preclinical,topical sunscreen agent,,,
dipeptamin,HJCMDXDYPOUFDY-WHFBIAKZSA-N,Launched,,,,
diperodon,YUGZHQHSNYIFLG-HXUWFJFHSA-N,Preclinical,local anesthetic,,,
diphemanil,LCTZPQRFOZKZNK-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM3,neurology/psychiatry,spasms
diphencyprone,HCIBTBXNLVOFER-UHFFFAOYSA-N,Phase 2,immunostimulant,,,
diphenhydramine,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,neurology/psychiatry,headache
diphenidol,OGAKLTJNUQRZJU-UHFFFAOYSA-N,Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,neurology/psychiatry,vertigo
diphenyleneiodonium,ZSZPLBNCHKXQRY-UHFFFAOYSA-N,Preclinical,nitric oxide synthase inhibitor,NOS2|NOS3,,
diphenylguanidine,OWRCNXZUPFZXOS-UHFFFAOYSA-N,Preclinical,,,,
diphenylpyraline,OWQUZNMMYNAXSL-UHFFFAOYSA-N,Launched,dopamine reuptake inhibitor,HRH1|SLC6A3,allergy,allergic rhinitis
dipivefrine,OCUJLLGVOUDECM-CYBMUJFWSA-N,Launched,adrenergic receptor agonist,,ophthalmology,glaucoma|intraocular pressure
dipraglurant,LZXMUJCJAWVHPZ-UHFFFAOYSA-N,Phase 2,glutamate receptor negative allosteric modulator,GRM5,,
DIPT,ZRVAAGAZUWXRIP-UHFFFAOYSA-N,Launched,dopamine reuptake inhibitor|serotonin reuptake inhibitor,HTR1A|HTR2A|HTR2C,,
dipyridamole,IZEKFCXSFNUWAM-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1,cardiology,coronary artery disease (CAD)|peripheral artery disease (PAD)|hypertension
dipyrocetyl,NYIZXMGNIUSNKL-UHFFFAOYSA-N,Launched,chelating agent,,endocrinology|neurology/psychiatry,fever|pain relief
diquafosol,NMLMACJWHPHKGR-NCOIDOBVSA-N,Phase 3,purinergic receptor activator,,,
dirithromycin,WLOHNSSYAXHWNR-FDEBZETHSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,pulmonary,bronchitis
diroximel-fumarate,YIMYDTCOUQIDMT-SNAWJCMRSA-N,Phase 3,anti-inflammatory agent,,,
disodium-sebacate,CXMXRPHRNRROMY-UHFFFAOYSA-N,Phase 1,,HBB,,
disopyramide,UVTNFZQICZKOEM-UHFFFAOYSA-N,Launched,sodium channel blocker,CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A,cardiology,ventricular tachycardia (VT)|ventricular arrhythmias
disulfiram,AUZONCFQVSMFAP-UHFFFAOYSA-N,Launched,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist,ALDH2|DBH,neurology/psychiatry,abstinence from alcohol
dithranol,YUTJCNNFTOIOGT-UHFFFAOYSA-N,Launched,DNA synthesis inhibitor,,dermatology,psoriasis
ditiocarb-sodium-trihydrate,LMBWSYZSUOEYSN-UHFFFAOYSA-N,Phase 3,immunostimulant,CA1|CA2|CA4,,
ditolylguanidine,OPNUROKCUBTKLF-UHFFFAOYSA-N,Preclinical,sigma receptor agonist,GRIN1|GRIN2A|GRIN2B|SIGMAR1,,
dixanthogen,FVIGODVHAVLZOO-UHFFFAOYSA-N,Preclinical,,,,
dixyrazine,MSYUMPGNGDNTIQ-HXUWFJFHSA-N,Preclinical,antipsychotic,,,
dizocilpine-(-),LBOJYSIDWZQNJS-JKSUJKDBSA-N,Phase 1,glutamate receptor antagonist,,,
dizocilpine-(+),LBOJYSIDWZQNJS-CVEARBPZSA-N,Preclinical,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
DMAB-anabaseine,KHUUTHZSRXABAC-DTQAZKPQSA-N,Preclinical,adrenergic receptor agonist,CHRNA7,,
DMeOB,FBNPHFBYHYNMHC-JYFOCSDGSA-N,Preclinical,glutamate receptor modulator,GRM5,,
DMH1,JMIFGARJSWXZSH-UHFFFAOYSA-N,Preclinical,ALK tyrosine kinase receptor inhibitor,ACVR1,,
DMH4,SKZQZGSPYYHTQG-UHFFFAOYSA-N,Preclinical,VEGFR inhibitor,KDR,,
DMNB,YWSPWKXREVSQCA-UHFFFAOYSA-N,Preclinical,DNA dependent protein kinase inhibitor,,,
DMP-543,MUJBUUDUXGDXLW-UHFFFAOYSA-N,Phase 2,acetylcholine release enhancer,,,
DMP-777,ZSDCIRYNTCVTMF-GIGWZHCTSA-N,Phase 2,elastase inhibitor,MPO,,
DMPS,JLVSRWOIZZXQAD-VKHMYHEASA-N,Phase 1,chelating agent,,,
DMSO,CETRZFQIITUQQL-UHFFFAOYSA-N,Preclinical,control vehicle,,,
DNQX,RWVIMCIPOAXUDG-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIA1|GRIA2|GRIK1|GRIN1|GRIN2A|GRIN2B,,
dobutamine,JRWZLRBJNMZMFE-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRB1|ADRB2,cardiology,congestive heart failure
docebenone,WDEABJKSGGRCQA-UHFFFAOYSA-N,Phase 2,lipoxygenase inhibitor,ALOX5,,
docetaxel,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,Launched,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,breast cancer|non-small cell lung cancer (NSCLC)|prostate cancer|gastric adenocarcinoma|head and neck squamous cell carcinoma (HNSCC)
doconexent,MBMBGCFOFBJSGT-KUBAVDMBSA-N,Launched,PPAR receptor agonist,FFAR1|PTGS1|PTGS2,,
doconexent-ethyl-ester,ITNKVODZACVXDS-YNUSHXQLSA-N,Launched,omega 3 fatty acid stimulant,,endocrinology,hypertriglyceridemia
docosanol,NOPFSRXAKWQILS-UHFFFAOYSA-N,Launched,lipase clearing factor inhibitor,TLR7,dental,cold sore
docusate,HNSDLXPSAYFUHK-SQNIBIBYSA-N,Launched,laxative,,gastroenterology,constipation
dodecyl-sulfate,MOTZDAYCYVMXPC-UHFFFAOYSA-N,Preclinical,,LYZ,,
dofequidar,KLWUUPVJTLHYIM-UHFFFAOYSA-N,Phase 3,MRP inhibitor|P glycoprotein inhibitor,ABCB1,,
dofetilide,IXTMWRCNAAVVAI-UHFFFAOYSA-N,Withdrawn,potassium channel blocker,KCNH1|KCNH2|KCNJ12|KCNK2,,
dolasetron,UKTAZPQNNNJVKR-YXSUXZIUSA-N,Launched,serotonin receptor antagonist,HTR3A,gastroenterology,nausea|vomiting
dolastatin-10,OFDNQWIFNXBECV-VFSYNPLYSA-N,Phase 2,tubulin polymerization inhibitor,TUBB,,
dolutegravir,RHWKPHLQXYSBKR-BMIGLBTASA-N,Launched,HIV integrase inhibitor,CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1,infectious disease,human immunodeficiency virus (HIV-1)
domiphen,YXUPZGKORWTXID-UHFFFAOYSA-N,Preclinical,,,,
domperidone,FGXWKSZFVQUSTL-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD2|DRD3,infectious disease,fescue toxicosis
donepezil,ADEBPBSSDYVVLD-HXUWFJFHSA-N,Launched,acetylcholinesterase inhibitor,ACHE,neurology/psychiatry,Alzheimer's disease
donitriptan,SOHCKWZVTCTQBG-UHFFFAOYSA-N,Phase 2,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6,,
dopamine,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Launched,dopamine receptor agonist,DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4,cardiology|neurology/psychiatry,ventricular arrhythmias|depression|headache|tremors
doramapimod,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,Phase 2,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK13|MAPK14,,
doramectin,QLFZZSKTJWDQOS-YDBLARSUSA-N,Launched,,,infectious disease,gastrointestinal roundworms
doravirine,ZIAOVIPSKUPPQW-UHFFFAOYSA-N,Launched,non-nucleoside reverse transcriptase inhibitor,,,
doripenem,AVAACINZEOAHHE-VFZPANTDSA-N,Launched,bacterial cell wall synthesis inhibitor,DPEP1,infectious disease,intra-abdominal infections|urinary tract infections|pyelonephritis
dorsomorphin,XHBVYDAKJHETMP-UHFFFAOYSA-N,Preclinical,AMPK inhibitor,ACVR1|BMPR1A|BMPR1B|EPHA2|FKBP1A|FLT1|FLT3|KDR|LCK|MKNK1|PRKAA1|RPS6KA1|SRC,,
dorsomorphin,"InChI=1S/C24H25N5O/c1-2-12-28(13-3-1)14-15-30-22-6-4-19(5-7-22)21-16-26-24-23(17-27-29(24)18-21)20-8-10-25-11-9-20/h4-11,16-18H,1-3,12-15H2",Preclinical,AMPK inhibitor,ACVR1|BMPR1A|BMPR1B|EPHA2|FKBP1A|FLT1|FLT3|KDR|LCK|MKNK1|PRKAA1|RPS6KA1|SRC,,
dorzolamide,IAVUPMFITXYVAF-XPUUQOCRSA-N,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,ophthalmology,intraocular pressure|glaucoma
dosulepin,PHTUQLWOUWZIMZ-GZTJUZNOSA-N,Launched,norepinephrine reuptake inhibitor|serotonin–norepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4,neurology/psychiatry,depression
DOTMP,RCXMQNIDOFXYDO-UHFFFAOYSA-N,Preclinical,,,,
dovitinib,PIQCTGMSNWUMAF-UHFFFAOYSA-N,Phase 3,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB,,
doxapram,XFDJYSQDBULQSI-JOCHJYFZSA-N,Launched,potassium channel blocker,,pulmonary|neurology/psychiatry,respiratory depression|central nervous system depression|acute hypercapnia (AHC)
doxazosin,RUZYUOTYCVRMRZ-HXUWFJFHSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension
doxepin,ODQWQRRAPPTVAG-BOPFTXTBSA-N,Launched,histamine receptor antagonist,HRH1|SLC6A2|SLC6A4,neurology/psychiatry,depression|anxiety
doxercalciferol,HKXBNHCUPKIYDM-ZKVKAWQFSA-N,Launched,vitamin D receptor agonist,VDR,nephrology|endocrinology,chronic kidney disease (CKD)|hyperparathyroidism
doxifluridine,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,Launched,thymidylate synthase inhibitor,TYMS,oncology,colorectal cancer
doxofylline,HWXIGFIVGWUZAO-UHFFFAOYSA-N,Launched,adenosine receptor antagonist,ADORA1|PDE4A|PDE4B|PDE4C|PDE4D,pulmonary,asthma
doxorubicin,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Launched,topoisomerase inhibitor,TOP2A,hematologic malignancy|oncology,acute lymphoblastic leukemia (ALL)|acute myeloid leukemia (AML)|Wilm's tumor|breast cancer|ovarian cancer|Hodgkin's lymphoma|bladder cancer|multiple myeloma
doxycycline,JBIWCJUYHHGXTC-AKNGSSGZSA-N,Launched,bacterial 30S ribosomal subunit inhibitor|metalloproteinase inhibitor,MMP8,dental,periodontitis
doxylamine,HCFDWZZGGLSKEP-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,neurology/psychiatry,sedative
DpC,GNLZNQJBZNOUBM-UHFFFAOYSA-N,Phase 1,,,,
DPC-681,PNIFFZXGBAYVMQ-RKKDRKJOSA-N,Phase 1,HIV protease inhibitor,,,
DPCPX,FFBDFADSZUINTG-UHFFFAOYSA-N,Phase 1,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
DPI-201106,BYBYHCOEAFHGJL-RUZDIDTESA-N,Phase 2,sodium channel activator,ADRB2,,
DPO-1,BPCNGVCAHAIZEE-COPCDDAFSA-N,Preclinical,potassium channel blocker,KCNA5,,
DPPE,NFIXBCVWIPOYCD-UHFFFAOYSA-N,Phase 3,histamine receptor antagonist,ABCB1|HRH1,,
DQP-1105,MVYNQMRZRULRIE-DEOSSOPVSA-N,Preclinical,glutamate receptor antagonist,GRIN2C|GRIN2D,,
DR-2313,HRYKZAKEAVZGJD-UHFFFAOYSA-N,Preclinical,PARP inhibitor,PARP1|PARP3,,
DR-4485,SBTRHJHOLCAPFT-AREMUKBSSA-N,Preclinical,serotonin receptor antagonist,HTR7,,
DRF053-(R),LWANFAFTTOKZAX-QGZVFWFLSA-N,Preclinical,CDK inhibitor,CSNK1A1,,
drofenine,AGJBLWCLQCKRJP-LJQANCHMSA-N,Launched,,,neurology/psychiatry,spasms
droloxifene,ZQZFYGIXNQKOAV-OCEACIFDSA-N,Phase 3,selective estrogen receptor modulator (SERM),ESR1,,
dromostanolone-propionate,NOTIQUSPUUHHEH-QOMQUSCHSA-N,Launched,androgen receptor modulator,AR,oncology,breast cancer
dronedarone,ZQTNQVWKHCQYLQ-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A,cardiology,atrial fibrillation (AF)
droperidol,RMEDXOLNCUSCGS-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,ADRA1A|DRD2|DRD3|DRD4|HTR2A,gastroenterology,nausea|vomiting
dropropizine,PTVWPYVOOKLBCG-ZDUSSCGKSA-N,Launched,antitussive,,pulmonary,cough suppressant
drospirenone,METQSPRSQINEEU-HXCATZOESA-N,Launched,mineralocorticoid receptor antagonist,AR|NR3C2|PGR,endocrinology,contraceptive
drotaverine,NCVXEYAKRVJMTQ-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,,obstetrics/gynecology,labor induction
droxicam,OEHFRZLKGRKFAS-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1,rheumatology,rheumatoid arthritis|osteoarthritis
droxidopa,QXWYKJLNLSIPIN-JGVFFNPUSA-N,Launched,norepinephrine precursor,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH,cardiology|neurology/psychiatry,hypertension|Parkinson's Disease
droxinostat,JHSXDAWGLCZYSM-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC6|HDAC8,,
DS2-(806622),AZKMWHRDICVYEI-UHFFFAOYSA-N,Preclinical,,,,
DSM265,OIZSVTOIBNSVOS-UHFFFAOYSA-N,Phase 2,dihydroorotate dehydrogenase inhibitor,,,
DSPC,NRJAVPSFFCBXDT-WBCKFURZSA-O,Preclinical,,,,
DSR-6434,SSZHESNDOMBSRV-UHFFFAOYSA-N,Preclinical,toll-like receptor agonist,TLR7,,
DU-728,NNRFRJQMBSBXGO-CIUDSAMLSA-N,Phase 1,structural glycoprotein antagonist,ITGA2B|ITGB3,,
duloxetine,ZEUITGRIYCTCEM-KRWDZBQOSA-N,Launched,norepinephrine reuptake inhibitor|serotonin–norepinephrine reuptake inhibitor (SNRI),HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression|generalized anxiety disorder (GAD)|muscle pain|peripheral neuropathy
DUP-697,AJFTZWGGHJXZOB-UHFFFAOYSA-N,Phase 1,cyclooxygenase inhibitor,PTGS2,,
dutasteride,JWJOTENAMICLJG-QWBYCMEYSA-N,Launched,5 alpha reductase inhibitor,SRD5A1|SRD5A2|SRD5A3,urology,benign prostatic hyperplasia (BPH)
duvelisib,SJVQHLPISAIATJ-ZDUSSCGKSA-N,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
DVD-111,PJNSMUBMSNAEEN-AWEZNQCLSA-N,Phase 2,,,,
DWK-1339,CUEPJIGXQLIOIK-UHFFFAOYSA-N,Preclinical,beta amyloid aggregation inhibitor,,,
DY131,WLKOCYWYAWBGKY-CPNJWEJPSA-N,Preclinical,estrogen-related receptor agonist,ESRRB|ESRRG,,
dyclonine,BZEWSEKUUPWQDQ-UHFFFAOYSA-N,Launched,sodium channel blocker,SCN10A|SCN5A,neurology/psychiatry,local anesthetic
dydrogesterone,JGMOKGBVKVMRFX-HQZYFCCVSA-N,Launched,progesterone receptor agonist,PGR,obstetrics/gynecology,infertility
dynasore,SYNDQCRDGGCQRZ-VXLYETTFSA-N,Preclinical,dynamin inhibitor,DNM1|DNM1L|DNM2,,
dynole-34-2,MYIMRONQBLZJFI-DYTRJAOYSA-N,Preclinical,dynamin inhibitor,DNM1,,
dyphylline,KSCFJBIXMNOVSH-ZCFIWIBFSA-N,Launched,adenosine receptor antagonist|phosphodiesterase inhibitor,PDE4A,pulmonary,asthma|bronchitis|emphysema
E-2001,WPFPDSUMDURRRW-UHFFFAOYSA-N,Preclinical,antioxidant,,,
E-2012,PUOAETJYKQITMO-LANLRWRYSA-N,Phase 1,gamma secretase modulator,APH1A|APH1B|PSENEN,,
E-4031,SRUISGSHWFJION-UHFFFAOYSA-N,Phase 1,potassium channel blocker,KCNH1|KCNH2,,
E-64,LTLYEAJONXGNFG-DCAQKATOSA-N,Preclinical,calpain inhibitor|cysteine protease inhibitor,CTSS,,
E3330,AALSSIXXBDPENJ-FYWRMAATSA-N,Preclinical,NFkB pathway inhibitor,,,
E7046,MKLKAQMPKHNQPR-NSHDSACASA-N,Phase 1,prostanoid receptor antagonist,,,
E7449,JLFSBHQQXIAQEC-UHFFFAOYSA-N,Phase 2,PARP inhibitor,PARP1|PARP2|TNKS|TNKS2,,
E7820,LWGUASZLXHYWIV-UHFFFAOYSA-N,Phase 2,angiogenesis inhibitor,,,
eact,ZUXNHFFVQWADJL-UHFFFAOYSA-N,Preclinical,calcium-activated chloride channel inhibitor,ANO1,,
EB-47,DDFLFKTXUWPNMV-LFALDJFMSA-N,Preclinical,PARP inhibitor,PARP1,,
ebastine,MJJALKDDGIKVBE-UHFFFAOYSA-N,Launched,histamine receptor antagonist,CYP3A4|HRH1,allergy,allergic rhinitis|urticaria
EBPC,FQMSSTZJKSWSMP-LLVKDONJSA-N,Preclinical,aldose reductase inhibitor,AKR1B1,,
ebrotidine,ZQHFZHPUZXNPMF-UHFFFAOYSA-N,Withdrawn,histamine receptor antagonist,HRH2,,
ebselen,DYEFUKCXAQOFHX-UHFFFAOYSA-N,Phase 2/Phase 3,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,ALB,,
EC-144,VOASEWXFCTZRDF-UHFFFAOYSA-N,Preclinical,HSP inhibitor,HSP90AA1|HSP90AB1,,
EC-23,OQVLOWLEEHYBJH-UHFFFAOYSA-N,Preclinical,retinoid receptor agonist,RARA|RARB|RARG,,
ecabapide,JTAGHJPZEDNHHA-UHFFFAOYSA-N,Phase 3,,,,
ecabet,IWCWQNVIUXZOMJ-MISYRCLQSA-N,Launched,gastrin inhibitor|urease inhibitor,NOXO1,ophthalmology,dry eye syndrome
ecamsule-triethanolamine,HEAHZSUCFKFERC-MPPVQRIUSA-N,Launched,,,dermatology,skin protectant|sunscreen lotion
echinomycin,AUJXLBOHYWTPFV-DYWXRLDNSA-N,Phase 2,DNA intercalating agent,,,
econazole,LEZWWPYKPKIXLL-SFHVURJKSA-N,Launched,lanosterol demethylase inhibitor|sterol demethylase inhibitor,NPY1R|NPY2R|TRPM2|TRPV5,infectious disease,tinea pedis|tinea cruris|tinea corporis|tinea versicolor|cutaneous candidiasis
ectoine,WQXNXVUDBPYKBA-YFKPBYRVSA-N,Launched,anti-inflammatory agent,,,
edaglitazone,HAAXAFNSRADSMK-FQEVSTJZSA-N,Phase 2,PPAR receptor agonist,PPARG,,
edaravone,KZQYIMCESJLPQH-UHFFFAOYSA-N,Launched,nootropic agent,BCL2,neurology/psychiatry,stroke
edasalonexent,JQLBBYLGWHUHRW-KUBAVDMBSA-N,Phase 3,NFkB pathway inhibitor,,,
edelfosine,MHFRGQHAERHWKZ-HHHXNRCGSA-O,Phase 2,phospholipase inhibitor,,,
editol,NSOXQYCFHDMMGV-AAVRWANBSA-N,Preclinical,,,,
EDO-S101,GISXTRIGVCKQBX-UHFFFAOYSA-N,Phase 1/Phase 2,HDAC inhibitor,,,
edonerpic-maleate,HQNACSFBDBYLJP-UHFFFAOYSA-N,Preclinical,beta amyloid inhibitor,,,
edoxaban,HGVDHZBSSITLCT-JLJPHGGASA-N,Launched,coagulation factor inhibitor,F10,neurology/psychiatry|hematology|cardiology,stroke|pulmonary embolism (PE)|systemic embolism|deep vein thrombosis (DVT)|atrial fibrillation (AF)
edoxudine,XACKNLSZYYIACO-DJLDLDEBSA-N,Launched,DNA directed DNA polymerase inhibitor,,infectious disease,virus herpes simplex (HSV)
edrophonium,VWLHWLSRQJQWRG-UHFFFAOYSA-O,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,neurology/psychiatry,myasthenia gravis
EDTMP,NFDRPXJGHKJRLJ-UHFFFAOYSA-N,Preclinical,chelating agent,,,
EED226,DYIRSNMPIZZNBK-UHFFFAOYSA-N,Preclinical,polycomb protein inhibitor,EED,,
EF5,JGGDSDPOPRWSCX-UHFFFAOYSA-N,Phase 2,cytochrome P450 activator,,,
efaproxiral,BNFRJXLZYUTIII-UHFFFAOYSA-N,Phase 3,hemoglobin oxygen release stimulant,HBA1|HBB,,
efaroxan,RATZLMXRALDSJW-UHFFFAOYSA-N,Phase 2,adrenergic receptor antagonist,ADORA2A,,
efatutazone,JCYNMRJCUYVDBC-HSZRJFAPSA-N,Phase 2,PPAR receptor agonist,PPARG,,
efavirenz,XPOQHMRABVBWPR-ZDUSSCGKSA-N,Launched,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4,infectious disease,human immunodeficiency virus (HIV-1)
efinaconazole,NFEZZTICAUWDHU-KDOFPFPSSA-N,Launched,lanosterol demethylase inhibitor,CYP51A1,infectious disease,onychomycosis
efletirizine,BAWMMJAUVBLLEE-UHFFFAOYSA-N,Phase 3,antihistamine,,,
eflornithine,VLCYCQAOQCDTCN-UHFFFAOYSA-N,Launched,ornithine decarboxylase inhibitor,ARG2|ODC1,dermatology,facial hair reduction
efloxate,ZVXBAHLOGZCFTP-UHFFFAOYSA-N,Preclinical,vasodilator,,,
efonidipine,NSVFSAJIGAJDMR-HKBQPEDESA-N,Launched,calcium channel blocker,,cardiology,hypertension
EG00229,ZWWMEDURALZMEV-NSHDSACASA-N,Preclinical,neuropilin receptor antagonist,NRP1,,
EGF816,IOMMMLWIABWRKL-WUTDNEBXSA-N,Phase 2,EGFR inhibitor,EGFR,,
eglumetad,VTAARTQTOOYTES-RGDLXGNYSA-N,Phase 2,glutamate receptor agonist,GRM2|GRM3|GRM6|GRM8,,
EHop-016,AFTZZRFCMOAFCR-UHFFFAOYSA-N,Preclinical,Ras GTPase inhibitor,RAC1|RAC3,,
EHop-016,"InChI=1S/C25H30N6O/c1-2-31-22-7-4-3-6-20(22)21-18-19(8-9-23(21)31)28-24-10-12-27-25(29-24)26-11-5-13-30-14-16-32-17-15-30/h3-4,6-10,12,18H,2,5,11,13-17H2,1H3,(H2,26,27,28,29)",Preclinical,Ras GTPase inhibitor,RAC1|RAC3,,
EI1,PFHDWRIVDDIFRP-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EZH2,,
EIPA,QDERNBXNXJCIQK-UHFFFAOYSA-N,Preclinical,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,ADRA2A|ASIC1|PKD2L1,,
EIT-hydrobromide,VFIZBHJTOHUOEK-UHFFFAOYSA-N,Preclinical,nitric oxide synthase inhibitor,NOS2|NOS3,,
elacestrant,SIFNOOUKXBRGGB-AREMUKBSSA-N,Phase 3,estrogen receptor degrader,,,
elacridar,OSFCMRGOZNQUSW-UHFFFAOYSA-N,Phase 1,P glycoprotein inhibitor,ABCB1,,
elactocin,YACHGFWEQXFSBS-ZNDZZNGASA-N,Phase 1,exportin antagonist,XPO1,,
elacytarabine,FLFGNMFWNBOBGE-FNNZEKJRSA-N,Phase 3,antineoplastic agent,DCK,,
elafibranor,AFLFKFHDSCQHOL-IZZDOVSWSA-N,Phase 3,PPAR receptor agonist,PPARA|PPARD|PPARG,,
elagolix,HEAUOKZIVMZVQL-VWLOTQADSA-N,Launched,gonadotropin releasing factor hormone receptor antagonist,GNRHR,,
elbasvir,BVAZQCUMNICBAQ-PZHYSIFUSA-N,Launched,HCV inhibitor,,infectious disease,hepatitis C
eldecalcitol,FZEXGDDBXLBRTD-AYIMTCTASA-N,Phase 3,bone formation stimulant,VDR,,
eleclazine,YNUAEEJQYHYLMS-UHFFFAOYSA-N,Phase 3,late sodium current inhibitor,,,
elemene,OPFTUNCRGUEPRZ-RBSFLKMASA-N,Phase 3,VEGFR inhibitor,,,
elesclomol,BKJIXTWSNXCKJH-UHFFFAOYSA-N,Phase 3,oxidative stress inducer,HSPA1A,,
eletriptan,PWVXXGRKLHYWKM-LJQANCHMSA-N,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7,neurology/psychiatry,migraine headache
eliglustat,FJZZPCZKBUKGGU-AUSIDOKSSA-N,Launched,glycosyl transferase inhibitor,UGCG,hematology,Gaucher disease
elinogrel,LGSDFTPAICUONK-UHFFFAOYSA-N,Phase 2,purinergic receptor antagonist,P2RY12,,
eliprodil,GGUSQTSTQSHJAH-FQEVSTJZSA-N,Phase 3,glutamate receptor antagonist,GRIN1|GRIN2B,,
ellagic-acid,AFSDNFLWKVMVRB-UHFFFAOYSA-N,Phase 2,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK,,
ELN-441958,ARYQHSWJGHCGJS-UHFFFAOYSA-N,Preclinical,bradykinin receptor antagonist,BDKRB1,,
eltanexor,JFBAVWVBLRIWHM-MLPAPPSSSA-N,Preclinical,exportin inhibitor,,,
eltanolone,AURFZBICLPNKBZ-YZRLXODZSA-N,Phase 3,GABA receptor positive allosteric modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2,,
eltoprazine,WVLHGCRWEHCIOT-UHFFFAOYSA-N,Phase 2,serotonin receptor agonist,HTR1A|HTR1B,,
eltrombopag,XDXWLKQMMKQXPV-QYQHSDTDSA-N,Launched,thrombopoietin receptor agonist,MPL,hematology|infectious disease,anemia|hepatitis C|thrombocytopenia
eluxadoline,QFNHIDANIVGXPE-FNZWTVRRSA-N,Launched,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,gastroenterology,irritable bowel syndrome
elvitegravir,JUZYLCPPVHEVSV-LJQANCHMSA-N,Launched,HIV integrase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
emamectin,DXIOOXFZLKCVHK-HGIWSLISSA-N,Preclinical,GABA receptor agonist,,,
embelin,HQWGBIUMYSOPFP-UHFFFAOYSA-N,Preclinical,HCV inhibitor|XIAP inhibitor,XIAP,,
EMD-1214063,AHYMHWXQRWRBKT-UHFFFAOYSA-N,Phase 2,hepatocyte growth factor receptor inhibitor,MET,,
EMD-386088,BPPGPYJBCVXILI-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR6,,
EMD-53998,IZLRMTJLQCLMKF-CYBMUJFWSA-N,Phase 1,phosphodiesterase inhibitor,TNNC1,,
EMD-66684,CQVJTTOZTTVVBK-UHFFFAOYSA-N,Preclinical,angiotensin receptor antagonist,AGTR1,,
EMD534085,MARIUIDCPUZLKZ-FUKQBSRTSA-N,Preclinical,kinesin inhibitor,,,
emedastine,KBUZBQVCBVDWKX-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis
emeramide,JUTBAVRYDAKVGQ-UHFFFAOYSA-N,Phase 2,antioxidant,,,
emetine,AUVVAXYIELKVAI-CKBKHPSWSA-N,Phase 2,protein synthesis inhibitor,RPS2,,
emiglitate,NWWORXYTJRPSMC-QKPAOTATSA-N,Preclinical,alpha glucoside inhibitor,,,
emixustat,WJIGGYYSZBWCGC-MRXNPFEDSA-N,Phase 3,retinoid isomerohydrolase inhibitor,,,
emodepside,ZMQMTKVVAMWKNY-CZOLZNPPSA-N,Phase 1,nematocide,,,
emodin,RHMXXJGYXNZAPX-UHFFFAOYSA-N,Preclinical,11-beta hydroxysteroid dehydrogenase inhibitor,CSNK2A1,,
emorfazone,URJQOOISAKEBKW-UHFFFAOYSA-N,Launched,anti-inflammatory agent|cyclooxygenase inhibitor,,dental,mouth inflammation
emoxipin,JPGDYIGSCHWQCC-UHFFFAOYSA-N,Phase 3,,,,
empagliflozin,OBWASQILIWPZMG-QZMOQZSNSA-N,Launched,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,endocrinology,diabetes mellitus
emricasan,SCVHJVCATBPIHN-SJCJKPOMSA-N,Phase 2,caspase inhibitor,CASP1|CASP3|CASP7,,
emtricitabine,XQSPYNMVSIKCOC-NTSWFWBYSA-N,Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
EN460,RSLFQCNAOMQAIH-WJDWOHSUSA-N,Preclinical,endoplasmic reticulum oxidation inhibitor,ERO1A,,
enalapril,GBXSMTUPTTWBMN-XIRDDKMYSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure|left ventricular systolic dysfunction (LVSD)
enalaprilat,LZFZMUMEGBBDTC-QEJZJMRPSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension
enasidenib,DYLUUSLLRIQKOE-UHFFFAOYSA-N,Launched,isocitrate dehydrogenase inhibitor,IDH1,hematologic malignancy,acute myeloid leukemia (AML)
enbucrilate,JJJFUHOGVZWXNQ-UHFFFAOYSA-N,Launched,,,dermatology,skin lacerations|tissue adhesive
enciprazine,KSQCNASWXSCJTD-QGZVFWFLSA-N,Phase 3,GABA receptor modulator,GABRA1,,
encorafenib,CMJCXYNUCSMDBY-ZDUSSCGKSA-N,Launched,RAF inhibitor,BRAF,oncology,melanoma
endo-IWR-1,ZGSXEXBYLJIOGF-ALFLXDJESA-N,Preclinical,PARP inhibitor,TNKS|TNKS2,,
endoxifen,MHJBZVSGOZTKRH-IZHYLOQSSA-N,Phase 2,estrogen receptor antagonist,ESR1,,
enflurane,JPGQOUSTVILISH-PVQJCKRUSA-N,Launched,membrane permeability inhibitor,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,neurology/psychiatry,anesthetic
enilconazole,PZBPKYOVPCNPJY-CQSZACIVSA-N,Launched,sterol demethylase inhibitor,CYP19A1|CYP1A2|CYP2B6|CYP2C9|CYP2J2|CYP3A4|CYP3A5|NR1I2|PPARA|PTGER2,infectious disease,skin infections
eniluracil,JOZGNYDSEBIJDH-UHFFFAOYSA-N,Phase 3,dihydropyrimidine dehydrogenase inhibitor,AOX1|DPYD|XDH,,
eniporide,UADMBZFZZOBWBB-UHFFFAOYSA-N,Preclinical,sodium/hydrogen antiport inhibitor,,,
enisamium-iodide,QOEJDHLJOKRPJG-UHFFFAOYSA-O,Launched,,,,
ENMD-2076,BLQYVHBZHAISJM-CMDGGOBGSA-N,Phase 2,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,AURKA|FLT3|KDR|PDGFRA|PTK2|SRC,,
enocitabine,SAMRUMKYXPVKPA-VFKOLLTISA-N,Launched,DNA synthesis inhibitor,CMPK1|RRM1|TYMS,hematologic malignancy,acute myeloid leukemia (AML)
enoxacin,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,Launched,topoisomerase inhibitor,TOP2A,infectious disease,urinary tract infections|gonorrhea
enoximone,ZJKNESGOIKRXQY-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE3A,cardiology,congestive heart failure
enoxolone,MPDGHEJMBKOTSU-YKLVYJNSSA-N,Launched,gap junction modulator,HSD11B1,gastroenterology|otolaryngology,peptic ulcer disease (PUD)|common cold
enprofylline,SIQPXVQCUCHWDI-UHFFFAOYSA-N,Phase 3,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B,,
enrofloxacin,SPFYMRJSYKOXGV-UHFFFAOYSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections
entacapone,JRURYQJSLYLRLN-BJMVGYQFSA-N,Launched,catechol O methyltransferase inhibitor,COMT,neurology/psychiatry,Parkinson's Disease
entasobulin,LJIUXAHLYIPHOK-UHFFFAOYSA-N,Preclinical,tubulin polymerization inhibitor,,,
entecavir,QDGZDCVAUDNJFG-FXQIFTODSA-N,Launched,DNA replication inhibitor|nucleoside reverse transcriptase inhibitor,,infectious disease,hepatitis B
entinostat,INVTYAOGFAGBOE-UHFFFAOYSA-N,Phase 3,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC9,,
entrectinib,HAYYBYPASCDWEQ-UHFFFAOYSA-N,Launched,ALK tyrosine kinase receptor inhibitor|proto-oncogene tyrosine protein kinase inhibitor,ALK|NTRK1|NTRK2|NTRK3|ROS1,oncology,non-small cell lung cancer (NSCLC)
enzalutamide,WXCXUHSOUPDCQV-UHFFFAOYSA-N,Launched,androgen receptor antagonist,AR,oncology,prostate cancer
enzastaurin,AXRCEOKUDYDWLF-UHFFFAOYSA-N,Phase 3,PKC inhibitor,AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG,,
EO-1428,HDCLCHNAEZNGNV-UHFFFAOYSA-N,Preclinical,p38 MAPK inhibitor,MAPK11|MAPK14,,
epacadostat,FBKMWOJEPMPVTQ-UHFFFAOYSA-N,Phase 3,"indoleamine 2,3-dioxygenase inhibitor",IDO1,,
epalrestat,CHNUOJQWGUIOLD-NFZZJPOKSA-N,Launched,aldose reductase inhibitor,AKR1B1,nephrology,diabetic nephropathy
eperezolid,SIMWTRCFFSTNMG-AWEZNQCLSA-N,Phase 1,bacterial 30S ribosomal subunit inhibitor,,,
eperisone,SQUNAWUMZGQQJD-AWEZNQCLSA-N,Launched,acetylcholine receptor antagonist,CYP2J2,neurology/psychiatry,amyotrophic lateral sclerosis (ALS)|spasms|head injury|spinal injury
epetraborole,FXQIIDINBDJDKL-SNVBAGLBSA-N,Preclinical,leucyl-tRNA synthetase inhibitor,,,
ephedrine,KWGRBVOPPLSCSI-WPRPVWTQSA-N,Launched,adrenergic receptor agonist,ACHE|ADRA1A|ADRB2|SLC18A2|SLC6A2,cardiology|pulmonary|neurology/psychiatry|endocrinology,hypotension|asthma|narcolepsy|obesity
ephedrine-(racemic),KWGRBVOPPLSCSI-WCBMZHEXSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA2A|ADRB1|ADRB2|ATF1|ATF2|ATF3|ATF4|ATF5|ATF6|ATF7|FOS|IL2|JDP2|JUN|NFATC1|SLC6A2|SLC6A3|SLC6A4|TNF,cardiology|pulmonary|neurology/psychiatry|endocrinology,hypotension|asthma|narcolepsy|obesity
epiandrosterone,QGXBDMJGAMFCBF-LUJOEAJASA-N,Preclinical,steroid,G6PD,,
epicatechin-gallate-(-),LSHVYAFMTMFKBA-TZIWHRDSSA-N,Phase 2,bacterial DNA gyrase inhibitor,BACE1|FASN,,
epiestriol,PROQIPRRNZUXQM-ZMSHIADSSA-N,Preclinical,,,,
epigallocatechin-(-),XMOCLSLCDHWDHP-IUODEOHRSA-N,Phase 2,,,,
epigallocatechin-gallate-(-),WMBWREPUVVBILR-WIYYLYMNSA-N,Phase 2/Phase 3,bacterial DNA gyrase inhibitor,ELANE|EP300|FASN|KAT2B|MMP14|MMP2,,
epinastine,WHWZLSFABNNENI-OAHLLOKOSA-N,Launched,histamine receptor antagonist,HRH1,ophthalmology,conjunctivitis
epinephrine,UCTWMZQNUQWSLP-VIFPVBQESA-N,Launched,adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF,cardiology|allergy|pulmonary,cardiac arrest|anaphylactic shock|asthma
epirizole,RHAXSHUQNIEUEY-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
epirubicin,AOJJSUZBOXZQNB-VTZDEGQISA-N,Launched,topoisomerase inhibitor,CHD1|TOP2A,oncology,breast cancer
epirubicin,"InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1",Launched,topoisomerase inhibitor,CHD1|TOP2A,oncology,breast cancer
epitiostanol,OBMLHUPNRURLOK-XGRAFVIBSA-N,Launched,androgen receptor agonist,AR,oncology,breast cancer
eplerenone,JUKPWJGBANNWMW-VWBFHTRKSA-N,Launched,cytochrome P450 inhibitor,NR3C2,cardiology,congestive heart failure|hypertension
epomediol,JSNQSLSBBZFGBM-XAKJDZQGSA-N,Launched,cholesterol inhibitor,CYP7A1,neurology/psychiatry,itching
epoprostenol,KAQKFAOMNZTLHT-OZUDYXHBSA-N,Launched,prostacyclin analog,P2RY12|PTGER1|PTGER4|PTGIR|PTGIS,cardiology,hypertension
epoprostenol,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1",Launched,prostacyclin analog,P2RY12|PTGER1|PTGER4|PTGIR|PTGIS,cardiology,hypertension
epothilone-A,HESCAJZNRMSMJG-QJCAGBKWSA-N,Preclinical,microtubule stabilizing agent,,,
epothilone-B,QXRSDHAAWVKZLJ-QBNZTRRJSA-N,Phase 3,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,,
epothilone-D,XOZIUKBZLSUILX-HFHFCCBWSA-N,Phase 2,microtubule stabilizing agent|tubulin polymerization inhibitor,TUBB,,
EPPTB,KLFVWQCQUXXLOU-UHFFFAOYSA-N,Preclinical,trace amine associated receptor antagonist,TAAR1,,
eprazinone,BSHWLCACYCVCJE-OFNKIYASSA-N,Launched,mucolytic agent,,pulmonary,bronchospasm
eprinomectin,ZKWQQXZUCOBISE-NQMKODOQSA-N,Launched,benzodiazepine receptor agonist,,infectious disease,gastrointestinal roundworms|lungworms
epristeride,VAPSMQAHNAZRKC-PQWRYPMOSA-N,Preclinical,5 alpha reductase inhibitor,,,
eprobemide,YYFGRAGNYHYWEZ-UHFFFAOYSA-N,Launched,monoamine oxidase inhibitor,MAOA,neurology/psychiatry,depression
eprodisate,MGNVWUDMMXZUDI-UHFFFAOYSA-N,Phase 3,amyloid protein inhibitor|antiamyloidogenic agent,SAA1,,
eprosartan,OROAFUQRIXKEMV-LDADJPATSA-N,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension
eptifibatide,CZKPOZZJODAYPZ-IQENKEMDSA-N,Launched,platelet aggregation inhibitor,ITGA2B|ITGB3,cardiology,acute coronary syndrome (ACS)|percutaneous coronary intervention (PCI)
EPZ-5676,LXFOLMYKSYSZQS-LURJZOHASA-N,Phase 1,histone lysine methyltransferase inhibitor,DOT1L,,
EPZ004777,WXRGFPHDRFQODR-ICLZECGLSA-N,Preclinical,histone lysine methyltransferase inhibitor,DOT1L,,
EPZ005687,ZOIBZSZLMJDVDQ-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EZH2,,
EPZ011989,XQFINGFCBFHOPE-WXUXXXNLSA-N,Preclinical,histone lysine methyltransferase inhibitor,EZH2,,
EPZ015666,ZKXZLIFRWWKZRY-KRWDZBQOSA-N,Preclinical,protein arginine N-methyltransferase inhibitor,PRMT5,,
EPZ020411,QMDKVNSQXPVCRD-RQNOJGIXSA-N,Preclinical,protein arginine N-methyltransferase inhibitor,PRMT6,,
equilin,WKRLQDKEXYKHJB-UWWQBHOKSA-N,Preclinical,estrogen receptor agonist,HSD17B1,,
equol,ADFCQWZHKCXPAJ-GFCCVEGCSA-N,Launched,estrogen receptor agonist,ESR1|ESR2,,
ER-27319,CFPDEQBPNROZDC-UHFFFAOYSA-N,Preclinical,mediator release inhibitor|SYK inhibitor,SYK,,
ER-50891,LSGNKLDHMQVTEK-UHFFFAOYSA-N,Preclinical,retinoid receptor antagonist,RARA,,
erastin,BKQFRNYHFIQEKN-OAQYLSRUSA-N,Preclinical,ion channel antagonist,VDAC2,,
eravacycline,LSZZJAUTRJAFCO-KKCFVTAMSA-N,Launched,antibacterial,,,
erbstatin-analog,BQCNSTFWSKOWMA-GORDUTHDSA-N,Preclinical,EGFR inhibitor|tyrosine kinase inhibitor,EGFR,,
ercalcitriol,ZGLHBRQAEXKACO-XJRQOBMKSA-N,Phase 1,vitamin D receptor agonist,VDR,,
erdafitinib,OLAHOMJCDNXHFI-UHFFFAOYSA-N,Launched,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4,,
erdosteine,QGFORSXNKQLDNO-YFKPBYRVSA-N,Launched,mucolytic agent,,pulmonary|infectious disease,bronchitis|cough suppressant|chronic obstructive pulmonary disease (COPD)|respiratory tract infections
ergocalciferol,MECHNRXZTMCUDQ-RKHKHRCZSA-N,Launched,vitamin analog,VDR,endocrinology|orthopedics,hypoparathyroidism|rickets|hypophosphatemia
ergonovine,WVVSZNPYNCNODU-XTQGRXLLSA-N,Launched,adrenergic receptor agonist|serotonin receptor agonist,ADRA1A|HTR1E,hematology,postpartum hemorrhage (PPH)
ergosterol,DNVPQKQSNYMLRS-APGDWVJJSA-N,Preclinical,vitamin D precursor,,,
ergotamine,XCGSFFUVFURLIX-VFGNJEKYSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|DRD1|DRD2|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|SLC6A2,neurology/psychiatry,migraine headache
eribulin,UFNVPOGXISZXJD-JBQZKEIOSA-N,Launched,microtubule inhibitor,,oncology,breast cancer
ERK5-IN-1,DDTPGANIPBKTNU-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor,MAPK7,,
erlotinib,AAKJLRGGTJKAMG-UHFFFAOYSA-N,Launched,EGFR inhibitor,EGFR|NR1I2,oncology,non-small cell lung cancer (NSCLC)|pancreatic cancer
erlotinib,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)",Launched,EGFR inhibitor,EGFR|NR1I2,oncology,non-small cell lung cancer (NSCLC)|pancreatic cancer
ertapenem,JUZNIMUFDBIJCM-FKTXGUMASA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,intra-abdominal infections|skin infections|pneumonia|urinary tract infections|gynecologic infections|postpartum endomyometritis
erteberel,XIESSJVMWNJCGZ-VKJFTORMSA-N,Phase 2,estrogen receptor agonist,ESR1|ESR2,,
ertugliflozin,MCIACXAZCBVDEE-CUUWFGFTSA-N,Launched,sodium/glucose cotransporter inhibitor,SLC5A2,endocrinology,diabetes mellitus
erythritol,UNXHWFMMPAWVPI-ZXZARUISSA-N,Launched,,,,
erythromycin,ULGZDMOVFRHVEP-BCQGSPHWSA-N,Launched,NFkB pathway inhibitor,MLNR,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma
erythromycin-estolate,TYQXKHPOXXXCTP-JKQIPHDKSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma
erythromycin-ethylsuccinate,NSYZCCDSJNWWJL-ZBFNRKITSA-N,Launched,cytochrome P450 inhibitor|protein synthesis inhibitor,ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma
erythrosine,OALHHIHQOFIMEF-UHFFFAOYSA-N,Preclinical,coloring agent,,,
esaprazole,RTFADALJKSFJDZ-UHFFFAOYSA-N,Phase 2,,,,
esaxerenone,NOSNHVJANRODGR-UHFFFAOYSA-N,Preclinical,mineralocorticoid receptor antagonist,,,
escin,AXNVHPCVMSNXNP-FDGZCRRKSA-N,Launched,nitric oxide synthase stimulant,,dermatology,varicose veins
escitalopram,WSEQXVZVJXJVFP-FQEVSTJZSA-N,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4,neurology/psychiatry,depression|generalized anxiety disorder (GAD)
escitalopram,KTGRHKOEFSJQNS-BDQAORGHSA-N,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4,neurology/psychiatry,depression|generalized anxiety disorder (GAD)
esculin,XHCADAYNFIFUHF-TVKJYDDYSA-N,Phase 1,antioxidant,,,
eseroline-(-),HKGWQUVGHPDEBZ-OLZOCXBDSA-N,Preclinical,acetylcholinesterase inhibitor,OPRD1|OPRM1,,
ESI-09,DXEATJQGQHDURZ-DEDYPNTBSA-N,Preclinical,EPAC inhibitor,RAPGEF3|RAPGEF4,,
eslicarbazepine-acetate,QIALRBLEEWJACW-INIZCTEOSA-N,Launched,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures
esmolol,AQNDDEOPVVGCPG-AWEZNQCLSA-N,Launched,adrenergic receptor antagonist,ADRB1,cardiology,ventricular tachycardia (VT)|hypertension
esomeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Launched,ATPase inhibitor,ATP4A,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD)
esonarimod,YRSSFEUQNAXQMX-LBPRGKRZSA-N,Preclinical,antirheumatic drug,,,
estetrol,AJIPIJNNOJSSQC-NYLIRDPKSA-N,Phase 3,selective estrogen receptor modulator (SERM),ESR1,,
estradiol,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Launched,estrogen receptor agonist,ESR1|ESR2|GPER1|KCNMA1|NR1I2,endocrinology,contraceptive
estradiol-3-O-sulfamate,YXYXCSOJKUAPJI-ZBRFXRBCSA-N,Phase 2,steryl sulfatase inhibitor,,,
estradiol-acetate,FHXBMXJMKMWVRG-SLHNCBLASA-N,Launched,estrogen receptor agonist,ESR1,endocrinology|obstetrics/gynecology,menopause|vaginal atrophy
estradiol-benzoate,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Preclinical,contraceptive agent,ESR1,,
estradiol-cypionate,UOACKFBJUYNSLK-XRKIENNPSA-N,Launched,estrogen receptor agonist,ESR1,endocrinology,hypoestrogenism|menopause
estradiol-valerate,RSEPBGGWRJCQGY-RBRWEJTLSA-N,Launched,estrogen receptor agonist,ESR1,oncology|endocrinology|obstetrics/gynecology,prostate cancer|hypoestrogenism|menopause|vaginal atrophy
estramustine,FRPJXPJMRWBBIH-RBRWEJTLSA-N,Launched,DNA alkylating agent,ESR1|ESR2|MAP1A|MAP2,oncology,prostate cancer
estramustine-phosphate,ADFOJJHRTBFFOF-RBRWEJTLSA-N,Launched,DNA synthesis inhibitor|microtubule inhibitor,ESR1|ESR2|MAP1A|MAP2,oncology,prostate cancer
estriol,PROQIPRRNZUXQM-ZXXIGWHRSA-N,Launched,estrogen receptor agonist,ESR1|ESR2,endocrinology|obstetrics/gynecology|infectious disease,menopause|vaginal atrophy|urinary tract infections
estrone,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Launched,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2,endocrinology,menopause
estropipate,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Launched,estrogen receptor agonist,ESR1|ESR2,orthopedics|endocrinology|obstetrics/gynecology,osteoporosis|menopause|vaginal atrophy|hypoestrogenism
etacrynic-acid,AVOLMBLBETYQHX-UHFFFAOYSA-N,Launched,sodium/potassium/chloride transporter inhibitor,ATP1A1|SLC12A1,cardiology|gastroenterology|nephrology|rheumatology,hypertension|congestive heart failure|edema|hepatic cirrhosis|chronic renal failure|nephrotic syndrome
etafenone,OEGDFSLNGABBKJ-UHFFFAOYSA-N,Launched,calcium channel blocker,,,
etamsylate,IKQCSJBQLWJEPU-UHFFFAOYSA-N,Launched,hemostatic agent,,hematology,hemorrhage
etanidazole,WCDWBPCFGJXFJZ-UHFFFAOYSA-N,Phase 3,bacterial cell wall synthesis inhibitor,,,
etazolate,OPQRBXUBWHDHPQ-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,GABRB3|PDE4A,,
ETC-159,QTRXIFVSTWXRJJ-UHFFFAOYSA-N,Phase 1,beta catenin inhibitor|porcupine inhibitor,PORCN,,
ETC-206,FWRFPHJSGLYXTD-UHFFFAOYSA-N,Phase 1,MAPK-interacting kinase inhibitor,,,
etebenecid,UACOQEQOBAQRDQ-UHFFFAOYSA-N,Preclinical,uricosuric blocker,,,
eterobarb,DACOQFZGGLCXMA-UHFFFAOYSA-N,Phase 2,anticonvulsant,,,
ethacizin,PQXGNJKJMFUPPM-UHFFFAOYSA-N,Launched,anticonvulsant,,cardiology,ventricular tachycardia (VT)|Wolff-Parkinson-White Syndrome (WPW)
ethacridine-lactate-monohydrate,CIKWKGFPFXJVGW-UHFFFAOYSA-N,Preclinical,DNA intercalating agent,,,
ethambutol,AEUTYOVWOVBAKS-UWVGGRQHSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,tuberculosis
ethamivan,BQJODPIMMWWMFC-UHFFFAOYSA-N,Preclinical,respiratory stimulant,,,
ethanolamine-oleate,KGWDUNBJIMUFAP-KVVVOXFISA-N,Launched,immunostimulant,F12|FABP4|FFAR1|FFAR4|PLD2,gastroenterology,esophageal varices
ethaverine,ZOWYFYXTIWQBEP-UHFFFAOYSA-N,Launched,calcium channel blocker,,neurology/psychiatry,muscle relaxant|spasms
ethenzamide,SBNKFTQSBPKMBZ-UHFFFAOYSA-N,Launched,analgesic agent,,neurology/psychiatry|endocrinology|otolaryngology,headache|fever|common cold
ethimizol,RYRFAMRQBZNEPX-UHFFFAOYSA-N,Phase 1,,,,
ethinyl-estradiol,BFPYWIDHMRZLRN-SLHNCBLASA-N,Launched,estrogen receptor agonist|estrogenic hormone,ESR1|ESR2|NR1I2,endocrinology,contraceptive
ethionamide,AEOCXXJPGCBFJA-UHFFFAOYSA-N,Launched,mycolic synthesis inhibitor,,infectious disease,tuberculosis
ethisterone,CHNXZKVNWQUJIB-CEGNMAFCSA-N,Launched,progestogen hormone,TYR,endocrinology,amenorrhea
ethopabate,GOVWOKSKFSBNGD-UHFFFAOYSA-N,Launched,antiprotozoal agent,,infectious disease,coccidiosis
ethosuximide,HAPOVYFOVVWLRS-ZETCQYMHSA-N,Launched,succinimide antiepileptic,CACNA1G|CACNA1H|CACNA1I,neurology/psychiatry,epilepsy
ethotoin,SZQIFWWUIBRPBZ-SECBINFHSA-N,Launched,hydantoin antiepileptic,SCN5A,neurology/psychiatry,seizures
ethoxyquin,DECIPOUIJURFOJ-UHFFFAOYSA-N,Preclinical,antioxidant,,,
ethoxzolamide,OUZWUKMCLIBBOG-UHFFFAOYSA-N,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9,ophthalmology|gastroenterology,glaucoma|duodenal ulcer disease
ethyl-2-(carbamoyloxy)benzoate,JFMIIMPCFQKAAD-UHFFFAOYSA-N,Phase 1,,,,
ethyl-paraben,NUVBSKCKDOMJSU-UHFFFAOYSA-N,Preclinical,,,,
ethyl-pyruvate,PSYUBHDPOIZRST-UHFFFAOYSA-N,Phase 2,tumor necrosis factor production inhibitor,,,
ethyl-vanillin,CBOQJANXLMLOSS-UHFFFAOYSA-N,Preclinical,,,,
ethylenediaminetetraacetic-acid,KCXVZYZYPLLWCC-UHFFFAOYSA-N,Launched,PKC inhibitor,,neurology/psychiatry,metal toxicity
ethylnorepinephrine,LENNRXOJHWNHSD-XCBNKYQSSA-N,Preclinical,bronchodilator,,,
ethynodiol-diacetate,ONKUMRGIYFNPJW-KIEAKMPYSA-N,Launched,,ESR1|PGR,endocrinology,contraceptive
ethynylcytidine,JFIWEPHGRUDAJN-DYUFWOLASA-N,Preclinical,antimetabolite,,,
eticlopride,AADCDMQTJNYOSS-LBPRGKRZSA-N,Preclinical,dopamine receptor antagonist,DRD2|DRD3|DRD4,,
etidronic-acid,DBVJJBKOTRCVKF-UHFFFAOYSA-N,Launched,bone resorption inhibitor,ATP6V1A|PTPRS,endocrinology|orthopedics,Paget's disease|heterotopic ossification
etifenin,WNIDXAKKFOKNEF-UHFFFAOYSA-N,Preclinical,renal function diagnostic agent,,,
etifoxine,IBYCYJFUEJQSMK-KRWDZBQOSA-N,Launched,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5,neurology/psychiatry,anxiety
etilefrine,SQVIAVUSQAWMKL-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRB1,neurology/psychiatry|otolaryngology|endocrinology|pulmonary,headache|nasal congestion|fever|cough suppressant|common cold
etilevodopa,NULMGOSOSZBEQL-QMMMGPOBSA-N,Phase 3,dopamine receptor agonist,DRD3,,
etizolam,VMZUTJCNQWMAGF-UHFFFAOYSA-N,Launched,benzodiazepine receptor agonist,GABRA1,neurology/psychiatry,insomnia|anxiety
etodolac,NNYBQONXHNTVIJ-KRWDZBQOSA-N,Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis
etofenamate,XILVEPYQJIOVNB-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry|rheumatology,muscle pain|joint pain
etofibrate,XXRVYAFBUDSLJX-UHFFFAOYSA-N,Launched,PPAR receptor agonist,PPARA,endocrinology,hypertriglyceridemia
etofylline,NWPRCRWQMGIBOT-UHFFFAOYSA-N,Launched,adenosine receptor antagonist,ADORA1,pulmonary,asthma|bronchitis
etofylline-clofibrate,KYAKGJDISSNVPZ-UHFFFAOYSA-N,Launched,platelet aggregation inhibitor,PPARA,endocrinology,hyperlipidemia
etomidate,NPUKDXXFDDZOKR-LLVKDONJSA-N,Launched,GABA receptor modulator,ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,neurology/psychiatry,general anaesthetic
etomoxir,DZLOHEOHWICNIL-QGZVFWFLSA-N,Phase 2,carnitine palmitoyltransferase inhibitor,CPT1A,,
etonogestrel,GCKFUYQCUCGESZ-BPIQYHPVSA-N,Launched,progesterone receptor agonist,ESR1|PGR,endocrinology,contraceptive
etoposide,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Launched,topoisomerase inhibitor,TOP2A|TOP2B,oncology,non-small cell lung cancer (NSCLC)
etoposide-phosphate,LIQODXNTTZAGID-OCBXBXKTSA-N,Launched,topoisomerase inhibitor,TOP2A,oncology,testicular carcinoma|small cell lung cancer
etoricoxib,MNJVRJDLRVPLFE-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,rheumatoid arthritis|psoriatic arthritis|osteoarthritis|gout|ankylosing spondylitis
etosalamide,XBNRCMFFZFCWMH-UHFFFAOYSA-N,Preclinical,anti-inflammatory agent,,,
etoxybamide,MFHPPMMWHSHDSI-UHFFFAOYSA-N,Phase 2,,,,
ETP-45658,BJVRNXSHJLDZJR-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
ETP-46464,DPLMXAYKJZOTKO-UHFFFAOYSA-N,Preclinical,ATR kinase inhibitor,,,
ETP-46464,"InChI=1S/C30H22N4O2/c1-30(2,18-31)23-8-10-24(11-9-23)34-28-22(17-36-29(34)35)16-33-27-12-7-19(14-25(27)28)21-13-20-5-3-4-6-26(20)32-15-21/h3-16H,17H2,1-2H3",Preclinical,ATR kinase inhibitor,,,
etrabamine,YDSVAKPJAOSZJA-LURJTMIESA-N,Phase 2,dopamine receptor agonist,,,
etrasimod,MVGWUTBTXDYMND-QGZVFWFLSA-N,Phase 3,sphingosine 1-phosphate receptor antagonist,,,
etravirine,PYGWGZALEOIKDF-UHFFFAOYSA-N,Launched,non-nucleoside reverse transcriptase inhibitor,CYP2C19|CYP2C9|CYP3A4,infectious disease,human immunodeficiency virus (HIV-1)
etretinate,HQMNCQVAMBCHCO-DJRRULDNSA-N,Withdrawn,protein synthesis inhibitor,RARA|RXRG,,
eucalyptol,WEEGYLXZBRQIMU-UHFFFAOYSA-N,Launched,acetylcholinesterase inhibitor,ACHE,dental,gingivitis
eucatropine,QSAVEGSLJISCDF-QEJZJMRPSA-N,Preclinical,acetylcholine receptor antagonist,,,
eugenol,RRAFCDWBNXTKKO-UHFFFAOYSA-N,Launched,androgen receptor antagonist,AR,dental,toothache
EUK-134,QCAWBJDECIOVBU-GAMUHHASSA-K,Preclinical,catalase stimulant,APP|SOD2,,
eupatilin,DRRWBCNQOKKKOL-UHFFFAOYSA-N,Launched,mucus protecting agent,,,
evacetrapib,IHIUGIVXARLYHP-YBXDKENTSA-N,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,,
evans-blue,LIRUWPZKVZZTHC-UHFFFAOYSA-N,Launched,glutamate receptor negative allosteric modulator,GRIA1|PTPN1,,
evatanepag,WOHRHWDYFNWPNG-UHFFFAOYSA-N,Phase 2,prostaglandin inhibitor,PTGER2|PTGER4,,
evenamide,GRHBODILPPXVKN-UHFFFAOYSA-N,Phase 2,voltage-gated sodium channel blocker,,,
everolimus,HKVAMNSJSFKALM-FLOWVUKKSA-N,Launched,mTOR inhibitor,MTOR,oncology|neurology/psychiatry|genetics|urology,breast cancer|neuroendocrine tumors of pancreatic origin (PNET)|renal cell carcinoma (RCC)|subependymal giant cell astrocytoma (SEGA)|tuberous sclerosis complex (TSC)|renal angiomyolipoma
evobrutinib,QUIWHXQETADMGN-UHFFFAOYSA-N,Phase 2,Bruton's tyrosine kinase (BTK) inhibitor,,,
evocalcet,RZNUIYPHQFXBAN-XLIONFOSSA-N,Phase 3,calcium sensitizer,,,
evodiamine,TXDUTHBFYKGSAH-SFHVURJKSA-N,Preclinical,ATPase inhibitor|TRPV agonist,TRPV1,,
EVP-6124,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,Phase 3,acetylcholine receptor agonist,CHRNA7,,
EVP4593,IBAKVEUZKHOWNG-UHFFFAOYSA-N,Preclinical,NFkB pathway inhibitor,,,
EW-7197,FJCDSQATIJKQKA-UHFFFAOYSA-N,Phase 2,TGF beta receptor inhibitor,ACVR1B|TGFBR1,,
EX-527,FUZYTVDVLBBXDL-VIFPVBQESA-N,Phase 2,SIRT inhibitor,SIRT1,,
exalamide,CKSJXOVLXUMMFF-UHFFFAOYSA-N,Launched,membrane permeability inhibitor,,,
examorelin,RVWNMGKSNGWLOL-GIIHNPQRSA-N,Phase 2,growth hormone releasing factor agonist,GHRHR|GHSR,,
exatecan-mesylate,ZVYVPGLRVWUPMP-FYSMJZIKSA-N,Phase 3,topoisomerase inhibitor,TOP1,,
exemestane,BFYIZQONLCFLEV-DAELLWKTSA-N,Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer
exenatide,HTQBXNHDCUEHJF-XWLPCZSASA-N,Launched,GLP receptor agonist,GLP1R,endocrinology,diabetes mellitus
exherin,FQVLRGLGWNWPSS-XDKAFHOCSA-N,Phase 2,cadherin antagonist,CDH2,,
exifone,XEDWWPGWIXPVRQ-UHFFFAOYSA-N,Withdrawn,nootropic agent,TYR,,
exisulind,MVGSNCBCUWPVDA-MFOYZWKCSA-N,Phase 3,phosphodiesterase inhibitor,PDE5A,,
EXO-1,KIAPWMKFHIKQOZ-UHFFFAOYSA-N,Preclinical,ARF inhibitor,,,
exo-IWR-1,ZGSXEXBYLJIOGF-BTYSMDAFSA-N,Preclinical,WNT signaling inhibitor negative control,TNKS,,
ezatiostat,GWEJFLVSOGNLSS-WPFOTENUSA-N,Phase 2,glutathione transferase inhibitor,GSTP1,,
ezetimibe,OLNTVTPDXPETLC-XPWALMASSA-N,Launched,cholesterol inhibitor|Niemann-Pick C1-like 1 protein antagonist,ANPEP|NPC1L1|SOAT1,endocrinology|metabolism,hyperlipidemia|hypercholesterolemia|sitosterolemia
ezutromid,WRIPKYOZKAJHRL-UHFFFAOYSA-N,Phase 2,utrophin enhancer,UTRN,,
F-11440,NMYAHEULKSYAPP-UHFFFAOYSA-N,Phase 2,serotonin receptor agonist,HTR1A,,
F-16915,BUWVEXMRBAWBPJ-KUBAVDMBSA-N,Preclinical,,,,
F351,NETTXQJYJRFTFS-UHFFFAOYSA-N,Phase 2,TGF beta receptor inhibitor,TGFB1,,
fadrozole,CLPFFLWZZBQMAO-CQSZACIVSA-N,Launched,aromatase inhibitor,CYP11B1|CYP19A1,oncology,breast cancer
fagomine,YZNNBIPIQWYLDM-HSUXUTPPSA-N,Phase 2,glucosidase inhibitor,GLB1,,
falecalcitriol,XPYGGHVSFMUHLH-UUSULHAXSA-N,Launched,vitamin D receptor agonist,VDR,endocrinology,hyperparathyroidism
famciclovir,GGXKWVWZWMLJEH-UHFFFAOYSA-N,Launched,DNA polymerase inhibitor,,dental|infectious disease,cold sore|genitial herpes|shingles
famotidine,XUFQPHANEAPEMJ-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH2,gastroenterology,heartburn
famprofazone,GNUXVOXXWGNPIV-IBGZPJMESA-N,Preclinical,cyclooxygenase inhibitor,,,
fananserin,VGIGHGMPMUCLIQ-UHFFFAOYSA-N,Phase 2,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A,,
fanetizole,WEEYMMXMBFJUAI-UHFFFAOYSA-N,Phase 3,neutrophil superoxide production,,,
fantofarone,ITAMRBIZWGDOHW-UHFFFAOYSA-N,Preclinical,calcium channel blocker,,,
farampator,XFVRBYKKGGDPAJ-UHFFFAOYSA-N,Preclinical,ionotropic glutamate receptor agonist,,,
farnesyl-thiosalicylic-acid-amide,GZTMFRUGZMZCRD-CFBAGHHKSA-N,Phase 1,Ras GTPase inhibitor,HRAS,,
faropenem,HGGAKXAHAYOLDJ-OJKLQORTSA-N,Launched,lactamase inhibitor,,infectious disease|pulmonary|otolaryngology,pneumonia|bronchitis|skin infections|urinary tract infections|sinusitis
faropenem-medoxomil,JQBKWZPHJOEQAO-DVPVEWDBSA-N,Launched,lactamase inhibitor,,otolaryngology|infectious disease|pulmonary,sinusitis|pneumonia|bronchitis|skin infections|urinary tract infections
fasoracetam,GOWRRBABHQUJMX-MRVPVSSYSA-N,Preclinical,GABA receptor antagonist,,,
fasudil,NGOGFTYYXHNFQH-UHFFFAOYSA-N,Launched,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1|ROCK2,neurology/psychiatry,cerebral vasospasm
favipiravir,ZCGNOVWYSGBHAU-UHFFFAOYSA-N,Phase 3,RNA polymerase inhibitor,,,
FCE-22250,JEGGQYICWGMXOZ-KLZPLVFYSA-N,Phase 1,DNA directed DNA polymerase inhibitor,,,
fdcyd,IDYKCXHJJGMAEV-RRKCRQDMSA-N,Phase 2,DNA methyltransferase inhibitor,,,
febuprol,WBLXZPHICYCDGN-GFCCVEGCSA-N,Launched,choleretic agent,,,
febuxostat,BQSJTQLCZDPROO-UHFFFAOYSA-N,Launched,xanthine oxidase inhibitor,XDH,nephrology,hyperuricemia
fedratinib,JOOXLOJCABQBSG-UHFFFAOYSA-N,Launched,FLT3 inhibitor|JAK inhibitor,BRD4|JAK1|JAK2|JAK3|TYK2,hematologic malignancy,myelofibrosis
felbamate,WKGXYQFOCVYPAC-UHFFFAOYSA-N,Launched,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,neurology/psychiatry,epilepsy
felbinac,QRZAKQDHEVVFRX-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,CTSL,rheumatology|neurology/psychiatry,rheumatoid arthritis|muscle pain
felbinac-ethyl,NPPJLSILDPVHCM-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,,
felodipine,RZTAMFZIAATZDJ-HNNXBMFYSA-N,Launched,calcium channel blocker,CFTR,cardiology,hypertension
felypressin,SFKQVVDKFKYTNA-HLQBGFAYSA-N,Preclinical,vasopressin receptor agonist,,,
fenaclon,BITWVVLBVUMFHU-UHFFFAOYSA-N,Preclinical,,,,
fenbendazole,HDDSHPAODJUKPD-UHFFFAOYSA-N,Launched,tubulin polymerization inhibitor,TUBB,infectious disease,gastrointestinal parasites|gastrointestinal roundworms
fenbufen,ZPAKPRAICRBAOD-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
fenclonine-(+/-),NIGWMJHCCYYCSF-QMMMGPOBSA-N,Preclinical,tryptophan hydroxylase inhibitor,PAH|TPH1|TPH2,,
fendiline,NMKSAYKQLCHXDK-LJQANCHMSA-N,Preclinical,calcium channel blocker,HTR2B,,
fenebrutinib,WNEODWDFDXWOLU-QHCPKHFHSA-N,Phase 2,Bruton's tyrosine kinase (BTK) inhibitor,,,
fenigam,DAFOCGYVTAOKAJ-SECBINFHSA-N,Launched,benzodiazepine receptor agonist,GABBR1|GABBR2,neurology/psychiatry,posttraumatic stress disorder|anxiety|depression
fenipentol,OVGORFFCBUIFIA-LLVKDONJSA-N,Launched,choleretic agent,,gastroenterology,bile stimulation
fenobam,DWPQODZAOSWNHB-UHFFFAOYSA-N,Phase 2,glutamate receptor antagonist,GRM5,,
fenofibrate,YMTINGFKWWXKFG-UHFFFAOYSA-N,Launched,PPAR receptor agonist,MMP25|PPARA,endocrinology,hypercholesterolemia|hypertriglyceridemia
fenofibric-acid,MQOBSOSZFYZQOK-UHFFFAOYSA-N,Launched,cytochrome P450 inhibitor,CLCN1|PPARA,cardiology,dyslipidemia
fenoldopam,TVURRHSHRRELCG-CYBMUJFWSA-N,Launched,dopamine receptor agonist,DRD1|DRD4,cardiology,hypertension
fenoprofen,RDJGLLICXDHJDY-LLVKDONJSA-N,Launched,prostaglandin inhibitor,PTGS1|SLC5A8,rheumatology,rheumatoid arthritis|osteoarthritis
fenoterol,LSLYOANBFKQKPT-APPDUMDISA-N,Withdrawn,adrenergic receptor agonist,ADRB2,,
fenoverine,UBAJTZKNDCEGKL-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,,neurology/psychiatry,spasms
fenoxaprop-p-ethyl,PQKBPHSEKWERTG-LLVKDONJSA-N,Preclinical,,NOS3,,
fenretinide,AKJHMTWEGVYYSE-FXILSDISSA-N,Phase 3,apoptosis stimulant|retinoid receptor agonist,RARA,,
fenspiride,FVNFBBAOMBJTST-UHFFFAOYSA-N,Launched,bronchodilator,,pulmonary|otolaryngology,asthma|otitis|sinusitis|rhinopharyngitis|laryngitis
fenthion,PNVJTZOFSHSLTO-UHFFFAOYSA-N,Launched,cholinesterase inhibitor,,,
fentiazac,JIEKMACRVQTPRC-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry|rheumatology,muscle pain|joint pain
fenticonazole,ZCJYUTQZBAIHBS-XMMPIXPASA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,vulvovaginal candidiasis
FERb-033,LRRMQNGSYOUANY-OMCISZLKSA-N,Preclinical,EGFR inhibitor,ERBB2,,
ferroquine,UZTPLPOYSVSMBU-UHFFFAOYSA-N,Phase 2,antimalarial agent,,,
ferrostatin-1,UJHBVMHOBZBWMX-UHFFFAOYSA-N,Preclinical,ferroptosis inhibitor,,,
ferulic-acid,KSEBMYQBYZTDHS-HWKANZROSA-N,Phase 2,antioxidant,CA1|CA12|CA14|CA2|CA4|CA6|CA9,,
fesoterodine,DCCSDBARQIPTGU-HSZRJFAPSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,urology,urinary incontinence
fevipiprant,GFPPXZDRVCSVNR-UHFFFAOYSA-N,Phase 2,prostaglandin inhibitor,,,
fexaramine,VLQTUNDJHLEFEQ-KGENOOAVSA-N,Preclinical,FXR agonist,NR1H4,,
fexinidazole,MIWWSGDADVMLTG-UHFFFAOYSA-N,Phase 3,,,,
fexofenadine,RWTNPBWLLIMQHL-LJAQVGFWSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria
fezolinetant,PPSNFPASKFYPMN-SECBINFHSA-N,Phase 2,neurokinin receptor antagonist,,,
FG-2216,OUQVKRKGTAUJQA-UHFFFAOYSA-N,Phase 2,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN1|EGLN2|HIF1A,,
FG-4592,YOZBGTLTNGAVFU-UHFFFAOYSA-N,Phase 3,hypoxia inducible factor prolyl hydroxylase inhibitor,EGLN1|EGLN2|EGLN3,,
FG-7142,QMCOPDWHWYSJSA-UHFFFAOYSA-N,Preclinical,GABA benzodiazepine site receptor inverse agonist,,,
FGIN-1-27,VUWXAQFLTSBUDB-UHFFFAOYSA-N,Preclinical,inositol monophosphatase inhibitor,TSPO,,
FGIN-1-43,XTZUPNNVXIMWAR-UHFFFAOYSA-N,Preclinical,benzodiazepine receptor agonist,TSPO,,
FH-535,AXNUEXXEQGQWPA-UHFFFAOYSA-N,Preclinical,PPAR receptor antagonist|WNT signaling inhibitor,PPARD|PPARG,,
FH1,OEXMNSOPAKOPEF-UHFFFAOYSA-N,Preclinical,hepatocyte function enhancer,,,
fiacitabine,GIMSJJHKKXRFGV-BYPJNBLXSA-N,Phase 2,DNA synthesis inhibitor,,,
fidarestat,WAAPEIZFCHNLKK-PELKAZGASA-N,Phase 3,aldose reductase inhibitor,AKR1B1,,
fidaxomicin,ZVGNESXIJDCBKN-UUEYKCAUSA-N,Launched,RNA polymerase inhibitor,,gastroenterology,diarrhea
filanesib,LLXISKGBWFTGEI-FQEVSTJZSA-N,Phase 3,kinesin inhibitor|kinesin-like spindle protein inhibitor,KIF11,,
filgotinib,RIJLVEAXPNLDTC-UHFFFAOYSA-N,Phase 3,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,,
fimasartan,AMEROGPZOLAFBN-UHFFFAOYSA-N,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension|congestive heart failure
finafloxacin,FYMHQCNFKNMJAV-HOTGVXAUSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease|pulmonary,intra-abdominal infections|chronic obstructive pulmonary disease (COPD)|cystic fibrosis
finasteride,DBEPLOCGEIEOCV-WSBQPABSSA-N,Launched,5 alpha reductase inhibitor,AKR1D1|SRD5A1|SRD5A2,endocrinology,androgenetic alopecia
fingolimod,KKGQTZUTZRNORY-UHFFFAOYSA-N,Launched,immunosuppressant|sphingosine 1-phosphate receptor agonist,S1PR1|S1PR5,neurology/psychiatry,multiple sclerosis
fipexide,BFUJHVVEMMWLHC-UHFFFAOYSA-N,Withdrawn,psychoactive drug,,,
FIPI,LHABRXRGDLASIH-UHFFFAOYSA-N,Preclinical,phospholipase inhibitor,PLD1|PLD2,,
fipronil,ZOCSXAVNDGMNBV-AREMUKBSSA-N,Launched,chloride channel blocker|GABA gated chloride channel blocker,,infectious disease,flea control
firategrast,YLFZHHDVRSYTKT-NRFANRHFSA-N,Phase 2,integrin antagonist,ITGA4,,
firocoxib,FULAPETWGIGNMT-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,osteoarthritis
firsocostat,ZZWWXIBKLBMSCS-FQEVSTJZSA-N,Phase 2,acetyl-CoA carboxylase inhibitor,,,
fisetin,XHEFDIBZLJXQHF-UHFFFAOYSA-N,Preclinical,Aurora kinase inhibitor,CDK6|FASN,,
fisogatinib,MGZKYOAQVGSSGC-DLBZAZTESA-N,Phase 1,fibroblast growth factor inhibitor,,,
FIT,VDKBIFPJULZUPU-UHFFFAOYSA-N,Preclinical,opioid receptor agonist,OPRD1,,
FK-33-824,HYZHONGSQNXMPH-YJRDZJJMSA-N,Phase 2,opioid receptor agonist,OPRM1,,
FK-3311,DIIYLGZNZGPXRR-UHFFFAOYSA-N,Phase 2,cyclooxygenase inhibitor,PTGS2,,
FK-409,MZAGXDHQGXUDDX-FGCOBAPNSA-N,Phase 2,guanylyl cyclase activator,,,
FK-866,KPBNHDGDUADAGP-VAWYXSNFSA-N,Phase 2,niacinamide phosphoribosyltransferase inhibitor,NAMPT,,
FK-888,BFNKQTIJVFGCKQ-PDJGWCFMSA-N,Phase 2,tachykinin antagonist,TACR1|TACR2,,
FK-962,VBHVOHJOTMCSBQ-UHFFFAOYSA-N,Phase 2,somatostatin receptor agonist,,,
flavin-adenine-dinucleotide,VWWQXMAJTJZDQX-UYBVJOGSSA-N,Preclinical,,ACAD8|ACADM|ACADS|ACOX1|AIFM1|CYB5R1|CYB5R3|DAO|DLD|DPYD|ERO1LB|FDXR|GCDH|GFER|GSR|IL4I1|IVD|MAOA|MAOB|NOS1|NQO1|NQO2|POR|TXNRD1|XDH,,
flavoxate,SPIUTQOUKAMGCX-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2,urology,urinary incontinence|interstitial cystitis (IC)|urethritis|prostatitis
flecainide,DJBNUMBKLMJRSA-UHFFFAOYSA-N,Launched,sodium channel blocker,KCNA5|KCNA7|SCN5A,cardiology,ventricular tachycardia (VT)|atrial fibrillation (AF)|ventricular arrhythmias
fleroxacin,XBJBPGROQZJDOJ-UHFFFAOYSA-N,Launched,topoisomerase inhibitor,TOP2A,infectious disease|gastroenterology,gonorrhea|enteritis|diarrhea|respiratory tract infections
FLI-06,DUGBYNJMBYPWGS-FOIFJWKZSA-N,Preclinical,notch signaling inhibitor,,,
flibanserin,PPRRDFIXUUSXRA-UHFFFAOYSA-N,Launched,serotonin receptor agonist,DRD4|HTR1A|HTR2A,neurology/psychiatry,hypoactive sexual desire disorder
flindokalner,ULYONBAOIMCNEH-HNNXBMFYSA-N,Phase 3,potassium channel agonist,KCNMA1|KCNN4|KCNQ2|KCNQ4|KCNQ5,,
floctafenine,APQPGQGAWABJLN-GFCCVEGCSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
flopropione,PTHLEKANMPKYDB-UHFFFAOYSA-N,Launched,serotonin receptor antagonist,HTR1A,neurology/psychiatry,spasms
florfenicol,AYIRNRDRBQJXIF-NXEZZACHSA-N,Launched,protein synthesis inhibitor,,pulmonary,bovine respiratory disease (BRD)
florifenine,DQOYUDHAZMAVLD-UHFFFAOYSA-N,Preclinical,anti-inflammatory agent,,,
flosequinan,UYGONJYYUKVHDD-MRXNPFEDSA-N,Withdrawn,phosphodiesterase inhibitor,,,
floxuridine,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,Launched,DNA synthesis inhibitor,TYMS,oncology,colorectal cancer
floxuridine,"InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",Launched,DNA synthesis inhibitor,TYMS,oncology,colorectal cancer
FLT3-IN-1,HJFSVYUFOXAVAA-YUAYGMJFSA-N,Preclinical,FLT3 inhibitor,,,
flubendazole,CPEUVMUXAHMANV-UHFFFAOYSA-N,Launched,tubulin polymerization inhibitor,TUBB,infectious disease,gastrointestinal parasites
flucloxacillin,UIOFUWFRIANQPC-JKIFEVAISA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology|dermatology|gastroenterology,gram-positive bacterial infections|tonsillitis|sinusitis|pneumonia|eczema|endocarditis|meningitis|enteritis|bacterial septicemia
fluconazole,RFHAOTPXVQNOHP-UHFFFAOYSA-N,Launched,sterol demethylase inhibitor,CYP51A1,infectious disease,esophageal candidiasis|meningitis
flucytosine,XRECTZIEBJDKEO-UHFFFAOYSA-N,Launched,other antifungal,DNMT1,infectious disease,bacterial septicemia|endocarditis|urinary tract infections|meningitis
fludarabine,HBUBKKRHXORPQB-FJFJXFQQSA-N,Launched,ribonucleotide reductase inhibitor,ADA|DCK|POLA1|RRM1|RRM2,hematologic malignancy,chronic lymphocytic leukemia (CLL)
fludarabine-phosphate,GIUYCYHIANZCFB-FJFJXFQQSA-N,Launched,ribonucleotide reductase inhibitor,POLA1|POLD1|POLE|RRM1|RRM2|RRM2B,hematologic malignancy,chronic lymphocytic leukemia (CLL)
fludrocortisone-acetate,SYWHXTATXSMDSB-GSLJADNHSA-N,Launched,,NR3C2,endocrinology,Addison's disease|adrenogenital syndrome
fludroxycortide,POPFMWWJOGLOIF-XWCQMRHXSA-N,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,infectious disease|dermatology,skin infections|psoriasis
flufenamic-acid,LPEPZBJOKDYZAD-UHFFFAOYSA-N,Preclinical,chloride channel blocker,AKR1C3|ANO1|AR|GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|PANX1|PANX2|PANX3|PKD2L1|PTGS1|PTGS2|TRPC5|TRPM2|TRPM5,,
flumatinib,BJCJYEYYYGBROF-UHFFFAOYSA-N,Phase 3,Bcr-Abl kinase inhibitor,ABL1|PDGFRB,,
flumazenil,OFBIFZUFASYYRE-UHFFFAOYSA-N,Launched,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,neurology/psychiatry,sedative
flumecinol,DVASNQYQOZHAJN-OAHLLOKOSA-N,Launched,,,,
flumequine,DPSPPJIUMHPXMA-ZETCQYMHSA-N,Launched,topoisomerase inhibitor,,infectious disease,urinary tract infections
flumethasone,WXURHACBFYSXBI-GQKYHHCASA-N,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,otolaryngology|infectious disease|dermatology,otitis|ear infections|corticosteroid-responsive dermatoses
flumethasone-pivalate,JWRMHDSINXPDHB-OJAGFMMFSA-N,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,allergy,allergic rhinitis
flumexadol,GXPYCYWPUGKQIJ-SNVBAGLBSA-N,Preclinical,,,,
flunarizine,SMANXXCATUTDDT-QPJJXVBHSA-N,Launched,calcium channel blocker,CACNA1G|CACNA1H|CACNA1I|CALM1|HRH1,neurology/psychiatry|cardiology,migraine headache|vertigo|peripheral artery disease (PAD)
flunisolide,XSFJVAJPIHIPKU-XWCQMRHXSA-N,Launched,cytochrome P450 inhibitor,NR3C1,allergy,allergic rhinitis
flunixin-meglumin,NOOCSNJCXJYGPE-UHFFFAOYSA-N,Launched,prostanoid receptor antagonist,,pulmonary,bovine respiratory disease (BRD)
fluocinolone-acetonide,FEBLZLNTKCEFIT-VSXGLTOVSA-N,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,dermatology,seborrheic dermatitis
fluocinonide,WJOHZNCJWYWUJD-IUGZLZTKSA-N,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6|SMO,dermatology,seborrheic dermatitis|eczema
fluorescein,GNBHRKFJIUUOQI-UHFFFAOYSA-N,Launched,,SLC22A6,ophthalmology,ophthalmology diagnostic
fluorometholone,FAOZLTXFLGPHNG-KNAQIMQKSA-N,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology,eye inflammation
fluorometholone-acetate,YRFXGQHBPBMFHW-SBTZIJSASA-N,Launched,,NR3C1,ophthalmology,eye inflammation
fluoromethylcholine,PBVFROWIWWGIFK-UHFFFAOYSA-N,Launched,,,,
fluoxetine,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,Launched,selective serotonin reuptake inhibitor (SSRI),ANO1|HTR2B|SLC6A4,neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|bulimia nervosa|panic disorders|bipolar disorder
flupentixol,NJMYODHXAKYRHW-DVZOWYKESA-N,Launched,dopamine receptor antagonist,ADRA1A|CHRM1|DRD1|DRD2|DRD3|DRD5|HTR2A,neurology/psychiatry,schizophrenia|depression
fluphenazine,PLDUPXSUYLZYBN-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7,neurology/psychiatry,schizophrenia
fluphenazine-decanoate,VIQCGTZFEYDQMR-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD2|HTR1B|HTR4,neurology/psychiatry,schizophrenia
flupirtine,JUUFBMODXQKSTD-UHFFFAOYSA-N,Launched,glutamate receptor antagonist,ADRA2A|KCNQ1|KCNQ2,neurology/psychiatry,pain relief
fluprazine,CHQKHXJPWDSTPY-UHFFFAOYSA-N,Phase 1,serotonin receptor agonist,HTR1A|HTR1B,,
fluralaner,MLBZKOGAMRTSKP-HXUWFJFHSA-N,Preclinical,GABA receptor antagonist,,,
flurbiprofen-(+/-),SYTBZMRGLBWNTM-SNVBAGLBSA-N,Launched,cyclooxygenase inhibitor,,rheumatology,rheumatoid arthritis|osteoarthritis
flurbiprofen-(S)-(+),SYTBZMRGLBWNTM-JTQLQIEISA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,rheumatoid arthritis|osteoarthritis
flurbiprofen-axetil,ALIVXCSEERJYHU-TZMCWYRMSA-N,Launched,analgesic agent,,,
flurizan,SYTBZMRGLBWNTM-SNVBAGLBSA-N,Phase 3,gamma secretase inhibitor,APH1B|BACE1|IKBKG|PSEN1|PSEN2|PTGS1|PTGS2,,
flurofamide,QWZFVMCWPLMLTL-UHFFFAOYSA-N,Preclinical,urease inhibitor,,,
flurothyl,KGPPDNUWZNWPSI-UHFFFAOYSA-N,Preclinical,,,,
fluroxene,DLEGDLSLRSOURQ-UHFFFAOYSA-N,Preclinical,local anesthetic,,,
fluspirilene,QOYHHIBFXOOADH-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A,neurology/psychiatry,schizophrenia
flutamide,MKXKFYHWDHIYRV-UHFFFAOYSA-N,Launched,androgen receptor antagonist,AHR|AR,oncology,prostate cancer
fluticasone-propionate,WMWTYOKRWGGJOA-CENSZEJFSA-N,Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|PGR|PLA2G4A,dermatology,corticosteroid-responsive dermatoses
flutrimazole,QHMWCHQXCUNUAK-UHFFFAOYSA-N,Launched,sterol demethylase inhibitor,,infectious disease,mycosis
fluvastatin,FJLGEFLZQAZZCD-MCBHFWOFSA-N,Launched,HMGCR inhibitor,HMGCR,endocrinology|cardiology,hypercholesterolemia|congenital heart defects
fluvoxamine,CJOFXWAVKWHTFT-XSFVSMFZSA-N,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A4,neurology/psychiatry,obsessive compulsive disorder (OCD)
fmoc-L-leucine,CBPJQFCAFFNICX-IBGZPJMESA-N,Phase 2,PPAR receptor agonist,,,
FN-1501,VXLAKHWYGRKCGI-UHFFFAOYSA-N,Phase 1,tyrosine kinase inhibitor,,,
folic-acid,OVBPIULPVIDEAO-LBPRGKRZSA-N,Launched,folate receptor ligand,FOLR2|FOLR3|SLC19A1|SLC46A1,hematology,megaloblastic anemia
fomepizole,RIKMMFOAQPJVMX-UHFFFAOYSA-N,Launched,alcohol dehydrogenase inhibitor,ADH1A|ADH1B|ADH1C|AKR1A1|CAT,critical care,poison antidote
fomocaine,CVHGCWVMTZWGAY-UHFFFAOYSA-N,Launched,voltage-gated sodium channel modulator,,neurology/psychiatry,local anesthetic
fondaparinux,KANJSNBRCNMZMV-ABRZTLGGSA-N,Launched,coagulation factor inhibitor,F10|SERPINC1,hematology,deep vein thrombosis (DVT)
foretinib,CXQHYVUVSFXTMY-UHFFFAOYSA-N,Phase 2,VEGFR inhibitor,FLT1|FLT4|KDR|MET,,
foretinib,"InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)",Phase 2,VEGFR inhibitor,FLT1|FLT4|KDR|MET,,
formestane,ZMEULISFKSVRLQ-LZBOESDWSA-N,Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer
formononetin,HKQYGTCOTHHOMP-UHFFFAOYSA-N,Preclinical,alcohol dehydrogenase inhibitor,ADH1C|SLC5A2,,
formoterol,BPZSYCZIITTYBL-ORAYPTAESA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma|chronic obstructive pulmonary disease (COPD)|bronchospasm
forodesine,IWKXDMQDITUYRK-KUBHLMPHSA-N,Launched,purinergic receptor antagonist,PNP,hematologic malignancy,peripheral T-cell lymphoma (PTCL)
foropafant,VVBFISAUNSXQGZ-UHFFFAOYSA-N,Phase 3,platelet activating factor receptor antagonist,PTAFR,,
forskolin,OHCQJHSOBUTRHG-KGGHGJDLSA-N,Launched,adenylyl cyclase activator,ADCY2|ADCY5|GNAS,,
fosamprenavir,MLBVMOWEQCZNCC-OEMFJLHTSA-N,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
fosaprepitant-dimeglumine,BARDROPHSZEBKC-OITMNORJSA-N,Launched,tachykinin antagonist,TACR1,gastroenterology,nausea|vomiting
fosbretabulin,WDOGQTQEKVLZIJ-WAYWQWQTSA-N,Phase 3,tubulin polymerization inhibitor|VE-cadherin antagonist,CDH5,,
foscarnet,ZJAOAACCNHFJAH-UHFFFAOYSA-N,Launched,DNA polymerase inhibitor,,infectious disease,cytomegalovirus retinitis|acquired immunodeficiency syndrome (AIDS)|virus herpes simplex (HSV)
fosfestrol,NLORYLAYLIXTID-ISLYRVAYSA-N,Launched,synthetic estrogen,ESR1|ESR2,oncology,prostate cancer
fosfluconazole,GHJWNRRCRIGGIO-UHFFFAOYSA-N,Preclinical,other antifungal,,,
fosfomycin,YMDXZJFXQJVXBF-STHAYSLISA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections
fosfosal,FFKUDWZICMJVPA-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
fosfructose,XPYBSIWDXQFNMH-UYFOZJQFSA-N,Phase 3,fructose diphosphate stimulant,,,
fosinopril,BIDNLKIUORFRQP-AJTMIRJTSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure
fosinoprilat,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension
fosphenytoin,XWLUWCNOOVRFPX-UHFFFAOYSA-N,Launched,sodium channel blocker,SCN5A,neurology/psychiatry,epilepsy|seizures
fostamatinib,GKDRMWXFWHEQQT-UHFFFAOYSA-N,Launched,SYK inhibitor,SYK,hematology,chronic immune thrombocytopenia (ITP)
fostemsavir,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Phase 3,antiviral,,,
fotemustine,UETIXAMLWBFWOE-QMMMGPOBSA-N,Launched,thioredoxin inhibitor,,oncology,melanoma
foxy-5,WFZPJYYCTSHDJI-ATIWLJMLSA-N,Phase 2,WNT5a peptide mimetic,WNT5A,,
FPA-124,HZRXQEVFXXQYFS-VBPDOGLUSA-L,Preclinical,AKT inhibitor,,,
FPH1-(BRD-6125),WAOBCCBUTHNTFO-UHFFFAOYSA-N,Preclinical,hepatocyte function enhancer,,,
FPL-12495,JINQHBRSXWQJAZ-UHFFFAOYSA-N,Phase 1,glutamate receptor antagonist,,,
FPL-55712,LMQBMWHHGVZWMR-MRXNPFEDSA-N,Phase 1,leukotriene receptor antagonist,,,
FPL-62064,WKLGNFJHVJIZPK-UHFFFAOYSA-N,Phase 2,cyclooxygenase inhibitor|lipoxygenase inhibitor,,,
FPL-64176,MDMWHKZANMNXTF-UHFFFAOYSA-N,Preclinical,calcium channel activator,CACNA1C|CACNA1S,,
FPS-ZM1,XDFKWGIBQMHSOH-UHFFFAOYSA-N,Preclinical,RAGE receptor antagonist,AGER,,
FR-122047,UBHKJRYGKOSQDJ-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,,,
FR-139317,LIOKMIQQPDDTNO-UPRLRBBYSA-N,Phase 1,endothelin receptor antagonist,EDNRA,,
FR-180204,XVECMUKVOMUNLE-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor,MAPK1|MAPK3,,
FRAX486,DHKFOIHIUYFSOF-UHFFFAOYSA-N,Preclinical,serine/threonine kinase inhibitor,PAK1|PAK2|PAK3|PAK4,,
frentizole,JHBWYQRKOUBPCA-UHFFFAOYSA-N,Phase 1,immunosuppressant,,,
freselestat,HMPQTEPEMQZWQH-QZTJIDSGSA-N,Preclinical,elastase inhibitor,CELA1|ELANE,,
frovatriptan,XPSQPHWEGNHMSK-SECBINFHSA-N,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D,neurology/psychiatry,migraine headache
fruquintinib,BALLNEJQLSTPIO-UHFFFAOYSA-N,Launched,VEGFR inhibitor,KDR,oncology,colorectal cancer
FT011,UIWZIDIJCUEOMT-PKNBQFBNSA-N,Preclinical,TGF beta receptor inhibitor,,,
ftaxilide,LLECMGGNFBKPRH-UHFFFAOYSA-N,Preclinical,,,,
ftorafur,WFWLQNSHRPWKFK-ZCFIWIBFSA-N,Launched,thymidylate synthase inhibitor,TYMS,oncology,colorectal cancer
fucoxanthin,SJWWTRQNNRNTPU-BWRPRJLXSA-N,Phase 2,anticancer agent,,,
fudosteine,KINWYTAUPKOPCQ-YFKPBYRVSA-N,Launched,mucolytic agent,,pulmonary,chest congestion
fulvestrant,VWUXBMIQPBEWFH-CIAKRVSBSA-N,Launched,estrogen receptor antagonist,ESR1|ESR2|GPER1,oncology,breast cancer
fumagillin,NGGMYCMLYOUNGM-FKSJYSFPSA-N,Launched,methionine aminopeptidase inhibitor,METAP2,infectious disease,microsporidiosis
fumonisin-B1,UVBUBMSSQKOIBE-DSLOAKGESA-N,Preclinical,,CERS1,,
funapide,NEBUOXBYNAHKFV-NRFANRHFSA-N,Preclinical,sodium channel blocker,,,
furagin,DECBQELQORZLLP-UAIOPKHMSA-N,Preclinical,antibacterial,,,
furaltadone,YVQVOQKFMFRVGR-LLUUXILJSA-N,Launched,bacterial DNA inhibitor,,infectious disease,gram-negative bacterial infections
furamidine,ZJHZBDRZEZEDGB-UHFFFAOYSA-N,Preclinical,protein arginine N-methyltransferase inhibitor,PRMT1,,
furazolidone,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,Launched,bacterial DNA inhibitor,,gastroenterology|infectious disease,diarrhea|enteritis|cholera
furegrelate,VHWFITPGPFLBGT-UHFFFAOYSA-N,Phase 1,thromboxane synthase inhibitor,TBXAS1,,
furosemide,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,Launched,diuretic,CA2|GPR35|SLC12A1|SLC12A2,cardiology|rheumatology,edema|hypertension|congestive heart failure|nephrotic syndrome
fursultiamine,JTLXCMOFVBXEKD-XYGUXCPDSA-N,Launched,vitamin B,,metabolism,thiamine deficiency
furvina,MJPPGVVIDGQOQT-HYXAFXHYSA-N,Preclinical,quorum sensing signaling inhibitor,,,
fusidic-acid,IECPWNUMDGFDKC-MZJAQBGESA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,dermatology,acne vulgaris (AV)
futibatinib,KEIPNCCJPRMIAX-HNNXBMFYSA-N,Phase 3,FGFR inhibitor,,,
G-1,VHSVKVWHYFBIFJ-HKZYLEAXSA-N,Preclinical,G protein-coupled receptor agonist,GPER1,,
G-15,YOLTZIVRJAPVPH-MVBJNABHSA-N,Preclinical,estrogen receptor antagonist,GPER1,,
G-749,SXWMIXPJPNCXQQ-UHFFFAOYSA-N,Preclinical,tyrosine kinase inhibitor,,,
g-caryophyllene,NPNUFJAVOOONJE-GFUGXAQUSA-N,Preclinical,acetylcholinesterase inhibitor,ACHE,,
G007-LK,HIWVLHPKZNBSBE-OUKQBFOZSA-N,Preclinical,tankyrase inhibitor,TNKS|TNKS2,,
GABA-linoleamide,YGFYZZQGVSUXJE-HZJYTTRNSA-N,Phase 2,benzodiazepine receptor agonist,,,
gabapentin,UGJMXCAKCUNAIE-UHFFFAOYSA-N,Launched,calcium channel blocker,ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,infectious disease|neurology/psychiatry,virus herpes simplex (HSV)|shingles|seizures|restless leg syndrome
gabapentin-enacarbil,TZDUHAJSIBHXDL-GFCCVEGCSA-N,Launched,adrenergic receptor agonist,CACNA1G,neurology/psychiatry,restless leg syndrome|postherpetic neuralgia
gabazine,ACVGNKYJVGNLIL-UHFFFAOYSA-N,Preclinical,GABA receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRG2,,
gabexate,YKGYIDJEEQRWQH-UHFFFAOYSA-N,Launched,serine protease inhibitor,PRSS1|TPSAB1,gastroenterology,pancreatitis
gaboxadol,ZXRVKCBLGJOCEE-UHFFFAOYSA-N,Phase 3,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3,,
gadobutrol,ZPDFIIGFYAHNSK-YYLIZZNMSA-K,Launched,radiopaque medium,,radiology,MRI contrast agent
gadodiamide,HZHFFEYYPYZMNU-UHFFFAOYSA-K,Launched,radiopaque medium,,radiology,MRI contrast agent
gadopentetic-acid,IZOOGPBRAOKZFK-UHFFFAOYSA-K,Launched,contrast agent,PGD,radiology,contrast agent
gadoterate-meglumine,WDLRUFUQRNWCPK-UHFFFAOYSA-N,Launched,radiopaque medium,,radiology,MRI contrast agent
gadoteridol,DPNNNPAKRZOSMO-PFEQFJNWSA-K,Launched,radiopaque medium,,radiology,MRI contrast agent
GAL-021,FJNLCHNQVJVCPY-UHFFFAOYSA-N,Preclinical,calcium channel blocker,,,
galantamine,ASUTZQLVASHGKV-JDFRZJQESA-N,Launched,acetylcholinesterase inhibitor,ACHE|BCHE|CHRNA1|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB1|CHRNB2|CHRNB3|CHRNB4|CHRND|CHRNE|CHRNG,neurology/psychiatry,senile dementia
galeterone,PAFKTGFSEFKSQG-PAASFTFBSA-N,Phase 3,androgen receptor modulator,AR|CYP17A1,,
galidesivir,AMFDITJFBUXZQN-KUBHLMPHSA-N,Phase 1,antiviral,,,
gallamine-triethiodide,OZLPUNFFCJDMJD-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM2|CHRNA1,neurology/psychiatry,muscle relaxant
gallic-acid,LNTHITQWFMADLM-UHFFFAOYSA-N,Preclinical,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,CA1|CA12|CA14|CA2|CA4|CA6|CA9|SELP,,
gallium-triquinolin-8-olate,KWQNQSDKCINQQP-UHFFFAOYSA-K,Phase 1,,,,
gallopamil,XQLWNAFCTODIRK-UHFFFAOYSA-N,Launched,L-type calcium channel blocker,ATP2A2,cardiology,hypertension|cardiac arrythmia
gambogic-acid,GEZHEQNLKAOMCA-RRZNCOCZSA-N,Phase 2,caspase activator,BCL2,,
gamithromycin,VWAMTBXLZPEDQO-RHJMDXJBSA-N,Preclinical,antibacterial ,,,
gamma-aminobutyric-acid,BTCSSZJGUNDROE-UHFFFAOYSA-N,Preclinical,benzodiazepine receptor agonist,GABBR1|GABBR2|GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2|GATM|KCTD12|KCTD16|KCTD8|SLC6A1,,
gamma-linolenic-acid,VZCCETWTMQHEPK-QNEBEIHSSA-N,Phase 2,cyclooxygenase inhibitor|prostanoid receptor agonist,PTGS1|PTGS2,,
ganaxolone,PGTVWKLGGCQMBR-FLBATMFCSA-N,Phase 3,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6,,
ganciclovir,IRSCQMHQWWYFCW-UHFFFAOYSA-N,Launched,DNA polymerase inhibitor,,infectious disease,cytomegalovirus (CMV)
ganetespib,RVAQIUULWULRNW-UHFFFAOYSA-N,Phase 3,HSP inhibitor,HSP90AA1,,
ganoderic-acid-a,DYOKDAQBNHPJFD-JNTBEZBXSA-N,Preclinical,JAK inhibitor,,,
GANT-58,USWLOKMMUTWFMD-UHFFFAOYSA-N,Preclinical,GLI antagonist,GLI1,,
GANT-61,KVQOGDQTWWCZFX-UHFFFAOYSA-N,Preclinical,GLI antagonist,GLI1|GLI2,,
garenoxacin,NJDRXTDGYFKORP-LLVKDONJSA-N,Launched,topoisomerase inhibitor,TOP2A,infectious disease,respiratory tract infections
gastrodin,PUQSUZTXKPLAPR-UJPOAAIJSA-N,Phase 2,,,,
gatifloxacin,XUBOMFCQGDBHNK-JTQLQIEISA-N,Withdrawn,bacterial DNA gyrase inhibitor,,,
gavestinel,WZBNEZWCNKUOSM-VOTSOKGWSA-N,Phase 3,glutamate receptor antagonist,GLRB|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,,
GBR-12783,XFBDGHFDKJITGC-JLHYYAGUSA-N,Preclinical,dopamine reuptake inhibitor,,,
GBR-12935,RAQPOZGWANIDQT-UHFFFAOYSA-N,Preclinical,dopamine reuptake inhibitor,AGTR1|SLC6A3,,
GBR-13069,DASHZBBQOARCMQ-QPJJXVBHSA-N,Preclinical,dopamine reuptake inhibitor,SLC6A3,,
GDC-0068,GRZXWCHAXNAUHY-NSISKUIASA-N,Phase 3,AKT inhibitor,AKT1|AKT2|AKT3|PRKG1,,
GDC-0077,SGEUNORSOZVTOL-CABZTGNLSA-N,Phase 1,PI3K inhibitor,,,
GDC-0084,LGWACEZVCMBSKW-UHFFFAOYSA-N,Phase 2,mTOR inhibitor|PI3K inhibitor,,,
GDC-0152,WZRFLSDVFPIXOV-LRQRDZAKSA-N,Phase 1,XIAP inhibitor,BIRC2|BIRC3|BIRC7|XIAP,,
GDC-0349,RGJOJUGRHPQXGF-INIZCTEOSA-N,Phase 1,Pim kinase inhibitor,PIK3CA,,
GDC-0575,BAZRWWGASYWYGB-SNVBAGLBSA-N,Phase 1,CHK inhibitor,,,
GDC-0623,RFWVETIZUQEJEF-UHFFFAOYSA-N,Phase 1,MEK inhibitor,,,
GDC-0810,BURHGPHDEVGCEZ-KJGLQBJMSA-N,Phase 2,selective estrogen receptor destabilizer,ESR1,,
GDC-0834,CDOOFZZILLRUQH-LJAQVGFWSA-N,Phase 1,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,
GDC-0879,DEZZLWQELQORIU-RELWKKBWSA-N,Preclinical,RAF inhibitor,BRAF,,
GDC-0927,KJAAPZIFCQQQKX-NDEPHWFRSA-N,Phase 1,estrogen receptor antagonist,,,
GDC-0941,LHNIIDJUOCFXAP-UHFFFAOYSA-N,Phase 2,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
GDC-0941,"InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)",Phase 2,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
GDC-0980,YOVVNQKCSKSHKT-HNNXBMFYSA-N,Phase 2,mTOR inhibitor|PI3K inhibitor,FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK,,
GDC-0994,RZUOCXOYPYGSKL-SFHVURJKSA-N,Phase 1,MAP kinase inhibitor,MAPK1|MAPK3,,
gedunin,YJXDGWUNRYLINJ-BHAPSIHVSA-N,Preclinical,HSP inhibitor,HSP90AA1,,
gefapixant,HLWURFKMDLAKOD-UHFFFAOYSA-N,Phase 3,purinergic receptor antagonist,,,
gefitinib,XGALLCVXEZPNRQ-UHFFFAOYSA-N,Launched,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC)
geldanamycin,QTQAWLPCGQOSGP-SLOAUYBXSA-N,Preclinical,HSP inhibitor,HSP90AA1,,
gemcadiol,DJKWDKJYFYUEBQ-UHFFFAOYSA-N,Phase 2,antilipemic,,,
gemcitabine,SDUQYLNIPVEERB-QPPQHZFASA-N,Launched,ribonucleotide reductase inhibitor,CMPK1|RRM1|RRM2|TYMS,oncology,ovarian cancer|breast cancer|non-small cell lung cancer (NSCLC)|pancreatic cancer
gemcitabine-elaidate,HESSNRGIEVBPRB-QDDPNBLJSA-N,Phase 1,apoptosis inhibitor|DNA synthesis inhibitor,CMPK1|RRM1|TYMS,,
gemfibrozil,HEMJJKBWTPKOJG-UHFFFAOYSA-N,Launched,lipoprotein lipase activator,LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1,endocrinology|cardiology,hyperlipidemia|coronary heart disease
gemifloxacin,ZRCVYEYHRGVLOC-NOTZLVJDSA-N,Launched,bacterial DNA gyrase inhibitor,,pulmonary|infectious disease,bronchitis|pneumonia
gemigliptin,ZWPRRQZNBDYKLH-VIFPVBQESA-N,Launched,dipeptidyl peptidase inhibitor,,,
genipin,AZKVWQKMDGGDSV-BCMRRPTOSA-N,Preclinical,choleretic agent,,,
geniposide,IBFYXTRXDNAPMM-BVTMAQQCSA-N,Preclinical,GLP receptor agonist,GLP1R,,
geniposidic-acid,ZJDOESGVOWAULF-OGJQONSISA-N,Preclinical,cyclooxygenase inhibitor,,,
genistein,TZBJGXHYKVUXJN-UHFFFAOYSA-N,Phase 2/Phase 3,tyrosine kinase inhibitor,CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,,
gentamycin,CEAZRRDELHUEMR-CAMVTXANSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,HSPA8,infectious disease|critical care,bone and joint infections|endocarditis|pelvic inflammatory disease|meningitis|pneumonia|urinary tract infections|sepsis
gentiopicrin,DUAGQYUORDTXOR-GPQRQXLASA-N,Phase 3,glutamate receptor downregulator,GRIN2B,,
genz-123346,JMNXWOFCUJJYEO-HYBUGGRVSA-N,Preclinical,glucosylceramidase inhibitor,UGCG,,
genz-644282,BAORCAMWLWRZQG-UHFFFAOYSA-N,Phase 1,topoisomerase inhibitor,TOP1,,
gepefrine,WTDGMHYYGNJEKQ-SSDOTTSWSA-N,Launched,adrenergic receptor agonist,,cardiology,hypotension
gepon,HTQONPPEZULJKY-MUPFFGQUSA-N,Phase 1,,,,
gepotidacin,PZFAZQUREQIODZ-LJQANCHMSA-N,Phase 2,topoisomerase inhibitor,,,
geranyl-farnesylacetate,ZPACYDRSPFRDHO-ROBAGEODSA-N,Phase 2,mucin production enhancer,,,
gestodene,SIGSPDASOTUPFS-XUDSTZEESA-N,Launched,contraceptive agent,,endocrinology,contraceptive
gestrinone,BJJXHLWLUDYTGC-ANULTFPQSA-N,Launched,progesterone receptor antagonist,AR|ESR1|PGR,obstetrics/gynecology,endometriosis
GF109203X,QMGUOJYZJKLOLH-UHFFFAOYSA-N,Preclinical,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,,
GF109203X,"InChI=1S/C25H24N4O2/c1-28(2)12-7-13-29-15-19(17-9-4-6-11-21(17)29)23-22(24(30)27-25(23)31)18-14-26-20-10-5-3-8-16(18)20/h3-6,8-11,14-15,26H,7,12-13H2,1-2H3,(H,27,30,31)",Preclinical,PKC inhibitor,PDPK1|PIM1|PRKCI|PRKCZ,,
GGsTop,NTFPDEDRMYYPAC-FAYKFVSFSA-N,Preclinical,gamma glutamyltransferase Inhibitor,GGT1,,
GGTI-298,XVWPFYDMUFBHBF-CLOONOSVSA-N,Preclinical,GGTase inhibitor,CDKN1A,,
gilteritinib,GYQYAJJFPNQOOW-UHFFFAOYSA-N,Launched,FLT3 inhibitor,FLT3,,
gimeracil,ZPLQIPFOCGIIHV-UHFFFAOYSA-N,Launched,dihydropyrimidine dehydrogenase inhibitor,DPYD,oncology,gastric adenocarcinoma
ginkgolide-A,FPUXKXIZEIDQKW-UEHATNFXSA-N,Preclinical,GABA receptor antagonist,GLRA1|GLRB,,
ginkgolide-B,SQOJOAFXDQDRGF-AIQFLADASA-N,Phase 3,platelet activating factor receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,,
ginsenoside-C-K,FVIZARNDLVOMSU-IRFFNABBSA-N,Phase 1,NFkB pathway inhibitor|nitric oxide synthase inhibitor,PTGS2,,
ginsenoside-RD,RLDVZILFNVRJTL-ZMHPOSLNSA-N,Phase 3,calcium channel blocker,,,
ginsenoside-RE,PWAOOJDMFUQOKB-WCZZMFLVSA-N,Phase 1,anti-inflammatory agent,,,
ginsenoside-RE3,RWXIFXNRCLMQCD-CZIWJLDFSA-N,Launched,angiogenesis inhibitor|apoptosis stimulant,KCNH2,,
givinostat,YALNUENQHAQXEA-UHFFFAOYSA-N,Phase 3,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,
givinostat,"InChI=1S/C24H27N3O4/c1-3-27(4-2)15-17-5-7-21-14-18(6-8-20(21)13-17)16-31-24(29)25-22-11-9-19(10-12-22)23(28)26-30/h5-14,30H,3-4,15-16H2,1-2H3,(H,25,29)(H,26,28)",Phase 3,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,
GK921,MNYJJHBAEYKXEG-UHFFFAOYSA-N,Preclinical,transglutaminase inhibitor,TGM2,,
GKA-50,OCBMECSFDVUYQN-ROUUACIJSA-N,Preclinical,glucokinase activator,GCK,,
GKT137831,RGYQPQARIQKJKH-UHFFFAOYSA-N,Phase 2,NADPH oxidase inhibitor,NOX1|NOX4,,
glafenine,GWOFUCIGLDBNKM-CYBMUJFWSA-N,Withdrawn,DeltaF508-CFTR Correctors,CFTR,,
glasdegib,SFNSLLSYNZWZQG-VQIMIIECSA-N,Launched,hedgehog pathway inhibitor,SMO,hematologic malignancy,acute myeloid leukemia (AML)
glecaprevir,MLSQGNCUYAMAHD-ITNVBOSISA-N,Launched,serine protease inhibitor,,infectious disease,hepatitis C
glesatinib,YRCHYHRCBXNYNU-UHFFFAOYSA-N,Phase 2,tyrosine kinase inhibitor,,,
gliclazide,BOVGTQGAOIONJV-CHWSQXEVSA-N,Launched,ATP channel blocker|insulin secretagogue,,endocrinology,diabetes mellitus
glimepiride,WIGIZIANZCJQQY-RUCARUNLSA-N,Launched,insulin secretagogue,ABCC8|KCNJ1|KCNJ11,endocrinology,diabetes mellitus
glipizide,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,Launched,sulfonylurea,ABCC8|KCNJ10|KCNJ11|PPARG,endocrinology,diabetes mellitus|hyperglycemia
gliquidone,LLJFMFZYVVLQKT-UHFFFAOYSA-N,Launched,sulfonylurea,ABCC8|KCNJ10|KCNJ8,endocrinology,diabetes mellitus
Gln-1062,JKVNJTYHRABHIY-WXVUKLJWSA-N,Preclinical,cholinesterase inhibitor,,,
GLPG0187,CXHCNOMGODVIKB-VWLOTQADSA-N,Phase 1,integrin antagonist,,,
GLPG0492,VAJGULUVTFDTAS-GOSISDBHSA-N,Phase 1,androgen receptor modulator,AR,,
GLPG0492-R-enantiomer,VAJGULUVTFDTAS-SFHVURJKSA-N,Phase 1,androgen receptor modulator,AR,,
GLPG1837,GHTGYZMBQPXTCQ-UHFFFAOYSA-N,Phase 2,CFTR channel potentiator,,,
glucaric-acid,DSLZVSRJTYRBFB-LLEIAEIESA-N,Phase 1,,,,
gluconolactone,PHOQVHQSTUBQQK-KLVWXMOXSA-N,Launched,,LCT,,
glucosamine,MSWZFWKMSRAUBD-QZABAPFNSA-N,Launched,glycosylated protein precursor,IL1B,neurology/psychiatry|rheumatology,muscle pain|rheumatoid arthritis|joint pain|backache
glutathione,RWSXRVCMGQZWBV-WDSKDSINSA-N,Phase 3,antioxidant,ESD|GGT1|GLO1|GLRX|GLRX2|GPX1|GPX2|GPX3|GPX4|GPX5|GPX6|GPX7|GPX8|GSR|GSS|GSTA1|GSTA2|GSTA3|GSTA4|GSTA5|GSTK1|GSTM1|GSTM2|GSTM3|GSTM4|GSTM5|GSTO1|GSTO2|GSTP1|GSTT1|GSTZ1|HAGH|HPGDS|LTC4S|MGST1|MGST2|MGST3|TXNDC12,,
glutathione-monoisopropyl-ester,MVNCPACIPXNJIW-IUCAKERBSA-N,Phase 2,lipid peroxidase inhibitor,,,
gly-gln,PNMUAGGSDZXTHX-BYPYZUCNSA-N,Phase 2,,,,
glyburide,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,Launched,ATP channel blocker|insulin secretagogue|sulfonylurea,ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1,endocrinology,diabetes mellitus|hyperglycemia
glycerol-monolaurate,ARIWANIATODDMH-AWEZNQCLSA-N,Launched,beta lactamase inhibitor,,,
glycerol-phenylbutyrate,ZSDBFLMJVAGKOU-UHFFFAOYSA-N,Phase 1,sigma receptor ligand,,,
glycitein,DXYUAIFZCFRPTH-UHFFFAOYSA-N,Phase 3,tumor necrosis factor release inhibitor,TNF,,
glycopyrrolate,ANGKOCUUWGHLCE-HKUYNNGSSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,gastroenterology,peptic ulcer disease (PUD)
GM-1485,FOPALECPEUVCTL-QMMMGPOBSA-N,Preclinical,immunophilin ligand,FKBP1A,,
GMX1778,BOIPLTNGIAPDBY-UHFFFAOYSA-N,Phase 1/Phase 2,NAMPT inhibitor,NAMPT,,
GNE-7915,XCFLWTZSJYBCPF-UHFFFAOYSA-N,Preclinical,leucine rich repeat kinase inhibitor,,,
GNF-2,WEVYNIUIFUYDGI-UHFFFAOYSA-N,Preclinical,Bcr-Abl kinase inhibitor,ABL1|BCR,,
GNF-5,IIQUYGWWHIHOCF-UHFFFAOYSA-N,Preclinical,Bcr-Abl kinase inhibitor,ABL1|BCR,,
GNF-5837,YYDUWLSETXNJJT-MTJSOVHGSA-N,Preclinical,growth factor receptor inhibitor,NTRK1|NTRK2|NTRK3,,
GNF-5837,"InChI=1S/C28H21F4N5O2/c1-15-4-6-19(35-27(39)37-25-11-16(28(30,31)32)5-9-22(25)29)13-23(15)34-18-7-8-20-21(12-17-3-2-10-33-17)26(38)36-24(20)14-18/h2-14,33-34H,1H3,(H,36,38)(H2,35,37,39)/b21-12-",Preclinical,growth factor receptor inhibitor,NTRK1|NTRK2|NTRK3,,
GNF-7,SZNYUUZOQHNEKB-UHFFFAOYSA-N,Preclinical,glucokinase inhibitor|protein kinase inhibitor,GCK|TNK2,,
GNTI,VLNHDKDBGWXJEE-GYHUNEDQSA-N,Preclinical,opioid receptor antagonist,OPRK1|OPRM1,,
go-6983,LLJJDLHGZUOMQP-UHFFFAOYSA-N,Preclinical,protein kinase inhibitor,PRKCA|PRKCB|PRKCD|PRKCG|PRKCZ,,
golgicide-A,NJZHEQOUHLZCOX-WOSRLPQWSA-N,Preclinical,ARF inhibitor,GBF1,,
golvatinib,UQRCJCNVNUFYDX-UHFFFAOYSA-N,Phase 2,VEGFR inhibitor,KDR|MET,,
gonadorelin,XLXSAKCOAKORKW-AQJXLSMYSA-N,Launched,gonadotropin releasing factor hormone receptor agonist,GNRHR,obstetrics/gynecology,cystic ovaries|reproductive synchrony
goserelin-acetate,BLCLNMBMMGCOAS-URPVMXJPSA-N,Launched,gonadotropin releasing factor hormone receptor agonist,GNRHR|LHCGR,oncology|obstetrics/gynecology,prostate cancer|breast cancer|endometriosis
gossypol,QBKSWRVVCFFDOT-UHFFFAOYSA-N,Phase 2,BCL inhibitor|MCL1 inhibitor,BCL2,,
GP1a,FNOMTMVRTBHRET-UHFFFAOYSA-N,Preclinical,cannabinoid receptor agonist,CNR2,,
GP2a,SPEFJYZGXZENAF-UHFFFAOYSA-N,Preclinical,cannabinoid receptor agonist,CNR2,,
GPBAR-A,ZIXNJVGTAXRKAP-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor agonist,GPBAR1,,
GPI-1046,OQAHHWOPVDDWHD-INIZCTEOSA-N,Preclinical,FKBP inhibitor,FKBP1A,,
GPi-688,UICNBXVDHCBKCE-TZMCWYRMSA-N,Preclinical,glycogen phosphorylase inhibitor,,,
GPP-78,SJOLTIOPWDLDEB-UHFFFAOYSA-N,Preclinical,NAMPT inhibitor,NAMPT,,
GPR120-modulator-1,FONSSTYHKIFEBM-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor modulator,FFAR4,,
GR-103691,JARNORYOPMINDY-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,DRD3,,
GR-113808,MOZPSIXKYJUTKI-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR4,,
GR-127935,YDBCEBYHYKAFRX-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6,,
GR-135531,MPZVHKLZCUEJFO-UHFFFAOYSA-N,Preclinical,melatonin receptor agonist,,,
GR-144053,QGEGSJUSWLLZLH-UHFFFAOYSA-N,Preclinical,integrin antagonist,ITGA2B|ITGB3,,
GR-159897,BANYJBHWTOJQDU-GDLZYMKVSA-N,Preclinical,tachykinin antagonist,TAC1|TACR2,,
GR-235,WDXRGPWQVHZTQJ-NRJJLHBYSA-N,Launched,estrogen receptor agonist|FXR antagonist|progesterone receptor agonist,NR1H4,,
GR-79236,GYWXTRVEUURNEW-TVDBPQCTSA-N,Phase 1,adenosine receptor agonist,ADORA1|ADORA2A,,
GR125487,SSPCCAYAIDNNJX-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR4,,
GR46611,LBVZWEWTNUDWNS-YRNVUSSQSA-N,Preclinical,serotonin receptor agonist,HTR1D,,
gramicidin,ZWCXYZRRTRDGQE-LUPIJMBPSA-N,Launched,bacterial permeability inducer,,infectious disease,first-aid antibiotic
gramine,OCDGBSUVYYVKQZ-UHFFFAOYSA-N,Preclinical,norepinephrine reputake inhibitor,,,
granisetron,MFWNKCLOYSRHCJ-BTTYYORXSA-N,Launched,serotonin receptor antagonist,HTR3A,gastroenterology,nausea|vomiting
grapiprant,HZVLFTCYCLXTGV-UHFFFAOYSA-N,Launched,prostaglandin inhibitor,PTGER4,rheumatology,osteoarthritis
grazoprevir,OBMNJSNZOWALQB-NCQNOWPTSA-N,Launched,HCV inhibitor,,infectious disease,hepatitis C
griseofulvin,DDUHZTYCFQRHIY-RBHXEPJQSA-N,Launched,tubulin polymerization inhibitor,KRT12,infectious disease,ringworm|tinea pedis
GS-143,IZPMWFSVTDOCDI-HAVVHWLPSA-N,Preclinical,ubiquitin ligase inhibitor,BTRC|NFKBIA,,
GS-39783,GSGVDKOCBKBMGG-UHFFFAOYSA-N,Preclinical,GABA receptor modulator,GABBR1,,
GS-6201,KOYXXLLNCXWUNF-UHFFFAOYSA-N,Phase 1,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
GS-9620,VFOKSTCIRGDTBR-UHFFFAOYSA-N,Phase 2,toll-like receptor agonist,TLR7,,
GS-967,FEVBKJITJDHASC-UHFFFAOYSA-N,Preclinical,voltage-gated sodium channel blocker,,,
GS-9973,XSMSNFMDVXXHGJ-UHFFFAOYSA-N,Phase 2,SYK inhibitor,SYK,,
GSK-3-inhibitor-IX,DDLZLOKCJHBUHD-UJZLGWIISA-N,Preclinical,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,GSK3A|GSK3B,,
GSK-J1,AVZCPICCWKMZDT-UHFFFAOYSA-N,Preclinical,histone demethylase inhibitor,KDM6B,,
GSK-J2,LJIFOCRGDDQFJF-UHFFFAOYSA-N,Preclinical,histone demethylase inhibitor,,,
GSK-J4,WBKCKEHGXNWYMO-UHFFFAOYSA-N,Preclinical,histone lysine demethylase inhibitor,KDM6A|KDM6B,,
GSK-J5,LQPGVGSKBNXQDU-UHFFFAOYSA-N,Preclinical,histone demethylase control,,,
GSK-LSD-1,BASFYRLYJAZPPL-UONOGXRCSA-N,Preclinical,histone lysine demethylase inhibitor,KDM1A,,
GSK-LSD-1,"InChI=1S/C14H20N2/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12/h1-5,12-16H,6-10H2/t13-,14+/m0/s1",Preclinical,histone lysine demethylase inhibitor,KDM1A,,
GSK0660,NDFKBGWLUHKMFY-UHFFFAOYSA-N,Preclinical,PPAR receptor antagonist,PPARD,,
GSK1059615,QDITZBLZQQZVEE-YBEGLDIGSA-N,Phase 1,PI3K inhibitor,PIK3CG,,
GSK1070916,QTBWCSQGBMPECM-UHFFFAOYSA-N,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC|CYP2D6|CYP3A4,,
GSK1292263,AYJRTVVIBJSSKN-UHFFFAOYSA-N,Phase 2,glucose dependent insulinotropic receptor agonist,GRPR,,
GSK1562590,QDUMEBKFKOODFN-SANMLTNESA-N,Preclinical,urotensin receptor antagonist,UTS2R,,
GSK163090,ANGUXJDGJCHGOG-UHFFFAOYSA-N,Phase 2,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D,,
GSK1838705A,HZTYDQRUAWIZRE-UHFFFAOYSA-N,Preclinical,insulin growth factor receptor inhibitor,ALK|IGF1R|INSR|RPS6KA1,,
GSK189254,WROHEWWOCPRMIA-UHFFFAOYSA-N,Phase 2,histamine receptor antagonist,,,
GSK1904529A,MOSKATHMXWSZTQ-UHFFFAOYSA-N,Preclinical,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,IGF1R|INSR,,
GSK2110183,AFJRDFWMXUECEW-LBPRGKRZSA-N,Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,,
GSK2126458,CGBJSGAELGCMKE-UHFFFAOYSA-N,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
GSK2190915,DFQGDHBGRSTTHX-UHFFFAOYSA-N,Phase 2,lipoxygenase inhibitor,ALOX5AP,,
GSK2193874,UIVOZBSCHXCGPS-UHFFFAOYSA-N,Preclinical,transient receptor potential channel antagonist,TRPV4,,
GSK2194069,AQTPWCUIYUOEMG-INIZCTEOSA-N,Preclinical,fatty acid synthase inhibitor,FASN,,
GSK2239633A,YTEVTHHGQMUPHC-UHFFFAOYSA-N,Preclinical,CC chemokine receptor antagonist,,,
GSK2256098,BVAHPPKGOOJSPU-UHFFFAOYSA-N,Phase 2,kinase inhibitor,,,
GSK2256294A,LQHDJQIMETZMPH-ZBFHGGJFSA-N,Phase 1,epoxide hydolase inhibitor,EPHX2,,
GSK2330672,CZGVOBIGEBDYTP-VSGBNLITSA-N,Phase 2,bile acid transporter inhibitor,SLC10A2,,
GSK2334470,QLPHOXTXAKOFMU-WBVHZDCISA-N,Preclinical,phosphoinositide dependent kinase inhibitor,AURKA|AURKB|PDPK1,,
GSK239512,YFRBKEVUUCQYOW-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,,,
GSK256066,JFHROPTYMMSOLG-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,PDE4A,,
GSK2578215A,WCIGMFCFPXZRMQ-UHFFFAOYSA-N,Preclinical,leucine rich repeat kinase inhibitor,LRRK2,,
GSK2606414,SIXVRXARNAVBTC-UHFFFAOYSA-N,Preclinical,protein kinase inhibitor,EIF2AK3|MYLK2,,
GSK2636771,XTKLTGBKIDQGQL-UHFFFAOYSA-N,Phase 2,PI3K inhibitor,PIK3CB,,
GSK2656157,PRWSIEBRGXYXAJ-UHFFFAOYSA-N,Preclinical,PERK inhibitor,,,
GSK269962,YOVNFNXUCOWYSG-UHFFFAOYSA-N,Preclinical,rho associated kinase inhibitor,ROCK1|ROCK2,,
GSK2801,KHWCPNJRJCNVRI-UHFFFAOYSA-N,Preclinical,bromodomain inhibitor,BAZ2A|BAZ2B,,
GSK2816126,FKSFKBQGSFSOSM-QFIPXVFZSA-N,Phase 1,histone lysine methyltransferase inhibitor,EZH2,,
GSK2830371,IVDUVEGCMXCMSO-FQEVSTJZSA-N,Preclinical,protein phosphatase inhibitor,PPM1D,,
GSK2837808A,RZBCPMYJIARMGV-UHFFFAOYSA-N,Preclinical,lactate dehydrogenase inhibitor,LDHA,,
GSK2838232,MEOWKUXNVNJAMY-PZFKGGKESA-N,Phase 2,HIV gag inhibitor,,,
GSK2879552,LRULVYSBRWUVGR-FCHUYYIVSA-N,Phase 1/Phase 2,histone lysine demethylase inhibitor,KDM1A,,
GSK2881078,SKDVMPZQJMZEAC-SECBINFHSA-N,Phase 2,androgen receptor modulator,,,
GSK2981278,LZLBRISQTJVZNP-UHFFFAOYSA-N,Phase 1/Phase 2,ROR modulator,,,
GSK2982772,LYPAFUINURXJSG-AWEZNQCLSA-N,Phase 2,RIPK inhibitor,,,
GSK3117391,AFDPFLDWOXXHQM-NRFANRHFSA-N,Phase 1/Phase 2,HDAC inhibitor,,,
GSK3179106,IDXKJSSOUXWLDB-UHFFFAOYSA-N,Phase 1,RET tyrosine kinase inhibitor,,,
GSK3326595,JLCCNYVTIWRPIZ-NRFANRHFSA-N,Phase 1/Phase 2,protein arginine N-methyltransferase inhibitor,,,
GSK356278,AWDJJMXJUOHGLC-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,,,
GSK369796,ZVMMVSSEAMUNGI-UHFFFAOYSA-N,Phase 1,potassium channel antagonist,,,
GSK37647,FQUAFMNPXPXOJE-UHFFFAOYSA-N,Preclinical,free fatty acid receptor agonist,FFAR4,,
GSK3787,JFUIMTGOQCQTPF-UHFFFAOYSA-N,Preclinical,PPAR receptor antagonist,PPARD,,
GSK429286A,OLIIUAHHAZEXEX-AWEZNQCLSA-N,Preclinical,rho associated kinase inhibitor,ROCK1,,
GSK461364,ZHJGWYRLJUCMRT-QGZVFWFLSA-N,Phase 1,PLK inhibitor,PLK1,,
GSK503,HRDQQHUKUIKFHT-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EZH2,,
GSK650394,WVSBGSNVCDAMCF-UHFFFAOYSA-N,Preclinical,serum/glucocorticoid regulated kinase inhibitor,SGK1|SGK2,,
GSK656,DJUOWOXTPXUHDQ-MRVPVSSYSA-N,Preclinical,leucyl-tRNA synthetase inhibitor,,,
GSK690693,KGPGFQWBCSZGEL-ZDUSSCGKSA-N,Phase 1,AKT inhibitor,AKT1|AKT2|AKT3|PAK4|PAK6|PAK7|PRKCQ|PRKG1|PRKX,,
GSK9027,DXBJGDVBQPEMOB-UHFFFAOYSA-N,Preclinical,glucocorticoid receptor agonist,NR3C1,,
GSK923295,WHMXDBPHBVLYRC-OFVILXPXSA-N,Phase 1,centromere associated protein inhibitor,CENPE,,
GTP-14564,DZQLVVLATXPWBK-UHFFFAOYSA-N,Preclinical,FLT3 inhibitor|tyrosine kinase inhibitor,CSF1R|FLT3|KIT|PDGFRB,,
GTS21,RPYWXZCFYPVCNQ-RVDMUPIBSA-N,Phase 1/Phase 2,cholinergic receptor agonist,CHRNA7,,
guacetisal,HSJFYRYGGKLQBT-UHFFFAOYSA-N,Launched,immunosuppressant,,pulmonary,cough suppressant
guadecitabine,GUWXKKAWLCENJA-WGWHJZDNSA-N,Phase 3,DNA methyltransferase inhibitor,,,
guaiacol,LHGVFZTZFXWLCP-UHFFFAOYSA-N,Launched,local anesthetic,CA2,pulmonary,cough suppressant
guaifenesin,HSRJKNPTNIJEKV-QMMMGPOBSA-N,Launched,expectorant,,pulmonary,cough suppressant
guanaben-acetate,WDZVGELJXXEGPV-YIXHJXPBSA-N,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,cardiology,hypertension
guanadrel,HPBNRIOWIXYZFK-QMMMGPOBSA-N,Launched,adrenergic inhibitor,,cardiology,hypertension
guancydine,VZVGEDRCVUKSEL-UHFFFAOYSA-N,Preclinical,antihypertensive agent,,,
guanethidine,ACGDKVXYNVEAGU-UHFFFAOYSA-N,Launched,adrenergic inhibitor,SLC6A2,cardiology,hypertension
guanfacine,INJOMKTZOLKMBF-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,cardiology,hypertension
guanidine,ZRALSGWEFCBTJO-UHFFFAOYSA-N,Launched,HSP inhibitor,ALDH2|DLG4|GAMT|RNASE1,neurology/psychiatry,Lambert-Eaton myasthenic syndrome (LEMS)
guanidinoethyldisulfide-bicarbonate,IRMTXMJNHRISQH-UHFFFAOYSA-N,Phase 2,nitric oxide synthase inhibitor,NOS2,,
guanidinopropionic-acid,KMXXSJLYVJEBHI-UHFFFAOYSA-N,Phase 2,creatine kinase inhibitor,CKM,,
guanosine,NYHBQMYGNKIUIF-UUOKFMHZSA-N,Preclinical,,PNP,,
Gue-1654,UFOBDFMYJABXGK-UHFFFAOYSA-N,Preclinical,oxoeicosanoid receptor modulator,OXER1,,
guvacine,QTDZOWFRBNTPQR-UHFFFAOYSA-N,Preclinical,GABA uptake inhibitor,SLC6A1|SLC6A11|SLC6A12|SLC6A13,,
GW-0742,HWVNEWGKWRGSRK-UHFFFAOYSA-N,Preclinical,PPAR receptor agonist,PPARD,,
GW-1100,PTPNCCWOTBBVJR-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor agonist,FFAR1,,
GW-1929,QTQMRBZOBKYXCG-MHZLTWQESA-N,Preclinical,PPAR receptor agonist,PPARG,,
GW-2580,MYQAUKPBNJWPIE-UHFFFAOYSA-N,Preclinical,cFMS kinase inhibitor,CSF1R,,
GW-311616,NDNKNUMSTIMSHQ-URZKGLGPSA-N,Phase 1,elastase inhibitor|leukocyte elastase inhibitor,ELANE,,
GW-3965,NAXSRXHZFIBFMI-UHFFFAOYSA-N,Preclinical,LXR agonist,NR1H2|NR1H3,,
GW-405833,FSFZRNZSZYDVLI-UHFFFAOYSA-N,Preclinical,cannabinoid receptor agonist,CNR2,,
GW-4064,BYTNEISLBIENSA-MDZDMXLPSA-N,Preclinical,FXR agonist,NR1H4,,
GW-438014A,CDUDZZGLFOFINU-UHFFFAOYSA-N,Preclinical,neuropeptide receptor antagonist,NPY5R,,
GW-441756,NXNQLECPAXXYTR-LCYFTJDESA-N,Preclinical,growth factor receptor inhibitor,NTRK1,,
GW-501516,YDBLKRPLXZNVNB-UHFFFAOYSA-N,Phase 2,PPAR receptor agonist,PPARA|PPARD,,
GW-5074,LMXYVLFTZRPNRV-UHFFFAOYSA-N,Phase 1/Phase 2,leucine rich repeat kinase inhibitor|RAF inhibitor,NTRK1|RAF1,,
GW-542573X,SAXGSDIZIYFNKD-UHFFFAOYSA-N,Preclinical,calcium channel activator,KCNN1,,
GW-583340,MNNXRVSQOABRRP-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR|ERBB2,,
GW-627368,XREWXJVMYAXCJV-UHFFFAOYSA-N,Preclinical,prostanoid receptor antagonist,PTGER4,,
GW-6471,TYEFSRMOUXWTDN-DYQICHDWSA-N,Preclinical,PPAR receptor antagonist,PPARA,,
GW-7647,PKNYXWMTHFMHKD-UHFFFAOYSA-N,Preclinical,PPAR receptor agonist,PPARA,,
GW-788388,SAGZIBJAQGBRQA-UHFFFAOYSA-N,Preclinical,ALK tyrosine kinase receptor inhibitor,LCK|MAPK14|TGFBR1,,
GW-803430,MWULMTACIBZPGN-UHFFFAOYSA-N,Phase 1,melanin inhibitor,KCNH2|MCHR1,,
GW-842166,TWQYWUXBZHPIIV-UHFFFAOYSA-N,Phase 2,cannabinoid receptor agonist,CNR2,,
GW-843682X,JSKUWFIZUALZLX-UHFFFAOYSA-N,Preclinical,PLK inhibitor,PLK1|PLK3,,
GW-9508,DGENZVKCTGIDRZ-UHFFFAOYSA-N,Preclinical,free fatty acid receptor agonist|G protein-coupled receptor agonist,FFAR1|FFAR4,,
GW-9662,DNTSIBUQMRRYIU-UHFFFAOYSA-N,Preclinical,PPAR receptor antagonist,NCOA2|PPARG|RXRA,,
GW274150,MOLOJNHYNHBPCW-ZETCQYMHSA-N,Phase 2,nitric oxide synthase inhibitor,,,
GYKI-52466,LFBZZHVSGAHQPP-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,,
GYKI-52466,"InChI=1S/C17H15N3O2/c1-10-6-12-7-15-16(22-9-21-15)8-14(12)17(20-19-10)11-2-4-13(18)5-3-11/h2-5,7-8H,6,9,18H2,1H3",Preclinical,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,,
gynostemma-extract,ZTQSADJAYQOCDD-HUGMCNGHSA-N,Phase 2,calcium channel modulator,,,
GZD824,TZKBVRDEOITLRB-UHFFFAOYSA-N,Preclinical,Bcr-Abl kinase inhibitor,ABL1|BCR,,
H-151,UJZDIKVQFMCLBE-UHFFFAOYSA-N,Preclinical,STING antagonist,,,
H-89,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,Preclinical,PKA inhibitor,GSG2|PKIA|PRKACA,,
H2L-5765834,HFYPTENHTPNXGP-UHFFFAOYSA-N,Preclinical,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3,,
HA-1004,MZNDNBFMSVMUCX-UHFFFAOYSA-N,Phase 2,calcium channel blocker,,,
HA-130,VTNKMYWFWQTEHE-XKZIYDEJSA-N,Preclinical,autotaxin inhibitor,ENPP2,,
HA-966-(R)-(+),HCKUBNLZMKAEIN-GSVOUGTGSA-N,Preclinical,glutamate receptor agonist,GRIA1,,
HA-966-(S)-(-),HCKUBNLZMKAEIN-VKHMYHEASA-N,Preclinical,glutamate receptor antagonist,GRIA1,,
HA14-1,SXJDCULZDFWMJC-AAEUAGOBSA-N,Preclinical,BCL inhibitor,BCL2,,
halazone,XPDVQPODLRGWPL-UHFFFAOYSA-N,Launched,,,infectious disease,disinfectant
halcinonide,MUQNGPZZQDCDFT-JNQJZLCISA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
halobetasol-propionate,BDSYKGHYMJNPAB-LICBFIPMSA-N,Launched,glucocorticoid receptor agonist,NR3C1|PLA2G1B,dermatology,corticosteroid-responsive dermatoses
halofantrine,FOHHNHSLJDZUGQ-RUZDIDTESA-N,Launched,antimalarial agent,KCNN4,infectious disease,malaria
halofuginone,LVASCWIMLIKXLA-CABCVRRESA-N,Launched,collagenase inhibitor,COL1A1|MMP2,rheumatology,scleroderma
halopemide,NBHPRWLFLUBAIE-UHFFFAOYSA-N,Phase 2,phospholipase inhibitor,PLD1|PLD2,,
haloperidol,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1,neurology/psychiatry,schizophrenia|Tourette's disorder
haloperidol-decanoate,GUTXTARXLVFHDK-UHFFFAOYSA-N,Launched,psychoactive drug,DRD2|DRD3|DRD4|HTR2A,neurology/psychiatry,schizophrenia
haloprogin,CTETYYAZBPJBHE-UHFFFAOYSA-N,Launched,other antifungal,,infectious disease,tinea pedis
halothane,BCQZXOMGPXTTIC-PVQJCKRUSA-N,Launched,glutamate receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK12|KCNK13|KCNK15|KCNK18|KCNK2|KCNK3|KCNK9,neurology/psychiatry,general anaesthetic
harmane,PSFDQSOCUJVVGF-UHFFFAOYSA-N,Preclinical,monoamine oxidase inhibitor,MAOA|MAOB,,
harringtonine,HAVJATCHLFRDHY-KSZYUSJVSA-N,Phase 3,protein synthesis inhibitor,,,
HBED,GRUVVLWKPGIYEG-UHFFFAOYSA-N,Phase 3,chelating agent,,,
HC-030031,HEQDZPHDVAOBLN-UHFFFAOYSA-N,Phase 1,TRPA1 channel blocker,TRPA1,,
HC-067047,NCZYSQOTAYFTNM-UHFFFAOYSA-N,Preclinical,transient receptor potential channel antagonist,TRPV4,,
HC-070,VYJPVPHNGWEIBT-UHFFFAOYSA-N,Preclinical,transient receptor potential channel antagonist,,,
heclin,SPTWXRJNCFIDRQ-ZHACJKMWSA-N,Preclinical,ubiquitin ligase inhibitor,NEDD4|SMURF2|WWP1,,
HEMADO,KOCIMZNSNPOGOP-IWCJZZDYSA-N,Preclinical,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
hematoporphyrin,DWZDGMDDUHAIQA-XEAGYAAOSA-N,Launched,,,neurology/psychiatry,depression|psychosis
hematoxylin,WZUVPPKBWHMQCE-XJKSGUPXSA-N,Preclinical,,,,
hemin,BMUDPLZKKRQECS-HXFTUNQESA-K,Launched,enzyme inducer,,hematology|cardiology,acute intermittent porphyria (AIP)|hypertension|ventricular tachycardia (VT)
hemomex-s,SHCBCKBYTHZQGZ-CJPZEJHVSA-N,Launched,,PPARG,,
hepsulfam,GOJJWDOZNKBUSR-UHFFFAOYSA-N,Preclinical,DNA cross-linking,,,
heptaminol,LREQLEBVOXIEOM-SSDOTTSWSA-N,Launched,vasoconstrictor,,cardiology,hypotension
HER2-Inhibitor-1,QVMNYGOVNWWFKF-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,,,
hesperadin,GLDSKRNGVVYJAB-DQSJHHFOSA-N,Preclinical,Aurora kinase inhibitor,AURKB,,
hesperetin,AIONOLUJZLIMTK-AWEZNQCLSA-N,Launched,ACAT inhibitor,DGAT1|MTTP|SOAT1|SOAT2,,
hesperidin,QUQPHWDTPGMPEX-QJBIFVCTSA-N,Launched,flavanone glycoside,AURKB|CACNA1B,,
hetacillin,DXVUYOAEDJXBPY-NFFDBFGFSA-N,Launched,bacterial cell wall synthesis inhibitor,,obstetrics/gynecology,mastitis
hexachlorophene,ACGUYXCXAPNIKK-UHFFFAOYSA-N,Launched,potassium channel activator,GLUD1|SDHD,infectious disease,gram-positive bacterial infections
hexamethonium,VZJFGSRCJCXDSG-UHFFFAOYSA-N,Preclinical,cholinergic receptor antagonist,CHRNA2|CHRNA3|CHRNA4|CHRNA6,,
hexamethylenebisacetamide,BNQSTAOJRULKNX-UHFFFAOYSA-N,Phase 2,AKT inhibitor|differentiation inducer|NFKB pathway inhibitor,AKT1,,
hexaminolevulinate,RYQOILLJDKPETL-UHFFFAOYSA-N,Launched,,,radiology,diagnostic agent
hexasodium-phytate,IMQLKJBTEOYOSI-GPIVLXJGSA-N,Phase 2,,,,
hexestrol,PBBGSZCBWVPOOL-HDICACEKSA-N,Launched,synthetic estrogen,AKR1C1|ESR1|ESR2,endocrinology,hypoestrogenism
hexetidine,DTOUUUZOYKYHEP-AERCQKQUSA-N,Launched,local anesthetic,,otolaryngology|infectious disease|dental|gastroenterology,pharyngitis|meningitis|laryngitis|gingivitis|ulcerative colitis
hexonic-acid,RGHNJXZEOKUKBD-TXICZTDVSA-N,Preclinical,,,,
hexoprenaline,OXLZNBCNGJWPRV-SZPZYZBQSA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma
hexylcaine,DKLKMKYDWHYZTD-ZDUSSCGKSA-N,Launched,sodium channel blocker,SCN5A,neurology/psychiatry,local anesthetic
hexylene-glycol,SVTBMSDMJJWYQN-RXMQYKEDSA-N,Preclinical,,AKR1C3|CTPS1|DLG4|HSP90AA1|NOS3|PGF|PLA2G1B|PTPN1|SELP,,
hexylresorcinol,WFJIVOKAWHGMBH-UHFFFAOYSA-N,Launched,local anesthetic,TYR,infectious disease,skin infections|first-aid antiseptic
higenamine,WZRCQWQRFZITDX-CQSZACIVSA-N,Phase 1,adrenergic receptor agonist,ADRB2,,
hippuric-acid,QIAFMBKCNZACKA-UHFFFAOYSA-N,Preclinical,,,,
histamine,NTYJJOPFIAHURM-UHFFFAOYSA-N,Launched,histamine receptor agonist,HRH1|HRH2|HRH3|HRH4,allergy,allergic rhinitis
HJC-0350,AFZWZVLPIMHLSE-UHFFFAOYSA-N,Preclinical,GTPase inhibitor,RAPGEF4,,
HKI-357,NERXPXBELDBEPZ-RMKNXTFCSA-N,Phase 1,EGFR inhibitor,EGFR,,
HLCL-61,FIOIJUCPVZEPFX-UHFFFAOYSA-N,Preclinical,protein arginine N-methyltransferase inhibitor,PRMT5,,
HM-30181,AHJUHHDDCJQACA-UHFFFAOYSA-N,Phase 1,P glycoprotein inhibitor,,,
HMN-214,OCKHRKSTDPOHEN-BQYQJAHWSA-N,Phase 1,PLK inhibitor,PLK1,,
HOKU-81,LIXBJWRFCNRAPA-NSHDSACASA-N,Preclinical,bronchodilator,,,
homatropine,ZTVIKZXZYLEVOL-YJNKXOJESA-N,Launched,acetylcholine receptor antagonist,CHRM1,ophthalmology,uveal tract inflammation|pupil dilation
homatropine-methylbromide,WKWOJBUWWZTUQV-JJXSEGSLSA-N,Launched,acetylcholine receptor antagonist,CHRM5,ophthalmology,uveal tract inflammation
homidium,QTANTQQOYSUMLC-UHFFFAOYSA-O,Preclinical,,,,
homochlorcyclizine,WEUCDJCFJHYFRL-IBGZPJMESA-N,Launched,antihistamine,HRH1,allergy,allergic rhinitis
homoharringtonine,HYFHYPWGAURHIV-JFIAXGOJSA-N,Launched,protein synthesis inhibitor,RPL3,hematologic malignancy,chronic myeloid leukemia (CML)
homoquinolinic-acid,HQPMJFFEXJELOQ-UHFFFAOYSA-N,Preclinical,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
homosalate,WSSJONWNBBTCMG-RYUDHWBXSA-N,Preclinical,HSP inducer,,,
homoveratrylamine,ANOUKFYBOAKOIR-UHFFFAOYSA-N,Preclinical,monoamine oxidase inhibitor,,,
honokiol,FVYXIJYOAGAUQK-UHFFFAOYSA-N,Phase 3,AKT inhibitor,ALOX5|PTGS1|PTGS2,,
hordenine,KUBCEEMXQZUPDQ-UHFFFAOYSA-N,Preclinical,,,,
HP-228,UHKZNDVUBSEJJO-XAYNKGEHSA-N,Preclinical,nitric oxide synthase inhibitor,,,
hPGDS-IN-1,VJCLAPUACUQZOV-UHFFFAOYSA-N,Preclinical,prostaglandin inhibitor,,,
HPPH,PVXGCBZIVFCMJK-AUSGGWNYSA-N,Phase 2,photosensitizing agent,,,
HQK-1001,VUAXHMVRKOTJKP-UHFFFAOYSA-N,Phase 2,,,,
HSR6071,LUJDHCXCWJFNOJ-UHFFFAOYSA-N,Preclinical,antiallergic agent,,,
HT-2157,TXCGMRVPXUBHAL-PLRJNAJWSA-N,Phase 1/Phase 2,galanin receptor 3 antagonist,,,
HTH-01-015,CHSDJDLAKKAWCI-UHFFFAOYSA-N,Preclinical,protein kinase inhibitor,NUAK1,,
HTHQ,ATMNQRRJNBCQJO-UHFFFAOYSA-N,Preclinical,antioxidant,,,
HTMT,PMKJGGBYYNEYPA-AWEZNQCLSA-N,Preclinical,histamine receptor agonist,HRH4,,
huperzine-A,ZRJBHWIHUMBLCN-YQEJDHNASA-N,Phase 2,acetylcholinesterase inhibitor,ACHE,,
hyaluronic-acid,WCDDVEOXEIYWFB-VXORFPGASA-N,Launched,,C1QBP|CD44|HABP2|HAPLN1|HAPLN3|HAPLN4|HMMR|ICAM1|NCAN|VCAN,rheumatology|urology,osteoarthritis|interstitial cystitis (IC)
hycanthone,MFZWMTSUNYWVBU-UHFFFAOYSA-N,Launched,RNA synthesis inhibitor,,infectious disease,schistosomiasis
hydralazine,RPTUSVTUFVMDQK-UHFFFAOYSA-N,Launched,vasodilator,,cardiology,hypertension
"hydrastine-(1R,9S)",JZUTXVTYJDCMDU-MOPGFXCFSA-N,Preclinical,tyrosine hydroxylase inhibitor,,,
hydrastinine,LGDCROILDUSHQX-UHFFFAOYSA-N,Preclinical,hemostatic agent,,,
hydrochlorothiazide,JZUFKLXOESDKRF-UHFFFAOYSA-N,Launched,thiazide diuretic,CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A3,cardiology,hypertension|congestive heart failure
hydrocortisone,JYGXADMDTFJGBT-VWUMJDOOSA-N,Launched,glucocorticoid receptor agonist,ANXA1|NOS2|NR3C1|NR3C2,dermatology|neurology/psychiatry,eczema|psoriasis|seborrheic dermatitis|itching
hydrocortisone-acetate,ALEXXDVDDISNDU-JZYPGELDSA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
hydrocortisone-butyrate,BMCQMVFGOVHVNG-TUFAYURCSA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses|eczema
hydrocortisone-hemisuccinate,VWQWXZAWFPZJDA-CGVGKPPMSA-N,Phase 2/Phase 3,,,,
hydrocortisone-phosphate,BGSOJVFOEQLVMH-SBXZOHCASA-N,Launched,,,pulmonary|gastroenterology|hematologic malignancy|ophthalmology,asthma|nausea|vomiting|multiple myeloma|contact dermatitis|enteritis|colitis
hydrocortisone-valerate,FZCHYNWYXKICIO-FZNHGJLXSA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
hydroflumethiazide,DMDGGSIALPNSEE-UHFFFAOYSA-N,Launched,sodium/potassium/chloride transporter inhibitor,ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3,cardiology|gastroenterology|rheumatology|nephrology,edema|congestive heart failure|hepatic cirrhosis|nephrotic syndrome|chronic renal failure|acute glomerulonephritis (AGN)|hypertension
hydroquinidine,LJOQGZACKSYWCH-LHHVKLHASA-N,Launched,antiarrhythmic,,cardiology,cardiac arrythmia
hydroquinone,QIGBRXMKCJKVMJ-UHFFFAOYSA-N,Launched,melanin inhibitor,TYR,dermatology,dyschromia
hydroxocobalamin,YOZNUFWCRFCGIH-WZHZPDAFSA-L,Launched,vitamin B,,,
hydroxyamphetamine,GIKNHHRFLCDOEU-SSDOTTSWSA-N,Launched,trace amine associated receptor agonist,TAAR1,ophthalmology,mydriasis
hydroxychloroquine,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,Launched,antimalarial agent,TLR7|TLR9,infectious disease,malaria
hydroxyfasudil,ZAVGJDAFCZAWSZ-UHFFFAOYSA-N,Preclinical,rho associated kinase inhibitor,PKIA|PRKACA|ROCK1,,
hydroxyprogesterone,DBPWSSGDRRHUNT-CEGNMAFCSA-N,Launched,progesterone receptor agonist,PGR,obstetrics/gynecology,spontaneous preterm birth
hydroxyprogesterone-acetate,VTHUYJIXSMGYOQ-KOORYGTMSA-N,Launched,progesterone receptor agonist,PGR,,
hydroxypropyl-beta-cyclodextrin,ODLHGICHYURWBS-LWHSBNEASA-N,Phase 2/Phase 3,,,,
hydroxysafflor-yellow-A,DKEZDPGUJMMUCC-GJVNFNJISA-N,Preclinical,antitumor agent,,,
hydroxystilbamidine,TUESWZZJYCLFNL-DAFODLJHSA-N,Launched,,,,
"hydroxytacrine-maleate-(R,S)",HLVVITIHAZBPKB-NSHDSACASA-N,Preclinical,cholinesterase inhibitor,ACHE,,
hydroxytoluic-acid,WHSXTWFYRGOBGO-UHFFFAOYSA-N,Preclinical,,,,
hydroxyurea,VSNHCAURESNICA-UHFFFAOYSA-N,Launched,ribonucleotide reductase inhibitor,RRM1|RRM2|RRM2B,hematologic malignancy|oncology,chronic myeloid leukemia (CML)|head and neck squamous cell carcinoma (HNSCC)
hydroxyzine,ZQDWXGKKHFNSQK-NRFANRHFSA-N,Launched,antihistamine,HRH1,neurology/psychiatry|allergy|dermatology,anxiety|urticaria|itching|dermatosis
hygromycin-B,GRRNUXAQVGOGFE-SIGCQSELSA-N,Preclinical,polypeptide synthesis inhibitor,,,
hymecromone,HSHNITRMYYLLCV-UHFFFAOYSA-N,Phase 2,monoamine oxidase inhibitor,MAOA|MAOB,,
hyodeoxycholic-acid,DGABKXLVXPYZII-SIBKNCMHSA-N,Phase 1,atherosclerosis formation inhibitor,,,
hyoscyamine,RKUNBYITZUJHSG-FXUDXRNXSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,gastroenterology|urology|neurology/psychiatry|allergy,peptic ulcer disease (PUD)|acute abdominal visceral spasm|ulcerative colitis|interstitial cystitis (IC)|enterocolitis|irritable bowel syndrome|tremors|allergic rhinitis
hypericin,BTXNYTINYBABQR-UHFFFAOYSA-N,Phase 3,tyrosine kinase inhibitor,,,
hyperin,OVSQVDMCBVZWGM-FHYQVQSVSA-N,Preclinical,aldose reductase inhibitor,ACE|AKR1B1,,
hypoestoxide,HNPAHGHFONBTLV-KSJQNFQUSA-N,Phase 1,IKK inhibitor,IKBKB|IL1B|TNF,,
hypoxanthine,FDGQSTZJBFJUBT-UHFFFAOYSA-N,Preclinical,PARP inhibitor,PNP,,
I-BET-762,AAAQFGUYHFJNHI-SFHVURJKSA-N,Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,,
I-BET-762,"InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1",Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,,
I-BET151,VUVUVNZRUGEAHB-CYBMUJFWSA-N,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4,,
I-BRD9,WRUWGLUCNBMGPS-UHFFFAOYSA-N,Preclinical,bromodomain inhibitor,BRD9,,
I-BZA,HRVWCNMOEFNEON-UHFFFAOYSA-N,Phase 2,,,,
I-BZA2,WNSWOZIBBVUJBI-UHFFFAOYSA-N,Phase 3,,,,
I-CBP-112,YKNAKDFZAWQEEO-IBGZPJMESA-N,Preclinical,bromodomain inhibitor,CREBBP|EP300,,
IACS-10759,HWJWNWZJUYCGKV-UHFFFAOYSA-N,Preclinical,mitochondrial complex I inhibitor,,,
IB-MECA,HUJXGQILHAUCCV-MOROJQBDSA-N,Phase 3,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
ibandronate,MPBVHIBUJCELCL-UHFFFAOYSA-N,Launched,bone resorption inhibitor,FDPS,orthopedics,osteoporosis
IBC-293,RUTVRAJKELSHCC-UHFFFAOYSA-N,Preclinical,hydroxycarboxylic acid receptor agonist,HCAR3,,
iberdomide,IXZOHGPZAQLIBH-NRFANRHFSA-N,Preclinical,cereblon modulator,,,
ibiglustat,YFHRCLAKZBDRHN-MRXNPFEDSA-N,Preclinical,glucosylceramidase inhibitor,,,
IBMX,APIXJSLKIYYUKG-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,ADORA1|PDE2A|PDE3B|PDE4D|PDE5A|PDE6G|PDE7A|PDE8A|PDE9A,,
ibotenic-acid,IRJCBFDCFXCWGO-SCSAIBSYSA-N,Preclinical,glutamate receptor agonist,GRIN1,,
ibrolipim,KPRTURMJVWXURQ-UHFFFAOYSA-N,Phase 2,lipoprotein lipase activator,LPL,,
ibrutinib,XYFPWWZEPKGCCK-GOSISDBHSA-N,Launched,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,hematologic malignancy,chronic lymphocytic leukemia (CLL)|mantle cell lymphoma (MCL)|Waldenstrom's macroglobulinemia (WM)
ibrutinib,"InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1",Launched,Bruton's tyrosine kinase (BTK) inhibitor,BLK|BMX|BTK,hematologic malignancy,chronic lymphocytic leukemia (CLL)|mantle cell lymphoma (MCL)|Waldenstrom's macroglobulinemia (WM)
ibudilast,ZJVFLBOZORBYFE-UHFFFAOYSA-N,Launched,leukotriene receptor antagonist|phosphodiesterase inhibitor,IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A,pulmonary|neurology/psychiatry,asthma|stroke
ibuprofen,HEFNNWSXXWATRW-SNVBAGLBSA-N,Launched,cyclooxygenase inhibitor,,neurology/psychiatry|rheumatology|otolaryngology|obstetrics/gynecology|endocrinology|dental,headache|muscle pain|rheumatoid arthritis|backache|common cold|menstrual pain|fever|toothache
ibuprofen-(S),HEFNNWSXXWATRW-JTQLQIEISA-N,Launched,cyclooxygenase inhibitor,ASIC1|PTGS1|PTGS2|SLC5A8,neurology/psychiatry,pain relief
ibuprofen-lysine,IHHXIUAEPKVVII-APFIOPMWSA-N,Launched,cyclooxygenase inhibitor,,cardiology,patent ductus arteriosus (PDA)
ibuprofen-piconol,ACEWLPOYLGNNHV-OAHLLOKOSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
ibuproxam,BYPIURIATSUHDW-SNVBAGLBSA-N,Launched,cyclooxygenase inhibitor|prostaglandin inhibitor,ALOX5,endocrinology|rheumatology|neurology/psychiatry,fever|joint inflammation|pain relief
ibutamoren,UMUPQWIGCOZEOY-JOCHJYFZSA-N,Phase 2,growth hormone secretagogue receptor agonist,GHR|GHSR,,
ibutilide,ALOBUEHUHMBRLE-HXUWFJFHSA-N,Launched,potassium channel blocker,CACNA1C|KCNH2,cardiology,atrial fibrillation (AF)
IC261,JBJYTZXCZDNOJW-JLHYYAGUSA-N,Preclinical,casein kinase inhibitor,CSNK1A1|CSNK1D|CSNK1E|CSNK1G2,,
ICA-069673,IIBSHMFXVWTQSJ-UHFFFAOYSA-N,Preclinical,voltage-gated potassium channel activator,KCNQ2|KCNQ3,,
ICA-110381,FOYOGIUAMYSVIT-UHFFFAOYSA-N,Preclinical,voltage-gated potassium channel activator,KCNQ2,,
ICA-121431,URSQNPPONHUJDL-UHFFFAOYSA-N,Preclinical,sodium channel blocker,SCN1A|SCN3A,,
icariin,TZJALUIVHRYQQB-XLRXWWTNSA-N,Phase 3,phosphodiesterase inhibitor,PDE5A,,
icaritin,TUUXBSASAQJECY-UHFFFAOYSA-N,Phase 3,PPAR receptor antagonist,PDE5A,,
icatibant-acetate,QURWXBZNHXJZBE-SKXRKSCCSA-N,Launched,bradykinin receptor antagonist,BDKRB2,cardiology,angioedema
ICG-001,HQWTUOLCGKIECB-XZWHSSHBSA-N,Preclinical,beta-catenin inhibitor,CTNNB1,,
"ICI-118,551",VFIDUCMKNJIJTO-XJKSGUPXSA-N,Phase 2,adrenergic receptor antagonist,ADRB2|ADRB3,,
ICI-162846,ALCSGJCIESECFD-UHFFFAOYSA-N,Phase 1,histamine receptor antagonist,HRH2,,
ICI-169369,HYOLQGVNMQNERE-UHFFFAOYSA-N,Phase 2,serotonin receptor antagonist,,,
"ICI-185,282",ZWAVGFSZMACJHA-PMNBYGLBSA-N,Phase 1,thromboxane receptor antagonist,,,
ICI-192605,WHUIENZXNGAHQI-GKZDNZBASA-N,Phase 2,thromboxane receptor antagonist,TBXA2R,,
ICI-199441,AEJOEPSMZCEYJN-HXUWFJFHSA-N,Preclinical,opioid receptor agonist,CYP2D6|OPRD1|OPRK1|OPRM1|UTS2R,,
"ICI-215,001",MXWICZOXPUWAHY-HNNXBMFYSA-N,Preclinical,adrenergic receptor agonist,ADRB3,,
ICI-63197,UQDVRVNMIJAGRK-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,,,
ICI-89406,HTLWRKRZKFAAAH-KRWDZBQOSA-N,Phase 1,adrenergic receptor antagonist,ADRB1|ADRB2,,
icilin,RCEFMOGVOYEGJN-UHFFFAOYSA-N,Phase 1,TRPV agonist,TRPA1|TRPM8,,
iclaprim,HWJPWWYTGBZDEG-AWEZNQCLSA-N,Phase 3,dihydrofolate reductase inhibitor,,,
icomucret,JSFATNQSLKRBCI-VAEKSGALSA-N,Phase 3,mucin production enhancer,LTB4R2,,
icosapent,JAZBEHYOTPTENJ-JLNKQSITSA-N,Launched,platelet aggregation inhibitor,ACSL3|ACSL4|FADS1|FFAR1|PPARD|PPARG|PTGS1|PTGS2|SLC8A1|TRPV1,endocrinology,hypertriglyceridemia
icotinib,QQLKULDARVNMAL-UHFFFAOYSA-N,Launched,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC)
iCRT-14,NCSHZXNGQYSKLR-UNOMPAQXSA-N,Preclinical,beta catenin inhibitor|WNT signaling inhibitor,CTNNB1|TCF4,,
ID-1101,OSCCDBFHNMXNME-YUPRTTJUSA-N,Phase 1,insulin sensitizer,INS,,
ID-8,VVZNWYXIOADGSW-UHFFFAOYSA-N,Preclinical,,,,
idalopirdine,YBAWYTYNMZWMMJ-UHFFFAOYSA-N,Phase 3,serotonin receptor antagonist,HTR6,,
idarubicin,XDXDZDZNSLXDNA-TZNDIEGXSA-N,Launched,topoisomerase inhibitor,TOP2A,hematologic malignancy,acute myeloid leukemia (AML)
idasanutlin,TVTXCJFHQKSQQM-LJQIRTBHSA-N,Phase 3,MDM inhibitor,MDM2|TP53,,
idasanutlin,"InChI=1S/C31H29Cl2F2N3O4/c1-30(2,3)14-24-31(15-36,19-10-9-17(32)13-21(19)34)25(18-6-5-7-20(33)26(18)35)27(38-24)28(39)37-22-11-8-16(29(40)41)12-23(22)42-4/h5-13,24-25,27,38H,14H2,1-4H3,(H,37,39)(H,40,41)/t24-,25-,27+,31-/m0/s1",Phase 3,MDM inhibitor,MDM2|TP53,,
idazoxan,HPMRFMKYPGXPEP-SNVBAGLBSA-N,Phase 3,adrenergic receptor antagonist,ADRA2A|PTGS2,,
idebenone,JGPMMRGNQUBGND-UHFFFAOYSA-N,Launched,calcium channel modulator,,neurology/psychiatry|ophthalmology,Alzheimer's disease|Friedreich's ataxia|Leber hereditary optic neuropathy (LHON)
idelalisib,IFSDAJWBUCMOAH-HNNXBMFYSA-N,Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,hematologic malignancy,chronic lymphocytic leukemia (CLL)
idelalisib,"InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1",Launched,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,hematologic malignancy,chronic lymphocytic leukemia (CLL)
IDF-11774,QGBBBLPWBSWERZ-UHFFFAOYSA-N,Preclinical,hypoxia inducible factor inhibitor,,,
IDH-305,DCGDPJCUIKLTDU-SUNYJGFJSA-N,Phase 2,isocitrate dehydrogenase inhibitor,,,
IDO5L,HGXSLPIXNPASGZ-UHFFFAOYSA-N,Preclinical,"indoleamine 2,3-dioxygenase inhibitor",IDO1,,
idoxuridine,XQFRJNBWHJMXHO-RRKCRQDMSA-N,Launched,DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor,,infectious disease,virus herpes simplex (HSV)
IDRA-21,VZRNTCHTJRLTMU-YFKPBYRVSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4,,
idramantone,TZBDEVBNMSLVKT-XYYXLIQBSA-N,Preclinical,,,,
idronoxil,ZZUBHVMHNVYXRR-UHFFFAOYSA-N,Phase 3,XIAP inhibitor,ENOX2|SPHK1,,
IEM1460,IWYZMMIPAJDJBN-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIA2,,
IEM1754,UWWMQHVWAYFCDT-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIA1,,
ifenprodil,UYNVMODNBIQBMV-KKSFZXQISA-N,Launched,adrenergic receptor antagonist|glutamate receptor antagonist,GRIN2B,,
ifosfamide,HOMGKSMUEGBAAB-CQSZACIVSA-N,Launched,DNA alkylating agent,CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1,oncology|urology,testicular carcinoma|hemorrhagic cystitis
igmesine,VCZSWYIFCKGTJI-JLHYYAGUSA-N,Phase 2,sigma receptor agonist,SIGMAR1,,
iguratimod,ANMATWQYLIFGOK-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor|NFkB pathway inhibitor,PTGS2,rheumatology,rheumatoid arthritis
IKK-16,BWZJBXAPRCVCKQ-UHFFFAOYSA-N,Preclinical,IKK inhibitor,IKBKB,,
IKK-2-inhibitor,BMUACLADCKCNKZ-UHFFFAOYSA-N,Preclinical,IKK inhibitor|SYK inhibitor,IKBKB,,
IKK-2-inhibitor-V,CHILCFMQWMQVAL-UHFFFAOYSA-N,Phase 1,IKK inhibitor|NFkB pathway inhibitor,IKBKB,,
ilaprazole,HRRXCXABAPSOCP-AREMUKBSSA-N,Launched,proton pump inhibitor,,gastroenterology,gastroesophageal reflux disease (GERD)
ilepcimide,BLPUOQGPBJPXRL-FNORWQNLSA-N,Phase 3,anticonvulsant,,,
ilomastat,NITYDPDXAAFEIT-DYVFJYSZSA-N,Phase 3,matrix metalloprotease inhibitor,ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9,,
iloperidone,XMXHEBAFVSFQEX-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR2A|HTR6|HTR7,neurology/psychiatry,schizophrenia
iloprost,HIFJCPQKFCZDDL-GBSCXWAGSA-N,Launched,platelet aggregation inhibitor|prostanoid receptor agonist,PTGDR|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R,pulmonary,pulmonary arterial hypertension (PAH)
imatinib,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Launched,Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET,hematologic malignancy|oncology,chronic myeloid leukemia (CML)|acute lymphoblastic leukemia (ALL)|myelodysplastic diseases (MDS)|aggressive systemic mastocytosis (ASM)|hypereosinophilic syndrome (HES)|chronic eosinophilic leukemia (CEL)|dermatofibrosarcoma protuberans (DFSP)|gastrointestinal stromal tumors (GIST)
Imazodan,VXMYWVMXSWJFCV-UHFFFAOYSA-N,Phase 1,phosphodiesterase inhibitor,,,
imeglimin,GFICWFZTBXUVIG-SCSAIBSYSA-N,Phase 2,gluconeogenesis inhibitor,,,
imetit,PEHSVUKQDJULKE-UHFFFAOYSA-N,Preclinical,histamine receptor agonist,HRH3|HRH4,,
imexon,BIXBBIPTYBJTRY-VBMBUWLQSA-N,Phase 2,apoptosis stimulant|ribonucleotide reductase inhibitor,,,
imidacloprid,YWTYJOPNNQFBPC-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,,,
imidafenacin,SQKXYSGRELMAAU-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM3,neurology/psychiatry,spasms
imidapril,KLZWOWYOHUKJIG-BPUTZDHNSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure
imidazoacridinone,CUNDRHORZHFPLY-UHFFFAOYSA-N,Preclinical,anticancer agent,,,
imidurea,ZCTXEAQXZGPWFG-RFZPGFLSSA-N,Preclinical,other antibiotic,,,
imiloxan,UXABARREKCJULM-NSHDSACASA-N,Phase 1,adrenergic receptor antagonist,ADRA2A|ADRA2B,,
imipenem,ZSKVGTPCRGIANV-ZXFLCMHBSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,pneumonia|urinary tract infections|intra-abdominal infections|gynecologic infections|bacterial septicemia|bone and joint infections|skin infections|endocarditis
imipramine,BCGWQEUPMDMJNV-UHFFFAOYSA-N,Launched,norepinephrine reputake inhibitor|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry|urology,depression|nocturnal enuresis
imiquimod,DOUYETYNHWVLEO-UHFFFAOYSA-N,Launched,interferon inducer|toll-like receptor agonist,TLR7|TLR8,dermatology|infectious disease|oncology,actinic keratosis (AK)|genital warts|basal cell carcinoma (BCC)
imirestat,QCCHBHSAIQIQGO-UHFFFAOYSA-N,Preclinical,aldose reductase inhibitor,,,
imisopasem-manganese,UWYSKLMRWPKZES-XNPJUPKFSA-L,Preclinical,superoxide dismutase mimetic,,,
immepip,MCNGUYXRBCIGOV-UHFFFAOYSA-N,Preclinical,histamine receptor agonist,HRH3|HRH4,,
immethridine,DFVSGZHJSIEEQQ-UHFFFAOYSA-N,Phase 1,histamine receptor agonist,HRH3,,
impentamine,MZCJWLAXZRFUPI-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,HRH3,,
IMREG-1,HIINQLBHPIQYHN-JTQLQIEISA-N,Phase 3,,,,
inarigivir,LYMICVBGNUEHGE-NLKZJYKHSA-N,Phase 2,antiviral,,,
inarigivir-soproxil,CJCYTUJOSMYXLE-NHMFLIHISA-N,Phase 2,antiviral,,,
INC-280,LIOLIMKSCNQPLV-UHFFFAOYSA-N,Phase 3,c-Met inhibitor,MET,,
INCA-6,GCHPUOHXXCNSQL-UHFFFAOYSA-N,Preclinical,calcineurin inhibitor,NFATC1,,
INCB-003284,NXZNYBUBXWWKCP-JMOWIOHXSA-N,Phase 2,CC chemokine receptor antagonist,,,
INCB-057643,ZNFWPFHSBWLNSO-UHFFFAOYSA-N,Phase 1/Phase 2,bromodomain inhibitor,,,
INCB-3284,NXZNYBUBXWWKCP-DNRQZRRGSA-N,Phase 2,CC chemokine receptor antagonist,CCR2,,
incyclinide,MDYVZYDNBUAVCN-WCAKBIDQSA-N,Phase 2,matrix metalloprotease inhibitor,,,
indacaterol,QZZUEBNBZAPZLX-QFIPXVFZSA-N,Launched,adrenergic receptor agonist,ADRB1|ADRB2,pulmonary,chronic obstructive pulmonary disease (COPD)
indalpine,SADQVAVFGNTEOD-UHFFFAOYSA-N,Withdrawn,selective serotonin reuptake inhibitor (SSRI),SLC6A4,,
indapamide,NDDAHWYSQHTHNT-JTQLQIEISA-N,Launched,thiazide diuretic,CA2|HTR3A|KCNQ1,cardiology,hypertension|congestive heart failure
indatraline,SVFXPTLYMIXFRX-XJKSGUPXSA-N,Preclinical,norepinephrine transporter inhibitor,MAOA|MAOB,,
indeglitazar,YMPALHOKRBVHOJ-UHFFFAOYSA-N,Phase 2,PPAR receptor agonist,NCOA1|PPARA|PPARD|PPARG,,
indeloxazine,MADRVGBADLFHMO-GFCCVEGCSA-N,Withdrawn,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,,,
indibulin,SOLIIYNRSAWTSQ-UHFFFAOYSA-N,Phase 1/Phase 2,tubulin polymerization inhibitor,,,
indinavir,CBVCZFGXHXORBI-PXQQMZJSSA-N,Launched,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1)
indinavir,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",Launched,HIV protease inhibitor,CYP3A4|CYP3A5|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1)
indiplon,CBIAWPMZSFFRGN-UHFFFAOYSA-N,Phase 3,benzodiazepine receptor agonist,GABRA1,,
indirubin,CRDNMYFJWFXOCH-YPKPFQOOSA-N,Phase 2/Phase 3,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK5|GSK3A,,
indirubin-3-monoxime,HBDSHCUSXQATPO-BGBJRWHRSA-N,Preclinical,CDK inhibitor|glycogen synthase kinase inhibitor,CDK1|CDK2|CDK5|CDK5R1|GSK3B,,
indisulam,SETFNECMODOHTO-UHFFFAOYSA-N,Phase 2,CDK inhibitor,CA1|CA12|CA14|CA2|CA6|CA7|CA9,,
indium-tri(2-propanolate),OVZUSPADPSOQQN-UHFFFAOYSA-N,Preclinical,,,,
indium(III)-isopropoxide,JUUUERJZVKCDOT-UHFFFAOYSA-N,Preclinical,,,,
indobufen,AYDXAULLCROVIT-OAHLLOKOSA-N,Launched,cyclooxygenase inhibitor|platelet aggregation inhibitor,PTGS1|PTGS2,hematology,thrombosis
indocyanine-green,BDBMLMBYCXNVMC-UHFFFAOYSA-O,Launched,contrast agent,SLCO1B1,cardiology,vascular imaging agent
indole-3-carbinol,IVYPNXXAYMYVSP-UHFFFAOYSA-N,Phase 2/Phase 3,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",AHR,,
indole-3-pyrubate,KDCSRTPNDBPWQZ-UHFFFAOYSA-N,Phase 2,melatonin receptor agonist,,,
indomethacin,CGIGDMFJXJATDK-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1,rheumatology|orthopedics,rheumatoid arthritis|ankylosing spondylitis|osteoarthritis|bursitis|tendinitis
indoprofen,RJMIEHBSYVWVIN-LLVKDONJSA-N,Withdrawn,cyclooxygenase inhibitor|prostanoid receptor antagonist,CXCR1|CXCR2|PTGS1|PTGS2,,
indoramin,JXZZEXZZKAWDSP-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension
indoximod,ZADWXFSZEAPBJS-SNVBAGLBSA-N,Phase 2,"indoleamine 2,3-dioxygenase inhibitor",IDO1,,
ingenol,VEBVPUXQAPLADL-POYOOMFHSA-N,Launched,PKC activator,PRKCD|PRKCE,dermatology,keratosis
ingenol-mebutate,VDJHFHXMUKFKET-WDUFCVPESA-N,Launched,PKC activator,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG,dermatology,actinic keratosis (AK)
INH1,JPMOKRWIYQGMJL-UHFFFAOYSA-N,Preclinical,Hec1 inhibitor,NDC80,,
inimur,SRQKTCXJCCHINN-ORMNHXAVSA-N,Launched,other antifungal,,,
iniparib,MDOJTZQKHMAPBK-UHFFFAOYSA-N,Phase 3,PARP inhibitor,PARP1,,
inosine,UGQMRVRMYYASKQ-KQYNXXCUSA-N,Launched,neurotrophic agent,PARP1|PNP,,
inositol,CDAISMWEOUEBRE-GPIVLXJGSA-N,Launched,insulin sensitizer,CDIPT,obstetrics/gynecology,polycystic ovary syndrom (PCOS)
inositol-hexanicotinate,MFZCIDXOLLEMOO-GYSGTQPESA-N,Launched,,,dermatology|cardiology|rheumatology|neurology/psychiatry,statis dermatitis|claudication|Raynaud's disease|hypertension|insomnia|atherosclerosis|restless leg syndrome|schizophrenia|psoriasis|acne vulgaris (AV)
INS316,PGAVKCOVUIYSFO-PXBUCIJWSA-N,Phase 2,purinergic receptor antagonist,,,
INT-747,ZXERDUOLZKYMJM-ZWECCWDJSA-N,Phase 3,FXR agonist,,,
INT-767,XGIYOABXZNJOHV-APIYUPOTSA-N,Phase 1,FXR agonist,GPBAR1,,
integrin-antagonist-1,ZMXBIIQMSGOIRZ-RCZVLFRGSA-N,Phase 1,integrin antagonist,ITGAV|ITGB6,,
INX-08189,YFXGICNMLCGLHJ-KGSOWIGMSA-N,Phase 2,antiviral,,,
iobenguane,PDWUPXJEEYOOTR-UHFFFAOYSA-N,Launched,antineoplastic agent,,oncology|cardiology|endocrinology,neuroblastoma|congestive heart failure|pheochromocytoma
iocetamic-acid,GSVQIUGOUKJHRC-YFKPBYRVSA-N,Launched,radiopaque medium,,radiology,contrast agent
iodipamide,FFINMCNLQNTKLU-UHFFFAOYSA-N,Launched,radiopaque medium,ALB,radiology,contrast agent
iodixanol,NBQNWMBBSKPBAY-BRSBDYLESA-N,Launched,radiopaque medium,,radiology,contrast agent
iodoantipyrine,ZZOBLCHCPLOXCE-UHFFFAOYSA-N,Preclinical,,,,
iododexetimide,WJLRTFJPHDSXAF-QHCPKHFHSA-N,Phase 2,acetylcholine receptor antagonist,,,
iodophenpropit,UBHYDQAARZKHEZ-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,HRH3|HRH4,,
iodoquinol,UXZFQZANDVDGMM-UHFFFAOYSA-N,Launched,antiseptic,,infectious disease,amebiasis
iohexol,NTHXOOBQLCIOLC-GMTAPVOTSA-N,Launched,radiopaque medium,,radiology,contrast agent
iopamidol,XQZXYNRDCRIARQ-LURJTMIESA-N,Launched,radiopaque medium,,radiology,contrast agent
iopanic-acid,OIRFJRBSRORBCM-YFKPBYRVSA-N,Withdrawn,thyroid hormone inhibitor,,,
iopodic-acid,YQNFBOJPTAXAKV-OMCISZLKSA-N,Launched,,,radiology,contrast agent
iopromide,DGAIEPBNLOQYER-RKDXNWHRSA-N,Launched,radiopaque medium,,radiology,contrast agent
iothalamic-acid-d3,UXIGWFXRQKWHHA-UHFFFAOYSA-N,Preclinical,radiopaque medium,,,
ioversol,AMDBBAQNWSUWGN-RKDXNWHRSA-N,Launched,radiopaque medium,,radiology,contrast agent
IOWH032,DSFNLJXHXBIKDS-UHFFFAOYSA-N,Phase 2,CFTR channel antagonist,CFTR,,
IOX1,JGRPKOGHYBAVMW-UHFFFAOYSA-N,Preclinical,histone demethylase inhibitor,EGLN1|KDM3A|KDM4C|KDM6B,,
IOX2,CAOSCCRYLYQBES-UHFFFAOYSA-N,Preclinical,hypoxia inducible factor inhibitor,EGLN1|KDM2A|KDM5C,,
ioxaglic-acid,TYYBFXNZMFNZJT-UHFFFAOYSA-N,Launched,radiopaque medium,,radiology,contrast agent
ioxilan,UUMLTINZBQPNGF-NXEZZACHSA-N,Launched,radiopaque medium,,radiology,angiography
IPA-3,RFAXLXKIAKIUDT-UHFFFAOYSA-N,Preclinical,p21 activated kinase inhibitor,PAK1,,
IPAG,UUKPIWYXWLJPJF-UHFFFAOYSA-N,Preclinical,,,,
IPI549,XUMALORDVCFWKV-IBGZPJMESA-N,Phase 2,PI3K inhibitor,,,
ipidacrine,YLUSMKAJIQOXPV-UHFFFAOYSA-N,Phase 3,acetylcholinesterase inhibitor,ACHE,,
ipragliflozin-L-proline,AHFWIQIYAXSLBA-RQXATKFSSA-N,Launched,sodium/glucose cotransporter inhibitor,SLC5A2,endocrinology,diabetes mellitus
ipratropium,OEXHQOGQTVQTAT-KKKDIUQISA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,pulmonary,bronchospasm|chronic obstructive pulmonary disease (COPD)|bronchitis|emphysema
ipriflavone,SFBODOKJTYAUCM-UHFFFAOYSA-N,Launched,bone resorption inhibitor,,orthopedics,osteoporosis
iproniazid,NYMGNSNKLVNMIA-UHFFFAOYSA-N,Withdrawn,monoamine oxidase inhibitor,MAOA|MAOB,,
ipsapirone,TZJUVVIWVWFLCD-UHFFFAOYSA-N,Phase 3,serotonin receptor agonist,HTR1A,,
irbesartan,YOSHYTLCDANDAN-UHFFFAOYSA-N,Launched,angiotensin receptor antagonist,AGTR1|JUN|SLC10A1,cardiology|nephrology,hypertension|diabetic nephropathy
irganox-1010,BGYHLZZASRKEJE-UHFFFAOYSA-N,Preclinical,antioxidant,,,
iRGD-peptide,YHTTWXCDIRTOQX-YDZOEDPBSA-N,Preclinical,integrin signaling activator,,,
irinotecan,UWKQSNNFCGGAFS-XIFFEERXSA-N,Launched,topoisomerase inhibitor,TOP1|TOP1MT,oncology,colorectal cancer
IRL-2500,UZDORQWMYRRLQV-JHOUSYSJSA-N,Preclinical,endothelin receptor antagonist,EDNRB,,
irosustat,DSLPMJSGSBLWRE-UHFFFAOYSA-N,Phase 2,steroid sulfatase inhibitor,CA2|STS,,
irsogladine,ATCGGEJZONJOCL-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE4A,gastroenterology,peptic ulcer disease (PUD)
isamoltane,XVTVPGKWYHWYAD-CQSZACIVSA-N,Phase 1,adrenergic receptor antagonist,HTR1A|HTR1B,,
isavuconazole,DDFOUSQFMYRUQK-FPTDNZKUSA-N,Phase 3,cytochrome P450 inhibitor,CYP3A4,,
isaxonine,FTCYIGBVOHNHCD-UHFFFAOYSA-N,Withdrawn,nerve growth factor agonist,,,
isbufylline,WHUWQSQEVISUMC-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,,,
isepamicin,UDIIBEDMEYAVNG-ZKFPOVNWSA-N,Launched,protein synthesis inhibitor,,infectious disease,pneumonia|peritonitis
ISO-1,AIXMJTYHQHQJLU-SNVBAGLBSA-N,Preclinical,macrophage migration inhibiting factor inhibitor,MIF,,
isobutamben,PUYOAVGNCWPANW-UHFFFAOYSA-N,Preclinical,local anesthetic,,,
isobutyramide,WFKAJVHLWXSISD-UHFFFAOYSA-N,Phase 2,gene expression stimulant,HBE1|HBG1,,
isocarboxazid,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,Launched,monoamine oxidase inhibitor,MAOA|MAOB,neurology/psychiatry,depression
isoconazole,MPIPASJGOJYODL-GOSISDBHSA-N,Launched,fungal lanosterol demethylase inhibitor,CYP17A1,infectious disease,gram-positive bacterial infections
isodibut,ZHXRDXTYPCPBTI-UHFFFAOYSA-N,Phase 2,aldehyde reductase inhibitor,,,
isoetharine,HUYWAWARQUIQLE-MFKMUULPSA-N,Launched,adrenergic receptor agonist,,pulmonary,bronchospasm|asthma
isofloxythepin,XDBMBHVYXPBOPL-OAQYLSRUSA-N,Phase 2,dopamine receptor antagonist,,,
isoflupredone-acetate,ZOCUOMKMBMEYQV-GSLJADNHSA-N,Preclinical,,NR3C1,,
isoflurane,PIWKPBJCKXDKJR-PVQJCKRUSA-N,Launched,inhaled anaesthetic,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9,neurology/psychiatry,general anaesthetic
isoflurophate,MUCZHBLJLSDCSD-UHFFFAOYSA-N,Launched,cholinesterase inhibitor,ACHE|BCHE,ophthalmology,glaucoma
isoguvacine,KRVDMABBKYMBHG-UHFFFAOYSA-N,Preclinical,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3,,
isoleucine,AGPKZVBTJJNPAG-RFZPGFLSSA-N,Launched,,,,
isoliquiritigenin,DXDRHHKMWQZJHT-FPYGCLRLSA-N,Preclinical,guanylate cyclase activator,GABBR1,,
isometheptene-mucate,XVQUOJBERHHONY-VIFPVBQESA-N,Launched,,,neurology/psychiatry,headache
isoniazid,QRXWMOHMRWLFEY-UHFFFAOYSA-N,Launched,FABI inhibitor,CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4,infectious disease,tuberculosis
isopentyl-4-methoxycinnamate,UBNYRXMKIIGMKK-RMKNXTFCSA-N,Launched,,,dermatology,sunscreen lotion
isoprenaline,JWZZKOKVBUJMES-LLVKDONJSA-N,Launched,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,cardiology|pulmonary,bradycardia|heart block|asthma
isopropamide-iodide,JTPUMZTWMWIVPA-UHFFFAOYSA-O,Launched,acetylcholine receptor antagonist,CHRM3|CHRM4,gastroenterology,peptic ulcer disease (PUD)|gastrointestinal acidosis
isopropyl-myristate,AXISYYRBXTVTFY-UHFFFAOYSA-N,Launched,,,dermatology,cosmetic
isopropyl-palmitate,XUGNVMKQXJXZCD-UHFFFAOYSA-N,Launched,cosmetic moisturizer,,dermatology,cosmetic
isoquercitrin,OVSQVDMCBVZWGM-QSOFNFLRSA-N,Phase 2/Phase 3,antioxidant,,,
"Isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,",HMYJLVDKPJHJCF-QMMMGPOBSA-N,Preclinical,,,,
isosorbide,KLDXJTOLSGUMSJ-JGWLITMVSA-N,Launched,nitric oxide stimulant,,cardiology,angina pectoris|coronary artery disease (CAD)
isosorbide-dinitrate,MOYKHGMNXAOIAT-JGWLITMVSA-N,Launched,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3|NPR1,cardiology,angina pectoris|coronary artery disease (CAD)
isosorbide-mononitrate,YWXYYJSYQOXTPL-SLPGGIOYSA-N,Launched,nitric oxide stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,cardiology,angina pectoris|coronary artery disease (CAD)
isosteviol,KFVUFODCZDRVSS-XGBBNYNSSA-N,Phase 2,,,,
isotiquimide,PWPWEYFVLITGNU-SECBINFHSA-N,Phase 1,,,,
isotretinoin,SHGAZHPCJJPHSC-XFYACQKRSA-N,Launched,retinoid receptor agonist,RARA|RARB|RARG,dermatology,acne vulgaris (AV)
isovaleramide,SANOUVWGPVYVAV-UHFFFAOYSA-N,Phase 2,alcohol dehydrogenase inhibitor,,,
isoxepac,QFGMXJOBTNZHEL-UHFFFAOYSA-N,Phase 2,anti-inflammatory agent,,,
isoxicam,YYUAYBYLJSNDCX-UHFFFAOYSA-N,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,,
isoxsuprine,BMUKKTUHUDJSNZ-PMUMKWKESA-N,Launched,adrenergic receptor agonist,ADRB2,rheumatology|cardiology,Raynaud's disease|arteriosclerosis|Buerger's disease
ispinesib,QJZRFPJCWMNVAV-HHHXNRCGSA-N,Phase 2,kinesin inhibitor,KIF11,,
isradipine,HMJIYCCIJYRONP-MRXNPFEDSA-N,Launched,calcium channel blocker,CACNA1D|CACNA1F|CACNA2D1,cardiology,hypertension
ISRIB,HJGMCDHQPXTGAV-IYARVYRRSA-N,Preclinical,eukaryotic translation initiation factor inhibitor|PERK inhibitor,EIF2A|EIF2AK3,,
istaroxime,MPYLDWFDPHRTEG-PAAYLBSLSA-N,Phase 2,ATPase inhibitor,ATP1A1,,
istradefylline,IQVRBWUUXZMOPW-PKNBQFBNSA-N,Launched,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,neurology/psychiatry,Parkinson's Disease|dyskinesia
ISX-9,SYENTKHGMVKGAQ-UHFFFAOYSA-N,Preclinical,neural stem cell inducer,NEUROD1,,
IT1t,OOSUDWRRWZVFEB-UHFFFAOYSA-N,Preclinical,CC chemokine receptor antagonist,CXCR4,,
itacitinib,KTBSXLIQKWEBRB-UHFFFAOYSA-N,Phase 3,JAK inhibitor,JAK1,,
ITD-1,ULFUJLFTRWWLPO-XMMPIXPASA-N,Preclinical,TGF beta receptor inhibitor,TGFBR2,,
ITE,KDDXOGDIPZSCTM-UHFFFAOYSA-N,Preclinical,aryl hydrocarbon receptor agonist,AHR,,
ITI214,BBIPVJCGIASXJB-PKTZIBPZSA-N,Phase 1/Phase 2,phosphodiesterase inhibitor,PDE1A,,
itopride,QQQIECGTIMUVDS-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,CHRM3|DRD2,gastroenterology|neurology/psychiatry,dyspepsia|gastroparesis|heartburn|nausea|vomiting|anorexia
itraconazole,VHVPQPYKVGDNFY-TUJWMRSMSA-N,Launched,cytochrome P450 inhibitor,,infectious disease,onychomycosis|histoplasmosis|blastomycosis|aspergillosis
ITX3,SJMYMKPBODEZSH-DEDYPNTBSA-N,Preclinical,GEF inhibitor,TRIO,,
ITX5061,UUROSJLZNDSXRF-UHFFFAOYSA-N,Phase 1,SR-BI inhibitor,,,
IU1,JUWDSDKJBMFLHE-UHFFFAOYSA-N,Preclinical,ubiquitin C-terminal hydrolase inhibitor,USP14,,
ivabradine,ACRHBAYQBXXRTO-OAQYLSRUSA-N,Launched,HCN channel blocker|potassium channel blocker|sodium channel blocker,HCN1|HCN3|HCN4,cardiology,angina pectoris
ivacaftor,PURKAOJPTOLRMP-UHFFFAOYSA-N,Launched,CFTR channel potentiator,CFTR,pulmonary,cystic fibrosis
ivermectin,AZSNMRSAGSSBNP-XPNPUAGNSA-N,Launched,benzodiazepine receptor agonist,CHRNA7|P2RX7,infectious disease,gastrointestinal roundworms|lungworms|cattle grubs|mites|lice|horn flies
ivosidenib,WIJZXSAJMHAVGX-DHLKQENFSA-N,Launched,isocitrate dehydrogenase inhibitor,IDH1,hematologic malignancy,acute myeloid leukemia (AML)
IWP-L6,QESQGTFWEQMCMH-UHFFFAOYSA-N,Preclinical,porcupine inhibitor,PORCN,,
ixabepilone,FABUFPQFXZVHFB-QBNZTRRJSA-N,Launched,microtubule stabilizing agent,TUBB,oncology,breast cancer
ixazomib,MXAYKZJJDUDWDS-LBPRGKRZSA-N,Launched,proteasome inhibitor,,hematologic malignancy,multiple myeloma
ixazomib-citrate,YTXSYWAKVMZICI-VBKZILBWSA-N,Launched,proteasome inhibitor,,hematologic malignancy,multiple myeloma
J147,HYMZAYGFKNNHDN-SSDVNMTOSA-N,Phase 1,BDNF inducer,,,
JAK3-inhibitor-V,FOTCGZPFSUWZBN-UHFFFAOYSA-N,Preclinical,JAK inhibitor,JAK3,,
JD-5037,GTCSIQFTNPTSLO-RPWUZVMVSA-N,Preclinical,cannabinoid receptor antagonist,,,
JDTic,ZLVXBBHTMQJRSX-VMGNSXQWSA-N,Phase 1,opioid receptor antagonist,OPRK1,,
JHW-007,HZEVDVGPBUFIAW-JKHIJQBDSA-N,Preclinical,dopamine reuptake inhibitor,SLC6A3,,
JI-101,ZXBFYBLSJMEBEP-UHFFFAOYSA-N,Phase 1/Phase 2,kinase inhibitor,,,
JIB04,YHHFKWKMXWRVTJ-OQKWZONESA-N,Preclinical,histone lysine demethylase inhibitor,KDM4E,,
JK-184,ROYXIPOUVGDTAO-UHFFFAOYSA-N,Preclinical,hedgehog pathway inhibitor,,,
JLK-6,AMDGKLWVCUXONP-UHFFFAOYSA-N,Preclinical,gamma secretase inhibitor,PSEN1,,
JNJ-10191584,MOIWSUQWIOVGRH-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,HRH4,,
JNJ-10397049,RBKIJGLHFFQHBE-IRXDYDNUSA-N,Preclinical,orexin receptor antagonist,HCRTR1|HCRTR2,,
JNJ-16259685,QOTAQTRFJWLFCR-XFHMXUHZSA-N,Preclinical,glutamate receptor antagonist,GRM1,,
JNJ-1661010,BHBOSTKQCZEAJM-UHFFFAOYSA-N,Preclinical,FAAH inhibitor,FAAH,,
JNJ-17203212,JFRYYGVYCWYIDQ-UHFFFAOYSA-N,Preclinical,TRPV antagonist,TRPV1,,
JNJ-26481585,PAWIYAYFNXQGAP-UHFFFAOYSA-N,Phase 2,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2,,
JNJ-26990990,AWSKBQNOSRREEY-UHFFFAOYSA-N,Phase 2,anticonvulsant,,,
JNJ-27141491,SYARXICKXVXWNA-LBPRGKRZSA-N,Preclinical,CC chemokine receptor antagonist,CCR2,,
JNJ-37822681,UVUYWJWYRLJHEN-UHFFFAOYSA-N,Phase 2,dopamine receptor antagonist,DRD2,,
JNJ-38877605,JRWCBEOAFGHNNU-UHFFFAOYSA-N,Phase 1,tyrosine kinase inhibitor,MET,,
JNJ-38877618,KOAWAWHSMVKCON-UHFFFAOYSA-N,Phase 1,c-Met inhibitor,,,
JNJ-39758979,COOGVHJHSCBOQT-MRVPVSSYSA-N,Phase 2,histamine receptor antagonist,,,
JNJ-40411813,HYOGJHCDLQSAHX-UHFFFAOYSA-N,Phase 2,glutamate receptor positive allosteric modulator,GRM2,,
JNJ-42041935,FXHHASJVTYRJHH-UHFFFAOYSA-N,Preclinical,hypoxia inducible factor prolyl hydroxylase inhibitor,PDK2,,
JNJ-42165279,YWGYNGCRVZLMCS-UHFFFAOYSA-N,Phase 2,FAAH inhibitor,FAAH,,
JNJ-47965567,XREFXUCWSYMIOG-UHFFFAOYSA-N,Preclinical,purinergic receptor antagonist,P2RX7,,
JNJ-54175446,CWFVVQFVGMFTBD-SECBINFHSA-N,Phase 1,purinergic receptor antagonist,,,
JNJ-63533054,MWDVCHRYCKXEBY-LBPRGKRZSA-N,Preclinical,G protein-coupled receptor agonist,GPR139,,
JNJ-64619178,DBSMLQTUDJVICQ-CJODITQLSA-N,Phase 1,protein arginine N-methyltransferase inhibitor,,,
JNJ-678,GTQTUABHRCWVLL-UHFFFAOYSA-N,Phase 1,RSV fusion inhibitor,,,
JNJ-7706621,KDKUVYLMPJIGKA-UHFFFAOYSA-N,Preclinical,CDK inhibitor,AURKA|AURKB|CDK1|CDK2,,
JNJ-7706621,"InChI=1S/C15H12F2N6O3S/c16-10-2-1-3-11(17)12(10)13(24)23-14(18)21-15(22-23)20-8-4-6-9(7-5-8)27(19,25)26/h1-7H,(H2,19,25,26)(H3,18,20,21,22)",Preclinical,CDK inhibitor,AURKA|AURKB|CDK1|CDK2,,
JNJ-7777120,HUQJRYMLJBBEDO-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,HRH4,,
josamycin,XJSFLOJWULLJQS-MJKZEBMBSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,pulmonary,bronchitis
JPH203,XNRZJPQTMQZBCE-SFHVURJKSA-N,Preclinical,solute carrier family member inhibitor,,,
JQ1-(+),DNVXATUJJDPFDM-KRWDZBQOSA-N,Preclinical,bromodomain inhibitor,BRD4|BRDT,,
JTC-801,VTGBZWHPJFMTKS-UHFFFAOYSA-N,Phase 2,opioid receptor antagonist,OPRL1,,
JTE-013,RNSLRQNDXRSASX-UHFFFAOYSA-N,Preclinical,lysophospholipid receptor antagonist,P2RY10|S1PR2,,
JTE-607,IPSSXIMJJXSJQB-FQEVSTJZSA-N,Phase 2,cytokine production inhibitor,IL10|IL1B|IL6|TNF,,
JTE-907,GRAJFFFXJYFVOC-UHFFFAOYSA-N,Phase 1,cannabinoid receptor inverse agonist,CNR2,,
JW-55,ZJZWZIXSGNFWQQ-UHFFFAOYSA-N,Preclinical,tankyrase inhibitor,TNKS|TNKS2,,
JW-642,AVSCNEOUWSVZEY-UHFFFAOYSA-N,Preclinical,monoacylglycerol lipase inhibitor,MGLL,,
JW-67,BTXRSHKJNDFHGA-UHFFFAOYSA-N,Preclinical,WNT pathway inhibitor,APC|AXIN1|GSK3B,,
JW-74,KRIKILRRJCIWNB-UHFFFAOYSA-N,Preclinical,tankyrase inhibitor|WNT signaling inhibitor,TNKS|TNKS2,,
JX-401,OMGLGPKQUFSRNN-UHFFFAOYSA-N,Preclinical,p38 MAPK inhibitor,MAPK14,,
JZL-184,SEGYOKHGGFKMCX-UHFFFAOYSA-N,Preclinical,monoacylglucerol lipase inhibitor,MGLL,,
JZL-195,QNYRAEKLMNDRFY-UHFFFAOYSA-N,Preclinical,FAAH inhibitor|monoacylglycerol lipase inhibitor,FAAH|MGLL,,
K-247,QNUBRHYSSHJWDH-CHWFTXMASA-N,Phase 1,,,,
K-858,JEFVYQYZCAVNTP-ZDUSSCGKSA-N,Preclinical,kinesin-like spindle protein inhibitor,KIF11,,
K-MAP,VXMVXDITZWJXJN-LDMBFOFVSA-N,Phase 2,,,,
K-Ras(G12C)-inhibitor-12,JFIFBWVNHLXJFY-UHFFFAOYSA-N,Preclinical,K-Ras inhibitor,KRAS,,
K-Ras(G12C)-inhibitor-6,ZPXCEHMKUTXHRZ-UHFFFAOYSA-N,Preclinical,K-Ras inhibitor,,,
K-strophanthidin,ODJLBQGVINUMMR-HZXDTFASSA-N,Phase 2,ATPase inhibitor,ATP1A1,,
K02288,CJLMANFTWLNAKC-UHFFFAOYSA-N,Preclinical,bone morphogenic protein inhibitor,BMP1,,
K145,MPZXLTZVPUSTFY-SOFYXZRVSA-N,Preclinical,sphingosine kinase inhibitor,SPHK2,,
kaempferol,IYRMWMYZSQPJKC-UHFFFAOYSA-N,Preclinical,bone resorption inhibitor|estrogen-related receptor inverse agonist,AKR1B1|ALOX15B|ALOX5|AR|CYP1B1|GLO1|HSD17B1|UGT3A1,,
KAF-156,BUPRVECGWBHCQV-UHFFFAOYSA-N,Preclinical,antimalarial agent,,,
kainic-acid,VLSMHEGGTFMBBZ-OOZYFLPDSA-N,Preclinical,kainate receptor agonist,GRIA1|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5,,
kakonein,HKEAFJYKMMKDOR-YAJUCGGBSA-N,Phase 2,GABA receptor antagonist|serotonin receptor antagonist,,,
kanamycin,SBUJHOSQTJFQJX-NOAMYHISSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections
karenitecin,POADTFBBIXOWFJ-VWLOTQADSA-N,Phase 3,topoisomerase inhibitor,TOP1,,
kartogenin,SLUINPGXGFUMLL-UHFFFAOYSA-N,Preclinical,chondrocyte differentiation stimulator,FLNA,,
kasugamycin,PVTHJAPFENJVNC-MHRBZPPQSA-N,Preclinical,bacterial 30S ribosomal subunit inhibitor,,,
KB-R7943,UMJUNUMSJDTYTM-UHFFFAOYSA-N,Preclinical,sodium/calcium exchange inhibitor,SLC8A1|TRPC3|TRPC5|TRPC6,,
KB-SRC-4,UHIZYQVRKSWIFO-UHFFFAOYSA-N,Preclinical,SRC inhibitor,SRC,,
KBG,FOLRUCXBTYDAQK-PTEOKISQSA-N,Phase 2,neprilysin inhibitor,MME,,
KD-023,CZRCFAOMWRAFIC-UHFFFAOYSA-N,Phase 2,ACAT inhibitor,ACACA|ACACB,,
KD025,GKHIVNAUVKXIIY-UHFFFAOYSA-N,Phase 2,rho associated kinase inhibitor,ROCK2,,
kenpaullone,QQUXFYAWXPMDOE-UHFFFAOYSA-N,Preclinical,CDK inhibitor|glycogen synthase kinase inhibitor,CCNB1|CDK1|CDK5|GSK3B,,
ketanserin,FPCCSQOGAWCVBH-UHFFFAOYSA-N,Launched,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2,cardiology,hypertension
ketoconazole,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,Launched,sterol demethylase inhibitor,KCNA10,dermatology,seborrheic dermatitis
ketohexokinase-inhibitor-1,MDUYWDNWFXSMJJ-XWLWVQCSSA-N,Preclinical,kinase inhibitor,,,
ketoprofen,DKYWVDODHFEZIM-LLVKDONJSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2|SLC5A8,rheumatology,rheumatoid arthritis|osteoarthritis
ketorolac,OZWKMVRBQXNZKK-NSHDSACASA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
ketotifen,OVJRNFMIYGGLDL-UHFFFAOYSA-N,Launched,histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor,HRH1,neurology/psychiatry,itching
kevetrin,PRDJGNVQBVXXEO-UHFFFAOYSA-N,Phase 1,p53 activator,,,
KF-38789,NHFIAAAMCYVRIW-QGZVFWFLSA-N,Preclinical,P selectin inhibitor,SELP,,
KG-5,CMYHZFCJPORPHY-UHFFFAOYSA-N,Preclinical,RAF inhibitor,BRAF|FLT3|KIT|PDGFRB,,
KH-CB19,DXZRBHUCOHBAHP-UHFFFAOYSA-N,Preclinical,CDC inhibitor,CLK1|CLK3|DYRK1A,,
khellin,HSMPDPBYAYSOBC-UHFFFAOYSA-N,Phase 2,vasodilator,,,
KHK-IN-1,HFLMLZKGLUEWBU-UHFFFAOYSA-N,Preclinical,hexokinase inhibitor,KHK,,
KHS-101,DGRJOOOHPBSAHD-UHFFFAOYSA-N,Preclinical,neural stem cell inducer,TACC3,,
KI-16425,LLIFMNUXGDHTRO-OAHLLOKOSA-N,Preclinical,lysophosphatidic acid receptor antagonist,LPAR1|LPAR3,,
KI-20227,SHPFDGWALWEPGS-AWEZNQCLSA-N,Preclinical,c-Fms inhibitor,CSF1R|KDR|KIT|PDGFRB,,
KI-8751,LFKQSJNCVRGFCC-UHFFFAOYSA-N,Preclinical,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,,
ki16198,HHVJBROTJWPHHX-INIZCTEOSA-N,Preclinical,lipoprotein antagonist,LPA,,
kifunensine,OIURYJWYVIAOCW-PQMKYFCFSA-N,Phase 1,mannosidase inhibitor,MAN1B1|MAN2A1,,
kinetin,QANMHLXAZMSUEX-UHFFFAOYSA-N,Launched,cell division inducer,,dermatology,sunburn
KL-001,OQAFDLPAPSSOHY-MRXNPFEDSA-N,Preclinical,proteasome inhibitor,CRY1|CRY2,,
KM-0118,CQVAQQNDZCZBSU-UHFFFAOYSA-N,Phase 1,anticancer agent,,,
KME-4,DFPYHQJPGCODSB-UKTHLTGXSA-N,Preclinical,prostaglandin inhibitor,,,
KML29,SXHQLPHDBLTFPM-UHFFFAOYSA-N,Preclinical,monoacylglucerol lipase inhibitor,MGLL,,
KN-62,RJVLFQBBRSMWHX-DHUJRADRSA-N,Preclinical,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,AKT1|CAMK2A|CHEK1|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|P2RX7|PRKCA|ROCK1|RPS6KB1|SGK1,,
KN-93,LLLQTDSSHZREGW-AATRIKPKSA-N,Preclinical,calcium/calmodulin dependent protein kinase inhibitor,CAMK2A,,
Ko143,NXNRAECHCJZNRF-JBACZVJFSA-N,Preclinical,BCRP inhibitor,ABCB1|ABCC1,,
KP-1212,LAOLDMMWVYDDID-HSUXUTPPSA-N,Phase 2,,,,
KPT-185,NLNGWFLRRRYNIL-PLNGDYQASA-N,Preclinical,exportin antagonist,XPO1,,
KPT-276,JCHAWRDHMUSLMM-UPHRSURJSA-N,Preclinical,exportin antagonist,XPO1,,
KPT-9274,MRFOPLWJZULAQD-SWGQDTFXSA-N,Phase 1,NAMPT inhibitor,,,
KR-33494,ZRLJEHIUGYTTSZ-UHFFFAOYSA-N,Preclinical,cell death inhibitor ,,,
KRCA-0008,TXDIRJCYNAWBOS-UHFFFAOYSA-N,Preclinical,ALK inihibitor,ALK,,
KRN-633,VPBYZLCHOKSGRX-UHFFFAOYSA-N,Preclinical,VEGFR inhibitor,FLT1|FLT4|KDR,,
KS-176,LTWQQWSXYYXVGA-UHFFFAOYSA-N,Preclinical,BCRP inhibitor,ABCG2,,
KT-433,XSDFWTIKVXKOGJ-UHFFFAOYSA-N,Phase 2,uricosuric agent,,,
KU-0063794,RFSMUFRPPYDYRD-CALCHBBNSA-N,Preclinical,mTOR inhibitor,MTOR,,
KU-55933,XRKYMMUGXMWDAO-UHFFFAOYSA-N,Preclinical,ATM kinase inhibitor,ATM|PRKDC,,
KU-60019,SCELLOWTHJGVIC-BGYRXZFFSA-N,Preclinical,ATM kinase inhibitor,ATM,,
KU14R,JCWVNNMJXQJVNC-ZDUSSCGKSA-N,Preclinical,imidazoline receptor antagonist,,,
kuromanin,RKWHWFONKJEUEF-GQUPQBGVSA-O,Preclinical,ribosyl cyclase inhibitor,CD38,,
KW-2449,YYLKKYCXAOBSRM-JXMROGBWSA-N,Phase 1,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,ABL1|AURKA|AURKB|FLT3,,
KW-2478,VFUXSYAXEKYYMB-UHFFFAOYSA-N,Phase 1/Phase 2,HSP inhibitor,,,
KW-3902,PJBFVWGQFLYWCB-XEDLVCFGSA-N,Phase 3,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
KX2-391,HUNGUWOZPQBXGX-UHFFFAOYSA-N,Phase 3,SRC inhibitor|tubulin polymerization inhibitor,SRC,,
KX2-391,"InChI=1S/C26H29N3O3/c30-26(28-19-21-4-2-1-3-5-21)18-24-9-6-23(20-27-24)22-7-10-25(11-8-22)32-17-14-29-12-15-31-16-13-29/h1-11,20H,12-19H2,(H,28,30)",Phase 3,SRC inhibitor|tubulin polymerization inhibitor,SRC,,
KY02111,LXFKEVQQSKQXPR-UHFFFAOYSA-N,Preclinical,WNT pathway inhibitor,DKK1,,
kynurenic-acid,HCZHHEIFKROPDY-UHFFFAOYSA-N,Phase 1,glutamate receptor antagonist,GPR35|GRIN1|GRIN2A|GRIN2B,,
L-(+)-rhamnose-monohydrate,SHZGCJCMOBCMKK-HGVZOGFYSA-N,Preclinical,,,,
L-152804,XQDXIHYKAGHZRX-LJQANCHMSA-N,Preclinical,neuropeptide receptor antagonist,NPY5R,,
L-161982,MMDNKTXNUZFVKD-UHFFFAOYSA-N,Preclinical,prostanoid receptor antagonist,PTGER4,,
L-165041,HBBVCKCCQCQCTJ-UHFFFAOYSA-N,Preclinical,PPAR receptor agonist,PPARD,,
L-168049,HHBOWXZOLYQFNY-UHFFFAOYSA-N,Preclinical,glucagon receptor antagonist,GCGR,,
L-365260,KDFQABSFVYLGPM-QFIPXVFZSA-N,Phase 2,CCK receptor antagonist,CCKAR|CCKBR|KCNQ1,,
L-368899,MWIASLNTAGRGGA-ZJPWWDJASA-N,Phase 1,oxytocin receptor antagonist,AVPR1A|AVPR2|OXTR,,
"L-655,708",YKYOQIXTECBVBB-AWEZNQCLSA-N,Preclinical,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRG2,,
L-655240,JLPYLHLUHJOPNL-UHFFFAOYSA-N,Phase 1,thromboxane receptor antagonist,PTGES,,
L-670596,GMJWAIMJHBTYPD-CQSZACIVSA-N,Preclinical,prostanoid receptor antagonist,,,
L-689560,UCKHICKHGAOGAP-UONOGXRCSA-N,Preclinical,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
L-690330,JKOCAAWWDVHWKB-UHFFFAOYSA-N,Preclinical,inositol monophosphatase inhibitor,IMPA1,,
L-693403,GSXJSGMDWKPVBY-UHFFFAOYSA-N,Preclinical,sigma receptor agonist|sigma receptor antagonist,DRD2|SIGMAR1,,
L-694247,HKXMQLISPYELRD-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR1A|HTR1B|HTR1D,,
L-701252,MXEFWCFPCLDOOG-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIN1,,
L-701324,FLVRDMUHUXVRET-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
"L-732,138",BYYQYXVAWXAYQC-LJQANCHMSA-N,Preclinical,tachykinin antagonist,TACR1|TACR2,,
L-733060,FCDRFVCGMLUYPG-ROUUACIJSA-N,Preclinical,tachykinin antagonist,TACR1,,
L-741742,QDMAKDIDFJTXEL-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,DRD3|DRD4|SCN1A|SCN3A,,
L-745870,OGJGQVFWEPNYSB-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR6|HTR7,,
L-755507,NYYJKMXNVNFOFQ-MHZLTWQESA-N,Preclinical,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,,
L-760735,USRYEHHMJIRICK-ZNZBMKLDSA-N,Preclinical,tachykinin antagonist,TACR1,,
L-778123,JNUGFGAVPBYSHF-UHFFFAOYSA-N,Phase 1,farnesyltransferase inhibitor,FNTA|FNTB|PGGT1B,,
L-798106,ODTKFNUPVBULRJ-NTCAYCPXSA-N,Preclinical,prostanoid receptor antagonist,PTGER3,,
L-838417,BQDUNOMMYOKHEP-UHFFFAOYSA-N,Preclinical,GABA receptor partial agonist,GABRA1|GABRA2|GABRA3|GABRA5,,
L-alanine,QNAYBMKLOCPYGJ-REOHCLBHSA-N,Launched,,AARS|AARS2|ABAT|AGXT|AGXT2|GPRC6A|GPT|GPT2|KYNU|NFS1|PHYKPL|SLC1A4|SLC36A1|SLC7A8,,
L-arginine,ODKSFYDXXFIFQN-BYPYZUCNSA-N,Launched,nitric oxide precursor,ARG2|ASL|ASS1|AZIN2|GPRC6A|NOS2|NOS3|SLC7A1|SLC7A3|SLC7A4,cardiology|neurology/psychiatry|urology|obstetrics/gynecology|otolaryngology,congestive heart failure|hypertension|coronary artery disease (CAD)|claudication|senile dementia|erectile dysfunction|infertility|common cold
L-ascorbyl-6-palmitate,CYJPUZLKFAUFHF-HFSMHLIXSA-N,Preclinical,,,,
L-asparagine,DCXYFEDJOCDNAF-REOHCLBHSA-N,Phase 3,,ASNS|ASRGL1|NARS|NARS2|SLC1A5|SLC38A3,,
L-asparagine-N-hydroxy,ZBYVTTSIVDYQSO-REOHCLBHSA-N,Preclinical,,,,
L-aspartic-acid,CKLJMWTZIZZHCS-REOHCLBHSA-N,Launched,metallic radical formation stimulant,ACY1|ACY3|ADSS|ADSSL1|ASNS|ASPA|ASPH|ASRGL1|ASS1|CAD|DARS|DARS2|GOT1|GOT2|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|LYZ|PAICS|RNASE1|SLC1A1|SLC25A12|SLC25A13,,
L-citrulline,RHGKLRLOHDJJDR-BYPYZUCNSA-N,Launched,nitric oxide stimulant,ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6,cardiology|urology,hypertension|erectile dysfunction
L-cysteine,XUJNEKJLAYXESH-REOHCLBHSA-N,Launched,,CARS|CARS2|CBS|CDO-1|CDO1|CSAD|CTH|GCLC|GCLM|GOT1|GSS|MGMT|NFS1|SLC19A3,rheumatology,osteoarthritis|rheumatoid arthritis
L-cysteinesulfinic-acid,ADVPTQAUNPRNPO-REOHCLBHSA-N,Preclinical,glutamate receptor agonist,GRM1|GRM5|GSR|HMGCS2|PAPOLA|PRDX2,,
L-cystine,LEVWYRKDKASIDU-IMJSIDKUSA-N,Launched,,CTNS|SLC3A1|SLC7A11|SLC7A9,,
L-ergothioneine,SSISHJJTAXXQAX-ZETCQYMHSA-O,Phase 3,free radical scavenger,,,
L-glutamic-acid,WHUUTDBJXJRKMK-VKHMYHEASA-N,Launched,glutamate receptor agonist,AADAT|AASS|ABAT|ALDH18A1|ASNS|BCAT1|BCAT2|CCBL2|DNPEP|EARS2|ENPEP|EPRS|FOLH1|FPGS|FTCD|GAD1|GAD2|GATB|GCLC|GCLM|GGCX|GLS|GLS2|GLUD1|GLUD2|GLUL|GMPS|GOT1|GOT2|GPT|GPT2|GRIA1|GRIA2|GRIA3|GRIA4|GRID1|GRID2|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|GRM1|GRM2|GRM3|GRM4|GRM6|GRM7|GRM8|LGSN|NADSYN1|NAGS|OPLAH|PFAS|PGCP|PSAT1|SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7|SLC25A18|SLC25A22|SLC7A11|TAT,,
L-glutamine,ZDXPYRJPNDTMRX-VKHMYHEASA-N,Launched,,CTPS1|GLUL|GPRC6A|PPAT,gastroenterology|dental|neurology/psychiatry|rheumatology,diarrhea|mucositis|muscle pain|joint pain|peptic ulcer disease (PUD)|ulcerative colitis|Crohn's disease|anxiety|insomnia
L-hydroxyproline,PMMYEEVYMWASQN-DMTCNVIQSA-N,Launched,,,,
L-kynurenine,YGPSJZOEDVAXAB-QMMMGPOBSA-N,Phase 1,aryl hydrocarbon receptor agonist,,,
L-leucine,ROHFNLRQFUQHCH-YFKPBYRVSA-N,Phase 3,,BCAT1|BCAT2|LARS|LARS2|LCMT1|LCMT2,,
L-lysine,KDXKERNSBIXSRK-YFKPBYRVSA-N,Phase 2,serotonin receptor agonist,GPRC6A|KARS|SLC7A1|SLC7A2|SLC7A3|SLC7A4,,
L-methionine,FFEARJCKVFRZRR-BYPYZUCNSA-N,Launched,voltage-gated calcium channel ligand,BHMT|BHMT2|METAP2|MTR|MTRR,pulmonary|allergy|neurology/psychiatry,asthma|allergic rhinitis|depression|Parkinson's Disease|schizophrenia
L-mimosine,BLYDGIISUNWHLF-YFKPBYRVSA-N,Preclinical,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,DBH|EIF5A,,
L-monomethylarginine,NTWVQPHTOUKMDI-YFKPBYRVSA-N,Phase 3,nitric oxide synthase inhibitor,NOS1|NOS2,,
L-NAME,KCWZGJVSDFYRIX-YFKPBYRVSA-N,Phase 2/Phase 3,nitric oxide synthase inhibitor,NOS3,,
L-NIL,ONYFNWIHJBLQKE-ZETCQYMHSA-N,Preclinical,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,,
L-phenylisopropyladenosine,RIRGCFBBHQEQQH-SSFGXONLSA-N,Preclinical,,,,
L-proline,ONIBWKKTOPOVIA-BYPYZUCNSA-N,Launched,glutamate receptor agonist,EPRS|L3HYPDH|P3H1|P3H2|P3H3|P4HA1|P4HA2|PARS2|PPIA|PPIB|PPIC|PPIF|PPIG|PPIH|PRODH|PROSC|PYCR1|PYCR2|PYCRL|SLC6A14|SLC6A7,,
L-quisqualic-acid,ASNFTDCKZKHJSW-REOHCLBHSA-N,Preclinical,glutamate receptor agonist,FOLH1|GRIA2|GRIK1|GRIK2|GRM1|GRM2|GRM3|GRM5|GRM7|GRM8,,
L-theanine,DATAGRPVKZEWHA-YFKPBYRVSA-N,Launched,glutamate receptor antagonist,,,
L-threonine,AYFVYJQAPQTCCC-GBXIJSLDSA-N,Phase 2,,TARS|TARS2|THNSL1,,
L-valine,KZSNJWFQEVHDMF-SCSAIBSYSA-N,Phase 2,,,,
labetalol,SGUAFYQXFOLMHL-SCLBCKFNSA-N,Launched,adrenergic receptor antagonist,ADRA1D|ADRB1|ADRB2,cardiology,hypertension
lacidipine,GKQPCPXONLDCMU-CCEZHUSRSA-N,Launched,calcium channel blocker,CACNA1C,cardiology,hypertension
lacitol,VQHSOMBJVWLPSR-JVCRWLNRSA-N,Launched,laxative,,gastroenterology,constipation
lactulose,JCQLYHFGKNRPGE-FCVZTGTOSA-N,Launched,laxative,,gastroenterology,portal-systemic encephalopathy (PSE)
lafutidine,KMZQAVXSMUKBPD-FCRIZLRQSA-N,Launched,histamine receptor antagonist,HRH2,gastroenterology,duodenal ulcer disease|peptic ulcer disease (PUD)
lamivudine,JTEGQNOMFQHVDC-NKWVEPMBSA-N,Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)|acquired immunodeficiency syndrome (AIDS)|hepatitis B
lamotrigine,PYZRQGJRPPTADH-UHFFFAOYSA-N,Launched,serotonin receptor antagonist|sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,epilepsy|bipolar disorder
lanabecestat,WKDNQONLGXOZRG-HRNNMHKYSA-N,Phase 3,beta secretase inhibitor,,,
lanatoside-C,JAYAGJDXJIDEKI-FUVOQQLASA-N,Preclinical,cardiac glycoside,,,
landiolol,WMDSZGFJQKSLLH-RBBKRZOGSA-N,Launched,adrenergic receptor antagonist,ADRB1,cardiology,cardiac arrythmia
lanifibranor,OQDQIFQRNZIEEJ-UHFFFAOYSA-N,Phase 2,PPAR receptor agonist,,,
lanoconazole,ZRTQSJFIDWNVJW-MNWMYKRDSA-N,Launched,sterol demethylase inhibitor,,infectious disease,fungal infection
lansoprazole,MJIHNNLFOKEZEW-RUZDIDTESA-N,Launched,ATPase inhibitor,ATP4A|ATP4B,gastroenterology,heartburn
lapatinib,BCFGMOOMADDAQU-UHFFFAOYSA-N,Launched,EGFR inhibitor,EGFR|ERBB2,oncology,breast cancer
lappaconite,NWBWCXBPKTTZNQ-QOQRDJBUSA-N,Phase 2,sodium channel blocker,,,
laquinimod,GKWPCEFFIHSJOE-UHFFFAOYSA-N,Phase 3,immunosuppressant,CXCL2,,
larazotide-acetate,ORFLZNAGUTZRLQ-ZMBVWFSWSA-N,Phase 2,tight junction regulator,,,
laropiprant,NXFFJDQHYLNEJK-CYBMUJFWSA-N,Launched,prostanoid receptor antagonist,PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R,cardiology,cholesterol
larotrectinib,NYNZQNWKBKUAII-KBXCAEBGSA-N,Launched,tropomyosin receptor kinase inhibitor,NTRK1|NTRK2|NTRK3,,
lasalocid,BBMULGJBVDDDNI-OWKLGTHSSA-N,Launched,bacterial permeability inducer,,infectious disease,coccidiosis
lasmiditan,XEDHVZKDSYZQBF-UHFFFAOYSA-N,Launched,serotonin receptor agonist,,,
lasofoxifene,INEHJXCWEVNEDZ-LUDNRVPPSA-N,Launched,selective estrogen receptor modulator (SERM),ESR1|ESR2,orthopedics|oncology,osteoporosis|breast cancer
latanoprost,GGXICVAJURFBLW-CEYXHVGTSA-N,Launched,prostanoid receptor agonist,PTGFR,ophthalmology,ocular hypertension|glaucoma
latrepirdine,JNODQFNWMXFMEV-UHFFFAOYSA-N,Phase 3,glutamate receptor antagonist,HRH1|HTR6,,
latrunculin-B,NSHPHXHGRHSMIK-JRIKCGFMSA-N,Phase 1,actin polymerization inhibitor,ACTA1|MKL1|SPIRE2,,
lauric-acid,POULHZVOKOAJMA-UHFFFAOYSA-N,Phase 3,bacterial permeability inducer,GPR84|HNF4A|LTF|LY96|PLA2G2A|TLR4,,
lauric-diethanolamide,AOMUHOFOVNGZAN-UHFFFAOYSA-N,Preclinical,,,,
laurocapram,AXTGDCSMTYGJND-UHFFFAOYSA-N,Phase 3,,,,
lazabemide,JZXRLKWWVNUZRB-UHFFFAOYSA-N,Phase 3,monoamine oxidase inhibitor,MAOB,,
lazertinib,RRMJMHOQSALEJJ-UHFFFAOYSA-N,Phase 1/Phase 2,tyrosine kinase inhibitor,,,
LB-100,JUQMLSGOTNKJKI-YTWAJWBKSA-N,Phase 2,protein phosphatase inhibitor,,,
LB42708,GUUIRIMAQGOLHT-UHFFFAOYSA-N,Preclinical,farnesyltransferase inhibitor,,,
LCL-161,UFPFGVNKHCLJJO-SSKFGXFMSA-N,Phase 2,XIAP inhibitor,BIRC2|XIAP,,
LCQ908,GXALXAKNHIROPE-QAQDUYKDSA-N,Phase 3,diacylglycerol O acyltransferase inhibitor,DGAT1,,
LCZ696,XTKIDERFOUYBDE-QEPKIHTBSA-N,Launched,angiotensin receptor antagonist,,cardiology,angioedema|hypotension
LDC1267,ISPBCAXOSOLFME-UHFFFAOYSA-N,Preclinical,protein tyrosine kinase inhibitor,AXL|MERTK|TYRO3,,
LDN-209929,XMMAOXMYUGQGJD-UHFFFAOYSA-N,Preclinical,haspin kinase inhibitor,GSG2,,
LDN-212854,BBDGBGOVJPEFBT-UHFFFAOYSA-N,Preclinical,bone morphogenic protein inhibitor,ABL1|ACVR1|RIPK2,,
LDN-27219,WLBUICQBNZXIDJ-UHFFFAOYSA-N,Preclinical,tissue transglutaminase inhibitor,TGM2,,
LDN-57444,OPQRFPHLZZPCCH-LTGZKZEYSA-N,Preclinical,ubiquitin C-terminal hydrolase inhibitor,,,
LDN193189,CDOVNWNANFFLFJ-UHFFFAOYSA-N,Preclinical,bone morphogenic protein inhibitor,ACVR1|BMPR1A,,
LE-135,YZZAIQOVMHVWBS-UHFFFAOYSA-N,Preclinical,retinoid receptor agonist,RARB,,
ledipasvir,VRTWBAAJJOHBQU-KMWAZVGDSA-N,Launched,HCV inhibitor,,infectious disease,hepatitis C
leflunomide,VHOGYURTWQBHIL-UHFFFAOYSA-N,Launched,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor,AHR|DHODH|PTK2B,rheumatology,rheumatoid arthritis
lemborexant,MUGXRYIUWFITCP-PGRDOPGGSA-N,Launched,orexin receptor antagonist,HCRTR1|HCRTR2,,
lenalidomide,GOTYRUGSSMKFNF-JTQLQIEISA-N,Launched,anticancer agent,TNF,hematologic malignancy,multiple myeloma|mantle cell lymphoma (MCL)|myelodysplastic diseases (MDS)
leniolisib,MWKYMZXCGYXLPL-ZDUSSCGKSA-N,Phase 2/Phase 3,PI3K inhibitor,,,
lenvatinib,WOSKHXYHFSIKNG-UHFFFAOYSA-N,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT4|KDR,oncology,thyroid cancer
leonurine,WNGSUWLDMZFYNZ-UHFFFAOYSA-N,Preclinical,anti-inflammatory agent,,,
LEQ506,POERAARDVFVDLO-QGZVFWFLSA-N,Phase 1,G protein signaling inhibitor,,,
lercanidipine,ZDXUKAKRHYTAKV-MGBGTMOVSA-N,Launched,calcium channel blocker,CACNA2D1,cardiology,hypertension
lerisetron,PWWDCRQZITYKDV-UHFFFAOYSA-N,Phase 3,serotonin receptor antagonist,HTR3A,,
lersivirine,MCPUZZJBAHRIPO-UHFFFAOYSA-N,Phase 2,non-nucleoside reverse transcriptase inhibitor,,,
lesinurad,FGQFOYHRJSUHMR-UHFFFAOYSA-N,Launched,uric acid diuretic,SLC22A12,rheumatology,gout
lestaurtinib,UIARLYUEJFELEN-DMVVYWCZSA-N,Phase 3,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,FLT3|NTRK1,,
leteprinim,JMPOIZCOJJMTHI-UHFFFAOYSA-N,Phase 2,nerve growth factor agonist,,,
letermovir,FWYSMLBETOMXAG-QHCPKHFHSA-N,Launched,CMV terminase inhibitor,,infectious disease,cytomegalovirus (CMV)
letosteine,IKOCLISPVJZJEA-YUMQZZPRSA-N,Launched,mucolytic agent,,pulmonary|infectious disease,bronchitis|pneumonia
letrazuril,XQKYUBTUOHHNDV-GFCCVEGCSA-N,Phase 1,antiinfective drug,,,
letrozole,HPJKCIUCZWXJDR-UHFFFAOYSA-N,Launched,aromatase inhibitor,CYP19A1,oncology,breast cancer
leucomethylene-blue,QTWZICCBKBYHDM-UHFFFAOYSA-N,Phase 3,nitric oxide production inhibitor|tau aggregation inhibitor,MAPT,,
leucovorin,VVIAGPKUTFNRDU-STQMWFEESA-N,Launched,folate receptor ligand,,oncology,osteosarcoma
leucylleucine-methyl-ester,AJMOLNFDYWTVQW-QWRGUYRKSA-N,Phase 2,,,,
leuprolide,GFIJNRVAKGFPGQ-LIJARHBVSA-N,Launched,gonadotropin releasing factor hormone receptor agonist,GNRHR,oncology,prostate cancer
levalbuterol,NDAUXUAQIAJITI-LBPRGKRZSA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,bronchospasm
levallorphan,OZYUPQUCAUTOBP-QXAKKESOSA-N,Launched,opioid receptor antagonist,CHRNA2|OPRM1,pulmonary,respiratory depression
levamisole,HLFSDGLLUJUHTE-SNVBAGLBSA-N,Withdrawn,acetylcholine receptor agonist,ALPL,,
levamlodipine,HTIQEAQVCYTUBX-KRWDZBQOSA-N,Launched,calcium channel blocker,,cardiology,hypertension
levcromakalim,TVZCRIROJQEVOT-CABCVRRESA-N,Phase 3,potassium channel activator,KCNJ5,,
levetiracetam,HPHUVLMMVZITSG-LURJTMIESA-N,Launched,calcium channel blocker,CACNA1B|SCN1A|SV2A,neurology/psychiatry,seizures
levo-phencynonate,ROZOEEGFKDFEFP-AXRVMRSRSA-N,Launched,acetylcholine receptor antagonist,CHRM1,,
levobetaxolol,NWIUTZDMDHAVTP-KRWDZBQOSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,ophthalmology,intraocular pressure|glaucoma
levobunolol,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,ophthalmology,glaucoma|ocular hypertension
levobunolol-(+),IXHBTMCLRNMKHZ-GFCCVEGCSA-N,Preclinical,adrenergic receptor antagonist,,,
levobunolol-(+/-),IXHBTMCLRNMKHZ-GFCCVEGCSA-N,Preclinical,adrenergic receptor antagonist,,,
levocabastine,ZCGOMHNNNFPNMX-KYTRFIICSA-N,Launched,histamine receptor antagonist,HRH1|NTSR2,ophthalmology,conjunctivitis
levocarnitine,PHIQHXFUZVPYII-ZCFIWIBFSA-O,Launched,,CRAT|CROT,endocrinology,carnitine deficiency
levocarnitine-propionate,UFAHZIUFPNSHSL-MRVPVSSYSA-O,Launched,carnitine palmitoyltransferase inhibitor,CRAT,neurology/psychiatry|endocrinology,peripheral neuropathy|carnitine deficiency
levocetirizine,ZKLPARSLTMPFCP-OAQYLSRUSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria
levodopa,WTDRDQBEARUVNC-LURJTMIESA-N,Launched,dopamine precursor,DRD1|DRD2|DRD3|DRD4|DRD5|GPR143,neurology/psychiatry,Parkinson's Disease
levodropropizine,PTVWPYVOOKLBCG-ZDUSSCGKSA-N,Launched,antitussive,,pulmonary,cough suppressant
levofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,Launched,bacterial DNA gyrase inhibitor,TOP2A,infectious disease|otolaryngology|pulmonary|urology,pneumonia|sinusitis|bronchitis|skin infections|prostatitis|urinary tract infections|pyelonephritis|anthrax|plague
levomenol,RGZSQWQPBWRIAQ-CABCVRRESA-N,Launched,,,neurology/psychiatry|infectious disease,spasms|skin infections
levomenthol,NOOLISFMXDJSKH-KXUCPTDWSA-N,Launched,,OPRK1|TRPA1|TRPM8|TRPV3,neurology/psychiatry,pain relief
levomepromazine,VRQVVMDWGGWHTJ-CQSZACIVSA-N,Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR2A|HTR2C,neurology/psychiatry|gastroenterology,psychosis|schizophrenia|bipolar disorder|nausea|insomnia
levomequitazine,HOKDBMAJZXIPGC-MRXNPFEDSA-N,Phase 2,histamine receptor antagonist,HRH1,,
levonordefrin,GEFQWZLICWMTKF-CDUCUWFYSA-N,Launched,vasodilator,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|SLC6A2,hematology,hemorrhage
levonorgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,Launched,estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist,PGR,endocrinology,contraceptive
levopropoxyphene,XLMALTXPSGQGBX-HXBUSHRASA-N,Launched,antitussive,,pulmonary,cough suppressant
levosimendan,WHXMKTBCFHIYNQ-SECBINFHSA-N,Launched,calcium sensitizer,KCNJ11|KCNJ8|PDE3A|TNNC1,cardiology,congestive heart failure
levosulpiride,BGRJTUBHPOOWDU-NSHDSACASA-N,Launched,dopamine receptor antagonist,CA1|CA12|CA7|DRD2|DRD3,neurology/psychiatry|gastroenterology|urology,schizophrenia|psychosis|anxiety|vertigo|dyspepsia|irritable bowel syndrome|premature ejaculation (PE)
levothyroxine,XUIIKFGFIJCVMT-LBPRGKRZSA-N,Launched,thyroid hormone stimulant,THRA|THRB,endocrinology,myxedema coma
LFM-A13,BQLDGDMKDYAGNE-MRVPVSSYSA-N,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,
LGD-6972,HKJMCBYPVCGZFB-LDLOPFEMSA-N,Phase 2,glucagon receptor antagonist,,,
LGK-974,XXYGTCZJJLTAGH-UHFFFAOYSA-N,Phase 2,porcupine inhibitor,PORCN,,
LH846,DYHAMRNAHTWYKY-UHFFFAOYSA-N,Preclinical,casein kinase inhibitor,CSNK1D,,
liarozole,UGFHIPBXIWJXNA-QGZVFWFLSA-N,Phase 2/Phase 3,cytochrome P450 inhibitor,CYP19A1|CYP26A1,,
licarbazepine,BMPDWHIDQYTSHX-CQSZACIVSA-N,Phase 3,voltage-gated sodium channel blocker,SCN5A,,
licochalcone-A,KAZSKMJFUPEHHW-DHZHZOJOSA-N,Phase 3,topoisomerase inhibitor,PTPN1,,
licofelone,UAWXGRJVZSAUSZ-UHFFFAOYSA-N,Phase 3,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5|PLA2G2E|PTGS2,,
licogliflozin,XFJAMQQAAMJFGB-ZQGJOIPISA-N,Preclinical,sodium/glucose cotransporter inhibitor,,,
licostinel,CHFSOFHQIZKQCR-UHFFFAOYSA-N,Phase 1,NMDA receptor antagonist ,,,
lidamidine,RRHJHSBDJDZUGL-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,,gastroenterology,diarrhea
lidocaine,NNJVILVZKWQKPM-UHFFFAOYSA-N,Launched,histamine receptor agonist,EGFR|SCN10A|SCN5A|SCN9A,neurology/psychiatry|dermatology|hematology,itching|eczema|hemorrhage
lidoflazine,ZBIAKUMOEKILTF-UHFFFAOYSA-N,Launched,calcium channel blocker,SCN1A|SCN3A|SLC29A1,cardiology,coronary artery disease (CAD)
lifirafenib,NGFFVZQXSRKHBM-FKBYEOEOSA-N,Phase 1/Phase 2,RAF inhibitor,,,
lifitegrast,JFOZKMSJYSPYLN-QHCPKHFHSA-N,Launched,lymphocyte function-associated antigen negative modulator,,ophthalmology,dry eye syndrome
ligustilide,IQVQXVFMNOFTMU-FLIBITNWSA-N,Preclinical,tumor necrosis factor production inhibitor,TNF,,
limaprost-alfadex,OJZYRQPMEIEQFC-UAWLTFRCSA-N,Launched,prostanoid receptor agonist,PTGER1,cardiology,claudication
LIMKi-3,IVUGBSGLHRJSSP-UHFFFAOYSA-N,Preclinical,LIM kinase inhibitor,LIMK1,,
limonin,KBDSLGBFQAGHBE-MSGMIQHVSA-N,Preclinical,HIV protease inhibitor,,,
linaclotide,KXGCNMMJRFDFNR-WDRJZQOASA-N,Launched,guanylate cyclase activator,GUCY2C,gastroenterology,irritable bowel syndrome|constipation
linagliptin,LTXREWYXXSTFRX-QGZVFWFLSA-N,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus
linalool,CDOSHBSSFJOMGT-JTQLQIEISA-N,Phase 1,anticonvulsant,,,
linaprazan,GHVIMBCFLRTFHI-UHFFFAOYSA-N,Preclinical,ATP-sensitive potassium channel inhibitor,,,
lincomycin,OJMMVQQUTAEWLP-KIDUDLJLSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,gastroenterology,enteritis
lindane,JLYXXMFPNIAWKQ-GNIYUCBRSA-N,Launched,,GABRB1|GLRA1|GLRA2|GLRA3|GLRB,infectious disease,scabies
linezolid,TYZROVQLWOKYKF-ZDUSSCGKSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,MAOA|MAOB,infectious disease,pneumonia|skin infections
linifanib,MPVGZUGXCQEXTM-UHFFFAOYSA-N,Phase 3,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK,,
linoleic-acid,OYHQOLUKZRVURQ-HZJYTTRNSA-N,Phase 3,oxidative stress inducer,FABP4|FFAR1|FFAR4|HNF4A|KCNB1|PPARG|TRPM8,,
linopirdine,YEJCDKJIEMIWRQ-UHFFFAOYSA-N,Phase 3,potassium channel blocker,KCNQ2|KCNQ3|KCNQ4|KCNQ5,,
linsidomine,XZYRDNUZENBYFI-UHFFFAOYSA-N,Launched,nitric oxide donor,,urology,erectile dysfunction
linsitinib,PKCDDUHJAFVJJB-VLZXCDOPSA-N,Phase 3,IGF-1 inhibitor,IGF1R|INSR|INSRR,,
lintopride,MJCKISCWHDATBN-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,,,
liothyronine,AUYYCJSJGJYCDS-LBPRGKRZSA-N,Launched,thyroid hormone stimulant,THRA|THRB,endocrinology,hypothyroidism|myxedema coma
liothyronine-(isomer),AUYYCJSJGJYCDS-GFCCVEGCSA-N,Preclinical,,,,
lipoamide,FCCDDURTIIUXBY-ZETCQYMHSA-N,Preclinical,,,,
liquiritin,DEMKZLAVQYISIA-ZRWXNEIDSA-N,Preclinical,antioxidant,,,
liraglutide,YSDQQAXHVYUZIW-QCIJIYAXSA-N,Launched,GLP receptor agonist,GLP1R,endocrinology,weight-loss aid|diabetes mellitus
liranaftate,VPHPQNGOVQYUMG-UHFFFAOYSA-N,Launched,fungal squalene epoxidase inhibitor,,infectious disease,fungal infection
lirimilast,YPFLFUJKZDAXRA-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,,,
lisadimate,WHQOKFZWSDOTQP-VIFPVBQESA-N,Launched,topical sunscreen agent,,dermatology,sunscreen lotion
lisinopril,RLAWWYSOJDYHDC-BZSNNMDCSA-N,Launched,angiotensin converting enzyme inhibitor,ACE|ACE2,cardiology|endocrinology,hypertension|congestive heart failure|diabetes mellitus
lisofylline,NSMXQKNUPPXBRG-SECBINFHSA-N,Phase 2,interleukin receptor antagonist|STAT inhibitor,,,
lisuride,BKRGVLQUQGGVSM-KBXCAEBGSA-N,Launched,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6,neurology/psychiatry,Parkinson's Disease
lithium-acetoacetate,WDJHALXBUFZDSR-UHFFFAOYSA-N,Preclinical,,FAH,,
lithium-citrate,PTYJGLZVOMGTRG-UHFFFAOYSA-N,Launched,,,neurology/psychiatry,bipolar disorder|depression
lithocholic-acid,SMEROWZSTRWXGI-HVATVPOCSA-N,Preclinical,FXR antagonist|vitamin D receptor agonist,GPBAR1|NR1H4|NR1I2|VDR,,
litronesib,YVAFBXLHPINSIK-QHCPKHFHSA-N,Phase 2,kinesin-like spindle protein inhibitor,KIF11,,
lixivaptan,PPHTXRNHTVLQED-UHFFFAOYSA-N,Phase 3,vasopressin receptor antagonist,AVPR2,,
LM-22A4,RGWJKANXFYJKHN-UHFFFAOYSA-N,Preclinical,tropomyosin receptor kinase inhibitor,NTRK2,,
LM11A-31,YNMUTYLWSRFTPX-GHMZBOCLSA-N,Phase 1,neurotrophic agent,NGFR,,
LMI070,STWTUEAWRAIWJG-UHFFFAOYSA-N,Phase 1/Phase 2,survival motor neuron protein modulator,SMN1,,
LMK-235,VRYZCEONIWEUAV-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC4|HDAC5,,
LMK-235,"InChI=1S/C15H22N2O4/c1-11-8-12(2)10-13(9-11)15(19)17-21-7-5-3-4-6-14(18)16-20/h8-10,20H,3-7H2,1-2H3,(H,16,18)(H,17,19)",Preclinical,HDAC inhibitor,HDAC4|HDAC5,,
lobeline,MXYUKLILVYORSK-HBMCJLEFSA-N,Launched,acetylcholine receptor antagonist,CHRNA10|CHRNA9|SLC18A2,neurology/psychiatry,smoking cessation
lobendazole,OKOVSTKGUBOSTB-UHFFFAOYSA-N,Preclinical,anthelmintic agent,,,
lobenzarit,UGDPYGKWIHHBMB-UHFFFAOYSA-N,Launched,immunosuppressant,,rheumatology,rheumatoid arthritis
lodenosine,KBEMFSMODRNJHE-JFWOZONXSA-N,Phase 2,antiretroviral ,,,
lodoxamide,RVGLGHVJXCETIO-UHFFFAOYSA-N,Launched,histamine receptor antagonist,,ophthalmology,vernal keratoconjunctivitis (VKC)
lofemizole,MBKWNJVQSFBLQI-UHFFFAOYSA-N,Phase 3,cyclooxygenase inhibitor,,,
lofepramine,SAPNXPWPAUFAJU-UHFFFAOYSA-N,Launched,norepinephrine reuptake inhibitor|serotonin–norepinephrine reuptake inhibitor (SNRI),HTR1A|SLC6A2|SLC6A4,neurology/psychiatry,depression
lofexidine,KSMAGQUYOIHWFS-SSDOTTSWSA-N,Launched,adrenergic receptor agonist,,neurology/psychiatry,opioid withdrawal
lomefloxacin,ZEKZLJVOYLTDKK-VIFPVBQESA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,respiratory tract infections|urinary tract infections
lomeguatrib,JUJPKFNFCWJBCX-UHFFFAOYSA-N,Phase 2,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,,
lomerizine,JQSAYKKFZOSZGJ-UHFFFAOYSA-N,Launched,calcium channel blocker,CACNA1B|SCN5A,neurology/psychiatry,migraine headache
lometrexol,ZUQBAQVRAURMCL-DOMZBBRYSA-N,Phase 2,glycinamide ribonucleotide formyltransferase inhibitor,GART,,
lomitapide,MBBCVAKAJPKAKM-UHFFFAOYSA-N,Launched,microsomal trigylceride transfer protein inhibitor,MTTP,endocrinology,hypercholesterolemia
lomustine,NEXPKUGJJKVILF-UHFFFAOYSA-N,Launched,DNA synthesis inhibitor,,hematologic malignancy|oncology,Hodgkin's lymphoma|brain tumors
lonafarnib,DHMTURDWPRKSOA-RUZDIDTESA-N,Phase 3,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,,
lonafarnib,"InChI=1S/C27H31Br2ClN4O2/c28-20-12-19-2-1-18-13-21(30)14-22(29)24(18)25(26(19)32-15-20)17-5-9-33(10-6-17)23(35)11-16-3-7-34(8-4-16)27(31)36/h12-17,25H,1-11H2,(H2,31,36)/t25-/m1/s1",Phase 3,farnesyltransferase inhibitor,FNTA|HRAS|KRAS|NRAS,,
lonidamine,WDRYRZXSPDWGEB-UHFFFAOYSA-N,Launched,glucokinase inhibitor,GCK,,
loperamide,RDOIQAHITMMDAJ-UHFFFAOYSA-N,Launched,opioid receptor agonist,CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC,gastroenterology,diarrhea
lopinavir,KJHKTHWMRKYKJE-SUGCFTRWSA-N,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
loracarbef,JAPHQRWPEGVNBT-UTUOFQBUSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease|otolaryngology|pulmonary,ear infections|laryngitis|bronchitis|pneumonia|urinary tract infections|skin infections
loratadine,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,allergy|neurology/psychiatry,allergic rhinitis|itching
loreclezole,XGLHZTBDUXXHOM-WMZJFQQLSA-N,Phase 2,benzodiazepine receptor agonist,GABRB2|GABRB3,,
lorediplon,NQPOCLFSADOXBR-UHFFFAOYSA-N,Phase 2,GABA receptor modulator,GABRA1,,
lorglumide,IEKOTSCYBBDIJC-LJQANCHMSA-N,Phase 1,CCK receptor antagonist,CCKAR|CCKBR,,
lorlatinib,IIXWYSCJSQVBQM-UHFFFAOYSA-N,Launched,ALK tyrosine kinase receptor inhibitor,ALK,oncology,non-small cell lung cancer (NSCLC)
lornoxicam,WLHQHAUOOXYABV-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology|neurology/psychiatry,osteoarthritis|sciata
losartan,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,Launched,angiotensin receptor antagonist,AGTR1,cardiology|nephrology,hypertension|diabetic nephropathy|hypertension
losmapimod,KKYABQBFGDZVNQ-UHFFFAOYSA-N,Phase 3,p38 MAPK inhibitor,MAPK14,,
lotamilast,BBTFKAOFCSOZMB-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,,,
loteprednol,DMKSVUSAATWOCU-HROMYWEYSA-N,Launched,glucocorticoid receptor agonist|phospholipase inhibitor,NR3C1,ophthalmology,conjunctivitis
lovastatin,PCZOHLXUXFIOCF-BXMDZJJMSA-N,Launched,HMGCR inhibitor,HDAC2|HMGCR|ITGAL|NR1I2,cardiology|endocrinology,coronary heart disease|myocardial infarction|hypercholesterolemia
loxapine,XJGVXQDUIWGIRW-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,schizophrenia
loxistatin-acid,SCMSYZJDIQPSDI-SRVKXCTJSA-N,Preclinical,cysteine peptidase inhibitor,CTSB,,
loxoprofen,YMBXTVYHTMGZDW-ZWNOBZJWSA-N,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGS2,neurology/psychiatry,pain relief
LP-533401,JZWUKILTKYJLCN-URXFXBBRSA-N,Preclinical,tryptophan hydroxylase inhibitor,,,
LPA2-antagonist-1,BPRNMVDTWIHULJ-AWEZNQCLSA-N,Preclinical,lysophosphatidic acid receptor antagonist,LPAR2,,
LRRK2-IN-1,IWMCPJZTADUIFX-UHFFFAOYSA-N,Preclinical,leucine rich repeat kinase inhibitor,LRRK2,,
LSN-2463359,STAFRSGTRKNXHF-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM5,,
LSZ-102,SJXNPGGVGZXKKI-NYYWCZLTSA-N,Phase 1,selective estrogen receptor modulator (SERM),,,
LTA,RCORNHOUCUDCAC-UHFFFAOYSA-N,Phase 2,,,,
LTB4,VNYSSYRCGWBHLG-AMOLWHMGSA-N,Phase 2,leukocyte activator,LTB4R|LTB4R2,,
LTX-315,GGAKLYWEFZCVIT-TVEKFXMRSA-N,Phase 2,anticancer agent,,,
Lu-AA-47070,MSWIQSFUBYCFJE-PGMHBOJBSA-N,Phase 2,adenosine receptor antagonist,ADORA2A,,
lubiprostone,DBVFKLAGQHYVGQ-BFYDXBDKSA-N,Launched,chloride channel activator,CLCN2,gastroenterology,constipation|irritable bowel syndrome
lucanthone,FBQPGGIHOFZRGH-UHFFFAOYSA-N,Phase 2,endonuclease inhibitor,APEX1|TOP1|TOP2A,,
lucitanib,CUDVHEFYRIWYQD-UHFFFAOYSA-N,Phase 2,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,,
lucitanib,"InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)",Phase 2,FGFR inhibitor|VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,,
LUF-5834,OFHKDLYFKPBXER-UHFFFAOYSA-N,Preclinical,adenosine receptor agonist,ADORA2A|ADORA2B,,
lufenuron,PWPJGUXAGUPAHP-AWEZNQCLSA-N,Launched,chitin inhibitor,,infectious disease,flea control
luliconazole,YTAOBBFIOAEMLL-REQDGWNSSA-N,Launched,sterol demethylase inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis
lumacaftor,UFSKUSARDNFIRC-UHFFFAOYSA-N,Launched,CFTR channel agonist,CFTR,pulmonary,cystic fibrosis
lumateperone,HOIIHACBCFLJET-SFTDATJTSA-N,Launched,dopamine receptor modulator|serotonin receptor antagonist,DRD2|HTR2A,,
lumefantrine,DYLGFOYVTXJFJP-OXTLUBNBSA-N,Launched,antimalarial agent,ATP1A1,infectious disease,malaria
lumiracoxib,KHPKQFYUPIUARC-UHFFFAOYSA-N,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,,
lupanine,JYIJIIVLEOETIQ-XDQVBPFNSA-N,Phase 1,sodium channel blocker,INS,,
lurasidone,PQXKDMSYBGKCJA-CVTJIBDQSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7,neurology/psychiatry,schizophrenia
lurbinectedin,YDDMIZRDDREKEP-HWTBNCOESA-N,Phase 3,DNA binding agent,,,
lusaperidone,ZYXHQIPQIKTEDI-UHFFFAOYSA-N,Preclinical,adrenergic receptor antagonist,,,
lusutrombopag,NOZIJMHMKORZBA-KJCUYJGMSA-N,Launched,thrombopoietin receptor agonist,,,
lutein,KBPHJBAIARWVSC-RGZFRNHPSA-N,Launched,antioxidant,,ophthalmology,macular degeneration|cataracts|retinitis pigmentosa (RP)
luteolin,IQPNAANSBPBGFQ-UHFFFAOYSA-N,Phase 2,glucosidase inhibitor,TOP1,,
luzindole,WVVXBPKOIZGVNS-UHFFFAOYSA-N,Preclinical,melatonin receptor antagonist,MTNR1A|MTNR1B,,
LX1031,XNMUICFMGGQSMZ-WIOPSUGQSA-N,Phase 2,tryptophan hydroxylase inhibitor,TPH1,,
LX7101,PWPNYABQEOGNNC-UHFFFAOYSA-N,Phase 1/Phase 2,LIM kinase inhibitor|rho associated kinase inhibitor,LIMK2|ROCK1|ROCK2,,
LXH254,UEPXBTCUIIGYCY-UHFFFAOYSA-N,Phase 1,RAF inhibitor,,,
LXR-623,KYWWJENKIMRJBI-UHFFFAOYSA-N,Phase 1,LXR agonist,AR|NR1H2|NR1H3|NR1I2|NR3C1,,
LXS196,XXJXHXJWQSCNPX-UHFFFAOYSA-N,Phase 1,PKC inhibitor,,,
LY2090314,HRJWTAWVFDCTGO-UHFFFAOYSA-N,Phase 2,glycogen synthase kinase inhibitor,GSK3B,,
LY2109761,IHLVSLOZUHKNMQ-UHFFFAOYSA-N,Preclinical,TGF beta receptor inhibitor,TGFBR1|TGFBR2,,
LY2140023,AVDUGNCTZRCAHH-MDASVERJSA-N,Phase 3,glutamate receptor agonist,GRM3,,
LY215490,ZXFRFPSZAKNPQQ-YTWAJWBKSA-N,Phase 1,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1,,
LY2157299,IVRXNBXKWIJUQB-UHFFFAOYSA-N,Phase 2/Phase 3,TGF beta receptor inhibitor,TGFBR1,,
LY2183240,GZNIYOXWFCDBBJ-UHFFFAOYSA-N,Preclinical,FAAH inhibitor|FAAH reuptake inhibitor,FAAH,,
LY2228820,XPPBBJCBDOEXDN-UHFFFAOYSA-N,Phase 2,p38 MAPK inhibitor,MAPK14,,
LY223982,SYZSSLLFRVDRHL-QPJJXVBHSA-N,Phase 2,leukotriene receptor antagonist,LTB4R,,
LY225910,KUECXUACQOYKNB-UHFFFAOYSA-N,Preclinical,CCK receptor antagonist,CCKBR,,
LY231617,WQNYIWJBDGLKEB-UHFFFAOYSA-N,Preclinical,lipid peroxidase inhibitor,,,
LY2334737,MEOYFIHNRBNEPI-UXIGCNINSA-N,Phase 1,antitumor agent|ribonucleotide reductase inhibitor,,,
LY2365109,FKPLJWGRBCQLTL-UHFFFAOYSA-N,Preclinical,glycine transporter inhibitor,SLC6A9,,
LY2452473,IHIWYQYVBNODSV-KRWDZBQOSA-N,Phase 2,androgen receptor modulator,AR,,
LY2510924,IJHWVENTEFSNBC-FHYZPQNHSA-N,Phase 2,CC chemokine receptor antagonist,,,
LY255283,WCGXJPFHTHQNJL-UHFFFAOYSA-N,Preclinical,leukotriene receptor antagonist,LTB4R|LTB4R2,,
LY2584702,FYXRSVDHGLUMHB-UHFFFAOYSA-N,Phase 1,ribosomal protein inhibitor,RPS6KB1,,
LY2603618,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,Phase 2,CHK inhibitor,CHEK1,,
LY2606368,DOTGPNHGTYJDEP-UHFFFAOYSA-N,Phase 2,CHK inhibitor,CHEK1,,
LY2608204,QIIVJLHCZUTGSD-CUBQBAPOSA-N,Phase 2,glucokinase activator,GCK,,
LY266097,NJLHHCITDFZZSE-QGZVFWFLSA-N,Preclinical,serotonin receptor antagonist,HTR2B,,
LY2784544,SQSZANZGUXWJEA-UHFFFAOYSA-N,Phase 2,JAK inhibitor,JAK2|JAK3,,
LY2784544,"InChI=1S/C23H25ClFN7O/c1-14-9-21(29-28-14)27-22-11-17(13-31-5-7-33-8-6-31)23-26-15(2)20(32(23)30-22)10-16-3-4-18(24)12-19(16)25/h3-4,9,11-12H,5-8,10,13H2,1-2H3,(H2,27,28,29,30)",Phase 2,JAK inhibitor,JAK2|JAK3,,
LY2795050,LOOCZNLSXJHWTG-NRFANRHFSA-N,Preclinical,opioid receptor antagonist,,,
LY2801653,QHADVLVFMKEIIP-UHFFFAOYSA-N,Phase 2,MET inhibitor,MET,,
LY2811376,MJQMRGWYPNIERM-HNNXBMFYSA-N,Phase 1,beta-secretase inhibitor,BACE1,,
LY2828360,UCMNDPDJRSEZPL-UHFFFAOYSA-N,Phase 2,cannabinoid receptor agonist,,,
LY2857785,LHIUZPIDLZYPRL-MXVIHJGJSA-N,Preclinical,CDK inhibitor,CDK9,,
LY2874455,GKJCVYLDJWTWQU-CXLRFSCWSA-N,Phase 1,FGFR antagonist,FGFR1|FGFR2|FGFR3|FGFR4|KDR,,
LY288513,LMUQHXHWJWQXSD-PMACEKPBSA-N,Preclinical,CCK receptor antagonist,CCKBR,,
LY2886721,NIDRNVHMMDAAIK-YPMLDQLKSA-N,Phase 1/Phase 2,beta-secretase inhibitor,BACE1,,
LY294002,CZQHHVNHHHRRDU-UHFFFAOYSA-N,Preclinical,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PIM1|PLK1|PRKCA|PRKDC|ROCK1|RPS6KB1|SGK1,,
LY2979165,BBGHHIUQOKQCBW-LDZWZCGGSA-N,Phase 1,glutamate receptor agonist,GRM2,,
LY3000328,NDEBZCZEAVMSQF-GOTSBHOMSA-N,Phase 1,cathepsin inhibitor,CTSS,,
LY3009120,HHCBMISMPSAZBF-UHFFFAOYSA-N,Phase 1,RAF inhibitor,BRAF|RAF1,,
LY3023414,ACCFLVVUVBJNGT-AWEZNQCLSA-N,Phase 2,mTOR inhibitor|PI3K inhibitor,MTOR,,
LY303511,NGAGMBNBKCDCDJ-UHFFFAOYSA-N,Preclinical,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,BRD2|BRD3|BRD4,,
LY310762,KDXISMANFPJVJY-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR1D,,
LY311727,OPWQYOUZRHDKBR-UHFFFAOYSA-N,Preclinical,phospholipase inhibitor,,,
LY3200882,PNPFMWIDAKQFPY-UHFFFAOYSA-N,Phase 1,TGF beta receptor inhibitor,,,
LY320135,RYNSGDFWBJWWSZ-UHFFFAOYSA-N,Preclinical,cannabinoid receptor antagonist,CNR1,,
LY3214996,JNPRPMBJODOFEC-UHFFFAOYSA-N,Phase 1,ERK inhibitor,,,
LY3295668,YQQZZYYQTCPEAS-OYLFLEFRSA-N,Phase 1/Phase 2,Aurora kinase inhibitor,,,
LY334370,MDMJLMDBRQXOOI-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,,,
LY344864,GKWHICIUSVVNGX-MRXNPFEDSA-N,Preclinical,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR7,,
LY364947,IBCXZJCWDGCXQT-UHFFFAOYSA-N,Preclinical,p38 MAPK inhibitor|TGF beta receptor inhibitor,TGFBR1,,
LY393558,QUSLYAPLTMMCFE-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR1B|HTR1D|HTR2A|HTR2B,,
LY404187,HOQAVGZLYRYHSO-HNNXBMFYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRIA1|GRIA2|GRIA3|GRIA4,,
LY411575,ULSSJYNJIZWPSB-CVRXJBIPSA-N,Preclinical,gamma secretase inhibitor,,,
LY450108,ACOXQYLJOQAHST-ZDUSSCGKSA-N,Phase 1,glutamate receptor modulator,,,
LY456236,XPJOMFBGKIABQW-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRM1,,
lycopene,OAIJSZIZWZSQBC-GYZMGTAESA-N,Launched,free radical scavenger,,,
lylamine,JVVXZOOGOGPDRZ-SLFFLAALSA-N,Preclinical,cannabinoid receptor agonist,CNR1,,
lymecycline,DZTKAWPWXGIREW-KKSKXDPKSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,dermatology,acne vulgaris (AV)
lynestrenol,YNVGQYHLRCDXFQ-XGXHKTLJSA-N,Launched,progestogen hormone,,endocrinology,contraceptive
lypressin,BJFIDCADFRDPIO-KKSWSVFASA-N,Launched,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2,endocrinology,central diabetes insipidus
M-14157,LMHJFKYQYDSOQO-UHFFFAOYSA-N,Phase 2,ATP-sensitive potassium channel antagonist,KCNQ1,,
M-25,WATNXVHKRRTUFK-UHFFFAOYSA-N,Preclinical,smoothened receptor antagonist,DHH|IHH|SMO,,
M-344,MXWDSZWTBOCWBK-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC8,,
m-3M3FBS,ZIIUUSVHCHPIQD-UHFFFAOYSA-N,Preclinical,phospholipase activator,PLCB2|PLCB3|PLCD1|PLCG1|PLCG2,,
m-chlorophenylbiguanide,DIHXJZHAIHGSAW-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR3A|HTR3B,,
m-THP,XAEPFBXVLMACNN-LWQDQPMZSA-N,Phase 1,,,,
M8-B,UOGGWHBYFVBUIY-UHFFFAOYSA-N,Preclinical,transient receptor potential channel antagonist,TRPM8,,
mabuprofen,JVGUNCHERKJFCM-GFCCVEGCSA-N,Launched,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief
mabuterol,JSJCTEKTBOKRST-SNVBAGLBSA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma
macelignan,QDDILOVMGWUNGD-UONOGXRCSA-N,Preclinical,anti-inflammatory agent|antioxidant,,,
macitentan,JGCMEBMXRHSZKX-UHFFFAOYSA-N,Launched,endothelin receptor antagonist,EDNRA|EDNRB,endocrinology,contraceptive
macitentan-n-butyl-analogue,OZBDTKLWBSATSN-UHFFFAOYSA-N,Preclinical,endothelin receptor antagonist,,,
macozinone,BJDZBXGJNBMCAV-UHFFFAOYSA-N,Preclinical,DPRE1 inhibitor,,,
madecassoside,BNMGUJRJUUDLHW-HCZMHFOYSA-N,Preclinical,anti-inflammatory agent,,,
madrasin,QQJIYKXTEMDJFM-UHFFFAOYSA-N,Preclinical,cell splicing inhibitor,,,
mafenide,TYMRLRRVMHJFTF-UHFFFAOYSA-N,Launched,carbonic anhydrase inhibitor,CA12|CA14|CA2|CA4|CA6|CA9,infectious disease,first-aid antibiotic|skin infections
magnolol,VVOAZFWZEDHOOU-UHFFFAOYSA-N,Preclinical,PPAR receptor agonist,GABRA1|PPARG,,
malathion,JXSJBGJIGXNWCI-MRVPVSSYSA-N,Launched,cholinesterase inhibitor,ACHE,infectious disease,lice
malic-acid,BJEPYKJPYRNKOW-REOHCLBHSA-N,Launched,,PKD2L1,,
malotilate,YPIQVCUJEKAZCP-UHFFFAOYSA-N,Launched,protein synthesis stimulant,,gastroenterology,hepatic cirrhosis
maltobionic-acid,JYTUSYBCFIZPBE-AMTLMPIISA-N,Launched,matrix metalloprotease inhibitor,,dermatology,cosmetic
mandelic-acid,IWYDHOAUDWTVEP-SSDOTTSWSA-N,Launched,,,,
mangafodipir,CXFKOLCMCRBYPL-UHFFFAOYSA-L,Launched,contrast agent,,radiology,contrast agent
manidipine,ANEBWFXPVPTEET-JGCGQSQUSA-N,Launched,calcium channel blocker,CACNA1C|CACNA1D,cardiology,hypertension
manitimus,MYMWDZLPEPMSCN-GFCCVEGCSA-N,Preclinical,dehydrogenase inhibitor,,,
mannitol-D,FBPFZTCFMRRESA-KVTDHHQDSA-N,Launched,diuretic,,neurology/psychiatry|ophthalmology|gastroenterology,intracranial pressure|intraocular pressure|constipation
maprotiline,QSLMDECMDJKHMQ-GSXCWMCISA-N,Launched,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2,neurology/psychiatry,depression|dysthymic disorder
maraviroc,GSNHKUDZZFZSJB-QYOOZWMWSA-N,Launched,CC chemokine receptor antagonist,CCR5,infectious disease,human immunodeficiency virus (HIV-1)
marbofloxacin,BPFYOAJNDMUVBL-UHFFFAOYSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections
maribavir,KJFBVJALEQWJBS-XUXIUFHCSA-N,Phase 3,cytomegalovirus inhibitor|protein kinase inhibitor,PYGM,,
marimastat,OCSMOTCMPXTDND-OUAUKWLOSA-N,Phase 3,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,,
marimastat,"InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1",Phase 3,matrix metalloprotease inhibitor,MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9,,
maropitant,OMPCVMLFFSQFIX-CONSDPRKSA-N,Launched,neurokinin receptor antagonist,TACR1,gastroenterology,vomiting
masitinib,WJEOLQLKVOPQFV-UHFFFAOYSA-N,Launched,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor,FGFR3|KIT|PDGFRA|PDGFRB,dermatology,mastocytoma
masoprocol,HCZKYJDFEPMADG-RYUDHWBXSA-N,Launched,lipoxygenase inhibitor,ALOX5,dermatology,actinic keratosis (AK)
matrine,ZSBXGIUJOOQZMP-JLNYLFASSA-N,Phase 2,opioid receptor agonist,OPRK1,,
mavacamten,RLCLASQCAPXVLM-NSHDSACASA-N,Phase 3,myosin inhibitor ,,,
mavatrep,ORDHXXHTBUZRCN-NTEUORMPSA-N,Preclinical,transient receptor potential channel antagonist,,,
mavoglurant,ZFPZEYHRWGMJCV-ZHALLVOQSA-N,Phase 2,glutamate receptor antagonist,GRM5,,
maxacalcitol,DTXXSJZBSTYZKE-ZDQKKZTESA-N,Launched,vitamin D receptor agonist,VDR,endocrinology,hyperparathyroidism
maytansinol-isobutyrate,OPQNCARIZFLNLF-HSBZPDDFSA-N,Preclinical,,,,
MBX-2982,NFTMKHWBOINJGM-UHFFFAOYSA-N,Phase 2,glucose dependent insulinotropic receptor agonist,GPR119,,
MC-1,NGVDGCNFYWLIFO-UHFFFAOYSA-N,Phase 3,,AADAT|ABAT|AGXT|AGXT2|ALAS1|AZIN2|BCAT1|BCAT2|CBS|CCBL1|CCBL2|CSAD|CTH|DDC|FTCD|GAD1|GAD2|GADL1|GCAT|GLDC|GOT1|GOT2|GPT|GPT2|HDC|IGSF10|KYNU|MOCOS|NFS1|OAT|ODC1|PDXDC1|PDXP|PHYKPL|PNPO|PROSC|PSAT1|PYGB|PYGL|PYGM|SCLY|SDS|SDSL|SEPSECS|SGPL1|SHMT1|SHMT2|SPTLC1|SPTLC2|SPTLC3|SRR|TAT|THNSL1,,
MC1568,QQDIFLSJMFDTCQ-FIFLTTCUSA-N,Preclinical,HDAC inhibitor,HDAC2,,
MCC950,HUUSXLKCTQDPGL-UHFFFAOYSA-N,Preclinical,NOD like receptor inhibitor,NLRP3,,
McN-5652-(+/-),YVKDUIAAPBKHMJ-MOPGFXCFSA-N,Preclinical,selective serotonin reuptake inhibitor (SSRI),,,
MCOPPB,CYYNMPPFEJPBJD-OAQYLSRUSA-N,Preclinical,nociceptin/orphanin FQ receptor agonist,OPRL1,,
mCPP,VHFVKMTVMIZMIK-UHFFFAOYSA-N,Phase 2,serotonin receptor agonist,HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6,,
MD-920,IXORZMNAPKEEDV-OBDJNFEBSA-N,Phase 1,NFkB pathway inhibitor,AADACL2,,
mdivi-1,NZJKEVWTYMOYOR-UHFFFAOYSA-N,Preclinical,dynamin inhibitor,DNM1,,
MDL-11939,AXNGJCOYCMDPQG-HXUWFJFHSA-N,Phase 2,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,,
MDL-27531,DPGDRICHXKQXEN-UHFFFAOYSA-N,Preclinical,glycine receptor agonist,,,
MDL-29951,KNBSYZNKEAWABY-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,FBP1,,
MDL-72832,HCVRCHQFYYZPHT-KRWDZBQOSA-N,Preclinical,serotonin receptor agonist,HTR1A,,
MDL-73005EF,BVMYCHKQPGEOSI-HNNXBMFYSA-N,Phase 1,serotonin receptor antagonist,HTR1A,,
MDMS,IQLZWWDXNXZGPK-UHFFFAOYSA-N,Phase 2,DNA inhibitor,,,
ME-0328,QIHBWVVVRYYYRO-ZDUSSCGKSA-N,Preclinical,PPAR receptor antagonist,PARP3,,
ME0328,QIHBWVVVRYYYRO-CYBMUJFWSA-N,Preclinical,PARP inhibitor,PARP3,,
mebendazole,OPXLLQIJSORQAM-UHFFFAOYSA-N,Launched,tubulin polymerization inhibitor,TUBA1A|TUBB|TUBB4B,infectious disease,pinworm|whipworm|hookworm|ascariasis
mebeverine,VYVKHNNGDFVQGA-IBGZPJMESA-N,Launched,acetylcholine receptor antagonist,CHRM1,gastroenterology,irritable bowel syndrome
mebhydrolin,FQQIIPAOSKSOJM-UHFFFAOYSA-N,Launched,antihistamine,,allergy,allergic rhinitis|urticaria
mebicar,XIUUSFJTJXFNGH-UHFFFAOYSA-N,Launched,anxiolytic,,neurology/psychiatry,anxiety
mebrofenin,MHPZZZZLAQGTHT-UHFFFAOYSA-N,Launched,,,radiology,diagnostic agent
mecamylamine,IMYZQPCYWPFTAG-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4,cardiology,hypertension
mecarbinate,YTBNTDMBGXAOCG-UHFFFAOYSA-N,Preclinical,,,,
meclinertant,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Phase 2/Phase 3,neurotensin receptor antagonist,NTSR1|NTSR2,,
meclizine,OCJYIGYOJCODJL-VWLOTQADSA-N,Launched,constitutive androstane receptor (CAR) agonist,NR1I3,gastroenterology|neurology/psychiatry,nausea|vomiting|motion sickness
meclocycline-sulfosalicylate,MEFKOOXNVFALTA-IWVLMIASSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,dermatology|infectious disease,acne vulgaris (AV)|skin infections
meclofenamic-acid,SBDNJUWAMKYJOX-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2,rheumatology|neurology/psychiatry|endocrinology,joint pain|muscle pain|rheumatoid arthritis|primary dysmenorrhea (PD)
meclofenoxate,XZTYGFHCIAKPGJ-UHFFFAOYSA-N,Launched,nootropic agent,,neurology/psychiatry,senile dementia|Alzheimer's disease
mecysteine,MCYHPZGUONZRGO-VKHMYHEASA-N,Launched,analgesic agent,,pulmonary,chest congestion
medetomidine,CUHVIMMYOGQXCV-LLVKDONJSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,neurology/psychiatry,sedative
medica-16,HYSMCRNFENOHJH-UHFFFAOYSA-N,Phase 2,ATP citrase lyase inhibitor,FFAR1,,
medorinone,OCCZJXAHSUCJSA-UHFFFAOYSA-N,Phase 1,,,,
medronic-acid,MBKDYNNUVRNNRF-UHFFFAOYSA-N,Launched,bone resorption inhibitor,,radiology,skeletal imaging agent
medroxyprogesterone,FRQMUZJSZHZSGN-HBNHAYAOSA-N,Launched,progesterone receptor agonist,PGR,endocrinology,contraceptive
medroxyprogesterone-acetate,PSGAAPLEWMOORI-PEINSRQWSA-N,Launched,progesterone receptor agonist,ESR1|PGR,endocrinology,contraceptive
medrysone,GZENKSODFLBBHQ-ILSZZQPISA-N,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology,conjunctivitis|episcleritis
mefenamic-acid,HYYBABOKPJLUIN-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,KCNQ1|PTGS1|PTGS2|TRPM3,endocrinology,primary dysmenorrhea (PD)
mefexamide,HUNIPYLVUPMFCZ-UHFFFAOYSA-N,Preclinical,psychoactive drug,,,
mefloquine,XEEQGYMUWCZPDN-DOMZBBRYSA-N,Launched,adenosine receptor antagonist|hemoglobin antagonist,,infectious disease,malaria
megestrol,VXIMPSPISRVBPZ-NWUMPJBXSA-N,Launched,progesterone receptor agonist,,oncology,breast cancer
megestrol-acetate,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,Launched,progesterone receptor agonist,NR3C1|PGR,neurology/psychiatry|endocrinology,anorexia|cachexia
meglitinide,SWLAMJPTOQZTAE-UHFFFAOYSA-N,Phase 2,potassium channel blocker,CCR2,,
meglumine,MBBZMMPHUWSWHV-BDVNFPICSA-N,Launched,excipient,,,
meglutol,NPOAOTPXWNWTSH-UHFFFAOYSA-N,Launched,HMGCR inhibitor,HMGCR,,
meisoindigo,QNOCRUSVMMAKSC-CCEZHUSRSA-N,Phase 3,STAT inhibitor,STAT3,,
MEK1-2-inhibitor,XQRVCODIGHFXKQ-UHFFFAOYSA-N,Preclinical,MEK inhibitor,MAP2K2,,
melanotan-ii,JDKLPDJLXHXHNV-VEUPWBLKSA-N,Launched,melanocortin receptor agonist,,,
melatonin,DRLFMBDRBRZALE-UHFFFAOYSA-N,Launched,melatonin receptor agonist|nitric oxide synthase inhibitor,ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB,neurology/psychiatry,sleep cycle support
meldonium,PVBQYTCFVWZSJK-UHFFFAOYSA-O,Launched,gamma butyrobetaine hydroxylase inhibitor,BBOX1,cardiology,coronary artery disease (CAD)
melengestrol-acetate,UDKABVSQKJNZBH-AKZSSJSASA-N,Preclinical,progesterone receptor agonist,,,
melevodopa,XBBDACCLCFWBSI-ZETCQYMHSA-N,Launched,dopamine precursor|dopamine receptor agonist,DDC,neurology/psychiatry,Parkinson's Disease
meloxicam,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis
melperone,DKMFBWQBDIGMHM-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,neurology/psychiatry,psychosis
melphalan,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,Launched,DNA alkylating agent|DNA inhibitor,,hematologic malignancy,multiple myeloma
melphalan-n-oxide,GSKQMLGAUOTSKT-LBPRGKRZSA-N,Phase 1,hypoxia inducible factor inhibitor,HIF1A,,
meluadrine,LIXBJWRFCNRAPA-LLVKDONJSA-N,Preclinical,,,,
memantine,BUGYDGFZZOZRHP-CDECOKDKSA-N,Launched,glutamate receptor antagonist,,neurology/psychiatry,Alzheimer's disease|senile dementia
menadione,MJVAVZPDRWSRRC-UHFFFAOYSA-N,Launched,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor,AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1,gastroenterology|neurology/psychiatry|dermatology|rheumatology,ulcerative colitis|diarrhea|headache|varicose veins|rheumatoid arthritis
menadione-bisulfite,WIXFIQKTHUVFDI-LLVKDONJSA-N,Phase 2,vitamin K,GGCX|VKORC1|VKORC1L1,,
menatetrenone,DKHGMERMDICWDU-GHDNBGIDSA-N,Launched,bone resorption inhibitor,,orthopedics,osteoporosis
menbutone,FHGJSJFIQNQBCK-UHFFFAOYSA-N,Launched,,,gastroenterology,bile stimulation
mepacrine,GPKJTRJOBQGKQK-MRXNPFEDSA-N,Launched,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator,PLA2G1B,infectious disease,giardiasis
meparfylon,QXLPXWSKPNOQLE-UHFFFAOYSA-N,Preclinical,,,,
mepazine,CBHCDHNUZWWAPP-OAHLLOKOSA-N,Phase 2,MALT1 inhibitor (JH),MALT1,,
mepenzolate,GKNPSSNBBWDAGH-IBGZPJMESA-N,Launched,acetylcholine receptor antagonist,,gastroenterology,peptic ulcer disease (PUD)
mephenesin,JWDYCNIAQWPBHD-VIFPVBQESA-N,Launched,muscle relaxant,,neurology/psychiatry,muscle relaxant
mephentermine,RXQCGGRTAILOIN-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,cardiology,hypotension
mephenytoin,GMHKMTDVRCWUDX-LBPRGKRZSA-N,Launched,hydantoin antiepileptic,SCN5A,neurology/psychiatry,seizures
mepiroxol,LQYJAVWWKTWWKN-UHFFFAOYSA-N,Preclinical,,,,
mepivacaine,INWLQCZOYSRPNW-CYBMUJFWSA-N,Launched,potassium channel blocker|sodium channel blocker,,neurology/psychiatry,local anesthetic
meprednisone,PIDANAQULIKBQS-RNUIGHNZSA-N,Launched,,NR3C1,,
meprylcaine,VXJABHHJLXLNMP-UHFFFAOYSA-N,Preclinical,local anesthetic,,,
meptazinol,JLICHNCFTLFZJN-OAHLLOKOSA-N,Launched,opioid receptor agonist,BCHE,neurology/psychiatry,pain relief
mepyramine,YECBIJXISLIIDS-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,otolaryngology|obstetrics/gynecology,common cold|menstrual pain
mequinol,NWVVVBRKAWDGAB-UHFFFAOYSA-N,Launched,,TYR,dermatology,skin depigmentation
merbarone,GFYRZTLCYQQVHZ-UHFFFAOYSA-N,Phase 2,topoisomerase inhibitor,TOP2A,,
merbromin,OHCFGBLQZMYRTR-UHFFFAOYSA-M,Launched,antiseptic,,infectious disease,first-aid antiseptic
mercaptopurine,GLVAUDGFNGKCSF-UHFFFAOYSA-N,Launched,immunosuppressant|protein synthesis inhibitor|purine antagonist,HPRT1|IMPDH1|IMPDH2|PPAT,hematologic malignancy,acute lymphoblastic leukemia (ALL)
mercaptosuccinic-acid,NJRXVEJTAYWCQJ-UWTATZPHSA-N,Launched,,,,
Merck60,ABZSPJVXTTUFAA-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC1|HDAC2,,
mericitabine,MLESJYFEMSJZLZ-MAAOGQSESA-N,Phase 2,HCV inhibitor,,,
merimepodib,JBPUGFODGPKTDW-SFHVURJKSA-N,Phase 2,inosine monophosphate dehydrogenase inhibitor,IMPDH1,,
meropenem,DMJNNHOOLUXYBV-PQTSNVLCSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections|intra-abdominal infections|meningitis
mertansine,ANZJBCHSOXCCRQ-UTOUECMYSA-N,Phase 2,microtubule inhibitor,,,
mesalazine,KBOPZPXVLCULAV-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist,ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2,gastroenterology,ulcerative colitis|inflammatory bowel disease
mesna,ZNEWHQLOPFWXOF-UHFFFAOYSA-N,Launched,antioxidant,,urology,hemorrhagic cystitis
mesoridazine,SLVMESMUVMCQIY-AKJBCIBTSA-N,Launched,dopamine receptor antagonist,DRD2|HTR2A,neurology/psychiatry,schizophrenia
mestinon,RVOLLAQWKVFTGE-UHFFFAOYSA-N,Launched,cholinesterase inhibitor,ACHE|BCHE,neurology/psychiatry,myasthenia gravis
mestranol,IMSSROKUHAOUJS-MJCUULBUSA-N,Launched,estrogen receptor agonist,ESR1,endocrinology,contraceptive
mesulergine,JLVHTNZNKOSCNB-YSVLISHTSA-N,Phase 2,dopamine receptor agonist,HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7,,
meta-cresyl-acetate,OTGAHJPFNKQGAE-UHFFFAOYSA-N,Preclinical,,,,
metacetamol,QLNWXBAGRTUKKI-UHFFFAOYSA-N,Preclinical,analgesic agent,,,
metacresol,RLSSMJSEOOYNOY-UHFFFAOYSA-N,Launched,,INS,,
metafolin,ZNOVTXRBGFNYRX-STQMWFEESA-N,Launched,,,,
metamizole,LVWZTYCIRDMTEY-UHFFFAOYSA-N,Withdrawn,cyclooxygenase inhibitor|opioid receptor agonist,PTGS1,,
metaphit,FGSGBQAQSPSRJK-UHFFFAOYSA-N,Preclinical,phencyclidine receptor acylator,,,
metaproterenol,LMOINURANNBYCM-LLVKDONJSA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,bronchospasm|asthma|bronchitis|emphysema
metaraminol,WXFIGDLSSYIKKV-RCOVLWMOSA-N,Launched,adrenergic receptor agonist,ADRA1A,cardiology,hypotension
metatinib,PDYXPCKITKHFOZ-UHFFFAOYSA-N,Phase 1,Bcr-Abl kinase inhibitor,ABL1|BCR,,
metaxalone,IMWZZHHPURKASS-LLVKDONJSA-N,Launched,muscle relaxant,,neurology/psychiatry,muscle pain
metazosin,YEOTYALSMRNXLJ-NSHDSACASA-N,Phase 2,adrenergic receptor antagonist,ADRA1A,,
metenkephalin,YFGBQHOOROIVKG-BHDDXSALSA-N,Phase 2,immunostimulant,OPRD1,,
metergoline,WZHJKEUHNJHDLS-QTGUNEKASA-N,Launched,dopamine receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,neurology/psychiatry|endocrinology,seasonal affective disorder|anxiety|hyperprolactinemia
metformin,XZWYZXLIPXDOLR-UHFFFAOYSA-N,Launched,insulin sensitizer,ACACB|PRKAB1,endocrinology,diabetes mellitus
methacholine,NZWOPGCLSHLLPA-ZETCQYMHSA-N,Launched,acetylcholine receptor agonist,CHRM2|CHRM4,pulmonary,bronchial hyperresponsiveness diagnostic
methacycline,QNJKSUYWBCNWFI-IKHBEOKZSA-N,Preclinical,protein synthesis inhibitor,,pulmonary,bronchitis
methanesulfonyl-fluoride,KNWQLFOXPQZGPX-UHFFFAOYSA-N,Phase 2,acetylcholinesterase inhibitor,ACHE,,
methantheline,GZHFODJQISUKAY-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM1|HRH2,gastroenterology|neurology/psychiatry|urology,peptic ulcer disease (PUD)|irritable bowel syndrome|pancreatitis|dyskinesia|neurogenic bladder
methapyrilene,HNJJXZKZRAWDPF-UHFFFAOYSA-N,Withdrawn,histamine receptor antagonist,HRH1,,
metharbital,FWJKNZONDWOGMI-UHFFFAOYSA-N,Launched,GABA receptor modulator,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2,neurology/psychiatry,epilepsy
methazolamide,FLOSMHQXBMRNHR-UHFFFAOYSA-N,Launched,carbonic anhydrase inhibitor,CA1|CA12|CA14|CA2|CA4|CA7,ophthalmology,glaucoma|intraocular pressure
methenamine,VKYKSIONXSXAKP-UHFFFAOYSA-N,Launched,bacterial DNA inhibitor,,infectious disease,urinary tract infections
methiazole,SXJIZQPZESTWLD-UHFFFAOYSA-N,Preclinical,anthelmintic agent,,,
methicillin,RJQXTJLFIWVMTO-TYNCELHUSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
methimazole,PMRYVIKBURPHAH-UHFFFAOYSA-N,Launched,antithyroid agent,TPO,endocrinology,hyperthyroidism
methionine,FFEARJCKVFRZRR-SCSAIBSYSA-N,Launched,,METAP2,,
methiopril,JHFOAISYWJRTIM-PSASIEDQSA-N,Phase 2,angiotensin converting enzyme inhibitor,ACE,,
methocarbamol,GNXFOGHNGIVQEH-MRVPVSSYSA-N,Launched,muscle relaxant,CA1,neurology/psychiatry,muscle relaxant
methoprene-(s),NFGXHKASABOEEW-GYMWBFJFSA-N,Preclinical,,,,
methotrexate,FBOZXECLQNJBKD-ZDUSSCGKSA-N,Launched,dihydrofolate reductase inhibitor,DHFR,oncology|hematologic malignancy|dermatology|rheumatology,gestational choriocarcinoma|hydatidiform mole|acute lymphoblastic leukemia (ALL)|psoriasis|rheumatoid arthritis
methoxamine,WJAJPNHVVFWKKL-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,cardiology,hypotension
methoxsalen,QXKHYNVANLEOEG-UHFFFAOYSA-N,Launched,DNA synthesis inhibitor,CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4,dermatology,psoriasis
methoxyamine,GMPKIPWJBDOURN-UHFFFAOYSA-N,Phase 2,DNA repair enzyme inhibitor,APEX1,,
methoxyflurane,RFKMCNOHBTXSMU-UHFFFAOYSA-N,Launched,membrane permeability inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|MT-ND1,neurology/psychiatry,general anaesthetic
methoxyphenamine,OEHAYUOVELTAPG-VIFPVBQESA-N,Launched,adrenergic receptor agonist,,pulmonary,asthma
methscopolamine,LZCOQTDXKCNBEE-IKIFYQGPSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,gastroenterology,peptic ulcer disease (PUD)
methsuximide,AJXPJJZHWIXJCJ-GFCCVEGCSA-N,Launched,T-type calcium channel blocker,CACNA1G|CACNA1H|CACNA1I,neurology/psychiatry,seizures
methyclothiazide,CESYKOGBSMNBPD-VIFPVBQESA-N,Launched,chloride reabsorption inhibitor,SLC12A1|SLC12A3,cardiology,hypertension|edema
methyl-5-hydroxytryptamine,LYPCGXKCQDYTFV-SSDOTTSWSA-N,Preclinical,,,,
methyl-aminolevulinate,YUUAYBAIHCDHHD-UHFFFAOYSA-N,Launched,oxidizing agent,FCGR1A|FECH,dermatology,actinic keratosis (AK)
methyl-nicotinate,YNBADRVTZLEFNH-UHFFFAOYSA-N,Phase 2,,,,
methyl-salicylate,OSWPMRLSEDHDFF-UHFFFAOYSA-N,Launched,,,endocrinology|neurology/psychiatry,fever|pain relief
methylatropine-nitrate,PIPAJLPNWZMYQA-HZMVEIRTSA-N,Preclinical,acetylcholine receptor antagonist,CHRM1,,
methylbenactyzium-bromide,HDAMOICMOAXFLJ-UHFFFAOYSA-N,Preclinical,cholinergic receptor antagonist,,,
methylbenzethonium-chloride,UQOOPIMXBSPVJI-UHFFFAOYSA-N,Preclinical,other antibiotic,,,
methylcobalamin,JEWJRMKHSMTXPP-WDJKBINPSA-M,Phase 3,vitamin B,,,
methyldopa,CJCSPKMFHVPWAR-JTQLQIEISA-N,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|DDC,cardiology,hypertension
methyldopate,SVEBYYWCXTVYCR-LBPRGKRZSA-N,Launched,,,cardiology,hypertension
methylene-blue,RBTBFTRPCNLSDE-UHFFFAOYSA-N,Launched,guanylyl cyclase inhibitor|nitric oxide production inhibitor,ACHE,hematology,methemoglobinemia
methylergometrine,UNBRKDKAWYKMIV-QWQRMKEZSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C,hematology|neurology/psychiatry,postpartum hemorrhage (PPH)|migraine headache
methyllycaconitine,XLTANAWLDBYGFU-VTLKBQQISA-N,Preclinical,acetylcholine receptor antagonist,CHRNA7,,
methylnaltrexone,JVLBPIPGETUEET-WIXLDOGYSA-O,Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,gastroenterology,constipation
methylparaben,LXCFILQKKLGQFO-UHFFFAOYSA-N,Launched,other antifungal,,dermatology,cosmetic
methylprednisolone,VHRSUDSXCMQTMA-PJHHCJLFSA-N,Launched,glucocorticoid receptor agonist,NR3C1,endocrinology|rheumatology|dermatology|infectious disease|allergy|hematology|neurology/psychiatry|gastroenterology,hypercalcemia|thyroiditis|ankylosing spondylitis|bursitis|osteoarthritis|psoriatic arthritis|seborrheic dermatitis|mycosis|allergic rhinitis|psoriasis|anemia|multiple sclerosis|ulcerative colitis|enteritis
methylprednisolone-aceponate,DALKLAYLIPSCQL-YPYQNWSCSA-N,Launched,anti-inflammatory agent|glucocorticoid receptor agonist,NR3C1,endocrinology|rheumatology|infectious disease|allergy|pulmonary|gastroenterology|dermatology|neurology/psychiatry|hematology,congenital adrenal hyperplasia|thyroiditis|hypercalcemia|rheumatoid arthritis|bursitis|epicondylitis|allergic rhinitis|asthma|ulcerative colitis|enteritis|osteoarthritis|psoriasis|multiple sclerosis|anemia
methylprednisolone-sodium-succinate,IMBXEJJVJRTNOW-XYMSELFBSA-N,Launched,glucocorticoid receptor agonist,,endocrinology|rheumatology|dermatology|pulmonary|allergy|infectious disease|ophthalmology|gastroenterology|hematology|neurology/psychiatry,hypercalcemia|thyroiditis|osteoarthritis|rheumatoid arthritis|seborrheic dermatitis|asthma|allergic rhinitis|shingles|conjunctivitis|ulcerative colitis|enteritis|anemia|multiple sclerosis|mycosis
methylthiouracil,HWGBHCRJGXAGEU-UHFFFAOYSA-N,Launched,,,endocrinology,hyperthyroidism
methysergide,KPJZHOPZRAFDTN-ZRGWGRIASA-N,Launched,serotonin receptor antagonist,HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,neurology/psychiatry,headache
meticrane,FNQQBFNIYODEMB-UHFFFAOYSA-N,Launched,diuretic,,cardiology,edema
metipranolol,BQIPXWYNLPYNHW-OAHLLOKOSA-N,Withdrawn,adrenergic receptor antagonist,,,
metirosine,NHTGHBARYWONDQ-JTQLQIEISA-N,Launched,tyrosine hydroxylase inhibitor,TH,cardiology,hypertension
metitepine,RLJFTICUTYVZDG-GOSISDBHSA-N,Preclinical,anti-HCVE2,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,,
metixene,MJFJKKXQDNNUJF-HNNXBMFYSA-N,Launched,acetylcholine receptor antagonist,CHRM5,neurology/psychiatry,Parkinson's Disease
metoclopramide,TTWJBBZEZQICBI-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,CHRM1|DRD2|HTR3A|HTR3B|HTR4,gastroenterology,gastroparesis|nausea|vomiting
metocurine,JFXBEKISTKFVAB-AJQTZOPKSA-N,Launched,acetylcholine receptor antagonist,CHRM2|CHRNA2,neurology/psychiatry,muscle relaxant
metolazone,AQCHWTWZEMGIFD-JTQLQIEISA-N,Launched,carbonic anhydrase inhibitor,SLC12A3,cardiology,edema|hypertension
metoprolol,IUBSYMUCCVWXPE-AWEZNQCLSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,cardiology,hypertension|angina pectoris|myocardial infarction
metoxibutropate,FVRWRGBTEHAPDI-HNNXBMFYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,,
metrifonate,NFACJZMKEDPNKN-GSVOUGTGSA-N,Phase 3,acetylcholinesterase inhibitor,ACHE,,
metrizamide,BAQCROVBDNBEEB-KSDLJXBFSA-N,Launched,radiopaque medium,,radiology,contrast agent
metrizoic-acid,GGGDNPWHMNJRFN-UHFFFAOYSA-N,Launched,radiopaque medium,,radiology,contrast agent
metronidazole,VAOCPAMSLUNLGC-UHFFFAOYSA-N,Launched,DNA inhibitor,CYP2C9|CYP3A4,dermatology,rosacea
metyrapone,FJLBFSROUSIWMA-UHFFFAOYSA-N,Launched,cytochrome P450 inhibitor,CYP11B1,nephrology,adrenal diagnostic agent
mevastatin,AJLFOPYRIVGYMJ-INTXDZFKSA-N,Preclinical,HMGCR inhibitor,HMGCR,,
mexeneone,MJVGBKJNTFCUJM-UHFFFAOYSA-N,Preclinical,,,,
mexiletine,VLPIATFUUWWMKC-SNVBAGLBSA-N,Launched,sodium channel blocker,PLAU|SCN4A|SCN5A,cardiology,ventricular arrhythmias|ventricular tachycardia (VT)
mezlocillin,YPBATNHYBCGSSN-ZJOBFFGXSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
MF-101,FURUXTVZLHCCNA-AWEZNQCLSA-N,Phase 3,estrogen receptor agonist,CYP19A1|XDH,,
MG-132,TZYWCYJVHRLUCT-VABKMULXSA-N,Preclinical,proteasome inhibitor,PSMB1,,
MG-624,YIMFXBPXUPTIEJ-OUKQBFOZSA-N,Preclinical,acetylcholine receptor antagonist,CHRNA7,,
MGCD-265,UFICVEHDQUKCEA-UHFFFAOYSA-N,Preclinical,VEGFR inhibitor,AXL|MET,,
MI-14,PSTAJIONBVMKLA-UHFFFAOYSA-N,Preclinical,PI4K inhibitor,PI4KB,,
mianserin,UEQUQVLFIPOEMF-UHFFFAOYSA-N,Launched,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7,neurology/psychiatry,depression
mibampator,ULRDYYKSPCRXAJ-KRWDZBQOSA-N,Phase 2,glutamate receptor modulator,GRIA1,,
mibefradil,HBNPJJILLOYFJU-VMPREFPWSA-N,Withdrawn,T-type calcium channel blocker,ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4,,
micafungin,PIEUQSKUWLMALL-YABMTYFHSA-N,Launched,"fungal 1,3-beta-D-glucan synthase inhibitor",,infectious disease,candidemia|peritonitis|esophageal candidiasis
miconazole,BYBLEWFAAKGYCD-SFHVURJKSA-N,Launched,bacterial cell wall synthesis inhibitor,TRPM2|TRPV5,infectious disease|neurology/psychiatry,yeast infection|itching
micronomicin,DNYGXMICFMACRA-XHEDQWPISA-N,Launched,protein synthesis inhibitor,,infectious disease,gram-negative bacterial infections
midafotel,VZXMZMJSGLFKQI-ABVWVHJUSA-N,Phase 3,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
midecamycin,DMUAPQTXSSNEDD-RVVOCHMRSA-N,Launched,protein synthesis inhibitor,,infectious disease,respiratory tract infections|ear infections|skin infections
midodrine,PTKSEFOSCHHMPD-JTQLQIEISA-N,Launched,adrenergic receptor agonist,,cardiology,hypotension
midostaurin,BMGQWWVMWDBQGC-IIFHNQTCSA-N,Launched,FLT3 inhibitor|KIT inhibitor|PKC inhibitor,FLT3|PRKCG,hematologic malignancy,acute myeloid leukemia (AML)
mifepristone,VKHAHZOOUSRJNA-GCNJZUOMSA-N,Launched,glucocorticoid receptor antagonist|progesterone receptor antagonist,AR|NR1I2|NR3C1|PGR,endocrinology,hyperglycemia|diabetes mellitus
mifobate,VQHUQHAPWMNBLP-LLVKDONJSA-N,Phase 2,PPAR receptor antagonist,PPARG,,
miglitol,IBAQFPQHRJAVAV-ULAWRXDQSA-N,Launched,glucosidase inhibitor,GAA|GANAB|GANC|MGAM,endocrinology,diabetes mellitus
miglustat,UQRORFVVSGFNRO-UTINFBMNSA-N,Launched,glycosyl transferase inhibitor,UGCG,hematology,Gaucher disease
milacemide,GJNNXIYZWIZFRH-UHFFFAOYSA-N,Phase 3,monoamine oxidase inhibitor,MAOB,,
milademetan,RYAYYVTWKAOAJF-QISPRATLSA-N,Phase 1,MDM inhibitor,,,
milnacipran,GJJFMKBJSRMPLA-DZGCQCFKSA-N,Launched,serotonin–norepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,rheumatology,fibromyalgia
milrinone,PZRHRDRVRGEVNW-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE2A|PDE3A|PDE3B|PDE5A,cardiology,congestive heart failure
miltefosine,PQLXHQMOHUQAKB-UHFFFAOYSA-O,Launched,membrane integrity inhibitor,PLA2G1B,infectious disease,leishmaniasis
mimosine,WZNJWVWKTVETCG-YFKPBYRVSA-N,Preclinical,DNA replication inhibitor,CCL2|SHMT1|SHMT2|TYR,,
minaprine,LDMWSLGGVTVJPG-UHFFFAOYSA-N,Withdrawn,serotonin reuptake inhibitor,ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4,,
minerval,JBSOOFITVPOOSY-DOOKAGJSSA-N,Phase 1/Phase 2,FAAH inhibitor,,,
minocycline,ZZZRUAITSXLWBH-NOHUXHDNSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,endocrinology|infectious disease|ophthalmology|urology,fever|respiratory tract infections|psittacosis|trachoma|conjunctivitis|urethritis|chancroid|tularemia|cholera|brucellosis
minodronic-acid,VMMKGHQPQIEGSQ-UHFFFAOYSA-N,Launched,bone resorption inhibitor,FDPS|GGPS1,orthopedics,osteoporosis
minoxidil,ZFMITUMMTDLWHR-UHFFFAOYSA-N,Launched,KATP activator|Kir6 channel (KATP) activator|vasodilator,ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1,endocrinology,androgenetic alopecia
miocamycin,GQNZGCARKRHPOH-XUDBFGHTSA-N,Launched,other antibiotic,,infectious disease,urinary tract infections|chlamydia
MIRA-1,YXEWPGYLMHXLPS-UHFFFAOYSA-N,Preclinical,apoptosis stimulant,,,
mirabegron,PBAPPPCECJKMCM-IBGZPJMESA-N,Launched,adrenergic receptor agonist,ADRB1|ADRB2|ADRB3,urology,urinary incontinence
miridesap,HZLAWYIBLZNRFZ-VXGBXAGGSA-N,Preclinical,amyloid protein inhibitor,,,
mirin,YBHQCJILTOVLHD-YVMONPNESA-N,Preclinical,MRE11A exonuclease inhibitor,MRE11A,,
mirin,"InChI=1S/C10H8N2O2S/c11-10-12-9(14)8(15-10)5-6-1-3-7(13)4-2-6/h1-5,13H,(H2,11,12,14)/b8-5-",Preclinical,MRE11A exonuclease inhibitor,MRE11A,,
miriplatin,BGIHRZPJIYJKAZ-JPLLOCSESA-N,Launched,DNA synthesis inhibitor,,oncology,hepatocellular carcinoma (HCC)
mirodenafil,MIJFNYMSCFYZNY-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE5A,urology,erectile dysfunction
mirogabalin-besylate,FTBQORVNHOIASH-CKYFFXLPSA-N,Preclinical,calcium channel antagonist,,,
mirtazapine,RONZAEMNMFQXRA-INIZCTEOSA-N,Launched,adrenergic receptor antagonist|serotonin receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C,neurology/psychiatry,depression
misonidazole,OBBCSXFCDPPXOL-LURJTMIESA-N,Phase 3,,,,
misoprostol,OJLOPKGSLYJEMD-URPKTTJQSA-N,Launched,prostanoid receptor agonist,PTGER2|PTGER3|PTGER4|PTGIR,gastroenterology,duodenal ulcer disease
mitapivat,XAYGBKHKBBXDAK-UHFFFAOYSA-N,Preclinical,pyruvate kinase isozyme activator,,,
mitiglinide,WPGGHFDDFPHPOB-BBWFWOEESA-N,Launched,insulin secretagogue,ABCC8|KCNJ10|PPARG,endocrinology,diabetes mellitus
mitoflaxone,TZZNWMJZDWYJAZ-UHFFFAOYSA-N,Phase 2,antitumor agent,VWF,,
mitomycin-C,NWIBSHFKIJFRCO-WUDYKRTCSA-N,Launched,DNA alkylating agent|DNA synthesis inhibitor,,oncology,pancreatic cancer|gastric adenocarcinoma
mitoquinone,OIIMUKXVVLRCAF-UHFFFAOYSA-N,Launched,antioxidant,,,
mitotane,JWBOIMRXGHLCPP-ZDUSSCGKSA-N,Launched,antineoplastic agent,CYP11A1|CYP11B1|ESR1,oncology,adrenal cortical carcinoma
mitoxantrone,KKZJGLLVHKMTCM-UHFFFAOYSA-N,Launched,topoisomerase inhibitor,TOP2A,neurology/psychiatry|oncology|hematologic malignancy,multiple sclerosis|prostate cancer|acute myeloid leukemia (AML)
mivacurium,ILVYCEVXHALBSC-GZICNWBJSA-N,Launched,acetylcholine receptor antagonist,CHRNA2,critical care|neurology/psychiatry,endotracheal intubation|muscle relaxant
mivebresib,RDONXGFGWSSFMY-UHFFFAOYSA-N,Phase 1,bromodomain inhibitor,,,
mivobulin,XOJFFEJRKAIVCH-UHFFFAOYSA-N,Phase 2,microtubule inhibitor,,,
MIW-815,IZJJFUQKKZFVLH-YBVMPXGUSA-N,Preclinical,interferon inducer,,,
mizolastine,PVLJETXTTWAYEW-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,allergy,urticaria|allergic rhinitis
mizoribine,OPMVDWXPLVKNQN-AAXBYFMASA-N,Launched,immunosuppressant|inosine monophosphate dehydrogenase inhibitor,IMPDH1,transplant|rheumatology,organ rejection|nephrotic syndrome
MJ-15,PJEIKJFNEFJFLA-UHFFFAOYSA-N,Preclinical,cannabinoid receptor antagonist,CNR1,,
MK-0354,LTQYSJKGRPGMPO-UHFFFAOYSA-N,Phase 2,niacin receptor agonist,HCAR2|HCAR3,,
MK-0557,RMYZIRFUCOMQRH-XLOAEROZSA-N,Phase 3,neuropeptide receptor antagonist,,,
MK-0608,IRZRJANZDIOOIF-GAJNKVMBSA-N,Phase 1,antiviral,,,
MK-0752,XCGJIFAKUZNNOR-QCKZDCLWSA-N,Phase 1/Phase 2,gamma secretase inhibitor,,,
MK-0773,GBEUKTWTUSPHEE-JWJWXJQQSA-N,Phase 2,androgen receptor modulator,AR,,
MK-0812,MTMDXAIUENDNDL-RJSMDTJLSA-N,Phase 2,CC chemokine receptor antagonist,CCR2,,
MK-0893,DNTVJEMGHBIUMW-IBGZPJMESA-N,Phase 2,glucagon receptor antagonist,GCGR,,
MK-1064,CKTWQGHVNRYNCM-UHFFFAOYSA-N,Phase 1,orexin receptor antagonist,,,
MK-1775,BKWJAKQVGHWELA-UHFFFAOYSA-N,Phase 2,WEE1 kinase inhibitor,WEE1,,
MK-1775,"InChI=1S/C27H32N8O2/c1-5-13-34-25(36)21-18-28-26(29-19-9-11-20(12-10-19)33-16-14-32(4)15-17-33)31-24(21)35(34)23-8-6-7-22(30-23)27(2,3)37/h5-12,18,37H,1,13-17H2,2-4H3,(H,28,29,31)",Phase 2,WEE1 kinase inhibitor,WEE1,,
MK-1903,CUTZNERBKDMLAP-QWWZWVQMSA-N,Phase 2,niacin receptor agonist,,,
MK-2048,JSRREMIKIHJGAA-JTQLQIEISA-N,Preclinical,HIV integrase inhibitor,,,
MK-2206,ULDXWLCXEDXJGE-UHFFFAOYSA-N,Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,,
MK-2206,"InChI=1S/C25H21N5O/c26-25(12-4-13-25)18-9-7-17(8-10-18)22-19(16-5-2-1-3-6-16)15-20-21(27-22)11-14-30-23(20)28-29-24(30)31/h1-3,5-11,14-15H,4,12-13,26H2,(H,29,31)",Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,,
MK-2295,VTANGSDRFFLTSQ-UHFFFAOYSA-N,Phase 2,TRPV antagonist,TRPV1,,
MK-2461,JGEBLDKNWBUGRZ-HXUWFJFHSA-N,Phase 1/Phase 2,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB,,
MK-2894,QJZQFVRFJCGDKF-UHFFFAOYSA-N,Preclinical,prostaglandin inhibitor,PTGER4,,
MK-3207,AZAANWYREOQRFB-SETSBSEESA-N,Phase 2,calcitonin antagonist,CALCA,,
MK-3697,VSOUDUXMPUHJEU-UHFFFAOYSA-N,Phase 2,orexin receptor antagonist,HCRTR2,,
MK-4074,WDBNGXLHMZSUEI-UHFFFAOYSA-N,Phase 1,acetyl-CoA carboxylase inhibitor,,,
MK-5046,UJINBEQCDMOAHM-SFHVURJKSA-N,Preclinical,bombesin receptor agonist,BRS3|GRPR|NMBR,,
MK-5108,LCVIRAZGMYMNNT-VVONHTQRSA-N,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,
MK-571,AXUZQJFHDNNPFG-JORPFSLRSA-N,Phase 2,leukotriene receptor antagonist,ABCC2|CYSLTR1,,
MK-6096,NPFDWHQSDBWQLH-QZTJIDSGSA-N,Phase 2,orexin receptor antagonist,HCRTR1|HCRTR2,,
MK-7246,JTCAGRAKUAAYDY-OAHLLOKOSA-N,Preclinical,CRTH receptor antagonist,,,
MK-7622,JUVQLZBJFOGEEO-GOTSBHOMSA-N,Phase 2,cholinergic receptor agonist,,,
MK-8033,VMJFTOSOFDEKTM-UHFFFAOYSA-N,Phase 1,c-Met inhibitor,MET,,
MK-8245,UJEAABFSXKCSGI-UHFFFAOYSA-N,Phase 2,stearoyl-CoA desaturase inhibitor,SCD,,
MK-8617,WXLPERVDMILVIF-UHFFFAOYSA-N,Preclinical,hypoxia inducible factor prolyl hydroxylase inhibitor,,,
MK-8745,YCRFPWKUUNKNDN-UHFFFAOYSA-N,Preclinical,Aurora kinase inhibitor,AURKA,,
MK-886,QAOAOVKBIIKRNL-UHFFFAOYSA-N,Preclinical,lipoxygenase inhibitor,,,
MK-8998,IQIKXZMPPBEWAD-CQSZACIVSA-N,Phase 2,T-type calcium channel blocker,,,
MK2-IN-1,LIPNXDIBECKOMJ-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor,MAPKAPK2,,
MKT-077,QLYHOWIZHHZGPV-XUTLUUPISA-N,Phase 1,HSP inhibitor,,,
ML10302,RVFIAQAAZUEPPE-UHFFFAOYSA-N,Preclinical,serotonin receptor partial agonist,HTR3A|HTR3B|HTR4,,
ML130,SRFABRWQVPCPRG-UHFFFAOYSA-N,Preclinical,NOD1 inhibitor,,,
ML133,GIFYKGIODMXYNT-UHFFFAOYSA-N,Preclinical,potassium channel blocker,,,
ML141,QBNZBMVRFYREHK-JOCHJYFZSA-N,Preclinical,GTPase inhibitor,CDC42,,
ML161,DFOVLSMXPWPCFH-UHFFFAOYSA-N,Preclinical,protease-activated receptor inhibitor,,,
ML167,ROCFOIBAEVAOLQ-UHFFFAOYSA-N,Preclinical,CLK inhibitor|DYRK inhibitor,CLK4|DYRK1B,,
ML179,MFABFKUNLDYKGH-UHFFFAOYSA-N,Preclinical,liver receptor homolog inverse agonist,NR5A2,,
ML193,HTSLEZOTMYUPLU-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor antagonist,GPR55,,
ML204,USYRQXDHKXGTCK-UHFFFAOYSA-N,Preclinical,transient receptor potential channel antagonist,TRPC4|TRPC5,,
ML213,SIQGKPGBLYKQBB-RRFJBIMHSA-N,Preclinical,potassium channel activator,KCNQ4,,
ML218,GSJIGYLGKSBYBC-OSYLJGHBSA-N,Preclinical,T-type calcium channel blocker,CACNA1G|CACNA1H|CACNA1I,,
ML228,QNRODODTMXCRKU-UHFFFAOYSA-N,Preclinical,hypoxia inducible factor activator,HIF1A,,
ML228,"InChI=1S/C27H21N5/c1-3-9-21(10-4-1)22-16-14-20(15-17-22)19-29-27-25(23-11-5-2-6-12-23)31-32-26(30-27)24-13-7-8-18-28-24/h1-18H,19H2,(H,29,30,32)",Preclinical,hypoxia inducible factor activator,HIF1A,,
ML277,OXQNLLVUVDAEHC-OAQYLSRUSA-N,Preclinical,potassium channel activator,KCNQ1,,
ML281,HWOYIOLMBQSTQS-UHFFFAOYSA-N,Preclinical,serine/threonine kinase inhibitor,STK33,,
ML297,IEKSMUSSYJUQMY-UHFFFAOYSA-N,Preclinical,inward rectifier potassium channel activator,KCNJ3,,
ML297,"InChI=1S/C17H14F2N4O/c1-11-9-16(23(22-11)13-5-3-2-4-6-13)21-17(24)20-12-7-8-14(18)15(19)10-12/h2-10H,1H3,(H2,20,21,24)",Preclinical,inward rectifier potassium channel activator,KCNJ3,,
ML298,XAPVAKKLQGLNOY-UHFFFAOYSA-N,Preclinical,phospholipase inhibitor,PLD2,,
ML314,SWEOAXMICIJCQC-UHFFFAOYSA-N,Preclinical,neurotensin agonist,NTSR1,,
ML323,VUIRVWPJNKZOSS-UHFFFAOYSA-N,Preclinical,ubiquitin specific protease inhibitor,USP1,,
ML324,QDBVSOZTVKXUES-UHFFFAOYSA-N,Preclinical,histone lysine demethylase inhibitor,KDM4A,,
ML3403,VXPWQNBKEIVYIS-HNNXBMFYSA-N,Preclinical,MAP kinase inhibitor,CYP3A4|MAPK11|MAPK12|MAPK14,,
ML347,FVRYPYDPKSZGNS-UHFFFAOYSA-N,Preclinical,ALK tyrosine kinase receptor inhibitor,ACVR1|ACVRL1|BMPR1A,,
ML348,OXKNHBBDOIMFFQ-UHFFFAOYSA-N,Preclinical,lysophospholipase inhibitor,LYPLA1,,
ML365,UTAJHKSGYJSZBR-UHFFFAOYSA-N,Preclinical,potassium channel blocker,KCNK3|KCNK9,,
ML786,GXEGTVQATHKFDH-OAQYLSRUSA-N,Preclinical,RAF inhibitor,BRAF|RAF1,,
ML9,OZSMSRIUUDGTEP-UHFFFAOYSA-N,Preclinical,myosin light chain kinase inhibitor,TRPC6,,
MLN0128,GYLDXIAOMVERTK-UHFFFAOYSA-N,Phase 2,mTOR inhibitor,MTOR|PIK3CA|PIK3CD|PIK3CG,,
MLN1117,BLGWHBSBBJNKJO-UHFFFAOYSA-N,Phase 2,PI3K inhibitor,PIK3CA,,
MLN2480,VWMJHAFYPMOMGF-ZCFIWIBFSA-N,Phase 1/Phase 2,RAF inhibitor,,,
MLN8054,HHFBDROWDBDFBR-UHFFFAOYSA-N,Phase 1,Aurora kinase inhibitor,AURKA,,
MLN9708,MBOMYENWWXQSNW-AWEZNQCLSA-N,Phase 3,proteasome inhibitor,,,
MM-102,RZKSQRIPRKWVBU-MHZLTWQESA-N,Preclinical,WDR5/MLL interaction inhibitor,,,
MM-11253,DPVGXUNWCVEIGT-UHFFFAOYSA-N,Preclinical,retinoid receptor antagonist,RARG,,
MM-206,ZXJHEANDHXHGMV-UHFFFAOYSA-N,Preclinical,STAT inhibitor,,,
MM77,MQHOGPLXAXSQAJ-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR1A,,
MMPX,NBLBCGUCPBXKOV-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,,,
MMV-390048,RTJQABCNNLMCJF-UHFFFAOYSA-N,Preclinical,PI4K inhibitor,,,
MN-64,PYTOHIUBXSJKQH-UHFFFAOYSA-N,Preclinical,tankyrase inhibitor,TNKS,,
MNITMT,NMBDIMPYACLUDE-UHFFFAOYSA-N,Preclinical,lymphocyte inhibitor,,,
mocetinostat,HRNLUBSXIHFDHP-UHFFFAOYSA-N,Phase 2,HDAC inhibitor,HDAC1|HDAC11|HDAC2|HDAC3,,
moclobemide,YHXISWVBGDMDLQ-UHFFFAOYSA-N,Launched,monoamine oxidase inhibitor,MAOA|MAOB,neurology/psychiatry,depression|anxiety
modaline,BJHCGMHPEKLROM-UHFFFAOYSA-N,Preclinical,,,,
moexipril,UWWDHYUMIORJTA-HSQYWUDLSA-N,Launched,angiotensin converting enzyme inhibitor,ACE|ACE2,cardiology,hypertension
mofegiline,VXLBSYHAEKDUSU-JXMROGBWSA-N,Phase 1,monoamine oxidase inhibitor,MAOA|MAOB,,
mofezolac,DJEIHHYCDCTAAH-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1,rheumatology|orthopedics,rheumatoid arthritis|osteoporosis
moguisteine,WSYVIAQNTFPTBI-OAHLLOKOSA-N,Phase 2,ATP-sensitive potassium channel inhibitor,,,
molidustat,IJMBOKOTALXLKS-UHFFFAOYSA-N,Phase 3,hypoxia inducible factor inhibitor,EGLN2,,
molindone,KLPWJLBORRMFGK-LBPRGKRZSA-N,Launched,dopamine receptor antagonist,DRD2|HRH1|HTR2A,neurology/psychiatry,schizophrenia
molsidomine,XLFWDASMENKTKL-UHFFFAOYSA-O,Launched,guanylate cyclase stimulant,GUCY1A3,cardiology,coronary artery disease (CAD)
mometasone,QLIIKPVHVRXHRI-CXSFZGCWSA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
mometasone-furoate,WOFMFGQZHJDGCX-ZULDAHANSA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
monastrol,LOBCDGHHHHGHFA-GFCCVEGCSA-N,Preclinical,kinesin inhibitor,KIF11,,
monensin,GAOZTHIDHYLHMS-KEOBGNEYSA-N,Launched,bacterial permeability inducer,,infectious disease,gastrointestinal parasites
monepantel,WTERNLDOAPYGJD-SFHVURJKSA-N,Preclinical,mTOR inhibitor,,,
monobenzone,VYQNWZOUAUKGHI-UHFFFAOYSA-N,Launched,melanin inhibitor,TYR,dermatology,skin depigmentation
monocrotaline,QVCMHGGNRFRMAD-XFGHUUIASA-N,Preclinical,antitumor agent,,,
monoctanoin,GHBFNMLVSPCDGN-JTQLQIEISA-N,Launched,,,gastroenterology,gallstones
monomethyl-fumarate,NKHAVTQWNUWKEO-NSCUHMNNSA-N,Launched,,,neurology/psychiatry,multiple sclerosis
monosodium-alpha-luminol,HWYHZTIRURJOHG-UHFFFAOYSA-N,Launched,,,,
monostearin,VBICKXHEKHSIBG-FQEVSTJZSA-N,Preclinical,,,,
montelukast,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Launched,leukotriene receptor antagonist,ALOX5|CYSLTR1,pulmonary|allergy,asthma|allergic rhinitis|exercise-induced bronchoconstriction (EIB)
moprolol,LFTFGCDECFPSQD-NSHDSACASA-N,Launched,adrenergic receptor antagonist,,cardiology|ophthalmology|neurology/psychiatry,hypertension|glaucoma|anxiety
moracizine,FUBVWMNBEHXPSU-UHFFFAOYSA-N,Withdrawn,sodium channel blocker,SCN5A,cardiology,ventricular arrhythmias
morantel,NVEPPWDVLBMNMB-SNAWJCMRSA-N,Launched,acetylcholine receptor agonist,,infectious disease,tapeworm
morin,YXOLAZRVSSWPPT-UHFFFAOYSA-N,Preclinical,cytochrome P450 inhibitor,ADORA2A|ESR2|FASN|MCL1|SLC22A12,,
morinidazole,GAZGHCHCYRSPIV-JTQLQIEISA-N,Launched,other antibiotic,CYP51A1,,
morniflumate,LDXSPUSKBDTEKA-UHFFFAOYSA-N,Launched,anti-inflammatory agent,,neurology/psychiatry,pain relief
moroxydine,KJHOZAZQWVKILO-UHFFFAOYSA-N,Launched,antiviral,,infectious disease,influenza A virus infection
morphothiadin,SQGRDKSRFFUBBU-GOSISDBHSA-N,Preclinical,antiinfective drug,,,
mosapride,YPELFRMCRYSPKZ-INIZCTEOSA-N,Launched,serotonin receptor agonist,HTR4,gastroenterology,hypertrophic gastritis (GHG)|gastroesophageal reflux disease (GERD)|dyspepsia|irritable bowel syndrome
motapizone,IQHAKYLSMONFMT-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,,,
motesanib,RAHBGWKEPAQNFF-UHFFFAOYSA-N,Phase 3,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FLT1|FLT4|KDR|KIT,,
motolimod,QSPOQCXMGPDIHI-UHFFFAOYSA-N,Phase 2,toll-like receptor agonist,TLR8,,
moxalactam,JWCSIUVGFCSJCK-UOXRKKOCSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections|skin infections|bone and joint infections|pneumonia|urinary tract infections|meningitis
moxaverine,MYCMTMIGRXJNSO-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,,neurology/psychiatry,spasms
moxidectin,YZBLFMPOMVTDJY-LSGXYNIPSA-N,Launched,chloride channel antagonist,,infectious disease,gastrointestinal parasites
moxifloxacin,FABPRXSRWADJSP-MEDUHNTESA-N,Launched,bacterial DNA gyrase inhibitor,TOP2A,otolaryngology|pulmonary|infectious disease,sinusitis|bronchitis|pneumonia|skin infections|intra-abdominal infections
moxisylyte,VRYMTAVOXVTQEF-UHFFFAOYSA-N,Withdrawn,adrenergic receptor antagonist,,,
moxonidine,WPNJAUFVNXKLIM-UHFFFAOYSA-N,Launched,imidazoline receptor agonist,ADRA2A|ADRA2B|ADRA2C,cardiology,hypertension
mozavaptan,WRNXUQJJCIZICJ-DEOSSOPVSA-N,Launched,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2,endocrinology,hyponatremia
MPEP,NEWKHUASLBMWRE-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRM1|GRM4|GRM5,,
MPI-0479605,OVJBNYKNHXJGSA-UHFFFAOYSA-N,Preclinical,mitotic kinase inhibitor,TTK,,
Mps-BAY-2a,MDYKTGNHXNTATG-UHFFFAOYSA-N,Preclinical,monopolar spindle 1 kinase inhibitor,TTK,,
Mps1-IN-1,NMJMRSQTDLRCRQ-UHFFFAOYSA-N,Preclinical,monopolar spindle 1 kinase inhibitor,TTK,,
Mps1-IN-5,NRJKIOCCERLIDG-GOSISDBHSA-N,Phase 1,protein kinase inhibitor,,,
MR-16728,AGKAAJMNNVUNDK-JOCHJYFZSA-N,Preclinical,acetylcholine release enhancer,,,
MR-948,LQQIZTXSZOYPPS-UHFFFAOYSA-N,Phase 1,thromboxane synthase inhibitor,TBXAS1,,
MRK-016,QYSYOGCIDRANAR-UHFFFAOYSA-N,Phase 1,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5,,
MRK-409,GOIFCXRIFSYPFG-UHFFFAOYSA-N,Phase 1,benzodiazepine receptor agonist,,,
MRK-560,WDZVWDXOIGQJIO-UJKQEGAGSA-N,Preclinical,gamma secretase inhibitor,APP,,
MRS-1220,TWWFAXQOKNBUCR-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA2B|ADORA3,,
MRS-1334,QFLOJAMZLQXHFS-AREMUKBSSA-N,Preclinical,adenosine receptor antagonist,ADORA3,,
MRS-1845,BITHABUTZRAUGT-IBGZPJMESA-N,Preclinical,calcium channel blocker,,,
MRS-2578,QOHNRGHTJPFMSL-UHFFFAOYSA-N,Preclinical,purinergic receptor antagonist,P2RY6,,
MRS-3777,ZYVKEIQGOGHCFB-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
MRS-3777,OGCQBCHLFMBCCE-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
MRX-2843,LBEJYFVJIPQSNX-SOAUALDESA-N,Phase 1,MER tyrosine kinase inhibitor,,,
MS-424,AEHLCVKEOAFFJC-MRVPVSSYSA-N,Phase 2,glutamate transporter modulator,,,
MSDC-0160,IRNJSRAGRIZIHD-KRWDZBQOSA-N,Phase 2,insulin sensitizer,,,
MSDC-0602K,JIJXYXYLGRAIGV-UHFFFAOYSA-N,Phase 2,mitochondrial pyruvate carrier modulator,,,
MSX-122,PXZXYRKDDXKDTK-UHFFFAOYSA-N,Phase 2,CC chemokine receptor antagonist,CXCR4,,
MTPG,OZBFBAYESADVDX-JTQLQIEISA-N,Preclinical,glutamate receptor antagonist,GRM2|GRM3,,
mubritinib,ZTFBIUXIQYRUNT-MDWZMJQESA-N,Phase 1,protein tyrosine kinase inhibitor,EGFR|ERBB2,,
mupirocin,MINDHVHHQZYEEK-HBBNESRFSA-N,Launched,isoleucyl-tRNA synthetase inhibitor,,infectious disease,impetigo
muscimol,ZJQHPWUVQPJPQT-UHFFFAOYSA-N,Phase 1,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRR1|GABRR2|GABRR3,,
MUT056399,QUHARGDBJJUOEB-UHFFFAOYSA-N,Phase 1,FABI inhibitor,,,
MY-5445,CEHQLKSLMFIHBF-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor|platelet aggregation inhibitor,PDE5A,,
mycophenolate-mofetil,RTGDFNSFWBGLEC-SYZQJQIISA-N,Launched,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,transplant,organ rejection
mycophenolic-acid,HPNSFSBZBAHARI-RUDMXATFSA-N,Launched,dehydrogenase inhibitor|inositol monophosphatase inhibitor,IMPDH1|IMPDH2,transplant,organ rejection
myricetin,IKMDFBPHZNJCSN-UHFFFAOYSA-N,Preclinical,androgen receptor agonist|cytochrome P450 inhibitor,PIK3CG,,
myricitrin,DCYOADKBABEMIQ-OWMUPTOHSA-N,Preclinical,PKC inhibitor,NOS1|PRKCA,,
myristyl-nicotinate,TVGLGJWCZSCAEM-UHFFFAOYSA-N,Phase 1,topical sunscreen agent,,,
N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide,YYLKOELWSMRYHV-UHFFFAOYSA-N,Preclinical,,,,
N-(p-amylcinnamoyl)-anthranilic-acid,GAMRBCZMOOMBSQ-CCEZHUSRSA-N,Preclinical,phospholipase inhibitor,,,
N-[2-(piperidinylamino)ethyl]-4-iodobenzamide,WCMWVYQHPUQKHW-UHFFFAOYSA-N,Preclinical,sigma receptor ligand,,,
N-acetyl-D-glucosamine,MBLBDJOUHNCFQT-LXGUWJNJSA-N,Phase 2/Phase 3,,B4GALT1|B4GALT2|B4GALT3|B4GALT4|NAGK|NAGLU|NAGPA|RENBP,,
N-acetyl-tyrosine,CAHKINHBCWCHCF-JTQLQIEISA-N,Launched,,,,
N-acetylcarnosine,BKAYIFDRRZZKNF-VIFPVBQESA-N,Launched,,,,
N-acetylglycyl-D-glutamic-acid,CQTYJLQESPLSOP-ZCFIWIBFSA-N,Preclinical,glutamate receptor agonist,,,
N-acetylmannosamine,OVRNDRQMDRJTHS-SHGPDSBTSA-N,Phase 2,,,,
N-acetyltryptamine,NVUGEQAEQJTCIX-UHFFFAOYSA-N,Preclinical,melatonin receptor agonist,,,
N-alpha-methylhistamine-dihydrochloride,PHSPJQZRQAJPPF-UHFFFAOYSA-N,Phase 3,histamine receptor agonist,HRH4,,
N-benzylnaltrindole,PSPANKCQVWSVHM-OUDZLNJNSA-N,Preclinical,opioid receptor antagonist,,,
N-cyclohexyl-2-benzothiazolesulfenamide,DEQZTKGFXNUBJL-UHFFFAOYSA-N,Preclinical,,,,
N-hydroxynicotinamide,IYCHDNQCHLMLJZ-UHFFFAOYSA-N,Preclinical,,,,
"N-methyl-(-)ephedrine-[1R,2S]",FMCGSUUBYTWNDP-ONGXEEELSA-N,Preclinical,,,,
N-methylformamide,ATHHXGZTWNVVOU-UHFFFAOYSA-N,Phase 2,,,,
N-methyllidocaine-iodide,HFRFLLYLVAKRMZ-UHFFFAOYSA-O,Preclinical,antiarrhythmic medication,,,
N-methylpyrrolidone,SECXISVLQFMRJM-UHFFFAOYSA-N,Phase 1,,,,
N-methylquipazine,HOMWNUXPSJQSSU-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,,,
N-MPPP,OVZWUDZIAAHNFG-HXUWFJFHSA-N,Preclinical,opioid receptor agonist,,,
N-oxydiethylenebenzothiazole-2-sulfenamide,MHKLKWCYGIBEQF-UHFFFAOYSA-N,Preclinical,,,,
N-salicoylaminophenol,LGCMKPRGGJRYGM-UHFFFAOYSA-N,Phase 1/Phase 2,ribonucleotide reductase inhibitor,,,
N20C,BYGXICRJQZKUPA-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,,,
N6-cyclopentyladenosine,SQMWSBKSHWARHU-SDBHATRESA-N,Preclinical,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3|SLC29A1,,
N6-methyladenosine,VQAYFKKCNSOZKM-IOSLPCCCSA-N,Preclinical,,,,
N6022,YVPGZQLRPAGKLA-UHFFFAOYSA-N,Phase 1/Phase 2,alcohol dehydrogenase inhibitor,ADH5,,
NAB-2,CZSLEMCYYGEGKP-UHFFFAOYSA-N,Preclinical,ubiquitin ligase transport promoter,NEDD4,,
nabumetone,BLXXJMDCKKHMKV-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,rheumatoid arthritis|osteoarthritis
nadide,BAWFJGJZGIEFAR-NNYOXOHSSA-O,Launched,free radical scavenger,AHCY|AKR1A1|ALDH2|BLVRA|DHPS|DLD|GALE|HMGCR|HSD17B1|HSD17B4|IMPDH2|MGAM|P2RY11|SORD|TRPM2,,
nadifloxacin,JYJTVFIEFKZWCJ-JTQLQIEISA-N,Launched,bacterial DNA gyrase inhibitor,,dermatology|infectious disease,acne vulgaris (AV)|skin infections
nadolol,VWPOSFSPZNDTMJ-YUELXQCFSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,cardiology,angina pectoris|hypertension
NADPH,PTKRUDMLGIIORX-ITGWJZMWSA-N,Preclinical,,DRD2|DRD3|DRD4|GHSR|HTR2A|HTR2C,,
nafadotride,IDZASIQMRGPBCQ-QGZVFWFLSA-N,Preclinical,dopamine receptor antagonist,DRD2|DRD3|HTR1A,,
nafamostat,MQQNFDZXWVTQEH-UHFFFAOYSA-N,Launched,serine protease inhibitor,ASIC1|ASIC2|ASIC3|C1R|PRSS1|TPSAB1|TRPM7,cardiology,anticoagulent
nafcillin,GPXLMGHLHQJAGZ-JTDSTZFVSA-N,Launched,bacterial cell wall synthesis inhibitor,CYP1A2|CYP3A4|SLC22A6,infectious disease,gram-positive bacterial infections
naftidrofuryl,KBAFPSLPKGSANY-FGZHOGPDSA-N,Launched,adrenergic receptor antagonist,,cardiology,claudication
naftifine,OZGNYLLQHRPOBR-DHZHZOJOSA-N,Launched,fungal squalene epoxidase inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis
naftopidil,HRRBJVNMSRJFHQ-HXUWFJFHSA-N,Launched,adrenergic receptor antagonist,ADRA1A,urology,benign prostatic hyperplasia (BPH)
nalbuphine,NETZHAKZCGBWSS-CEDHKZHLSA-N,Launched,opioid receptor agonist|opioid receptor antagonist,OPRD1|OPRK1|OPRM1,neurology/psychiatry,pain relief
nalfurafine,XGZZHZMWIXFATA-UEZBDDGYSA-N,Launched,opioid receptor agonist,OPRK1|OPRM1,nephrology,uremic pruritus
nalidixic-acid,MHWLWQUZZRMNGJ-UHFFFAOYSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,urinary tract infections
nalmefene,WJBLNOPPDWQMCH-MBPVOVBZSA-N,Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,pulmonary,respiratory depression
naloxegol,XNKCCCKFOQNXKV-ZRSCBOBOSA-N,Launched,opioid receptor antagonist,OPRM1,gastroenterology,constipation
naloxone,UZHSEJADLWPNLE-GRGSLBFTSA-N,Launched,opioid receptor antagonist,CREB1|ESR1|OPRD1|OPRK1|OPRM1|TLR4,pulmonary,respiratory depression
naloxone-benzoylhydrazone,AKXCFAYOTIEFOH-XTNAHFASSA-N,Preclinical,opioid receptor antagonist,OPRK1|OPRM1,,
naltrexone,DQCKKXVULJGBQN-XFWGSAIBSA-N,Launched,opioid receptor antagonist,OPRD1|OPRK1|OPRM1|SIGMAR1,neurology/psychiatry,abstinence from alcohol
naltriben,ZHVWWEYETMPAMX-IFKAHUTRSA-N,Preclinical,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,,
naltrindole,WIYUZYBFCWCCQJ-IFKAHUTRSA-N,Preclinical,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,,
Nampt-IN-1,QHHSCLARESIWBH-UHFFFAOYSA-N,Preclinical,,,,
NAN-190,SJDOMIRMMUGQQK-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1F,,
nanchangmycin,FELYAZAWTURXNF-KWJIWYEDSA-N,Preclinical,other antibiotic,,,
napabucasin,DPHUWDIXHNQOSY-UHFFFAOYSA-N,Phase 3,STAT inhibitor,STAT3,,
napamezole,WETRBJOSGIDJHQ-UHFFFAOYSA-N,Preclinical,adrenergic receptor antagonist|monoamine reuptake inhibitor,,,
naphazoline,CNIIGCLFLJGOGP-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA2A,ophthalmology,eye irritation
naphthoquine-phosphate,VEVMYTDOWUQLGI-UHFFFAOYSA-N,Launched,antimalarial agent,,infectious disease,malaria
napirimus,CNUPQURTHORUGH-UHFFFAOYSA-N,Phase 1,immunosuppressant,,,
naproxen,CMWTZPSULFXXJA-VIFPVBQESA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry|rheumatology|dental|otolaryngology|endocrinology,pain relief|rheumatoid arthritis|headache|toothache|backache|muscle pain|common cold|fever
naquotinib,QKDCLUARMDUUKN-XMMPIXPASA-N,Phase 3,EGFR inhibitor,,,
narasin,VHKXXVVRRDYCIK-OQMITHEGSA-N,Launched,antiprotozoal agent,,infectious disease,coccidiosis
naratriptan,AMKVXSZCKVJAGH-UHFFFAOYSA-N,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,neurology/psychiatry,migraine headache
naringenin,FTVWIRXFELQLPI-ZDUSSCGKSA-N,Phase 1,aromatase inhibitor|TRPV antagonist,CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1,,
naringeninic-acid,NGSWKAQJJWESNS-ZZXKWVIFSA-N,Phase 1,,HCAR2|PTGR1,,
naringin,DFPMSGMNTNDNHN-ZPHOTFPESA-N,Preclinical,cytochrome P450 inhibitor,SLCO1A2,,
naringin-dihydrochalcone,CWBZAESOUBENAP-QVNVHUMTSA-N,Preclinical,cytochrome P450 inhibitor,,,
narlaprevir,RICZEKWVNZFTNZ-LFGITCQGSA-N,Phase 3,HCV inhibitor,,,
NAS-181,RTKDBEOSPDFLGD-QGZVFWFLSA-N,Preclinical,serotonin receptor antagonist,HTR1B,,
nastorazepide,VIJCCFFEBCOOIE-JOCHJYFZSA-N,Phase 2,CCK receptor antagonist,CCKBR,,
natamycin,NCXMLFZGDNKEPB-FFPOYIOWSA-N,Launched,fungal ergosterol inhibitor,,ophthalmology|infectious disease,conjunctivitis|fungal keratosis|blepharitis
nateglinide,OELFLUMRDSZNSF-BRWVUGGUSA-N,Launched,insulin secretagogue,ABCC8|KCNJ10|KCNJ11|PPARG,endocrinology,diabetes mellitus
NAV-26,ICGMZCVSHDKQTE-IBGZPJMESA-N,Preclinical,voltage-gated sodium channel blocker,SCN9A,,
navarixin,RXIUEIPPLAFSDF-CYBMUJFWSA-N,Phase 2,CC chemokine receptor antagonist,CXCR1|CXCR2,,
navitoclax,JLYAXFNOILIKPP-KXQOOQHDSA-N,Phase 2,BCL inhibitor,BCL2|BCL2L1|BCL2L2,,
naxagolide,JCSREICEMHWFAY-HUUCEWRRSA-N,Phase 3,dopamine receptor agonist,,,
NB-001,CVPTTZZCRDVGSU-UHFFFAOYSA-N,Preclinical,antiviral,,,
NBI-27914,KNADXBVKFAUMCR-UHFFFAOYSA-N,Preclinical,corticotropin releasing factor receptor antagonist,CRHR1,,
NBI-74330-(+/-),XMRGQUDUVGRCBS-HXUWFJFHSA-N,Preclinical,CC chemokine receptor antagonist,CXCR3,,
NBI-98782,WEQLWGNDNRARGE-DJIMGWMZSA-N,Preclinical,vesicular monoamine transporter inhibitor,,,
NBQX,UQNAFPHGVPVTAL-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIN1|GRIN2A|GRIN2B,,
NCS-382,UADPGHINQMWEAG-FROQITRMSA-N,Preclinical,GABA receptor antagonist,GABBR1|GABBR2|SLC52A2,,
NCX-1015,MJHYBJOMJPGNMM-KGWLDMEJSA-N,Preclinical,interleukin sythesis stimulator,,,
NDD-094,CTUICISGLKIJLG-UHFFFAOYSA-N,Preclinical,,,,
NDT-9513727,ITACCRHKSPSKKL-UHFFFAOYSA-N,Preclinical,complement antagonist,C5AR1,,
NE-100,YBLIQJGXRLZBCZ-UHFFFAOYSA-N,Phase 2,sigma receptor antagonist,SIGMAR1,,
nebivolol,KOHIRBRYDXPAMZ-YHBROIRLSA-N,Launched,adrenergic receptor antagonist,ADRB1,cardiology,hypertension
nebracetam,LCAFGJGYCUMTGS-NSHDSACASA-N,Phase 3,acetylcholine receptor agonist,CHRM1,,
NECA,JADDQZYHOWSFJD-FLNNQWSLSA-N,Launched,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
necrostatin-1,TXUWMXQFNYDOEZ-NSHDSACASA-N,Preclinical,RIPK inhibitor,RIPK1,,
necrostatin-2,WIKGAEMMNQTUGL-SNVBAGLBSA-N,Preclinical,necroptosis inhibitor|RIPK inhibitor,RIPK2,,
nedaplatin,AUZDMWWRYCUANI-UHFFFAOYSA-L,Launched,DNA inhibitor,,oncology,non-small cell lung cancer (NSCLC)|small cell lung cancer|esophageal cancer
nedocromil,RQTOOFIXOKYGAN-UHFFFAOYSA-N,Launched,histamine receptor antagonist,CYSLTR1|CYSLTR2|FPR1|HSP90AA1|PTGDR,neurology/psychiatry|ophthalmology,itching|conjunctivitis
nefazodone,VRBKIVRKKCLPHA-UHFFFAOYSA-N,Withdrawn,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4,,
nefiracetam,NGHTXZCKLWZPGK-UHFFFAOYSA-N,Phase 3,acetylcholine receptor agonist|benzodiazepine receptor agonist,CHRM1,,
nefopam,RGPDEAGGEXEMMM-KRWDZBQOSA-N,Launched,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief
nelarabine,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,Launched,DNA synthesis inhibitor|T cell inhibitor,POLA1,hematologic malignancy,acute lymphoblastic leukemia (ALL)
nelfinavir,QAGYKUNXZHXKMR-HKWSIXNMSA-N,Launched,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1)
nelfinavir,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",Launched,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1)
nelociguat,FTQHGWIXJSSWOY-UHFFFAOYSA-N,Preclinical,guanylate cyclase stimulant,,,
nelotanserin,COSPVUFTLGQDQL-UHFFFAOYSA-N,Phase 2,serotonin receptor inverse agonist,,,
nemazoline,OEOYJZUHFXEJEI-UHFFFAOYSA-N,Phase 2,adrenergic receptor agonist|adrenergic receptor antagonist,,,
nemiralisib,MCIDWGZGWVSZMK-UHFFFAOYSA-N,Phase 2,,,,
nemonapride,KRVOJOCLBAAKSJ-RDTXWAMCSA-N,Launched,dopamine receptor antagonist,DRD2|DRD3|DRD4,neurology/psychiatry,schizophrenia
nemorexant,NBGABHGMJVIVBW-QHCPKHFHSA-N,Preclinical,orexin receptor antagonist,,,
nemorubicin,CTMCWCONSULRHO-UHQPFXKFSA-N,Phase 2,topoisomerase inhibitor,TOP1|TOP2A,,
neo-gilurytmal,UAUHEPXILIZYCU-JSQPETPRSA-N,Launched,,,cardiology,cardiac arrythmia
neohesperidin,ARGKVCXINMKCAZ-UZRWAPQLSA-N,Preclinical,,,,
neohesperidin-dihydrochalcone,ITVGXXMINPYUHD-CUVHLRMHSA-N,Preclinical,,,,
neomycin,PGBHMTALBVVCIT-VCIWKGPPSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,CXCR4,infectious disease|gastroenterology,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections
neostigmine,ALWKGYPQUAPLQC-UHFFFAOYSA-N,Launched,acetylcholinesterase inhibitor,ACHE,neurology/psychiatry,myasthenia gravis
nepafenac,QEFAQIPZVLVERP-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,ophthalmology,eye inflammation
nepicastat,YZZVIKDAOTXDEB-JTQLQIEISA-N,Phase 2,dopamine beta hydroxylase inhibitor,DBH,,
neratinib,JWNPDZNEKVCWMY-VQHVLOKHSA-N,Launched,EGFR inhibitor,EGFR|ERBB2|KDR,oncology,breast cancer
nerbacadol,ZWNGSOLJLMBZFZ-UHFFFAOYSA-N,Phase 3,cyclooxygenase inhibitor,,,
neridronic-acid,PUUSSSIBPPTKTP-UHFFFAOYSA-N,Launched,bone resorption inhibitor,FDPS,endocrinology,brittle bone disease|Paget's disease
nesbuvir,WTDWVLJJJOTABN-UHFFFAOYSA-N,Phase 2,RNA polymerase inhibitor,,,
netilmicin,CIDUJQMULVCIBT-MQDUPKMGSA-N,Launched,protein synthesis inhibitor,,infectious disease,gram-negative bacterial infections
netupitant,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Launched,tachykinin antagonist,TACR1,gastroenterology,nausea|vomiting
Neu2000,HABROHXUHNHQMY-UHFFFAOYSA-N,Phase 2,ionotropic glutamate receptor antagonist,,,
neurodazine,FEEOFPAEDSMOTO-UHFFFAOYSA-N,Preclinical,neurogenesis of non-pluripotent C2C12 myoblast inducer,,,
neuropathiazol,MGKYEWWFHSESJN-UHFFFAOYSA-N,Preclinical,neural stem cell inducer,BMP2|LIF,,
neuropathiazol,"InChI=1S/C19H18N2O2S/c1-3-23-19(22)15-9-11-16(12-10-15)21(2)17-13-24-18(20-17)14-7-5-4-6-8-14/h4-13H,3H2,1-2H3",Preclinical,neural stem cell inducer,BMP2|LIF,,
nevirapine,NQDJXKOVJZTUJA-UHFFFAOYSA-N,Launched,non-nucleoside reverse transcriptase inhibitor,CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5,infectious disease,human immunodeficiency virus (HIV-1)
nexturastat-A,JZWXMCPARMXZQV-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC1|HDAC6,,
NFKB-activation-inhibitor-II,YMFNPBSZFWXMAD-UHFFFAOYSA-N,Preclinical,NFkB pathway inhibitor,RELA,,
NG-nitro-arginine,MRAUNPAHJZDYCK-BYPYZUCNSA-N,Phase 1,nitric oxide synthase inhibitor,NOS1|NOS2|NOS3,,
NGB-2904,YJPWVCIGSHWNON-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,DRD3,,
NGD-94-1,OTVQCHUIPJYASM-UHFFFAOYSA-N,Phase 1,dopamine receptor antagonist,DRD4,,
NGD-98-2,PSUFQBRCUSJTDO-UHFFFAOYSA-N,Preclinical,corticotropin releasing factor receptor antagonist,CRHR1,,
NGP555,WDEKUGNKKOGFOA-UHFFFAOYSA-N,Phase 1,gamma secretase modulator,,,
NH125,ZZXUNAFAKNKXFW-UHFFFAOYSA-N,Preclinical,eukaryotic translation elongation factor 2 inhibitor,,,
NHI-2,YPPFWRWCZNXINO-UHFFFAOYSA-N,Preclinical,lactate dehydrogenase inhibitor,LDHA,,
NI-57,UEMQPCYDWCSVCU-UHFFFAOYSA-N,Preclinical,bromodomain inhibitor,BRD1|BRPF1|BRPF3,,
niacin,PVNIIMVLHYAWGP-UHFFFAOYSA-N,Launched,NAD precursor|vitamin B,DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT,endocrinology,hypertriglyceridemia
nialamide,NOIIUHRQUVNIDD-UHFFFAOYSA-N,Withdrawn,monoamine oxidase inhibitor,COMT|MAOA|MAOB,,
nibentan,YRFYIORBFFGPPZ-OAQYLSRUSA-N,Phase 2,potassium channel blocker,,,
nicainoprol,AUIHHZBJBKRDIE-SFHVURJKSA-N,Preclinical,angiotensin converting enzyme inhibitor,,,
nicaraven,KTXBOOWDLPUROC-NSHDSACASA-N,Phase 3,free radical scavenger,,,
nicardipine,ZBBHBTPTTSWHBA-XMMPIXPASA-N,Launched,calcium channel blocker,ADORA3,cardiology,chronic stable angina|hypertension
nicergoline,YSEXMKHXIOCEJA-FVFQAYNVSA-N,Launched,adrenergic receptor antagonist,ADRA1A,rheumatology|neurology/psychiatry|cardiology|hematology,Raynaud's disease|migraine headache|atherosclerosis|thrombosis
niceritrol,KUEUWHJGRZKESU-UHFFFAOYSA-N,Launched,NAD precursor,,endocrinology,hyperlipidemia
niclosamide,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,Launched,DNA replication inhibitor|STAT inhibitor,STAT3,infectious disease,tapeworm
nicodicosapent,YYQALOWPCKMFDQ-JLNKQSITSA-N,Preclinical,sterol regulatory element binding protein (SREBP) inhibitor,,,
nicorandil,LBHIOVVIQHSOQN-UHFFFAOYSA-N,Launched,nitric oxide donor|potassium channel activator,KCNJ11,cardiology,angina pectoris
nicotinamide,DFPAKSUCGFBDDF-UHFFFAOYSA-N,Launched,protein synthesis stimulant,BST1|LDHA|PARP1|SIRT5,dermatology,acne vulgaris (AV)
nicotine,SNICXCGAKADSCV-JTQLQIEISA-N,Launched,acetylcholine receptor agonist,CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1,neurology/psychiatry,smoking cessation
nicotinyl-alcohol-tartrate,MVQVNTPHUGQQHK-UHFFFAOYSA-N,Launched,,,cardiology|neurology/psychiatry,vascular spasm|vertigo
NIDA-41020,KWDBQJRWPWTGPF-UHFFFAOYSA-N,Preclinical,cannabinoid receptor antagonist,CNR1,,
nifedipine,HYIMSNHJOBLJNT-UHFFFAOYSA-N,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1H|CACNA1S|CACNA2D1|CACNB2|CALM1|GLRA1|GLRA3|GLRB|KCNA1|KCNA5|NR1I2|TRPM3,cardiology,vasospastic angina|chronic stable angina
nifekalant,OEBPANQZQGQPHF-UHFFFAOYSA-N,Launched,potassium channel blocker,,cardiology,ventricular arrhythmias|ventricular tachycardia (VT)
nifenalol,UAORFCGRZIGNCI-LLVKDONJSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,,
nifenazone,BRZANEXCSZCZCI-UHFFFAOYSA-N,Launched,analgesic agent,,neurology/psychiatry,pain relief
niflumic-acid,JZFPYUNJRRFVQU-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,ANO1|CLCN1|CLCNKA|CLCNKB|KCNQ1|PLA2G1B|PLA2G4A|PTGS1|PTGS2|UGT1A9,rheumatology|neurology/psychiatry,joint pain|muscle pain
nifuroxazide,YCWSUKQGVSGXJO-NTUHNPAUSA-N,Launched,bacterial DNA inhibitor,,gastroenterology,colitis|diarrhea
nifursol,XXUXXCZCUGIGPP-WLRTZDKTSA-N,Launched,bacterial DNA inhibitor,,,
nifurtimox,ARFHIAQFJWUCFH-KIFNTFBYSA-N,Launched,DNA inhibitor,,infectious disease,Chagas disease|African trypanosomiasis
niguldipine-(R)-(-),SVJMLYUFVDMUHP-MGBGTMOVSA-N,Preclinical,,,,
niguldipine-(S)-(+),SVJMLYUFVDMUHP-XIFFEERXSA-N,Preclinical,adrenergic receptor antagonist,ADRA1A,,
nikethamide,NCYVXEGFNDZQCU-UHFFFAOYSA-N,Withdrawn,immunostimulant,,,
nilotinib,HHZIURLSWUIHRB-UHFFFAOYSA-N,Launched,Abl kinase inhibitor|Bcr-Abl kinase inhibitor,ABL1|KIT,hematologic malignancy,chronic myeloid leukemia (CML)
nilutamide,XWXYUMMDTVBTOU-UHFFFAOYSA-N,Launched,androgen receptor antagonist,AR,oncology,prostate cancer
nilvadipine,FAIIFDPAEUKBEP-INIZCTEOSA-N,Launched,calcium channel blocker,CACNA1C|CACNA1D,cardiology,hypertension|cerebral artery occlusion
NIM811,RPJPZDVUUKWPGT-FOIHOXPVSA-N,Phase 2,mitochondrial permeability transition inhibitor,,,
nimesulide,HYWYRSMBCFDLJT-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,LTF|PLA2G2E|PTGS1|PTGS2,rheumatology|obstetrics/gynecology,osteoarthritis|menstrual pain
nimodipine,UIAGMCDKSXEBJQ-LJQANCHMSA-N,Launched,calcium channel blocker,CFTR|NR3C2,hematology,hemorrhage
nimorazole,MDJFHRLTPRPZLY-UHFFFAOYSA-N,Launched,bacterial DNA inhibitor,,oncology,head and neck squamous cell carcinoma (HNSCC)
nimustine,QMAZPCHGABINAB-UHFFFAOYSA-N,Launched,DNA alkylating agent,,,
ningetinib-tosylate,VQYYQSZNRVQLIS-UHFFFAOYSA-N,Preclinical,protein tyrosine kinase inhibitor,,,
nintedanib,XZXHXSATPCNXJR-ZIADKAODSA-N,Launched,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,pulmonary,idiopathic pulmonary fibrosis (IPF)
niraparib,PCHKPVIQAHNQLW-CQSZACIVSA-N,Launched,PARP inhibitor,PARP1,oncology,primary peritoneal cancer (PPC)
niridazole,RDXLYGJSWZYTFJ-UHFFFAOYSA-N,Launched,phosphofructokinase inhibitor,,infectious disease,schistosomiasis
nisin,NVNLLIYOARQCIX-GSJOZIGCSA-N,Phase 1,bacterial cell wall synthesis inhibitor,,,
nisoldipine,VKQFCGNPDRICFG-GOSISDBHSA-N,Launched,calcium channel blocker,CACNA1C|CACNA1D|CACNA1F|CACNA1S,cardiology,hypertension
nisoxetine,ITJNARMNRKSWTA-OAHLLOKOSA-N,Phase 1,norepinephrine reuptake inhibitor,SLC6A2|SLC6A3|SLC6A4,,
nitarsone,FUUFQLXAIUOWML-UHFFFAOYSA-N,Launched,,,dermatology,blackhead disease
nitazoxanide,YQNQNVDNTFHQSW-UHFFFAOYSA-N,Launched,pyruvate ferredoxin oxidoreductase inhibitor,,gastroenterology,diarrhea
nitecapone,UPMRZALMHVUCIN-UHFFFAOYSA-N,Phase 2,catechol O methyltransferase inhibitor,COMT,,
nitenpyram,CFRPSFYHXJZSBI-DHZHZOJOSA-N,Launched,,,infectious disease,flea control
nithiamide,UJRRDDHEMZLWFI-UHFFFAOYSA-N,Preclinical,bacterial DNA inhibitor,,,
nitisinone,PMHVFNYNPNKNRO-UHFFFAOYSA-N,Launched,hydroxyphenylpyruvate dioxygenase inhibitor,,metabolism,tyrosinemia
nitrendipine,PVHUJELLJLJGLN-INIZCTEOSA-N,Launched,calcium channel blocker,CACNA1D|CACNA2D1|KCNN4,cardiology,hypertension
nitrocaramiphen,NSHMVLOWOAQFTP-UHFFFAOYSA-N,Preclinical,cholinergic receptor antagonist,CHRM1,,
nitroflurbiprofen,DLWSRGHNJVLJAH-CQSZACIVSA-N,Preclinical,cyclooxygenase inhibitor,,,
nitrofurantoin,NXFQHRVNIOXGAQ-YCRREMRBSA-N,Launched,DNA inhibitor,,infectious disease,urinary tract infections|pyelonephritis
nitrofurazone,IAIWVQXQOWNYOU-FPYGCLRLSA-N,Launched,bacterial DNA inhibitor,,infectious disease,first-aid antibiotic
nitromide,UUKWKUSGGZNXGA-UHFFFAOYSA-N,Launched,,,infectious disease,coccidiosis
nitrosodimethylurea,RCUSTCPNMVCLLN-UHFFFAOYSA-N,Preclinical,DNA synthesis inhibitor,,,
nitroxoline,RJIWZDNTCBHXAL-UHFFFAOYSA-N,Launched,cathepsin inhibitor,METAP2,infectious disease,urinary tract infections
nizatidine,SGXXNSQHWDMGGP-IZZDOVSWSA-N,Launched,histamine receptor antagonist,HRH2,gastroenterology,duodenal ulcer disease|erosive esophagitis (EE)|ulcerative esophagitis (UE)|gastroesophageal reflux disease (GERD)
nizofenone,WZGBZLHGOVJDET-UHFFFAOYSA-N,Launched,ion channel antagonist,,neurology/psychiatry,stroke
NK-252,FNSCFQXZZNCDAI-UHFFFAOYSA-N,Preclinical,nuclear factor erythroid derived|like (NRF2) activator,NFE2L2,,
NKP-1339,KNLORLKZMHLRBH-UHFFFAOYSA-J,Phase 1,HSP inhibitor,,,
NKY-80,SOJUSNIBPPMLCC-SSDOTTSWSA-N,Preclinical,adenylyl cyclase inhibitor,ADCY5,,
NLG919,YTRRAUACYORZLX-WMZOPIPTSA-N,Phase 1,"indoleamine 2,3-dioxygenase inhibitor",IDO1,,
NM107,PPUDLEUZKVJXSZ-VPCXQMTMSA-N,Phase 2,RNA polymerase inhibitor,,,
NMDA,HOKKHZGPKSLGJE-GSVOUGTGSA-N,Preclinical,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
NMS-1286937,QHLVBNKYJGBCQJ-UHFFFAOYSA-N,Phase 2,PLK inhibitor,FLT3|PLK1|PLK2|PLK3,,
NMS-873,UJGTUKMAJVCBIS-UHFFFAOYSA-N,Preclinical,ATPase inhibitor,VCP,,
NMS-E973,YLQODGGPIHWTHR-UHFFFAOYSA-N,Preclinical,HSP inhibitor,,,
NMS-P715,JFOAJUGFHDCBJJ-UHFFFAOYSA-N,Preclinical,protein kinase inhibitor,,,
NN-DNJ,FTSCEGKYKXESFF-LXTVHRRPSA-N,Preclinical,glucosidase inhibitor,GBA,,
NNC-05-2090,XZZYCJOGZYEPPW-UHFFFAOYSA-N,Preclinical,GABA uptake inhibitor|GAT inhibitor,SLC6A12,,
NNC-55-0396,VHHVPDKNKPNKHY-JDXGNMNLSA-N,Preclinical,T-type calcium channel blocker,CATSPER1|CATSPER2|CATSPER3|CATSPER4,,
NNC-63-0532,AQMPIDSGLFVVPL-UHFFFAOYSA-N,Preclinical,opioid receptor agonist,OPRL1,,
NNC-711,NGNALWDRPKNJGR-UHFFFAOYSA-N,Preclinical,GABA uptake inhibitor,SIGMAR1|SLC6A1,,
NO-ASA,IOJUJUOXKXMJNF-UHFFFAOYSA-N,Phase 2,cyclooxygenase inhibitor,PTGS2,,
nobiletin,MRIAQLRQZPPODS-UHFFFAOYSA-N,Preclinical,MEK inhibitor,MAP2K1,,
nocodazole,KYRVNWMVYQXFEU-UHFFFAOYSA-N,Preclinical,tubulin polymerization inhibitor,HPGDS,,
nolatrexed,XHWRWCSCBDLOLM-UHFFFAOYSA-N,Phase 3,thymidylate synthase inhibitor,TYMS,,
nomegestrol-acetate,IIVBFTNIGYRNQY-YQLZSBIMSA-N,Launched,progesterone receptor agonist,PGR,endocrinology,contraceptive
nomifensine,XXPANQJNYNUNES-AWEZNQCLSA-N,Withdrawn,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,DRD2|SLC6A2|SLC6A3,,
nonivamide,RGOVYLWUIBMPGK-UHFFFAOYSA-N,Launched,TRPV agonist,TRPV1,rheumatology|neurology/psychiatry,rheumatoid arthritis|muscle pain
nonoxynol-9,FBWNMEQMRUMQSO-UHFFFAOYSA-N,Launched,membrane integrity inhibitor,,endocrinology,contraceptive
nor-binaltorphimine,APSUXPSYBJVPPS-YAUKWVCOSA-N,Preclinical,opioid receptor antagonist,OPRD1|OPRK1|OPRM1,,
norcyclobenzaprine,XECQQDXTQRYYBH-UHFFFAOYSA-N,Preclinical,adrenergic receptor agonist|serotonin receptor antagonist,,,
norelgestromin,ISHXLNHNDMZNMC-VTKCIJPMSA-N,Launched,,PGR,endocrinology,contraceptive
norepinephrine,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|SLC18A1|SLC18A2,cardiology|allergy|neurology/psychiatry,hypertension|urticaria|headache|seasonal affective disorder
norethindrone,VIKNJXKGJWUCNN-XGXHKTLJSA-N,Launched,progesterone receptor agonist,PGR,obstetrics/gynecology,endometriosis
norethindrone-acetate,IMONTRJLAWHYGT-ZCPXKWAGSA-N,Launched,progesterone receptor agonist,PGR,endocrinology|orthopedics|obstetrics/gynecology,menopause|osteoporosis|vaginal atrophy
norethisterone-enanthate,APTGJECXMIKIET-WOSSHHRXSA-N,Launched,contraceptive agent,,endocrinology,contraceptive
noretynodrel,ICTXHFFSOAJUMG-SLHNCBLASA-N,Launched,progestogen hormone,PGR,endocrinology,contraceptive
norfloxacin,OGJPXUAPXNRGGI-UHFFFAOYSA-N,Launched,bacterial DNA gyrase inhibitor,TOP2A,infectious disease|urology,urinary tract infections|gonorrhea|prostatitis
norfluoxetine,WIQRCHMSJFFONW-OAHLLOKOSA-N,Phase 1,selective serotonin reuptake inhibitor (SSRI),HTR2B,,
norgestimate,KIQQMECNKUGGKA-NMYWJIRASA-N,Launched,progesterone receptor agonist,ESR1|PGR,endocrinology,contraceptive
norgestrel,WWYNJERNGUHSAO-XUDSTZEESA-N,Launched,progesterone receptor agonist,AR|ESR1|PGR|SRD5A1,endocrinology,contraceptive
nornicotine,MYKUKUCHPMASKF-SECBINFHSA-N,Preclinical,acetylcholine receptor agonist,,,
nortriptyline,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,Launched,tricyclic antidepressant,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4,neurology/psychiatry,depression
norvancomycin,NUAQIRUAZSJTAI-YRPZDAAMSA-N,Preclinical,,,,
noscapine,AKNNEGZIBPJZJG-MSOLQXFVSA-N,Launched,bradykinin receptor antagonist|tubulin polymerization inhibitor,SIGMAR1,pulmonary,cough suppressant
NOV-002,YPZRWBKMTBYPTK-USZNOCQGSA-N,Phase 3,,GSR,,
novobiocin,YJQPYGGHQPGBLI-KGSXXDOSSA-N,Launched,bacterial DNA gyrase inhibitor,,obstetrics/gynecology,mastitis
NPC-01,WSCUHXPGYUMQEX-KCZNZURUSA-N,Phase 3,steroid,,,
NPC-15199,CBPJQFCAFFNICX-LJQANCHMSA-N,Phase 2,ICAM1 antagonist,PPARG,,
NPPB,WBSMIPAMAXNXFS-UHFFFAOYSA-N,Preclinical,chloride channel blocker,ANO1|CLCN2|CLCN7|TRPA1,,
NPS-2143,PZUJQWHTIRWCID-HXUWFJFHSA-N,Preclinical,calcium receptor antagonist,CASR,,
NPS-2407,DQEWVIJXZPUPQA-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,,,
NPY-5RA972,ZNFMHLDBJPAFEQ-UHFFFAOYSA-N,Preclinical,neuropeptide receptor antagonist,NPY5R,,
NQDI-1,UFJGFNHRMPMALC-UHFFFAOYSA-N,Preclinical,caspase inhibitor,CASP3,,
NS-018,UQTPDWDAYHAZNT-AWEZNQCLSA-N,Phase 1/Phase 2,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,,
NS-11021,MDKAFDIKYQMOMF-UHFFFAOYSA-N,Preclinical,calcium-activated potassium channel activator,KCNMA1,,
NS-11394,HLKYSQGBIIIQJN-UHFFFAOYSA-N,Preclinical,GABA receptor agonist,,,
NS-1643,NJFVQMRYJZHGME-UHFFFAOYSA-N,Preclinical,voltage-gated potassium channel activator,KCNH2|KCNH6|KCNMA1,,
NS-19504,HGWLTZOMQZIUBW-UHFFFAOYSA-N,Preclinical,calcium-activated potassium channel activator,KCNMA1,,
NS-309,CVOUSAVHMDXCKG-UHFFFAOYSA-N,Preclinical,calcium-activated potassium channel activator,KCNN1|KCNN2|KCNN3|KCNN4,,
NS-3623,JXPULDIATMTIIN-UHFFFAOYSA-N,Preclinical,voltage-gated potassium channel activator,KCNH2,,
NS-3861,ZJCNRVHZJADROC-VHSXEESVSA-N,Preclinical,acetylcholine receptor agonist,CHRNA3|CHRNB4,,
NS-5806,UZWJWROOLOOCPQ-UHFFFAOYSA-N,Preclinical,voltage-gated potassium channel activator,KCND3,,
NS-8,KVDWOQGDMAEJLM-UHFFFAOYSA-N,Phase 2,potassium channel agonist,KCNMA1,,
NS-8593,XZIZUQSOFMLIIR-CQSZACIVSA-N,Preclinical,calcium-activated potassium channel modulator,KCNN1|KCNN2|KCNN3,,
NS-9283,HGFXDSQLRSWUBO-UHFFFAOYSA-N,Preclinical,acetylcholine receptor allosteric modulator,CHRNA4,,
NSC-23766,DEFBCZWQLILOJF-MRXNPFEDSA-N,Preclinical,Ras GTPase inhibitor,,,
NSC-319726,XDHBUMNIQRLHGO-UKTHLTGXSA-N,Preclinical,p53 activator,,,
NSC-3852,RZWRYPGAUIOOMK-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC1,,
NSC-405020,ARDYECYBETXQFD-MRVPVSSYSA-N,Preclinical,matrix metalloprotease inhibitor,MMP1,,
NSC-4644,FVWJYYTZTCVBKE-ROUWMTJPSA-N,Phase 2,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,PYGM,,
NSC-5844,SSXYXSMMVMVYEV-UHFFFAOYSA-N,Preclinical,CC chemokine receptor agonist,CCR1,,
NSC-625987,KFAKESMKRPNZTM-UHFFFAOYSA-N,Preclinical,CDK inhibitor,CDK2|CDK4,,
NSC-632839,PKCYYPHSCUSQDK-AYKLPDECSA-N,Preclinical,ubiquitin specific protease inhibitor,SENP2|USP1|USP2|USP7,,
NSC-636819,YYZPXBXVBQSBDG-IJIVKGSJSA-N,Preclinical,histone demethylase inhibitor,KDM4A|KDM4B,,
NSC-663284,BMKPVDQDJQWBPD-UHFFFAOYSA-N,Preclinical,CDC inhibitor,CDC25A|CDC25B|CDC25C,,
NSC-697923,GAUHIPWCDXOLCZ-UHFFFAOYSA-N,Preclinical,ubiquitin-conjugating enzyme inhibitor,UBE2N,,
NSC-95397,MAASHDQFQDDECQ-UHFFFAOYSA-N,Preclinical,CDC inhibitor,CDC25A|CDC25B,,
NSC-9965,ALSKYCOJJPXPFS-BBRMVZONSA-N,Preclinical,acetylcholine receptor antagonist,CHRNA4|CHRNB2,,
NSI-189,DYTOQURYRYYNOR-UHFFFAOYSA-N,Phase 2,neurotrophic agent,,,
NSP-805,VSEWBFSTIMFCDL-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,,,
NT157,NIPUPOUEGOSAAO-OWOJBTEDSA-N,Preclinical,IGF-1 inhibitor,IGF1R,,
NTNCB,ISSSVYKMIIAPTH-ACRUOGEOSA-N,Preclinical,neuropeptide receptor antagonist,NPY5R,,
NTRC-824,SOOLLEBJNGCDOZ-FQEVSTJZSA-N,Preclinical,neurotensin receptor antagonist,NTSR2,,
nTZDpa,VUPOTURDKDMIGQ-UHFFFAOYSA-N,Preclinical,PPAR receptor agonist,PPARG,,
NU-1025,YJDAOHJWLUNFLX-UHFFFAOYSA-N,Preclinical,PARP inhibitor,PARP1,,
NU-2058,MWGXGTJJAOZBNW-UHFFFAOYSA-N,Preclinical,cyclin D inhibitor,CCNA2|CDK2,,
NU-6027,DGWXOLHKVGDQLN-UHFFFAOYSA-N,Preclinical,CDK inhibitor,CCNA2|CDK2,,
NU-7026,KKTZALUTXUZPSN-UHFFFAOYSA-N,Preclinical,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,PRKDC,,
NU-7441,JAMULYFATHSZJM-UHFFFAOYSA-N,Preclinical,DNA dependent protein kinase inhibitor,PRKDC,,
NU-7441,"InChI=1S/C25H19NO3S/c27-21-15-23(26-11-13-28-14-12-26)29-24-17(6-3-9-20(21)24)19-8-4-7-18-16-5-1-2-10-22(16)30-25(18)19/h1-10,15H,11-14H2",Preclinical,DNA dependent protein kinase inhibitor,PRKDC,,
nuclomedone,QSKVYHYMQQQAFS-JTQLQIEISA-N,Phase 3,immunosuppressant,,,
nutlin-3,BDUHCSBCVGXTJM-WUFINQPMSA-N,Preclinical,MDM inhibitor,MDM2|TP53,,
nuvenzepine,HPKYRXAEGNUARA-UHFFFAOYSA-N,Preclinical,acetylcholine receptor antagonist,,,
NVP-231,MVSSJPGNLQPWSW-UHFFFAOYSA-N,Preclinical,ceramidase inhibitor,CERK,,
NVP-ADW742,LSFLAQVDISHMNB-AFARHQOCSA-N,Preclinical,insulin growth factor receptor inhibitor,IGF1R,,
NVP-AEW541,AECDBHGVIIRMOI-GRGXKFILSA-N,Preclinical,IGF-1 inhibitor,IGF1R|INSR,,
NVP-AUY922,NDAZATDQFDPQBD-UHFFFAOYSA-N,Phase 2,HSP inhibitor,HSP90AA1|HSP90AB1,,
NVP-BEZ235,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,Phase 3,mTOR inhibitor|PI3K inhibitor,ATR|MTOR|PIK3CA|PIK3CD|PIK3CG,,
NVP-BGJ398,QADPYRIHXKWUSV-UHFFFAOYSA-N,Phase 3,FGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|KDR,,
NVP-BHG712,ZCCPLJOKGAACRT-UHFFFAOYSA-N,Preclinical,ephrin inhibitor,EPHB4,,
NVP-BSK805,IBPVXAOOVUAOKJ-UHFFFAOYSA-N,Preclinical,JAK inhibitor,JAK2,,
NVP-BVU972,RNCNPRCUHHDYPC-UHFFFAOYSA-N,Preclinical,MET inhibitor,MET,,
NVP-DPP728,VFFZWMWTUSXDCB-ZDUSSCGKSA-N,Phase 2,dipeptidyl peptidase inhibitor,DPP4,,
NVP-HSP990,WSMQUUGTQYPVPD-OAHLLOKOSA-N,Phase 1,HSP inhibitor,HSP90AA1|HSP90AB1,,
NVP-TAE226,UYJNQQDJUOUFQJ-UHFFFAOYSA-N,Preclinical,protein tyrosine kinase inhibitor,PTK2,,
NVP-TAE684,QQWUGDVOUVUTOY-UHFFFAOYSA-N,Preclinical,ALK tyrosine kinase receptor inhibitor,ALK|INSR,,
NVP-TNKS656,DYGBNAYFDZEYBA-UHFFFAOYSA-N,Preclinical,tankyrase inhibitor,TNKS2,,
NVS-PAK1-1,OINGHOPGNMYCAB-INIZCTEOSA-N,Preclinical,p21 activated kinase inhibitor,PAK1,,
NXY-059,OVTCHWSLKGENKP-GHXNOFRVSA-N,Phase 3,free radical scavenger,,,
nystatin,VQOXZBDYSJBXMA-MSHYPYPPSA-N,Launched,fungal ergosterol inhibitor,,infectious disease,esophageal candidiasis|skin infections|yeast infection
O-1918,ICHJMVMWPKLUKT-JKSUJKDBSA-N,Preclinical,cannabinoid receptor antagonist,,,
O-304,WEDWLYRQKUTOAX-UHFFFAOYSA-N,Preclinical,AMPK activator,,,
o-3M3FBS,SKJJIFRWCCSXGL-UHFFFAOYSA-N,Preclinical,phospholipase activator,,,
O-acetyl-L-serine,VZXPDPZARILFQX-BYPYZUCNSA-N,Preclinical,,PTGS1,,
o-mercapto-benzoic-acid,NBOMNTLFRHMDEZ-UHFFFAOYSA-N,Preclinical,,,,
O4I1,QJEJLARVLKHYFW-UHFFFAOYSA-N,Preclinical,Oct inducer,POU5F1,,
O6-benzylguanine,KRWMERLEINMZFT-UHFFFAOYSA-N,Phase 3,O6-alkylguanine-DNA alkyltransferase inhibitor,MGMT,,
OAC1,HWJRIFZDXJKJJN-UHFFFAOYSA-N,Preclinical,Oct activator,,,
OAC2,JCAFGYWSIWYMOX-UHFFFAOYSA-N,Preclinical,Oct activator,POU5F1,,
obatoclax,RFTSSZJZXOSICM-GRSHGNNSSA-N,Phase 3,BCL inhibitor,BCL2,,
obeticholic-acid,ZXERDUOLZKYMJM-XNNZWSTBSA-N,Launched,FXR agonist,NR1H4,gastroenterology,primary biliary cholangitis
obidoxime,HIGRLDNHDGYWQJ-UHFFFAOYSA-P,Launched,cholinesterase reactivator,ACHE,critical care|neurology/psychiatry,poison antidote|nerve gas poisoning
OC000459,FATGTHLOZSXOBC-UHFFFAOYSA-N,Phase 2,CRTH receptor antagonist,PTGDR2,,
ocaperidone,ZZQNEJILGNNOEP-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,,,
ochromycinone,ZAWXOCUFQSQDJS-VIFPVBQESA-N,Phase 1,STAT inhibitor,STAT3,,
ocinaplon,OQJFBUOFGHPMSR-UHFFFAOYSA-N,Phase 3,GABA receptor modulator,GABRA1|GABRA2|GABRA3|GABRA5,,
OCO-1112,ODLDHXPJRGNTPC-UHFFFAOYSA-N,Phase 2,cholesterol inhibitor,,,
octadecan-1-ol,GLDOVTGHNKAZLK-UHFFFAOYSA-N,Preclinical,,,,
octamethyltrisiloxane,CXQXSVUQTKDNFP-UHFFFAOYSA-N,Preclinical,,,,
octenidine,ZVXNYZWXUADSRV-UHFFFAOYSA-N,Launched,membrane integrity inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
octinoxate,YBGZDTIWKVFICR-NRMKIYEFSA-N,Launched,,,dermatology,sunscreen lotion
octisalate,FMRHJJZUHUTGKE-GFCCVEGCSA-N,Launched,,,dermatology,sunscreen lotion
octocrylene,FMJSMJQBSVNSBF-LJQANCHMSA-N,Launched,,,dermatology,sunscreen lotion
octodrine,QNIVIMYXGGFTAK-MRVPVSSYSA-N,Preclinical,antitumor agent,,,
octopamine,QHGUCRYDKWKLMG-UHFFFAOYSA-N,Preclinical,trace amine associated receptor agonist,F10|TAAR1,,
octreotide,DEQANNDTNATYII-KWPKQMLXSA-N,Launched,somatostatin receptor agonist,SSTR2|SSTR3|SSTR5,gastroenterology|endocrinology|oncology,diarrhea|acromegaly|carcinoid tumors
odanacatib,FWIVDMJALNEADT-SFTDATJTSA-N,Phase 3,cathepsin inhibitor,CTSK,,
ODQ,LZMHWZHOZLVYDL-UHFFFAOYSA-N,Preclinical,guanylyl cyclase inhibitor,GUCY1A2|GUCY1A3|GUCY1B3,,
OF-1,YUNQZQREIHWDQT-UHFFFAOYSA-N,Preclinical,bromodomain inhibitor,BRD1,,
ofloxacin,GSDSWSVVBLHKDQ-JTQLQIEISA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease|otolaryngology|gastroenterology|endocrinology,respiratory tract infections|sinusitis|skin infections|bone and joint infections|intra-abdominal infections|diarrhea|fever|urinary tract infections
OG-L002,DSOJSZXQRJGBCW-CABCVRRESA-N,Preclinical,histone lysine demethylase inhibitor,KDM1A,,
ogerin,MDGIEDNDSFMSLP-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor modulator,,,
oglemilast,OKFDRAHPFKMAJH-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,,,
oglufanide,LLEUXCDZPQOJMY-AAEUAGOBSA-N,Phase 2,VEGF antagonist,,,
OICR-9429,DJOVLOYCGXNVPI-UHFFFAOYSA-N,Preclinical,WDR5/MLL interaction inhibitor,WDR5,,
olanzapine,KVWDHTXUZHCGIO-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7,neurology/psychiatry,schizophrenia|bipolar disorder
olaparib,FDLYAMZZIXQODN-UHFFFAOYSA-N,Launched,PARP inhibitor,PARP1|PARP2,oncology,ovarian cancer
OLDA,QQBPLXNESPTPNU-KTKRTIGZSA-N,Preclinical,TRPV agonist,GPR119,,
oleamide,FATBGEAMYMYZAF-KTKRTIGZSA-N,Preclinical,cannabinoid receptor agonist,HTR7|PLA2G2A,,
oleandrin,JLPDBLFIVFSOCC-XYXFTTADSA-N,Phase 1,Na/K-ATPase inhibitor,,,
oleanolic-acid,MIJYXULNPSFWEK-GTOFXWBISA-N,Preclinical,G protein-coupled receptor agonist,GPBAR1,,
oleoylethanolamide,BOWVQLFMWHZBEF-KTKRTIGZSA-N,Preclinical,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,CNR1|GPR119|GPR55|PPARA,,
olesoxime,QNTASHOAVRSLMD-SIWSWZRQSA-N,Phase 2/Phase 3,apoptosis stimulant,,,
oleuropein,RFWGABANNQMHMZ-JIBQERFGSA-N,Phase 2,estrogen receptor agonist,GPER1,,
oligomycin-A,MNULEGDCPYONBU-BGLGBHOCSA-N,Preclinical,ATP synthase inhibitor|ATPase inhibitor,ATP5A1,,
olmesartan,VTRAEEWXHOVJFV-UHFFFAOYSA-N,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension
olmesartan-medoxomil,UQGKUQLKSCSZGY-UHFFFAOYSA-N,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension
olmutinib,FDMQDKQUTRLUBU-UHFFFAOYSA-N,Launched,Bruton's tyrosine kinase (BTK) inhibitor|EGFR inhibitor,BTK|EGFR,oncology,non-small cell lung cancer (NSCLC)
olodanrigan,GHBCIXGRCZIPNQ-MHZLTWQESA-N,Phase 2,angiotensin antagonist,,,
olomoucine,GTVPOLSIJWJJNY-UHFFFAOYSA-N,Preclinical,CDK inhibitor,CDK1|CDK2|CDK5|MAPK1,,
olopatadine,JBIMVDZLSHOPLA-LSCVHKIXSA-N,Launched,histamine receptor antagonist,HRH1|S100A1|S100A12|S100A13|S100A2|S100B,ophthalmology,conjunctivitis
olprinone,JPAWFIIYTJQOKW-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE3A,cardiology,congestive heart failure
olsalazine,QQBDLJCYGRGAKP-FOCLMDBBSA-N,Launched,cyclooxygenase inhibitor,IFNG|TPMT,gastroenterology,ulcerative colitis
oltipraz,CKNAQFVBEHDJQV-UHFFFAOYSA-N,Phase 3,nuclear factor erythroid derived|like (NRF2) activator,ANG,,
olumacostat-glasaretil,FYJLDICZGDFWKP-UHFFFAOYSA-N,Phase 3,acetyl-CoA carboxylase inhibitor,,,
olvanil,OPZKBPQVWDSATI-KHPPLWFESA-N,Preclinical,TRPV agonist,CNR1|GPR119|TRPV1,,
omadacycline,OVIWLBQFYMOVOF-NXSZOOMBSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,pneumonia
omapatrilat,LVRLSYPNFFBYCZ-VGWMRTNUSA-N,Preclinical,metalloproteinase inhibitor,ACE|MME,,
omarigliptin,MKMPWKUAHLTIBJ-ISTRZQFTSA-N,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus
ombitasvir,PIDFDZJZLOTZTM-KHVQSSSXSA-N,Launched,HCV inhibitor,,infectious disease,hepatitis C
ombrabulin,IXWNTLSTOZFSCM-YVACAVLKSA-N,Phase 3,tubulin polymerization inhibitor,,,
OMDM-2,ICDMLAQPOAVWNH-HAAQQRBASA-N,Preclinical,FAAH inhibitor,GPR119,,
omecamtiv-mecarbil,RFUBTTPMWSKEIW-UHFFFAOYSA-N,Phase 3,cardiac myosin activator,MYBPC3,,
omega-(4-iodophenyl)pentadecanoic-acid,YAONEUNUMVOKNQ-UHFFFAOYSA-N,Preclinical,,,,
omega-3-acid-esters,SSQPWTVBQMWLSZ-AAQCHOMXSA-N,Launched,cholesterol inhibitor,,,
omeprazole,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Launched,ATPase inhibitor,ATP4A|CLCN2,gastroenterology,heartburn
omeprazole-magnesium,KWORUUGOSLYAGD-YPPDDXJESA-N,Launched,proton pump inhibitor,ATP4A|ATP4B,gastroenterology,gastroesophageal reflux disease (GERD)|heartburn
omeprazole-sulfide,XURCIPRUUASYLR-UHFFFAOYSA-N,Phase 1,ATPase inhibitor,,,
omtriptolide,HROMYAWHLUOUPY-AHCCQAQQSA-N,Preclinical,ERK1 and ERK2 phosphorylation inhibitor,,,
ON-01500,KUTAVMCJCVADGZ-BQYQJAHWSA-N,Preclinical,apoptosis stimulant,,,
ON123300,VADOZMZXXRBXNY-UHFFFAOYSA-N,Preclinical,CDK inhibitor,CDK4|NUAK1|PDGFRB,,
ONC201,VLULRUCCHYVXOH-UHFFFAOYSA-N,Phase 2,AKT inhibitor|MAP kinase inhibitor,TNFSF10,,
oncrasin-1,ZDRQMXCSSAPUMM-UHFFFAOYSA-N,Preclinical,apoptosis stimulant,,,
oncrasin-1,"InChI=1S/C16H12ClNO/c17-14-7-5-12(6-8-14)9-18-10-13(11-19)15-3-1-2-4-16(15)18/h1-8,10-11H,9H2",Preclinical,apoptosis stimulant,,,
ondansetron,FELGMEQIXOGIFQ-CYBMUJFWSA-N,Launched,serotonin receptor antagonist,HTR3A|HTR3B,gastroenterology,nausea|vomiting
ONO-4059,SEJLPXCPMNSRAM-GOSISDBHSA-N,Phase 1,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,
ONO-4817,HDWWQELUBWGQGA-WMZOPIPTSA-N,Phase 1,matrix metalloprotease inhibitor,MMP8,,
ONO-8130,IOXMDBQCUCDLAF-UHFFFAOYSA-N,Preclinical,prostanoid receptor antagonist,PTGER1,,
ONO-AE3-208,MTDIMKNAJUQTIO-OAHLLOKOSA-N,Preclinical,prostanoid receptor antagonist,PTGER4,,
ONX-0914,WQAVPPWWLLVGFK-VTNASVEKSA-N,Preclinical,proteasome inhibitor,,,
OP-0595,RSBPYSTVZQAADE-RQJHMYQMSA-N,Preclinical,beta lactamase inhibitor,,,
OPC-21268,KSNUCNRMDYJBKT-UHFFFAOYSA-N,Phase 1,vasopressin receptor antagonist,AVPR1A|AVPR2|OXTR,,
opicapone,ASOADIZOVZTJSR-UHFFFAOYSA-N,Phase 3,catechol O methyltransferase inhibitor,COMT,,
opipramol,YNZFUWZUGRBMHL-UHFFFAOYSA-N,Launched,sigma receptor agonist,,neurology/psychiatry,generalized anxiety disorder (GAD)
oprozomib,SWZXEVABPLUDIO-WSZYKNRRSA-N,Phase 1/Phase 2,proteasome inhibitor,,,
OR-486,VDCDWNDTNSWDFJ-UHFFFAOYSA-N,Preclinical,catechol O methyltransferase inhibitor,COMT,,
orantinib,NHFDRBXTEDBWCZ-ZROIWOOFSA-N,Phase 3,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB,,
orbifloxacin,QIPQASLPWJVQMH-DTORHVGOSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,urinary tract infections
ORE1001,NTCCRGGIJNDEAB-IRXDYDNUSA-N,Phase 1/Phase 2,angiotensin converting enzyme inhibitor,ACE2,,
ORG-12962,QZYYPQAYSFBKPW-UHFFFAOYSA-N,Phase 2,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,,
ORG-25543,ZCYOBMASPXQBSZ-UHFFFAOYSA-N,Preclinical,glycine transporter inhibitor,GLRB|SLC6A5,,
ORG-26576,FIKUEZUFASUKAH-QMMMGPOBSA-N,Phase 2,glutamate receptor modulator,,,
ORG-27569,AHFZDNYNXFMRFQ-UHFFFAOYSA-N,Preclinical,cannabinoid receptor modulator,CNR1,,
ORG-9768,JOLKQWPKJFRPOU-UHFFFAOYSA-N,Phase 1,adrenergic receptor antagonist,ADRA2A,,
oridonin,SDHTXBWLVGWJFT-XKCURVIJSA-N,Preclinical,BCL inhibitor,BCL2,,
oritavancin,VHFGEBVPHAGQPI-LXKZPTCJSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,skin infections
orlistat,AHLBNYSZXLDEJQ-FWEHEUNISA-N,Launched,lipase inhibitor,CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP,endocrinology,weight-loss aid
ormeloxifene,XZEUAXYWNKYKPL-WDYNHAJCSA-N,Launched,selective estrogen receptor modulator (SERM),,endocrinology,contraceptive
ornidazole,IPWKIXLWTCNBKN-LURJTMIESA-N,Launched,antiprotozoal agent,,infectious disease,protozoan infection
ornipressin,MUNMIGOEDGHVLE-FGJIEJSYSA-N,Preclinical,vasoconstrictor,,,
ornithine,GGTYBZJRPHEQDG-PGMHMLKASA-N,Launched,NFkB pathway modulator,GPRC6A,,
orotic-acid,PXQPEWDEAKTCGB-UHFFFAOYSA-N,Phase 2,,DHODH,,
orphanin-fq,PULGYDLMFSFVBL-SMFNREODSA-N,Phase 1,opioid receptor agonist,OPRL1|OPRM1,,
orphenadrine,QVYRGXJJSLMXQH-SFHVURJKSA-N,Launched,acetylcholine receptor antagonist,,neurology/psychiatry,muscle pain
orteronel,OZPFIJIOIVJZMN-GOSISDBHSA-N,Phase 3,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,CYP17A1,,
ORY-1001,ALHBJBCQLJZYON-PFSRBDOWSA-N,Phase 1/Phase 2,histone lysine demethylase inhibitor,KDM1A,,
oseltamivir-carboxylate,NENPYTRHICXVCS-YNEHKIRRSA-N,Launched,neuraminidase inhibitor,,infectious disease,influenza A virus infection
oseltamivir-phosphate,VSZGPKBBMSAYNT-RRFJBIMHSA-N,Launched,neuraminidase inhibitor,CES1|NEU1|NEU2,infectious disease,influenza A virus infection
osemozotan,MEEQBDCQPIZMLY-HNNXBMFYSA-N,Phase 2/Phase 3,serotonin receptor agonist,HTR1A,,
OSI-027,JROFGZPOBKIAEW-HAQNSBGRSA-N,Phase 1,mTOR inhibitor,MTOR,,
OSI-420,KOQIAZNBAWFSQM-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR,,
OSI-930,FGTCROZDHDSNIO-UHFFFAOYSA-N,Phase 1,KIT inhibitor|VEGFR inhibitor,FLT1|KDR|KIT,,
osilodrostat,USUZGMWDZDXMDG-CYBMUJFWSA-N,Launched,cytochrome P450 inhibitor,,,
osimertinib,DUYJMQONPNNFPI-UHFFFAOYSA-N,Launched,EGFR inhibitor,EGFR,oncology,non-small cell lung cancer (NSCLC)
ospemifene,LUMKNAVTFCDUIE-VHXPQNKSSA-N,Launched,selective estrogen receptor modulator (SERM),ESR1|ESR2,obstetrics/gynecology|endocrinology,vaginal atrophy|dyspareunia|menopause
ostarine,JNGVJMBLXIUVRD-SFHVURJKSA-N,Phase 3,androgen receptor modulator,AR,,
osthol,MBRLOUHOWLUMFF-UHFFFAOYSA-N,Preclinical,calcium channel blocker,,,
OT-R-antagonist-1,IBXGJPAYWMFXSF-UEEONYLUSA-N,Preclinical,oxytocin receptor antagonist,AVPR1A|OXTR,,
otamixaban,PFGVNLZDWRZPJW-OPAMFIHVSA-N,Phase 3,coagulation factor inhibitor,F10,,
otenzepad,UBRKDAVQCKZSPO-GOSISDBHSA-N,Phase 3,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,,
otilonium,NQHNLNLJPDMBFN-UHFFFAOYSA-O,Launched,acetylcholine receptor antagonist,CACNA1C,gastroenterology,irritable bowel syndrome
OTS167,DKZYXHCYPUVGAF-JCNLHEQBSA-N,Phase 1/Phase 2,maternal embryonic leucine zipper kinase inhibitor,MELK,,
OTS514,OETLNMOJNONWOY-LBPRGKRZSA-N,Preclinical,TOPK inhibitor,,,
OTX015,GNMUEVRJHCWKTO-FQEVSTJZSA-N,Phase 1/Phase 2,bromodomain inhibitor,BRD2|BRD3|BRD4,,
ouabain,LPMXVESGRSUGHW-VGFRVVOQSA-N,Launched,ATPase inhibitor,ATP1A1,cardiology,hypertension|cardiac arrythmia
OXA-06,XUIUXXQVHPEQNM-UHFFFAOYSA-N,Preclinical,rho associated kinase inhibitor,ROCK1|ROCK2,,
oxaceprol,BAPRUDZDYCKSOQ-RITPCOANSA-N,Preclinical,anti-inflammatory agent,,,
oxacillin,UWYHMGVUTGAWSP-JKIFEVAISA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,staphylococcal infections
oxacyclohexadecan-2-one,FKUPPRZPSYCDRS-UHFFFAOYSA-N,Preclinical,protein kinase inhibitor,,,
oxaliplatin,DWAFYCQODLXJNR-BNTLRKBRSA-L,Launched,DNA inhibitor,,oncology,colorectal cancer
oxaloacetate,UWYVPFMHMJIBHE-UHFFFAOYSA-N,Phase 2/Phase 3,glutamate release inhibitor,,,
oxantel,VRYKTHBAWRESFI-VOTSOKGWSA-N,Launched,anthelmintic agent,,infectious disease,gastrointestinal parasites
oxaprozin,OFPXSFXSNFPTHF-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis
oxatomide,BAINIUMDFURPJM-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis
oxcarbazepine,CTRLABGOLIVAIY-UHFFFAOYSA-N,Launched,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures
oxelaidin,IQADUMSPOQKAAO-UHFFFAOYSA-N,Launched,antitussive,,pulmonary,cough suppressant
oxethazaine,FTLDJPRFCGDUFH-UHFFFAOYSA-N,Launched,local anesthetic,,neurology/psychiatry,local anesthetic
OXF-BD-02,FEQUIPXIENTMJN-SFHVURJKSA-N,Preclinical,bromodomain inhibitor,BRD4,,
oxfendazole,BEZZFPOZAYTVHN-QFIPXVFZSA-N,Launched,anthelmintic agent,,infectious disease,lungworms|tapeworm|gastrointestinal roundworms
oxfenicine,LJCWONGJFPCTTL-SSDOTTSWSA-N,Phase 1,carnitine palmitoyltransferase inhibitor,CPT1A|CPT1B,,
oxibendazole,RAOCRURYZCVHMG-UHFFFAOYSA-N,Launched,tubulin polymerization inhibitor,TUBB|TUBB4B,infectious disease,strongyles
oxiconazole,QRJJEGAJXVEBNE-HKOYGPOVSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis
oxidopamine,DIVDFFZHCJEHGG-UHFFFAOYSA-N,Preclinical,neurotoxin,,,
oxiniacic-acid,FJCFFCXMEXZEIM-UHFFFAOYSA-N,Preclinical,,,,
oxiperomide,NVDBBGBUTKLRSN-UHFFFAOYSA-N,Phase 2,dopamine receptor antagonist,,,
oxiracetam,IHLAQQPQKRMGSS-SCSAIBSYSA-N,Launched,acetylcholine receptor agonist,,neurology/psychiatry,senile dementia
oxolamine,IDCHQQSVJAAUQQ-UHFFFAOYSA-N,Launched,antitussive,,pulmonary,cough suppressant
oxolinic-acid,KYGZCKSPAKDVKC-UHFFFAOYSA-N,Preclinical,bacterial DNA gyrase inhibitor,,,
oxonic-acid,RYYCJUAHISIHTL-UHFFFAOYSA-N,Preclinical,uricase inhibitor,,,
oxotremorine-M,CANZROMYQDHYHR-UHFFFAOYSA-N,Preclinical,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,,
oxotremorine-sesquifumarate,RSDOPYMFZBJHRL-UHFFFAOYSA-N,Preclinical,cholinergic receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4,,
oxprenolol,CEMAWMOMDPGJMB-CYBMUJFWSA-N,Launched,adrenergic receptor antagonist,ADRB1,cardiology,angina pectoris|hypertension|cardiac arrythmia
oxybenzone,DXGLGDHPHMLXJC-UHFFFAOYSA-N,Launched,lipase inhibitor,LIPE,dermatology,sunscreen lotion
oxybuprocaine,CMHHMUWAYWTMGS-UHFFFAOYSA-N,Launched,local anesthetic,SCN10A,neurology/psychiatry,local anesthetic
oxybutynin,XIQVNETUBQGFHX-QFIPXVFZSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,urology,urinary incontinence
oxyclozanide,JYWIYHUXVMAGLG-UHFFFAOYSA-N,Launched,,,infectious disease,fascioliasis
oxyfedrine,GDYUVHBMFVMBAF-LIRRHRJNSA-N,Launched,adrenergic receptor agonist,,cardiology,angina pectoris
oxymatrine,XVPBINOPNYFXID-JARXUMMXSA-N,Launched,,,,
oxymetazoline,WYWIFABBXFUGLM-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C,otolaryngology,nasal congestion
oxyphenbutazone,HFHZKZSRXITVMK-KRWDZBQOSA-N,Withdrawn,cyclooxygenase inhibitor,,,
oxyphencyclimine,DUDKAZCAISNGQN-FQEVSTJZSA-N,Launched,cholinergic receptor antagonist,,gastroenterology,peptic ulcer disease (PUD)
oxyphenonium,GFRUPHOKLBPHTQ-UHFFFAOYSA-N,Launched,cholinergic receptor antagonist,CHRM1|CHRM3,gastroenterology,peptic ulcer disease (PUD)
oxypurinol,HXNFUBHNUDHIGC-UHFFFAOYSA-N,Phase 2/Phase 3,xanthine oxidase inhibitor,XDH,,
oxyquinoline,MCJGNVYPOGVAJF-UHFFFAOYSA-N,Launched,chelating agent,METAP2,dermatology,cosmetic
oxytetracycline,KTUXFHGUHYRDNF-PXOLEDIWSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease|urology,chlamydia|urinary tract infections|skin infections|ear infections|gonorrhea|urethritis|Lyme disease
oxytocin,XNOPRXBHLZRZKH-LGMJNFKNSA-N,Launched,oxytocin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,obstetrics/gynecology,labor induction
ozagrel,SHZKQBHERIJWAO-AATRIKPKSA-N,Launched,thromboxane synthase inhibitor,TBXAS1,neurology/psychiatry,stroke
ozanimod,XRVDGNKRPOAQTN-FQEVSTJZSA-N,Phase 3,sphingosine 1-phosphate receptor agonist,S1PR1,,
ozenoxacin,XPIJWUTXQAGSLK-UHFFFAOYSA-N,Phase 3,antiinfective drug,,,
ozolinone,NQFBZYYUAFJYNS-SKVAFPRGSA-N,Phase 3,diuretic,,,
p-dimethylinamyl-benzoate,LXTZRIBXKVRLOA-UHFFFAOYSA-N,Preclinical,,,,
P22077,RMAMGGNACJHXHO-UHFFFAOYSA-N,Preclinical,ubiquitin specific protease inhibitor,USP7,,
P276-00,QLUYMIVVAYRECT-OCCSQVGLSA-N,Phase 2,CDK inhibitor,CDK1|CDK4|CDK9,,
P5091,LKZLGMAAKNEGCH-UHFFFAOYSA-N,Preclinical,ubiquitin specific protease inhibitor,USP7,,
P7C3,FZHHRERIIVOATI-KRWDZBQOSA-N,Preclinical,NAMPT inhibitor,NAMPT,,
PA-452,JJUUTJCZMGZJDZ-UHFFFAOYSA-N,Preclinical,retinoid receptor antagonist,RXRA,,
PAC-1,YQNRVGJCPCNMKT-LFVJCYFKSA-N,Phase 1,caspase activator,CASP3,,
paclitaxel,RCINICONZNJXQF-MZXODVADSA-N,Launched,tubulin polymerization inhibitor,BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,ovarian cancer|breast cancer|non-small cell lung cancer (NSCLC)
PACOCF3,MAHYXYTYTLCTQD-UHFFFAOYSA-N,Preclinical,phospholipase inhibitor,PLA2G4A,,
pacritinib,HWXVIOGONBBTBY-ONEGZZNKSA-N,Phase 3,FLT3 inhibitor|JAK inhibitor,FLT3|JAK1|JAK2|JAK3,,
padsevonil,DCXFIOLWWRXEQH-SSDOTTSWSA-N,Phase 3,antiepileptic,,,
paeoniflorin,YKRGDOXKVOZESV-WRJNSLSBSA-N,Preclinical,anticonvulsant,,,
paeonol,UILPJVPSNHJFIK-UHFFFAOYSA-N,Preclinical,anti-inflammatory agent,,,
pafuramidine,UKOQVLAXCBRRGH-UHFFFAOYSA-N,Phase 3,DNA synthesis inhibitor,,,
pagoclone,HIUPRQPBWVEQJJ-IBGZPJMESA-N,Phase 2/Phase 3,GABA receptor agonist,,,
palbociclib,AHJRHEGDXFFMBM-UHFFFAOYSA-N,Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer
palbociclib,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)",Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer
palifosfamide,BKCJZNIZRWYHBN-UHFFFAOYSA-N,Phase 3,DNA alkylating agent,,,
paliperidone,PMXMIIMHBWHSKN-IBGZPJMESA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|HTR2A,neurology/psychiatry,schizophrenia
palmatine-chloride,QUCQEUCGKKTEBI-UHFFFAOYSA-N,Preclinical,dopamine synthesis inhibitor,CYP3A4,,
palmitoleic-acid,SECPZKHBENQXJG-FPLPWBNLSA-N,Preclinical,,,,
palmitoylcarnitine,XOMRRQXKHMYMOC-NRFANRHFSA-O,Preclinical,protein kinase inhibitor,,,
palmitoylethanolamide,HXYVTAGFYLMHSO-UHFFFAOYSA-N,Launched,cannabinoid receptor agonist,CNR2|GPR119|GPR55,,
palomid-529,YEAHTLOYHVWAKW-CQSZACIVSA-N,Phase 1,AKT inhibitor|mTOR inhibitor,MTOR,,
palonosetron,CPZBLNMUGSZIPR-NVXWUHKLSA-N,Launched,serotonin receptor antagonist,HTR3A,gastroenterology,nausea|vomiting
palosuran,WYJCYXOCHXWTHG-UHFFFAOYSA-N,Phase 2,urotensin receptor antagonist,UTS2R,,
palovarotene,YTFHCXIPDIHOIA-DHZHZOJOSA-N,Phase 3,retinoid receptor agonist,RARG,,
pamabrom,ATOTUUBRFJHZQG-UHFFFAOYSA-N,Launched,diuretic,,gastroenterology,bloating
pamidronate,WRUUGTRCQOWXEG-UHFFFAOYSA-N,Launched,bone resorption inhibitor,FDPS,endocrinology|oncology|hematologic malignancy,hypercalcemia|Paget's disease|breast cancer|multiple myeloma
pamiparib,DENYZIUJOTUUNY-MRXNPFEDSA-N,Phase 3,PARP inhibitor,,,
pancuronium,GVEAYVLWDAFXET-XGHATYIMSA-N,Launched,acetylcholine receptor antagonist,CHRM2|CHRM3|CHRNA1|CHRNA2,critical care|neurology/psychiatry,endotracheal intubation|muscle relaxant
panipenem,UIWSCWBHZRPIKR-DLYFRVTGSA-N,Preclinical,antibacterial ,,,
panobinostat,FPOHNWQLNRZRFC-ZHACJKMWSA-N,Launched,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,multiple myeloma
pantethine,DJWYOLJPSHDSAL-ROUUACIJSA-N,Launched,coenzyme A precursor,,,
pantoprazole,IQPSEEYGBUAQFF-AREMUKBSSA-N,Launched,ATPase inhibitor,ATP4A,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|Zollinger-Ellison syndrome
pantothenic-acid,GHOKWGTUZJEAQD-ZETCQYMHSA-N,Launched,coenzyme A precursor,,,
PAOPA,QXHVGEXNEZRSGG-JGVFFNPUSA-N,Preclinical,dopamine receptor modulator,DRD2,,
papaverine,XQYZDYMELSJDRZ-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE10A|PDE4B|PDE5A,cardiology|hematology|gastroenterology,myocardial infarction|angina pectoris|pulmonary embolism (PE)|colitis|vascular spasm
paquinimod,DIKSYHCCYVYKRO-UHFFFAOYSA-N,Phase 2,S100A9 inhibitor,,,
para-toluenesulfonamide,LMYRWZFENFIFIT-UHFFFAOYSA-N,Phase 3,,CA12|CA2|CA6|CA9,,
paracetamol,RZVAJINKPMORJF-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,neurology/psychiatry|endocrinology,pain relief|fever
paracetamol,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",Launched,cyclooxygenase inhibitor,FAAH|PTGS1|PTGS2|TRPV1,neurology/psychiatry|endocrinology,pain relief|fever
parachlorophenol,WXNZTHHGJRFXKQ-UHFFFAOYSA-N,Launched,antiinfective drug,,infectious disease,first-aid antiseptic
paramethadione,VQASKUSHBVDKGU-SSDOTTSWSA-N,Launched,anticonvulsant,CACNA1G,neurology/psychiatry,seizures
paraxanthine,QUNWUDVFRNGTCO-UHFFFAOYSA-N,Phase 1,adenosine receptor antagonist,,,
parbendazole,YRWLZFXJFBZBEY-UHFFFAOYSA-N,Preclinical,tubulin polymerization inhibitor,TUBB,,
parcetasal,ZAPRLADYRFPQSH-KRWDZBQOSA-N,Preclinical,anti-inflammatory agent,,,
pardoprunox,YVPUUUDAZYFFQT-UHFFFAOYSA-N,Phase 3,dopamine receptor agonist|serotonin receptor agonist,DRD2|DRD3|DRD4|HTR1A|HTR7,,
parecoxib,TZRHLKRLEZJVIJ-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,LTF,neurology/psychiatry,pain relief
parethoxycaine,OWWVHQUOYSPNNE-UHFFFAOYSA-N,Preclinical,local anesthetic,,,
pargyline,DPWPWRLQFGFJFI-UHFFFAOYSA-N,Launched,monoamine oxidase inhibitor,MAOA|MAOB,cardiology,hypertension
paricalcitol,BPKAHTKRCLCHEA-UBFJEZKGSA-N,Launched,vitamin D receptor agonist,VDR,nephrology|endocrinology,chronic kidney disease (CKD)|hyperthyroidism
paritaprevir,UAUIUKWPKRJZJV-QPLHLKROSA-N,Launched,HCV inhibitor,,infectious disease,hepatitis C
paromomycin,UOZODPSAJZTQNH-LSWIJEOBSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,amebiasis
paroxetine,AHOUBRCZNHFOSL-YOEHRIQHSA-N,Launched,selective serotonin reuptake inhibitor (SSRI),CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4,neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|generalized anxiety disorder (GAD)|panic disorders|posttraumatic stress disorder|social anxiety disorder
paroxypropione,RARSHUDCJQSEFJ-UHFFFAOYSA-N,Launched,gonadotropin inhibitor,,,
parsaclisib,ZQPDJCIXJHUERQ-QWRGUYRKSA-N,Phase 2,PI3K inhibitor,,,
parthenolide,KTEXNACQROZXEV-SLXBATTESA-N,Phase 1,NFkB pathway inhibitor,,,
parthenolide-(-),KTEXNACQROZXEV-QLIGOWBFSA-N,Preclinical,NFkB pathway inhibitor,HDAC1,,
parthenolide-(alternate-stereo),KTEXNACQROZXEV-PVLRGYAZSA-N,Preclinical,NFkB pathway inhibitor,IKBKB|RELA,,
pasireotide,VMZMNAABQBOLAK-DBILLSOUSA-N,Launched,somatostatin receptor agonist,SSTR1|SSTR2|SSTR3|SSTR5,endocrinology,Cushing's syndrome|acromegaly
PAT-1251,ODGXXYXJORZPHE-ZIAGYGMSSA-N,Phase 1,lysyl oxidase inhibitor,,,
pavinetant,QYTBBBAHNIWFOD-NRFANRHFSA-N,Phase 2,neurokinin receptor antagonist,,,
pazopanib,CUIHSIWYWATEQL-UHFFFAOYSA-N,Launched,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3,oncology,renal cell carcinoma (RCC)|soft tissue sarcoma (STS)
pazufloxacin,XAGMUUZPGZWTRP-ZETCQYMHSA-N,Launched,topoisomerase inhibitor,,infectious disease,pneumonia|peritonitis|bacterial septicemia
PBI-4050,PEGQOIGYZLJMIB-UHFFFAOYSA-N,Phase 2/Phase 3,free fatty acid receptor agonist,,,
PBT-1033,YZPOQCQXOSEMAZ-UHFFFAOYSA-N,Preclinical,chelating agent,,,
PCA-4248,DHCNAWNKZMNTIS-GFCCVEGCSA-N,Phase 1,platelet activating factor receptor antagonist,PTAFR,,
PCI-24781,MAUCONCHVWBMHK-UHFFFAOYSA-N,Phase 3,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC6,,
PCI-27483,WDJHHCAKBRKCLW-IBGZPJMESA-N,Phase 2,ERK1 and ERK2 phosphorylation inhibitor,,,
PCI-29732,GMJUPMONHWAZCP-UHFFFAOYSA-N,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,
PCI-34051,AJRGHIGYPXNABY-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC1|HDAC10|HDAC6|HDAC8,,
PCO-400,WJBHHTPFTVKZCV-CVEARBPZSA-N,Phase 1,potassium channel activator,KCNJ8,,
PD-0325901,SUDAHWBOROXANE-SECBINFHSA-N,Phase 2,MEK inhibitor,MAP2K1,,
PD-102807,VDDUJINYXKGZLV-JOCHJYFZSA-N,Preclinical,acetylcholine receptor antagonist,CHRM4,,
PD-118057,ZCQOSCDABPVAFB-UHFFFAOYSA-N,Preclinical,potassium channel activator,KCNH2,,
PD-123319,YSTVFDAKLDMYCR-NDEPHWFRSA-N,Phase 1,angiotensin antagonist,AGTR2,,
PD-128907,YOILXOMTHPUMRG-TZMCWYRMSA-N,Preclinical,dopamine receptor agonist,DRD2|DRD3,,
PD-153035,LSPANGZZENHZNJ-UHFFFAOYSA-N,Phase 1,EGFR inhibitor,EGFR|KDR,,
PD-156707,OFCTYBMKKTVKCR-QQTULTPQSA-N,Preclinical,endothelin receptor antagonist,EDNRA|EDNRB,,
PD-158780,KFHMLBXBRCITHF-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR,,
PD-158780,"InChI=1S/C14H12BrN5/c1-16-13-6-11-12(7-17-13)18-8-19-14(11)20-10-4-2-3-9(15)5-10/h2-8H,1H3,(H,16,17)(H,18,19,20)",Preclinical,EGFR inhibitor,EGFR,,
PD-160170,YUVNGBZROXQYQH-UHFFFAOYSA-N,Preclinical,neuropeptide receptor antagonist,NPY1R,,
PD-161570,MKVMEJKNLUWFSQ-UHFFFAOYSA-N,Preclinical,FGFR inhibitor,FGFR1,,
PD-166285,IFPPYSWJNWHOLQ-UHFFFAOYSA-N,Preclinical,SRC inhibitor,EGFR|FGFR1|PDGFRB|PKMYT1|SRC|WEE1,,
PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,Preclinical,collagenase inhibitor|metalloproteinase inhibitor,MMP13|MMP2|MMP3,,
PD-168077,DNULYRGWTFLJQL-UHFFFAOYSA-N,Preclinical,dopamine receptor agonist,DRD2,,
PD-168393,HTUBKQUPEREOGA-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR|ERBB2|SRC,,
PD-168393,"InChI=1S/C17H13BrN4O/c1-2-16(23)21-13-6-7-15-14(9-13)17(20-10-19-15)22-12-5-3-4-11(18)8-12/h2-10H,1H2,(H,21,23)(H,19,20,22)",Preclinical,EGFR inhibitor,EGFR|ERBB2|SRC,,
PD-168568,WQEPZBNLBWDIRZ-OAQYLSRUSA-N,Preclinical,dopamine receptor antagonist,DRD2|DRD4,,
PD-173074,DXCUKNQANPLTEJ-UHFFFAOYSA-N,Preclinical,FGFR inhibitor|VEGFR inhibitor,FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB,,
PD-173212,GCDHMGROXQUFNR-HEVIKAOCSA-N,Preclinical,calcium channel blocker,CACNA1B,,
PD-184352,GFMMXOIFOQCCGU-UHFFFAOYSA-N,Phase 2,MEK inhibitor,MAP2K1|MAP3K1|MAP3K2,,
PD-184352,"InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)",Phase 2,MEK inhibitor,MAP2K1|MAP3K1|MAP3K2,,
PD-198306,UHAXDAKQGVISBZ-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor|MEK inhibitor,MAP2K1|MAP2K2,,
PD-318088,XXSSGBYXSKOLAM-MRVPVSSYSA-N,Preclinical,MEK inhibitor,,,
PD-407824,IAUZTOZLTFSMIE-UHFFFAOYSA-N,Preclinical,PKC inhibitor,WEE1,,
PD-81723,KKDKAWKYGCUOGR-UHFFFAOYSA-N,Preclinical,adenosine receptor agonist,ADORA1,,
PD-98059,QFWCYNPOPKQOKV-UHFFFAOYSA-N,Preclinical,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,,
PD1-PDL-inhibitor-1,ZBOYJODMIAUJHH-SANMLTNESA-N,Preclinical,programmed death ligand inhibitor,CD274,,
PDD-00017273,IFWUBRBMMNTBRZ-UHFFFAOYSA-N,Preclinical,PARG inhibitor,,,
PDE10-IN-1,ZLHNYULRKIEGAY-HZPDHXFCSA-N,Preclinical,phosphodiesterase inhibitor,PDE10A,,
PDP-EA,BIOVSNWTCKRADD-UHFFFAOYSA-N,Preclinical,FAAH activator,FAAH,,
peficitinib,DREIJXJRTLTGJC-ZKVNVPQCSA-N,Launched,JAK inhibitor,JAK1|JAK2|JAK3,rheumatology,rheumatoid arthritis
pefloxacin,FHFYDNQZQSQIAI-UHFFFAOYSA-N,Launched,bacterial DNA gyrase inhibitor,TOP2A,infectious disease|urology,gastrointestinal infections|urethritis|gonorrhea|urinary tract infections
pelanserin,WPKPLSFHHBBLRY-UHFFFAOYSA-N,Phase 2,serotonin receptor antagonist,HTR2A,,
pelitinib,WVUNYSQLFKLYNI-AATRIKPKSA-N,Phase 2,EGFR inhibitor,EGFR,,
pelrinone,NZXHFDXOCVIYLO-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,,,
pemafibrate,ZHKNLJLMDFQVHJ-RUZDIDTESA-N,Phase 3,PPAR receptor agonist,,,
pemetrexed,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,Launched,dihydrofolate reductase inhibitor|thymidylate synthase inhibitor,ATIC|DHFR|GART|TYMS,oncology,non-small cell lung cancer (NSCLC)|mesothelioma
pemirolast,HIANJWSAHKJQTH-UHFFFAOYSA-N,Launched,mediator release inhibitor,HRH1,pulmonary,asthma
pempidine,XULIXFLCVXWHRF-UHFFFAOYSA-N,Launched,ganglionic blocker,,cardiology,hypertension
penbutolol,KQXKVJAGOJTNJS-HNNXBMFYSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR1B,cardiology,hypertension
penciclovir,JNTOCHDNEULJHD-UHFFFAOYSA-N,Launched,DNA directed DNA polymerase inhibitor,,dental,cold sore
penfluridol,MDLAAYDRRZXJIF-UHFFFAOYSA-N,Launched,T-type calcium channel blocker,CACNA1G,neurology/psychiatry,schizophrenia
penicillamine-(D),VVNCNSJFMMFHPL-VKHMYHEASA-N,Launched,chelating agent,,metabolism|rheumatology|nephrology,Wilson's disease|rheumatoid arthritis|cystinuria
penicillamine-(racemic),VVNCNSJFMMFHPL-VKHMYHEASA-N,Launched,,,,
penicillin-v-potassium,BPLBGHOLXOTWMN-MBNYWOFBSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,pneumonia|ear infections|skin infections|throat infections|cholera|scarlet fever
pentacosanoic-acid,MWMPEAHGUXCSMY-UHFFFAOYSA-N,Preclinical,,,,
pentagastrin,NEYNJQRKHLUJRU-DZUOILHNSA-N,Launched,CCK receptor agonist,CCKBR,gastroenterology,anacidity diagnostic|gastric hypersecretion diagnostic
pentamidine,XDRYMKDFEDOLFX-UHFFFAOYSA-N,Launched,anti-pneumocystis agent,TRDMT1,infectious disease,pneumonia
pentetic-acid,QPCDCPDFJACHGM-UHFFFAOYSA-N,Phase 2,chelating agent,,,
pentolinium,XSBSKEQEUFOSDD-UHFFFAOYSA-N,Launched,cholinergic receptor antagonist,CHRNA10|CHRNA3|CHRNA4|CHRNB4,cardiology,hypertension
pentostatin,FPVKHBSQESCIEP-JQCXWYLXSA-N,Launched,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor,ADA,hematologic malignancy,hairy cell leukemia
pentoxifylline,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF,cardiology,claudication
pentylenetetrazol,CWRVKFFCRWGWCS-UHFFFAOYSA-N,Withdrawn,GABA receptor antagonist,,,
peposertib,MOWXJLUYGFNTAL-DEOSSOPVSA-N,Phase 1/Phase 2,DNA dependent protein kinase inhibitor,,,
pepstatin,FAXGPCHRFPCXOO-LXTPJMTPSA-N,Preclinical,aspartic protease inhibitor,CTSB|CTSD|CTSL|REN,,
peramivir,XRQDFNLINLXZLB-CKIKVBCHSA-N,Launched,neuraminidase inhibitor,,infectious disease,influenza A virus infection
perchlozone,QTSJJDIDTYFLFC-BJMVGYQFSA-N,Launched,,,infectious disease,tuberculosis
peretinoin,UUBHZHZSIKRVIV-KCXSXWJSSA-N,Phase 3,retinoid receptor agonist,RXRA,,
perfluamine,JAJLKEVKNDUJBG-UHFFFAOYSA-N,Launched,,,,
perflubron,WTWWXOGTJWMJHI-UHFFFAOYSA-N,Launched,contrast agent,,radiology,contrast agent
perfluorodecalin,UWEYRJFJVCLAGH-UHFFFAOYSA-N,Launched,,,dermatology,cosmetic
perfluorohexyloctane,WRYIIOKOQSICTB-UHFFFAOYSA-N,Launched,,,,
pergolide,YEHCICAEULNIGD-MZMPZRCHSA-N,Withdrawn,dopamine receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,,
perhexiline,CYXKNKQEMFBLER-GOSISDBHSA-N,Launched,carnitine palmitoyltransferase inhibitor,CPT1A,cardiology,angina pectoris
perhexiline,"InChI=1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2/t18-/m1/s1",Launched,carnitine palmitoyltransferase inhibitor,CPT1A,cardiology,angina pectoris
perifosine,SZFPYBIJACMNJV-UHFFFAOYSA-O,Phase 3,AKT inhibitor,AKT1,,
perillyl-alcohol,NDTYTMIUWGWIMO-SNVBAGLBSA-N,Phase 2,apoptosis stimulant|farnesyltransferase inhibitor,FNTA,,
perindopril,IPVQLZZIHOAWMC-QXKUPLGCSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|myocardial infarction|coronary artery disease (CAD)
perindoprilat,ODAIHABQVKJNIY-PEDHHIEDSA-N,Phase 2,angiotensin converting enzyme inhibitor,ACE,,
permethrin,RLLPVAHGXHCWKJ-PKOBYXMFSA-N,Launched,,,infectious disease,lice
perospirone,FBVFZWUMDDXLLG-HDICACEKSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD2|DRD3|DRD4,neurology/psychiatry,schizophrenia|bipolar disorder
perphenazine,RGCVKNLCSQQDEP-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,CALM1|DRD1|DRD2|HRH1|HTR2A|HTR2C|HTR6|HTR7,neurology/psychiatry|gastroenterology,schizophrenia|nausea|vomiting
peruvoside,PMTSPAGBAFCORP-BZEWZVDJSA-N,Phase 1,cardiac glycoside,,,
perzinfotel,BDABGOLMYNHHTR-UHFFFAOYSA-N,Phase 2,glutamate receptor antagonist,GRIN1|GRIN2A|GRIN2B,,
PETCM,NGTDJJKTGRNNAU-ZETCQYMHSA-N,Preclinical,caspase activator,CASP3,,
pevonedistat,MPUQHZXIXSTTDU-QXGSTGNESA-N,Phase 3,nedd activating enzyme inhibitor,NAE1|UBA3,,
pevonedistat,"InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1",Phase 3,nedd activating enzyme inhibitor,NAE1|UBA3,,
pexidartinib,JGWRKYUXBBNENE-UHFFFAOYSA-N,Launched,tyrosine kinase inhibitor,CSF1R|FLT3|KIT,,
pexmetinib,LNMRSSIMGCDUTP-UHFFFAOYSA-N,Phase 1,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MAPK14|TEK,,
PF-02413873,QSFGZNVRVZHUGV-UHFFFAOYSA-N,Phase 1,progesterone receptor antagonist,,,
PF-02545920,AZEXWHKOMMASPA-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,PDE10A,,
PF-03049423,MNLNAGRCHNMKKJ-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,PDE5A,,
PF-03084014,VFCRKLWBYMDAED-REWPJTCUSA-N,Phase 3,gamma secretase inhibitor,,,
PF-03758309,AYCPARAPKDAOEN-LJQANCHMSA-N,Phase 1,p21 activated kinase inhibitor,PAK4,,
PF-03758309,"InChI=1S/C25H30N8OS/c1-15-26-18-11-12-35-20(18)23(27-15)29-22-17-13-33(25(2,3)21(17)30-31-22)24(34)28-19(14-32(4)5)16-9-7-6-8-10-16/h6-12,19H,13-14H2,1-5H3,(H,28,34)(H2,26,27,29,30,31)/t19-/m1/s1",Phase 1,p21 activated kinase inhibitor,PAK4,,
PF-03814735,RYYNGWLOYLRZLK-RBUKOAKNSA-N,Phase 1,Aurora kinase inhibitor,AURKA|AURKB,,
PF-03882845,XNULRSOGWPFPBL-AKRCKQFNSA-N,Phase 1,mineralocorticoid receptor antagonist,,,
PF-04136309,ZNSVOHSYDRPBGI-LXWOLXCRSA-N,Phase 2,CC chemokine receptor antagonist,,,
PF-04217903,PDMUGYOXRHVNMO-UHFFFAOYSA-N,Phase 1,c-Met inhibitor,MET,,
PF-04217903,"InChI=1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2",Phase 1,c-Met inhibitor,MET,,
PF-04418948,LWJGMYMNSNVCEM-UHFFFAOYSA-N,Phase 1,prostaglandin inhibitor,PTGER2,,
PF-04447943,IWXUVYOOUMLUTQ-CZUORRHYSA-N,Phase 2,phosphodiesterase inhibitor,PDE9A,,
PF-04457845,BATCTBJIJJEPHM-UHFFFAOYSA-N,Phase 2,FAAH inhibitor,FAAH,,
PF-04620110,GEVVQZHMFVFGLN-HDJSIYSDSA-N,Phase 1,diacylglycerol O acyltransferase inhibitor,DGAT1,,
PF-04691502,XDLYKKIQACFMJG-WKILWMFISA-N,Phase 2,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,,
PF-04885614,AGORGFNWYAUYSU-UHFFFAOYSA-N,Preclinical,voltage-gated sodium channel blocker,SCN10A,,
PF-04937319,MASKQITXHVYVFL-UHFFFAOYSA-N,Phase 2,glucokinase activator,GCK,,
PF-04995274,WLLOFQROROXOMO-GOSISDBHSA-N,Phase 1,serotonin receptor agonist,,,
PF-05089771,ZYSCOUXLBXGGIM-UHFFFAOYSA-N,Preclinical,sodium channel blocker,,,
PF-05175157,BDXXSFOJPYSYOC-UHFFFAOYSA-N,Phase 2,acetyl-CoA carboxylase inhibitor,,,
PF-05180999,CLGCHUKGBICQTE-UHFFFAOYSA-N,Phase 1,phosphodiesterase inhibitor,,,
PF-05190457,ZIUDADZJCKGWKR-AREMUKBSSA-N,Phase 2,growth hormone secretagogue receptor inverse agonist,GHSR,,
PF-05212384,DWZAEMINVBZMHQ-UHFFFAOYSA-N,Phase 2,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,,
PF-06260414,ZKAVFOXYJCREBQ-SNVBAGLBSA-N,Phase 1,androgen receptor modulator,,,
PF-06273340,BPIWZDNVMQQBQX-UHFFFAOYSA-N,Phase 1,tyrosine kinase receptor inhibitor,,,
PF-06282999,ICYNYWFGIDGBRD-UHFFFAOYSA-N,Phase 1,myeloperoxidase inhibitor,,,
PF-06305591,APWZIFIAVVFPNT-PELKAZGASA-N,Phase 1,sodium channel blocker,,,
PF-06409577,FHQXLWCFSUSXBF-UHFFFAOYSA-N,Phase 1,protein kinase activator,,,
PF-06412562,IDIUJOHYYBNCPC-UHFFFAOYSA-N,Phase 1,dopamine receptor partial agonist,,,
PF-06447475,BHTWDJBVZQBRKP-UHFFFAOYSA-N,Preclinical,serine/threonine kinase inhibitor,LRRK2,,
PF-06459988,ODMXWZROLKITMS-RISCZKNCSA-N,Phase 2,receptor tyrosine protein kinase inhibitor,,,
PF-06463922,IIXWYSCJSQVBQM-UHFFFAOYSA-N,Launched,ALK tyrosine kinase receptor inhibitor,ALK|FES|ROS1,oncology,non-small cell lung cancer (NSCLC)
PF-06650833,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,Phase 1,kinase inhibitor,,,
PF-06651600,CBRJPFGIXUFMTM-WDEREUQCSA-N,Phase 2/Phase 3,JAK inhibitor,,,
PF-06747775,JYIUNVOCEFIUIU-GHMZBOCLSA-N,Phase 2,EGFR inhibitor,,,
PF-06751979,ZLZUHACSRMOLLV-RAALSFIWSA-N,Phase 1,beta secretase inhibitor,,,
PF-06840003,MXKLDYKORJEOPR-MRVPVSSYSA-N,Phase 1,"indoleamine 2,3-dioxygenase inhibitor",,,
PF-06873600,QIEKHLDZKRQLLN-FOIQADDNSA-N,Phase 2,CDK inhibitor,,,
PF-06928215,PHGTYMRDHDEHLI-HIFRSBDPSA-N,Preclinical,cyclic GMP-AMP synthase inhibitor,,,
PF-3274167,HNIFCPBQMKPRCX-UHFFFAOYSA-N,Phase 2,oxytocin receptor antagonist,AVPR1A|OXTR,,
PF-3845,NBOJHRYUGLRASX-UHFFFAOYSA-N,Preclinical,FAAH inhibitor,FAAH,,
PF-4191834,DVNQWYLVSNPCJZ-UHFFFAOYSA-N,Preclinical,lipoxygenase inhibitor,,,
PF-429242,XKPJTOHUPQWSOJ-HSZRJFAPSA-N,Preclinical,SREBP inhibitor,MBTPS1,,
PF-431396,POJZIZBONPAWIV-UHFFFAOYSA-N,Preclinical,focal adhesion kinase inhibitor,PTK2|PTK2B,,
PF-4708671,FBLPQCAQRNSVHB-UHFFFAOYSA-N,Preclinical,ribosomal protein inhibitor,RPS6KB1,,
PF-477736,NDEXUOWTGYUVGA-LJQANCHMSA-N,Phase 1,CHK inhibitor,CHEK1|CHEK2,,
PF-4800567,AUMDBEHGJRZSOO-UHFFFAOYSA-N,Preclinical,casein kinase inhibitor,CSNK1D|CSNK1E,,
PF-4981517,WDWIMDKOXZZYHH-FQEVSTJZSA-N,Preclinical,cytochrome P450 inhibitor,CYP3A4,,
PF-514273,FJMQJSUOOGOWBD-UHFFFAOYSA-N,Preclinical,cannabinoid receptor antagonist,,,
PF-5274857,BBVNTTZIOTWDSV-UHFFFAOYSA-N,Preclinical,smoothened receptor antagonist,SMO,,
PF-562271,MZDKLVOWGIOKTN-UHFFFAOYSA-N,Phase 1,focal adhesion kinase inhibitor,PTK2|PTK2B,,
PF-573228,HESLKTSGTIBHJU-UHFFFAOYSA-N,Preclinical,focal adhesion kinase inhibitor,CDK1|CDK2|CDK7|GSK3B|IKBKB,,
PF-670462,WUDBUIUHVNECTM-UHFFFAOYSA-N,Preclinical,casein kinase inhibitor,CSNK1D|CSNK1E,,
PF-750,BIODYGOZWZNCAG-UHFFFAOYSA-N,Preclinical,FAAH inhibitor,FAAH,,
PF-8380,JMSUDQYHPSNBSN-UHFFFAOYSA-N,Preclinical,autotaxin inhibitor,ENPP2,,
PF-915275,ZESFDAKNYJQYKO-UHFFFAOYSA-N,Phase 1,11-beta hydroxysteroid dehydrogenase inhibitor,HSD11B1,,
PFI-1,TXZPMHLMPKIUGK-UHFFFAOYSA-N,Preclinical,bromodomain inhibitor,BRD4,,
PFI-3,INAICWLVUAKEPB-QSTFCLMHSA-N,Preclinical,bromodomain inhibitor,PBRM1|SMARCA4,,
PFI-4,QCIJLRJBZDBVDB-UHFFFAOYSA-N,Preclinical,bromodomain inhibitor,BRPF1,,
PFK-015,UJJUKZPBUMCSJZ-BQYQJAHWSA-N,Phase 1,phosphofructokinase inhibitor,PFKFB3,,
PFK-158,IAJOMYABKVAZCN-AATRIKPKSA-N,Phase 1,phosphofructokinase inhibitor,PFKFB3,,
PG-9,GHDWIFTUSXQYGK-FWYOQMDTSA-N,Preclinical,acetylcholine receptor agonist,,,
PGL5001,XCPPIJCBCWUBNT-HXUWFJFHSA-N,Phase 2,JNK inhibitor,MAPK10|MAPK8|MAPK9,,
PH-797804,KCAJXIDMCNPGHZ-UHFFFAOYSA-N,Phase 2,p38 MAPK inhibitor,MAPK11|MAPK14,,
PHA-543613,IPKZCLGGYKRDES-ZDUSSCGKSA-N,Preclinical,nicotinic receptor agonist,,,
PHA-568487,LUVXHMJTVXZFPD-ZDUSSCGKSA-N,Preclinical,nicotinic receptor agonist,CHRNA7,,
PHA-665752,OYONTEXKYJZFHA-SSHUPFPWSA-N,Preclinical,c-Met inhibitor,MET,,
PHA-680632,OBWNXGOQPLDDPS-UHFFFAOYSA-N,Preclinical,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,
PHA-767491,DKXHSOUZPMHNIZ-UHFFFAOYSA-N,Preclinical,CDC inhibitor,CDK1|RPS6KB1,,
PHA-793887,HUXYBQXJVXOMKX-UHFFFAOYSA-N,Phase 1,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CDK7|CDK9,,
PHA-848125,RXZMYLDMFYNEIM-UHFFFAOYSA-N,Phase 2,CDK inhibitor|growth factor receptor inhibitor,CDK2|CDK4|CDK7|NTRK1,,
PHCCC,FPXPIEZPAXSELW-RGNAGUPPSA-N,Preclinical,glutamate receptor agonist,GRM1|GRM4,,
phenacaine,QXDAEKSDNVPFJG-UHFFFAOYSA-N,Launched,local anesthetic,,neurology/psychiatry,local anesthetic
phenacemide,XPFRXWCVYUEORT-UHFFFAOYSA-N,Launched,sodium channel blocker,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,epilepsy|seizures
phenacetin,CPJSUEIXXCENMM-UHFFFAOYSA-N,Withdrawn,cyclooxygenase inhibitor,PTGS1,,
phenazone,VEQOALNAAJBPNY-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
phenazopyridine,QPFYXYFORQJZEC-FOCLMDBBSA-N,Launched,local anesthetic,SCN1A,infectious disease,urinary tract infections
phenelzine,RMUCZJUITONUFY-UHFFFAOYSA-N,Launched,monoamine oxidase inhibitor,ABAT|AOC3|GAD2|GPT|GPT2|MAOA|MAOB|SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression
phenethicillin,NONJJLVGHLVQQM-ADGXKJENSA-N,Launched,bacterial cell wall synthesis inhibitor,,,
phenethyl-isothiocyanate,IZJDOKYDEWTZSO-UHFFFAOYSA-N,Phase 2,anticancer agent,CYP2E1,,
phenformin,ICFJFFQQTFMIBG-UHFFFAOYSA-N,Withdrawn,AMPK activator,KCNJ8|PRKAA1,,
phenindamine,ISFHAYSTHMVOJR-LJQANCHMSA-N,Launched,histamine receptor antagonist,HRH1,allergy|otolaryngology,allergic rhinitis|common cold
phenindione,NFBAXHOPROOJAW-UHFFFAOYSA-N,Launched,vitamin K antagonist,VKORC1,hematology,deep vein thrombosis (DVT)
pheniramine,IJHNSHDBIRRJRN-HNNXBMFYSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis|urticaria
phenol,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,Preclinical,,CA1|CA12|CA14|CA2|CA4|CA9,otolaryngology,pharyngitis
phenolphthalein,KJFMBFZCATUALV-UHFFFAOYSA-N,Withdrawn,indicator dye,UGT1A9,,
phenolsulfonphthalein,BELBBZDIHDAJOR-UHFFFAOYSA-N,Launched,,,,
phenothiazine,WJFKNYWRSNBZNX-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,,,
phenothrin,SBNFWQZLDJGRLK-SFTDATJTSA-N,Launched,,,infectious disease,lice
phenoxybenzamine,QZVCTJOXCFMACW-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,cardiology|endocrinology,hypertension|pheochromocytoma
phenprobamate,CAMYKONBWHRPDD-UHFFFAOYSA-N,Launched,muscle relaxant,,neurology/psychiatry,anxiety|muscle relaxant
phenprocoumon,DQDAYGNAKTZFIW-ZDUSSCGKSA-N,Launched,vitamin K antagonist,VKORC1,hematology,thrombosis|pulmonary embolism (PE)
phenserine,PBHFNBQPZCRWQP-QUCCMNQESA-N,Phase 3,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,ACHE|BCHE,,
phensuximide,WLWFNJKHKGIJNW-SECBINFHSA-N,Launched,succinimide antiepileptic,,neurology/psychiatry,seizures
phentolamine,MRBDMNSDAVCSSF-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,endocrinology|cardiology,pheochromocytoma|hypertension
phenyl-aminosalicylate,DNVVZWSVACQWJE-UHFFFAOYSA-N,Launched,,,infectious disease,tuberculosis
phenyl-salicylate,ZQBAKBUEJOMQEX-UHFFFAOYSA-N,Launched,antiseptic,,urology,interstitial cystitis (IC)
phenylacetylglutamine,JFLIEFSWGNOPJJ-JTQLQIEISA-N,Phase 2,DNA methylase inhibitor|protein synthesis inhibitor,,,
phenylbenzimidazole-sulfonic-acid,UVCJGUGAGLDPAA-UHFFFAOYSA-N,Launched,,,dermatology,sunscreen lotion
phenylbutazone,VYMDGNCVAMGZFE-UHFFFAOYSA-N,Withdrawn,cyclooxygenase inhibitor|prostanoid receptor antagonist,PTGIS|PTGS1|PTGS2,,
phenylbutyrate,OBKXEAXTFZPCHS-UHFFFAOYSA-N,Launched,HDAC inhibitor,HDAC1,metabolism,urea cycle disorders
phenylephrine,SONNWYBIRXJNDC-VIFPVBQESA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D,otolaryngology|gastroenterology|cardiology,nasal congestion|hemorrhoids|hypotension
phenylethyl-alcohol,WRMNZCZEMHIOCP-UHFFFAOYSA-N,Preclinical,,,,
phenylmercuric-acetate,XEBWQGVWTUSTLN-UHFFFAOYSA-M,Preclinical,other antifungal,,,
phenylmethylsulfonyl-fluoride,YBYRMVIVWMBXKQ-UHFFFAOYSA-N,Preclinical,serine protease inhibitor,,,
phenylpiracetam,LYONXVJRBWWGQO-SNVBAGLBSA-N,Launched,noradrenaline uptake inhibitor,,neurology/psychiatry,anxiety|fatigue|depression
phenytoin,CXOFVDLJLONNDW-UHFFFAOYSA-N,Launched,hydantoin antiepileptic,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures
PhiKan-083,LBPNOEAFWYTTEB-UHFFFAOYSA-N,Preclinical,p53 stabilizing agent,TP53,,
phloretin,VGEREEWJJVICBM-UHFFFAOYSA-N,Launched,sodium/glucose cotransporter inhibitor,AQP9|CLCN3|SLC23A1,,
phlorizin,IOUVKUPGCMBWBT-QNDFHXLGSA-N,Preclinical,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A11|SLC5A2|SLC5A3,,
phloroglucin,QCDYQQDYXPDABM-UHFFFAOYSA-N,Launched,,,neurology/psychiatry,spasms
phortress,LFDOEFHQLNGBQQ-HNNXBMFYSA-N,Phase 1,aryl hydrocarbon receptor ligand,AHR,,
phosphatidylcholine,JLPULHDHAOZNQI-ZTIMHPMXSA-O,Launched,,,infectious disease|dermatology|gastroenterology|cardiology|obstetrics/gynecology,hepatitis B|hepatitis C|eczema|gallbladder disease|cholesterol|premenstrual syndrome
PHP-501,UHEYIOPHTBWBQN-UHFFFAOYSA-N,Preclinical,GABA receptor antagonist,GABRA1|GABRB2|GABRG2,,
PHT-427,BYWWNRBKPCPJMG-UHFFFAOYSA-N,Preclinical,AKT inhibitor|pyruvate dehydrogenase inhibitor,AKT2|PDPK1,,
phthalylsulfacetamide,SNWQKAWITMVCQW-UHFFFAOYSA-N,Preclinical,,,,
phthalylsulfathiazole,PBMSWVPMRUJMPE-UHFFFAOYSA-N,Launched,dihydropteroate synthetase inhibitor,,infectious disease|gastroenterology,dysentry|colitis
PHTPP,AEZPAUSGTAHLOQ-UHFFFAOYSA-N,Preclinical,estrogen receptor antagonist,ESR2,,
physostigmine,PIJVFDBKTWXHHD-HIFRSBDPSA-N,Launched,acetylcholinesterase inhibitor|cholinesterase inhibitor,ACHE|BCHE,cardiology|neurology/psychiatry|ophthalmology|gastroenterology,hypotension|Alzheimer's disease|glaucoma|gastroparesis
phytonadione,MBWXNTAXLNYFJB-NKFFZRIASA-N,Launched,,BGLAP|GGCX,hematology,vitamin K deficiency|anticoagulation reversal
phytosphingosine,AERBNCYCJBRYDG-KSZLIROESA-N,Phase 1,,,,
phytosphingosine,"InChI=1S/C18H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17(21)18(22)16(19)15-20/h16-18,20-22H,2-15,19H2,1H3/t16-,17+,18-/m0/s1",Phase 1,,,,
PI-103,TUVCWJQQGGETHL-UHFFFAOYSA-N,Preclinical,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,,
PI-103,"InChI=1S/C19H16N4O3/c24-13-4-1-3-12(11-13)17-21-15-14-5-2-6-20-19(14)26-16(15)18(22-17)23-7-9-25-10-8-23/h1-6,11,24H,7-10H2",Preclinical,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,,
PI-828,WUKMIBOGGXMBAC-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,,,
PI3K-IN-2,ADGGYDAFIHSYFI-UHFFFAOYSA-N,Phase 2,PI3K inhibitor,,,
PI3Kd-IN-2,NVWKNQGHVMMAJW-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,,,
PI4KIII-beta-inhibitor-1,PLUYFBRIGUAKBR-UHFFFAOYSA-N,Preclinical,PI4K inhibitor,PI4K2B,,
pibenzimol,INAAIJLSXJJHOZ-UHFFFAOYSA-N,Phase 2,DNA inhibitor,,,
piboserod,KVCSJPATKXABRQ-UHFFFAOYSA-N,Phase 2,serotonin receptor antagonist,HTR2B|HTR4,,
picartamide,ITNLONMDUMHEOK-NSHDSACASA-N,Phase 2,H+/K+-ATPase inhibitor,ATP4A,,
piceatannol,CDRPUGZCRXZLFL-OWOJBTEDSA-N,Preclinical,SYK inhibitor,ATP5A1|ATP5B|ATP5C1|IRF3,,
piclamilast,RRRUXBQSQLKHEL-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,,
picolamine,HDOUGSFASVGDCS-UHFFFAOYSA-N,Preclinical,,,,
picolinic-acid,SIOXPEMLGUPBBT-UHFFFAOYSA-N,Phase 2,chelating agent,,,
piconol,SHNUBALDGXWUJI-UHFFFAOYSA-N,Preclinical,,,,
picotamide,KYWCWBXGRWWINE-UHFFFAOYSA-N,Launched,thromboxane receptor antagonist|thromboxane synthase inhibitor,TBXA2R,hematology,thrombosis
picrotin,RYEFFICCPKWYML-XSVQNFTRSA-N,Phase 2,GABA receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB,,
picrotoxinin,PIMZUZSSNYHVCU-KBLUICEQSA-N,Preclinical,GABA receptor antagonist,GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B,,
pidolic-acid,ODHCTXKNWHHXJC-VKHMYHEASA-N,Launched,,ADAM28|AMY1A|AMY2A|AMY2B|ANG|CCL8|HCRT|IGLC1|KRTAP5-2|TFF2|VEGFA,dermatology,xerosis cutis
pidotimod,UUTKICFRNVKFRG-WDSKDSINSA-N,Launched,interferon receptor agonist|interleukin receptor agonist,,infectious disease,immune adjuvant
pifithrin-alpha,OLTZHXYLLRJLST-UHFFFAOYSA-N,Preclinical,TP53 inhibitor,TP53,,
pifithrin-cyclic,IMUKUMUNZJILCG-UHFFFAOYSA-N,Preclinical,TP53 inhibitor,TP53,,
pifithrin-mu,ZZUZYEMRHCMVTB-UHFFFAOYSA-N,Preclinical,HSP inhibitor,HSPA1A|TP53,,
PIK-293,KQDBVHKNIYROHU-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
PIK-294,WFSLJOPRIJSOJR-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,,
PIK-75,QTHCAAFKVUWAFI-DJKKODMXSA-N,Preclinical,DNA protein kinase inhibitor|PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC,,
PIK-93,JFVNFXCESCXMBC-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,PI4KB|PIK3C3|PIK3CG,,
pikamilone,NAJVRARAUNYNDX-UHFFFAOYSA-N,Phase 1,,,,
piketoprofen,ASFKKFRSMGBFRO-MRXNPFEDSA-N,Launched,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief
pilaralisib,QINPEPAQOBZPOF-UHFFFAOYSA-N,Phase 2,PI3K inhibitor,,,
pilocarpine,QCHFTSOMWOSFHM-WPRPVWTQSA-N,Launched,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,ophthalmology|cardiology,glaucoma|hypertension
pilsicainide,BCQTVJKBTWGHCX-UHFFFAOYSA-N,Launched,sodium channel blocker,SCN5A,cardiology,cardiac arrythmia
PIM-1-Inhibitor-2,AQVFETGXIRKVAQ-UHFFFAOYSA-N,Preclinical,Pim kinase inhibitor,PIM1,,
PIM-447,VRQXRVAKPDCRCI-ZNMIVQPWSA-N,Phase 1,Pim kinase inhibitor,,,
pimavanserin,RKEWSXXUOLRFBX-UHFFFAOYSA-N,Launched,serotonin receptor inverse agonist,DRD2|HTR2A,neurology/psychiatry,Parkinson's Disease
pimecrolimus,KASDHRXLYQOAKZ-YFMQXNBHSA-N,Launched,calcineurin inhibitor,,dermatology,eczema
pimethixene,NZLVRVYNQYGMAB-UHFFFAOYSA-N,Launched,antihistamine,,neurology/psychiatry|allergy,attention-deficit/hyperactivity disorder (ADHD)|anxiety|sleep cycle support|allergic rhinitis
pimobendan,GLBJJMFZWDBELO-LLVKDONJSA-N,Launched,calcium sensitizer|phosphodiesterase inhibitor,PDE3A,cardiology,congestive heart failure
pimodivir,JGPXDNKSIXAZEQ-SBBZOCNPSA-N,Phase 3,antiviral,,,
pimonidazole,WVWOOAYQYLJEFD-JTQLQIEISA-N,Phase 3,,,,
pimozide,YVUQSNJEYSNKRX-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2,neurology/psychiatry,Tourette's disorder
pinacidil,IVVNZDGDKPTYHK-SNVBAGLBSA-N,Launched,ATP channel activator|potassium channel activator,ABCC8|ABCC9,cardiology,hypertension
pinanediol,MOILFCKRQFQVFS-OORONAJNSA-N,Preclinical,,,,
pinaverium,DDHUTBKXLWCZCO-CEMLEFRQSA-N,Launched,T-type calcium channel blocker,CACNA1C,gastroenterology,irritable bowel syndrome
pincainide,RJOUHGWLHPOQSA-UHFFFAOYSA-N,Phase 1,antiarrhythmic,,,
pindolol,JZQKKSLKJUAGIC-LLVKDONJSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|HTR1A|HTR2A|HTR2B,cardiology,hypertension
pindolol-(-),JZQKKSLKJUAGIC-NSHDSACASA-N,Phase 2,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A,,
pinitol,DSCFFEYYQKSRSV-KLJZZCKASA-N,Phase 2,gamma secretase inhibitor,,,
pinocembrin,URFCJEUYXNAHFI-ZDUSSCGKSA-N,Phase 2,cytochrome P450 inhibitor,CYP1B1,,
pioglitazone,HYAFETHFCAUJAY-QGZVFWFLSA-N,Launched,insulin sensitizer|PPAR receptor agonist,PPARG|TRPM3,endocrinology,diabetes mellitus
pipamperone,AXKPFOAXAHJUAG-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR2A,neurology/psychiatry,schizophrenia
pipecuronium,OWWLUIWOFHMHOQ-XGHATYIMSA-N,Launched,neuromuscular blocker,CHRM2|CHRM3|CHRNA2,neurology/psychiatry,anesthetic
pipemidic-acid,JOHZPMXAZQZXHR-UHFFFAOYSA-N,Launched,topoisomerase inhibitor,,infectious disease,gram-negative bacterial infections
pipenzolate,WPUKUEMZZRVAKZ-REWPJTCUSA-N,Launched,cholinergic receptor antagonist,CHRM1,neurology/psychiatry,spasms
piperacetazine,BTFMCMVEUCGQDX-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,,neurology/psychiatry,schizophrenia
piperacillin,IVBHGBMCVLDMKU-GXNBUGAJSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,intra-abdominal infections|skin infections|pelvic inflammatory disease|pneumonia
piperaquine-phosphate,UCRHFBCYFMIWHC-UHFFFAOYSA-N,Launched,antimalarial agent,,infectious disease,malaria
piperazine,GLUUGHFHXGJENI-UHFFFAOYSA-N,Launched,benzodiazepine receptor agonist,GABRB3,infectious disease,gastrointestinal roundworms
piperazinedione,BXRNXXXXHLBUKK-UHFFFAOYSA-N,Phase 2,DNA synthesis inhibitor,,,
piperidolate,KTHVBAZBLKXIHZ-IBGZPJMESA-N,Launched,acetylcholine receptor antagonist,CHRM1,neurology/psychiatry,spasms
piperine,MXXWOMGUGJBKIW-YPCIICBESA-N,Phase 1,monoamine oxidase inhibitor,MAOA|MAOB|TRPV1,,
piperonyl-butoxide,FIPWRIJSWJWJAI-UHFFFAOYSA-N,Launched,cytochrome P450 inhibitor,,infectious disease,lice
pipobroman,NJBFOOCLYDNZJN-UHFFFAOYSA-N,Launched,DNA alkylating agent,,hematology,polycythemia vera|thrombocythemia
pipofezine,SDYYIRPAZHJOLM-UHFFFAOYSA-N,Preclinical,selective serotonin reuptake inhibitor (SSRI),,,
pipotiazine,JOMHSQGEWSNUKU-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD1|DRD2|HTR1A|HTR2A,neurology/psychiatry,schizophrenia
pipotiazine-palmitate,KTOYYUONFQWSMW-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,DRD1|DRD2|HTR1A|HTR2A,neurology/psychiatry,schizophrenia
piracetam,GMZVRMREEHBGGF-UHFFFAOYSA-N,Launched,acetylcholine receptor agonist,GRIA1|GRIA2|GRIA3|GRIA4,neurology/psychiatry,senile dementia
pirarubicin,KMSKQZKKOZQFFG-YXRRJAAWSA-N,Launched,topoisomerase inhibitor,TOP2A,oncology,breast cancer
pirenoxine,OKPNYGAWTYOBFZ-UHFFFAOYSA-N,Launched,AGE inhibitor,,ophthalmology,cataracts
pirenperone,HXCNRYXBZNHDNE-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR2A|HTR7,,
pirenzepine,RMHMFHUVIITRHF-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,gastroenterology,peptic ulcer disease (PUD)
piretanide,UJEWTUDSLQGTOA-UHFFFAOYSA-N,Launched,glucocorticoid receptor agonist,SLC12A1|SLC12A2,cardiology,hypertension|edema
pirfenidone,ISWRGOKTTBVCFA-UHFFFAOYSA-N,Launched,TGF beta receptor inhibitor,FURIN|TNF,pulmonary,idiopathic pulmonary fibrosis (IPF)
piribedil,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,Launched,dopamine receptor agonist,ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B,neurology/psychiatry,Parkinson's Disease|dizziness
piricapiron,NCMIPRCQUMYAEC-JPYJTQIMSA-N,Phase 2,dopamine receptor antagonist|serotonin receptor antagonist,HTR2A,,
pirinixic-acid,SZRPDCCEHVWOJX-UHFFFAOYSA-N,Preclinical,PPAR receptor agonist,PPARA,,
pirlindole,IWVRVEIKCBFZNF-ZDUSSCGKSA-N,Launched,monoamine oxidase inhibitor,MAOA,neurology/psychiatry,depression
pirmenol,APUDBKTWDCXQJA-XQBPLPMBSA-N,Preclinical,acetylcholine receptor inhibitor,,,
piroctone-olamine,OIQJEQLSYJSNDS-NSHDSACASA-N,Launched,,,infectious disease,fungal infection
pirodavir,KCHIOGFOPPOUJC-UHFFFAOYSA-N,Phase 2,,,,
piromidic-acid,RCIMBBZXSXFZBV-UHFFFAOYSA-N,Phase 2,bacterial DNA gyrase inhibitor,,,
piroxicam,QYSPLQLAKJAUJT-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis
piroximone,OQGWJZOWLHWFME-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,PDE3A,,
pirozadil,DIIBXMIIOQXTHW-UHFFFAOYSA-N,Preclinical,hypolipidemic,,,
pirquinozol,XLUKOGNIEDDIMV-UHFFFAOYSA-N,Phase 1,histamine release inhibitor,,,
PIT,LXEZPPZLNVOLDI-UHFFFAOYSA-N,Preclinical,purinergic receptor antagonist,P2RY1,,
pitavastatin,VGYFMXBACGZSIL-MCBHFWOFSA-N,Launched,HMGCR inhibitor,HMGCR,endocrinology,hyperlipidemia
pitolisant,NNACHAUCXXVJSP-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH3,,
pivagabine,SRPNQDXRVRCTNK-UHFFFAOYSA-N,Launched,corticotropin releasing factor receptor antagonist,CRHR1|CRHR2,neurology/psychiatry,depression
pivampicillin,ZEMIJUDPLILVNQ-ZXFNITATSA-N,Launched,bacterial cell wall synthesis inhibitor,,pulmonary|infectious disease,bronchitis|pneumonia|gynecologic infections
pivanex,GYKLFBYWXZYSOW-UHFFFAOYSA-N,Phase 2,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,,
pivmecillinam,NPGNOVNWUSPMDP-UTEPHESZSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,urinary tract infections|gram-negative bacterial infections
pixantrone,PEZPMAYDXJQYRV-UHFFFAOYSA-N,Launched,topoisomerase inhibitor,TOP2A,hematologic malignancy,non-Hodgkin lymphoma (NHL)
pizotifen,FIADGNVRKBPQEU-UHFFFAOYSA-N,Launched,serotonin receptor antagonist,HTR1A|HTR2A|HTR2C,neurology/psychiatry,migraine headache
PJ-34,UYJZZVDLGDDTCL-UHFFFAOYSA-N,Preclinical,PARP inhibitor,EEF2|PARP1|PARP15|PARP3,,
PK-11195,RAVIZVQZGXBOQO-CQSZACIVSA-N,Phase 1,benzodiazepine receptor antagonist,TSPO,,
PK-44,LIPWZZYFIVYJSI-MRVPVSSYSA-N,Preclinical,dipeptidyl peptidase inhibitor,DPP4,,
PK-THPP,CJZGRIRZVHNUSM-UHFFFAOYSA-N,Preclinical,potassium channel blocker,KCNK9,,
PKI-166,XRYJULCDUUATMC-CYBMUJFWSA-N,Phase 1,EGFR inhibitor,EGFR,,
PKI-179,WXUUCRLKXQMWRY-OYRHEFFESA-N,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR,,
pleconaril,KQOXLKOJHVFTRN-UHFFFAOYSA-N,Phase 3,,,,
plerixafor,YIQPUIGJQJDJOS-UHFFFAOYSA-N,Launched,CC chemokine receptor antagonist,ACKR3|CCR4|CXCR4,hematologic malignancy,non-Hodgkin lymphoma (NHL)|multiple myeloma
plicamycin,CFCUWKMKBJTWLW-BGLFSJPPSA-N,Launched,alcohol dehydrogenase inhibitor,,oncology|endocrinology,testicular carcinoma|Paget's disease|hypercalcemia
plinabulin,UNRCMCRRFYFGFX-TYPNBTCFSA-N,Phase 3,tubulin polymerization inhibitor,,,
plovamer-acetate,OUYCCCASQSFEME-QMMMGPOBSA-N,Phase 2,,TAT|TH|YARS|YARS2,,
plumbagin,VCMMXZQDRFWYSE-UHFFFAOYSA-N,Preclinical,anticancer agent,,,
plurisin-1,HUDWXDLBWRHCKO-UHFFFAOYSA-N,Preclinical,stearoyl-CoA desaturase inhibitor,SCD,,
PLX4720,YZDJQTHVDDOVHR-UHFFFAOYSA-N,Preclinical,RAF inhibitor,BRAF|KDR,,
PLX51107,AMSUHYUVOVCWTP-INIZCTEOSA-N,Phase 1,bromodomain inhibitor,,,
PLX647,NODCQQSEMCESEC-UHFFFAOYSA-N,Preclinical,receptor tyrosine protein kinase inhibitor,CSF1R|KIT,,
PLX8394,YYACLQUDUDXAPA-MRXNPFEDSA-N,Phase 1/Phase 2,serine/threonine kinase inhibitor,BRAF,,
PMPA,ISEYJGQFXSTPMQ-BYPYZUCNSA-N,Preclinical,glutamate receptor antagonist,FOLH1,,
PNU-120596,CEIIEALEIHQDBX-UHFFFAOYSA-N,Preclinical,acetylcholine receptor agonist,CHRNA7,,
PNU-142633,PNTVCCRNJOGKGA-QFIPXVFZSA-N,Phase 2,serotonin receptor agonist,HTR1D,,
PNU-177864,JGGQWSXZZQPZTR-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,DRD3,,
PNU-22394,ZBXDOQWPGBISAR-UHFFFAOYSA-N,Phase 2,serotonin receptor agonist,HTR2A|HTR2B|HTR2C|MAOA|MAOB,,
PNU-282987,WECKJONDRAUFDD-ZDUSSCGKSA-N,Preclinical,cholinergic receptor agonist,CHRNA7,,
PNU-37883,GKCGWXNLOYTUNC-UHFFFAOYSA-N,Preclinical,ATP-sensitive potassium channel antagonist,,,
PNU-74654,JJEDWBQZCRESJL-DEDYPNTBSA-N,Preclinical,beta-catenin inhibitor,CTNNB1|TCF4,,
PNU-89843,UADIKEUOAMACNA-UHFFFAOYSA-N,Preclinical,benzodiazepine receptor agonist,GABBR1,,
pocapavir,XXMDDBVNWRWNCW-UHFFFAOYSA-N,Preclinical,Enterovirus capsid inhibitor,,,
podophyllotoxin,YJGVMLPVUAXIQN-XVVDYKMHSA-N,Launched,microtubule inhibitor|tubulin polymerization inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,infectious disease,genital warts
polaprezinc,VBHDYBCWTAXBNA-FJXQXJEOSA-M,Preclinical,chelating agent,,,
polidocanol,ONJQDTZCDSESIW-UHFFFAOYSA-N,Launched,local anesthetic,,dermatology,varicose veins
polydatin,HSTZMXCBWJGKHG-CUYWLFDKSA-N,Phase 2,ICAM1 expression inhibitor,ICAM1,,
polyinosine,GRSZFWQUAKGDAV-SQQSDITASA-N,Preclinical,immunostimulant,HPRT1|IMPDH2|PYGM,,
polymyxin-B-sulfate,WQVJHHACXVLGBL-XLCZGQJLSA-N,Launched,bacterial permeability inducer,,ophthalmology,eye infection
polythiazide,CYLWJCABXYDINA-JTQLQIEISA-N,Launched,sodium/chloride cotransporter inhibitor,SLC12A3,cardiology|gastroenterology|rheumatology|nephrology,edema|congestive heart failure|hepatic cirrhosis|nephrotic syndrome|acute glomerulonephritis (AGN)|chronic renal failure|hypertension
pomalidomide,UVSMNLNDYGZFPF-QMMMGPOBSA-N,Launched,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,hematologic malignancy,multiple myeloma
pomalidomide,"InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18)/t8-/m0/s1",Launched,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,hematologic malignancy,multiple myeloma
ponatinib,PHXJVRSECIGDHY-UHFFFAOYSA-N,Launched,Bcr-Abl kinase inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor,ABL1|BCR|FGFR1|FGFR2|FGFR3|FGFR4|FLT3|KDR|KIT|LCK|LYN|PDGFRA|RET|SRC|TEK,hematologic malignancy,chronic myeloid leukemia (CML)|acute lymphoblastic leukemia (ALL)
ponesimod,LPAUOXUZGSBGDU-STDDISTJSA-N,Phase 3,sphingosine 1-phosphate receptor agonist,S1PR1,,
posaconazole,RAGOYPUPXAKGKH-XAKZXMRKSA-N,Launched,sterol demethylase inhibitor,CYP3A4,infectious disease,oropharyngeal candidiasis
potassium-canrenoate,PBKZPPIHUVSDNM-WNHSNXHDSA-N,Launched,mineralocorticoid receptor antagonist,NR3C2,cardiology,edema
potassium-iodide,KIRAUJWBCMCUBY-UHFFFAOYSA-N,Launched,,,pulmonary,asthma|bronchitis|emphysema
potassium-p-aminobenzoate,ALYNCZNDIQEVRV-UHFFFAOYSA-N,Launched,,,rheumatology|urology,scleroderma|dermatomyositis|Peyronie's disease
pozanicline,YRVIKLBSVVNSHF-JTQLQIEISA-N,Phase 2,acetylcholine receptor antagonist,CHRNA4|CHRNB2,,
poziotinib,LPFWVDIFUFFKJU-UHFFFAOYSA-N,Phase 2,EGFR inhibitor,EGFR|ERBB2|ERBB4,,
PP-1,ZVPDNRVYHLRXLX-UHFFFAOYSA-N,Preclinical,SRC inhibitor,HCK|RET,,
PP-121,NVRXTLZYXZNATH-UHFFFAOYSA-N,Preclinical,protein tyrosine kinase inhibitor,ABL1|EGFR|HCK|KDR|MTOR|PDGFRA|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC|SRC,,
PP-2,PBBRWFOVCUAONR-UHFFFAOYSA-N,Preclinical,SRC inhibitor,ABL1|LCK|RIPK2|SRC,,
PP242,MFAQYJIYDMLAIM-UHFFFAOYSA-N,Preclinical,mTOR inhibitor,MTOR|PASK,,
PPT,IOTXSIGGFRQYKW-UHFFFAOYSA-N,Preclinical,estrogen receptor agonist,ESR1,,
PPY-A,GYQRHHQPEMOLKH-UHFFFAOYSA-N,Preclinical,Abl kinase inhibitor,ABL1|BCR,,
PQ-401,YBLWOZUPHDKFOT-UHFFFAOYSA-N,Preclinical,IGF-1 inhibitor,IGF1R,,
PR-619,ZXOBLNBVNROVLC-UHFFFAOYSA-N,Preclinical,DUB inhibitor,,,
practolol,DURULFYMVIFBIR-CYBMUJFWSA-N,Withdrawn,adrenergic receptor antagonist,ADRB1,,
pradefovir,GWNHAOBXDGOXRR-HJFSHJIFSA-N,Phase 2,cytochrome P450 activator,,,
pralatrexate,OGSBUKJUDHAQEA-ZBFHGGJFSA-N,Launched,dihydrofolate reductase inhibitor,DHFR,hematologic malignancy,peripheral T-cell lymphoma (PTCL)
pralatrexate,"InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14-,16+/m1/s1",Launched,dihydrofolate reductase inhibitor,DHFR,hematologic malignancy,peripheral T-cell lymphoma (PTCL)
pralidoxime,JBKPUQTUERUYQE-UHFFFAOYSA-O,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,critical care,organophosphate poisoning
pralidoxime-chloride,MHOAUIZFSQGCNM-UHFFFAOYSA-N,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,pulmonary,respiratory depression
pralmorelin,HRNLPPBUBKMZMT-RDRUQFPZSA-N,Launched,growth hormone releasing peptide ligand agonist,,,
pramipexole,FASDKYOPVNHBLU-ZETCQYMHSA-N,Launched,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,neurology/psychiatry,Parkinson's Disease
pramiracetam,ZULJGOSFKWFVRX-UHFFFAOYSA-N,Launched,acetylcholine receptor agonist,,neurology/psychiatry,senile dementia
pramoxine,DQKXQSGTHWVTAD-UHFFFAOYSA-N,Launched,topical anesthetic,,dermatology,corticosteroid-responsive dermatoses
pranidipine,XTFPDGZNWTZCMF-OXHGWOFKSA-N,Phase 2,calcium channel blocker,CACNA1C,,
pranlukast,NBQKINXMPLXUET-UHFFFAOYSA-N,Launched,leukotriene receptor antagonist,CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF,pulmonary,bronchospasm|asthma
pranoprofen,TVQZAMVBTVNYLA-SECBINFHSA-N,Launched,cyclooxygenase inhibitor,,neurology/psychiatry,pain relief
prasterone-acetate,NCMZQTLCXHGLOK-ZKHIMWLXSA-N,Preclinical,,,,
prasugrel,DTGLZDAWLRGWQN-LJQANCHMSA-N,Launched,purinergic receptor antagonist,P2RY12,cardiology,myocardial infarction|acute coronary syndrome (ACS)
pravadoline,MEUQWHZOUDZXHH-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,CNR1|CNR2,,
pravastatin,TUZYXOIXSAXUGO-PZAWKZKUSA-N,Launched,HMGCR inhibitor,HMGCR|SLCO1B1,endocrinology|cardiology,hypercholesterolemia|myocardial infarction|hyperlipidemia
praziquantel,FSVJFNAIGNNGKK-QGZVFWFLSA-N,Launched,anthelmintic agent,,infectious disease,gastrointestinal parasites|cystic hydatid disease|schistosomiasis
prazosin,IENZQIKPVFGBNW-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7,cardiology,hypertension
PRE-084,RQHKZUBCUZVZEF-UHFFFAOYSA-N,Preclinical,sigma receptor agonist,SIGMAR1,,
preclamol,HTSNFXAICLXZMA-ZDUSSCGKSA-N,Phase 2,dopamine receptor agonist,DRD2,,
prednicarbate,FNPXMHRZILFCKX-HGVFMWMISA-N,Launched,phospholipase activator,PLA2G1B,dermatology|ophthalmology|neurology/psychiatry,eczema|contact dermatitis|itching
prednisolone,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Launched,glucocorticoid receptor agonist,NR3C1|NR3C2|SERPINA6,ophthalmology|dermatology|infectious disease,conjunctivitis|rosacea|punctate keratitis|shingles|iritis|cyclitis
prednisolone-acetate,LRJOMUJRLNCICJ-JZYPGELDSA-N,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology|dermatology|infectious disease,conjunctivitis|rosacea|punctate keratitis|shingles|iritis|cyclitis
prednisolone-acetate,LRJOMUJRLNCICJ-WXLIAARGSA-N,Launched,glucocorticoid receptor agonist,NR3C1,ophthalmology|dermatology|infectious disease,conjunctivitis|rosacea|punctate keratitis|shingles|iritis|cyclitis
prednisolone-hemisuccinate,APGDTXUMTIZLCJ-CGVGKPPMSA-N,Preclinical,glucocorticoid receptor agonist,NR3C1,,
prednisolone-sodium-phosphate,JDOZJEUDSLGTLU-VWUMJDOOSA-N,Launched,glucocorticoid receptor agonist,NR3C1,allergy|pulmonary|ophthalmology|infectious disease|rheumatology|endocrinology|neurology/psychiatry|gastroenterology|hematology,allergic rhinitis|asthma|contact dermatitis|mycosis|lupus|hypercalcemia|thyroiditis|congenital adrenal hyperplasia|multiple sclerosis|ulcerative colitis|enteritis|thrombocythemia|pneumonia|meningitis|psoriatic arthritis|rheumatoid arthritis
prednisolone-tebutate,HUMXXHTVHHLNRO-HGVFMWMISA-N,Launched,anti-inflammatory agent,,,
prednisone,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Launched,glucocorticoid receptor agonist,HSD11B1|NR3C1,endocrinology|rheumatology|infectious disease|dermatology|ophthalmology|hematology|gastroenterology|neurology/psychiatry,congenital adrenal hyperplasia|hypercalcemia|rheumatoid arthritis|psoriatic arthritis|ankylosing spondylitis|bursitis|osteoarthritis|epicondylitis|dermatomyositis|psoriasis|mycosis|conjunctivitis|anemia|ulcerative colitis|enteritis|multiple sclerosis|meningitis
pregnenolone,ORNBQBCIOKFOEO-QGVNFLHTSA-N,Launched,glutamate receptor modulator,SULT2B1,rheumatology,rheumatoid arthritis
pregnenolone-succinate,OZZAYJQNMKMUSD-VQLNUFJUSA-N,Preclinical,GABA receptor negative allosteric modulator,CYP17A1,,
preladenant,DTYWJKSSUANMHD-UHFFFAOYSA-N,Phase 3,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
prenylamine,IFFPICMESYHZPQ-FQEVSTJZSA-N,Withdrawn,calcium channel blocker,,,
presatovir,GOFXWTVKPWJNGD-UWJYYQICSA-N,Phase 2,RSV fusion inhibitor,,,
pretomanid,ZLHZLMOSPGACSZ-NSHDSACASA-N,Launched,nitric oxide donor,FASN,,
pridinol,RQXCLMGKHJWMOA-UHFFFAOYSA-N,Launched,muscle relaxant,,neurology/psychiatry,muscle relaxant
pridopidine,YGKUEOZJFIXDGI-UHFFFAOYSA-N,Phase 2,dopamine receptor antagonist,,,
prilocaine,MVFGUOIZUNYYSO-NSHDSACASA-N,Launched,local anesthetic,SCN5A,neurology/psychiatry,anesthetic
PRIMA1,RFBVBRVVOPAAFS-UHFFFAOYSA-N,Preclinical,TP53 inhibitor,ACHE,,
primaquine,INDBQLZJXZLFIT-NSHDSACASA-N,Launched,antimalarial agent|DNA inhibitor,,infectious disease,malaria
primidone,DQMZLTXERSFNPB-UHFFFAOYSA-N,Launched,GABA receptor antagonist,CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures
prinaberel,MQIMZDXIAHJKQP-UHFFFAOYSA-N,Phase 2,estrogen receptor agonist,ESR2|NCOA1,,
prinomastat,YKPYIPVDTNNYCN-INIZCTEOSA-N,Phase 3,matrix metalloprotease inhibitor,,,
priralfinamide,BHJIBOFHEFDSAU-LBPRGKRZSA-N,Phase 3,sodium channel blocker,CACNA1B,,
prisotinol,WQRPBKUCJBWQRT-SECBINFHSA-N,Phase 2,,,,
pritelivir,IVZKZONQVYTCKC-UHFFFAOYSA-N,Phase 2,helicase primase inhibitor,,,
PRLX-93936,OBWOSMGNXYUDFB-UHFFFAOYSA-N,Phase 1/Phase 2,voltage-dependent anion selective channel protein inhibitor,,,
PRN1008,LCFFREMLXLZNHE-GBOLQPHISA-N,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,,,
PRN1371,PUIXMSRTTHLNKI-UHFFFAOYSA-N,Phase 1,protein tyrosine kinase inhibitor,,,
proacipimox,KKKHJYGCTVKQEM-UHFFFAOYSA-N,Phase 1,cholesterol inhibitor,,,
proadifen,SNTQPLDRUZOSDP-UHFFFAOYSA-N,Preclinical,nitric oxide synthase inhibitor,NOS1,,
probenecid,DBABZHXKTCFAPX-UHFFFAOYSA-N,Launched,uricosuric blocker,PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1,nephrology|rheumatology,hyperuricemia|gout
probucol,FYPMFJGVHOHGLL-UHFFFAOYSA-N,Launched,atherogenesis inhibitor,ABCA1|ABCB11|CES1,cardiology,coronary artery disease (CAD)
procainamide,REQCZEXYDRLIBE-UHFFFAOYSA-N,Launched,sodium channel blocker,DNMT1|SCN5A,cardiology,ventricular arrhythmias|ventricular tachycardia (VT)
procaine,MFDFERRIHVXMIY-UHFFFAOYSA-N,Launched,HMGCR inhibitor,CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3,neurology/psychiatry,anesthetic
procarbazine,CPTBDICYNRMXFX-UHFFFAOYSA-N,Launched,monoamine oxidase inhibitor,,hematologic malignancy,Hodgkin's lymphoma
procaterol,FKNXQNWAXFXVNW-BLLLJJGKSA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma
prochlorperazine,WIKYUJGCLQQFNW-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4,gastroenterology,nausea|vomiting
procodazole,XYWJNTOURDMTPI-UHFFFAOYSA-N,Preclinical,immunostimulant,,,
procyanidin-B-2,XFZJEEAOWLFHDH-UKWJTHFESA-N,Phase 2,,,,
procyclidine,INDBQLZJXZLFIT-NSHDSACASA-N,Launched,acetylcholine receptor antagonist,,neurology/psychiatry,parkinsonism|Parkinson's Disease|akathisia|dystonia
procysteine,BMLMGCPTLHPWPY-REOHCLBHSA-N,Phase 3,glutathione synthase stimulant,,,
profenamine,CDOZDBSBBXSXLB-HNNXBMFYSA-N,Launched,butyrylcholinesterase inhibitor|cholinergic receptor antagonist,CHRM1,neurology/psychiatry,Parkinson's Disease
proflavine-hemisulfate,WDVSHHCDHLJJJR-UHFFFAOYSA-N,Phase 2,topical anesthetic,F2,,
progesterone,RJKFOVLPORLFTN-LEKSSAKUSA-N,Launched,progesterone receptor agonist,CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5,obstetrics/gynecology|endocrinology,infertility|amenorrhea
proglumetacin,PTXGHCGBYMQQIG-RRHRGVEJSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
proglumide,DGMKFQYCZXERLX-OAHLLOKOSA-N,Withdrawn,CCK receptor antagonist,CCKAR|CCKBR,,
proguanil,SSOLNOMRVKKSON-UHFFFAOYSA-N,Launched,dihydrofolate reductase inhibitor,DHFR,infectious disease,malaria
prolylleucylglycinamide,NOOJLZTTWSNHOX-NXEZZACHSA-N,Phase 2,melanocyte-stimulating hormone release inhibitor,,,
promazine,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|HRH1|HTR2A|HTR2C,neurology/psychiatry,schizophrenia
promestriene,IUWKNLFTJBHTSD-AANPDWTMSA-N,Launched,estrogen receptor agonist,ESR1,endocrinology,androgenetic alopecia
promethazine,PWWVAXIEGOYWEE-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,neurology/psychiatry|allergy,sedative|allergic rhinitis
pronethalol,HRSANNODOVBCST-OAHLLOKOSA-N,Withdrawn,adrenergic receptor antagonist,,,
propacetamol,QTGAJCQTLIRCFL-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS2,endocrinology|neurology/psychiatry,fever|pain relief
propafenone,JWHAUXFOSRPERK-GOSISDBHSA-N,Launched,antiarrhythmic,ADRB1|ADRB2|KCNA5|KCNH2,cardiology,atrial fibrillation (AF)|ventricular tachycardia (VT)|ventricular arrhythmias
propagermanium,XEABSBMNTNXEJM-UHFFFAOYSA-N,Launched,CCR agonist|interferon receptor agonist,CCR2,infectious disease,hepatitis B
propantheline,VVWYOYDLCMFIEM-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,gastroenterology,peptic ulcer disease (PUD)
propatylnitrate,YZZCJYJBCUJISI-UHFFFAOYSA-N,Launched,,,cardiology,angina pectoris
propentofylline,RBQOQRRFDPXAGN-UHFFFAOYSA-N,Launched,adenosine reuptake inhibitor|phosphodiesterase inhibitor,PDE1A,neurology/psychiatry,stroke
propidium-iodide,ZDWVWKDAWBGPDN-UHFFFAOYSA-O,Preclinical,,ACHE,,
propiolactone,VEZXCJBBBCKRPI-UHFFFAOYSA-N,Launched,,,infectious disease,antiseptic
propiverine,QPCVHQBVMYCJOM-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM1,urology,urinary incontinence
propofol,OLBCVFGFOZPWHH-UHFFFAOYSA-N,Launched,benzodiazepine receptor agonist,FAAH|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|SCN2A|SCN4A,neurology/psychiatry,anesthetic
propoxur,ISRUGXGCCGIOQO-UHFFFAOYSA-N,Launched,,,infectious disease,flea control
propoxycaine,CAJIGINSTLKQMM-UHFFFAOYSA-N,Launched,local anesthetic,,neurology/psychiatry,anesthetic
propranolol,AQHHHDLHHXJYJD-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,cardiology|neurology/psychiatry,hypertension|angina pectoris|migraine headache
propranolol-(R),AQHHHDLHHXJYJD-CQSZACIVSA-N,Preclinical,adrenergic receptor antagonist,ADRB2|ADRB3,,
propranolol-(S),AQHHHDLHHXJYJD-AWEZNQCLSA-N,Preclinical,adrenergic receptor antagonist,ADRB1|HTR1A|HTR5A|SLC10A1,,
propyl-benzoate,UDEWPOVQBGFNGE-UHFFFAOYSA-N,Launched,,,,
propylene-glycol,DNIAPMSPPWPWGF-GSVOUGTGSA-N,Launched,,,,
propylhexedrine,JCRIVQIOJSSCQD-VIFPVBQESA-N,Launched,adrenergic receptor agonist,,otolaryngology|endocrinology|allergy,nasal congestion|fever|allergic rhinitis
propylparaben,QELSKZZBTMNZEB-UHFFFAOYSA-N,Launched,,,,
propylthiouracil,KNAHARQHSZJURB-UHFFFAOYSA-N,Launched,thyroid peroxidase inhibitor,DIO1|TPO,endocrinology,hyperthyroidism|Grave's disease|goiter
propyphenazone,PXWLVJLKJGVOKE-UHFFFAOYSA-N,Preclinical,anti-inflammatory agent,,,
proquazone,JTIGKVIOEQASGT-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,neurology/psychiatry,pain relief
proscillaridin-A,MYEJFUXQJGHEQK-ALRJYLEOSA-N,Launched,,,cardiology,congestive heart failure|cardiac arrythmia
protionamide,VRDIULHPQTYCLN-UHFFFAOYSA-N,Launched,,,infectious disease,tuberculosis
protirelin,XNSAINXGIQZQOO-SRVKXCTJSA-N,Launched,thyrotropin releasing hormone receptor agonist,TRHR,radiology,thyroid function diagnostic
protoporphyrin-IX,HGXFBVDWWKPUKZ-UJJXFSCMSA-N,Preclinical,heme oxygenase inhibitor,HMOX1,,
protriptyline,BWPIARFWQZKAIA-UHFFFAOYSA-N,Launched,tricyclic antidepressant,SLC6A2|SLC6A4,neurology/psychiatry,depression
proxodolol,CEDZURSVVKNCSL-ZDUSSCGKSA-N,Launched,adrenergic receptor antagonist,,,
proxyfan,WNWALBVQAAIULR-UHFFFAOYSA-N,Preclinical,histamine receptor modulator,HRH3,,
proxymetacaine,KCLANYCVBBTKTO-UHFFFAOYSA-N,Launched,sodium channel blocker,SCN10A|SCN5A,neurology/psychiatry,anesthetic
Proxyphylline,KYHQZNGJUGFTGR-ZCFIWIBFSA-N,Launched,,,pulmonary,asthma
PRT062070,BGLPECHZZQDNCD-UHFFFAOYSA-N,Phase 2/Phase 3,JAK inhibitor|SYK inhibitor,SYK,,
PRT062607,TXGKRVFSSHPBAJ-JKSUJKDBSA-N,Phase 2,SYK inhibitor,FGR|MAP3K9|SYK,,
PRT062607,"InChI=1S/C19H23N9O/c20-15-6-1-2-7-16(15)26-19-22-11-14(17(21)29)18(27-19)25-12-4-3-5-13(10-12)28-23-8-9-24-28/h3-5,8-11,15-16H,1-2,6-7,20H2,(H2,21,29)(H2,22,25,26,27)/t15-,16+/m0/s1",Phase 2,SYK inhibitor,FGR|MAP3K9|SYK,,
PRT4165,OMHZFEWYVFWVLI-UHFFFAOYSA-N,Preclinical,polycomb repressive complex inhibitor,PRC1,,
prucalopride,ZPMNHBXQOOVQJL-UHFFFAOYSA-N,Launched,serotonin receptor agonist,HTR4,gastroenterology,constipation
prulifloxacin,PWNMXPDKBYZCOO-LLVKDONJSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease|pulmonary|gastroenterology,urinary tract infections|bronchitis|diarrhea
pruvanserin,AQRLDDAFYYAIJP-UHFFFAOYSA-N,Phase 2,serotonin receptor antagonist,HTR2A|HTR2C,,
PRX-07034,BSLXKMCHXRCBIH-AWEZNQCLSA-N,Phase 1,serotonin receptor antagonist,,,
PRX-08066,IENZFHBNCRQMNP-UHFFFAOYSA-N,Phase 2,serotonin receptor antagonist,HTR2B,,
PS178990,KEJORAMIZFOODM-PWSUYJOCSA-N,Phase 1,androgen receptor modulator,AR,,
PSB-06126,ZHQRPIRGSWEALJ-UHFFFAOYSA-N,Preclinical,NTPDase inhibitor,ENTPD3,,
PSB-11,RGDHRCXUMURWBJ-LLVKDONJSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA3,,
PSB-1115,UYDRRQPGDSIMNU-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2B|ADORA3,,
PSB-36,CIBIXJYFYPFMTN-FZUGUKJMSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
PSB-603,OVHCTHHFOHMNFV-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
PSI-6130,NYPIRLYMDJMKGW-VPCXQMTMSA-N,Phase 1,RNA polymerase inhibitor,,,
PSI-697,DIEPFYNZGUUVHD-UHFFFAOYSA-N,Phase 1,P selectin inhibitor,,,
PSI-7976,TTZHDVOVKQGIBA-YBSJRAAASA-N,Preclinical,HCV inhibitor,,,
PSN-375963,OAVLEYPTWABFLF-UHFFFAOYSA-N,Preclinical,glucose dependent insulinotropic receptor agonist,GPR119,,
PSNCBAM-1,HDAYFSFWIPRJSO-UHFFFAOYSA-N,Preclinical,cannabinoid receptor modulator,CNR1,,
psoralen,ZCCUUQDIBDJBTK-UHFFFAOYSA-N,Launched,,MAOA|MAOB,dermatology,psoriasis|eczema|vitiligo
PT-2385,ONBSHRSJOPSEGS-INIZCTEOSA-N,Phase 1,hypoxia inducible factor inhibitor,EPAS1,,
PTC-028,JEZGPBWIZWPDHP-UHFFFAOYSA-N,Preclinical,BMI-1 inhibitor,,,
PTC-209,XVOOCQSWCCRVDY-UHFFFAOYSA-N,Preclinical,BMI-1 inhibitor,,,
pterostilbene,VLEUZFDZJKSGMX-ONEGZZNKSA-N,Phase 2/Phase 3,cyclooxygenase inhibitor|PPAR receptor agonist,PTGS2,,
PU-H71,SUPVGFZUWFMATN-UHFFFAOYSA-N,Phase 1,HSP inhibitor,HSP90AA1,,
puerarin,HKEAFJYKMMKDOR-VPRICQMDSA-N,Phase 2,serotonin receptor antagonist,,,
pumosetrag,AFUWQWYPPZFWCO-LBPRGKRZSA-N,Phase 2,serotonin receptor agonist,HTR3A|HTR4,,
purmorphamine,FYBHCRQFSFYWPY-UHFFFAOYSA-N,Preclinical,smoothened receptor agonist,SMO,,
puromycin,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,Preclinical,protein synthesis inhibitor,NHP2L1|RPL10L|RPL11|RPL13A|RPL15|RPL19|RPL23|RPL23A|RPL26L1|RPL3|RPL37|RPL8|RSL24D1,,
purvalanol-A,PMXCMJLOPOFPBT-HNNXBMFYSA-N,Preclinical,CDK inhibitor,CDK1|CDK2|CDK4|CDK5|CSNK1G3|RPS6KA1|SRC,,
purvalanol-B,ZKDXRFMOHZVXSG-HNNXBMFYSA-N,Preclinical,tyrosine kinase inhibitor,CDK2|CDK4|CDK5|MAPK1|MAPK3|SRPK2,,
putrescine,KIDHWZJUCRJVML-UHFFFAOYSA-N,Phase 2,tissue transglutaminase inhibitor,AMD1|KCNJ4|ODC1,,
PX-12,BPBPYQWMFCTCNG-ZCFIWIBFSA-N,Phase 2,thioredoxin inhibitor,CNR1|TXN,,
PX-478,GSKQMLGAUOTSKT-LBPRGKRZSA-N,Phase 1,hypoxia inducible factor inhibitor,,,
PYM50028,GMBQZIIUCVWOCD-WWASVFFGSA-N,Phase 2,neurotrophic agent,,,
PYR-41,ARGIPZKQJGFSGQ-LCYFTJDESA-N,Preclinical,ubiquitin activating enzyme inhibitor,,,
pyrantel,WLJNZVDCPSBLRP-UHFFFAOYSA-N,Launched,acetylcholine receptor agonist|nicotinic receptor agonist,,infectious disease,gastrointestinal roundworms
pyrantel-pamoate,YSAUAVHXTIETRK-AATRIKPKSA-N,Launched,neuromuscular blocker,,infectious disease,hookworm|tapeworm
pyrazinamide,IPEHBUMCGVEMRF-UHFFFAOYSA-N,Launched,fatty acid synthase inhibitor,FASN,infectious disease,tuberculosis
pyrazinoylguanidine,WNBSDCKJFDZMHT-UHFFFAOYSA-N,Phase 1,diuretic,,,
pyrazolanthrone,ACPOUJIDANTYHO-UHFFFAOYSA-N,Preclinical,JNK inhibitor,MAPK10|MAPK8|MAPK8IP1|MAPK9|TTK,,
pyrazoloacridine,HVRZAFDJOWIDMM-UHFFFAOYSA-N,Phase 2,topoisomerase inhibitor,TOP1|TOP2A,,
pyrethrins,ROVGZAWFACYCSP-VUMXUWRFSA-N,Launched,,,infectious disease,flea control
pyridoxal,RADKZDMFGJYCBB-UHFFFAOYSA-N,Launched,,PDXK,neurology/psychiatry,epilepsy
pyridoxal-isonicotinoyl-hydrazone,BQYIXOPJPLGCRZ-REZTVBANSA-N,Phase 2,apoptosis stimulant,,,
pyridoxamine,NHZMQXZHNVQTQA-UHFFFAOYSA-N,Phase 3,AGE inhibitor,,,
pyridoxine,LXNHXLLTXMVWPM-UHFFFAOYSA-N,Launched,vitamin B,DDC|PDXK,metabolism,vitamin B6 deficiency
pyrimethamine,WKSAUQYGYAYLPV-UHFFFAOYSA-N,Launched,dihydrofolate reductase inhibitor,DHFR|SLC47A1,infectious disease,malaria
pyrintegrin,QRJTZIJWDLJKQO-UHFFFAOYSA-N,Preclinical,integrin signaling activator,,,
pyrithione-zinc,KTIHEFSORPLWRR-UHFFFAOYSA-L,Launched,ATP synthase inhibitor,KCNQ1|KCNQ2|KCNQ4|KCNQ5,dermatology,dandruff|cosmetic
pyrithyldione,NZASCBIBXNPDMH-UHFFFAOYSA-N,Withdrawn,psychoactive drug,,,
pyritinol,SIXLXDIJGIWWFU-UHFFFAOYSA-N,Launched,,,rheumatology|neurology/psychiatry,rheumatoid arthritis|senile dementia
pyronaridine,DJUFPMUQJKWIJB-UHFFFAOYSA-N,Phase 3,antimalarial agent,,,
pyrotinib,SADXACCFNXBCFY-IYNHSRRRSA-N,Phase 3,kinase inhibitor,,,
pyroxamide,PTJGLFIIZFVFJV-UHFFFAOYSA-N,Phase 1,HDAC inhibitor,HDAC1,,
pyrrolidine-dithiocarbamate,VSWDORGPIHIGNW-UHFFFAOYSA-N,Preclinical,NFkB pathway inhibitor,HSD11B1|RELA,,
pyrvinium-pamoate,QMHSXPLYMTVAMK-UHFFFAOYSA-N,Launched,androgen receptor antagonist,AR,infectious disease,pinworm
PZ-2891,LGWDVWIZDPGCFG-UHFFFAOYSA-N,Preclinical,pantothenate kinase activator,,,
Q-203,OJICYBSWSZGRFB-UHFFFAOYSA-N,Phase 2,ATP synthase inhibitor,,,
quazinone,BHZFZYLBVSWUMT-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,PDE3A|PDE3B,,
quercetin,REFJWTPEDVJJIY-UHFFFAOYSA-N,Launched,polar auxin transport inhibitor,ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1,neurology/psychiatry|allergy,fatigue|allergic rhinitis|drowsiness
quetiapine,URKOMYMAXPYINW-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2,neurology/psychiatry,schizophrenia|bipolar disorder
quiflapon,NZOONKHCNQFYCI-UHFFFAOYSA-N,Phase 2,leukotriene synthesis inhibitor,ALOX5|ALOX5AP,,
quinagolide,GDFGTRDCCWFXTG-ZIFCJYIRSA-N,Launched,dopamine receptor agonist,DRD2,endocrinology,hyperprolactinemia
quinapril,JSDRRTOADPPCHY-HSQYWUDLSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|congestive heart failure|angioedema
quinaprilat,FLSLEGPOVLMJMN-YSSFQJQWSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|angioedema
quinelorane,TUFADSGTJUOBEH-ZWNOBZJWSA-N,Phase 3,dopamine receptor agonist,DRD2|DRD3,,
quinestrol,PWZUUYSISTUNDW-VAFBSOEGSA-N,Launched,estrogen receptor agonist,ESR1|ESR2,endocrinology,menopause
quinethazone,AGMMTXLNIQSRCG-SECBINFHSA-N,Launched,thiazide diuretic,,cardiology,hypertension
quinidine,LOUPRKONTZGTKE-LHHVKLHASA-N,Launched,sodium channel blocker,KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4,infectious disease|cardiology,malaria|atrial fibrillation (AF)|ventricular arrhythmias
quinine,LOUPRKONTZGTKE-WZBLMQSHSA-N,Launched,hemozoin biocrystallization inhibitor,GP9|KCNB2|KCNN4|SLC29A4,infectious disease,malaria
quinine-ethyl-carbonate,NSBRKSWSLRQPJW-FRMGNDQPSA-N,Launched,,,infectious disease,malaria
quinolinic-acid,GJAWHXHKYYXBSV-UHFFFAOYSA-N,Preclinical,glutamate receptor agonist,,,
quinpirol-(-),FTSUPYGMFAPCFZ-ZWNOBZJWSA-N,Phase 2,dopamine receptor agonist,DRD1|DRD2|DRD3|DRD4|HTR1A|HTR2A|HTR2B|HTR2C,,
quipazine,XRXDAJYKGWNHTQ-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|SLC6A4,,
quizartinib,CVWXJKQAOSCOAB-UHFFFAOYSA-N,Phase 3,FLT3 inhibitor,CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET,,
QX-222,QYUXPWDVDMSTKR-UHFFFAOYSA-O,Preclinical,sodium channel blocker,,,
QX-314,PYEBKOFMWAMBFV-UHFFFAOYSA-O,Preclinical,sodium channel blocker,MAPK14|TGFBR1,,
R-121919,ANNRUWYFVIGKHA-UHFFFAOYSA-N,Preclinical,CRF receptor antagonist,,,
R-1479,ODLGMSQBFONGNG-JVZYCSMKSA-N,Phase 1,HCV inhibitor,,,
R-1485,UPROBLPRPWYJGN-UHFFFAOYSA-N,Phase 1,serotonin receptor antagonist,HTR6,,
R-1487,KKKRKRMVJRHDMG-UHFFFAOYSA-N,Phase 1,p38 MAPK inhibitor,,,
R-268712,JQGOCCALXFSRHZ-UHFFFAOYSA-N,Preclinical,serine/threonine kinase inhibitor,TGFBR1,,
R-428,KXMZDGSRSGHMMK-VWLOTQADSA-N,Phase 2,AXL kinase inhibitor,AXL,,
R-59022,MFVJXLPANKSLLD-UHFFFAOYSA-N,Preclinical,diacylglycerol kinase inhibitor|protein kinase inhibitor,DGKA,,
R-96544,AFZLABYDOCWQBQ-WOJBJXKFSA-N,Preclinical,serotonin receptor antagonist,HTR2A,,
R112,TVKGTSHBQZEFEE-UHFFFAOYSA-N,Phase 1,SYK inhibitor,SYK,,
R306465,MUTBJZVSRNUIHA-UHFFFAOYSA-N,Phase 1,HDAC inhibitor,,,
R406,NHHQJBCNYHBUSI-UHFFFAOYSA-N,Phase 1,SYK inhibitor,RET|SYK,,
R547,JRNJNYBQQYBCLE-UHFFFAOYSA-N,Phase 1,CDK inhibitor,CDK1|CDK2|CDK4|CDK7,,
rabeprazole,YREYEVIYCVEVJK-RUZDIDTESA-N,Launched,ATPase inhibitor|gastrin inhibitor,ATP4A,gastroenterology,gastroesophageal reflux disease (GERD)|duodenal ulcer disease|Zollinger-Ellison syndrome
rac-BHFF,RVNOANDLZIIFHB-MRXNPFEDSA-N,Preclinical,GABA receptor positive allosteric modulator,GABBR1,,
racecadotril,ODUOJXZPIYUATO-LJQANCHMSA-N,Launched,enkephalinase inhibitor,MME,gastroenterology,diarrhea
raclopride,WAOQONBSWFLFPE-VIFPVBQESA-N,Launched,dopamine receptor antagonist,DRD2|DRD3|HTR1A,,
ractopamine,YJQZYXCXBBCEAQ-SCLBCKFNSA-N,Launched,adrenergic receptor agonist,,endocrinology,weight-gain aid
RAD140,XMBUPPIEVAFYHO-KPZWWZAWSA-N,Phase 1,androgen receptor modulator,,,
radafaxine,RCOBKSKAZMVBHT-TVQRCGJNSA-N,Phase 2,dopamine-norepinephrine reuptake inhibitor,SLC6A3,,
radezolid,BTTNOGHPGJANSW-IBGZPJMESA-N,Phase 2,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,,,
radiprodil,GKGRZLGAQZPEHO-UHFFFAOYSA-N,Phase 2,acetylcholine receptor antagonist,,,
radotinib,DUPWHXBITIZIKZ-UHFFFAOYSA-N,Phase 3,Bcr-Abl kinase inhibitor,,,
RAF265,YABJJWZLRMPFSI-UHFFFAOYSA-N,Phase 2,RAF inhibitor|VEGFR inhibitor,BRAF,,
RAF709,FYNMINFUAIDIFL-UHFFFAOYSA-N,Preclinical,RAF inhibitor,,,
ralinepag,NPDKXVKJRHPDQT-IYARVYRRSA-N,Phase 3,IP1 prostacyclin receptor agonist,,,
raloxifene,GZUITABIAKMVPG-UHFFFAOYSA-N,Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1|ESR2,orthopedics|oncology,osteoporosis|breast cancer
raltegravir,CZFFBEXEKNGXKS-UHFFFAOYSA-N,Launched,HIV integrase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
raltitrexed,IVTVGDXNLFLDRM-HNNXBMFYSA-N,Launched,thymidylate synthase inhibitor,FPGS|TYMS,oncology,mesothelioma
ramatroban,LDXDSHIEDAPSSA-OAHLLOKOSA-N,Launched,prostanoid receptor antagonist,PTGDR2|TBXA2R,cardiology|pulmonary,coronary artery disease (CAD)|asthma
ramelteon,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,Launched,melatonin receptor agonist,MTNR1A|MTNR1B,neurology/psychiatry,insomnia
ramifenazone,XOZLRRYPUKAKMU-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,,neurology/psychiatry|endocrinology,pain relief|fever
ramipril,HDACQVRGBOVJII-JBDAPHQKSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension
ramosetron,NTHPAPBPFQJABD-LLVKDONJSA-N,Launched,serotonin receptor antagonist,HTR3A,gastroenterology,nausea|vomiting|irritable bowel syndrome
ranirestat,QCVNMNYRNIMDKV-QGZVFWFLSA-N,Phase 3,aldose reductase inhibitor,AKR1B1,,
ranitidine,SYNOVMDJYWJCON-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH2,gastroenterology,heartburn
ranolazine,XKLMZUWKNUAPSZ-FQEVSTJZSA-N,Launched,sodium channel blocker,SCN10A|SCN9A,cardiology,chronic stable angina
rapastinel,GIBQQARAXHVEGD-BSOLPCOYSA-N,Phase 2,glutamate receptor agonist,,,
rasagiline,RUOKEQAAGRXIBM-GFCCVEGCSA-N,Launched,monoamine oxidase inhibitor,BCL2|MAOB,neurology/psychiatry,Parkinson's Disease
rauwolscine,BLGXFZZNTVWLAY-DIRVCLHFSA-N,Preclinical,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR1E|HTR2B,,
ravoxertinib,RZUOCXOYPYGSKL-GOSISDBHSA-N,Phase 1,ERK1 and ERK2 phosphorylation inhibitor,MAPK1|MAPK3,,
ravuconazole,OPAHEYNNJWPQPX-RCDICMHDSA-N,Phase 2,sterol demethylase inhibitor,,,
RBC8,RFEAEBNMNYRJFD-VGAJERRHSA-N,Preclinical,Ral GTPase inhibitor,RALA|RALB,,
rebamipide,ALLWOAVDORUJLA-MRXNPFEDSA-N,Launched,free radical scavenger,FPR1,gastroenterology,peptic ulcer disease (PUD)|gastritis
rebastinib,WVXNSAVVKYZVOE-UHFFFAOYSA-N,Phase 1/Phase 2,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BCR|FGR|FLT3|HCK|LYN|SRC,,
reboxetine,CBQGYUDMJHNJBX-RTBURBONSA-N,Launched,adrenergic receptor antagonist,SLC6A2,neurology/psychiatry,depression
Rec-15/2615,ZZMFJJDBKSYGRM-UHFFFAOYSA-N,Phase 2,adrenergic receptor antagonist,ADRA1A,,
refametinib,RDSACQWTXKSHJT-NSHDSACASA-N,Phase 2,MEK inhibitor,MAP2K1|MAP2K2,,
regadenoson,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,Launched,adenosine receptor agonist,ADORA1|ADORA2A|ADORA2B|ADORA3,radiology,myocardial perfusion imaging (MPI)
regorafenib,FNHKPVJBJVTLMP-UHFFFAOYSA-N,Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,oncology,colorectal cancer|gastrointestinal stromal tumors (GIST)
regorafenib,"InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)",Launched,FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK,oncology,colorectal cancer|gastrointestinal stromal tumors (GIST)
relcovaptan,CEBYCSRFKCEUSW-NAYZPBBASA-N,Phase 2,vasopressin receptor antagonist,AVPR1A|AVPR1B|AVPR2|OXTR,,
relebactam,SMOBCLHAZXOKDQ-ZJUUUORDSA-N,Launched,beta lactamase inhibitor,,,
relugolix,AOMXMOCNKJTRQP-UHFFFAOYSA-N,Phase 3,gonadotropin releasing factor hormone receptor antagonist,,,
remacemide,YSGASDXSLKIKOD-KRWDZBQOSA-N,Phase 3,glutamate receptor antagonist,GRIN1,,
remetinostat,XDZAHHULFQIBFE-UHFFFAOYSA-N,Phase 2,HDAC inhibitor,,,
remimazolam,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,Phase 3,benzodiazepine receptor agonist,GABBR1,,
remodelin,XAEJIFARBQJLML-UHFFFAOYSA-N,Preclinical,transferase inhibitor,NAT10,,
remoxipride,GUJRSXAPGDDABA-NSHDSACASA-N,Withdrawn,dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR2A|SIGMAR1,,
repaglinide,FAEKWTJYAYMJKF-QHCPKHFHSA-N,Launched,insulin secretagogue,ABCC8|KCNJ11|PPARG,endocrinology,diabetes mellitus
reparixin,KQDRVXQXKZXMHP-LLVKDONJSA-N,Phase 3,CC chemokine receptor antagonist,CXCR1|CXCR2,,
repotrectinib,FIKPXCOQUIZNHB-VUWPPUDQSA-N,Phase 1/Phase 2,receptor tyrosine protein kinase inhibitor,,,
repsox,LBPKYPYHDKKRFS-UHFFFAOYSA-N,Preclinical,TGF beta receptor inhibitor,TGFBR1,,
resatorvid,LEEIJTHMHDMWLJ-CQSZACIVSA-N,Phase 3,toll-like receptor inhibitor,TLR4,,
reserpine,QEVHRUUCFGRFIF-MDEJGZGSSA-N,Launched,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,cardiology,hypertension
resibufogenin,ATLJNLYIJOCWJE-CWMZOUAVSA-N,Phase 2,Na/K-ATPase inhibitor,,,
resiquimod,BXNMTOQRYBFHNZ-UHFFFAOYSA-N,Phase 3,toll-like receptor agonist,TLR7|TLR8,,
resmetirom,FDBYIYFVSAHJLY-UHFFFAOYSA-N,Phase 3,thyroid hormone receptor agonist,,,
resminostat,FECGNJPYVFEKOD-VMPITWQZSA-N,Phase 2,HDAC inhibitor,HDAC1|HDAC3|HDAC6|HDAC8,,
resorcinol,GHMLBKRAJCXXBS-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,CA12|CA14|CA2|PTGS1,dermatology,acne vulgaris (AV)|eczema|psoriasis|seborrheic dermatitis
resorcinol-monoacetate,ZZPKZRHERLGEKA-UHFFFAOYSA-N,Launched,antiseptic,,,
resveratrol,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,Launched,cytochrome P450 inhibitor|SIRT activator,CSNK2A1|NQO2|PTGS1|PTGS2,,
retagliptin,WIIAMRXFUJLYEF-SNVBAGLBSA-N,Phase 1,dipeptidyl peptidase inhibitor,,,
retapamulin,STZYTFJPGGDRJD-NHUWBDDWSA-N,Launched,protein synthesis inhibitor,,infectious disease,impetigo
retaspimycin,OAKGNIRUXAZDQF-FBDSWQSESA-N,Phase 3,HSP inhibitor,HSP90AA1,,
retinaldehyde,NCYCYZXNIZJOKI-OVSJKPMPSA-N,Launched,,,dermatology,cosmetic
retinol,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,Launched,retinoid receptor ligand,ALDH1A1|ALDH1A2|ALDH1A3|DHRS3|DHRS4|LRAT|NR2C2|RBP1|RBP3|RDH11|RDH12|RDH13|RDH14|RDH5|RDH8|RETSAT|RHO|RLBP1|RXRA|RXRB|RXRG,dermatology,cosmetic|acne vulgaris (AV)|keratosis
retinyl-acetate,QGNJRVVDBSJHIZ-QHLGVNSISA-N,Launched,,,,
retinyl-palmitate,VYGQUTWHTHXGQB-FFHKNEKCSA-N,Launched,,,,
REV-5901,JRLOEMCOOZSCQP-JOCHJYFZSA-N,Phase 2,leukotriene receptor antagonist|lipoxygenase inhibitor,ALOX5,,
revaprazan,LECZXZOBEZITCL-MRXNPFEDSA-N,Launched,potassium-competitive acid antagonist,ATP4A,gastroenterology,gastritis
revefenacin,FYDWDCIFZSGNBU-UHFFFAOYSA-N,Launched,cholinergic receptor antagonist,,,
reversan,JTRXWCLQFAZHGP-UHFFFAOYSA-N,Preclinical,MRP inhibitor,ABCC1,,
reversine,ZFLJHSQHILSNCM-UHFFFAOYSA-N,Preclinical,Aurora kinase inhibitor,AURKB|INCENP|MAP2K1,,
reynoutrin,PZZRDJXEMZMZFD-BWYUNELBSA-N,Preclinical,antioxidant,,,
RG108,HPTXLHAHLXOAKV-INIZCTEOSA-N,Preclinical,DNA methyltransferase inhibitor,DNMT1|DNMT3B,,
RG1530,XXAKBYBCWYYQTL-UHFFFAOYSA-N,Phase 1,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,FGFR1|FGFR2,,
RG2833,VOPDXHFYDJAYNS-UHFFFAOYSA-N,Phase 1,HDAC inhibitor,HDAC1|HDAC3,,
RG4733,OJPLJFIFUQPSJR-INIZCTEOSA-N,Phase 2,gamma secretase inhibitor,PSEN1,,
RG7112,QBGKPEROWUKSBK-QPPIDDCLSA-N,Phase 1,MDM inhibitor,MDM2,,
RG7800,GYFRQCMDLBNZSF-UHFFFAOYSA-N,Preclinical,RNA splicing modifier,,,
RG7834,KBXLMOYQNDMHQT-KRWDZBQOSA-N,Preclinical,antiviral,,,
RGB-286638,XLSYZSRXVVCHLS-UHFFFAOYSA-N,Phase 1,CDK inhibitor,CDK1|CDK2|CDK3|CDK4|CDK5|CDK6|CDK7|CDK9|FLT3|GSK3B|JAK2|MAP3K7|MAPK9,,
RGFP966,BLVQHYHDYFTPDV-VCABWLAWSA-N,Preclinical,HDAC inhibitor,HDAC3,,
RGX-104,ZLJZDYOBXVOTSA-XMMPIXPASA-N,Phase 1,LXR agonist,,,
RHC-80267,RXSVYGIGWRDVQC-UHFFFAOYSA-N,Preclinical,triacylglycerol lipase inhibitor,DAGLA|DAGLB,,
rhein,FCDLCPWAQCPTKC-UHFFFAOYSA-N,Phase 1,,HSP90AA1,,
rheochrysidin,FFWOKTFYGVYKIR-UHFFFAOYSA-N,Preclinical,protein tyrosine kinase inhibitor,PTPN1,,
rhodamine-123,ZWODABSNRKVFCK-UHFFFAOYSA-N,Phase 1,,,,
RI-1,MWSUIZKGNWELRF-UHFFFAOYSA-N,Preclinical,,RAD51,,
ribavirin,IWUCXVSUMQZMFG-AFCXAGJDSA-N,Launched,antiviral,ADK|ENPP1|IMPDH1|IMPDH2|NT5C2,infectious disease,hepatitis C
ribitol,HEBKCHPVOIAQTA-ZXFHETKHSA-N,Preclinical,,,,
ribociclib,RHXHGRAEPCAFML-UHFFFAOYSA-N,Launched,CDK inhibitor,CDK4|CDK6,oncology,breast cancer
riboflavin,AUNGANRZJHBGPY-SCRDCRAPSA-N,Launched,vitamin B,BLVRB|RFK,gastroenterology,jaundice
riboflavin-5-phosphate-sodium,FVTCRASFADXXNN-SCRDCRAPSA-N,Launched,,BLVRB|DHODH|DPYD|HAO1|HAO2|MT-ND1|NOS1|PNPO|POR|PPCDC|RFK|RPS6KA4|SGK1,,
riboflavin-tetrabutyrate,MJNIWUJSIGSWKK-BBANNHEPSA-N,Preclinical,antioxidant,,,
ribostamycin,NSKGQURZWSPSBC-VVPCINPTSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,P4HB,infectious disease,human immunodeficiency virus (HIV-1)
ribostamycin-sulfate,NSKGQURZWSPSBC-NZJHKTKDSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections
ricinoleic-acid,WBHHMMIMDMUBKC-QJWNTBNXSA-N,Launched,prostanoid receptor agonist,PTGER3,,
ridinilazole,UHQFBTAJFNVZIV-UHFFFAOYSA-N,Phase 3,antibacterial,,,
rifabutin,ATEBXHFBFRCZMA-DVAZEERGSA-N,Launched,protein synthesis inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
rifampin,JQXXHWHPUNPDRT-YOPQJBRCSA-N,Launched,RNA polymerase inhibitor,NR1I2|SLCO1A2|SLCO1B1|SLCO1B3,infectious disease,tuberculosis|meningitis
rifamycin,HJYYPODYNSCCOU-WURVRSKISA-N,Launched,DNA directed RNA polymerase inhibitor,SLCO1A2|SLCO1B1|SLCO1B3|SLCO2B1,infectious disease,tuberculosis|leprosy
rifamycin-sv,HJYYPODYNSCCOU-WURVRSKISA-N,Phase 3,RNA synthesis inhibitor,,,
rifapentine,WDZCUPBHRAEYDL-NAFQJNKLSA-N,Launched,RNA polymerase inhibitor,CYP2C8|CYP2C9|CYP3A4,infectious disease,tuberculosis
rifaximin,NZCRJKRKKOLAOJ-LGPAXTBISA-N,Launched,RNA synthesis inhibitor,,gastroenterology,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE)
rigosertib,OWBFCJROIKNMGD-BQYQJAHWSA-N,Phase 3,cell cycle inhibitor|PLK inhibitor,PLK1,,
rilapladib,NNBGCSGCRSCFEA-UHFFFAOYSA-N,Phase 2,phospholipase inhibitor,,,
rilmenidine,CQXADFVORZEARL-UHFFFAOYSA-N,Launched,adrenergic receptor agonist|imidazoline receptor agonist,ADRA2A,cardiology,hypertension
rilpivirine,YIBOMRUWOWDFLG-ONEGZZNKSA-N,Launched,non-nucleoside reverse transcriptase inhibitor,NR1I2|SCN10A,infectious disease,human immunodeficiency virus (HIV-1)
riluzole,FTALBRSUTCGOEG-UHFFFAOYSA-N,Launched,glutamate inhibitor,KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11,neurology/psychiatry,amyotrophic lateral sclerosis (ALS)
rimantadine,UBCHPRBFMUDMNC-AAWJQDODSA-N,Launched,antiviral|RNA synthesis inhibitor,,infectious disease,influenza A virus infection
rimcazole,GUDVQJXODNJRIJ-CALCHBBNSA-N,Phase 1,sigma receptor antagonist,SIGMAR1,,
rimegepant,KRNAOFGYEFKHPB-ANJVHQHFSA-N,Launched,calcitonin antagonist,CALCA,,
rimeporide,GROMEQPXDKRRIE-UHFFFAOYSA-N,Phase 1,sodium/hydrogen exchanger inhibitor,,,
rimexolone,QTTRZHGPGKRAFB-OOKHYKNYSA-N,Launched,glucocorticoid receptor agonist,NR3C1|SERPINA6,ophthalmology,anterior uveitis
rimonabant,JZCPYUJPEARBJL-UHFFFAOYSA-N,Withdrawn,cannabinoid receptor antagonist,CNR1|GPR55,,
riociguat,WXXSNCNJFUAIDG-UHFFFAOYSA-N,Launched,guanylate cyclase stimulant,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,cardiology,hypertension
riodipine,AZVFIZVKGSPGPK-UHFFFAOYSA-N,Phase 2,calcium channel blocker,,,
riodoxol,XKFZYVWWXHCHIX-UHFFFAOYSA-N,Launched,other antibiotic,,,
ripasudil,QSKQVZWVLOIIEV-NSHDSACASA-N,Launched,rho associated kinase inhibitor,ROCK1|ROCK2,ophthalmology,glaucoma|ocular hypertension
ripazepam,YFHYNLHGFKXAIQ-UHFFFAOYSA-N,Phase 2,benzodiazepine receptor agonist,GABRA1,,
ripretinib,CEFJVGZHQAGLHS-UHFFFAOYSA-N,Phase 3,receptor tyrosine protein kinase inhibitor,,,
risdiplam,ASKZRYGFUPSJPN-UHFFFAOYSA-N,Phase 2/Phase 3,RNA splicing inhibitor,,,
risedronate,IIDJRNMFWXDHID-UHFFFAOYSA-N,Launched,osteoclast inhibitor,FDPS,orthopedics|endocrinology,osteoporosis|Paget's disease
rislenemdaz,RECBFDWSXWAXHY-IAGOWNOFSA-N,Preclinical,ionotropic glutamate receptor antagonist,,,
risperidone,RAPZEAPATHNIPO-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7,neurology/psychiatry,schizophrenia|bipolar disorder|irritability
RITA,KZENBFUSKMWCJF-UHFFFAOYSA-N,Preclinical,MDM inhibitor,MDM2,,
ritanserin,JUQLTPCYUFPYKE-UHFFFAOYSA-N,Phase 3,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7,,
ritodrine,IOVGROKTTNBUGK-SJKOYZFVSA-N,Withdrawn,adrenergic receptor agonist,,obstetrics/gynecology,premature labor
ritonavir,NCDNCNXCDXHOMX-XGKFQTDJSA-N,Launched,HIV protease inhibitor,CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7,infectious disease,human immunodeficiency virus (HIV-1)
rivanicline,JUOSGGQXEBBCJB-GORDUTHDSA-N,Phase 2,acetylcholine receptor agonist,CHRNA4|CHRNB2|CXCL8,,
rivaroxaban,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,Launched,coagulation factor inhibitor,F10,neurology/psychiatry|hematology|cardiology,stroke|systemic embolism|atrial fibrillation (AF)|deep vein thrombosis (DVT)|pulmonary embolism (PE)
rivastigmine,XSVMFMHYUFZWBK-NSHDSACASA-N,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,neurology/psychiatry,Alzheimer's disease|Parkinson's Disease|senile dementia
rizatriptan,ULFRLSNUDGIQQP-UHFFFAOYSA-N,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,neurology/psychiatry,migraine headache
RKI-1447,GDVRVPIXWXOKQO-UHFFFAOYSA-N,Preclinical,rho associated kinase inhibitor,CDC42BPA|DMPK|LIMK1|MYLK|PAK1|PKN1|ROCK1|ROCK2,,
RLX,HTLIIBRHXAULMB-UHFFFAOYSA-N,Preclinical,,,,
RMC-4550,IKUYEYLZXGGCRD-ORAYPTAESA-N,Preclinical,SHIP2 phosphatase inhibitor,,,
RN-1,YAMSXCOVJUUMCT-FCHUYYIVSA-N,Preclinical,histone demethylase inhibitor,KDM1A,,
RN-1734,IHYZMEAZAIFMTN-UHFFFAOYSA-N,Preclinical,TRPV antagonist,TRPV4,,
RN-1747,ZNLVYSJQUMALEO-UHFFFAOYSA-N,Preclinical,TRPV agonist,TRPV4,,
Ro-04-5595,DSTWURHEHMZWEI-KRWDZBQOSA-N,Preclinical,glutamate receptor antagonist,GRIN2B,,
Ro-08-2750,JDEMVNYMYPJJIM-UHFFFAOYSA-N,Preclinical,NGF binding inhibitor,NGF|NGFR,,
Ro-10-5824,KABDATZAOUSYES-UHFFFAOYSA-N,Preclinical,dopamine receptor agonist,DRD4,,
Ro-106-9920,JFSXSNSCPNFCDM-KRWDZBQOSA-N,Preclinical,NFkB pathway inhibitor,,,
Ro-1138452,GYYRMJMXXLJZAB-UHFFFAOYSA-N,Preclinical,prostanoid receptor antagonist,PTGIR,,
Ro-15-4513,CFSOJZTUTOQNIA-UHFFFAOYSA-N,Preclinical,GABA benzodiazepine site receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB2|GABRG2,,
Ro-19-4605,ZIGMMUKDYCABPW-UHFFFAOYSA-N,Preclinical,GABA benzodiazepine site receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5,,
Ro-20-1724,PDMUULPVBYQBBK-LBPRGKRZSA-N,Preclinical,phosphodiesterase inhibitor,PDE3A|PDE4A|PDE4B|PDE4C|PDE4D,,
Ro-25-6981,WVZSEUPGUDIELE-HTAPYJJXSA-N,Preclinical,glutamate receptor antagonist|monamine transporter modulator,GRIN2B,,
Ro-28-1675,NEQSWPCDHDQINX-MRXNPFEDSA-N,Preclinical,glucokinase activator,GCK,,
Ro-3,PYNPWUIBJMVRIG-UHFFFAOYSA-N,Preclinical,purinergic receptor antagonist,P2RX3,,
Ro-3306,XOLMRFUGOINFDQ-YBEGLDIGSA-N,Preclinical,CDK inhibitor,CDK1,,
Ro-48-6791,NOQIYRGMEFBZTI-UHFFFAOYSA-N,Preclinical,GABA receptor modulator,,,
Ro-48-8071,CMYCCJYVZIMDFU-UHFFFAOYSA-N,Preclinical,oxidosqualene cyclase inhibitor,LSS,,
Ro-4987655,FIMYFEGKMOCQKT-UHFFFAOYSA-N,Phase 1,MEK inhibitor,MAP2K1,,
Ro-5028442,QZXVLRCMAHJVIP-UHFFFAOYSA-N,Phase 1,vasopressin receptor antagonist,,,
Ro-5126766,LMMJFBMMJUMSJS-UHFFFAOYSA-N,Phase 1,MEK inhibitor|RAF inhibitor,BRAF|MAP2K1|MAP2K2|RAF1,,
Ro-5263397,IOHOUWIYOVWGHV-SECBINFHSA-N,Preclinical,trace amine associated receptor agonist,,,
Ro-60-0175,XJJZQXUGLLXTHO-ZETCQYMHSA-N,Preclinical,serotonin receptor agonist,HTR2A|HTR2B|HTR2C,,
Ro-61-8048,NDPBMCKQJOZAQX-UHFFFAOYSA-N,Preclinical,kynurenine 3-monooxygenase inhibitor,KMO,,
Ro-67-7476,DAEHFYNGSSBGSS-KRWDZBQOSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM1,,
Ro-90-7501,PAGZCEHLFCJSPV-UHFFFAOYSA-N,Preclinical,beta amyloid protein neurotoxicity inhibitor,APP,,
Ro-9187,ODLGMSQBFONGNG-XZMZPDFPSA-N,Preclinical,HCV inhibitor,,,
robalzotan,MQTUXRKNJYPMCG-CYBMUJFWSA-N,Phase 2,serotonin receptor antagonist,HTR1A,,
roblitinib,BHKDKKZMPODMIQ-UHFFFAOYSA-N,Preclinical,FGFR inhibitor,,,
rociletinib,HUFOZJXAKZVRNJ-UHFFFAOYSA-N,Phase 3,EGFR inhibitor,EGFR,,
rociletinib,"InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35)",Phase 3,EGFR inhibitor,EGFR,,
rocuronium,YXRDKMPIGHSVRX-OOJCLDBCSA-N,Launched,acetylcholine receptor antagonist,CHRM2|CHRNA2|HTR3A,neurology/psychiatry,anesthetic
rofecoxib,RZJQGNCSTQAWON-UHFFFAOYSA-N,Withdrawn,cyclooxygenase inhibitor,ELN|PTGS2,,
roflumilast,MNDBXUUTURYVHR-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE4A|PDE4B|PDE4C|PDE4D,pulmonary,chronic obstructive pulmonary disease (COPD)|bronchitis
rogaratinib,HNLRRJSKGXOYNO-UHFFFAOYSA-N,Phase 2/Phase 3,FGFR inhibitor,,,
rolapitant,FIVSJYGQAIEMOC-ZGNKEGEESA-N,Phase 3,neurokinin receptor antagonist,,,
rolipram,HJORMJIFDVBMOB-GFCCVEGCSA-N,Phase 3,phosphodiesterase inhibitor,,,
rolitetracycline,YEHCEZXUSLIKDU-IAHYZSEUSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
roluperidone,RNRYULFRLCBRQS-UHFFFAOYSA-N,Phase 2,,,,
rolziracetam,IEZDOKQWPWZVQF-UHFFFAOYSA-N,Phase 2,,,,
romidepsin,OHRURASPPZQGQM-WDCUYUQDSA-N,Launched,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,cutaneous T-cell lymphoma (CTCL)
romidepsin,"InChI=1S/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17-,19-,20?/m1/s1",Launched,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,hematologic malignancy,cutaneous T-cell lymphoma (CTCL)
ronidazole,PQFRTXSWDXZRRS-UHFFFAOYSA-N,Launched,antiprotozoal agent,,infectious disease,histomoniasis|dysentry
ropinirole,UHSKFQJFRQCDBE-UHFFFAOYSA-N,Launched,dopamine receptor agonist,ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,neurology/psychiatry,Parkinson's Disease|restless leg syndrome
ropivacaine,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,Launched,sodium channel blocker,SCN10A,neurology/psychiatry,anesthetic
roquinimex,SGOOQMRIPALTEL-UHFFFAOYSA-N,Phase 3,angiogenesis inhibitor|tumor necrosis factor production inhibitor,,,
rosamicin,IUPCWCLVECYZRV-WMNDRESDSA-N,Phase 2,protein synthesis inhibitor,,,
roscovitine,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,Phase 2,CDK inhibitor,CDK2|CDK9,,
rose-bengal,VDNLFJGJEQUWRB-UHFFFAOYSA-N,Launched,contrast agent|immunostimulant,,radiology,diagnostic agent
rose-bengal-lactone,IICCLYANAQEHCI-UHFFFAOYSA-N,Launched,coloring agent,,ophthalmology,staining agent
rosiglitazone,YASAKCUCGLMORW-OAHLLOKOSA-N,Withdrawn,insulin sensitizer|PPAR receptor agonist,FFAR1|PPARG|TRPC5|TRPM3,,
rosiptor,MDEJTPWQNNMAQF-BVMLLJBZSA-N,Phase 2,SHIP1 phosphatase activator,,,
rosmarinic-acid,DOUMFZQKYFQNTF-WUTVXBCWSA-N,Launched,GABA transaminase inhibitor,MCL1|TYR,,
rosoxacin,XBPZXDSZHPDXQU-UHFFFAOYSA-N,Launched,topoisomerase inhibitor,,infectious disease,urinary tract infections
rostafuroxine,AEAPORIZZWBIEX-DTBDINHYSA-N,Phase 2,ATPase inhibitor,ATP1A1,,
rosuvastatin,BPRHUIZQVSMCRT-VEUZHWNKSA-N,Launched,HMGCR inhibitor,HMGCR,endocrinology|cardiology,hyperlipidemia|dyslipidemia|hypertriglyceridemia|hypercholesterolemia|atherosclerosis
rotigotine,KFQYTPMOWPVWEJ-INIZCTEOSA-N,Launched,dopamine receptor agonist,ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A,neurology/psychiatry,Parkinson's Disease|restless leg syndrome
rotundine,AEQDJSLRWYMAQI-KRWDZBQOSA-N,Launched,serotonin receptor agonist,DRD1|DRD2|DRD3|HTR1A,neurology/psychiatry,anxiety|sedative
rovazolac,ZUMNJDGBYXHASJ-UHFFFAOYSA-N,Preclinical,LXR agonist,,,
roxarsone,XMVJITFPVVRMHC-UHFFFAOYSA-N,Launched,antiprotozoal agent,,endocrinology,weight-gain aid
roxatidine-acetate,SMTZFNFIKUPEJC-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH2,gastroenterology,Zollinger-Ellison syndrome|erosive esophagitis (EE)|gastroesophageal reflux disease (GERD)|gastritis
roxithromycin,RXZBMPWDPOLZGW-SWCVOMKCSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,MLNR,infectious disease,respiratory tract infections|urinary tract infections|skin infections
RP-001,WNDDDFYFTSGSEC-HXUWFJFHSA-N,Preclinical,sphingosine 1-phosphate receptor agonist,S1PR1,,
RP67580,VWBOQFANCXZMAU-LOSJGSFVSA-N,Preclinical,,,,
RQ-00203078,IJGQFZYYEHCCIZ-UHFFFAOYSA-N,Preclinical,transient receptor potential channel antagonist,TRPM8,,
RRx-001,JODKFOVZURLVTG-UHFFFAOYSA-N,Phase 3,glucose 6-phosphate dehydrogenase inhibitor,G6PD,,
RS-0481,MEXWLVVJOPSWLN-PBHICJAKSA-N,Phase 2,immunostimulant,,,
RS-100329,RCOBWVAGWYRNHZ-UHFFFAOYSA-N,Preclinical,adrenergic receptor antagonist,ADRA1A|ADRA1D,,
RS-102221,HZZZZODVDSHQRG-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,,
RS-102895,HIDWEYPGMLIQSN-UHFFFAOYSA-N,Preclinical,CCR antagonist,CCR2,,
RS-127445,ZZZQXCUPAJFVBN-UHFFFAOYSA-N,Phase 1,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,,
RS-16566,OGXMGJGFLBSEJW-HNNXBMFYSA-N,Preclinical,serotonin receptor antagonist,,,
RS-17053,XLZHXAXXJVKTFM-UHFFFAOYSA-N,Preclinical,adrenergic receptor antagonist,ADRA1A|ADRA1D,,
RS-23597-190,RLSGBCUXLRMTPF-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR4,,
RS-39604,BKVIWGRFRKLFIO-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR4,,
RS-45041-190,IVCMOOBKRRDNHX-UHFFFAOYSA-N,Preclinical,imidazoline receptor agonist,,,
RS-504393,ODNICNWASXKNNQ-UHFFFAOYSA-N,Preclinical,CC chemokine receptor antagonist,CCL2|CCR2,,
RS-56812,ZNAPADWWBWFMCQ-HNNXBMFYSA-N,Preclinical,serotonin receptor partial agonist,HTR3A,,
RS-67333,JBHLYIVFFLNISJ-UHFFFAOYSA-N,Preclinical,serotonin receptor partial agonist,HTR4,,
RS-67506,UATDVRSFFGFTAI-UHFFFAOYSA-N,Preclinical,serotonin receptor partial agonist,HTR4,,
RS-79948,UMGBFFAJXFXOIL-MNEFBYGVSA-N,Preclinical,adrenergic receptor antagonist,ADRA2A,,
RSV604,MTPVBMVUENFFLL-HXUWFJFHSA-N,Phase 2,RSV replication inhibitor,,,
RTA-408,RJCWBNBKOKFWNY-IDPLTSGASA-N,Phase 2,nitric oxide production inhibitor,NFE2L2,,
RU-24969,KRVMLPUDAOWOGN-UHFFFAOYSA-N,Phase 1,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR6,,
RU-28318,DNHCHRGCTVRAFT-JEHIOXJOSA-N,Phase 2,cytochrome P450 inhibitor,NR3C2,,
RU-42173,ZSTCZWJCLIRCOJ-DGCLKSJQSA-N,Phase 2,adrenergic receptor agonist,ADRB2,,
RU-58841,ARBYGDBJECGMGA-UHFFFAOYSA-N,Phase 2,androgen receptor antagonist,AR,,
RU-SKI-43,AEENEMOEBJOKGN-UZLBHIALSA-N,Preclinical,hedgehog pathway inhibitor,HHAT,,
rubitecan,VHXNKPBCCMUMSW-FQEVSTJZSA-N,Phase 3,topoisomerase inhibitor,TOP1,,
ruboxistaurin,ZCBUQCWBWNUWSU-SFHVURJKSA-N,Phase 3,PKC inhibitor,,,
rucaparib,HMABYWSNWIZPAG-UHFFFAOYSA-N,Phase 3,PARP inhibitor,PARP1|PARP2,,
rucinol,CSHZYWUPJWVTMQ-UHFFFAOYSA-N,Phase 1,tyrosinase inhibitor,TYR,,
rufinamide,POGQSBRIGCQNEG-UHFFFAOYSA-N,Launched,voltage-gated sodium channel blocker,GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures
rufloxacin,NJCJBUHJQLFDSW-UHFFFAOYSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections
rupatadine,WUZYKBABMWJHDL-UHFFFAOYSA-N,Launched,histamine receptor antagonist|platelet activating factor receptor antagonist,HRH1|PTAFR,allergy,allergic rhinitis|urticaria
rutaecarpine,ACVGWSKVRYFWRP-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,PTGS2,,
rutin,IKGXIBQEEMLURG-NVPNHPEKSA-N,Launched,antioxidant|capillary stabilizing agent|nitric oxide scavenger,AKR1C3,rheumatology|otolaryngology|gastroenterology|neurology/psychiatry|allergy,joint pain|nasal congestion|constipation|irritability|allergic rhinitis
ruxolitinib,HFNKQEVNSGCOJV-OAHLLOKOSA-N,Launched,JAK inhibitor,JAK1|JAK2|JAK3|TYK2,hematologic malignancy|hematology,myelofibrosis|polycythemia vera
ruxolitinib-(S),HFNKQEVNSGCOJV-HNNXBMFYSA-N,Preclinical,JAK inhibitor,JAK1|JAK2,,
RV1729,UBLOHCIYTDRGJH-UHFFFAOYSA-N,Phase 1,PI3K inhibitor,,,
RWJ-21757,VDCRFBBZFHHYGT-IOSLPCCCSA-N,Phase 2,toll-like receptor agonist,TLR7,,
RWJ-50271,HOFGTYCLOKDAES-UHFFFAOYSA-N,Preclinical,integrin inhibitor,ICAM1,,
RWJ-67657,QSUSKMBNZQHHPA-UHFFFAOYSA-N,Phase 1,MAP kinase inhibitor,MAPK14|PTGS2,,
RX-3117,QLLGKCJUPWYJON-HLTSFMKQSA-N,Phase 1/Phase 2,CDK inhibitor|DNA synthesis inhibitor,CDK2|DNMT1,,
RX-821002,HQGWKNGAKBPTBX-LBPRGKRZSA-N,Preclinical,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,,
ryuvidine,HFPLHASLIOXVGS-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,CDK2|CDK4,,
S-07662,UITFWLJMEZPXOF-UHFFFAOYSA-N,Preclinical,CAR antagonist,NR1I3,,
S-111,PYXFVCFISTUSOO-HKUCOEKDSA-N,Phase 2,PARP inhibitor,PARP1,,
S-14506,IFMQODYDAUKKEN-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR1A,,
S-17092,NXSXRIHXEQSYEZ-KNJMJIDISA-N,Preclinical,prolyl endopeptidase inhibitor,,,
S-3304,YWCLDDLVLSQGSZ-JOCHJYFZSA-N,Phase 1/Phase 2,matrix metalloprotease inhibitor,,,
S-38093,MRNMYWNBLVJWKG-GASCZTMLSA-N,Preclinical,histamine receptor antagonist,,,
S-isopropylisothiourea,XSSNABKEYXKKMK-UHFFFAOYSA-N,Preclinical,nitric oxide synthase inhibitor,NOS3,,
S-methylcysteine,IDIDJDIHTAOVLG-VKHMYHEASA-N,Phase 1,,CTSD|MGMT,,
S-nitrosoglutathione,HYHSBSXUHZOYLX-WDSKDSINSA-N,Phase 1,nitric oxide stimulant,PTPN1,,
S-sulfo-L-cysteine,NOKPBJYHPHHWAN-REOHCLBHSA-N,Preclinical,glutamate receptor agonist,,,
S-trityl-L-cysteine,DLMYFMLKORXJPO-HXUWFJFHSA-N,Preclinical,mitotic kinesin inhibitor,,,
S15535,QJPPEMXOOWNICQ-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,,,
S18986,MNTIJYGEITVWHU-SNVBAGLBSA-N,Phase 2,glutamate receptor modulator,GRIA1|GRIA2|GRIA3|GRIA4,,
S1P1-agonist-III,MLDQTQOMWDNTNN-UHFFFAOYSA-N,Preclinical,sphingosine kinase inhibitor,S1PR1,,
S26948,NSMJEHGOMXSLCW-UHFFFAOYSA-N,Preclinical,PPAR receptor agonist,PPARG,,
S4,HGVHSNXRZYOTPD-UHFFFAOYSA-N,Preclinical,carbonic anhydrase inhibitor,CA12|CA9,,
S49076,AREYWCZYVPSHGS-NVMNQCDNSA-N,Preclinical,tyrosine kinase inhibitor,,,
S63845,ZFBHXVOCZBPADE-SSEXGKCCSA-N,Preclinical,MCL1 inhibitor,,,
SA-47,HSYCMGWPPRTNKH-UHFFFAOYSA-N,Preclinical,FAAH inhibitor,FAAH,,
saccharin,CVHZOJJKTDOEJC-UHFFFAOYSA-N,Launched,DNA polymerase inhibitor,CA1|CA12|CA2|CA9,,
saclofen,JYLNVJYYQQXNEK-QMMMGPOBSA-N,Preclinical,GABA receptor antagonist,GABBR1|GABBR2|KCTD12|KCTD16|KCTD8,,
sacubitril,PYNXFZCZUAOOQC-UTKZUKDTSA-N,Launched,neprilysin inhibitor,MME,cardiology,congestive heart failure
sacubitrilat,DOBNVUFHFMVMDB-BEFAXECRSA-N,Preclinical,neprilysin inhibitor,,,
safflower-yellow,HLUBVUICXYRPPM-DVSWWXTKSA-N,Preclinical,anti-inflammatory agent,,,
safinamide,NEMGRZFTLSKBAP-LBPRGKRZSA-N,Launched,dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor,MAOB,neurology/psychiatry,Parkinson's Disease
safingol,OTKJDMGTUTTYMP-ZWKOTPCHSA-N,Phase 1,PKC inhibitor,TRPM3,,
safranal,SGAWOGXMMPSZPB-UHFFFAOYSA-N,Phase 2,benzodiazepine receptor agonist,GABBR1,,
SAG,VFSUUTYAEQOIMW-YHBQERECSA-N,Preclinical,smoothened receptor agonist,SMO|TRPC6,,
sal003,TVNBASWNLOIQML-RFKZRZAASA-N,Preclinical,eukaryotic translation initiation factor inhibitor,EIF2A,,
salazodine,YFUATOCFMCWUEH-UHFFFAOYSA-N,Phase 2,,,,
salicin,NGFMICBWJRZIBI-UJPOAAIJSA-N,Phase 1,anti-inflammatory agent,,,
salicyl-alcohol,CQRYARSYNCAZFO-UHFFFAOYSA-N,Preclinical,,,,
salicylamide,SKZKKFZAGNVIMN-UHFFFAOYSA-N,Launched,analgesic agent,,neurology/psychiatry|endocrinology,pain relief|fever
salicylanilide,WKEDVNSFRWHDNR-UHFFFAOYSA-N,Preclinical,other antibiotic,,,
salicylic-acid,YGSDEFSMJLZEOE-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,AKR1C1|ASIC3|PTGS1|PTGS2,dermatology|endocrinology|neurology/psychiatry,acne vulgaris (AV)|fever|pain relief
salidroside,ILRCGYURZSFMEG-RKQHYHRCSA-N,Preclinical,beta amyloid protein neurotoxicity inhibitor,APP,,
salinomycin,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,Launched,,,infectious disease,coccidiosis
salirasib,WUILNKCFCLNXOK-CFBAGHHKSA-N,Phase 2,mTOR inhibitor,TRPA1,,
salmeterol,GIIZNNXWQWCKIB-VWLOTQADSA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma|chronic obstructive pulmonary disease (COPD)|bronchospasm
salsolinol-1-carboxylic-acid,XHGLVMDBZZZXDP-LLVKDONJSA-N,Preclinical,,,,
salubrinal,LCOIAYJMPKXARU-CVTTXWKISA-N,Preclinical,eukaryotic translation initiation factor inhibitor,EIF2S1,,
salvianolic-acid-A,YMGFTDKNIWPMGF-UCPJVGPRSA-N,Phase 1,matrix metalloprotease inhibitor,,,
salvianolic-acid-B,SNKFFCBZYFGCQN-PDVBOLEISA-N,Phase 2,EGFR inhibitor|metalloproteinase inhibitor,MMP9,,
salvinorin-A,OBSYBRPAKCASQB-AGQYDFLVSA-N,Phase 1,opioid receptor agonist,OPRD1|OPRK1|OPRM1,,
SAM-315,FYOVZCDHYOEKDE-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,,,
sameridine,TYWUGCGYWNSRPS-UHFFFAOYSA-N,Preclinical,opioid receptor modulator,,,
sanazole,YKDRHKCETNMLHL-UHFFFAOYSA-N,Phase 1,,,,
sancycline,CRNIKQQPTHSPBA-IEPLVVIMSA-N,Preclinical,antitumor agent,,,
sangivamycin,OBZJZDHRXBKKTJ-JTFADIMSSA-N,Phase 1,DNA inhibitor,,,
sanguinarium-chloride,INVGWHRKADIJHF-UHFFFAOYSA-N,Phase 1,apoptosis stimulant,CASP3,,
SANT-1,FOORCIAZMIWALX-JJIBRWJFSA-N,Preclinical,smoothened receptor antagonist,SHH|SMO,,
SANT-2,VQOJFGFKIVFMDH-UHFFFAOYSA-N,Preclinical,smoothened receptor antagonist,SHH|SMO,,
sapacitabine,LBGFKUUHOPIEMA-PEARBKPGSA-N,Phase 3,DNA synthesis inhibitor,,,
sapropterin,FNKQXYHWGSIFBK-RPDRRWSUSA-N,Launched,phenylalanine 4-hydroxylase stimulant,NOS3|PAH|TH|TPH1,metabolism,hyperphenylalaninemia (HPA)
saquinavir,QWAXKHKRTORLEM-UGJKXSETSA-N,Launched,HIV protease inhibitor,CYP3A4,infectious disease,human immunodeficiency virus (HIV-1)
SAR-245409,HJSSPYJVWLTYHG-UHFFFAOYSA-N,Phase 1/Phase 2,PI3K inhibitor,MTOR|PIK3CG,,
SAR131675,PFMPOBVAYMTUOX-GOSISDBHSA-N,Preclinical,VEGFR inhibitor,FLT4,,
SAR405,SPDQRCUBFSRAFI-DOMZBBRYSA-N,Preclinical,PI3K inhibitor,PIK3C3,,
SAR405838,IDKAKZRYYDCJDU-HBMMIIHUSA-N,Phase 1,MDM inhibitor,MDM2,,
SAR407899,IPEXHQGMTHOKQV-UHFFFAOYSA-N,Phase 2,rho associated kinase inhibitor,ROCK1,,
saracatinib,OUKYUETWWIPKQR-UHFFFAOYSA-N,Phase 2/Phase 3,SRC inhibitor,ABL1|LCK|SRC|YES1,,
saracatinib,"InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)",Phase 2/Phase 3,SRC inhibitor,ABL1|LCK|SRC|YES1,,
sarafloxacin,XBHBWNFJWIASRO-UHFFFAOYSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
sarcosine,FSYKKLYZXJSNPZ-UHFFFAOYSA-N,Phase 2,glycine transporter inhibitor,SLC6A9,,
sardomozide,CYPGNVSXMAUSJY-CXUHLZMHSA-N,Preclinical,S-adenosylmethionine decarboxylase inhibitor,,,
sari-59-801,GMGOZCSXMVXXRS-HNNXBMFYSA-N,Phase 1,,,,
saroglitazar,MRWFZSLZNUJVQW-DEOSSOPVSA-N,Launched,PPAR receptor agonist,PPARA|PPARG,endocrinology|cardiology|gastroenterology,diabetes mellitus|dyslipidemia|non-alcoholic steatohepatitis (NASH)
sarpogrelate,FFYNAVGJSYHHFO-OAQYLSRUSA-N,Launched,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,endocrinology|cardiology|rheumatology,diabetes mellitus|angina pectoris|Raynaud's disease|atherosclerosis|Buerger's disease
sasapyrine,WVYADZUPLLSGPU-UHFFFAOYSA-N,Launched,NFkB pathway inhibitor,PTGS1|PTGS2,rheumatology,osteoarthritis|rheumatoid arthritis
satraplatin,JWTNVKZACPRKPF-UHFFFAOYSA-J,Phase 3,DNA alkylating agent,,,
savolitinib,XYDNMOZJKOGZLS-NSHDSACASA-N,Phase 3,c-Met inhibitor,MET,,
saxagliptin,QGJUIPDUBHWZPV-YQBUGCKMSA-N,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus
SB-200646,OJZZJTLBYXHUSJ-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR2B|HTR2C,,
SB-202190,QHKYPYXTTXKZST-UHFFFAOYSA-N,Preclinical,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|GSK3B|LCK|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|ROCK1|RPS6KB1|SGK1,,
SB-203186,YGKPIROTKVQCCU-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR4,,
SB-203580,CDMGBJANTYXAIV-HHHXNRCGSA-N,Preclinical,p38 MAPK inhibitor,AKT1|ALOX5|CHEK1|CYP2D6|CYP3A4|GAK|GSK3B|LCK|MAPK1|MAPK10|MAPK11|MAPK12|MAPK14|MAPK8|MAPK9|PRKCA|RAF1|RIPK2|ROCK1|RPS6KB1|SGK1|SRC|TNF,,
SB-205384,JDTZAGLGBRRCJT-JTQLQIEISA-N,Preclinical,GABA receptor modulator,GABRA3|GABRA5|GABRA6,,
SB-206553,QJQORSLQNXDVGE-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,,
SB-216641,JRNUKVFYILMMLX-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,,
SB-216763,JCSGFHVFHSKIJH-UHFFFAOYSA-N,Preclinical,glycogen synthase kinase inhibitor,CCNA2|CDK2|GSK3A|GSK3B,,
SB-218078,OTPNDVKVEAIXTI-UHFFFAOYSA-N,Preclinical,CHK inhibitor,CHEK1,,
SB-218795,IUMQXQJZIHWLIN-HSZRJFAPSA-N,Preclinical,tachykinin antagonist,TACR3,,
SB-221284,OQZOXHCRSXYSPM-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,,
SB-222200,MQNYRKWJSMQECI-QFIPXVFZSA-N,Preclinical,tachykinin antagonist,TACR3,,
SB-225002,MQBZVUNNWUIPMK-UHFFFAOYSA-N,Preclinical,CC chemokine receptor antagonist,CXCR2,,
SB-228357,RRJLJKRFFRZRAF-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,,
SB-2343,QYBGBLQCOOISAR-UHFFFAOYSA-N,Phase 1,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
SB-239063,ZQUSFAUAYSEREK-WKILWMFISA-N,Preclinical,p38 MAPK inhibitor,MAPK11|MAPK14|PTGS2,,
SB-242235,PDTYLGXVBIWRIM-UHFFFAOYSA-N,Phase 1,p38 MAPK inhibitor,HSPB1|MAPK14,,
SB-243213,ZETBBVYSBABLHL-UHFFFAOYSA-N,Phase 1,serotonin receptor inverse agonist,HTR2A|HTR2B|HTR2C|HTR6,,
SB-258585,BDHMSYNBSBZCAF-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR6,,
SB-268262,YXHLPJQQPOMPGE-HHHXNRCGSA-N,Preclinical,calcitonin antagonist,CALCA,,
SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Preclinical,serotonin receptor antagonist,HTR7,,
SB-271046,LOCQRDBFWSXQQI-UHFFFAOYSA-N,Phase 1,serotonin receptor antagonist,HTR6,,
SB-297006,BEZXGSZPWXRHIN-INIZCTEOSA-N,Preclinical,CC chemokine receptor antagonist,CCR3,,
SB-328437,VMFGCGRAIBLAFY-IBGZPJMESA-N,Preclinical,CCR antagonist,,,
SB-334867,AKMNUCBQGHFICM-UHFFFAOYSA-N,Preclinical,orexin receptor antagonist,HCRTR1|HCRTR2,,
SB-366791,RYAMDQKWNKKFHD-JXMROGBWSA-N,Preclinical,TRPV antagonist,TRPV1,,
SB-399885,ATKZKAYWARYLBW-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR6,,
SB-408124,JTARFZSNUAGHRB-UHFFFAOYSA-N,Preclinical,orexin receptor antagonist,HCRTR1|HCRTR2,,
SB-415286,PQCXVIPXISBFPN-UHFFFAOYSA-N,Preclinical,glycogen synthase kinase inhibitor,GSK3A|GSK3B|RPS6KB1,,
SB-431542,FHYUGAJXYORMHI-UHFFFAOYSA-N,Preclinical,TGF beta receptor inhibitor,ACVR1C|TGFBR1,,
SB-452533,IFJYEGJUQIBBQV-UHFFFAOYSA-N,Preclinical,TRPV antagonist,TRPV1,,
SB-505124,WGZOTBUYUFBEPZ-UHFFFAOYSA-N,Preclinical,ALK tyrosine kinase receptor inhibitor,TGFBR1,,
SB-525334,DKPQHFZUICCZHF-UHFFFAOYSA-N,Preclinical,TGF beta receptor inhibitor,TGFBR1,,
SB-590885,MLSAQOINCGAULQ-QFMPWRQOSA-N,Preclinical,RAF inhibitor,BRAF,,
SB-612111,OHRDCQFCAWLDBP-SBUREZEXSA-N,Preclinical,nociceptin/orphanin FQ receptor antagonist,OPRL1,,
SB-649868,ZJXIUGNEAIHSBI-IBGZPJMESA-N,Phase 2,orexin receptor antagonist,,,
SB-657510,KQCZCINJGIRLCD-CYBMUJFWSA-N,Preclinical,urotensin receptor antagonist,UTS2R,,
SB-683698,DRSJLVGDSNWQBI-SFHVURJKSA-N,Phase 1,integrin antagonist,ITGA4|ITGAV|ITGB1|ITGB7,,
SB-705498,JYILLRHXRVTRSH-GFCCVEGCSA-N,Phase 2,TRPV antagonist,TRPV1,,
SB-706375,BPOWQJYAMDEAFF-CYBMUJFWSA-N,Preclinical,urotensin receptor antagonist,UTS2R,,
SB-742457,JJZFWROHYSMCMU-UHFFFAOYSA-N,Phase 3,serotonin receptor antagonist,HTR6,,
SB-743921,PGXYIBJJCLWJST-MUUNZHRXSA-N,Phase 1/Phase 2,kinesin-like spindle protein inhibitor,KIF11,,
SB-747651A,MBCJUIJWPYUEBX-UHFFFAOYSA-N,Preclinical,kinase inhibitor,AKT1|AKT3|ROCK1|RPS6KA5|RPS6KB1,,
SB-756050,GJUFPAZNBPFNRI-UHFFFAOYSA-N,Phase 1,G protein-coupled receptor agonist,GPBAR1,,
SB-772077B,PHWHNHYZZNJPLB-QMMMGPOBSA-N,Preclinical,rho associated kinase inhibitor,ROCK1|ROCK2,,
SB-939,JHDKZFFAIZKUCU-ZRDIBKRKSA-N,Phase 3,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9,,
SBE-13,XNPRQBVQOJZMMA-UHFFFAOYSA-N,Preclinical,PLK inhibitor,PLK1,,
SBHA,IDQPVOFTURLJPT-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC1|HDAC3,,
SBI-115,IJPXOPBVXVPPEW-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor antagonist,,,
SC-10,MJMJERJFCHYXEM-UHFFFAOYSA-N,Preclinical,protein kinase activator,PRKCA,,
SC-12267,XPRDUGXOWVXZLL-UHFFFAOYSA-N,Phase 2,dihydroorotate dehydrogenase inhibitor,IL17A,,
SC-144,UEADAWQSJOWXBK-UHFFFAOYSA-N,Preclinical,P glycoprotein inhibitor,,,
SC-19220,KNURFLJTOUGOOQ-UHFFFAOYSA-N,Preclinical,prostanoid receptor antagonist,PTGER1,,
SC-236,NSQNZEUFHPTJME-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,PTGS2,,
SC-51089,XDJPQOUDGROSEU-UHFFFAOYSA-N,Preclinical,prostanoid receptor antagonist,PTGER1,,
SC-560,PQUGCKBLVKJMNT-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,PTGS1,,
SC-9,YUXMTDYHFPRPLG-UHFFFAOYSA-N,Preclinical,protein tyrosine kinase activator,PRKCA,,
scabertopin,FTPHYXGWMIZVMP-WQYRJXRXSA-N,Preclinical,anticancer agent,,,
SCH-202676,FFUBTEITUNMMOK-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor modulator,CHRM1|CHRM2|DRD1|DRD2,,
SCH-221510,LOSJNRBXNQTUNT-FOURXJPJSA-N,Preclinical,nociceptin/orphanin FQ receptor agonist,OPRL1,,
SCH-23390,GOTMKOSCLKVOGG-OAHLLOKOSA-N,Preclinical,dopamine receptor antagonist,DRD1|DRD5|HTR2C|KCNJ4|KCNJ6,,
SCH-28080,PYKJFEPAUKAXNN-UHFFFAOYSA-N,Phase 1,ATPase inhibitor,ATP4A,,
SCH-51344,YWEGXZZAORIRQR-UHFFFAOYSA-N,Preclinical,MTH1 inhibitor,NUDT1,,
SCH-58261,UTLPKQYUXOEJIL-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
SCH-900776,GMIZZEXBPRLVIV-SECBINFHSA-N,Phase 2,CHK inhibitor,CDK2|CHEK1,,
schisandrin-B,RTZKSTLPRTWFEV-QWHCGFSZSA-N,Preclinical,antioxidant,ATR,,
schisandrol-B,ZWRRJEICIPUPHZ-MYODQAERSA-N,Phase 3,lipid peroxidase inhibitor,,,
sclareol,XVULBTBTFGYVRC-SVPXJYONSA-N,Preclinical,,,,
sclareolide,IMKJGXCIJJXALX-SHUKQUCYSA-N,Launched,other antifungal,,,
SCMC-Lys,GBFLZEXEOZUWRN-VKHMYHEASA-N,Launched,mucolytic agent,GSTP1,pulmonary,chronic obstructive pulmonary disease (COPD)
scopine,FIMXSEMBHGTNKT-RZVDLVGDSA-N,Launched,,,,
scopolamine,STECJAGHUSJQJN-FWXGHANASA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI,neurology/psychiatry|gastroenterology,motion sickness|vomiting|nausea
scopolamine-N-oxide,GSYQNAMOFFWAPF-SXWCTKSRSA-N,Preclinical,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,,
SCP-1,PUPNJSIFIXXJCH-UHFFFAOYSA-N,Phase 1,analgesic agent,,,
scriptaid,JTDYUFSDZATMKU-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,
SCS,OMCYEZUIYGPHDJ-OQLLNIDSSA-N,Preclinical,,,,
SD-0006,CATQHDWESBRRQA-UHFFFAOYSA-N,Phase 2,p38 MAPK inhibitor,,,
SD-169,GQMYQEAXTITUAE-UHFFFAOYSA-N,Preclinical,p38 MAPK inhibitor,MAPK14,,
SD-208,BERLXWPRSBJFHO-UHFFFAOYSA-N,Preclinical,TGF beta receptor inhibitor,TGFBR1,,
SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,Preclinical,matrix metalloprotease inhibitor,MMP1|MMP13|MMP2,,
SDM25N,ZFMVWAWSKLAVOE-IFKAHUTRSA-N,Preclinical,opioid receptor antagonist,OPRD1,,
SDZ-205-557,FFNWMBDISAYHDC-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR3A|HTR3B,,
SDZ-21009,SJYFDORQYYEJLB-ZDUSSCGKSA-N,Preclinical,adrenergic receptor antagonist|serotonin receptor antagonist,HTR1A|HTR1B,,
SDZ-220-040,NYZFUZCCDOSQBG-AWEZNQCLSA-N,Preclinical,glutamate receptor antagonist,GRIN1,,
SDZ-220-581,VBRJFXSFCYEZMQ-HNNXBMFYSA-N,Preclinical,glutamate receptor antagonist,GRIN1,,
SDZ-NKT-343,PCVSIMQAFWRUEC-JDXGNMNLSA-N,Phase 1,tachykinin antagonist,TACR1,,
SDZ-SER-082,YASBOGFWAMXINH-TZMCWYRMSA-N,Preclinical,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C,,
SDZ-WAG-994,JAKAFSGZUXCHLF-LSCFUAHRSA-N,Phase 2,adenosine receptor agonist,ADORA1,,
Se-methylselenocysteine,XDSSPSLGNGIIHP-VKHMYHEASA-N,Phase 2,,,,
secalciferol,FCKJYANJHNLEEP-XRWYNYHCSA-N,Launched,vitamin D receptor agonist,VDR,critical care,bone fracture
seclazone,XWXVKXXKKLBDDJ-VIFPVBQESA-N,Phase 1,anti-inflammatory agent,,,
seclidemstat,MVSQDUZRRVBYLA-HYARGMPZSA-N,Phase 1,histone demethylase inhibitor,,,
secnidazole,KPQZUUQMTUIKBP-RXMQYKEDSA-N,Launched,acetylcholinesterase inhibitor|microtubule inhibitor,,infectious disease,protozoan infection
secoisolariciresinol-(-),PUETUDUXMCLALY-HOTGVXAUSA-N,Phase 2,,,,
secoisolariciresinol-diglucoside,SBVBJPHMDABKJV-PGCJWIIOSA-N,Phase 2,antioxidant,,,
securinine,SWZMSZQQJRKFBP-WZRBSPASSA-N,Preclinical,GABA receptor antagonist|TP53 activator,GABRA1,,
segesterone-acetate,CKFBRGLGTWAVLG-GOMYTPFNSA-N,Launched,progesterone receptor agonist,PGR,,
seladelpar,JWHYSEDOYMYMNM-QGZVFWFLSA-N,Phase 3,PPAR receptor agonist,,,
selamectin,AFJYYKSVHJGXSN-XHKIUTQPSA-N,Launched,nematocide,,infectious disease,flea control
selegiline,MEZLKOACVSPNER-GFCCVEGCSA-N,Launched,monoamine oxidase inhibitor,MAOA|MAOB,neurology/psychiatry,Parkinson's Disease
selenomethionine,RJFAYQIBOAGBLC-BYPYZUCNSA-N,Launched,,,,
seletalisib,LNLJHGXOFYUARS-OAQYLSRUSA-N,Preclinical,PI3K inhibitor,,,
selexipag,QXWZQTURMXZVHJ-UHFFFAOYSA-N,Launched,IP1 prostacyclin receptor agonist|platelet aggregation inhibitor,PTGIR,pulmonary,pulmonary arterial hypertension (PAH)
selfotel,LPMRCCNDNGONCD-NTSWFWBYSA-N,Phase 3,glutamate receptor antagonist,GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
selinexor,DEVSOMFAQLZNKR-RJRFIUFISA-N,Launched,exportin antagonist,XPO1,hematologic malignancy,multiple myeloma
selitrectinib,OEBIHOVSAMBXIB-SJKOYZFVSA-N,Phase 1/Phase 2,protein tyrosine kinase inhibitor,,,
selonsertib,YIDDLAAKOYYGJG-UHFFFAOYSA-N,Phase 2,MAP kinase activator,,,
selumetinib,CYOHGALHFOKKQC-UHFFFAOYSA-N,Phase 3,MEK inhibitor,MAP2K1,,
semagacestat,PKXWXXPNHIWQHW-RCBQFDQVSA-N,Phase 3,gamma secretase inhibitor,PSEN1,,
semapimod,PWDYHMBTPGXCSN-UHFFFAOYSA-N,Phase 2,cytokine production inhibitor|p38 MAPK inhibitor,MAPK14,,
semaxanib,WUWDLXZGHZSWQZ-WQLSENKSSA-N,Phase 3,VEGFR inhibitor,FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET,,
semustine,JUUWEJHZVBABHQ-UHFFFAOYSA-N,Phase 3,DNA alkylating agent,,,
SEN-1269,MFPAAKZZUIRMKR-UHFFFAOYSA-N,Preclinical,beta amyloid inhibitor,APP,,
senicapoc,SCTZUZTYRMOMKT-UHFFFAOYSA-N,Phase 3,intermediate conductance potassium channel blocker,KCNN4,,
sennoside-A,QFJIQUOMKJNYLI-QSXPFVSBSA-N,Launched,glycoside agonist,,gastroenterology,constipation
sennoside-protonated,QFJIQUOMKJNYLI-NGMZATEOSA-N,Preclinical,,,,
seocalcitol,LVLLALCJVJNGQQ-SEODYNFXSA-N,Phase 3,vitamin D receptor agonist,VDR,,
SEP-227900,MMAIBGHDBYQYDI-UHFFFAOYSA-N,Phase 1,D-amino acid oxidase Inhibitor,DAO,,
seratrodast,ZBVKEHDGYSLCCC-SFHVURJKSA-N,Launched,prostanoid receptor antagonist,TBXA2R,pulmonary,asthma
serdemetan,CEGSUKYESLWKJP-UHFFFAOYSA-N,Phase 1,MDM inhibitor,MDM2,,
serotonin,QZAYGJVTTNCVMB-UHFFFAOYSA-N,Launched,growth factor receptor activator,DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR4|HTR5A|HTR6|HTR7|SLC36A1,neurology/psychiatry,anxiety|depression|sleeplessness
sertaconazole,JLGKQTAYUIMGRK-LJQANCHMSA-N,Launched,sterol demethylase inhibitor,,infectious disease,tinea pedis
sertindole,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,Withdrawn,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2,,
sertraline,VGKDLMBJGBXTGI-SJCJKPOMSA-N,Launched,selective serotonin reuptake inhibitor (SSRI),SLC6A3|SLC6A4,neurology/psychiatry|obstetrics/gynecology,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder
sesamin,PEYUIKBAABKQKQ-AFHBHXEDSA-N,Preclinical,NFkB pathway inhibitor,,,
setipiprant,IHAXLPDVOWLUOS-UHFFFAOYSA-N,Phase 3,prostaglandin inhibitor,PTGDR2,,
setiptiline,GVPIXRLYKVFFMK-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,HRH1|HTR2A|HTR2C,neurology/psychiatry,depression
setmelanotide,HDHDTKMUACZDAA-PJHQLSNHSA-N,Phase 3,melanocortin receptor agonist,,,
sevoflurane,DFEYYRMXOJXZRJ-UHFFFAOYSA-N,Launched,membrane integrity inhibitor,ATP2C1|ATP5D|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GLRA1|GLRB|GRIA1|KCNA1|KCNK10|KCNK18|KCNK2|KCNK3|KCNK9|MT-ND1,neurology/psychiatry,anesthetic
SEW-2871,OYMNPJXKQVTQTR-UHFFFAOYSA-N,Preclinical,lysophospholipid receptor agonist,S1PR1,,
SF-11,PMEQBGAGFZDWQX-UHFFFAOYSA-N,Preclinical,neuropeptide receptor antagonist,MCOLN3|NPY2R,,
SGC-0946,IQCKJUKAQJINMK-HUBRGWSESA-N,Preclinical,histone lysine methyltransferase inhibitor,,,
SGC-707,DMIDPTCQPIJYFE-UHFFFAOYSA-N,Preclinical,protein arginine N-methyltransferase inhibitor,PRMT3,,
SGC-CBP30,GEPYBHCJBORHCE-SFHVURJKSA-N,Preclinical,bromodomain inhibitor,CREBBP|EP300,,
SGI-1027,QSYLKMKIVWJAAK-UHFFFAOYSA-N,Preclinical,DNA methyltransferase inhibitor,DNMT1|DNMT3A|DNMT3B,,
SGI-1776,MHXGEROHKGDZGO-UHFFFAOYSA-N,Phase 1,Pim kinase inhibitor,FLT3|PIM1|PIM2|PIM3,,
SGS-742,ONNMDRQRSGKZCN-UHFFFAOYSA-N,Preclinical,GABA receptor antagonist,GABBR1|GABBR2,,
SGX523,BCZUAADEACICHN-UHFFFAOYSA-N,Phase 1,hepatocyte growth factor receptor inhibitor,MET,,
SHA-68,SFRQIPRTNYHJHP-QHCPKHFHSA-N,Preclinical,neuropeptide receptor antagonist,NPSR1,,
shikimic-acid,JXOHGGNKMLTUBP-PBXRRBTRSA-N,Preclinical,,,,
SHP099,YGUFCDOEKKVKJK-UHFFFAOYSA-N,Preclinical,protein tyrosine kinase inhibitor,PTPN11,,
SIB-1553A,NVZGJSVPOOILDI-LLVKDONJSA-N,Phase 2,acetylcholine receptor agonist,CHRNB4,,
SIB-1757,UOJMXHLMOUOGPY-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRM5,,
SIB-1893,SISOFUCTXZKSOQ-ZHACJKMWSA-N,Preclinical,glutamate receptor antagonist,GRM4|GRM5,,
SID-7969543,KWMBIIQCLUIHDI-OAHLLOKOSA-N,Preclinical,steroidogenic factor antagonist,NR5A1,,
siguazodan,NUHPODZZKHQQET-VIFPVBQESA-N,Phase 1,phosphodiesterase inhibitor,PDE3A,,
sildenafil,BNRNXUUZRGQAQC-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3,urology,erectile dysfunction
silibinin,SEBFKMXJBCUCAI-HKTJVKLFSA-N,Launched,cytochrome P450 inhibitor,ALOX5,gastroenterology,hepatic cirrhosis
silodosin,PNCPYILNMDWPEY-QGZVFWFLSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,urology,benign prostatic hyperplasia (BPH)
silver-sulfadiazine,UEJSSZHHYBHCEL-UHFFFAOYSA-N,Launched,PABA antagonist,,critical care,sepsis
silymarin,FDQAOULAVFHKBX-HKTJVKLFSA-N,Launched,,,,
simeprevir,JTZZSQYMACOLNN-VDWJNHBNSA-N,Launched,HCV inhibitor,CYP1A2|CYP3A4,infectious disease,hepatitis C
simurosertib,XGVXKJKTISMIOW-CYBMUJFWSA-N,Preclinical,kinase inhibitor,,,
simvastatin,RYMZZMVNJRMUDD-HGQWONQESA-N,Launched,HMGCR inhibitor,HMGCR|ITGB2,endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia
sincalide,IZTQOLKUZKXIRV-YRVFCXMDSA-N,Preclinical,cholecystokinin agonist,,,
sinefungin,LMXOHSDXUQEUSF-YECHIGJVSA-N,Preclinical,DNA methyltransferase inhibitor|RNA synthesis inhibitor,CARM1,,
sinomenine,INYYVPJSBIVGPH-QHRIQVFBSA-N,Preclinical,angiogenesis inhibitor,,,
sipatrigine,PDOCBJADCWMDGL-UHFFFAOYSA-N,Phase 2,voltage-gated sodium channel blocker,CACNA1D|SCN10A|SCN1A|SCN3A|SCN4A|SCN5A|SCN9A,,
siponimod,KIHYPELVXPAIDH-HNSNBQBZSA-N,Launched,sphingosine 1-phosphate receptor modulator,S1PR1,neurology/psychiatry,multiple sclerosis
siramesine,XWAONOGAGZNUSF-UHFFFAOYSA-N,Phase 2,sigma receptor antagonist,ADRA1A|ADRA1B|ADRA1D,,
siremadlin,AGBSXNCBIWWLHD-FQEVSTJZSA-N,Preclinical,MDM inhibitor,,,
sirolimus,QFJCIRLUMZQUOT-MHOZHFGWSA-N,Launched,mTOR inhibitor,FKBP1A|MTOR,transplant|pulmonary,organ rejection|lymphangioleiomyomatosis
SirReal-2,MENNDDDTIIZDDN-UHFFFAOYSA-N,Preclinical,SIRT inhibitor,SIRT2,,
sirtinol,UXJFDYIHRJGPFS-OVKKOYPGSA-N,Preclinical,SIRT inhibitor,SIRT1|SIRT2,,
SIS3,IJYPHMXWKKKHGT-VAWYXSNFSA-N,Preclinical,serine/threonine kinase inhibitor,SMAD3|TGFBR1,,
sisomicin,URWAJWIAIPFPJE-YFMIWBNJSA-N,Launched,protein synthesis inhibitor,,ophthalmology,conjunctivitis|punctate keratitis
sisomicin-sulfate,URWAJWIAIPFPJE-YFMIWBNJSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,gram-negative bacterial infections
sitafloxacin,PNUZDKCDAWUEGK-CYZMBNFOSA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,buruli ulcer
sitagliptin,MFFMDFFZMYYVKS-SECBINFHSA-N,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus
sitaxentan,PHWXUGHIIBDVKD-UHFFFAOYSA-N,Withdrawn,endothelin receptor antagonist,EDNRA|EDNRB,,
sitosterol,KZJWDPNRJALLNS-VJSFXXLFSA-N,Preclinical,,,,
sitravatinib,WLAVZAAODLTUSW-UHFFFAOYSA-N,Phase 3,receptor tyrosine protein kinase inhibitor,,,
sivelestat,BTGNGJJLZOIYID-UHFFFAOYSA-N,Launched,elastase inhibitor,CELA1|ELANE,pulmonary,acute lung injury
SJ-172550,RKKFQJXGAQWHBZ-LICLKQGHSA-N,Preclinical,MDM inhibitor,MDM4,,
SJ-733,VKCPFWKTFZAOTO-LEWJYISDSA-N,Phase 1,ATPase inhibitor,,,
SJG-136,RWZVMMQNDHPRQD-SFTDATJTSA-N,Phase 2,DNA intercalating agent,,,
SK&F-10047-(+),LGQCVMYAEFTEFN-DQYPLSBCSA-N,Phase 1,sigma receptor agonist,SIGMAR1,,
SKA-31,FECQXVPRUCCUIL-UHFFFAOYSA-N,Preclinical,potassium channel activator,KCNN4,,
skepinone-L,HXMGCTFLLWPVFM-GOSISDBHSA-N,Preclinical,p38 MAPK inhibitor,MAPK14,,
SKF-38393,JUDKOGFHZYMDMF-AWEZNQCLSA-N,Preclinical,dopamine receptor agonist,CALY|DRD1|DRD5,,
SKF-77434,QBUVZVXIRYFENV-KRWDZBQOSA-N,Preclinical,dopamine receptor agonist,DRD1,,
SKF-81297,GHWJEDJMOVUXEC-UHFFFAOYSA-N,Preclinical,dopamine receptor agonist,DRD1|DRD5,,
SKF-83566,XFTVOHWWEQGXLS-HNNXBMFYSA-N,Preclinical,dopamine receptor antagonist,DRD1|DRD5,,
SKF-86002,YOELZIQOLWZLQC-UHFFFAOYSA-N,Preclinical,p38 MAPK inhibitor,ALOX5|MAPK14,,
SKF-89976A,TXQKSMSLZVKQBI-FQEVSTJZSA-N,Preclinical,GABA uptake inhibitor,SLC6A1,,
SKF-91488,UFYJLJINUGVUHO-UHFFFAOYSA-N,Preclinical,histamine N-methyltransferase inhibitor,HNMT,,
SKF-96365,HLMBXBGDBBCYII-QFIPXVFZSA-N,Preclinical,calcium channel blocker,CYP3A4|PKD2|TRPC1|TRPC3|TRPC4|TRPC5|TRPV2,,
SKI-II,ZFGXZJKLOFCECI-UHFFFAOYSA-N,Preclinical,sphingosine kinase inhibitor,SPHK1,,
SKLB-1028,WSOHOUHPUOAXIN-UHFFFAOYSA-N,Preclinical,Abl kinase inhibitor|EGFR inhibitor|FLT3 inhibitor,,,
SKLB1002,RQVGFDBMONQTBC-UHFFFAOYSA-N,Preclinical,VEGFR inhibitor,KDR,,
SLV-319-(+/-),AXJQVVLKUYCICH-OAQYLSRUSA-N,Phase 2,cannabinoid receptor antagonist,CNR1|DRD2|HTR1A,,
SLV-320,RBZNJGHIKXAKQE-HDJSIYSDSA-N,Phase 2,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
SM-108,PXQCVBRDIZZRGM-UHFFFAOYSA-N,Phase 2,,,,
SM-164,LGYDZXNSSLRFJS-IOQQVAQYSA-N,Preclinical,XIAP inhibitor,BIRC2|BIRC3|XIAP,,
SM-21,WTPAXDRULIZRDJ-ABFRBSLYSA-N,Preclinical,sigma receptor antagonist,PGRMC1,,
SMER-28,BCPOLXUSCUFDGE-UHFFFAOYSA-N,Preclinical,autophagy inducer,SNCA,,
SMI-4a,NGJLOFCOEOHFKQ-YVMONPNESA-N,Preclinical,Pim kinase inhibitor,PIM1,,
SN-2,WKLZNTYMDOPBSE-IARIHHJXSA-N,Preclinical,transient receptor potential channel agonist,MCOLN3,,
SN-38,FJHBVJOVLFPMQE-QFIPXVFZSA-N,Launched,topoisomerase inhibitor,TOP1,oncology,colorectal cancer
SN-6,ZVYIJXLMBWCGHP-RTBURBONSA-N,Preclinical,sodium/calcium exchange inhibitor,,,
SNAP,MLXCQEWOIZBBDM-YFKPBYRVSA-N,Phase 2,nitric oxide donor,PTPN1,,
SNAP-5089,FIIXCJGBCCCOQQ-XIFFEERXSA-N,Preclinical,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CACNA1C|CACNA1D,,
SNAP-94847,VMLZFUVIKCGATC-UHFFFAOYSA-N,Preclinical,,ADRA1A|DRD2,,
SNC-80,KQWVAUSXZDRQPZ-UMTXDNHDSA-N,Preclinical,,OPRD1,,
SNG-1153,OXHMDMVBLQNMGP-UHFFFAOYSA-N,Preclinical,selective estrogen receptor modulator (SERM),ESR1,,
SNS-314,FAYAUAZLLLJJGH-UHFFFAOYSA-N,Phase 1,Aurora kinase inhibitor,AURKA|AURKB|AURKC,,
SNX-2112,ZFVRYNYOPQZKDG-MQMHXKEQSA-N,Phase 1,HSP inhibitor,,,
SNX-5422,AVDSOVJPJZVBTC-CTYIDZIISA-N,Phase 1/Phase 2,HSP inhibitor,HSP90AA1|HSP90AB1,,
sobetirome,QNAZTOHXCZPOSA-UHFFFAOYSA-N,Phase 1/Phase 2,thyroid hormone receptor agonist,THRA|THRB,,
soblidotin,DZMVCVHATYROOS-ZBFGKEHZSA-N,Phase 2,microtubule inhibitor,,,
sobrepin,OMDMTHRBGUBUCO-BDAKNGLRSA-N,Launched,mucolytic agent,,pulmonary,chest congestion
sobuzoxane,OCOKWVBYZHBHLU-UHFFFAOYSA-N,Launched,topoisomerase inhibitor,,hematologic malignancy,peripheral T-cell lymphoma (PTCL)
sodium-ascorbate,SXZYCXMUPBBULW-NEEWWZBLSA-N,Launched,,,,
sodium-butyrate,FERIUCNNQQJTOY-UHFFFAOYSA-N,Phase 2,HDAC inhibitor,BCHE|FFAR2|FFAR3|HDAC1|HDAC2|HDAC3|HDAC8,,
sodium-danshensu,PAFLSMZLRSPALU-QMMMGPOBSA-N,Preclinical,,,,
sodium-dodecyl-sulfate,ISYOIFGRKUYTGX-UHFFFAOYSA-N,Launched,,ALB,,
sodium-gluconate,RGHNJXZEOKUKBD-SQOUGZDYSA-N,Launched,,,,
sodium-gualenate,VIZXMHCBZLGUET-UHFFFAOYSA-N,Launched,antacid,,gastroenterology|otolaryngology,peptic ulcer disease (PUD)|pharyngitis
sodium-monofluorophosphate,DWYMPOCYEZONEA-UHFFFAOYSA-N,Launched,,PYGM,dental,cavities
sodium-nitrite,ROODZSDSPAHHIS-UHFFFAOYSA-N,Launched,nitric oxide donor,,critical care,poison antidote|cyanide poisoning
sodium-nitroprusside,WTISQLWAPBSCSF-UHFFFAOYSA-N,Launched,nitric oxide donor,,cardiology,hypertension|congestive heart failure
sodium-orthovanadate,WQEVDHBJGNOKKO-UHFFFAOYSA-K,Preclinical,,,,
sodium-picosulfate,UJIDKYTZIQTXPM-UHFFFAOYSA-N,Launched,,,gastroenterology,constipation
sodium-stibogluconate,RPOBPHCDIPHDQL-XCCFGPONSA-L,Launched,tyrosine phosphatase inhibitor,PTPN6,infectious disease,leishmaniasis
sodium-tanshinone-II-A-sulfonate,UJCACMLMPLLRGW-UHFFFAOYSA-N,Phase 2,potassium channel activator,,,
sodium-tetradecyl-sulfate,GROJOWHVXQYQGN-KGLIPLIRSA-N,Launched,,PROC,dermatology,varicose veins
sofalcone,GFWRVVCDTLRWPK-KPKJPENVSA-N,Launched,mucus protecting agent,CBR1,gastroenterology,peptic ulcer disease (PUD)
sofosbuvir,TTZHDVOVKQGIBA-IQWMDFIBSA-N,Launched,HCV inhibitor,,infectious disease,hepatitis C|hepatitis C
sofosbuvir-impurity-m,WAKQLZVLNOKKHE-BFQGEBBDSA-N,Preclinical,antiviral,,,
sograzepide,YDZYKNJZCVIKPP-VWLOTQADSA-N,Phase 2,gastrin inhibitor,,,
solamargine,MBWUSSKCCUMJHO-OXBNUUDKSA-N,Phase 3,apoptosis inhibitor,,,
solcitinib,MPYACSQFXVMWNO-UHFFFAOYSA-N,Phase 1,JAK inhibitor,JAK1,,
solifenacin-succinate,FBOUYBDGKBSUES-VXKWHMMOSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,urology,urinary incontinence|urinary frequency
solithromycin,IXXFZUPTQVDPPK-ALZZPGSQSA-N,Phase 3,protein synthesis inhibitor,,,
solriamfetol,UCTRAOBQFUDCSR-SECBINFHSA-N,Launched,dopamine reuptake inhibitor,,neurology/psychiatry,narcolepsy
somantadine,OWKXRDQRMTVCEX-UHFFFAOYSA-N,Phase 1,antiviral,,,
somatostatin,NHXLMOGPVYXJNR-FMFSXUEQSA-N,Launched,somatostatin receptor agonist,OPRD1|OPRM1|SSTR1|SSTR2|SSTR3|SSTR4|SSTR5,hematology,hemorrhage
sonepiprazole,WNUQCGWXPNGORO-NRFANRHFSA-N,Phase 2,dopamine receptor antagonist,,,
sonidegib,VZZJRYRQSPEMTK-CALCHBBNSA-N,Launched,smoothened receptor antagonist,SMO,oncology,basal cell carcinoma (BCC)
sophocarpine,AAGFPTSOPGCENQ-JLNYLFASSA-N,Phase 3,,,,
sorafenib,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Launched,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET,oncology,renal cell carcinoma (RCC)|thyroid cancer|hepatocellular carcinoma (HCC)
soraprazan,PWILYDZRJORZDR-MISYRCLQSA-N,Preclinical,proton pump inhibitor,,,
sorbic-acid,WSWCOQWTEOXDQX-MQQKCMAXSA-N,Launched,,,,
sorbinil,LXANPKRCLVQAOG-NSHDSACASA-N,Phase 3,aldose reductase inhibitor,AKR1B1,,
sorbitan-monostearate,HVUMOYIDDBPOLL-XWVZOOPGSA-N,Preclinical,,,,
sorbitol,FBPFZTCFMRRESA-JGWLITMVSA-N,Launched,mucolytic agent,,gastroenterology,constipation
sotagliflozin,QKDRXGFQVGOQKS-CRSSMBPESA-N,Phase 3,sodium/glucose cotransporter inhibitor,SLC5A1|SLC5A2,,
sotalol,ZBMZVLHSJCTVON-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2|KCNH2,cardiology,atrial fibrillation (AF)|ventricular arrhythmias
sotrastaurin,OAVGBZOFDPFGPJ-UHFFFAOYSA-N,Phase 2,PKC inhibitor,PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ,,
SP-100030,GHMKQBWHPQMXSH-UHFFFAOYSA-N,Preclinical,NFkB pathway inhibitor,JUN|NFKB1,,
SP-141,AABFWJDLCCDJJN-UHFFFAOYSA-N,Preclinical,ubiquitin ligase inhibitor,MDM2,,
SP-420,YASYAEVZKXPYIZ-MRXNPFEDSA-N,Phase 1,,,,
spaglumic-acid,OPVPGKGADVGKTG-BQBZGAKWSA-N,Launched,glutamate receptor antagonist,GRM3,allergy,allergic conjunctivitis|allergic rhinitis
sparfloxacin,DZZWHBIBMUVIIW-DTORHVGOSA-N,Withdrawn,bacterial DNA gyrase inhibitor,TOP2A,,
sparfosate,ZZKNRXZVGOYGJT-GSVOUGTGSA-N,Phase 3,aspartate carbamoyltransferase inhibitor,CA2|CA4,,
sparsentan,WRFHGDPIDHPWIQ-UHFFFAOYSA-N,Phase 3,angiotensin receptor antagonist,,,
sparteine-(-),SLRCCWJSBJZJBV-ZQDZILKHSA-N,Launched,,,,
sparteine-(+),SLRCCWJSBJZJBV-TUVASFSCSA-N,Launched,,,,
sparteine-sulfate,SLRCCWJSBJZJBV-NMWPEEMBSA-N,Launched,,,,
spautin-1,AWIVHRPYFSSVOG-UHFFFAOYSA-N,Preclinical,deubiquitinase inhibitor,USP10|USP13,,
spectinomycin,UNFWWIHTNXNPBV-WXKVUWSESA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,pulmonary,airsacculitis|chronic respiratory disease
spermidine,ATHGHQPFGPMSJY-UHFFFAOYSA-N,Preclinical,glutamate receptor modulator,KCNJ4|TXNRD1,,
spermine,PFNFFQXMRSDOHW-UHFFFAOYSA-N,Preclinical,,CA14|CA4|CA6|CA9|CASR|GRIN1|GRIN2A|KCNJ4|ODC1|SMOX|SMS|TRPM4|TRPM5,,
sphingosylphosphorylcholine,JLVSPVFPBBFMBE-HXSWCURESA-O,Preclinical,gene expression stimulant,GPR12,,
spiperone,DKGZKTPJOSAWFA-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|ADRA1D|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7,neurology/psychiatry,schizophrenia
spiradoline,NYKCGQQJNVPOLU-ONTIZHBOSA-N,Phase 2,opioid receptor agonist,OPRK1,,
spiramycin,ACTOXUHEUCPTEW-VTGPZPQGSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,infectious disease,toxoplasmosis|soft tissue infection
spirobromin,JXEICPOBKSQAIU-UHFFFAOYSA-N,Phase 1,,,,
spironolactone,LXMSZDCAJNLERA-ZHYRCANASA-N,Launched,mineralocorticoid receptor antagonist,AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG,endocrinology|cardiology|gastroenterology|rheumatology,hyperaldosteronism|congestive heart failure|hepatic cirrhosis|nephrotic syndrome|hypertension|hypokalemia
spiroxatrine,JVGBTTIJPBFLTE-SFHVURJKSA-N,Preclinical,serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A|HTR2B,,
spizofurone,SETMGIIITGNLAS-UHFFFAOYSA-N,Withdrawn,,,,
splitomycin,ISFPDBUKMJDAJH-UHFFFAOYSA-N,Preclinical,SIRT inhibitor,SIRT1,,
SPP301,YBWLTKFZAOSWSM-UHFFFAOYSA-N,Phase 3,endothelin receptor antagonist,EDNRA,,
SPP86,JQOIRTDBHMDWMT-UHFFFAOYSA-N,Preclinical,receptor tyrosine protein kinase inhibitor,RET,,
SQ-109,JFIBVDBTCDTBRH-UNRAVDGJSA-N,Phase 3,bacterial cell wall synthesis inhibitor,FDFT1,,
SQ-22536,UKHMZCMKHPHFOT-ZCFIWIBFSA-N,Preclinical,adenylyl cyclase inhibitor,ADCY1,,
squalamine,UIRKNQLZZXALBI-MSVGPLKSSA-N,Phase 3,antiviral,,,
squaric-acid-dibutyl-ester,XBRWELTXMQSEIN-UHFFFAOYSA-N,Preclinical,oxidative stress inducer,,,
SR-1078,DUXWIYXHHGNUJU-UHFFFAOYSA-N,Preclinical,retinoid receptor agonist,RORA|RORC,,
SR-11302,RQANARBNMTXCDM-DKOHIBGUSA-N,Preclinical,,,,
SR-140333,RPDFDSQFBCJTDY-GAQXSTBRSA-N,Phase 2,neurokinin receptor antagonist,TACR1,,
SR-1664,IIJDFXNUWZTHIM-NRFANRHFSA-N,Preclinical,PPAR receptor ligand,PPARG,,
SR-2211,KVHKWAZUPPBMLL-UHFFFAOYSA-N,Preclinical,retinoid receptor inverse agonist,RORC,,
SR-2640,LMPZHLXYBWGGNT-UHFFFAOYSA-N,Phase 2,leukotriene receptor antagonist,CYSLTR1,,
SR-27897,ILNRQFBVVQUOLP-UHFFFAOYSA-N,Phase 2,CCK receptor antagonist,CCKAR,,
SR-3306,QDMXVKKPYBGIAS-UHFFFAOYSA-N,Preclinical,JNK inhibitor,MAPK10|MAPK8|MAPK9,,
SR-33805,GCVFQRRBTCHIPK-UHFFFAOYSA-N,Phase 1,calcium channel blocker,,,
SR-3576,MTFAYLZZDJGFGV-UHFFFAOYSA-N,Preclinical,JNK inhibitor,MAPK10,,
SR-3677,OQWZIAVXCYIZNN-OAQYLSRUSA-N,Preclinical,rho associated kinase inhibitor,ROCK2,,
SR-57227A,WPVVMKYQOMJPIN-UHFFFAOYSA-N,Phase 2,serotonin receptor agonist,HTR3A,,
SR-59230A,VFDHMSXXELYMRW-ICSRJNTNSA-N,Preclinical,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,,
SR-95639A,RUTYAHFAKWVMNH-UHFFFAOYSA-N,Preclinical,acetylcholine receptor agonist,CHRM1,,
SRC-kinase-inhibitor-I,DMWVGXGXHPOEPT-UHFFFAOYSA-N,Preclinical,SRC inhibitor,CSK|LCK|RIPK2,,
SRPIN340,DWFGGOFPIISJIT-UHFFFAOYSA-N,Preclinical,serine arginine protein kinase inhibitor,SRPK1|SRPK2,,
SRT1720,IASPBORHOMBZMY-UHFFFAOYSA-N,Preclinical,SIRT activator,SIRT1,,
SRT2104,LAMQVIQMVKWXOC-UHFFFAOYSA-N,Phase 2,SIRT activator,SIRT1,,
SRT3190,QVKPEMXUBULFBM-FZMZJTMJSA-N,Preclinical,CC chemokine receptor antagonist,,,
SSR128129E,SNMCWIDCSPHZRD-UHFFFAOYSA-N,Preclinical,,,,
SSR180711,RXLOZRCLQMJJLC-UHFFFAOYSA-N,Phase 2,acetylcholine receptor agonist,CHRNA7,,
SSR240612,QGWIQIAWOCJRPI-WSCVWKGISA-N,Preclinical,bradykinin receptor antagonist,,,
ST-1535,CYYQMAWUIRPCNW-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,,,
ST-1859,ZPANWZBSGMDWON-UHFFFAOYSA-N,Phase 1,antiamyloidogenic agent,,,
ST-2825,HBLHLJXFIPCEMW-ZJSFPPFMSA-N,Preclinical,myeloid differentiation primary response inhibitor,MYD88,,
ST-91,IALHTUPVRAQZFI-UHFFFAOYSA-N,Preclinical,adrenergic receptor agonist,,,
STA-5326,HSKAZIJJKRAJAV-KOEQRZSOSA-N,Phase 2,interleukin synthesis inhibitor,IL12A,,
STA-5326,"InChI=1S/C23H26N6O2/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28)/b25-17+",Phase 2,interleukin synthesis inhibitor,IL12A,,
STAT3-inhibitor-VI,HWNUSGNZBAISFM-UHFFFAOYSA-N,Preclinical,STAT inhibitor,STAT3,,
statil,LKBFFDOJUKLQNY-UHFFFAOYSA-N,Preclinical,aldose reductase inhibitor,,,
stattic,ZRRGOUHITGRLBA-UHFFFAOYSA-N,Preclinical,,,,
stavudine,XNKLLVCARDGLGL-JGVFFNPUSA-N,Launched,DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
stemregenin-1,BGFHMYJZJZLMHW-UHFFFAOYSA-N,Preclinical,aryl hydrocarbon receptor antagonist,AHR,,
stepronin,JNYSEDHQJCOWQU-ZCFIWIBFSA-N,Launched,mucolytic agent,,,
stetaderm,BFZHCUBIASXHPK-QJSKAATBSA-N,Launched,,,,
STF-083010,TVIVJHZHPKNDAQ-MHWRWJLKSA-N,Preclinical,serine/threonine kinase inhibitor,ERN1,,
STF-118804,DLFCEZOMHBPDGI-UHFFFAOYSA-N,Preclinical,NAMPT inhibitor,NAMPT,,
STF-31,NGQPRVWTFNBUHA-UHFFFAOYSA-N,Preclinical,NAMPT inhibitor,NAMPT|SLC2A1,,
STF-62247,KATNUHQNJGNLPW-UHFFFAOYSA-N,Preclinical,autophagy inducer,,,
stigmasterol,HCXVJBMSMIARIN-PHZDYDNGSA-N,Preclinical,,,,
stiripentol,IBLNKMRFIPWSOY-IYNGYCSASA-N,Launched,GABA uptake inhibitor,GABRA3,neurology/psychiatry,epilepsy
stobadine,CYJQCYXRNNCURD-DGCLKSJQSA-N,Phase 2,adrenergic receptor antagonist,ADRA1A,,
streptomycin,UCSJYZPVAKXKNQ-HZYVHMACSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,tuberculosis
streptozotocin,BKWHZSFINQBEQH-GKHCUFPYSA-N,Launched,DNA alkylating agent,,oncology,pancreatic cancer
strontium-ranelate,TWHPPRXFYWSOQF-UHFFFAOYSA-J,Launched,bone formation stimulant|bone resorption inhibitor,CASR,orthopedics|rheumatology,osteoporosis|osteoarthritis
strychnine,QMGVPVSNSZLJIA-FVWCLLPLSA-N,Preclinical,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA10|CHRNA9|GLRA1|GLRA2|GLRA3|GLRB,,
SU014813,CTNPALGJUAXMMC-PMFHANACSA-N,Phase 2,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,,
SU11274,FPYJSJDOHRDAMT-KQWNVCNZSA-N,Preclinical,hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor,MET,,
SU16f,APYYTEJNOZQZNA-MOSHPQCFSA-N,Preclinical,PDGFR tyrosine kinase receptor inhibitor,PDGFRB,,
SU3327,NQQBNZBOOHHVQP-UHFFFAOYSA-N,Preclinical,JNK inhibitor,MAPK8,,
SU4312,UAKWLVYMKBWHMX-PTNGSMBKSA-N,Preclinical,PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor,KDR|PDGFRB,,
SU9516,QNUKRWAIZMBVCU-WCIBSUBMSA-N,Preclinical,CDK inhibitor,CDK1|CDK2|CDK4|CDK5,,
substance-P,ADNPLDHMAVUMIW-CUZNLEPHSA-N,Phase 1,neurokinin receptor antagonist,TACR1|TACR2|TACR3,,
succinic-acid,KDYFGRWQOYBRFD-UHFFFAOYSA-N,Launched,,ALDH5A1|ASPH|BBOX1|HSD17B6|OXCT1|OXCT2|P3H1|P3H2|P3H3|P4HA1|P4HA2|PLOD1|PLOD3|SDHA|SDHB|SDHC|SDHD|SLC13A1|SLC13A2|SLC13A3|SLC25A10|SUCLA2|SUCLG1|SUCLG2|SUCNR1|TMLHE,,
succinobucol,RKSMVPNZHBRNNS-UHFFFAOYSA-N,Phase 2/Phase 3,antioxidant,VCAM1,,
succinylcholine-chloride,AXOIZCJOOAYSMI-UHFFFAOYSA-N,Launched,,CHRFAM7A|CHRM1|CHRM2|CHRM3|CHRNA1|CHRNA10,neurology/psychiatry,muscle relaxant
succinylsulfathiazole,SKVLYVHULOWXTD-UHFFFAOYSA-N,Phase 2,dihydrofolate reductase inhibitor,DHFR,,
sucralfate,DTULOKYBGCTCFP-QRLOXDDHSA-A,Launched,antacid,,gastroenterology,duodenal ulcer disease
sucralose,BAQAVOSOZGMPRM-QBMZZYIRSA-N,Launched,,,,
sucrose,CZMRCDWAGMRECN-UGDNZRGBSA-N,Launched,,ACTA1|ATOX1|C22orf28|LYZ,,
sucrose-octaacetate,ZIJKGAXBCRWEOL-SAXBRCJISA-N,Preclinical,,,,
sudan-IV,RCTGMCJBQGBLKT-PAMTUDGESA-N,Preclinical,,,,
sufugolix,UCQSBGOFELXYIN-UHFFFAOYSA-N,Preclinical,gonadotropin releasing factor hormone receptor antagonist,,,
sugammadex,WHRODDIHRRDWEW-WXUQZJQRSA-N,Launched,neuromuscular blockade reversal agent,,,
sulbactam,FKENQMMABCRJMK-RITPCOANSA-N,Launched,beta lactamase inhibitor,,infectious disease,skin infections|intra-abdominal infections|gynecologic infections
sulbactam-pivoxil,OHPVYKXTRACOSQ-NXEZZACHSA-N,Launched,beta lactamase inhibitor,,infectious disease,skin infections
sulbentine,QFVAWNPSRQWSDU-UHFFFAOYSA-N,Preclinical,other antifungal,,,
sulbutiamine,CKHJPWQVLKHBIH-GPAWKIAZSA-N,Launched,acetylcholine receptor antagonist,,neurology/psychiatry,asthenia
sulconazole,AFNXATANNDIXLG-SFHVURJKSA-N,Launched,sterol demethylase inhibitor,,infectious disease,tinea pedis|tinea cruris|tinea corporis
sulfabenzamide,PBCZLFBEBARBBI-UHFFFAOYSA-N,Launched,bacterial antifolate,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
sulfacarbamide,WVAKABMNNSMCDK-UHFFFAOYSA-N,Withdrawn,,,,
sulfacetamide,SKIVFJLNDNKQPD-UHFFFAOYSA-N,Launched,PABA antagonist,,ophthalmology,conjunctivitis
sulfachlorpyridazine,XOXHILFPRYWFOD-UHFFFAOYSA-N,Launched,bacterial antifolate,,infectious disease,urinary tract infections
sulfadiazine,SEEPANYCNGTZFQ-UHFFFAOYSA-N,Launched,bacterial antifolate,,infectious disease|ophthalmology,malaria|meningitis|urinary tract infections|conjunctivitis|trachoma|chancroid
sulfadoxine,PJSFRIWCGOHTNF-UHFFFAOYSA-N,Launched,dihydropteroate synthase inhibitor,,infectious disease,malaria
sulfafurazole,NHUHCSRWZMLRLA-UHFFFAOYSA-N,Launched,bacterial antifolate,,infectious disease,urinary tract infections
sulfaguanidine,BRBKOPJOKNSWSG-UHFFFAOYSA-N,Launched,bacterial antifolate,,infectious disease,urinary tract infections
sulfamerazine,QPPBRPIAZZHUNT-UHFFFAOYSA-N,Launched,bacterial antifolate,,infectious disease,coccidiosis|cholera
sulfameter,GPTONYMQFTZPKC-UHFFFAOYSA-N,Launched,dihydrofolate reductase inhibitor,DHFR,infectious disease,urinary tract infections
sulfamethazine,ASWVTGNCAZCNNR-UHFFFAOYSA-N,Launched,PABA antagonist,,gastroenterology,enteritis
sulfamethizole,VACCAVUAMIDAGB-UHFFFAOYSA-N,Launched,bacterial antifolate,,infectious disease,urinary tract infections
sulfamethoxazole,JLKIGFTWXXRPMT-UHFFFAOYSA-N,Launched,PABA antagonist,,infectious disease|gastroenterology,pneumonia|enteritis|urinary tract infections
sulfamethoxypyridazine,VLYWMPOKSSWJAL-UHFFFAOYSA-N,Withdrawn,bacterial antifolate,,,
sulfametopyrazine,KXRZBTAEDBELFD-UHFFFAOYSA-N,Launched,PABA antagonist,,infectious disease,malaria|urinary tract infections|respiratory tract infections
sulfamonomethoxine,WMPXPUYPYQKQCX-UHFFFAOYSA-N,Launched,bacterial antifolate,,infectious disease,urinary tract infections
sulfamoxole,CYFLXLSBHQBMFT-UHFFFAOYSA-N,Launched,PABA antagonist,,infectious disease,urinary tract infections
sulfanilamide,FDDDEECHVMSUSB-UHFFFAOYSA-N,Launched,carbonic anhydrase inhibitor,CYP2C19|CYP2C9|CYP2D6|CYP2E1|CYP3A4,infectious disease,vulvovaginal candidiasis
sulfanilate-zinc,RIUORJCWAHCMSA-UHFFFAOYSA-L,Preclinical,,,,
sulfanitran,GWBPFRGXNGPPMF-UHFFFAOYSA-N,Launched,,,infectious disease,coccidiosis
sulfaphenazole,QWCJHSGMANYXCW-UHFFFAOYSA-N,Launched,dihydropteroate synthetase inhibitor,DHPS,infectious disease,urinary tract infections
sulfapyridine,GECHUMIMRBOMGK-UHFFFAOYSA-N,Launched,PABA antagonist,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
sulfaquinoxaline,NHZLNPMOSADWGC-UHFFFAOYSA-N,Launched,vitamin K antagonist,,infectious disease,coccidiosis
sulfasalazine,NCEXYHBECQHGNR-QZQOTICOSA-N,Launched,cyclooxygenase inhibitor,ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1,gastroenterology,ulcerative colitis
sulfathiazole,JNMRHUJNCSQMMB-UHFFFAOYSA-N,Launched,dihydropteroate synthase inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
sulfatinib,TTZSNFLLYPYKIL-UHFFFAOYSA-N,Phase 1,tyrosine kinase inhibitor,,,
sulfinpyrazone,MBGGBVCUIVRRBF-LJAQVGFWSA-N,Launched,uricosuric blocker,ABCC1|FPR1|SLC22A12,rheumatology,gout
sulfisomidin,YZMCKZRAOLZXAZ-UHFFFAOYSA-N,Preclinical,antibacterial,,,
sulfisoxazole-acetyl,JFNWFXVFBDDWCX-UHFFFAOYSA-N,Launched,folic acid antagonist,,infectious disease|otolaryngology,meningitis|urinary tract infections|otitis|trachoma
sulforaphane,SUVMJBTUFCVSAD-SNVBAGLBSA-N,Phase 2,anticancer agent|aryl hydrocarbon receptor antagonist,NFE2L2,,
sulindac,MLKXDPUZXIRXEP-LQVWSKNFSA-N,Launched,cyclooxygenase inhibitor,AKR1B1,rheumatology,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis
sulisobenzone,CXVGEDCSTKKODG-UHFFFAOYSA-N,Launched,,,dermatology,sunscreen lotion
sulmazole,XMFCOYRWYYXZMY-HXUWFJFHSA-N,Phase 1,adenosine receptor antagonist,,,
sulmetozine,MVOUIYUWRXPNKD-UHFFFAOYSA-N,Launched,gastrin inhibitor,GAST,gastroenterology,peptic ulcer disease (PUD)
suloctidil,BFCDFTHTSVTWOG-YLJYHZDGSA-N,Withdrawn,adrenergic receptor antagonist,,,
sulopenem,FLSUCZWOEMTFAQ-PRBGKLEPSA-N,Phase 3,antibacterial,,,
sulphadimethoxine,ZZORFUFYDOWNEF-UHFFFAOYSA-N,Launched,dihydropteroate synthetase inhibitor,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
sulpiride,BGRJTUBHPOOWDU-LLVKDONJSA-N,Launched,dopamine receptor antagonist,,neurology/psychiatry,schizophrenia
sultamicillin,OPYGFNJSCUDTBT-PMLPCWDUSA-N,Launched,antibacterial ,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
sultiame,HMHVCUVYZFYAJI-UHFFFAOYSA-N,Phase 3,carbonic anhydrase inhibitor,CA2,,
sultopride,UNRHXEPDKXPRTM-ZDUSSCGKSA-N,Preclinical,dopamine receptor antagonist,,,
sumanirole,RKZSNTNMEFVBDT-MRVPVSSYSA-N,Phase 3,dopamine receptor agonist,DRD2,,
sumatriptan,KQKPFRSPSRPDEB-UHFFFAOYSA-N,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7,neurology/psychiatry,migraine headache
SUN-11602,KCODNOOPOPTZMO-UHFFFAOYSA-N,Preclinical,fibroblast growth factor mimetic,FGFR1,,
SUN-B-8155,SGJLINMLDNLWOS-CXUHLZMHSA-N,Preclinical,calcitonin agonist,CALCR,,
sunitinib,WINHZLLDWRZWRT-ATVHPVEESA-N,Launched,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,CSF1R|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB|RET,oncology,gastrointestinal stromal tumors (GIST)|renal cell carcinoma (RCC)|neuroendocrine tumors of pancreatic origin (PNET)
suplatast,DYZJXZOQQRXDLE-CQSZACIVSA-O,Launched,histamine release inhibitor|immunoglobulin inhibitor,,rheumatology,Kimura's disease
suprofen,MDKGKXOCJGEUJW-SECBINFHSA-N,Withdrawn,cyclooxygenase inhibitor,PTGS1|PTGS2,,
suramin,FIAFUQMPZJWCLV-UHFFFAOYSA-N,Launched,DNA synthesis inhibitor,F2|FSHR|P2RY1|P2RY11|P2RY13|P2RY2|PLA2G2A|RYR1|RYR2|SIRT5,infectious disease,African trypanosomiasis|onchocerciasis
suritozole,IWDUZEHNLHFBRZ-UHFFFAOYSA-N,Phase 2,GABA receptor inverse agonist,GABBR1,,
sutezolid,FNDDDNOJWPQCBZ-ZDUSSCGKSA-N,Phase 2,protein synthesis inhibitor,,,
suxibuzone,ONWXNHPOAGOMTG-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,,rheumatology|neurology/psychiatry,joint pain|muscle pain
swainsonine,FXUAIOOAOAVCGD-WCTZXXKLSA-N,Phase 2,alpha mannosidase inhibitor,MAN2A1,,
SX-011,GUTYHDCSDBBMGW-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor,MAPK14,,
SY-640,JIWDGIYBLGMPRV-UHFFFAOYSA-N,Phase 2,,,,
SYM-2081,KRKRAOXTGDJWNI-DMTCNVIQSA-N,Preclinical,kainate receptor antagonist,GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SLC1A2,,
SYM-2206,OFUDZKKOKPGXOH-LBPRGKRZSA-N,Preclinical,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,,
symclosene,YRIZYWQGELRKNT-UHFFFAOYSA-N,Preclinical,,,,
synephrine,YRCWQPVGYLYSOX-SECBINFHSA-N,Launched,adrenergic receptor agonist,ADRA1A,otolaryngology,sinusitis
T-0070907,FRPJSHKMZHWJBE-UHFFFAOYSA-N,Preclinical,PPAR receptor antagonist,PPARG,,
T-0156,JEMJAABFSYOLAP-UHFFFAOYSA-N,Preclinical,phosphodiesterase inhibitor,PDE5A,,
T-025,PMWVYONICYRLNY-UHFFFAOYSA-N,Preclinical,CLK inhibitor,,,
T-0901317,SGIWFELWJPNFDH-UHFFFAOYSA-N,Preclinical,LXR agonist,NCOA1|NCOA2|NR1H2|NR1H3|NR1I2|RXRB,,
T-1095,BXNCIERBDJYIQT-PRDVQWLOSA-N,Preclinical,sodium/glucose cotransporter inhibitor,,,
T-5224,DALCQQSLNPLQFZ-UHFFFAOYSA-N,Phase 2,AP inhibitor,JUN,,
T-5601640,XVOKFRPKSAWELK-UHFFFAOYSA-N,Preclinical,LIM kinase inhibitor,LIMK2,,
T-62,OTZVBZFYMFTYKH-UHFFFAOYSA-N,Phase 2,adenosine receptor modulator,ADORA2A,,
T-807,GETAAWDSFUCLBS-UHFFFAOYSA-N,Phase 2,PET radiotracer,,,
TA-01,TWPJJJZCYVFUOA-UHFFFAOYSA-N,Preclinical,casein kinase inhibitor|MAP kinase inhibitor,CSNK1D|CSNK1E|MAPK14,,
tabimorelin,WURGZWOTGMLDJP-ZCYANPAGSA-N,Phase 2,growth hormone secretagogue receptor agonist,GHSR,,
tacalcitol,BJYLYJCXYAMOFT-RSFVBTMBSA-N,Launched,vitamin D receptor agonist,VDR,dermatology,psoriasis|chapped lips
tacedinaline,VAZAPHZUAVEOMC-UHFFFAOYSA-N,Phase 3,HDAC inhibitor,HDAC1,,
tacrine,YLJREFDVOIBQDA-UHFFFAOYSA-N,Launched,acetylcholinesterase inhibitor,ACHE|BCHE,neurology/psychiatry,Alzheimer's disease
tacrolimus,QJJXYPPXXYFBGM-LFZNUXCKSA-N,Launched,calcineurin inhibitor,FKBP1A,transplant,organ rejection
tadalafil,WOXKDUGGOYFFRN-IIBYNOLFSA-N,Launched,phosphodiesterase inhibitor,PDE11A|PDE5A,urology,erectile dysfunction
tafamidis-meglumine,TXEIIPDJKFWEEC-UHFFFAOYSA-N,Launched,transthyretin amyloid inhibitor,TTR,neurology/psychiatry,familial amyloid polyneuropathy (FAP)
tafenoquine,LBHLFPGPEGDCJG-HNNXBMFYSA-N,Launched,antimalarial agent,,infectious disease,malaria
tafluprost,WSNODXPBBALQOF-VEJSHDCNSA-N,Launched,prostaglandin inhibitor,PTGFR,ophthalmology,glaucoma|ocular hypertension
tagatose,BJHIKXHVCXFQLS-PQLUHFTBSA-N,Launched,phosphorylase inhibitor,PYGL,,
TAK-063,KVHRYLNQDWXAGI-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,PDE10A,,
TAK-220,ASSJTMUEFHUKMJ-UHFFFAOYSA-N,Phase 1,CC chemokine receptor antagonist,CCR5,,
TAK-243,KJDAGXLMHXUAGV-DGWLBADLSA-N,Phase 1,ubiquitin activating enzyme inhibitor,,,
TAK-285,ZYQXEVJIFYIBHZ-UHFFFAOYSA-N,Phase 1,EGFR inhibitor,ERBB2,,
TAK-593,DZFZXPPHBWCXPQ-UHFFFAOYSA-N,Phase 1,VEGFR inhibitor,PDGFRA,,
TAK-632,OJFKUJDRGJSAQB-UHFFFAOYSA-N,Preclinical,RAF inhibitor,BRAF,,
TAK-659,MJHOMTRKVMKCNE-NWDGAFQWSA-N,Phase 2,spleen associated tyrosine kinase inhibitor,,,
TAK-715,HEKAIDKUDLCBRU-UHFFFAOYSA-N,Phase 2,p38 MAPK inhibitor,MAPK14,,
TAK-733,RCLQNICOARASSR-SECBINFHSA-N,Phase 1,MEK inhibitor,MAP2K1,,
TAK-779,XNHZXMPLVSJQFK-UHFFFAOYSA-O,Preclinical,CC chemokine receptor antagonist,,,
TAK-875,BZCALJIHZVNMGJ-HSZRJFAPSA-N,Phase 3,insulin secretagogue,FFAR1,,
TAK-901,WKDACQVEJIVHMZ-UHFFFAOYSA-N,Phase 1,Aurora kinase inhibitor,AURKB,,
TAK-960,GWRSATNRNFYMDI-UHFFFAOYSA-N,Phase 1,PLK inhibitor,PLK1,,
talabostat,FKCMADOPPWWGNZ-YUMQZZPRSA-N,Phase 3,dipeptidyl peptidase inhibitor|fibroblast activation protein inhibitor,DPP4,,
taladegib,SZBGQDXLNMELTB-UHFFFAOYSA-N,Phase 2,smoothened receptor antagonist,DHH|IHH|SMO,,
talampanel,JACAAXNEHGBPOQ-LLVKDONJSA-N,Phase 2,glutamate receptor antagonist,GRIA1|GRIA2|GRIA3|GRIA4,,
talaporfin,SIEXFRDYNDREBM-WSUYNKMOSA-N,Phase 3,photosensitizing agent,,,
talarozole,SNFYYXUGUBUECJ-FQEVSTJZSA-N,Phase 2,cytochrome P450 inhibitor,CYP26A1,,
talazoparib,HWGQMRYQVZSGDQ-HZPDHXFCSA-N,Launched,PARP inhibitor,PARP2,oncology,breast cancer
talinolol,MXFWWQICDIZSOA-QGZVFWFLSA-N,Launched,adrenergic receptor antagonist,ADRB1,cardiology,hypertension
talipexole,DHSSDEDRBUKTQY-UHFFFAOYSA-N,Launched,adrenergic receptor agonist|dopamine receptor agonist,ADRA2A|DRD2|HTR3A,infectious disease,genitial herpes
talmapimod,ZMELOYOKMZBMRB-DLBZAZTESA-N,Phase 2,p38 MAPK inhibitor,IL1B|MAPK11|MAPK14|MT-CO2|TNF,,
talnetant,BIAVGWDGIJKWRM-FQEVSTJZSA-N,Phase 2,tachykinin antagonist,TACR2|TACR3,,
talniflumate,ANMLJLFWUCQGKZ-HXUWFJFHSA-N,Launched,cyclooxygenase inhibitor,CLCA1,neurology/psychiatry,pain relief
talopram,LJBBMCNHIUJBDU-FQEVSTJZSA-N,Phase 2,adrenergic inhibitor,SLC6A2,,
talsaclidine,XVFJONKUSLSKSW-JTQLQIEISA-N,Phase 2/Phase 3,acetylcholine receptor agonist,,,
taltirelin,LQZAIAZUDWIVPM-SRVKXCTJSA-N,Launched,thyrotropin releasing hormone receptor agonist,TRHR,neurology/psychiatry,spinocerebellar ataxia
taltobulin,CNTMOLDWXSVYKD-PSRNMDMQSA-N,Phase 1,tubulin polymerization inhibitor,,,
TAME,FKMJXALNHKIDOD-LBPRGKRZSA-N,Preclinical,,,,
tamibarotene,MUTNCGKQJGXKEM-UHFFFAOYSA-N,Launched,retinoid receptor agonist,RARA|RARB,hematologic malignancy,acute promyelocytic leukemia (APL)
tamibarotene,"InChI=1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-16(9-10-17(18)21)23-19(24)14-5-7-15(8-6-14)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26)",Launched,retinoid receptor agonist,RARA|RARB,hematologic malignancy,acute promyelocytic leukemia (APL)
taminadenant,ATFXVNUWQOXRRU-UHFFFAOYSA-N,Phase 1/Phase 2,adenosine receptor antagonist,,,
tamoxifen,NKANXQFJJICGDU-QPLCGJKRSA-N,Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ,oncology,breast cancer
tamsulosin,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,urology,benign prostatic hyperplasia (BPH)
tanaproget,PYVFWTPEBMRKSR-UHFFFAOYSA-N,Phase 2,progesterone receptor agonist,PGR,,
tandospirone,CEIJFEGBUDEYSX-FZDBZEDMSA-N,Launched,serotonin receptor agonist,HTR1A,neurology/psychiatry,generalized anxiety disorder (GAD)|dysthymic disorder
tandutinib,UXXQOJXBIDBUAC-UHFFFAOYSA-N,Phase 2,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,CSF1R|FLT3|KIT|PDGFD|PDGFRB,,
tanespimycin,AYUNIORJHRXIBJ-FBDSWQSESA-N,Phase 3,HSP inhibitor,HSP90AA1,,
tangeritin,ULSUXBXHSYSGDT-UHFFFAOYSA-N,Preclinical,cell cycle inhibitor,,,
tannic-acid,LRBQNJMCXXYXIU-PPKXGCFTSA-N,Launched,PARG inhibitor,ANO1,gastroenterology,constipation
tanshinone-I,AIGAZQPHXLWMOJ-UHFFFAOYSA-N,Phase 2,AP inhibitor,IFNG,,
tanshinone-IIA,HYXITZLLTYIPOF-UHFFFAOYSA-N,Phase 2/Phase 3,anti-inflammatory agent|interleukin inhibitor,IL1B|NR1I2|TNF,,
tapinarof,ZISJNXNHJRQYJO-CMDGGOBGSA-N,Phase 3,aryl hydrocarbon receptor agonist,,,
taprenepag,MFFBXYNKZHTCEY-UHFFFAOYSA-N,Phase 2,prostaglandin receptor agonist,PTGER2,,
tarafenacin,UXZDMXYRRQJIBJ-IBGZPJMESA-N,Phase 2,acetylcholine receptor antagonist,CHRM3,,
taranabant,QLYKJCMUNUWAGO-GAJHUEQPSA-N,Phase 3,cannabinoid receptor inverse agonist,CNR1,,
targinine,NTNWOCRCBQPEKQ-YFKPBYRVSA-N,Phase 3,nitric oxide synthase inhibitor,NOS3,,
tariquidar,LGGHDPFKSSRQNS-UHFFFAOYSA-N,Phase 3,P glycoprotein inhibitor,ABCB1,,
tariquidar,"InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43)",Phase 3,P glycoprotein inhibitor,ABCB1,,
tartaric-acid,FEWJPZIEWOKRBE-JCYAYHJZSA-N,Launched,antioxidant,,,
TAS-103,ROWSTIYZUWEOMM-UHFFFAOYSA-N,Phase 1,topoisomerase inhibitor,TOP1,,
taselisib,BEUQXVWXFDOSAQ-UHFFFAOYSA-N,Phase 3,PI3K inhibitor,PIK3CA,,
taselisib,"InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33)",Phase 3,PI3K inhibitor,PIK3CA,,
tasimelteon,PTOIAAWZLUQTIO-GXFFZTMASA-N,Launched,melatonin receptor agonist,MTNR1A|MTNR1B,neurology/psychiatry,Non-24-Hour Sleep-Wake Disorder
tasisulam,WWONFUQGBVOKOF-UHFFFAOYSA-N,Phase 3,apoptosis stimulant,,,
tasquinimod,ONDYALNGTUAJDX-UHFFFAOYSA-N,Phase 3,angiogenesis inhibitor|S100A9 inhibitor,HDAC4,,
tasuldine,HMCTXMOKMWELFJ-UHFFFAOYSA-N,Phase 3,mucolytic agent,,,
taurine,XOAAWQZATWQOTB-UHFFFAOYSA-N,Launched,antioxidant,,neurology/psychiatry,anxiety|irritability|sleeplessness
taurocholate,WBWWGRHZICKQGZ-HZAMXZRMSA-N,Phase 1,G protein-coupled receptor agonist,CEL|FABP6|SLCO1C1,,
tauroglycocholate,URJQSMIFSMHWSP-VVHBOOHCSA-N,Preclinical,membrane permeability enhancer,,,
taurolidine,AJKIRUJIDFJUKJ-UHFFFAOYSA-N,Launched,apoptosis stimulant,,infectious disease,catheter-related bloodstream infection
tavaborole,LFQDNHWZDQTITF-UHFFFAOYSA-N,Launched,leucyl-tRNA synthetase inhibitor,,infectious disease,onychomycosis
tavilermide,DVJXNXPFYJIACK-ULQDDVLXSA-N,Phase 3,tyrosine kinase partial agonist,,,
taxifolin,CXQWRCVTCMQVQX-LSDHHAIUSA-N,Phase 2,opioid receptor antagonist,ADIPOR2,,
tazarotene,OGQICQVSFDPSEI-UHFFFAOYSA-N,Launched,retinoid receptor agonist,RARA|RARB|RARG|RXRB,dermatology,cosmetic|sunscreen lotion
tazemetostat,NSQSAUGJQHDYNO-UHFFFAOYSA-N,Launched,histone lysine methyltransferase inhibitor,EZH2,,
tazobactam,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,Launched,beta lactamase inhibitor,,infectious disease,pneumonia
TBA-354,ZXSGSFMORAILEY-HNNXBMFYSA-N,Phase 1,,,,
TBOA-(DL),CSEZCYBVEGIYNG-MFBWXLJUSA-N,Preclinical,excitatory amino acid transporter inhibitor,SLC1A1|SLC1A2|SLC1A3|SLC1A6|SLC1A7,,
TC-A-2317,XHHRGYCOEVNAKV-ZDUSSCGKSA-N,Preclinical,Aurora kinase inhibitor,AURKA,,
TC-ASK-10,SMJAMOAYGIVKRI-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor,MAP3K5|MAP3K6,,
TC-E-5002,NEHSERYKENINRH-UHFFFAOYSA-N,Preclinical,histone demethylase inhibitor,KDM2A|KDM4A|KDM4C|KDM5A|KDM6A|KDM7A|PHF8,,
TC-E-5006,ONYWALXTZFPKAS-WINIVTDRSA-N,Preclinical,gamma secretase modulator,APP,,
TC-F-2,NXTBLPPTZRPJCA-IBGZPJMESA-N,Preclinical,FAAH inhibitor,FAAH,,
TC-FPR-43,PAEBEUZTAPIOIO-UHFFFAOYSA-N,Preclinical,formyl peptide receptor agonist,FPR2,,
TC-G-1000,RLKWQKZPCMICPS-UHFFFAOYSA-N,Preclinical,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,,
TC-G-1004,JENSDTKXNVHSSN-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA2A,,
TC-G-1005,JQULIQJSYPZQMA-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor agonist,GPBAR1,,
TC-G-1008,DRSZMILOMUPIBJ-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor agonist,GPR39,,
TC-H-106,WTKBRPXPNAKVEQ-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,,
TC-H-106,"InChI=1S/C20H25N3O2/c1-15-11-13-16(14-12-15)22-19(24)9-3-2-4-10-20(25)23-18-8-6-5-7-17(18)21/h5-8,11-14H,2-4,9-10,21H2,1H3,(H,22,24)(H,23,25)",Preclinical,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,,
TC-I-15,XKLHCUGVLCGKKX-RBUKOAKNSA-N,Preclinical,integrin inhibitor,ITGA2|ITGB1,,
TC-I-2000,ADCDUDFEGFKKQH-NRFANRHFSA-N,Preclinical,transient receptor potential channel antagonist,TRPM8,,
TC-I-2014,VSMFCZZEKTVDHM-UHFFFAOYSA-N,Preclinical,transient receptor potential channel antagonist,TRPM8,,
TC-LPA5-4,BNALUYKEGYUHQC-UHFFFAOYSA-N,Preclinical,lysophosphatidic acid receptor antagonist,LPAR5,,
TC-Mps1-12,XDEFNAWAKYQBQY-UHFFFAOYSA-N,Preclinical,monopolar spindle 1 kinase inhibitor,TTK,,
TC-N-1752,QLKAFHZJICDACE-UHFFFAOYSA-N,Preclinical,sodium channel blocker,SCN9A,,
TC-NTR1-17,ZQUSYVORYNBGLG-FQEVSTJZSA-N,Preclinical,neurotensin agonist,NTSR1,,
TC-O-9311,KPTMSQHTGZMEFU-UHFFFAOYSA-N,Preclinical,G protein-coupled receptor agonist,GPR139,,
TC-OT-39,KSNHHKZYKYNBEI-NDEPHWFRSA-N,Preclinical,oxytocin receptor agonist|vasopressin receptor agonist,AVPR1A|OXT,,
TC-S-7003,BHJJWVDKNXABFS-UHFFFAOYSA-N,Preclinical,SRC inhibitor,LCK,,
TC-S-7004,CQKBSRPVZZLCJE-UHFFFAOYSA-N,Preclinical,DYRK inhibitor,DYRK1A|DYRK1B,,
TC-S-7005,DAAGOCSHXCDWDY-ZDUSSCGKSA-N,Preclinical,PLK inhibitor,PLK2,,
TC-S-7006,NMEUKWOOQOHUNA-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor,MAP3K8,,
TC-S-7009,CDQUJZKBRAFWNG-UHFFFAOYSA-N,Preclinical,hypoxia inducible factor inhibitor,EPAS1,,
TC-SP-14,GVXGVDIXINMAAL-UHFFFAOYSA-N,Preclinical,sphingosine 1-phosphate receptor agonist,S1PR1,,
TC1,FYGREZKTJIXWIH-APDWONGJSA-N,Preclinical,beta-secretase inhibitor,BACE1,,
TC1,"InChI=1S/C19H20FNO/c20-9-3-1-2-8(6-9)4-5-21-18-14-10-7-11-13-12(10)15(18)17(13)19(21,22)16(11)14/h1-3,6,10-18,22H,4-5,7H2/t10-,11+,12+,13-,14+,15+,16-,17+,18-,19-/m1/s1",Preclinical,beta-secretase inhibitor,BACE1,,
TC2559,HFZDMKMXPGRKCK-GQCTYLIASA-N,Preclinical,acetylcholine receptor agonist,CHRNA4,,
TCID,IDLAOWFFKWRNHB-UHFFFAOYSA-N,Preclinical,,,,
TCN201,FYIBXBFDXNPBSF-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRIN2A,,
TCN238,LNUXNUNUGIHCPA-VOTSOKGWSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM4,,
TCS-2002,RCKYSTKYIVULEK-DEOSSOPVSA-N,Preclinical,glycogen synthase kinase inhibitor,GSK3B,,
TCS-21311,CLGRAWDGLMENOD-UHFFFAOYSA-N,Preclinical,JAK inhibitor,JAK3,,
TCS-2210,ZOFZKGFBKISZRI-UHFFFAOYSA-N,Preclinical,neural stem cell inducer,,,
TCS-2314,ITXAAOWFOURIHK-DEOSSOPVSA-N,Preclinical,integrin inhibitor,ITGA4|ITGB1,,
TCS-3035,WXMCOLGPDOYHNK-UITAMQMPSA-N,Preclinical,G protein-coupled receptor agonist,GPR35,,
TCS-359,FSPQCTGGIANIJZ-UHFFFAOYSA-N,Preclinical,FLT3 inhibitor,FLT3,,
TCS-5861528,ZUTUWJYMCADJHD-GFCCVEGCSA-N,Preclinical,transient receptor potential channel antagonist,TRPA1,,
TCS-HDAC6-20b,DQZMLPMCOMRJOR-MOVGKWKRSA-N,Preclinical,HDAC inhibitor,HDAC6,,
TCS-OX2-29,COFVZFLCAOUMJT-OAQYLSRUSA-N,Preclinical,orexin receptor antagonist,HCRTR2,,
TCS-OX2-29,"InChI=1S/C23H31N3O3/c1-23(2,3)21(25-14-16-6-9-24-10-7-16)22(27)26-11-8-17-12-19(28-4)20(29-5)13-18(17)15-26/h6-7,9-10,12-13,21,25H,8,11,14-15H2,1-5H3/t21-/m1/s1",Preclinical,orexin receptor antagonist,HCRTR2,,
TCS-PIM-1-1,SVSYJTYGPLVUOZ-UHFFFAOYSA-N,Preclinical,Pim kinase inhibitor,PIM1,,
TCV-309,NWWZMECSQFUIGC-UHFFFAOYSA-O,Preclinical,platelet activating factor receptor antagonist,,,
TD139,YGIDGBAHDZEYMT-MQFIMZJJSA-N,Phase 2,anti-inflammatory agent,,,
tebipenem,SNUDIPVBUUXCDG-QHSBEEBCSA-N,Launched,bacterial cell wall synthesis inhibitor,CNR1,infectious disease|otolaryngology,pneumonia|otitis
tecadenoson,OESBDSFYJMDRJY-BAYCTPFLSA-N,Phase 2,adenosine receptor agonist,ADORA1,,
tecalcet,ZVQUCWXZCKWZBP-CQSZACIVSA-N,Phase 2,calcium-sensing receptor agonist,CASR,,
tecastemizole,SFOVDSLXFUGAIV-UHFFFAOYSA-N,Phase 3,histamine receptor antagonist,KCNH2,,
tecovirimat,CSKDFZIMJXRJGH-VWLPUNTISA-N,Launched,orthopoxvirus egress inhibitor,,infectious disease,smallpox
tedizolid,XFALPSLJIHVRKE-GFCCVEGCSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,infectious disease,skin infections
tedizolid-phosphate,QCGUSIANLFXSGE-GFCCVEGCSA-N,Launched,protein synthesis inhibitor,,infectious disease,skin infections
tegaserod,IKBKZGMPCYNSLU-RGVLZGJSSA-N,Withdrawn,serotonin receptor partial agonist,HTR2A|HTR2B|HTR2C|HTR4,,
tegobuvir,XBEQSQDCBSKCHJ-UHFFFAOYSA-N,Phase 3,HCV inhibitor|protease inhibitor,,,
teicoplanin,BJNLLBUOHPVGFT-SZRRLYCBSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections
teicoplanin-A2-1,YMWQIYMUNZBOOV-FEHVOAPLSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections
teicoplanin-A2-3,FHBQKTSCJKPYIO-VHULWTHOSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,gram-positive bacterial infections
teijin-compound-1,BAOQJSULMWXFRK-GOSISDBHSA-N,Preclinical,CC chemokine receptor antagonist,CCR2,,
telaprevir,BBAWEDCPNXPBQM-GDEBMMAJSA-N,Launched,HCV inhibitor,CTSA|PGR,infectious disease,hepatitis C
telatinib,QFCXANHHBCGMAS-UHFFFAOYSA-N,Phase 2,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,KDR,,
telbivudine,IQFYYKKMVGJFEH-CSMHCCOUSA-N,Launched,DNA polymerase inhibitor,,infectious disease,hepatitis B
telcagepant,CGDZXLJGHVKVIE-DNVCBOLYSA-N,Phase 3,calcitonin antagonist,CALCRL|RAMP1,,
telenzepine,VSWPGAIWKHPTKX-UHFFFAOYSA-N,Phase 3,acetylcholine receptor antagonist,CHRM1,,
telithromycin,LJVAJPDWBABPEJ-PIRKDXADSA-N,Launched,bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor,CYP1A2|CYP2D6|CYP3A4|CYP3A5|CYP3A7,infectious disease,pneumonia
telmesteine,XBJWOGLKABXFJE-RXMQYKEDSA-N,Launched,mucolytic agent,,pulmonary,cough suppressant
telmisartan,RMMXLENWKUUMAY-UHFFFAOYSA-N,Launched,angiotensin receptor antagonist,AGTR1|PPARG,cardiology,hypertension
telotristat,NCLGDOBQAWBXRA-PGRDOPGGSA-N,Launched,tryptophan hydroxylase inhibitor,TPH1,gastroenterology,diarrhea
telotristat-ethyl,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Launched,tryptophan hydroxylase inhibitor,TPH1,gastroenterology,diarrhea
telratolimod,RRTPWQXEERTRRK-UHFFFAOYSA-N,Preclinical,toll-like receptor agonist,,,
temanogrel,ZEOQUKRCASTCFR-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,,,
temefos,WWJZWCUNLNYYAU-UHFFFAOYSA-N,Launched,cholinesterase inhibitor,,,
temocapril,FIQOFIRCTOWDOW-BJLQDIEVSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology|nephrology,hypertension|congestive heart failure|diabetic nephropathy|coronary artery disease (CAD)
temoporfin,JGLSWAGTNWZKQU-WWMKMEMESA-N,Launched,radical formation stimulant,,oncology,head and neck squamous cell carcinoma (HNSCC)
temozolomide,BPEGJWRSRHCHSN-UHFFFAOYSA-N,Launched,DNA alkylating agent,MGMT,oncology,glioblastoma|astrocytoma
tempol,CSGAUKGQUCHWDP-UHFFFAOYSA-N,Phase 2,free radical scavenger,,,
temsirolimus,CBPNZQVSJQDFBE-NRNHWJPGSA-N,Launched,mTOR inhibitor,MTOR,oncology,renal cell carcinoma (RCC)
TEN-010,PKQXLRYFPSZKDU-QFIPXVFZSA-N,Preclinical,bromodomain inhibitor,,,
tenalisib,HDXDQPRPFRKGKZ-INIZCTEOSA-N,Phase 2,PI3K inhibitor,,,
tenapanor,DNHPDWGIXIMXSA-CXNSMIOJSA-N,Launched,sodium/hydrogen exchanger inhibitor,,,
tenatoprazole,ZBFDAUIVDSSISP-DEOSSOPVSA-N,Phase 2,ATPase inhibitor,IDO1,,
teneligliptin,WGRQANOPCQRCME-PMACEKPBSA-N,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus
tenidap,IGPDWKCUDHIIRL-LLVKDONJSA-N,Phase 3,cyclooxygenase inhibitor,KCNJ4|PTGS1,,
tenilsetam,BBACKDMGYMXYLE-SSDOTTSWSA-N,Phase 3,AGE inhibitor,,,
teniposide,NRUKOCRGYNPUPR-QBPJDGROSA-N,Launched,topoisomerase inhibitor,TOP2A|TOP2B,hematologic malignancy,acute lymphoblastic leukemia (ALL)
tenofovir,SGOIRFVFHAKUTI-ZCFIWIBFSA-N,Launched,HIV integrase inhibitor|nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)|hepatitis B
tenofovir-alafenamide,LDEKQSIMHVQZJK-FOCZCJQRSA-N,Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,hepatitis B
tenofovir-disoproxil,JFVZFKDSXNQEJW-CQSZACIVSA-N,Launched,nucleoside reverse transcriptase inhibitor,CYP1A2,infectious disease,human immunodeficiency virus (HIV-1)|hepatitis B
tenovin-1,WOWJIWFCOPZFGV-UHFFFAOYSA-N,Preclinical,SIRT inhibitor|TP53 activator,SIRT1,,
tenovin-6,BVJSXSQRIUSRCO-UHFFFAOYSA-N,Preclinical,SIRT inhibitor,SIRT1|SIRT2|SIRT3,,
tenoxicam,LZNWYQJJBLGYLT-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology|orthopedics,rheumatoid arthritis|osteoarthritis|ankylosing spondylitis|tendinitis|bursitis|periarthritis
tenylidone,KHXBULXCCPIELT-DCIPZJNNSA-N,Preclinical,,,,
tepoxalin,XYKWNRUXCOIMFZ-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor|lipoxygenase inhibitor,ALOX5,rheumatology|orthopedics,rheumatoid arthritis|hip dysplasia
TEPP-46,ZWKJWVSEDISQIS-RUZDIDTESA-N,Preclinical,pyruvate kinase isozyme activator,PKM,,
teprenone,HUCXKZBETONXFO-NJFMWZAGSA-N,Launched,mucus protecting agent,,dermatology,cosmetic
terameprocol,ORQFDHFZSMXRLM-IYBDPMFKSA-N,Phase 1/Phase 2,lipoxygenase inhibitor,BIRC5|CDK1,,
terazosin,VCKUSRYTPJJLNI-CQSZACIVSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension
terbinafine,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,Launched,fungal squalene epoxidase inhibitor,SQLE,infectious disease,tinea pedis|tinea cruris|tinea corporis
terbutaline,XWTYSIMOBUGWOL-LLVKDONJSA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,bronchospasm|bronchitis|emphysema
terciprazine,SDKXUWMRKYQIFU-HXUWFJFHSA-N,Phase 1,,,,
terconazole,BLSQLHNBWJLIBQ-OZXSUGGESA-N,Launched,sterol demethylase inhibitor,,infectious disease,vulvovaginal candidiasis
terfenadine,GUGOEEXESWIERI-PMERELPUSA-N,Withdrawn,histamine receptor antagonist,HRH1|KCNH1|KCNH2,,
terguride,JOAHPSVPXZTVEP-YXJHDRRASA-N,Launched,dopamine receptor agonist|serotonin receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C,neurology/psychiatry,Parkinson's Disease
teriflunomide,NABQBYDEMLGCEO-SNVBAGLBSA-N,Launched,dihydroorotate dehydrogenase inhibitor,DHODH,neurology/psychiatry,multiple sclerosis
terlipressin,BENFXAYNYRLAIU-WBNRJDGRSA-N,Launched,vasopressin receptor agonist,AVPR1A,cardiology,hypotension
terodiline,UISARWKNNNHPGI-INIZCTEOSA-N,Withdrawn,cholinergic receptor antagonist,,,
teroxirone,OUPZKGBUJRBPGC-CIUDSAMLSA-N,Phase 1,DNA inhibitor,,,
terpene,RBNWAMSGVWEHFP-CZMCAQCFSA-N,Preclinical,,,,
terreic-acid-(-),NYFMSQHOGRWGFD-OOVQLBIQSA-N,Preclinical,Bruton's tyrosine kinase (BTK) inhibitor,BTK,,
terutroban,HWEOXFSBSQIWSY-MRXNPFEDSA-N,Phase 3,prostanoid receptor antagonist,TBXA2R,,
tesaglitazar,CXGTZJYQWSUFET-IBGZPJMESA-N,Phase 3,insulin sensitizer|PPAR receptor agonist,PPARA|PPARG,,
tetomilast,XDBHURGONHZNJF-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,PDE4D,,
tetrabenazine,MKJIEFSOBYUXJB-HOCLYGCPSA-N,Launched,vesicular monoamine transporter inhibitor,SLC18A1|SLC18A2,infectious disease|neurology/psychiatry,cholera|Huntington's disease
tetracaine,GKCBAIGFKIBETG-UHFFFAOYSA-N,Launched,membrane integrity inhibitor,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,anesthetic
tetracycline,MUHBBHLZPHKTTR-VHOYBAKPSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease|dermatology,respiratory tract infections|pneumonia|skin infections|urinary tract infections|acne vulgaris (AV)|plague|psittacosis
tetradecylthioacetic-acid,IPBCWPPBAWQYOO-UHFFFAOYSA-N,Phase 2,lipid peroxidase inhibitor,,,
tetraethylenepentamine,FAGUFWYHJQFNRV-UHFFFAOYSA-N,Phase 2/Phase 3,superoxide dismutase inhibitor,SOD1|SOD2,,
tetrahydrofolic-acid,MSTNYGQPCMXVAQ-RYUDHWBXSA-N,Launched,,FOLR2,,
tetrahydropapaverine,YXWQTVWJNHKSCC-MRXNPFEDSA-N,Preclinical,,,,
tetrahydrouridine,UCKYOOZPSJFJIZ-FMDGEEDCSA-N,Phase 2,cytidine deaminase inhibitor,CDA,,
tetrahydrozoline,BYJAVTDNIXVSPW-LBPRGKRZSA-N,Launched,adrenergic receptor agonist,,ophthalmology,eye irritation
tetramethylthiuram-monosulfide,REQPQFUJGGOFQL-UHFFFAOYSA-N,Preclinical,,,,
tetramisole,HLFSDGLLUJUHTE-SNVBAGLBSA-N,Launched,immunostimulant,ALPPL2|CHRNA3,infectious disease,gastrointestinal parasites
tetrandrine,WVTKBKWTSCPRNU-KYJUHHDHSA-N,Preclinical,calcium channel blocker,SLC6A3,,
tetrazol-5-yl-glycine-(RS),UKBRUIZWQZHXFL-PVQJCKRUSA-N,Preclinical,glutamate receptor agonist,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D,,
tetrindole,AUXCHYJDVJZEPG-UHFFFAOYSA-N,Phase 3,monoamine oxidase inhibitor,MAOA,,
tetroquinone,GQPHQLHUIDOQTA-UHFFFAOYSA-N,Preclinical,,,,
tezacaftor,MJUVRTYWUMPBTR-MRXNPFEDSA-N,Launched,CFTR channel agonist,,pulmonary,cystic fibrosis
TFC-007,NLSSUSRERAMBTA-UHFFFAOYSA-N,Preclinical,prostaglandin inhibitor,HPGDS,,
TG-003,BGVLELSCIHASRV-QPEQYQDCSA-N,Preclinical,CLK inhibitor,CLK1|CLK4|DYRK1A|DYRK1B,,
TG-02,VXBAJLGYBMTJCY-NSCUHMNNSA-N,Phase 1/Phase 2,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,CDK1|CDK2|CDK7|CDK9|FLT3|JAK2,,
TG-100572,AQSSMEORRLJZLU-UHFFFAOYSA-N,Preclinical,SRC inhibitor|VEGFR inhibitor,KDR|SRC,,
TG-100713,UOORQSPLBHUQDQ-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,,,
TG-100801,JMGXJHWTVBGOKG-UHFFFAOYSA-N,Phase 2,SRC inhibitor|VEGFR inhibitor,CSK|FGFR1|FLT1|FLT4|KDR|SRC,,
TG-101209,JVDOKQYTTYUYDV-UHFFFAOYSA-N,Preclinical,JAK inhibitor,JAK2|JAK3,,
TG100-115,UJIAQDJKSXQLIT-UHFFFAOYSA-N,Phase 1/Phase 2,PI3K inhibitor,PIK3CA|PIK3CB|PIK3CD|PIK3CG,,
TGR-1202,IUVCFHHAEHNCFT-INIZCTEOSA-N,Phase 3,PI3K inhibitor,,,
TGX-221,CPRAGQJXBLMUEL-MRXNPFEDSA-N,Preclinical,PI3K inhibitor,PIK3CB|PIK3CD,,
TH-302,UGJWRPJDTDGERK-UHFFFAOYSA-N,Phase 3,DNA alkylating agent,,,
TH-588,PNMYJIOQIAEYQL-UHFFFAOYSA-N,Preclinical,MTH1 inhibitor,NUDT1,,
thaliblastine,ZCTJIMXXSXQXRI-KYJUHHDHSA-N,Phase 2,DNA inhibitor,,,
thalidomide,UEJJHQNACJXSKW-VIFPVBQESA-N,Launched,tumor necrosis factor production inhibitor,TNF,oncology,myeloma
theaflavin,SPQUOZYCYRJYJU-ZKSIBHASSA-N,Preclinical,antiviral,,,
theobromine,YAPQBXQYLJRXSA-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,ADORA1|ADORA2A|PDE4B,,
thiamet-g,PPAIMZHKIXDJRN-FMDGEEDCSA-N,Preclinical,GLCNAC phosphotransferase inhibitor,MGEA5,,
thiamine,JZRWCGZRTZMZEH-UHFFFAOYSA-N,Launched,vitamin B,SLC19A2|SLC19A3|TPK1,metabolism,thiamine deficiency
thiamine-pyrophosphate,AYEKOFBPNLCAJY-UHFFFAOYSA-O,Launched,,,hematology,anemia
thiamphenicol,OTVAEFIXJLOWRX-NXEZZACHSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,infectious disease,pelvic inflammatory disease
thiamylal,XLOMZPUITCYLMJ-MRVPVSSYSA-N,Launched,glutamate receptor antagonist,GABRA1,neurology/psychiatry,sedative
thiazovivin,DOBKQCZBPPCLEG-UHFFFAOYSA-N,Preclinical,rho associated kinase inhibitor,,,
thiethylperazine,XCTYLCDETUVOIP-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD1|DRD2|DRD4,gastroenterology,nausea
thiocolchicoside,LEQAKWQJCITZNK-AXHKHJLKSA-N,Launched,GABA receptor antagonist,GABRA1|GABRB2|GABRG2|GLRA1|GLRB,neurology/psychiatry,muscle relaxant
thioctic-acid,AGBQKNBQESQNJD-ZETCQYMHSA-N,Launched,reducing agent,ACHE|PTGS2,nephrology,diabetic nephropathy
thiodiglycol,YODZTKMDCQEPHD-UHFFFAOYSA-N,Preclinical,,,,
thioguanine,WYWHKKSPHMUBEB-UHFFFAOYSA-N,Launched,purine antagonist,IMPDH1|IMPDH2,hematologic malignancy,acute myeloid leukemia (AML)
thiomersal,HXQVQGWHFRNKMS-UHFFFAOYSA-M,Launched,other antibiotic,OXCT1,infectious disease,preservative
thiopental,IUJDSEJGGMCXSG-SSDOTTSWSA-N,Launched,GABA receptor antagonist,FAAH,neurology/psychiatry,anesthetic
thioperamide,JFAYRTHYLOZRNL-CQSZACIVSA-N,Preclinical,histamine receptor antagonist,HRH3|HRH4,,
thiophanate,QGHREAKMXXNCOA-UHFFFAOYSA-N,Preclinical,,,,
thioproperazine,VZYCZNZBPPHOFY-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,ADRA1A|ADRA1B|DRD1|DRD2|HTR1A|HTR2A,neurology/psychiatry,schizophrenia
thioridazine,KLBQZWRITKRQQV-UHFFFAOYSA-N,Withdrawn,dopamine receptor antagonist,DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7,,
thiorphan,LJJKNPQAGWVLDQ-SNVBAGLBSA-N,Phase 1,membrane metalloendopeptidase inhibitor,MME,,
thiostrepton,NSFFHOGKXHRQEW-AIHSUZKVSA-N,Launched,FOXM1 inhibitor|protein synthesis inhibitor,FOXM1,obstetrics/gynecology,mastitis
thiotepa,FOCVUCIESVLUNU-UHFFFAOYSA-N,Launched,cytochrome P450 inhibitor,CYP2B6|CYP3A4,oncology,breast cancer|ovarian cancer|bladder cancer
thiothixene,GFBKORZTTCHDGY-UWVJOHFNSA-N,Launched,dopamine receptor antagonist,DRD1|DRD2|HRH1|HTR2A,neurology/psychiatry,schizophrenia
thiram,KUAZQDVKQLNFPE-UHFFFAOYSA-N,Launched,,JAK2,ophthalmology,contact dermatitis
THK5351,DLVXFZWSPCOWSN-CQSZACIVSA-N,Phase 2,PET radiotracer ,,,
thonzonium,IOYZYMQFUSNATM-UHFFFAOYSA-N,Launched,ATPase inhibitor,,infectious disease,ear infections
thonzylamine,GULNIHOSWFYMRN-UHFFFAOYSA-N,Launched,antihistamine,,neurology/psychiatry,itching
threo-2-methylisocitrate-(DL),ZSOGGZWFKNMGJN-WREOTHMNSA-N,Preclinical,isocitrate lyase substrate,,,
thymalfasin,NZVYCXVTEHPMHE-ZSUJOUNUSA-N,Launched,immune response modulator,,infectious disease,hepatitis B|hepatitis C
thymol,MGSRCZKZVOBKFT-UHFFFAOYSA-N,Launched,GABA receptor positive allosteric modulator,TRPA1,infectious disease,ringworm|antiseptic
thymol-iodide,SHOKWSLXDAIZPP-UHFFFAOYSA-N,Preclinical,,,,
thymopentin,PSWFFKRAVBDQEG-YGQNSOCVSA-N,Launched,immune response stimulator,,,
THZ1,OBJNFLYHUXWUPF-IZZDOVSWSA-N,Preclinical,CDK inhibitor,CDK7,,
THZ1-R,TUERFPPIPKZNKE-UHFFFAOYSA-N,Preclinical,CDK inhibitor,CDK7,,
THZ2,FONRCZUZCHXWBD-VGOFMYFVSA-N,Preclinical,CDK inhibitor,CDK7,,
tiabendazole,WJCNZQLZVWNLKY-UHFFFAOYSA-N,Launched,angiogenesis inhibitor,,infectious disease,gastrointestinal roundworms|hookworm
tiagabine,PBJUNZJWGZTSKL-MRXNPFEDSA-N,Launched,GABA uptake inhibitor,SLC6A1,neurology/psychiatry,seizures
tianeptine,JICJBGPOMZQUBB-OAQYLSRUSA-N,Launched,selective serotonin reuptake enhancer (SSRE),OPRD1|OPRK1|OPRM1,neurology/psychiatry|pulmonary|gastroenterology,depression|asthma|irritable bowel syndrome
tiapride,JTVPZMFULRWINT-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,DRD2|DRD3,neurology/psychiatry,dyskinesia|abstinence from alcohol|psychosis
tiaprofenic-acid,GUHPRPJDBZHYCJ-SECBINFHSA-N,Launched,cyclooxygenase inhibitor,PTGS2,rheumatology,rheumatoid arthritis
tiaramide,HTJXMOGUGMSZOG-UHFFFAOYSA-N,Launched,anti-inflammatory agent,,pulmonary,asthma
tibolone,WZDGZWOAQTVYBX-TZTUDTKPSA-N,Launched,androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist,ESR1,obstetrics/gynecology,endometriosis
TIC10,RSAQARAFWMUYLL-UHFFFAOYSA-N,Phase 2,AKT inhibitor|TRAIL modulator,AKT1|MAPK1,,
ticagrelor,OEKWJQXRCDYSHL-FNOIDJSQSA-N,Launched,purinergic receptor antagonist,P2RY12,cardiology,acute coronary syndrome (ACS)|myocardial infarction
ticarcillin,OHKOGUYZJXTSFX-KZFFXBSXSA-N,Launched,lactamase inhibitor,,infectious disease,gram-negative bacterial infections
ticlopidine,PHWBOXQYWZNQIN-UHFFFAOYSA-N,Launched,purinergic receptor antagonist,P2RY12,hematology|neurology/psychiatry,thrombosis|stroke
tideglusib,PMJIHLSCWIDGMD-UHFFFAOYSA-N,Phase 2,glycogen synthase kinase inhibitor,GSK3B,,
tie2-kinase-inhibitor,SINQIEAULQKUPD-JGCGQSQUSA-N,Preclinical,TIE tyrosine kinase inhibitor,KDR|MAPK14,,
tienilic-acid,AGHANLSBXUWXTB-UHFFFAOYSA-N,Withdrawn,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,CYP2C9|SLC12A1,,
tifenazoxide,KYSFUHHFTIGRJN-UHFFFAOYSA-N,Phase 1,ATP-sensitive potassium channel agonist,ABCC8|KCNJ11,,
tigecycline,CGZOGNUFXMNYEI-PBZRBWFISA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,skin infections|pneumonia|intra-abdominal infections
tilmicosin,JTSDBFGMPLKDCD-UYPDHHONSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,pulmonary,bovine respiratory disease (BRD)
tilorone,MPMFCABZENCRHV-UHFFFAOYSA-N,Launched,interferon inducer,,infectious disease|gastroenterology|neurology/psychiatry,influenza A virus infection|diarrhea|hepatitis B|multiple sclerosis|urinary tract infections|virus herpes simplex (HSV)|hepatitis C
tiludronate,DKJJVAGXPKPDRL-UHFFFAOYSA-N,Launched,bone resorption inhibitor|osteoclast inhibitor,ATP6V1A|MMP2|PTPN1,orthopedics,navicular syndrome
timofibrate,QSNOWCXXECLALL-LLVKDONJSA-N,Phase 2,cholesterol inhibitor|lipase clearing factor inhibitor,LPL,,
timolol,BLJRIMJGRPQVNF-JTQLQIEISA-N,Launched,adrenergic receptor antagonist,ADRB1|ADRB2,ophthalmology,ocular hypertension|glaucoma
timonacic,DZLNHFMRPBPULJ-GSVOUGTGSA-N,Launched,antioxidant,,,
tinazoline,JENBDJGHNIOHAJ-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,,,
tinidazole,HJLSLZFTEKNLFI-UHFFFAOYSA-N,Launched,antiprotozoal agent,,infectious disease|obstetrics/gynecology,giardiasis|amebiasis|bacterial vaginosis|trichomoniasis
tinoridine,PFENFDGYVLAFBR-UHFFFAOYSA-N,Launched,anti-inflammatory agent,,neurology/psychiatry,pain relief
tioconazole,QXHHHPZILQDDPS-HNNXBMFYSA-N,Launched,sterol demethylase inhibitor,,infectious disease,yeast infection
tioguanine,OTDJAMXESTUWLO-UUOKFMHZSA-N,Launched,purine antagonist,,hematologic malignancy,acute myeloid leukemia (AML)|acute lymphoblastic leukemia (ALL)|chronic myeloid leukemia (CML)
tiopronin,YTGJWQPHMWSCST-GSVOUGTGSA-N,Launched,chelating agent|reducing agent,,urology,kidney stones
tiotidine,YDDXVAXDYKBWDX-UHFFFAOYSA-N,Phase 2,histamine receptor antagonist,HRH2,,
tiotropium,LERNTVKEWCAPOY-DZZGSBJMSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,pulmonary,chronic obstructive pulmonary disease (COPD)|bronchitis|emphysema
tioxolone,SLYPOVJCSQHITR-UHFFFAOYSA-N,Preclinical,carbonic anhydrase inhibitor,CA2,,
tipelukast,KPWYNAGOBXLMSE-UHFFFAOYSA-N,Phase 2,leukotriene receptor antagonist,,,
tipifarnib,PLHJCIYEEKOWNM-HHHXNRCGSA-N,Phase 3,farnesyltransferase inhibitor,FNTA|FNTB,,
tipifarnib,"InChI=1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m1/s1",Phase 3,farnesyltransferase inhibitor,FNTA|FNTB,,
tipiracil,QQHMKNYGKVVGCZ-UHFFFAOYSA-N,Launched,thymidine phosphorylase inhibitor,,oncology,colorectal cancer
tiplaxtinin,ODXQFEWQSHNQNI-UHFFFAOYSA-N,Phase 1,plasminogen activator inhibitor,SERPINE1,,
tipranavir,MYXACKZCYFKMTE-WWKQIGMOSA-N,Launched,HIV protease inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
tiprenolol,CSUNLSYSEQIDMO-NSHDSACASA-N,Phase 2,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,,
tiquizium,ZGSDGGRVFIYKKE-OXQOHEQNSA-N,Launched,acetylcholine receptor antagonist,,neurology/psychiatry,spasms
tiracizine,KJAMZCVTJDTESW-UHFFFAOYSA-N,Withdrawn,sodium channel blocker,SCN5A,,
tirapazamine,ORYDPOVDJJZGHQ-UHFFFAOYSA-N,Phase 3,DNA inhibitor,,,
tirasemtiv,RSQGZEAXODVTOL-UHFFFAOYSA-N,Phase 2,troponin activator,,,
tiratricol,UOWZUVNAGUAEQC-UHFFFAOYSA-N,Launched,thyroid hormone stimulant,THRA|THRB,endocrinology,Refetoff syndrome
tirofiban,COKMIXFXJJXBQG-NRFANRHFSA-N,Launched,platelet aggregation inhibitor|structural glycoprotein antagonist,ITGA2B|ITGB3,cardiology,myocardial infarction|refactory angina
titanocene-dichloride,XKLWATAZDMHTSH-UHFFFAOYSA-L,Phase 2,apoptosis stimulant,,,
tivantinib,UCEQXRCJXIVODC-PMACEKPBSA-N,Phase 3,tyrosine kinase inhibitor,MET,,
tivozanib,SPMVMDHWKHCIDT-UHFFFAOYSA-N,Launched,VEGFR inhibitor,FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB,oncology,renal cell carcinoma (RCC)
tizanidine,XFYDIVBRZNQMJC-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C|NISCH,neurology/psychiatry,spasms
TMC-353121,DKORMNNYNRPTBJ-UHFFFAOYSA-N,Phase 2,RSV fusion inhibitor,,,
TMC647055,UOBYJVFBFSLCTQ-UHFFFAOYSA-N,Phase 2,RNA polymerase inhibitor,,,
TMN-355,SFNLLCUAISZNRV-UHFFFAOYSA-N,Preclinical,cyclophilin inhibitor,PPIA,,
TMPH,PWWKJRFUJIFGGD-UHFFFAOYSA-N,Preclinical,,,,
TMS,JDBCWSHYEQUBLW-AATRIKPKSA-N,Preclinical,,,,
TNP-470,MSHZHSPISPJWHW-PVDLLORBSA-N,Phase 2,methionine aminopeptidase inhibitor,METAP2,,
tobramycin,NLVFBUXFDBBNBW-PBSUHMDJSA-N,Launched,bacterial 30S ribosomal subunit inhibitor,,infectious disease,bacterial septicemia|respiratory tract infections|meningitis|skin infections|urinary tract infections
tocainide,BUJAGSGYPOAWEI-SECBINFHSA-N,Launched,sodium channel blocker,SCN5A,cardiology,cardiac arrythmia
toceranib,SRSGVKWWVXWSJT-ATVHPVEESA-N,Launched,protein tyrosine kinase inhibitor,FLT1|FLT3|KDR|PDGFRA|PDGFRB,oncology,cutaneous mast cell tumors
tocofersolan,AOBORMOPSGHCAX-AZAGJHQNSA-N,Launched,antioxidant,,cardiology,cerebral cholesterosis
todralazine,WGZDBVOTUVNQFP-UHFFFAOYSA-N,Launched,antihypertensive agent,,cardiology,hypertension
tofacitinib,UJLAWZDWDVHWOW-YPMHNXCESA-N,Launched,JAK inhibitor,JAK1|JAK2|JAK3,rheumatology,rheumatoid arthritis
tofisopam,LOUZDJSQOFXLAP-UHFFFAOYSA-N,Launched,cytochrome P450 inhibitor|phosphodiesterase inhibitor,CYP3A4,neurology/psychiatry,anxiety|abstinence from alcohol
tofogliflozin,VWVKUNOPTJGDOB-BDHVOXNPSA-N,Launched,sodium/glucose cotransporter inhibitor,GCK,endocrinology,diabetes mellitus
tolamolol,SKQDKFOTIPJUSV-INIZCTEOSA-N,Phase 3,adrenergic receptor antagonist,ADRB1|ADRB2|ADRB3,,
tolazamide,OUDSBRTVNLOZBN-UHFFFAOYSA-N,Launched,ATP channel blocker,ABCC8|KCNJ1|KCNJ10|KCNJ11,endocrinology,diabetes mellitus
tolazoline,JIVZKJJQOZQXQB-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRA1A|ADRA2A|ADRA2B|ADRA2C|HRH1|HRH2,neurology/psychiatry,reverse sedative
tolbutamide,JLRGJRBPOGGCBT-UHFFFAOYSA-N,Launched,ATP channel blocker,ABCC8|KCNJ1|KCNJ11|KCNJ8,endocrinology,diabetes mellitus
tolcapone,MIQPIUSUKVNLNT-UHFFFAOYSA-N,Withdrawn,catechol O methyltransferase inhibitor,COMT,,
tolfenamic-acid,YEZNLOUZAIOMLT-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor|prostanoid receptor antagonist,,neurology/psychiatry,migraine headache
tolimidone,HJQILFPVRNHTIG-UHFFFAOYSA-N,Phase 2,SRC activator,LYN|SRC,,
tolmetin,UPSPUYADGBWSHF-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,rheumatology,rheumatoid arthritis|osteoarthritis
tolnaftate,FUSNMLFNXJSCDI-UHFFFAOYSA-N,Launched,fungal squalene epoxidase inhibitor,,infectious disease,tinea pedis|tinea corporis
tolonidine,KWBTZIFLQYYPTH-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,ADRA2A,,
tolonium,KZEUBCUXBNEMSQ-UHFFFAOYSA-O,Launched,,,hematology,methemoglobinemia
toloxatone,MXUNKHLAEDCYJL-JTQLQIEISA-N,Launched,monoamine oxidase inhibitor,MAOA|MAOB,neurology/psychiatry,depression
tolperisone,FSKFPVLPFLJRQB-AWEZNQCLSA-N,Launched,voltage-gated sodium channel blocker,CYP2C19|CYP2D6,neurology/psychiatry|infectious disease|rheumatology|cardiology,muscle relaxant|multiple sclerosis|encephalomyelitis|ankylosing spondylitis|atherosclerosis|Raynaud's disease
tolrestat,LUBHDINQXIHVLS-UHFFFAOYSA-N,Withdrawn,aldose reductase inhibitor,AKR1A1|AKR1B1|AKR1B10,,
tolterodine,OOGJQPCLVADCPB-HXUWFJFHSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,urology,urinary incontinence|urinary frequency
toltrazuril,OCINXEZVIIVXFU-UHFFFAOYSA-N,Launched,antiprotozoal agent,,infectious disease,coccidiosis
tolvaptan,GYHCTFXIZSNGJT-XMMPIXPASA-N,Launched,vasopressin receptor antagonist,AVPR1A|AVPR2,endocrinology|cardiology|gastroenterology,hyponatremia|congestive heart failure|hepatic cirrhosis
tomeglovir,OSQAKHSYTKBSPB-UHFFFAOYSA-N,Preclinical,antiviral,,,
tomelukast,MWYHLEQJTQJHSS-UHFFFAOYSA-N,Phase 3,leukotriene receptor antagonist,CYSLTR1,,
tomivosertib,HKTBYUWLRDZAJK-UHFFFAOYSA-N,Phase 2,MAPK-interacting kinase inhibitor,,,
tonabersat,XLIIRNOPGJTBJD-ROUUACIJSA-N,Phase 2,gap junction modulator|nitric oxide production inhibitor,,,
topilutamide,YCNCRLKXSLARFT-NSHDSACASA-N,Preclinical,androgen receptor antagonist,,,
topiramate,KJADKKWYZYXHBB-XBWDGYHZSA-N,Launched,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,epilepsy|migraine headache
topiroxostat,UBVZQGOVTLIHLH-UHFFFAOYSA-N,Launched,xanthine oxidase inhibitor,XDH,rheumatology|nephrology,gout|hyperuricemia
topotecan,UCFGDBYHRUNTLO-QHCPKHFHSA-N,Launched,topoisomerase inhibitor,TOP1|TOP1MT,oncology,small cell lung cancer|cervical cancer
torasemide,NGBFQHCMQULJNZ-UHFFFAOYSA-N,Launched,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,SLC12A1,cardiology,edema|congestive heart failure|hypertension
torcetrapib,CMSGWTNRGKRWGS-NQIIRXRSSA-N,Phase 3,cholesteryl ester transfer protein inhibitor,CETP,,
torcitabine,CKTSBUTUHBMZGZ-SHYZEUOFSA-N,Phase 2,DNA polymerase inhibitor,DCK|TK2,,
toremifene,XFCLJVABOIYOMF-QPLCGJKRSA-N,Launched,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),ESR1,oncology,breast cancer
torin-1,AKCRNFFTGXBONI-UHFFFAOYSA-N,Preclinical,mTOR inhibitor,MTOR,,
torin-2,GUXXEUUYCAYESJ-UHFFFAOYSA-N,Preclinical,mTOR inhibitor,MTOR,,
tosedostat,FWFGIHPGRQZWIW-SQNIBIBYSA-N,Phase 2,peptidase inhibitor,ANPEP|LAP3|NPEPPS,,
tosufloxacin,WUWFMDMBOJLQIV-JTQLQIEISA-N,Launched,bacterial DNA gyrase inhibitor,,infectious disease,gram-negative bacterial infections
toyocamycin,XOKJUSAYZUAMGJ-WOUKDFQISA-N,Phase 1,serine/threonine kinase inhibitor,ERN1,,
tozadenant,XNBRWUQWSKXMPW-UHFFFAOYSA-N,Phase 3,adenosine receptor antagonist,ADORA2A,,
tozasertib,GCIKSSRWRFVXBI-UHFFFAOYSA-N,Phase 2,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,AURKA|AURKB|AURKC|LCK,,
TP-003,SJMMDWXJSSJHOQ-UHFFFAOYSA-N,Preclinical,GABA receptor inverse agonist,GABRA1|GABRA2|GABRA3|GABRA5,,
TP-0903,YUAALFPUEOYPNX-UHFFFAOYSA-N,Phase 1/Phase 2,AXL kinase inhibitor,AXL,,
TP-3654,XRNVABDYQLHODA-JCNLHEQBSA-N,Phase 1,"1,4,5-trisphosphate inhibitor",,,
TPCA-1,SAYGKHKXGCPTLX-UHFFFAOYSA-N,Preclinical,IKK inhibitor,IKBKB,,
TPPS4,PBHVCRIXMXQXPD-LWQDQPMZSA-N,Phase 1,,,,
trabectedin,PKVRCIRHQMSYJX-AIFWHQITSA-N,Phase 3,antitumor agent,,,
trabodenoson,AQLVRTWKJDTWQQ-SDBHATRESA-N,Phase 3,adenosine receptor agonist,,,
tracazolate,PCTRYMLLRKWXGF-UHFFFAOYSA-N,Phase 2,GABA receptor modulator,GABRA1,,
tradipitant,CAVRKWRKTNINFF-UHFFFAOYSA-N,Phase 3,neurokinin receptor antagonist,,,
TRAM-34,KBFUQFVFYYBHBT-UHFFFAOYSA-N,Preclinical,potassium channel antagonist,KCNN4,,
TRAM-39,JHNRTPKGSCVKKC-UHFFFAOYSA-N,Preclinical,calcium-activated potassium channel activator,KCNN4,,
trametinib,LIRYPHYGHXZJBZ-UHFFFAOYSA-N,Launched,MEK inhibitor,MAP2K1|MAP2K2,oncology,melanoma
tramiprosate,SNKZJIOFVMKAOJ-UHFFFAOYSA-N,Phase 3,beta amyloid protein neurotoxicity inhibitor,APP,,
trandolapril,VXFJYXUZANRPDJ-WTNASJBWSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension|myocardial infarction
tranexamic-acid,GYDJEQRTZSCIOI-LJGSYFOKSA-N,Launched,antifibrinolytic|plasminogen activator inhibitor,PLG,hematology,hemophilia
tranilast,NZHGWWWHIYHZNX-CSKARUKUSA-N,Launched,angiogenesis inhibitor,HPGDS|HRH1,pulmonary,asthma
"trans-10,cis-12-conjugated-linoleic-acid",GKJZMAHZJGSBKD-NMMTYZSQSA-N,Launched,,,,
trans-2-undecenoic-acid,IGBBVTAVILYDIO-MDZDMXLPSA-N,Preclinical,,,,
"trans-4-[8-(3-fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid",XWVBOPKUSVZZPJ-UHFFFAOYSA-N,Preclinical,,,,
trans-4-hydroxycrotonic-acid,RMQJECWPWQIIPW-OWOJBTEDSA-N,Preclinical,gamma hydroxybutyric acid ligand,,,
trans-4-methoxycinnamic-acid,AFDXODALSZRGIH-QPJJXVBHSA-N,Preclinical,,,,
transcrocetinate,PANKHBYNKQNAHN-MQQNZMFNSA-N,Preclinical,glutamate receptor antagonist,,,
tranylcypromine,AELCINSCMGFISI-BDAKNGLRSA-N,Launched,monoamine oxidase inhibitor,KDM1A|MAOA|MAOB,neurology/psychiatry,depression
trap-101,DCRGHMJXEBSRQG-UHFFFAOYSA-N,Preclinical,nociceptin/orphanin FQ receptor antagonist|opioid receptor antagonist,OPRL1,,
trapidil,GSNOZLZNQMLSKJ-UHFFFAOYSA-N,Launched,PDGFR tyrosine kinase receptor inhibitor,PDGFRA,cardiology,coronary artery disease (CAD)
travoprost,MKPLKVHSHYCHOC-AHTXBMBWSA-N,Launched,prostanoid receptor agonist,PTGFR,ophthalmology,ocular hypertension|glaucoma
traxoprodil,QEMSVZNTSXPFJA-HNAYVOBHSA-N,Phase 2,glutamate receptor antagonist,GRIN2B,,
trazodone,PHLBKPHSAVXXEF-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4,neurology/psychiatry,depression
trebenzomine,FDJAKSHVOONYHX-KOLCDFICSA-N,Phase 2,,,,
trelagliptin,IWYJYHUNXVAVAA-OAHLLOKOSA-N,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus
tremorine,JSUAJTLKVREZHV-UHFFFAOYSA-N,Preclinical,acetylcholine receptor agonist,,,
treosulfan,YCPOZVAOBBQLRI-WDSKDSINSA-N,Launched,DNA synthesis inhibitor,,oncology,ovarian cancer
trepibutone,YPTFHLJNWSJXKG-UHFFFAOYSA-N,Launched,cholinergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,gastroenterology,irritable bowel syndrome
treprostinil,PAJMKGZZBBTTOY-ZFORQUDYSA-N,Launched,prostanoid receptor agonist,P2RY12|PPARD|PTGIR,pulmonary,pulmonary arterial hypertension (PAH)
trequinsin,MCMSJVMUSBZUCN-YYDJUVGSSA-N,Phase 1,phosphodiesterase inhibitor,PDE5A,,
tretazicar,WOCXQMCIOTUMJV-UHFFFAOYSA-N,Phase 2,DNA replication inhibitor,NQO2,,
tretinoin,SHGAZHPCJJPHSC-YCNIQYBTSA-N,Launched,retinoid receptor agonist|retinoid receptor ligand,ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG,hematologic malignancy,acute promyelocytic leukemia (APL)
triacetin,URAYPUMNDPQOKB-UHFFFAOYSA-N,Launched,,,,
triamcinolone,GFNANZIMVAIWHM-OBYCQNJPSA-N,Launched,glucocorticoid receptor agonist,NR3C1,dermatology,corticosteroid-responsive dermatoses
triamcinolone-acetonide,YNDXUCZADRHECN-JNQJZLCISA-N,Launched,glucocorticoid receptor agonist|immunosuppressant,NR3C1|SERPINA6,dermatology,corticosteroid-responsive dermatoses
triamcinolone-hexacetonide,TZIZWYVVGLXXFV-FLRHRWPCSA-N,Launched,anti-inflammatory agent,,,
triamterene,FNYLWPVRPXGIIP-UHFFFAOYSA-N,Launched,sodium channel blocker,SCNN1A|SCNN1B|SCNN1D|SCNN1G,endocrinology|cardiology,hypokalemia|hypertension|edema
triapine,XMYKNCNAZKMVQN-NYYWCZLTSA-N,Phase 2,ribonucleotide reductase inhibitor,RRM1|RRM2,,
tribenoside,ULLNJSBQMBKOJH-JPHCZMGXSA-N,Launched,anti-inflammatory agent|capillary stabilizing agent,,,
tribomsalan,KVSKGMLNBAPGKH-UHFFFAOYSA-N,Preclinical,,,,
tribromoethanol,YFDSDPIBEUFTMI-UHFFFAOYSA-N,Preclinical,analgesic agent,,,
tributyrin,UYXTWWCETRIEDR-UHFFFAOYSA-N,Phase 1,HDAC inhibitor,,,
tricaprylin,VLPFTAMPNXLGLX-UHFFFAOYSA-N,Launched,,,dermatology,cosmetic
trichlormethiazide,LMJSLTNSBFUCMU-QMMMGPOBSA-N,Launched,chloride channel blocker,PTGS1|PTGS2|SLC12A1,cardiology,hypertension|edema
trichloroacetic-acid,YNJBWRMUSHSURL-UHFFFAOYSA-N,Launched,,,dermatology,warts
trichloroethylene,XSTXAVWGXDQKEL-UHFFFAOYSA-N,Preclinical,,,,
trichostatin-a,RTKIYFITIVXBLE-QEQCGCAPSA-N,Phase 1,HDAC inhibitor,HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,,
triciribine,HOGVTUZUJGHKPL-HTVVRFAVSA-N,Phase 1/Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,,
triciribine-phosphate,URLYINUFLXOMHP-HTVVRFAVSA-N,Phase 1/Phase 2,AKT inhibitor,,,
triclabendazole,NQPDXQQQCQDHHW-UHFFFAOYSA-N,Launched,microtubule inhibitor,DNMT1,infectious disease,tapeworm
triclocarban,ICUTUKXCWQYESQ-UHFFFAOYSA-N,Launched,other antibiotic,,infectious disease,first-aid antiseptic
triclosan,XEFQLINVKFYRCS-UHFFFAOYSA-N,Launched,antibacterial agent,DNMT1,infectious disease,first-aid antiseptic
tridihexethyl,NPRHVSBSZMAEIN-NRFANRHFSA-N,Launched,acetylcholine receptor antagonist,,gastroenterology|ophthalmology,peptic ulcer disease (PUD)|nystagmus
trientine,VILCJCGEZXAXTO-UHFFFAOYSA-N,Launched,chelating agent,CA14,metabolism,Wilson's disease
trifloxystrobin,ONCZDRURRATYFI-TVJDWZFNSA-N,Preclinical,mitochondrial electron transport inhibitor,,,
trifluoperazine,ZEWQUBUPAILYHI-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1,neurology/psychiatry,schizophrenia
triflupromazine,XSCGXQMFQXDFCW-UHFFFAOYSA-N,Launched,dopamine receptor antagonist,CHRM1|CHRM2|DRD1|DRD2|HTR2B,neurology/psychiatry|gastroenterology,psychosis|nausea|vomiting
trifluridine,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,Launched,DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor,TYMS,infectious disease,virus herpes simplex (HSV)
triflusal,RMWVZGDJPAKBDE-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor|platelet aggregation inhibitor|thromboxane synthase inhibitor,NFKB1|NOS2|PDE10A|PTGS1,neurology/psychiatry|cardiology,stroke|myocardial infarction|atrial fibrillation (AF)
trigonelline,WWNNZCOKKKDOPX-UHFFFAOYSA-O,Phase 1,,,,
trihexyphenidyl,HWHLPVGTWGOCJO-HXUWFJFHSA-N,Launched,acetylcholine receptor antagonist,CHRM1,neurology/psychiatry,parkinsonism
trilaciclib,PDGKHKMBHVFCMG-UHFFFAOYSA-N,Phase 2,CDK inhibitor,,,
trilostane,RLQVKDVIBJCQGE-PORJLZOZSA-N,Launched,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,,endocrinology,Cushing's syndrome
TRIM,WZBWBNCQUTXYEL-UHFFFAOYSA-N,Preclinical,,,,
trimebutine,LORDFXWUHHSAQU-JOCHJYFZSA-N,Launched,opioid receptor agonist,OPRD1|OPRK1|OPRM1,gastroenterology,irritable bowel syndrome
trimetazidine,UHWVSEOVJBQKBE-UHFFFAOYSA-N,Launched,3-ketoacyl CoA thiolase inhibitor,ACAA2,cardiology,angina pectoris
trimethadione,IRYJRGCIQBGHIV-UHFFFAOYSA-N,Launched,oxazolidine antiepileptic,CACNA1G|CACNA1H|CACNA1I,neurology/psychiatry,seizures
trimethobenzamide,FEZBIKUBAYAZIU-UHFFFAOYSA-N,Launched,histamine receptor antagonist,DRD2,gastroenterology,vomiting|nausea|gastroenteritis
trimethoprim,IEDVJHCEMCRBQM-UHFFFAOYSA-N,Launched,dihydrofolate reductase inhibitor,DHFR|TYMS,infectious disease|gastroenterology,urinary tract infections|ear infections|diarrhea
trimethoquinol,RGVPOXRFEPSFGH-CQSZACIVSA-N,Launched,adrenergic receptor antagonist,ADRB2|ADRB3,pulmonary,asthma
trimethylolpropane-triacrylate,DAKWPKUUDNSNPN-UHFFFAOYSA-N,Preclinical,,,,
trimetozine,XWVOEFLBOSSYGM-UHFFFAOYSA-N,Launched,sedative,,neurology/psychiatry,sedative
trimetrexate,NOYPYLRCIDNJJB-UHFFFAOYSA-N,Phase 3,dihydrofolate reductase inhibitor,DHFR,,
trimipramine,ZSCDBOWYZJWBIY-INIZCTEOSA-N,Launched,norepinephrine reputake inhibitor|tricyclic antidepressant,SLC6A2|SLC6A3|SLC6A4,neurology/psychiatry,depression
trioxsalen,FMHHVULEAZTJMA-UHFFFAOYSA-N,Launched,DNA synthesis inhibitor,,dermatology,vitiligo|eczema
tripelennamine,UFLGIAIHIAPJJC-UHFFFAOYSA-N,Launched,histamine receptor antagonist,HRH1,pulmonary|allergy,asthma|allergic rhinitis|urticaria
triprolidine,CBEQULMOCCWAQT-WOJGMQOQSA-N,Launched,histamine receptor antagonist,HRH1,allergy,allergic rhinitis
triptan,ZISSAWUMDACLOM-UHFFFAOYSA-N,Phase 1,serotonin receptor agonist,HTR1B|HTR1D,,
triptolide,DFBIRQPKNDILPW-CIVMWXNOSA-N,Phase 3,RNA polymerase inhibitor,RELA,,
triptolide,"InChI=1S/C20H24O6/c1-8(2)18-13(25-18)14-20(26-14)17(3)5-4-9-10(7-23-15(9)21)11(17)6-12-19(20,24-12)16(18)22/h8,11-14,16,22H,4-7H2,1-3H3/t11-,12-,13-,14-,16+,17-,18-,19+,20+/m0/s1",Phase 3,RNA polymerase inhibitor,RELA,,
triptorelin,VXKHXGOKWPXYNA-PGBVPBMZSA-N,Launched,gonadotropin releasing factor hormone receptor agonist,GNRHR,oncology|endocrinology|obstetrics/gynecology,prostate cancer|breast cancer|precocious puberty|endometriosis|myoma|gender dysphoria
troclosene,CEJLBZWIKQJOAT-UHFFFAOYSA-N,Launched,,,,
trodusquemine,WUJVPODXELZABP-FWJXURDUSA-N,Phase 1,tyrosine phosphatase inhibitor,,,
trofinetide,JJGBXTYGTKWGAT-YUMQZZPRSA-N,Phase 2,cytokine production inhibitor,IFNG|IL6|TNF,,
trofosfamide,UMKFEPPTGMDVMI-KRWDZBQOSA-N,Launched,DNA alkylating agent,,oncology,medulloblastoma
troglitazone,GXPHKUHSUJUWKP-NTKDMRAZSA-N,Withdrawn,insulin sensitizer|PPAR receptor agonist,CYP2C8|PPARG|TRPM3,,
troleandomycin,LQCLVBQBTUVCEQ-FBZTUZAPSA-N,Launched,protein synthesis inhibitor,,infectious disease|pulmonary|otolaryngology,pneumonia|bronchitis|tonsillitis|sinusitis
trolox,GLEVLJDDWXEYCO-AWEZNQCLSA-N,Launched,antioxidant,,,
tromaril,HLNLBEFKHHCAMV-UHFFFAOYSA-N,Launched,prostanoid receptor antagonist,,ophthalmology,eye inflammation
trometamol,LENZDBCJOHFCAS-UHFFFAOYSA-N,Launched,,AMD1|CANT1|DCN|NEIL1|VEGFA,,
"tropanyl-3,5-dimethylbenzoate",HDDNYFLPWFSBLN-ZSHCYNCHSA-N,Preclinical,serotonin receptor antagonist,HTR3A|HTR3B,,
tropesin,UCCJWNPWWPJKGL-XMMPIXPASA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,,
tropicamide,BGDKAVGWHJFAGW-INIZCTEOSA-N,Launched,acetylcholine receptor antagonist,CHRM3|CHRM4,ophthalmology,mydriasis diagnostic|cycloplegia diagnostic
tropifexor,VYLOOGHLKSNNEK-PIIMJCKOSA-N,Phase 2,FXR agonist,,,
tropisetron,ZNRGQMMCGHDTEI-ITGUQSILSA-N,Launched,serotonin receptor antagonist,GLRA1|GLRA2|GLRB|HTR3A|HTR4,gastroenterology,nausea|vomiting
trospium,OYYDSUSKLWTMMQ-JKHIJQBDSA-N,Launched,acetylcholine receptor antagonist,CHRM1,urology,urinary incontinence|urinary frequency
trovafloxacin,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,Withdrawn,bacterial DNA gyrase inhibitor,TOP2A,,
troventol,QFWSRMACUIYPGS-ZVBHREPYSA-N,Phase 1,,,,
trovirdine,HOCFDYZWQYGULA-UHFFFAOYSA-N,Phase 1,non-nucleoside reverse transcriptase inhibitor,,,
troxerutin,IYVFNTXFRYQLRP-VVSTWUKXSA-N,Launched,antioxidant,,,
troxipide,YSIITVVESCNIPR-NSHDSACASA-N,Launched,glucosamine synthetase stimulant,,gastroenterology,gastroesophageal reflux disease (GERD)
TRV130,DMNOVGJWPASQDL-OAQYLSRUSA-N,Phase 3,opioid receptor agonist,OPRM1,,
tryptanthrin,VQQVWGVXDIPORV-UHFFFAOYSA-N,Preclinical,cyclooxygenase inhibitor,IDO1,,
tryptophan,QIVBCDIJIAJPQS-VIFPVBQESA-N,Launched,serotonin receptor partial agonist,CASR|IDO1|SLC36A1|WARS|WARS2,neurology/psychiatry|gastroenterology,anxiety|bloating|constipation|fatigue|sleeplessness
TS-011,CQMCOBQPZDLWIX-UHFFFAOYSA-N,Preclinical,delayed vasospasm antagonist,,,
TTNPB,FOIVPCKZDPCJJY-JQIJEIRASA-N,Phase 1,retinoid receptor agonist,RARA|RARB|RARG,,
TTP-22,RAOULLCLLOGTDA-UHFFFAOYSA-N,Preclinical,casein kinase inhibitor,CSNK2A1,,
TU-2100,LIBAUACOIKWWKP-UHFFFAOYSA-N,Phase 2,,,,
tuaminoheptane,VSRBKQFNFZQRBM-SSDOTTSWSA-N,Launched,,,otolaryngology,nasal congestion
tubastatin-A,GOVYBPLHWIEHEJ-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC6,,
tubocurarine,JFJZZMVDLULRGK-URLMMPGGSA-O,Launched,acetylcholine receptor antagonist,ACHE|CHRNA2|HTR3A|HTR3B|KCNN1|KCNN2|KCNN3|ZACN,neurology/psychiatry,anesthetic
tucatinib,SDEAXTCZPQIFQM-UHFFFAOYSA-N,Phase 3,EGFR inhibitor,ERBB2,,
tucidinostat,SZMJVTADHFNAIS-BJMVGYQFSA-N,Phase 3,HDAC inhibitor,,,
tuftsin,IESDGNYHXIOKRW-YXMSTPNBSA-N,Preclinical,macrophage activator,,,
TUG-770,KIZUBVPJNPVIIN-UHFFFAOYSA-N,Preclinical,free fatty acid receptor agonist,FFAR1,,
TUG-891,LPGBXHWIQNZEJB-UHFFFAOYSA-N,Preclinical,free fatty acid receptor agonist,FFAR4,,
tulobuterol,YREYLAVBNPACJM-NSHDSACASA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,asthma
tulrampator,JHCFQXNWYDLBOG-UHFFFAOYSA-N,Phase 2,antidepressant ,,,
TW-37,PQAPVTKIEGUPRN-UHFFFAOYSA-N,Preclinical,BCL inhibitor,BCL2|BCL2L1|MCL1,,
TWS-119,VPVLEBIVXZSOMQ-UHFFFAOYSA-N,Preclinical,glycogen synthase kinase inhibitor,GSK3B|JUN|MYC,,
TXA127,PVHLMTREZMEJCG-GDTLVBQBSA-N,Phase 2,angiotensin receptor agonist,,,
TY-52156,XONRRGIRSGNWFP-UHFFFAOYSA-N,Preclinical,sphingosine 1-phosphate receptor antagonist,S1PR3,,
tylosin,WBPYTXDJUQJLPQ-CQICKBAWSA-N,Launched,protein synthesis inhibitor,,infectious disease|gastroenterology,gram-positive bacterial infections|colitis
tymazoline,QRORCRWSRPKEHR-UHFFFAOYSA-N,Launched,,,allergy,allergic rhinitis
tyrphostin-A9,MZOPWQKISXCCTP-UHFFFAOYSA-N,Preclinical,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,,,
tyrphostin-A9,"InChI=1S/C18H22N2O/c1-17(2,3)14-8-12(7-13(10-19)11-20)9-15(16(14)21)18(4,5)6/h7-9,21H,1-6H3",Preclinical,protein tyrosine kinase inhibitor|tyrosine kinase inhibitor,,,
tyrphostin-AG-1296,QNOXYUNHIGOWNY-UHFFFAOYSA-N,Preclinical,FLT3 inhibitor,FLT3,,
tyrphostin-AG-1478,GFNNBHLJANVSQV-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR|MAPK14,,
tyrphostin-AG-18,VTJXFTPMFYAJJU-UHFFFAOYSA-N,Preclinical,EGFR inhibitor|tyrosine kinase inhibitor,EGFR,,
tyrphostin-AG-494,HKHOVJYOELRGMV-XYOKQWHBSA-N,Preclinical,EGFR inhibitor,EGFR,,
tyrphostin-AG-825,KXDONFLNGBQLTN-WUXMJOGZSA-N,Preclinical,protein tyrosine kinase inhibitor,ERBB2,,
tyrphostin-AG-835,UMGQVUWXNOJOSJ-DGGAMASNSA-N,Preclinical,protein tyrosine kinase inhibitor,EGFR,,
tyrphostin-AG-879,XRZYELWZLNAXGE-KPKJPENVSA-N,Preclinical,tyrosine kinase inhibitor,ERBB2|KDR|NTRK1,,
tyrphostin-AG-99,USOXQZNJFMKTKJ-XVNBXDOJSA-N,Preclinical,tyrosine kinase inhibitor,EGFR,,
U-0124,GXGXSVFKGDVBMD-UHFFFAOYSA-N,Preclinical,MEK inhibitor,,,
U-0126,ZCHZSBUNJOCWCW-UHFFFAOYSA-N,Preclinical,MEK inhibitor,AKT1|CHEK1|GSK3B|LCK|MAP2K1|MAP2K2|MAP2K7|MAPK1|MAPK11|MAPK12|MAPK14|MAPK8|PRKCA|RAF1|ROCK1|RPS6KB1|SGK1,,
U-0521,VDQLKIBLTMPAHI-UHFFFAOYSA-N,Preclinical,catechol O methyltransferase inhibitor,COMT,,
U-104,YJQZNWPYLCNRLP-UHFFFAOYSA-N,Phase 1/Phase 2,carbonic anhydrase inhibitor,CA1|CA12|CA2|CA9,,
U-18666A,DMZCCFMMPHJWQY-BKWLFHPQSA-N,Preclinical,oxidosqualene cyclase inhibitor,,,
U-50488-(-),VQLPLYSROCPWFF-ROUUACIJSA-N,Preclinical,opioid receptor agonist,OPRK1,,
U-54494A,JUBNVWGVNWIXMB-SJORKVTESA-N,Preclinical,opioid receptor agonist,OPRK1,,
U-75799E,WZHKXNSOCOQYQX-FUAFALNISA-N,Phase 1,growth hormone releasing factor agonist,GHSR,,
U-99194,UOLJKAPABHXFRE-UHFFFAOYSA-N,Preclinical,dopamine receptor antagonist,DRD3,,
UAMC-00039,DNVZYSMOLXCOLY-HNNXBMFYSA-N,Preclinical,dipeptidyl peptidase inhibitor,DPP4|DPP7,,
UB-165,TVSNVPGPFGAKPT-JQWIXIFHSA-N,Preclinical,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNB2,,
ubenimex,VGGGPCQERPFHOB-RDBSUJKOSA-N,Launched,leukotriene synthesis inhibitor,LTA4H|RNPEP,hematologic malignancy,acute myeloid leukemia (AML)
UBP-296,UUIYULWYHDSXHL-NSHDSACASA-N,Preclinical,glutamate receptor antagonist,GRIK1,,
UBP-302,UUIYULWYHDSXHL-NSHDSACASA-N,Preclinical,glutamate receptor antagonist,GRIK1,,
UBP-310,ZTAZUCRXCRXNSU-VIFPVBQESA-N,Preclinical,glutamate receptor antagonist,GRIK1|GRIK5,,
UC-112,LTGLGIQQZXSLLF-UHFFFAOYSA-N,Preclinical,XIAP inhibitor,XIAP,,
UCL-2077,PQFNWDHABGBCHB-UHFFFAOYSA-N,Preclinical,slow afterhyperpolarization channel blocker,,,
udenafil,IYFNEFQTYQPVOC-KRWDZBQOSA-N,Launched,phosphodiesterase inhibitor,,urology,erectile dysfunction
UF-010,BVQCFCYPFJOOAV-UHFFFAOYSA-N,Preclinical,HDAC inhibitor,HDAC1|HDAC2|HDAC3|HDAC8,,
ufenamate,JDLSRXWHEBFHNC-UHFFFAOYSA-N,Launched,cyclooxygenase inhibitor,PTGS1|PTGS2,dermatology,eczema|dermatitis
UH-232-(+),BTOJYCTUJJHANF-WMLDXEAASA-N,Preclinical,dopamine receptor antagonist,DRD2|DRD3|DRD4|HTR1A,,
UK-356618,JJHRUUKMPWUYIB-HVOSOHGQSA-N,Preclinical,metalloproteinase inhibitor,MMP13|MMP14|MMP2|MMP3|MMP9,,
UK-356618,"InChI=1S/C34H43N3O4/c1-23-21-25(19-20-29(23)27-16-10-7-11-17-27)13-12-18-28(22-30(38)37-41)32(39)36-31(34(3,4)5)33(40)35-24(2)26-14-8-6-9-15-26/h6-11,14-17,19-21,24,28,31,41H,12-13,18,22H2,1-5H3,(H,35,40)(H,36,39)(H,37,38)/t24-,28-,31-/m1/s1",Preclinical,metalloproteinase inhibitor,MMP13|MMP14|MMP2|MMP3|MMP9,,
UK-383367,ARJCBSRIPGJMAD-LLVKDONJSA-N,Phase 1,procollagen C-endopeptidase inhibitor,BMP1,,
UK-5099,BIZNHCWFGNKBBZ-JLHYYAGUSA-N,Preclinical,monocarboxylate transporter inhibitor,SLC16A1,,
uki-1,ISJSHQTWOHGCMM-NDEPHWFRSA-N,Preclinical,urokinase inhibitor,,,
ulifloxacin,SUXQDLLXIBLQHW-MRVPVSSYSA-N,Launched,,,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections
ulipristal,OOLLAFOLCSJHRE-ZHAKMVSLSA-N,Launched,progesterone receptor antagonist,PGR,endocrinology,contraceptive
umeclidinium,FVTWTVQXNAJTQP-UHFFFAOYSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM2|CHRM3,pulmonary,chronic obstructive pulmonary disease (COPD)|bronchitis|emphysema
unbs-5162,WCKZRLOUKYFJDY-UHFFFAOYSA-N,Phase 1,CC chemokine receptor antagonist,,,
UNC0224,XIVUGRBSBIXXJE-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,,
UNC0321,AULLUGALUBVBDD-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT2,,
UNC0631,XFAXSWXKPQWHDW-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT2,,
UNC0638,QOECJCJVIMVJGX-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,,
UNC0642,RNAMYOYQYRYFQY-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,,
UNC0646,OUKWLRHRXOPODD-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT2,,
UNC0737,ATORKVYCKKBNTF-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EHMT1|EHMT2,,
UNC1215,PQOOIERVZAXHBP-UHFFFAOYSA-N,Preclinical,L3MBTL antagonist,L3MBTL3,,
UNC1999,DPJNKUOXBZSZAI-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,EZH2,,
UNC2025,MJSHVHLADKXCML-RQNOJGIXSA-N,Preclinical,FLT3 inhibitor|MER tyrosine kinase inhibitor,FLT3|MERTK,,
UNC2250,HSYSSKFCQHXOBP-MXVIHJGJSA-N,Preclinical,MER tyrosine kinase inhibitor,MERTK,,
UNC2327,MYTRGTBDVGKKRO-UHFFFAOYSA-N,Preclinical,protein arginine N-methyltransferase inhibitor,PRMT3,,
UNC3230,RZCNASHHHSKTGP-UHFFFAOYSA-N,Preclinical,phosphatidyl-inositol activator,PIP5K1C,,
UNC669,CQERVFFAOOUFEQ-UHFFFAOYSA-N,Preclinical,L3MBTL antagonist,L3MBTL1,,
UNC926,OWGLFIKZKQOYHZ-UHFFFAOYSA-N,Preclinical,MBT inhibitor,L3MBTL1,,
undecylenic-acid,FRPZMMHWLSIFAZ-UHFFFAOYSA-N,Launched,other antifungal,,infectious disease,tinea pedis|tinea corporis
upadacitinib,WYQFJHHDOKWSHR-MNOVXSKESA-N,Launched,JAK inhibitor,,,
upamostat,HUASEDVYRABWCV-NDEPHWFRSA-N,Phase 2,serine protease inhibitor,,,
UPF-1069,JJWMRRNGWSITSQ-UHFFFAOYSA-N,Preclinical,PARP inhibitor,PARP2,,
uprifosbuvir,SFPFZQKYPOWCSI-IQWMDFIBSA-N,Preclinical,antiviral,,,
uprosertib,AXTAPYRUEKNRBA-JTQLQIEISA-N,Phase 2,AKT inhibitor,AKT1|AKT2|AKT3,,
uracil,ISAKRJDGNUQOIC-UHFFFAOYSA-N,Launched,,DPYD|UCKL1,,
uracil-mustard,IDPUKCWIGUEADI-UHFFFAOYSA-N,Launched,DNA synthesis inhibitor,,hematologic malignancy,non-Hodgkin lymphoma (NHL)
urapidil,ICMGLRUYEQNHPF-UHFFFAOYSA-N,Launched,adrenergic receptor antagonist,HTR1A,cardiology,hypertension
URB597,ROFVXGGUISEHAM-UHFFFAOYSA-N,Phase 1,FAAH inhibitor,FAAH|FAAH2|TRPA1,,
urea,XSQUKJJJFZCRTK-UHFFFAOYSA-N,Launched,hydroxy radical formation stimulant,ARG1|CA2|CTNNB1,dermatology,psoriasis|xerosis cutis|ichthyosis vulgaris|eczema|keratosis|dermatitis
urethane,JOYRKODLDBILNP-UHFFFAOYSA-N,Preclinical,local anesthetic,,,
uric-acid,LEHOTFFKMJEONL-UHFFFAOYSA-N,Phase 3,,PYGL,,
uridine,DRTQHJPVMGBUCF-XVFCMESISA-N,Phase 2,dopamine receptor agonist,LSM6|TYMP,,
uridine-5'-triphosphate,PGAVKCOVUIYSFO-XVFCMESISA-N,Launched,purinergic receptor activator,P2RY11|P2RY2|P2RY4|P2RY6|UCK2,,
uridine-triacetate,AUFUWRKPQLGTGF-FMKGYKFTSA-N,Launched,,,nephrology,orotic aciduria
URMC-099,QKKIWEILHCXECO-UHFFFAOYSA-N,Preclinical,mixed lineage kinase inhibitor,CDKL2|DAPK3|FLT3|LRRK2|MAP3K10|MAP3K11|MAP3K2|MAP3K9|SRPK2,,
urolithin-A,RIUPLDUFZCXCHM-UHFFFAOYSA-N,Phase 3,antioxidant,,,
ursodeoxycholyltaurine,BHTRKEVKTKCXOH-LBSADWJPSA-N,Phase 3,cholesterol inhibitor,,,
ursodiol,RUDATBOHQWOJDD-UZVSRGJWSA-N,Launched,nuclear factor erythroid derived|like (NRF2) activator,AKR1C2|NR1H4,gastroenterology,gallstones
ursolic-acid,WCGUUGGRBIKTOS-GPOJBZKASA-N,Phase 2/Phase 3,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,HSD11B1|PLA2G1B|PTPN1|PYGM,,
usniacin-(+),ZQHDVMCIDXEICF-GOSISDBHSA-N,Preclinical,MAP kinase activator,PTPN1,,
usniacin-(+),ZQHDVMCIDXEICF-SFHVURJKSA-N,Preclinical,MAP kinase activator,PTPN1,,
V-51,KKCOGNFFBYOKMA-UHFFFAOYSA-N,Phase 1,adrenergic receptor antagonist,,,
vaborbactam,IOOWNWLVCOUUEX-WPRPVWTQSA-N,Launched,beta lactamase inhibitor,,,
vadadustat,JGRXMPYUTJLTKT-UHFFFAOYSA-N,Phase 3,hypoxia inducible factor prolyl hydroxylase inhibitor,,,
val-tyr,VEYJKJORLPYVLO-RYUDHWBXSA-N,Preclinical,angiotensin converting enzyme inhibitor,,,
valaciclovir,HDOVUKNUBWVHOX-QMMMGPOBSA-N,Launched,DNA polymerase inhibitor,,infectious disease,shingles|virus herpes simplex (HSV)
valbenazine,GEJDGVNQKABXKG-CFKGEZKQSA-N,Launched,vesicular monoamine transporter inhibitor,,neurology/psychiatry,dyskinesia
valdecoxib,LNPDTQAFDNKSHK-UHFFFAOYSA-N,Withdrawn,cyclooxygenase inhibitor,CA12|PTGS2,,
valethamate,UPPMZCXMQRVMME-SJLPKXTDSA-N,Launched,acetylcholine receptor antagonist,CHRM1|CHRM4|CHRM5,obstetrics/gynecology,labor induction
valganciclovir,WPVFJKSGQUFQAP-BDAKNGLRSA-N,Launched,DNA synthesis inhibitor,,infectious disease,cytomegalovirus (CMV)
valnemulin,LLYYNOVSVPBRGV-MVNKZKPCSA-N,Launched,bacterial 50S ribosomal subunit inhibitor,,infectious disease|gastroenterology,dysentry|colitis|pneumonia
valnoctamide,QRCJOCOSPZMDJY-RNFRBKRXSA-N,Launched,arachidonic acid acylation inhibitor|benzodiazepine receptor agonist,,neurology/psychiatry,sleeplessness
valproic-acid,NIJJYAXOARWZEE-UHFFFAOYSA-N,Launched,benzodiazepine receptor agonist|HDAC inhibitor,ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,epilepsy|seizures|seizures
valpromide,OMOMUFTZPTXCHP-UHFFFAOYSA-N,Launched,epoxide hydolase inhibitor,,neurology/psychiatry,epilepsy
valrocemide,RALGCAOVRLYSMA-UHFFFAOYSA-N,Phase 2,,,,
valrubicin,ZOCKGBMQLCSHFP-KQRAQHLDSA-N,Launched,DNA inhibitor|topoisomerase inhibitor,TOP2A,oncology,bladder cancer
valsartan,ACWBQPMHZXGDFX-QFIPXVFZSA-N,Launched,angiotensin receptor antagonist,AGTR1,cardiology,hypertension|congestive heart failure|congestive heart failure
valspodar,YJDYDFNKCBANTM-QCWCSKBGSA-N,Phase 3,P glycoprotein inhibitor,ABCB1,,
vancomycin,MYPYJXKWCTUITO-LYRMYLQWSA-N,Launched,bacterial cell wall synthesis inhibitor,,infectious disease,endocarditis
vandetanib,UHTHHESEBZOYNR-UHFFFAOYSA-N,Launched,EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor,EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA,oncology,medullary thyroid cancer (MTC)
vanillin,MWOOGOJBHIARFG-UHFFFAOYSA-N,Preclinical,,ABAT|ALDH5A1,,
vanillylacetone,OJYLAHXKWMRDGS-UHFFFAOYSA-N,Preclinical,,,,
vaniprevir,KUQWGLQLLVFLSM-ONAXAZCASA-N,Phase 3,serine protease inhibitor,,,
vanitiolide,WQYRHRAZNNRDIA-UHFFFAOYSA-N,Preclinical,,,,
vanoxerine,NAUWTFJOPJWYOT-UHFFFAOYSA-N,Phase 3,dopamine reuptake inhibitor,SLC6A3,,
vapendavir,DKSVBVKHUICELN-UHFFFAOYSA-N,Phase 2,antiviral,,,
vardenafil,SECKRCOLJRRGGV-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,PDE5A|PDE6G|PDE6H,urology,erectile dysfunction
varenicline,JQSHBVHOMNKWFT-DTORHVGOSA-N,Launched,acetylcholine receptor agonist,CHRNA3|CHRNA4|CHRNA6|CHRNA7,neurology/psychiatry,smoking cessation
varespladib,BHLXTPHDSZUFHR-UHFFFAOYSA-N,Phase 3,secretory phospholipase inhibitor,PLA2G2A,,
vasopressin,KBZOIRJILGZLEJ-PLCMWKKKSA-N,Launched,vasopressin receptor agonist,AVPR1A|AVPR1B|AVPR2|OXTR,gastroenterology,abdominal distension
vatalanib,YCOYDOIWSSHVCK-UHFFFAOYSA-N,Phase 3,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR|PDGFRB,,
vatinoxan,GTBKISRCRQUFNL-OXJNMPFZSA-N,Preclinical,adrenergic receptor antagonist,,,
VBY-825,PPUXXDKQNAHHON-BJLQDIEVSA-N,Preclinical,cathepsin inhibitor,CTSB|CTSL|CTSS,,
VCH-916,LNYKGELUODVSNS-YSXIEMCBSA-N,Phase 1,HCV inhibitor,,,
VE-821,DUIHHZKTCSNTGM-UHFFFAOYSA-N,Preclinical,ATR kinase inhibitor,ATR,,
VE-822,JZCWLJDSIRUGIN-UHFFFAOYSA-N,Phase 2,ATR kinase inhibitor,ATM|ATR|MTOR|PIK3CG,,
vecabrutinib,QLRRJMOBVVGXEJ-XHSDSOJGSA-N,Phase 1/Phase 2,Bruton's tyrosine kinase (BTK) inhibitor,,,
vecuronium,BGSZAXLLHYERSY-XQIGCQGXSA-N,Launched,acetylcholine receptor antagonist,CHRNA2,neurology/psychiatry,muscle relaxant
vedaprofen,VZUGVMQFWFVFBX-ZDUSSCGKSA-N,Launched,anti-inflammatory agent,PTGS2,neurology/psychiatry|endocrinology,pain relief|fever
velaresol,NSUDGNLOXMLAEB-UHFFFAOYSA-N,Preclinical,,,,
veledimex,LZWZPGLVHLSWQX-XMMPIXPASA-N,Phase 2,cytochrome P450 inhibitor,,,
veliflapon,ZEYYDOLCHFETHQ-JOCHJYFZSA-N,Phase 3,leukotriene synthesis inhibitor,ALOX5AP,,
veliparib,JNAHVYVRKWKWKQ-CYBMUJFWSA-N,Phase 3,PARP inhibitor,PARP1|PARP2,,
velneperit,WGEWUYACXPEFPO-AULYBMBSSA-N,Phase 2,neuropeptide receptor antagonist,NPY5R,,
velpatasvir,FHCUMDQMBHQXKK-CDIODLITSA-N,Launched,antiviral,,infectious disease,hepatitis C
vemurafenib,GPXBXXGIAQBQNI-UHFFFAOYSA-N,Launched,RAF inhibitor,BRAF|RAF1,oncology,melanoma
venetoclax,LQBVNQSMGBZMKD-UHFFFAOYSA-N,Launched,BCL inhibitor,BCL2,hematologic malignancy,chronic lymphocytic leukemia (CLL)
venlafaxine,PNVNVHUZROJLTJ-MRXNPFEDSA-N,Launched,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin–norepinephrine reuptake inhibitor (SNRI),SLC6A2|SLC6A4,neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder
VER-155008,ZXGGCBQORXDVTE-UMCMBGNQSA-N,Preclinical,HSP inhibitor,HSPA1A,,
VER-49009,HUNAOTXNHVALTN-UHFFFAOYSA-N,Preclinical,HSP inhibitor,HSP90AA1,,
veralipride,RYJXBGGBZJGVQF-LBPRGKRZSA-N,Preclinical,dopamine receptor antagonist,,,
verapamil,SGTNSNPWRIOYBX-UHFFFAOYSA-N,Launched,calcium channel blocker,CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4,cardiology,hypertension
verbascoside,FBSKJMQYURKNSU-ZLSOWSIRSA-N,Phase 2/Phase 3,NFkB pathway inhibitor|PKC inhibitor,,,
vercirnon,JRWROCIMSDXGOZ-UHFFFAOYSA-N,Phase 3,CC chemokine receptor antagonist,CCR9,,
verdinexor,OPAKEJZFFCECPN-XQRVVYSFSA-N,Preclinical,exportin antagonist,,,
verdiperstat,FVJCUZCRPIMVLB-UHFFFAOYSA-N,Phase 3,myeloperoxidase inhibitor,,,
vericiguat,QZFHIXARHDBPBY-UHFFFAOYSA-N,Phase 3,guanylate cyclase stimulant,,,
verinurad,YYBOLPLTQDKXPM-UHFFFAOYSA-N,Phase 2,urate transporter inhibitor,SLC22A12,,
vernakalant,VBHQKCBVWWUUKN-KZNAEPCWSA-N,Launched,potassium channel blocker,KCNA5,cardiology,atrial fibrillation (AF)
verteporfin,VLGTZPSSBIXGAI-SUPIZNKRSA-N,Launched,photosensitizing agent,,ophthalmology,macular degeneration
verubecestat,YHYKUSGACIYRML-KRWDZBQOSA-N,Phase 3,beta secretase inhibitor,,,
verubulin,SNHCRNMVYDHVDT-UHFFFAOYSA-N,Phase 2,tubulin polymerization inhibitor,TUBB,,
verucerfont,VKHVAUKFLBBZFJ-SFHVURJKSA-N,Phase 2,corticotropin releasing factor receptor antagonist,,,
vesamicol,YSSBJODGIYRAMI-IAGOWNOFSA-N,Preclinical,acetylcholinesterase inhibitor,SLC18A3,,
vesnarinone,ZVNYJIZDIRKMBF-UHFFFAOYSA-N,Launched,phosphodiesterase inhibitor,KCNH2|PDE3A,cardiology,congestive heart failure
VGX-1027,MUFJHYRCIHHATF-SECBINFHSA-N,Phase 1,tumor necrosis factor receptor antagonist,TLR4,,
vicriviroc,CNPVJJQCETWNEU-CYFREDJKSA-N,Phase 3,CC chemokine receptor antagonist,CCR5,,
vidarabine,OIRDTQYFTABQOQ-UHTZMRCNSA-N,Launched,antiviral,ADA,infectious disease,virus herpes simplex (HSV)|varicella-zoster virus (VZV)
vigabatrin,PJDFLNIOAUIZSL-RXMQYKEDSA-N,Launched,GABA aminotransferase inhibitor,ABAT|SLC32A1,neurology/psychiatry,seizures|spasms
vilanterol,KLOLZALDXGTNQE-JIDHJSLPSA-N,Launched,adrenergic receptor agonist,ADRB2,pulmonary,chronic obstructive pulmonary disease (COPD)
vilazodone,SGEGOXDYSFKCPT-UHFFFAOYSA-N,Launched,serotonin reuptake inhibitor,DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4,neurology/psychiatry,depression
vildagliptin,SYOKIDBDQMKNDQ-NHMCJKAESA-N,Launched,dipeptidyl peptidase inhibitor,DPP4,endocrinology,diabetes mellitus
viloxazine,YWPHCCPCQOJSGZ-LLVKDONJSA-N,Launched,norepinephrine reuptake inhibitor,SLC6A2,neurology/psychiatry,depression
vinblastine,JXLYSJRDGCGARV-CFWMRBGOSA-N,Launched,microtubule inhibitor|tubulin polymerization inhibitor,JUN|TUBA1A|TUBB|TUBD1|TUBE1|TUBG1,hematologic malignancy|infectious disease|oncology,Hodgkin's lymphoma|true histiocytic lymphoma (THL)|mycosis|small lymphocytic lymphoma (SLL)|testicular carcinoma|Kaposi sarcoma
vinburnine,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Launched,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,neurology/psychiatry,stroke
vincamine,RXPRRQLKFXBCSJ-GIVPXCGWSA-N,Withdrawn,adrenergic receptor antagonist,CHRM1|CHRM2|CHRM3|CHRM4,,
vincristine,OGWKCGZFUXNPDA-CFWMRBGOSA-N,Launched,tubulin polymerization inhibitor,TUBA4A|TUBB,hematologic malignancy,acute lymphoblastic leukemia (ALL)
vindesine,HHJUWIANJFBDHT-KOTLKJBCSA-N,Launched,tubulin polymerization inhibitor,TUBB|TUBB1,oncology,breast cancer|non-small cell lung cancer (NSCLC)|melanoma
vinflunine,NOSAJPUYIASWEH-USRBKURZSA-N,Launched,microtubule inhibitor,,oncology,bladder cancer
vinorelbine,GBABOYUKABKIAF-IELIFDKJSA-N,Launched,tubulin polymerization inhibitor,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,oncology,non-small cell lung cancer (NSCLC)
vinpocetine,DDNCQMVWWZOMLN-IRLDBZIGSA-N,Launched,phosphodiesterase inhibitor|sodium channel blocker,PDE1A|PDE1C,neurology/psychiatry,stroke|senile dementia
viomycin,NSWGELWYFNCPHU-RWOORDGESA-N,Launched,protein synthesis inhibitor,,infectious disease,tuberculosis
vipadenant,HQSBCDPYXDGTCL-UHFFFAOYSA-N,Phase 1,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
vismodegib,BPQMGSKTAYIVFO-UHFFFAOYSA-N,Launched,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,oncology,basal cell carcinoma (BCC)
vismodegib,"InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)",Launched,hedgehog pathway inhibitor|smoothened receptor antagonist,SMO,oncology,basal cell carcinoma (BCC)
visomitin,ZFUDULLGKXSPPH-UHFFFAOYSA-N,Preclinical,antioxidant,,,
vitamin-B12,RMRCNWBMXRMIRW-WZHZPDAFSA-M,Launched,,,hematology,megaloblastic anemia
vitamin-E,GVJHHUAWPYXKBD-IEOSBIPESA-N,Launched,LDL oxidation inhibitor|PKC inhibitor,ALOX5|DGKA|NR1I2|PPP2CA|PPP2CB|PRKCA|PRKCB|SEC14L2|SEC14L3|SEC14L4,,
vixotrigine,JESCETIFNOFKEU-SJORKVTESA-N,Phase 2,sodium channel blocker,,,
VL285,HEDFFPYRFJKXQP-VJTSUQJLSA-N,Preclinical,PROTAC,,,
VLX1570,SCKXBVLYWLLALY-CZCYGEDCSA-N,Phase 1/Phase 2,deubiquitinase inhibitor,,,
VLX600,UQOSBPRTQFFUOA-UHFFFAOYSA-N,Phase 1,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,TP53|USP14,,
VLX600,UQOSBPRTQFFUOA-NHDPSOOVSA-N,Phase 1,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,TP53|USP14,,
VLX600,"InChI=1S/C17H15N7/c1-10-6-5-7-12-14(10)19-16-15(12)22-24-17(20-16)23-21-11(2)13-8-3-4-9-18-13/h3-9H,1-2H3,(H2,19,20,23,24)/b21-11-",Phase 1,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,TP53|USP14,,
voclosporin,BICRTLVBTLFLRD-PTWUADNWSA-N,Phase 3,calcineurin inhibitor,,,
voglibose,FZNCGRZWXLXZSZ-CIQUZCHMSA-N,Launched,glucosidase inhibitor,MGAM,endocrinology,diabetes mellitus|hyperglycemia
volasertib,SXNJFOWDRLKDSF-STROYTFGSA-N,Phase 3,PLK inhibitor,PLK1,,
volasertib,"InChI=1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25-,26-,28-/m1/s1",Phase 3,PLK inhibitor,PLK1,,
volinanserin,HXTGXYRHXAGCFP-OAQYLSRUSA-N,Phase 3,serotonin receptor antagonist,HTR2A|HTR2B|HTR2C|KCNH2,,
vonoprazan,BFDBKMOZYNOTPK-UHFFFAOYSA-N,Launched,potassium-competitive acid antagonist,ATP4A,gastroenterology,peptic ulcer disease (PUD)
vorapaxar,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,Launched,thrombin inhibitor,F2R,cardiology,myocardial infarction|peripheral artery disease (PAD)
vorasidenib,QCZAWDGAVJMPTA-RNFRBKRXSA-N,Preclinical,isocitrate dehydrogenase inhibitor,,,
voreloxin,XZAFZXJXZHRNAQ-STQMWFEESA-N,Phase 3,topoisomerase inhibitor,TOP2A,,
voriconazole,BCEHBSKCWLPMDN-MGPLVRAMSA-N,Launched,cytochrome P450 inhibitor,CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1,infectious disease,esophageal candidiasis|aspergillosis|skin infections
vorinostat,WAEXFXRVDQXREF-UHFFFAOYSA-N,Launched,HDAC inhibitor,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC5|HDAC6|HDAC8|HDAC9,hematologic malignancy,cutaneous T-cell lymphoma (CTCL)
vortioxetine,YQNWZWMKLDQSAC-UHFFFAOYSA-N,Launched,serotonin receptor agonist|serotonin receptor antagonist,HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4,neurology/psychiatry,depression
voruciclib,MRPGRAKIAJJGMM-OCCSQVGLSA-N,Phase 1,CDK9 inhibitor,,,
voxelotor,FWCVZAQENIZVMY-UHFFFAOYSA-N,Launched,hemoglobin modulator,,,
voxtalisib,RGHYDLZMTYDBDT-UHFFFAOYSA-N,Phase 2,mTOR inhibitor|PI3K inhibitor,MTOR|PIK3CA,,
VP-20629,GOLXRNDWAUTYKT-UHFFFAOYSA-N,Phase 1,beta amyloid antagonist,PLA2G2E|SLC36A1,,
VS-4718,IGUBBWJDMLCRIK-UHFFFAOYSA-N,Phase 1,focal adhesion kinase inhibitor,,,
VT-464,ZBRAJOQFSNYJMF-SFHVURJKSA-N,Phase 2,cytochrome P450 inhibitor,CYP17A1,,
VTP-27999,NXWASIVXQMMPLM-ZXMXYHOLSA-N,Phase 1,renin inhibitor,REN,,
VU0155069,DRIMIUYGTDAQOX-KRWDZBQOSA-N,Preclinical,phospholipase inhibitor,PLD1,,
VU0238429,CKLGZXFOLMHCMC-UHFFFAOYSA-N,Preclinical,acetylcholine receptor allosteric modulator,CHRM5,,
VU0240551,WJRWSLORVIHRNX-UHFFFAOYSA-N,Preclinical,potassium/chloride cotransporter inhibitor,SLC12A5,,
VU0357121,AHCYOTLTLQTPSU-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM5,,
VU0360172,NEMHWVUKNWAKTM-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM5,,
VU0361737,ARYUXFNGXHNNDM-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM4,,
VU0364439,IXHCGJXBIHHIEF-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM4,,
VU0364739,MSTXJJGAXXJCBY-UHFFFAOYSA-N,Preclinical,phospholipase inhibitor,PLD2,,
VU0364770,SUYUTNCKIOLMAJ-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM4,,
VU0422288,MZRLPXFGQKQHST-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM3,,
VU10010,FPRULFHDSFKYBV-UHFFFAOYSA-N,Preclinical,acetylcholine receptor allosteric modulator,CHRM4,,
VU152100,MDNWGCQSCGNTKH-UHFFFAOYSA-N,Preclinical,acetylcholine receptor allosteric modulator,CHRM4,,
VU1545,BRAZLURTFMCAHU-UHFFFAOYSA-N,Preclinical,glutamate receptor positive allosteric modulator,GRM5,,
VU29,KIALCSMRIHRFPL-UHFFFAOYSA-N,Preclinical,glutamate receptor potentiator,GRM5,,
VU591,ZQPXNYLXYNRFNP-UHFFFAOYSA-N,Preclinical,potassium channel blocker,KCNJ1,,
VUF10166,FFXVTQDGTKEXHF-UHFFFAOYSA-N,Preclinical,serotonin receptor antagonist,HTR3A|HTR3B,,
VUF10460,NIJGWJIOMPHDBP-UHFFFAOYSA-N,Preclinical,histamine receptor agonist,HRH4,,
VUF11207,JVRRRKAXHMGUHZ-JIKIWWBOSA-N,Preclinical,CC chemokine receptor agonist,ACKR3,,
VX-11e,WUTVMXLIGHTZJC-OAQYLSRUSA-N,Preclinical,MAP kinase inhibitor,MAPK1,,
VX-222,WPMJNLCLKAKMLA-UGLKCIBTSA-N,Phase 2,HCV inhibitor,,,
VX-702,FYSRKRZDBHOFAY-UHFFFAOYSA-N,Phase 2,p38 MAPK inhibitor,IL1B|IL6|MAPK11|MAPK12|MAPK14|TNF,,
VX-745,VEPKQEUBKLEPRA-UHFFFAOYSA-N,Phase 2,p38 MAPK inhibitor,MAPK11|MAPK12|MAPK14,,
VX-765,SJDDOCKBXFJEJB-MOKWFATOSA-N,Phase 2,caspase inhibitor,CASP1,,
W-54011,DVYASSBBADJRAS-MUUNZHRXSA-N,Preclinical,anaphylatoxin chemotactic receptor antagonist,C5AR1,,
walrycin-B,XRVMPTWWKLKLPB-UHFFFAOYSA-N,Preclinical,transcriptional regulatory protein WalR,,,
warfarin,PJVWKTKQMONHTI-HNNXBMFYSA-N,Launched,vitamin K antagonist,VKORC1,hematology|cardiology,deep vein thrombosis (DVT)|pulmonary embolism (PE)|atrial fibrillation (AF)|myocardial infarction
WAY-100635,SBPRIAGPYFYCRT-UHFFFAOYSA-N,Phase 1,serotonin receptor antagonist,HTR1A,,
WAY-161503,PHGWDAICBXUJDU-SNVBAGLBSA-N,Preclinical,serotonin receptor agonist,HTR2C,,
WAY-170523,FARMEEAGJWMFSZ-UHFFFAOYSA-N,Preclinical,metalloproteinase inhibitor,MMP13,,
WAY-200070,BAAILVWEAXFTSF-UHFFFAOYSA-N,Preclinical,estrogen receptor agonist,ERBB2|ERBB3|ERBB4|ESR2,,
WAY-207024,AVEVJMZJJJDOCI-UHFFFAOYSA-N,Preclinical,gonadotropin releasing factor hormone receptor antagonist,GNRHR|HRH2|TACR2,,
WAY-208466,SFSFIDVAEMDPIP-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,DRD2|HTR2A|HTR2C|HTR6|HTR7,,
WAY-213613,BNYDDAAZMBUFRG-ZDUSSCGKSA-N,Preclinical,glutamate inhibitor,SLC1A2,,
WAY-255348,KIOOLNRTWPFVHX-UHFFFAOYSA-N,Preclinical,progesterone receptor antagonist,,,
WAY-316606,ITBGJNVZJBVPLJ-UHFFFAOYSA-N,Preclinical,secreted frizzled related protein inhibitor,SFRP1,,
WAY-362450,INASOKQDNHHMRE-UHFFFAOYSA-N,Phase 1,FXR agonist,NR1H4,,
WAY-600,FPEIJQLXFHKLJV-UHFFFAOYSA-N,Preclinical,mTOR inhibitor,MTOR,,
WAY-629,OIGHTPDWPMLMGT-UHFFFAOYSA-N,Preclinical,serotonin receptor agonist,HTR2C,,
WB-4101,GYSZUJHYXCZAKI-AWEZNQCLSA-N,Preclinical,adrenergic receptor antagonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1A,,
WDR5-0103,ZPLBXOVTSNRBFB-UHFFFAOYSA-N,Preclinical,histone lysine methyltransferase inhibitor,WDR5,,
WEHI-345-analog,ZCZGSEXBXXYQQC-UHFFFAOYSA-N,Preclinical,SRC inhibitor,,,
WH-4-023,NBTNHSGBRGTFJS-UHFFFAOYSA-N,Preclinical,SRC inhibitor,LCK|SRC,,
WHI-P154,CBIAKDAYHRWZCU-UHFFFAOYSA-N,Preclinical,JAK inhibitor,EGFR|JAK1|JAK2|JAK3,,
WIKI4,RNUXIZKXJOGYQP-UHFFFAOYSA-N,Preclinical,tankyrase inhibitor|WNT pathway inhibitor,TNKS2,,
WIN-18446,FAOMZVDZARKPFJ-UHFFFAOYSA-N,Preclinical,aldehyde dehydrogenase inhibitor,ALDH1A2,,
WIN-64338,UKMJWGFHXMGRNG-QLKFWGTOSA-O,Preclinical,bradykinin receptor antagonist,BDKRB2,,
wiskostatin,XUBJEDZHBUPBKL-CYBMUJFWSA-N,Preclinical,actin related protein inhibitor|neural Wiskott-Aldrich syndrome protein inhibitor,WASL,,
wnt-c59,KHZOJCQBHJUJFY-UHFFFAOYSA-N,Preclinical,porcupine inhibitor,PORCN,,
wortmannin,QDLHCMPXEPAAMD-QAIWCSMKSA-N,Preclinical,PI3K inhibitor,PI4KA|PI4KB|PIK3CA|PIK3CD|PIK3CG|PIK3R1|PLK1|PRKDC,,
WP1066,VFUAJMPDXIRPKO-LQELWAHVSA-N,Phase 1,STAT inhibitor,STAT3,,
WP1130,LIDOPKHSVQTSJY-VMEIHUARSA-N,Preclinical,deubiquitinase inhibitor,JAK2|UCHL5|USP14|USP9X,,
WP921,DDVAZOPRCKAYOV-UHFFFAOYSA-N,Preclinical,,,,
WR99210,MJZJYWCQPMNPRM-UHFFFAOYSA-N,Preclinical,dihydrofolate reductase inhibitor,TYMS,infectious disease,malaria
WWL-113,AKIIPHDGVCFVCC-UHFFFAOYSA-N,Preclinical,carboxylesterase inhibitor,CES3,,
WWL-123,UUJGYRHAOHORFC-UHFFFAOYSA-N,Preclinical,monoacylglycerol lipase inhibitor,ABHD6,,
WY-16922,GGLRYZACPLNCKB-UHFFFAOYSA-N,Phase 1,histamine release inhibitor,,,
WYE-125132,QLHHRYZMBGPBJG-OYRHEFFESA-N,Preclinical,mTOR inhibitor,MTOR,,
WYE-354,IMXHGCRIEAKIBU-UHFFFAOYSA-N,Preclinical,mTOR inhibitor,MTOR,,
WYE-687,VDOCQQKGPJENHJ-UHFFFAOYSA-N,Preclinical,mTOR inhibitor,MTOR,,
WZ-3146,APHGZZPEOCCYNO-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR,,
WZ-4002,ITTRLTNMFYIYPA-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR|ERBB2,,
WZ4003,SDGJBAUIGHSMRI-UHFFFAOYSA-N,Preclinical,AMPK inhibitor,NUAK1|NUAK2,,
WZ8040,KIISCIGBPUVZBF-UHFFFAOYSA-N,Preclinical,EGFR inhibitor,EGFR,,
WZ811,KBVFRXIGQQRMEF-UHFFFAOYSA-N,Preclinical,CC chemokine receptor antagonist,CXCR4,,
xaliproden,WJJYZXPHLSLMGE-UHFFFAOYSA-N,Phase 3,serotonin receptor agonist,HTR1A,,
xamoterol,DXPOSRCHIDYWHW-UHFFFAOYSA-N,Phase 3,adrenergic receptor agonist,ADRB1,,
xanomeline,JOLJIIDDOBNFHW-UHFFFAOYSA-N,Phase 3,acetylcholine receptor agonist,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR6|HTR7,,
xanthone,JNELGWHKGNBSMD-UHFFFAOYSA-N,Preclinical,antimalarial agent,,,
XAV-939,KLGQSVMIPOVQAX-UHFFFAOYSA-N,Preclinical,tankyrase inhibitor,TNKS|TNKS2,,
XBD173,NBMBIEOUVBHEBM-UHFFFAOYSA-N,Phase 2,benzodiazepine receptor ligand,TSPO,,
XD-14,DPBKLIVPNYGQQG-UHFFFAOYSA-N,Preclinical,bromodomain inhibitor,BRD2|BRD3|BRD4|BRDT,,
XE-991,KHJFBUUFMUBONL-UHFFFAOYSA-N,Preclinical,potassium channel blocker,KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5,,
xenalipin,IQOMYCGTGFGDFN-UHFFFAOYSA-N,Phase 2,,,,
xibenolol,RKUQLAPSGZJLGP-ZDUSSCGKSA-N,Phase 3,adrenergic receptor antagonist,,,
xilobam,PAXRPWSXCPTPCA-QINSGFPZSA-N,Phase 1,,,,
xipamide,MTZBBNMLMNBNJL-UHFFFAOYSA-N,Launched,carbonic anhydrase inhibitor,SLC12A3,cardiology,edema|hypertension
XL019,ISOCDPQFIXDIMS-QHCPKHFHSA-N,Phase 1,JAK inhibitor,JAK1|JAK2|JAK3,,
XL041,HNAJDMYOTDNOBK-UHFFFAOYSA-N,Preclinical,LXR agonist,,,
XL147,MQMKRQLTIWPEDM-UHFFFAOYSA-N,Phase 2,PI3K inhibitor,PIK3CA|PIK3CD|PIK3CG,,
XL228,ALKJNCZNEOTEMP-UHFFFAOYSA-N,Phase 1,Abl kinase inhibitor|insulin growth factor receptor inhibitor|SRC inhibitor,IGF1R|SRC,,
XL388,LNFBAYSBVQBKFR-UHFFFAOYSA-N,Preclinical,mTOR inhibitor,MTOR,,
XL647,HVXKQKFEHMGHSL-QKDCVEJESA-N,Phase 3,EGFR inhibitor|VEGFR inhibitor,EGFR|EPHB4|ERBB2|FLT4|KDR,,
XL888,LHGWWAFKVCIILM-HLRQEUIKSA-N,Phase 1,HSP inhibitor,,,
XMD17-109,XVBGRTMNFNMINE-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor,MAPK7,,
XMD8-92,QAPAJIZPZGWAND-UHFFFAOYSA-N,Preclinical,MAP kinase inhibitor,DCLK2|MAPK7|PLK4|TNK1,,
xylazine,BPICBUSOMSTKRF-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA2A|ADRA2B|ADRA2C,neurology/psychiatry,anesthetic
xylometazoline,HUCJFAOMUPXHDK-UHFFFAOYSA-N,Launched,adrenergic receptor agonist,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,otolaryngology|allergy,nasal congestion|allergic rhinitis
xylose,PYMYPHUHKUWMLA-VPENINKCSA-N,Launched,,,,
Y-11,SQWGHMPVSMSPNY-UHFFFAOYSA-N,Preclinical,focal adhesion kinase inhibitor,PTK2,,
Y-134,LQEOPHGPHCWOAC-UHFFFAOYSA-N,Preclinical,estrogen receptor antagonist,ESR1|ESR2,,
Y-26763,IWTCFIIOUXJOOV-OLZOCXBDSA-N,Phase 1,potassium channel activator,KCNJ8,,
Y-27152,RHFUXPCCELGMFC-UXHICEINSA-N,Phase 1,potassium channel activator,KCNJ8,,
Y-27632,IYOZTVGMEWJPKR-IJLUTSLNSA-N,Preclinical,rho associated kinase inhibitor,PKIA|PKN2|PRKACA|PRKCE|ROCK1|ROCK2,,
Y-29794,HAGHKJDWBDSFKC-UHFFFAOYSA-N,Preclinical,prolyl endopeptidase inhibitor,PREP,,
Y-320,BWZNJVZTAWBIFG-UHFFFAOYSA-N,Preclinical,interleukin inhibitor,IL17A,,
Y-39983,JTVBXQAYBIJXRP-SNVBAGLBSA-N,Phase 2,rho associated kinase inhibitor,ROCK1|ROCK2,,
Y16,ITMLWGWTDWJSRZ-PXLXIMEGSA-N,Preclinical,rho associated kinase inhibitor,RHOA,,
YC-1,OQQVFCKUDYMWGV-UHFFFAOYSA-N,Preclinical,guanylyl cyclase activator,GUCY1A2|GUCY1A3|GUCY1B3|HIF1A,,
YIL-781,FRKXOBMDEXCHHD-SFHVURJKSA-N,Preclinical,ghrelin receptor antagonist,GHSR,,
YK-4-279,HLXSCTYHLQHQDJ-KRWDZBQOSA-N,Preclinical,apoptosis inhibitor,EWSR1|FLI1,,
YL0919,BGMVOROUOUVVRV-UHFFFAOYSA-N,Preclinical,selective serotonin reuptake inhibitor (SSRI),,,
YM-022,YCXFHPUBGMMWJQ-PMERELPUSA-N,Phase 2,CCK receptor antagonist,CCKBR,,
YM-155,OTSOOHRUMBRSHZ-UHFFFAOYSA-N,Phase 2,survivin inhibitor,BIRC5,,
YM-201636,YBPIBGNBHHGLEB-UHFFFAOYSA-N,Preclinical,PI3K inhibitor,,,
YM-244769,JZMLHJRKSJXARY-UHFFFAOYSA-N,Preclinical,sodium/calcium exchange inhibitor,,,
YM-298198,KCBXOMYXOBVLED-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRM1,,
YM-298198-desmethyl,VWOMTTIMBHBPBI-UHFFFAOYSA-N,Preclinical,glutamate receptor antagonist,GRM1,,
YM-511,GGPPBTSXFROGAE-UHFFFAOYSA-N,Phase 2,aromatase inhibitor,CYP19A1,,
YM-58483,XPRZIORDEVHURQ-UHFFFAOYSA-N,Preclinical,calcium channel blocker,TRPC3|TRPC5|TRPM4,,
YM-750,FMLJREWZCZHGGW-UHFFFAOYSA-N,Phase 1,ACAT inhibitor,SOAT1,,
YM-90709,HIXSPVQXXDULHS-UHFFFAOYSA-N,Preclinical,IL5 inhibitor,CSF2RB|IL5RA,,
YM-976,MNHXYNNKDDXKNP-UHFFFAOYSA-N,Phase 1,phosphodiesterase inhibitor,PDE4A,,
YO-01027,QSHGISMANBKLQL-OWJWWREXSA-N,Preclinical,gamma secretase inhibitor,,,
yoda-1,BQNXBSYSQXSXPT-UHFFFAOYSA-N,Preclinical,piezo channel activator,PIEZO1,,
yohimbine,BLGXFZZNTVWLAY-SCYLSFHTSA-N,Launched,adrenergic receptor antagonist,ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8,cardiology,cardiac arrythmia|bradycardia
YS-035,OXZMQFKVNVQMLI-UHFFFAOYSA-N,Preclinical,calcium channel blocker,,,
YS-201,LBSRZVRITCRLIU-JOCHJYFZSA-N,Preclinical,calcium receptor antagonist,,,
YZ9,IETDBZQIWIJQJG-UHFFFAOYSA-N,Preclinical,phosphofructokinase inhibitor,MIF|PFKFB3,,
Z160,VCPMZDWBEWTGNW-UHFFFAOYSA-N,Phase 2,N-type calcium channel blocker,CACNA2D1,,
zacopride,FEROPKNOYKURCJ-ZDUSSCGKSA-N,Phase 2,serotonin receptor antagonist,HTR3A|HTR3B|HTR4|HTR5A,,
zafirlukast,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Launched,leukotriene receptor antagonist,CYSLTR1|CYSLTR2,pulmonary,asthma
zalcitabine,WREGKURFCTUGRC-POYBYMJQSA-N,Launched,nucleoside reverse transcriptase inhibitor,,infectious disease,human immunodeficiency virus (HIV-1)
zaldaride,HTGCJAAPDHZCHL-SANMLTNESA-N,Phase 3,calmodulin antagonist,CALM1,,
zaltidine,GIMNAEMRNXUAQP-UHFFFAOYSA-N,Phase 3,histamine receptor antagonist,HRH2,,
zaltoprofen,MUXFZBHBYYYLTH-SNVBAGLBSA-N,Launched,cyclooxygenase inhibitor,,endocrinology|neurology/psychiatry,fever|pain relief
ZAMI-633,RSIPQHOWTCNEBI-UHFFFAOYSA-N,Phase 3,urease inhibitor,,,
zamifenacin,BDNFQGRSKSQXRI-XMMPIXPASA-N,Phase 3,acetylcholine receptor antagonist,CHRM3,,
zanamivir,ARAIBEBZBOPLMB-UFGQHTETSA-N,Launched,neuraminidase inhibitor,NEU2,infectious disease,influenza A virus infection
zanubrutinib,RNOAOAWBMHREKO-QFIPXVFZSA-N,Launched,Bruton's tyrosine kinase (BTK) inhibitor,,,
ZAPA,QEYNZJBVNYDZKZ-UPHRSURJSA-N,Preclinical,,,,
zaprinast,REZGGXNDEMKIQB-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,GPR35|PDE1A|PDE4D|PDE5A|PDE9A,,
zardaverine,HJMQDJPMQIHLPB-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,PDE4D,,
zatebradine,KEDQCFRVSHYKLR-UHFFFAOYSA-N,Phase 3,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,,
ZCL-278,XKZDWYDHEBCGCG-UHFFFAOYSA-N,Preclinical,CDC inhibitor,CDC42,,
ZD-0947,RUVMMEREJMHLOS-LBPRGKRZSA-N,Preclinical,potassium channel activator,,,
ZD-2079,SRBPKVWITYPHQR-KRWDZBQOSA-N,Phase 2,adrenergic receptor agonist,ADRB3,,
ZD-7114,RVMBDLSFFNKKLG-SFHVURJKSA-N,Phase 1,adrenergic receptor agonist,ADRB3,,
ZD-7155,BFVNEYDCFJNLGN-UHFFFAOYSA-N,Preclinical,angiotensin receptor antagonist,AGTR1,,
ZD-7288,JABSKGQQWUDVRU-UHFFFAOYSA-N,Phase 2,HCN channel blocker,HCN1|HCN2|HCN3|HCN4,,
zeatin,UZKQTCBAMSWPJD-FARCUNLSSA-N,Phase 1,,,,
zebularine,RPQZTTQVRYEKCR-WCTZXXKLSA-N,Preclinical,DNA methyltransferase inhibitor,CDA|DNMT1,,
zibotentan,FJHHZXWJVIEFGJ-UHFFFAOYSA-N,Phase 3,endothelin receptor antagonist,EDNRA,,
zidovudine,HBOMLICNUCNMMY-XLPZGREQSA-N,Launched,nucleoside reverse transcriptase inhibitor,TERT,infectious disease,human immunodeficiency virus (HIV-1)|acquired immunodeficiency syndrome (AIDS)
zileuton,MWLSOWXNZPKENC-SSDOTTSWSA-N,Launched,leukotriene synthesis inhibitor|lipoxygenase inhibitor,ALOX5,pulmonary,asthma
zilpaterol,ZSTCZWJCLIRCOJ-AAEUAGOBSA-N,Launched,adrenergic receptor agonist,ADRB2,endocrinology,weight-gain aid
zimelidine,OYPPVKRFBIWMSX-SXGWCWSVSA-N,Withdrawn,selective serotonin reuptake inhibitor (SSRI),MAOA|MAOB|SLC6A4,,
zinc-undecylenate,YMCOHQVWOBMDCZ-UHFFFAOYSA-L,Launched,other antifungal,,infectious disease,tinea pedis
zindotrine,YYHWOTFWBVRTQD-UHFFFAOYSA-N,Phase 2,phosphodiesterase inhibitor,,,
ziprasidone,MVWVFYHBGMAFLY-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4,neurology/psychiatry,schizophrenia|bipolar disorder
ziritaxestat,REQQVBGILUTQNN-UHFFFAOYSA-N,Phase 3,autotaxin inhibitor,,,
ZK-164015,LYJSJVYJLZOMCD-UHFFFAOYSA-N,Preclinical,estrogen receptor antagonist,ESR1|ESR2,,
ZK-200775,WZMQMKNCWDCCMT-UHFFFAOYSA-N,Phase 2,kainate receptor antagonist,,,
ZK-811752,XQYASZNUFDVMFH-CQSZACIVSA-N,Phase 2,CC chemokine receptor antagonist,CCR1,,
ZK-93423,ALBKMJDFBZVHAK-UHFFFAOYSA-N,Phase 3,benzodiazepine receptor agonist,GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2,,
ZK-93426,VMDUABMKBUKKPG-UHFFFAOYSA-N,Phase 1,benzodiazepine receptor antagonist,GABRA1|GABRA2|GABRA3|GABRA5,,
ZLN005,LQUNNCQSFFKSSK-UHFFFAOYSA-N,Preclinical,,,,
ZLN024,KWJRSHZSULRJHE-UHFFFAOYSA-N,Preclinical,AMPK activator,PRKAA1|PRKAB1|PRKAG1,,
ZM-226600,LJLXQHHFAKVTNP-OAHLLOKOSA-N,Preclinical,Kir6 channel (KATP) activator,,,
ZM-241385,PWTBZOIUWZOPFT-UHFFFAOYSA-N,Preclinical,adenosine receptor antagonist,ADORA1|ADORA2A|ADORA2B|ADORA3,,
ZM-306416,YHUIUSRCUKUUQA-UHFFFAOYSA-N,Preclinical,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,EGFR|FLT1|FLT4|KDR,,
ZM-323881,NVBNDZZLJRYRPD-UHFFFAOYSA-N,Preclinical,VEGFR inhibitor,KDR,,
ZM-336372,PYEFPDQFAZNXLI-UHFFFAOYSA-N,Preclinical,RAF inhibitor,BRAF|LCK|MAPK14|RAF1,,
ZM-39923,JSASWRWALCMOQP-UHFFFAOYSA-N,Preclinical,JAK inhibitor,JAK1|JAK3,,
ZM-447439,OGNYUTNQZVRGMN-UHFFFAOYSA-N,Preclinical,Aurora kinase inhibitor,AURKA|AURKB,,
zofenopril-calcium,IAIDUHCBNLFXEF-MNEFBYGVSA-N,Launched,angiotensin converting enzyme inhibitor,ACE,cardiology,hypertension
zolantidine,KUBONGDXTUOOLM-UHFFFAOYSA-N,Preclinical,histamine receptor antagonist,,,
zoledronic-acid,XRASPMIURGNCCH-UHFFFAOYSA-N,Launched,bone resorption inhibitor,FDPS|GGPS1,endocrinology,Paget's disease
zoliflodacin,ZSWMIFNWDQEXDT-ZESJGQACSA-N,Phase 3,antibacterial ,,,
zolimidine,VSLIUWLPFRVCDL-UHFFFAOYSA-N,Launched,mucus protecting agent,,gastroenterology,peptic ulcer disease (PUD)|gastroesophageal reflux disease (GERD)
zolmitriptan,ULSDMUVEXKOYBU-ZDUSSCGKSA-N,Launched,serotonin receptor agonist,HTR1A|HTR1B|HTR1D|HTR1E|HTR1F,neurology/psychiatry,migraine headache
zomepirac,ZXVNMYWKKDOREA-UHFFFAOYSA-N,Withdrawn,prostaglandin synthesis inhibitor,PTGDR2,,
zometapine,YCWROMXNZZIJDQ-UHFFFAOYSA-N,Phase 2,,,,
zoniporide,GDXBRVCQGGKXJY-UHFFFAOYSA-N,Phase 3,sodium/hydrogen exchanger inhibitor,SLC9A1,,
zonisamide,UBQNRHZMVUUOMG-UHFFFAOYSA-N,Launched,sodium channel blocker|T-type calcium channel blocker,CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A,neurology/psychiatry,seizures|epilepsy
zopolrestat,BCSVCWVQNOXFGL-UHFFFAOYSA-N,Phase 2,,AKR1B1|AKR1B10,,
zosuquidar,IHOVFYSQUDPMCN-DBEBIPAYSA-N,Phase 3,P glycoprotein inhibitor,ABCB1|ABCB4,,
zotarolimus,CGTADGCBEXYWNE-GYKXXMIGSA-N,Launched,mTOR inhibitor,FKBP1A,cardiology,coronary artery restenosis
zotepine,HDOZVRUNCMBHFH-UHFFFAOYSA-N,Launched,dopamine receptor antagonist|serotonin receptor antagonist,ADRA2B|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR6|HTR7|SLC6A2|SLC6A4,neurology/psychiatry,schizophrenia
zoxazolamine,YGCODSQDUUUKIV-UHFFFAOYSA-N,Phase 2,myorelaxant,,,
ZSET1446,QZWYXEBIQWJXAR-UHFFFAOYSA-N,Preclinical,nicotinic receptor agonist,,,
ZSTK-474,HGVNLRPZOWWDKD-UHFFFAOYSA-N,Phase 1/Phase 2,PI3K inhibitor,PIK3CB|PIK3CD|PIK3CG,,
zuclopenthixol,WFPIAZLQTJBIFN-DVZOWYKESA-N,Launched,dopamine receptor antagonist,ADRA1A|ADRA2A|DRD1|DRD2|DRD5|HRH1|HTR2A,neurology/psychiatry,schizophrenia|bipolar disorder
zuranolone,HARRKNSQXBRBGZ-GVKWWOCJSA-N,Phase 3,GABA receptor agonist,,,
